Citrus Sinensis ID: 037755
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 238 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.991 | 0.292 | 0.508 | 2e-63 | |
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.991 | 0.264 | 0.492 | 5e-62 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.983 | 0.287 | 0.466 | 2e-59 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.924 | 0.252 | 0.463 | 5e-52 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.970 | 0.278 | 0.428 | 1e-50 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.941 | 0.272 | 0.465 | 5e-50 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.974 | 0.279 | 0.427 | 5e-49 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.962 | 0.287 | 0.439 | 5e-47 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.936 | 0.255 | 0.393 | 8e-44 | |
| Q9SYS7 | 659 | Putative cysteine-rich re | no | no | 0.928 | 0.335 | 0.409 | 6e-41 |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 241 bits (616), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 123/242 (50%), Positives = 161/242 (66%), Gaps = 6/242 (2%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L++ K SAE+FINEV+++ + HVN+V LLGFC EGSKRA+VYEF+ NGSLD+ + +
Sbjct: 527 VLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNK 586
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S Q + L+ +A G A G+EYLH GC I+H DIKP NILLD N P VSDFGLAK
Sbjct: 587 SLTQDVT--TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAK 644
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
K +S+ TRGTIGYIAPE+ SR +G VS KSDVY FGM++++M G R ++
Sbjct: 645 LCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVET 704
Query: 181 TRS--SKAYFPSWVSDQLNKGGNLEL--RNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
S S YFP W+ L G + +T+ E IA+K+ V+GLWCIQ P+DRPSM
Sbjct: 705 VDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSM 764
Query: 237 TK 238
+
Sbjct: 765 NR 766
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 237 bits (605), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 124/252 (49%), Positives = 165/252 (65%), Gaps = 16/252 (6%)
Query: 1 MLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK 59
+L++SK + E+FINEV+++ + HVN+V LLGFC EGS+RA++YEF+ NGSLD+ I K
Sbjct: 585 VLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDK 644
Query: 60 ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
S + + L+ +A G A G+EYLH GC I+H DIKP N+LLD N P VSDFGLA
Sbjct: 645 SS--VNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLA 702
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL- 178
K K+ +S+ TRGTIGYIAPE+ISR +G+VS KSDVY +GM++LEM G R+
Sbjct: 703 KLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFD 762
Query: 179 KATRS--SKAYFPSWVSDQLNKG----------GNLELRNVTEIESMIARKLCVIGLWCI 226
+ +RS S YFP W+ L K G L ++ E IARK+ ++GLWCI
Sbjct: 763 QNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCI 822
Query: 227 QVKPADRPSMTK 238
Q P+DRP M K
Sbjct: 823 QSSPSDRPPMNK 834
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (582), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 113/242 (46%), Positives = 157/242 (64%), Gaps = 8/242 (3%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L++ K + ++FINEV+++ + HVN+V LLGFC EGSKRA++ EF+ +GSLD+ I
Sbjct: 525 VLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI---- 580
Query: 61 SRGQSCS--WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
SR +S + L+ +A G A G+EYLH GC I+H DIKP NILLD NF P V+DFGL
Sbjct: 581 SRNKSLTPNVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGL 640
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL 178
AK K +S+ TRGTIGYIAPE++SR +G +S KSDVY +GM++L+M G R
Sbjct: 641 AKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVET 700
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLEL--RNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
S AYFP W+ L G + + E ++ I +K+ ++ LWCI+ P+DRP M
Sbjct: 701 TTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPM 760
Query: 237 TK 238
K
Sbjct: 761 NK 762
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 107/231 (46%), Positives = 144/231 (62%), Gaps = 11/231 (4%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
EFI EV+TIG +HH+N+V+L G+CSE S R LVYE+M NGSLD+ IF E W
Sbjct: 570 EFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRT 629
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
E+A TA GI Y H C I+H DIKP NILLD NF P VSDFGLAK +E+ V
Sbjct: 630 RFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV- 688
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPS 190
++ RGT GY+APE +S ++ K+DVY +GM+LLE+ GGRRN ++ + + ++P
Sbjct: 689 VTMIRGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDM-SYDAEDFFYPG 745
Query: 191 WVSDQLNKGGNLE-----LRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
W +L G +L+ L+ V E E ++ K + WCIQ + + RPSM
Sbjct: 746 WAYKELTNGTSLKAVDKRLQGVAEEEEVV--KALKVAFWCIQDEVSMRPSM 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (506), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 105/245 (42%), Positives = 150/245 (61%), Gaps = 14/245 (5%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE ++F EV TIG I HVN+V+L GFCSEGSK+ LVY++MPNGSLD H+F +
Sbjct: 523 LEGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQV 582
Query: 62 RGQ-SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ W+ ++A GTA G+ YLH+ C CI+H DIKP NILLD F P V+DFGLAK
Sbjct: 583 EEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAK 642
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
++ V ++ RGT GY+APE IS ++ K+DVY +GM+L E+ GRRN+ ++
Sbjct: 643 LVGRDFSRV-LTTMRGTRGYLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTE-QS 698
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELR-------NVTEIESMIARKLCVIGLWCIQVKPADR 233
+FPSW + L K G++ + +IE + + C + WCIQ + + R
Sbjct: 699 ENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVT--RACKVACWCIQDEESHR 756
Query: 234 PSMTK 238
P+M++
Sbjct: 757 PAMSQ 761
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 5e-50, Method: Compositional matrix adjust.
Identities = 109/234 (46%), Positives = 146/234 (62%), Gaps = 10/234 (4%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+EF EVS IG IHH+++V+L GFC+EG+ R L YEF+ GSL+R IF K+ W+
Sbjct: 531 KEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWD 590
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
+A GTA G+ YLH CD I+H DIKP NILLD NF VSDFGLAK +E V
Sbjct: 591 TRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHV 650
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFP 189
+ RGT GY+APE I+ N+ +S KSDVY +GMVLLE+ GGR+N + T S K +FP
Sbjct: 651 -FTTMRGTRGYLAPEWIT-NYA-ISEKSDVYSYGMVLLELIGGRKNYDPSET-SEKCHFP 706
Query: 190 SWVSDQLNKGGNLE-----LRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
S+ ++ +G ++ ++NV + + R + LWCIQ RPSM+K
Sbjct: 707 SFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAM-KTALWCIQEDMQTRPSMSK 759
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 104/243 (42%), Positives = 149/243 (61%), Gaps = 11/243 (4%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE + ++F EV+TI HH+N+V+L+GFCS+G R LVYEFM NGSLD +F +S
Sbjct: 514 LEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDS 573
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK- 120
+ +WE +A GTA GI YLH C CI+H DIKP NIL+D NF VSDFGLAK
Sbjct: 574 -AKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKL 632
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+PK+N + ++S+ RGT GY+APE ++ ++ KSDVY +GMVLLE+ G+RN ++ +
Sbjct: 633 LNPKDNRY-NMSSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDV-S 688
Query: 181 TRSSKAYFPSWVSDQLNKGG-----NLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
+++ F W ++ KG + L ++ ++ WCIQ +P RP+
Sbjct: 689 EKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPT 748
Query: 236 MTK 238
M K
Sbjct: 749 MGK 751
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (476), Expect = 5e-47, Method: Compositional matrix adjust.
Identities = 108/246 (43%), Positives = 141/246 (57%), Gaps = 17/246 (6%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE EF EV TIG I HVN+V+L GFCSE R LVY++MP GSL ++ +
Sbjct: 492 LERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL--SRT 549
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
+ SWE +A GTA GI YLH GC CI+H DIKP NILLD ++ VSDFGLAK
Sbjct: 550 SPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKL 609
Query: 122 HPKENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL-- 178
+ DF + AT RGT GY+APE IS ++ K+DVY FGM LLE+ GGRRN +
Sbjct: 610 LGR--DFSRVLATMRGTWGYVAPEWISGL--PITTKADVYSFGMTLLELIGGRRNVIVNS 665
Query: 179 -----KATRSSKAYFPSWVSDQLNKG---GNLELRNVTEIESMIARKLCVIGLWCIQVKP 230
K T K +FP W + ++ +G ++ R E + ++ + +WCIQ
Sbjct: 666 DTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNE 725
Query: 231 ADRPSM 236
RP+M
Sbjct: 726 EIRPAM 731
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 8e-44, Method: Compositional matrix adjust.
Identities = 98/249 (39%), Positives = 142/249 (57%), Gaps = 26/249 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+EF E++ IG I H N+V+L GFC+ G + LVYE+M +GSL++ +F G W+
Sbjct: 554 QEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF--SGNGPVLEWQ 611
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
+ ++A GTA G+ YLH+GCD I+H D+KP NILL +F P +SDFGL+K +E +
Sbjct: 612 ERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL 671
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA--- 186
+ RGT GY+APE I+ +S K+DVY +GMVLLE+ GR+N + ++ +S
Sbjct: 672 -FTTMRGTRGYLAPEWITN--AAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDN 728
Query: 187 ---------------YFPSWVSDQLNKGGNLEL---RNVTEIESMIARKLCVIGLWCIQV 228
YFP + D +G +EL R + S A KL I L C+
Sbjct: 729 NQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHE 788
Query: 229 KPADRPSMT 237
+PA RP+M
Sbjct: 789 EPALRPTMA 797
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYS7|CRK39_ARATH Putative cysteine-rich receptor-like protein kinase 39 OS=Arabidopsis thaliana GN=CRK39 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (423), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 93/227 (40%), Positives = 127/227 (55%), Gaps = 6/227 (2%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
EF NEVS + R+ H N+V+LLGFC+EG ++ LVYEF+PN SLD IF E R +WE
Sbjct: 393 EFKNEVSLLTRLQHRNLVKLLGFCNEGDEQILVYEFVPNSSLDHFIFDDEKRSL-LTWEM 451
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
+ + G A G+ YLH + I+H D+K NILLD P V+DFG A+ +
Sbjct: 452 RYRIIEGIARGLLYLHEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAE 511
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPS 190
GT GY+APE + N G +S KSDVY FG++LLEM G RN++ + + +
Sbjct: 512 TKRIAGTRGYMAPEYL--NHGQISAKSDVYSFGVMLLEMISGERNNSFEGEGLAAFAWKR 569
Query: 191 WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
WV + + L E + KL IGL C+Q P RP+M+
Sbjct: 570 WVEGKPEIIIDPFLIEKPRNEII---KLIQIGLLCVQENPTKRPTMS 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 238 | ||||||
| 224101781 | 348 | predicted protein [Populus trichocarpa] | 1.0 | 0.683 | 0.701 | 1e-96 | |
| 255570697 | 631 | kinase, putative [Ricinus communis] gi|2 | 1.0 | 0.377 | 0.672 | 1e-93 | |
| 224108395 | 348 | predicted protein [Populus trichocarpa] | 1.0 | 0.683 | 0.672 | 7e-92 | |
| 225455116 | 608 | PREDICTED: probable receptor-like protei | 1.0 | 0.391 | 0.617 | 1e-87 | |
| 225455537 | 598 | PREDICTED: probable receptor-like protei | 0.987 | 0.392 | 0.612 | 1e-86 | |
| 359490247 | 658 | PREDICTED: probable receptor-like protei | 1.0 | 0.361 | 0.609 | 4e-85 | |
| 359495102 | 603 | PREDICTED: probable receptor-like protei | 1.0 | 0.394 | 0.615 | 7e-85 | |
| 357135051 | 680 | PREDICTED: probable receptor-like protei | 0.983 | 0.344 | 0.640 | 7e-85 | |
| 414876616 | 668 | TPA: putative protein kinase superfamily | 0.970 | 0.345 | 0.630 | 2e-84 | |
| 359490249 | 625 | PREDICTED: probable receptor-like protei | 0.983 | 0.374 | 0.594 | 7e-84 |
| >gi|224101781|ref|XP_002312418.1| predicted protein [Populus trichocarpa] gi|222852238|gb|EEE89785.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 358 bits (919), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 167/238 (70%), Positives = 194/238 (81%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
ML N+K + E+FINEVS IGRIHHVN+V+L+GFCSEGS RALV+E+M NGSLD+ +F +E
Sbjct: 64 MLGNAKCNDEDFINEVSIIGRIHHVNIVRLVGFCSEGSYRALVFEYMANGSLDKLLFSRE 123
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ SWEKL ++A GTA GIE+LH GC VCILHLDIKPHN+LLD NF+P VSDFGLAK
Sbjct: 124 TELLLVSWEKLLQIAVGTARGIEHLHGGCSVCILHLDIKPHNVLLDSNFIPKVSDFGLAK 183
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
F+P E DFVSIS TRGTIGY APE+ISRN G VSCKSDVY FGM+LLEM G RR SN K
Sbjct: 184 FYPSEKDFVSISTTRGTIGYFAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRKSNSKG 243
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
SS YFPSWV D L++GG+LEL NVTEIE+ IARKLC+ GLWCIQ +DRP+MTK
Sbjct: 244 NCSSDVYFPSWVYDHLSEGGDLELENVTEIEAAIARKLCIAGLWCIQKAASDRPTMTK 301
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570697|ref|XP_002526303.1| kinase, putative [Ricinus communis] gi|223534384|gb|EEF36092.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 348 bits (893), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 160/238 (67%), Positives = 194/238 (81%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
ML +SKFS ++FI+EVSTIG+IHH NVVQL+GFCSEGS AL++E++ GSLD+HIF +E
Sbjct: 346 MLGDSKFSDKDFIDEVSTIGKIHHANVVQLVGFCSEGSYHALLFEYIARGSLDKHIFSRE 405
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ Q SWEK ++A GTA GIE+LH GCDVCILH DIKPHN+LL HNF+P VSDFGLAK
Sbjct: 406 AEFQPFSWEKRLQIAIGTARGIEHLHVGCDVCILHFDIKPHNVLLHHNFIPKVSDFGLAK 465
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
F+PKENDFVS+S RGTIGYIAPELIS+N G+VSCKSDVY +G++LLEM GGRRN N
Sbjct: 466 FYPKENDFVSVSTARGTIGYIAPELISKNLGSVSCKSDVYSYGILLLEMVGGRRNINPNG 525
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
S K +F SWV D LN+GG+LEL +V E E+ IA+KLC++GLWCI +DRPSMTK
Sbjct: 526 NSSGKVHFASWVYDHLNEGGDLELESVNEAEAAIAKKLCIVGLWCINKNSSDRPSMTK 583
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108395|ref|XP_002314832.1| predicted protein [Populus trichocarpa] gi|222863872|gb|EEF01003.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 342 bits (877), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 160/238 (67%), Positives = 191/238 (80%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
ML+N K + E+FINEVS IGRIH VN+V L+GFCSEG RALV+E+M NGSLD+ +F +E
Sbjct: 64 MLDNPKCNDEDFINEVSIIGRIHQVNIVWLMGFCSEGCHRALVFEYMANGSLDKLLFSRE 123
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ WEKL ++A GTA GIE+LH GC+VCILH DIKP N+LLD+NF+P VSDFGL+K
Sbjct: 124 AERHLVGWEKLLQIALGTARGIEHLHGGCNVCILHSDIKPQNVLLDNNFIPKVSDFGLSK 183
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
F+P+E DFVSIS TRGTIGYIAPE+ISRN G VSCKSDVY FGM+LLEM G RRNSN K
Sbjct: 184 FYPEEKDFVSISTTRGTIGYIAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRNSNSKG 243
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
SS+ YFPSWV D L + +L+L NVTEIE+ I RKLC++GLWCIQ +DRPSMTK
Sbjct: 244 NCSSEVYFPSWVYDHLIERADLQLENVTEIEAGIPRKLCLVGLWCIQKAASDRPSMTK 301
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455116|ref|XP_002268775.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 328 bits (841), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 147/238 (61%), Positives = 191/238 (80%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
++ NSK + ++FINEV+TIG+IHHVNVVQLLGFC EGSKRALVY+FMPNGSLD++IFP++
Sbjct: 327 LMTNSKSNGQDFINEVATIGKIHHVNVVQLLGFCVEGSKRALVYDFMPNGSLDKYIFPEK 386
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S S+EK+++++ G AHGIEYLH GCD+ ILH DIKPHNILLD NF P VSDFGLAK
Sbjct: 387 EGNISLSFEKMYQISLGVAHGIEYLHRGCDMQILHFDIKPHNILLDKNFTPKVSDFGLAK 446
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+P ++ VS++A RGT+GY+APEL +N G VS K+DVY FGM+L+EM G R+N N+ A
Sbjct: 447 SYPVDHSIVSLTAARGTMGYMAPELFYKNIGGVSYKADVYSFGMLLMEMAGRRKNLNVFA 506
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
SS+ YFPSW DQ N+G N+E+ + TE E +A+K+ ++ LWCIQ+KP+DRPSM K
Sbjct: 507 EHSSQIYFPSWAYDQFNEGKNIEMGDATEEERTLAKKMVIVALWCIQLKPSDRPSMQK 564
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455537|ref|XP_002267723.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 325 bits (833), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 144/235 (61%), Positives = 192/235 (81%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
NSK + ++FINEV+TIGRIHHVNVVQL+GFC++GSKRALV++FMPNGSLD++IFP+
Sbjct: 334 NSKANGQDFINEVATIGRIHHVNVVQLIGFCAKGSKRALVFDFMPNGSLDKYIFPRTEAN 393
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
S ++EK++E++ G AHGIEYLH GCD+ ILH DIKPHNILLD NF P VSDFGLAK +P
Sbjct: 394 ISLNFEKMYEISLGVAHGIEYLHRGCDMQILHFDIKPHNILLDKNFSPKVSDFGLAKLYP 453
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183
++ VS++A RGT+GY+APEL+ +N G VS K+DVY FGM+L+EM G R+N N+ A S
Sbjct: 454 TDHSIVSVTAARGTMGYMAPELVYKNIGGVSYKADVYSFGMLLMEMAGRRKNLNVFAEHS 513
Query: 184 SKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
S+ YFPSWV DQ ++G ++E+ + TE E +A+K+ ++ LWCIQ+KP+DRPSM+K
Sbjct: 514 SQMYFPSWVYDQFSEGKDIEMGDATEEEQKLAKKMIIVALWCIQLKPSDRPSMSK 568
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359490247|ref|XP_002268038.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 320 bits (819), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 145/238 (60%), Positives = 188/238 (78%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
M+ +SK + ++FINEV+TIGRIHHVNVVQL+GFC EGSKR L+Y+FMPNGSLD++IFP++
Sbjct: 306 MMASSKANGQDFINEVATIGRIHHVNVVQLIGFCVEGSKRVLLYDFMPNGSLDKYIFPEK 365
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S S EK++E++ G AHGIEYLH GCD ILH DIKPHNILLD NF P VSDFGLAK
Sbjct: 366 EGNISLSLEKMYEISLGVAHGIEYLHRGCDTQILHFDIKPHNILLDKNFTPKVSDFGLAK 425
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+P ++ VS++A RGT+GY+APEL +N G VS K+DVY FGM+L+EM G R+N N+ A
Sbjct: 426 SYPIDHSIVSLTAARGTMGYMAPELFYKNIGGVSYKADVYSFGMLLMEMAGRRKNLNVFA 485
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
SS+ YFPSWV DQ +KG ++E+ + TE +++KL ++ LWCIQ+KP+DRPSM K
Sbjct: 486 EHSSQIYFPSWVYDQFSKGKDIEMEDATEEGKKLSKKLIIVALWCIQLKPSDRPSMNK 543
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495102|ref|XP_002263106.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 319 bits (817), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 147/239 (61%), Positives = 188/239 (78%), Gaps = 1/239 (0%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP-K 59
M+ NSK + ++FINEV+TIGRIHHVNVVQL+GFC+EGSKRALVY+FMPNGSLD++IFP K
Sbjct: 321 MMANSKANGQDFINEVATIGRIHHVNVVQLIGFCAEGSKRALVYDFMPNGSLDKYIFPEK 380
Query: 60 ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
E S EK++E++ G A+GIEYLH GCD ILH DIKPHNILLD NF P VSDFGLA
Sbjct: 381 EGNISLLSLEKMYEISLGVAYGIEYLHRGCDTQILHFDIKPHNILLDKNFTPKVSDFGLA 440
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLK 179
K +P ++ VS++A RGT GY+APEL +N G VS K+DVY FGM+L+EM G R+N N+
Sbjct: 441 KSYPTDHSIVSLTAARGTRGYMAPELFYKNIGGVSYKADVYSFGMLLMEMAGRRKNLNVF 500
Query: 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
A SS+ YFPSWV +Q N+G ++E+ + TE +++KL ++ LWCIQ+KP+DRPSM K
Sbjct: 501 AEHSSQIYFPSWVYEQFNEGKDIEMEDATEEGKELSKKLIIVALWCIQLKPSDRPSMNK 559
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357135051|ref|XP_003569125.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 319 bits (817), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 153/239 (64%), Positives = 191/239 (79%), Gaps = 5/239 (2%)
Query: 1 MLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK 59
MLE NS + E+FI+EVSTIGRIHHVNVV+L+GFCSE KRALVYE+MP+GSLD++IF
Sbjct: 398 MLEGNSSCNGEDFISEVSTIGRIHHVNVVRLVGFCSEEMKRALVYEYMPHGSLDKYIFSA 457
Query: 60 ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
E +S SW+KL+E+A G A GI YLH GCD+ ILH DIKPHNILLD NFVP V+DFGLA
Sbjct: 458 E---KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDSNFVPKVADFGLA 514
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLK 179
K +P++N FV +SA RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEM GGRRN++
Sbjct: 515 KLYPRDNSFVPLSALRGTIGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNADPN 574
Query: 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
A RSS+AY+PSWV DQL + E+ ++ + +KLCV+GLWCIQ+K DRP+M++
Sbjct: 575 AARSSQAYYPSWVYDQLTQQEAGEISPAADMHEL-EKKLCVVGLWCIQMKSHDRPTMSE 632
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|414876616|tpg|DAA53747.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 317 bits (812), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 152/241 (63%), Positives = 186/241 (77%), Gaps = 10/241 (4%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
ML NS + +EFI+EVSTIG IHHVNVV+L+GFCSE +KRAL+YE+MP GSLD+HIF E
Sbjct: 392 MLSNSLCNGDEFISEVSTIGSIHHVNVVRLVGFCSEETKRALIYEYMPRGSLDKHIFSSE 451
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
QS SW+KL+ +A G A GI YLH GC++ ILH DIKPHNILLD++F P V+DFGLAK
Sbjct: 452 ---QSFSWDKLNGIALGIARGINYLHQGCEMQILHFDIKPHNILLDNSFTPKVADFGLAK 508
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+P++N FV +SA RGTIGYIAPE+ISRNFG VSCKSDVY FGM+LLEM GGRRN + A
Sbjct: 509 LYPRDNSFVPVSAARGTIGYIAPEMISRNFGVVSCKSDVYSFGMLLLEMAGGRRNLDQHA 568
Query: 181 TRSSKAYFPSWVSDQLNK---GGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
R S+ Y+P+WV L + G E +V E+E RKLCV+GLWCIQ+KP DRP+M
Sbjct: 569 ERRSQTYYPAWVYSHLTRQEVGEICEAFDVHEVE----RKLCVVGLWCIQMKPHDRPTMA 624
Query: 238 K 238
+
Sbjct: 625 E 625
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359490249|ref|XP_002267821.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 315 bits (808), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 139/234 (59%), Positives = 186/234 (79%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQ 64
SK + ++FINEV+TIGRIHHVNVVQL+GFC+E SKRALVY+FMPNGSLD++IFP++
Sbjct: 348 SKANGQDFINEVATIGRIHHVNVVQLIGFCAEESKRALVYDFMPNGSLDKYIFPQQEDRI 407
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
S S+ K++E++ G AHGIEYLH GCD+ ILH DIKPHNILLD NF P +SDFGLAK +P
Sbjct: 408 SLSYRKMYEISLGVAHGIEYLHRGCDIQILHFDIKPHNILLDQNFTPKISDFGLAKSYPT 467
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSS 184
+++ VS++A RGT+GY+APEL +N G VS K+DVY +GM+L+EM R+N N+ A S
Sbjct: 468 DHNTVSLTAARGTMGYMAPELFYKNIGGVSYKADVYSYGMLLMEMASRRKNLNVFAESLS 527
Query: 185 KAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
+ YFP+WV DQL +G ++E+ + +E E +A+K+ + LWCIQ+KP+DRPSM K
Sbjct: 528 QIYFPTWVYDQLTEGKDIEMEDTSEEEQKLAKKMITVALWCIQLKPSDRPSMNK 581
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 238 | ||||||
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.991 | 0.354 | 0.495 | 1.5e-60 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.991 | 0.276 | 0.483 | 3.1e-60 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.987 | 0.352 | 0.493 | 3.9e-60 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.987 | 0.348 | 0.504 | 2.2e-59 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.991 | 0.292 | 0.508 | 5.7e-59 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.966 | 0.391 | 0.516 | 7.3e-59 | |
| TAIR|locus:2176707 | 579 | AT5G38250 [Arabidopsis thalian | 0.966 | 0.397 | 0.491 | 3.2e-58 | |
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.987 | 0.263 | 0.494 | 7.7e-58 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.991 | 0.295 | 0.473 | 1.4e-57 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.991 | 0.369 | 0.475 | 1.2e-56 |
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
Identities = 120/242 (49%), Positives = 162/242 (66%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L+ S+ + EEFINEV+++ R HVN+V LLGFC E +KRA++YEFMPNGSLD++I
Sbjct: 361 ILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANM 420
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S WE+L++VA G + G+EYLHN C I+H DIKP NIL+D N P +SDFGLAK
Sbjct: 421 ST--KMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAK 478
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+ +S+ RGT GYIAPE+ S+NFG VS KSDVY +GMV+LEM G + ++
Sbjct: 479 LCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEY 538
Query: 181 TRSSKA--YFPSWVSDQLNKGGNLEL--RNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ S+ YFP WV KG + ++T+ E IA+KL ++ LWCIQ+ P+DRP M
Sbjct: 539 SGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPM 598
Query: 237 TK 238
K
Sbjct: 599 IK 600
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
Identities = 118/244 (48%), Positives = 159/244 (65%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L+ SK + EEFINE+ ++ R HVN+V L GFC EGS+RA++YEFMPNGSLD+ I E
Sbjct: 550 ILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFI--SE 607
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ W+ L+ +A G A G+EYLHN C I+H DIKP NIL+D + P +SDFGLAK
Sbjct: 608 NMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAK 667
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLK- 179
K+ +S+ RGT+GYIAPE+ S+N+G VS KSDVY +GMV+LEM G + ++
Sbjct: 668 LCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVET 727
Query: 180 -ATRSSKAYFPSWVSDQLNKGGNLELRN----VTEIESMIARKLCVIGLWCIQVKPADRP 234
AT S YFP WV + L + + L E E I +++ ++GLWCIQ P+DRP
Sbjct: 728 SATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRP 787
Query: 235 SMTK 238
M K
Sbjct: 788 PMRK 791
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
Identities = 120/243 (49%), Positives = 168/243 (69%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L+ S+ + E+FINEV+++ + HVN+V LLGFCSEG KRA++YEFM NGSLD+ I K+
Sbjct: 377 VLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKK 436
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S + W +L+ +A G A G+EYLH+GC I+H DIKP N+LLD N P VSDFGLAK
Sbjct: 437 S--STMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAK 494
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
++ +S+ TRGTIGYIAPE+ SR +G VS KSDVY +GM++L++ G R ++ +
Sbjct: 495 LCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTED 554
Query: 181 TRSSKA--YFPSWVSDQLNK---GGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
T SS + YFP W+ L K G ++E ++ E IA+K+ ++GLWCIQ P DRP+
Sbjct: 555 TTSSTSSMYFPEWIYRDLEKAHNGKSIETA-ISNEEDEIAKKMTLVGLWCIQPWPLDRPA 613
Query: 236 MTK 238
M +
Sbjct: 614 MNR 616
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
Identities = 124/246 (50%), Positives = 163/246 (66%)
Query: 1 MLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK 59
+L+ SK + +E+FINEVS++ + HVN+V LLGFCSEGS+RA++YEF+ NGSLD+ I K
Sbjct: 375 VLKESKGNNSEDFINEVSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEK 434
Query: 60 ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
S L+ +A G A G+EYLH GC I+H DIKP N+LLD N P VSDFGLA
Sbjct: 435 TS--VILDLTALYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLA 492
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL- 178
K K+ +S+ TRGTIGYIAPE+ISR +G+VS KSDVY +GM++ EM G R+
Sbjct: 493 KLCEKKESVMSLMDTRGTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFG 552
Query: 179 -KATRSSKAYFPSWVSDQLNKGGNLELRNVTEI-----ESMIARKLCVIGLWCIQVKPAD 232
+ S YFP W+ L K N +L ++ EI E IA+K+ ++GLWCIQ P+D
Sbjct: 553 QNSANGSSMYFPEWIYKDLEKADNGDLEHI-EIGISSEEEEIAKKMTLVGLWCIQSSPSD 611
Query: 233 RPSMTK 238
RP M K
Sbjct: 612 RPPMNK 617
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 5.7e-59, P = 5.7e-59
Identities = 123/242 (50%), Positives = 161/242 (66%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L++ K SAE+FINEV+++ + HVN+V LLGFC EGSKRA+VYEF+ NGSLD+ + +
Sbjct: 527 VLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNK 586
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S Q + L+ +A G A G+EYLH GC I+H DIKP NILLD N P VSDFGLAK
Sbjct: 587 SLTQDVT--TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAK 644
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
K +S+ TRGTIGYIAPE+ SR +G VS KSDVY FGM++++M G R ++
Sbjct: 645 LCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVET 704
Query: 181 TRS--SKAYFPSWVSDQLNKGGNLEL--RNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
S S YFP W+ L G + +T+ E IA+K+ V+GLWCIQ P+DRPSM
Sbjct: 705 VDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSM 764
Query: 237 TK 238
+
Sbjct: 765 NR 766
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
Identities = 125/242 (51%), Positives = 161/242 (66%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L++S + E+FINEV++I + HVN+V LLGFC E SKRA+VYEF+ NGSLD +
Sbjct: 310 ILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEKSKRAIVYEFLENGSLD------Q 363
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S S L+ +A G A GIEYLH GC I+H DIKP N+LLD N P V+DFGLAK
Sbjct: 364 SSNLDVS--TLYGIALGVARGIEYLHFGCKKRIVHFDIKPQNVLLDENLKPKVADFGLAK 421
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
K+ +S+ TRGTIGYIAPEL SR +G VS KSDVY +GM++LEMTG R ++
Sbjct: 422 LCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSHKSDVYSYGMLVLEMTGARNKERVQN 481
Query: 181 TRS--SKAYFPSWVSDQLNKGGNLELR--NVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
S S AYFP W+ L G ++L +T E IA+K+ ++GLWCIQ +P+DRPSM
Sbjct: 482 ADSNNSSAYFPDWIFKDLENGDYVKLLADGLTREEEDIAKKMILVGLWCIQFRPSDRPSM 541
Query: 237 TK 238
K
Sbjct: 542 NK 543
|
|
| TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
Identities = 119/242 (49%), Positives = 160/242 (66%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L++SK + E+FINEV+++ + HVN+V LLGFC EGSKRA++YEF+ NGSLD+ +
Sbjct: 302 VLKDSKGNCEDFINEVASMSQTSHVNIVTLLGFCYEGSKRAIIYEFLENGSLDQSL---- 357
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ L+ +A G A G+EYLH GC I+H DIKP N+LLD N P V+DFGLAK
Sbjct: 358 ----NLDVSTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDENLRPKVADFGLAK 413
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
K+ +S+ TRGTIGYIAPEL SR +G+VS KSDVY +GM++LEM G R ++
Sbjct: 414 LCEKQESILSLLDTRGTIGYIAPELFSRMYGSVSHKSDVYSYGMLVLEMIGARNKERVQN 473
Query: 181 T--RSSKAYFPSWVSDQLNKGGNLELRN--VTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+S AYFP W+ L N L +T E A+K+ ++GLWCIQ +P+DRPSM
Sbjct: 474 ADPNNSSAYFPDWIYKDLENFDNTRLLGDGLTREEEKNAKKMILVGLWCIQFRPSDRPSM 533
Query: 237 TK 238
K
Sbjct: 534 NK 535
|
|
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 7.7e-58, P = 7.7e-58
Identities = 125/253 (49%), Positives = 167/253 (66%)
Query: 1 MLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK 59
+L++SK + E+FINEV+++ + HVN+V LLGFC EGS+RA++YEF+ NGSLD+ I K
Sbjct: 585 VLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDK 644
Query: 60 ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
S + + L+ +A G A G+EYLH GC I+H DIKP N+LLD N P VSDFGLA
Sbjct: 645 SS--VNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLA 702
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL- 178
K K+ +S+ TRGTIGYIAPE+ISR +G+VS KSDVY +GM++LEM G R+
Sbjct: 703 KLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFD 762
Query: 179 KATRS--SKAYFPSWVSDQLNK-----------GGNLELRNVTEIESMIARKLCVIGLWC 225
+ +RS S YFP W+ L K GG +E ++ E IARK+ ++GLWC
Sbjct: 763 QNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIE-NGISSEEEEIARKMTLVGLWC 821
Query: 226 IQVKPADRPSMTK 238
IQ P+DRP M K
Sbjct: 822 IQSSPSDRPPMNK 834
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.4e-57, P = 1.4e-57
Identities = 115/243 (47%), Positives = 154/243 (63%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L+ S E+FINE++++ R H N+V LLGFC EG K+A++YE MPNGSLD+ I +
Sbjct: 489 ILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFI--SK 546
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ W+ L+ +A G +HG+EYLH+ C I+H DIKP NIL+D + P +SDFGLAK
Sbjct: 547 NMSAKMEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAK 606
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+S+ RGTIGYIAPE+ S+NFG VS KSDVY +GMV+LEM G R +
Sbjct: 607 LCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQN 666
Query: 181 TRSSKA--YFPSWVSDQLNKGGNLELR--NVTEIES-MIARKLCVIGLWCIQVKPADRPS 235
SS YFP W+ L KG + +TE E I +K+ ++GLWCIQ P DRP
Sbjct: 667 AGSSNTSMYFPDWIYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPP 726
Query: 236 MTK 238
M+K
Sbjct: 727 MSK 729
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 1.2e-56, P = 1.2e-56
Identities = 115/242 (47%), Positives = 157/242 (64%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L++ K + E+FINEV+++ + HVN+V LLGFC EGSKRA+VYEF+ NGSLD+ + K+
Sbjct: 350 ILKDFKSNGEDFINEVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKK 409
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S S L+ +A G A G++YLH+GC I+H DIKP NILLD F P VSDFGLAK
Sbjct: 410 SLNLDVS--TLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAK 467
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNS--NL 178
K +S+ RGTIGYIAPE+ S +G VS KSDVY +GM++LEM G +
Sbjct: 468 LCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEET 527
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLEL--RNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
A+ SS AYFP W+ L G + ++ + +A+K+ ++GLWCIQ P +RP M
Sbjct: 528 AASNSSSAYFPDWIYKNLENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPM 587
Query: 237 TK 238
+
Sbjct: 588 NR 589
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 238 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-34 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.003 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-37
Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
E+S EE + E+ + +++H N+V+L G + + LV E+ GSL + +
Sbjct: 28 KEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL---KE 84
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAK 120
S +++ + G+EYLH+ I+H D+KP NILLD N ++DFGL+K
Sbjct: 85 NEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSK 141
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ + GT Y+APE++ G S KSD++ G++L E+
Sbjct: 142 LLTSDKSLLKT--IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 5e-37
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 33/234 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EEF+ E + ++ H N+V+LLG C+E +V E+MP G L ++ +++R + S
Sbjct: 46 EEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLS 103
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L A A G+EYL +H D+ N L+ N V +SDFGL++ ++D+
Sbjct: 104 DLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYY 159
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKATRSSKAYF 188
+ + I ++APE S G + KSDV+ FG++L E+ T G + +
Sbjct: 160 KVKGGKLPIRWMAPE--SLKEGKFTSKSDVWSFGVLLWEIFTLG------------EEPY 205
Query: 189 PSWVSDQLNKGGNLELRNVTEIESMIARKLC-----VIGLWCIQVKPADRPSMT 237
P + ++ L + + + C + L C P DRP+ +
Sbjct: 206 PGMSNAEV-------LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFS 252
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-35
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EEF+ E S + ++ H N+V+LLG C++G +V E+MP G L + G+ + +
Sbjct: 46 EEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLK 102
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L ++A A G+EYL +H D+ N L+ N V +SDFGL++ +++ +
Sbjct: 103 DLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR 159
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRR-NSNLKATRSSKAY 187
+ I ++APE + G + KSDV+ FG++L E+ T G + +
Sbjct: 160 KRGGGKLPIKWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----- 212
Query: 188 FPSWVSDQLNKGGNLELRNV---TEIESMIARKLCVIGLWCIQVKPADRPSMT 237
V + L G L R E+ ++ + C P DRP+ +
Sbjct: 213 ----VLELLEDGYRLP-RPENCPDELYELMLQ--------CWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-34
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 34/234 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EEF+ E + ++ H NVV+LLG C+E +V E+M G L ++ +++R + S
Sbjct: 46 EEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPK-LSLS 102
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L A A G+EYL +H D+ N L+ N V +SDFGL++ + D+
Sbjct: 103 DLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYY 158
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKATRSSKAYF 188
+ I ++APE S G + KSDV+ FG++L E+ T G + +
Sbjct: 159 RKRGGKLPIRWMAPE--SLKEGKFTSKSDVWSFGVLLWEIFTLG------------EQPY 204
Query: 189 PSWVSDQLNKGGNLELRNVTEIESMIARKLC-----VIGLWCIQVKPADRPSMT 237
P ++++ L + + C + L C P DRP+ +
Sbjct: 205 PGMSNEEV-------LEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-34
Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 40/239 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+ E+ + R+ H N+V+L+ + LV E+ G L ++ SRG S +
Sbjct: 43 QTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSED 98
Query: 70 KLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
+ ++A G+EYLH NG I+H D+KP NILLD N V ++DFGLAK K +
Sbjct: 99 EAKKIALQILRGLEYLHSNG----IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS 154
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR----------RNSNL 178
++ GT Y+APE++ G K DV+ G++L E+ G+ + +
Sbjct: 155 LTTFV--GTPWYMAPEVLLGGNG-YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ F ++ E +++ + C+ P+ RP+
Sbjct: 212 RRILGPPLEFDEPKWSSGSE----EAKDLIK--------------KCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-31
Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 28/180 (15%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI----- 56
+ K E + E+ + ++ H N+V+L + K LV E+ G L +
Sbjct: 34 KKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR 93
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
E + + +EYLH I+H D+KP NILLD + ++DF
Sbjct: 94 LS-EDEARFYLRQ--------ILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADF 141
Query: 117 GLAKF---HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
GLA+ K FV GT Y+APE++ D++ G++L E+ G+
Sbjct: 142 GLARQLDPGEKLTTFV------GTPEYMAPEVLLGK--GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-29
Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 35/239 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC--- 66
++F+ E + ++ H NVV+LLG C+E LV E+M G L ++ ++SR
Sbjct: 41 KDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYL--RKSRPVFPSPE 98
Query: 67 ----SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
S + L A A G+EYL + +H D+ N L+ + V +SDFGL++
Sbjct: 99 KSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR-NSNLKA 180
++ + + + I ++APE + G + KSDV+ FG++L E T G L
Sbjct: 156 YDDDYYRKKTGGKLPIRWMAPESL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 181 TRSSKAYFPSWVSDQLNKGGNLEL-RNVT-EIESMIARKLCVIGLWCIQVKPADRPSMT 237
V + L KG L E+ ++ L C Q+ P DRP+ +
Sbjct: 214 EE---------VLEYLRKGYRLPKPEYCPDELYELM--------LSCWQLDPEDRPTFS 255
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 33/212 (15%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VY-EFMPNGSLDRHIFPKE 60
+S+ E E+ + + H N+V+ G + K L ++ E++ GSL + +
Sbjct: 37 GDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL---K 93
Query: 61 SRGQSCSWEKLHE--VASGTA---HGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVS 114
G KL E + T G+ YLH NG I+H DIK NIL+D + V ++
Sbjct: 94 KFG------KLPEPVIRKYTRQILEGLAYLHSNG----IVHRDIKGANILVDSDGVVKLA 143
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR 173
DFG AK + RGT ++APE+I +D++ G ++EM TG
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKP 201
Query: 174 RNSNLK---------ATRSSKAYFPSWVSDQL 196
S L + P +S++
Sbjct: 202 PWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-24
Identities = 55/167 (32%), Positives = 81/167 (48%), Gaps = 9/167 (5%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+ ++F EV + R+ H +++ L CS G ++ E M GSL F + G
Sbjct: 41 DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEG 98
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
Q L ++A A G+ YL + +H D+ NIL+ + V V+DFGLA+
Sbjct: 99 QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARL-I 154
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170
KE D S + + APE S GT S KSDV+ FG++L EM
Sbjct: 155 KE-DVYLSSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-24
Identities = 52/165 (31%), Positives = 91/165 (55%), Gaps = 9/165 (5%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+F+ E S +G+ H N+++L G ++ ++ E+M NGSLD+ F +E+ G+ + +
Sbjct: 51 DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK--FLRENDGK-FTVGQ 107
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L + G A G++YL ++ +H D+ NIL++ N V VSDFGL++ +
Sbjct: 108 LVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ I + APE I+ + + SDV+ FG+V+ E M+ G R
Sbjct: 165 TKGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-23
Identities = 49/174 (28%), Positives = 92/174 (52%), Gaps = 10/174 (5%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
M+ S ++FI E + ++ H N+VQL G C++ +V E+M NG L ++ ++
Sbjct: 35 MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK 94
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ + E L ++ S +EYL + +H D+ N L+ + V VSDFGLA+
Sbjct: 95 GKLGT---EWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR 173
+ ++ + S T+ + + PE+ ++ S KSDV+ FG+++ E+ + G+
Sbjct: 149 Y-VLDDQYTSSQGTKFPVKWAPPEVF--DYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-23
Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 32/235 (13%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
S E+FI E + ++ H +VQL G C+E S LV+EFM +G L ++ + RG S
Sbjct: 42 SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRG-KFS 98
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
E L + G+ YL + ++H D+ N L+ N V VSDFG+ +F ++
Sbjct: 99 QETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQ 154
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY 187
+ S + T+ + + +PE+ S F S KSDV+ FG+++ E+ + + S
Sbjct: 155 YTSSTGTKFPVKWSSPEVFS--FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--- 209
Query: 188 FPSWVSDQLNKG-----GNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
V + +N G L ++V E+ C + +P DRPS +
Sbjct: 210 ----VVETINAGFRLYKPRLASQSVYELMQ-----------HCWKERPEDRPSFS 249
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-22
Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 13/169 (7%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
++F+ E + ++ H ++QL C+ +V E M GSL ++ + G++
Sbjct: 44 DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL--QGGAGRALK 101
Query: 68 WEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
+L ++A+ A G+ YL N +H D+ N+L+ N + V+DFGLA+ KE
Sbjct: 102 LPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVI-KE 155
Query: 126 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
+ + + + I + APE + S KSDV+ FG++L E +T GR
Sbjct: 156 DIYEAREGAKFPIKWTAPEAA--LYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.5 bits (228), Expect = 6e-22
Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 13/242 (5%)
Query: 2 LENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
LE+ E F+ E+ + + H N+V+L F + LV E++ GSL+ +
Sbjct: 34 LESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIG 93
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLA 119
+G E L + + +EYLH I+H DIKP NILLD + V + DFGLA
Sbjct: 94 RKGPLSESEALF-ILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
Query: 120 KFHPKENDFVSISATR----GTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMTGGRR 174
K P SI A GT GY+APE++ + S SD++ G+ L E+ G
Sbjct: 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
Query: 175 NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234
+ S+ + + + L +I++ + + P +R
Sbjct: 210 PFEGEKNSSATSQTLKIILELPTPSLASPLS--PSNPELISKAASDLLKKLLAKDPKNRL 267
Query: 235 SM 236
S
Sbjct: 268 SS 269
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 55/167 (32%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
S E F+ E + ++ H +VQL CSE +V E+M GSL F K G+
Sbjct: 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD--FLKSGEGKKLR 101
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+L ++A+ A G+ YL + +H D+ NIL+ N V ++DFGLA+ ++++
Sbjct: 102 LPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDE 157
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
+ + + I + APE N+G + KSDV+ FG++L E +T GR
Sbjct: 158 YTAREGAKFPIKWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-21
Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+ SK E+ INE+ + + H N+V+ G + + +V EF GSL + +
Sbjct: 33 IKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL---K 89
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
S Q+ + ++ V G+EYLH NG I+H DIK NILL + + DFGL+
Sbjct: 90 STNQTLTESQIAYVCKELLKGLEYLHSNG----IIHRDIKAANILLTSDGEVKLIDFGLS 145
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
++ GT ++APE+I+ K+D++ G+ +E+ G+
Sbjct: 146 AQLSDTKARNTMV---GTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-20
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL-HE 73
E+ T+ + H+N+VQ LGF + ++ E++P GS+ R + E+L
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFE----EQLVRF 112
Query: 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISA 133
G+ YLH+ ILH D+K N+L+D + + +SDFG++K D +
Sbjct: 113 FTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 134 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRN-SNLKA--------TRSS 184
+G++ ++APE+I S K D++ G V+LEM GRR S+ +A + S
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229
Query: 185 KAYFPSWVSDQLNKGGNLELRNVTEIES 212
P VS L+ L I
Sbjct: 230 APPIPPDVSMNLSPVALDFLNACFTINP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-20
Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 14/171 (8%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKESRGQSCSW 68
+F E+ + + H N+V+ G C + R+ L+ E++P+GSL R + +
Sbjct: 52 DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQINLK- 109
Query: 69 EKLHEVASGTAHGIEYLHN-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+L +S G++YL + +H D+ NIL++ + +SDFGLAK P++ D
Sbjct: 110 -RLLLFSSQICKGMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164
Query: 128 FVSISATRGT-IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNS 176
+ + + I + APE + + S SDV+ FG+ L E+ T G +
Sbjct: 165 YYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQ 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-20
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 8/168 (4%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
L+ EEF+ E + + I H N+VQLLG C+ ++ EFM G+L ++ +E
Sbjct: 39 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--REC 96
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
Q + L +A+ + +EYL +H D+ N L+ N + V+DFGL++
Sbjct: 97 NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 153
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ + + + + I + APE S + S KSDV+ FG++L E+
Sbjct: 154 M-TGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-19
Identities = 55/169 (32%), Positives = 94/169 (55%), Gaps = 14/169 (8%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+F++E S +G+ H N++ L G ++ ++ EFM NG+LD F +++ GQ + +
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS--FLRQNDGQ-FTVIQ 107
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF---HPKEND 127
L + G A G++YL ++ +H D+ NIL++ N V VSDFGL++F +
Sbjct: 108 LVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164
Query: 128 FVSISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ S + I + APE I+ R F + SDV+ +G+V+ E M+ G R
Sbjct: 165 YTSSLGGKIPIRWTAPEAIAYRKF---TSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-19
Identities = 53/170 (31%), Positives = 87/170 (51%), Gaps = 14/170 (8%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L++ +A+ F+ E S + + H N+VQLLG +G+ +V E+M GSL ++
Sbjct: 36 CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL---R 92
Query: 61 SRGQSC-SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
SRG++ + + A G+EYL +H D+ N+L+ + V VSDFGLA
Sbjct: 93 SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
K + D + + + + APE + S KSDV+ FG++L E+
Sbjct: 150 KEASQGQD-----SGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-19
Identities = 60/169 (35%), Positives = 95/169 (56%), Gaps = 16/169 (9%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+F++E S +G+ H N++ L G ++ +V E+M NGSLD F ++ GQ + +
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQF-TVIQ 107
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L + G A G++YL D+ +H D+ NIL++ N V VSDFGL++ E+D +
Sbjct: 108 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEA 162
Query: 131 ISATRG---TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
TRG I + APE I+ R F + SDV+ +G+V+ E M+ G R
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKF---TSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-19
Identities = 56/170 (32%), Positives = 96/170 (56%), Gaps = 16/170 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
++F++E S +G+ H N+++L G ++ ++ E+M NG+LD+ + ++ G+ S++
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK--YLRDHDGEFSSYQ 108
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L + G A G++YL D+ +H D+ NIL++ N VSDFGL++ E+D
Sbjct: 109 -LVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPE 162
Query: 130 SISATRG---TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
T G I + APE I+ R F + SDV+ FG+V+ E M+ G R
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA---SDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-18
Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
L+ S E F+ E + ++ H +VQL SE +V E+M GSL F K+
Sbjct: 38 LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSL--LDFLKDG 94
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
G++ L ++A+ A G+ Y+ + +H D++ NIL+ V ++DFGLA+
Sbjct: 95 EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARL 151
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR 173
++N++ + + I + APE + +G + KSDV+ FG++L E+ T GR
Sbjct: 152 -IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-18
Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 29/228 (12%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
E S + +E ++E + + H +VV+LLG C S+ L+ + MP G L ++ + +
Sbjct: 47 ETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYV--RNHK 103
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
S L+ A G+ YL + ++H D+ N+L+ ++DFGLAK
Sbjct: 104 DNIGSQYLLN-WCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNLKAT 181
+ + I ++A E I + KSDV+ +G+ + E MT G +
Sbjct: 160 DVDEKEYHAEGGKVPIKWMALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229
+ D L KG L +C I ++ + VK
Sbjct: 218 VE--------IPDLLEKGERLP-----------QPPICTIDVYMVLVK 246
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 6e-18
Identities = 60/240 (25%), Positives = 93/240 (38%), Gaps = 56/240 (23%)
Query: 14 NEVSTIGRIHHVNVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E+ T+ VV+ G F EG +V E+M GSL + + L
Sbjct: 48 RELKTLRSCESPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKIPEPV----LA 102
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP----KENDF 128
+A G++YLH I+H DIKP N+L++ ++DFG++K + N F
Sbjct: 103 YIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160
Query: 129 VSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY 187
V GT+ Y++PE I ++ +D++ G+ LLE G+
Sbjct: 161 V------GTVTYMSPERIQGESYSY---AADIWSLGLTLLECALGK-------------- 197
Query: 188 FP-------SWVS--DQLNKGGNLELRNVT---EIESMIARKLCVIGLWCIQVKPADRPS 235
FP S+ + G L E I+ C+Q P RPS
Sbjct: 198 FPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA--------CLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-17
Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
M++ S +EFI E + ++ H +VQL G C++ +V E+M NG L ++
Sbjct: 35 MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG 94
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
R Q +L E+ G+ YL + +H D+ N L+D VSDFGL++
Sbjct: 95 KRFQP---SQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ ++++ S ++ + + PE++ + S KSDV+ FG+++ E+
Sbjct: 149 Y-VLDDEYTSSVGSKFPVRWSPPEVL--LYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-17
Identities = 55/173 (31%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
L+ S E F+ E + ++ H +VQL SE +V E+M GSL F K
Sbjct: 38 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD--FLKGE 94
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
G+ +L ++A+ A G+ Y+ + +H D++ NIL+ N V V+DFGLA+
Sbjct: 95 MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL 151
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR 173
++N++ + + I + APE + +G + KSDV+ FG++L E+ T GR
Sbjct: 152 -IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-17
Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 43/239 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+ +NEV + +++H N+++ E K +V E+ G L + I ++ G+ E
Sbjct: 44 EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE 103
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ + ++YLH ILH DIKP NI L N + + DFG++K +
Sbjct: 104 QILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVD 158
Query: 130 SISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMTGGRR---NSNLKA--- 180
GT Y++PEL N+ KSD++ G VL E+ + NL
Sbjct: 159 LAKTVVGTPYYLSPELCQNKPYNY-----KSDIWSLGCVLYELCTLKHPFEGENLLELAL 213
Query: 181 --TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ PS S ELRN+ + S+ +Q P +RPS+
Sbjct: 214 KILKGQYPPIPSQYSS--------ELRNL--VSSL------------LQKDPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 52/156 (33%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 23 HHVNVVQLLG-FCSEGSKR-ALVYEFMPNGSLDRHIFPK-ESRGQSCSWEKLHEVASGTA 79
+V+ G F E S + E+ GSLD I+ K + RG + L ++A
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISAT-RGT 137
G+ YLH I+H DIKP NILL + DFG++ + V S++ T GT
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTFTGT 166
Query: 138 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y+APE I S SDV+ G+ LLE+ R
Sbjct: 167 SFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-17
Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 28/232 (12%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQS-C 66
+A+ F+ E + + ++HH N+V+LLG +V E M G+L + +RG++
Sbjct: 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFL---RTRGRALV 97
Query: 67 SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
S +L + + A G+EYL + ++H D+ NIL+ + V VSDFGLA+
Sbjct: 98 SVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154
Query: 127 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
D ++ + + APE + S KSDV+ +G++L E+ R K +
Sbjct: 155 D-----NSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-- 205
Query: 187 YFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
V + + KG + E + V+ C + +P RPS K
Sbjct: 206 -----VKECVEKGYRM------EPPEGCPADVYVLMTSCWETEPKKRPSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-17
Identities = 53/174 (30%), Positives = 93/174 (53%), Gaps = 12/174 (6%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKE 60
L+ S E F+ E + + ++ H +V+L ++ ++ E+M NGSL D F K
Sbjct: 38 LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVD---FLKT 93
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
G + KL ++A+ A G+ ++ +H D++ NIL+ ++DFGLA+
Sbjct: 94 PEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLAR 150
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR 173
++N++ + + I + APE I N+GT + KSDV+ FG++L E+ T GR
Sbjct: 151 L-IEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-17
Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 40/237 (16%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
S E+FI E + ++ H +VQL G C++ +V EFM NG L ++ ++ +G+ S
Sbjct: 42 SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL--RQRQGK-LS 98
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+ L + G+EYL +H D+ N L+ V VSDFG+ ++ +++
Sbjct: 99 KDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDE 154
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR----RNSNLKA-- 180
+ S S + + + PE+ NF S KSDV+ FG+++ E+ T G+ + SN +
Sbjct: 155 YTSSSGAKFPVKWSPPEVF--NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE 212
Query: 181 --TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
+R + Y P +L ++T E M + C KP RP+
Sbjct: 213 MISRGFRLYRP-------------KLASMTVYEVMYS---------CWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-17
Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 10/173 (5%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
L+ E F+ E + ++ H +V L SE +V EFM GSL F KE
Sbjct: 38 LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLD--FLKEG 94
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
G+ +L ++A+ A G+ Y+ + +H D++ NIL+ N V ++DFGLA+
Sbjct: 95 DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARL 151
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR 173
++N++ + + I + APE + +G + KSDV+ FG++L E+ T GR
Sbjct: 152 -IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-17
Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH-----------IFP 58
++F E + H N+V+ G C+EG +V+E+M +G L++ P
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 59 KESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
G+ + +L ++A A G+ YL + V H D+ N L+ ++ V + DFG+
Sbjct: 113 DSPMGE-LTLSQLLQIAVQIASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGM 168
Query: 119 AKFHPKENDFVSISATRG-TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++ D+ + I ++ PE I + + +SDV+ FG+VL E+
Sbjct: 169 SR-DVYTTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-16
Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 33/171 (19%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG-------QSCS 67
EV + ++ H N+V L + LV+E++ L+ + S G +S
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE---LLEASPGGLPPDAVRSYI 106
Query: 68 WEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF--HPK 124
W+ L I Y H + I+H DIKP NIL+ + V + DFG A+
Sbjct: 107 WQLLQ--------AIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154
Query: 125 ENDFVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ ATR Y APEL+ N+G DV+ G ++ E+ G
Sbjct: 155 ASPLTDYVATR---WYRAPELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-16
Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 45/241 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+F+ E + + H N+V+L+G C + +V E +P GSL + K++R + +
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVK 93
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
KL +++ A G+EYL + CI H D+ N L+ N V +SDFG+++ +E +
Sbjct: 94 KLLQMSLDAAAGMEYLESKN--CI-HRDLAARNCLVGENNVLKISDFGMSR---EEEGGI 147
Query: 130 -SISATRGTI--GYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGR---RNSNLKATR 182
++S I + APE + N+G + +SDV+ +G++L E + G + + TR
Sbjct: 148 YTVSDGLKQIPIKWTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR 205
Query: 183 SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLC-----VIGLWCIQVKPADRPSMT 237
+++ G M A +LC + L C P +RPS +
Sbjct: 206 -----------ERIESGYR-----------MPAPQLCPEEIYRLMLQCWAYDPENRPSFS 243
Query: 238 K 238
+
Sbjct: 244 E 244
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-15
Identities = 46/168 (27%), Positives = 87/168 (51%), Gaps = 8/168 (4%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
L+ S + F+ E + + + H +V+L ++ ++ E+M GSL F K
Sbjct: 38 LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD--FLKSD 95
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
G KL + ++ A G+ Y+ +H D++ N+L+ + + ++DFGLA+
Sbjct: 96 EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARV 152
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++N++ + + I + APE I NFG+ + KSDV+ FG++L E+
Sbjct: 153 -IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 27/184 (14%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-LD--RHIFP 58
LE + S +E EV + + +H NVV+ G + LV ++ GS LD + +P
Sbjct: 36 LEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP 95
Query: 59 KESRGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
+ ++ L EV G+EYLH NG +H DIK NILL + ++DFG
Sbjct: 96 RGGLDEAIIATVLKEVLK----GLEYLHSNG----QIHRDIKAGNILLGEDGSVKIADFG 147
Query: 118 LAKF--------HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++ FV GT ++APE++ + G K+D++ FG+ +E+
Sbjct: 148 VSASLADGGDRTRKVRKTFV------GTPCWMAPEVMEQVHGYDF-KADIWSFGITAIEL 200
Query: 170 TGGR 173
G
Sbjct: 201 ATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-15
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E++ + ++ H N+VQ LG E + E +P GSL + + + S +
Sbjct: 52 EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLY 107
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
G+EYLH+ +H DIK NIL+D N V ++DFG+AK E F +
Sbjct: 108 TRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSF--AKSF 161
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSW--- 191
+G+ ++APE+I++ G +D++ G +LEM G+ P W
Sbjct: 162 KGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGK---------------PPWSQL 205
Query: 192 --VSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
V+ G + EL + + S A+ L C+Q P+ RP+
Sbjct: 206 EGVAAVFKIGRSKELPPIPDHLSDEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-15
Identities = 55/169 (32%), Positives = 85/169 (50%), Gaps = 25/169 (14%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC 66
+A+ F+ E S + ++ H N+VQLLG E +V E+M GSL ++ SRG+S
Sbjct: 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSV 98
Query: 67 -SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
+ L + + +EYL +H D+ N+L+ + V VSDFGL K
Sbjct: 99 LGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 150
Query: 126 NDFVSISATRGT----IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 169
S+T+ T + + APE L + F T KSDV+ FG++L E+
Sbjct: 151 ----EASSTQDTGKLPVKWTAPEALREKKFST---KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-15
Identities = 49/164 (29%), Positives = 86/164 (52%), Gaps = 10/164 (6%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL 71
F+ E T+G+ H N+V+L G + G+ +V E+M NG+LD F ++ GQ +L
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQL 109
Query: 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI 131
+ G A G++YL ++ +H + H +L++ + V +S F + E + ++
Sbjct: 110 MGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM 166
Query: 132 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
S + + + APE I + S SDV+ FG+V+ E M+ G R
Sbjct: 167 SG-KSPVLWAAPEAI--QYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-15
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 13/162 (8%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+EF+ E S + ++ H +V+L+G C +G LV E P G L + K+ R S
Sbjct: 41 KEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPL--LKYLKKRREIPVS-- 95
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL-DHNFVPNVSDFGLAK-FHPKEND 127
L E+A A G+ YL +H D+ N+LL + + +SDFG+++ +
Sbjct: 96 DLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQA-KISDFGMSRALGAGSDY 151
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ + +A R + + APE I N+G S KSDV+ +G+ L E
Sbjct: 152 YRATTAGRWPLKWYAPECI--NYGKFSSKSDVWSYGVTLWEA 191
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-15
Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
S E F+ E + + + H +V+L ++ ++ EFM GSL F K G
Sbjct: 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD--FLKSDEGSKQP 100
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
KL + ++ A G+ ++ +H D++ NIL+ + V ++DFGLA+ ++N+
Sbjct: 101 LPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV-IEDNE 156
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY 187
+ + + I + APE I NFG+ + KSDV+ FG++L+E+ R
Sbjct: 157 YTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIP----------- 203
Query: 188 FPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
+P + ++ + LE +L I + C + +P +RP+
Sbjct: 204 YPGMSNPEVIRA--LERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-15
Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQ 64
+K + +F+ E+ + R+ + N+++LLG C ++ E+M NG L++ + +E
Sbjct: 57 TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 65 --------SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
S S L +A A G++YL + +H D+ N L+ +++ ++DF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 117 GLAKFHPKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
G+++ + D+ I R I ++A E I G + SDV+ FG+ L EM
Sbjct: 174 GMSR-NLYSGDYYRIQG-RAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-15
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 11/163 (6%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKESRGQSCS 67
+F E+ + + H N+V+ G C +R LV E++P GSL ++ R
Sbjct: 50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LD 106
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
KL AS G+EYL G + H D+ NIL++ + DFGL K P++ +
Sbjct: 107 HRKLLLYASQICKGMEYL--GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163
Query: 128 FVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ + I + APE ++ + S SDV+ FG+VL E+
Sbjct: 164 YYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-15
Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 13/170 (7%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKE 60
E + + + E++ + ++H N+V+ G CSE + L+ E++P GSL R PK
Sbjct: 44 ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL-RDYLPKH 102
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ +L A G+ YLH+ +H D+ N+LLD++ + + DFGLAK
Sbjct: 103 KLNLA----QLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155
Query: 121 FHPKENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
P+ +++ + + + A E + N S SDV+ FG+ L E+
Sbjct: 156 AVPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-15
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 44/246 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA------LVYEFMPNGSLDRHIFPKESRG 63
EEF++E + + H NV++L+G C E S ++ FM +G L + G
Sbjct: 46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG 105
Query: 64 QS--CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
+ L + A G+EYL N +H D+ N +L + V+DFGL+K
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKK 162
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKAT 181
+ + + + +IA E ++ T KSDV+ FG+ + E+ AT
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTS--KSDVWAFGVTMWEI----------AT 210
Query: 182 RSSKAYFP----SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW-----CIQVKPAD 232
R Y P + D L G L+ + C+ L+ C + P D
Sbjct: 211 RGQTPY-PGVENHEIYDYLRHGNRLK-----------QPEDCLDELYDLMYSCWRADPKD 258
Query: 233 RPSMTK 238
RP+ TK
Sbjct: 259 RPTFTK 264
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-15
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKE---SRGQ 64
EF+NE S + + +VV+LLG S G +V E M G L R P+
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
+ +K ++A+ A G+ YL +H D+ N ++ + + DFG+ + +
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170
+ + + ++APE S G + KSDV+ FG+VL EM
Sbjct: 172 TDYYRKGGKGLLPVRWMAPE--SLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-15
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+ + + +E + + +G + H +V+LLG C G+ LV + P GSL H+ ++ R
Sbjct: 48 SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHV--RQHRD 104
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
S ++L A G+ YL + ++H ++ NILL + + ++DFG+A
Sbjct: 105 -SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT--GGRRNSNLKAT 181
++ S + I ++A E I FG + +SDV+ +G+ + EM G + ++
Sbjct: 161 PDDKKYFYSEHKTPIKWMALESI--LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-- 216
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229
P V D L KG E + ++C I ++ + VK
Sbjct: 217 -------PHEVPDLLEKG-----------ERLAQPQICTIDVYMVMVK 246
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 8e-15
Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
INE+ + H N+V G + +V E+M GSL I R + ++
Sbjct: 63 INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIA 119
Query: 73 EVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA----KFHPKEND 127
V G+EYLH +H DIK NILL + ++DFG A K K N
Sbjct: 120 YVCREVLQGLEYLHSQNV----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
V GT ++APE+I R K D++ G++ +EM G
Sbjct: 176 VV------GTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 42/164 (25%), Positives = 85/164 (51%), Gaps = 16/164 (9%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73
+E++ +G++ H N+V+L+G C L++E++ +L + ++ SWE+ +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRK 784
Query: 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISA 133
+A G A + +LH C ++ ++ P I++D P++ L + SA
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA 843
Query: 134 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSN 177
Y+APE +R ++ KSD+YGFG++L+E+ G+ ++
Sbjct: 844 ------YVAPE--TRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-14
Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 39/237 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+ +NE+ + ++H N++ +G+K +V E+ P G L + I ++ + + +
Sbjct: 44 EDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ 103
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ + G++ LH + ILH D+K NILL N + + D G++K K
Sbjct: 104 EIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR--------RNSNLKAT 181
I GT Y+APE+ S KSD++ G +L EM ++ K
Sbjct: 161 QI----GTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
R P S L I +QVKP RP+ K
Sbjct: 215 RGKYPPIPPIYSQDLQN--------------FIR--------SMLQVKPKLRPNCDK 249
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-14
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 16/102 (15%)
Query: 81 GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF--HPKENDFVSISATRGT 137
G+ YLH +G I+H DIKP NI LDHN V + DFG A + + + GT
Sbjct: 111 GLAYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 138 IGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMTGGRR 174
Y+APE+I+ D++ G V+LEM G+R
Sbjct: 167 PAYMAPEVITGGKGKGHGRAA----DIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-14
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+ E+ + + + +V G ++ E+M GSLD+ KE +G+ L
Sbjct: 47 LRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPE-RILG 103
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK--FHPKENDFVS 130
++A G+ YLH I+H D+KP NIL++ + DFG++ + FV
Sbjct: 104 KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV- 160
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
GT Y+APE I N +V KSD++ G+ L+E+ GR
Sbjct: 161 -----GTSSYMAPERIQGNDYSV--KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 4e-14
Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 31/171 (18%)
Query: 23 HHVNVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81
H +++L F E V E+ PNG L ++I S + C+ E+
Sbjct: 60 GHPGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL----LA 114
Query: 82 IEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF-----HPKENDFVSISATR 135
+EYLH G I+H D+KP NILLD + ++DFG AK P+ N + +
Sbjct: 115 LEYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 136 -------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
GT Y++PEL++ SD++ G ++ +M G+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 5e-14
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 36/197 (18%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHI-----FPKESRGQS 65
+ E + + RI+H +V+L + ++ L V E+ P G L H+ F +E
Sbjct: 41 LTERNILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----- 93
Query: 66 CSWEKLH--EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
+ + E+ +EYLH+ + I++ D+KP NILLD + ++DFGLAK
Sbjct: 94 --RARFYAAEIVLA----LEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAK--E 142
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKA 180
++ + GT Y+APE++ + D + G++L EM G+ + K
Sbjct: 143 LSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV--DWWSLGVLLYEMLTGKPPFYAEDRKE 200
Query: 181 T----RSSKAYFPSWVS 193
FP ++S
Sbjct: 201 IYEKILKDPLRFPEFLS 217
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-14
Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 23/173 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKESRGQSCS 67
E+ EV + + HVN+VQ LG C + + ++ EF+P GS+ + F C
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK 106
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK------F 121
+ K G+ YLHN C++H DIK +N++L N + + DFG A+
Sbjct: 107 YTK------QILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157
Query: 122 HPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMTGGR 173
H ++ + + GT ++APE+I+ + +G KSD++ G + EM G+
Sbjct: 158 HGTHSNM--LKSMHGTPYWMAPEVINESGYGR---KSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-14
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E++ + H N+VQ LG SE + E +P GSL + K W L +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK--------WGPLKDN 106
Query: 75 ASGTAH-------GIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFG----LAKFH 122
G++YLH D I+H DIK N+L++ ++ V +SDFG LA +
Sbjct: 107 EQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
P F GT+ Y+APE+I + +D++ G ++EM G+
Sbjct: 164 PCTETF------TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-14
Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 10/164 (6%)
Query: 8 SAEEFINEVSTIG-RIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC 66
S + ++EV+ I ++ H N+V+ E + +V + + L H + + Q
Sbjct: 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF 110
Query: 67 SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
+ E++ + + YLH + I+H D+ P+NI+L + ++DFGLAK E+
Sbjct: 111 TEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES 168
Query: 127 DFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEM 169
S+ GTI Y PE++ + +G K+DV+ FG +L +M
Sbjct: 169 KLTSVV---GTILYSCPEIVKNEPYGE---KADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-14
Identities = 46/181 (25%), Positives = 86/181 (47%), Gaps = 22/181 (12%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR-------- 54
E S+ + ++F E + + H ++V+ G C+EG +V+E+M +G L+R
Sbjct: 45 EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 104
Query: 55 -HIFPKESRGQSC---SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFV 110
I + + ++ +AS A G+ YL + +H D+ N L+ V
Sbjct: 105 AKIL-AGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLV 160
Query: 111 PNVSDFGLAKFHPKENDFVSISA-TRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLE 168
+ DFG+++ D+ + T I ++ PE ++ R F T +SD++ FG+VL E
Sbjct: 161 VKIGDFGMSR-DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT---ESDIWSFGVVLWE 216
Query: 169 M 169
+
Sbjct: 217 I 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-14
Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 16/162 (9%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+F+ E + + H N+V+L+G C++ +V E + G + + G ++
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKE 95
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L ++ A G+EYL + CI H D+ N L+ V +SDFG+++ +E D V
Sbjct: 96 LIQMVENAAAGMEYLESKH--CI-HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV- 148
Query: 131 ISATRGT----IGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168
++T G + + APE + N+G S +SDV+ FG++L E
Sbjct: 149 YASTGGMKQIPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-13
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 9/164 (5%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EE I+E + ++ +++ + K +V E+ NG L H K RG+ +
Sbjct: 44 EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPED 101
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ G+ +LH+ ILH DIK N+ LD + D G+AK +F
Sbjct: 102 QVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ GT Y++PEL + KSDV+ G+VL E G+
Sbjct: 159 --NTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 24 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83
H N+V LLG C+ G ++ E+ G L F + R + E L + A G+
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLN--FLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAP 143
+L + CI H D+ N+LL H + + DFGLA+ ++++V R + ++AP
Sbjct: 156 FLAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 144 ELISRNFGTVSCKSDVYGFGMVLLEM 169
E I T +SDV+ +G++L E+
Sbjct: 213 ESIFNCVYTF--ESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-13
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
++F+ E + + + H N+++L G +V E P GSL DR ++
Sbjct: 41 DDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRL---RKDALGHFLI 96
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
L + A A+G+ YL + +H D+ NILL + + DFGL + P+ D
Sbjct: 97 STLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153
Query: 129 VSISATRGT-IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ + APE S T S SDV+ FG+ L EM
Sbjct: 154 YVMEEHLKVPFAWCAPE--SLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 27/177 (15%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF-----PKESRGQ 64
+EF E + + H N+V LLG C++ +++E++ +G L H F P G
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGA 110
Query: 65 SCSWEK----------LHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPN 112
E LH +A A G+EYL H+ +H D+ N L+
Sbjct: 111 ESGDETVKSSLDCSDFLH-IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVK 164
Query: 113 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+SDFGL++ + + S + + ++ PE I +G + +SD++ FG+VL E+
Sbjct: 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 21/178 (11%)
Query: 5 SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL----------- 52
SK +F E+ + ++ HH N++ LLG C L E+ P+G+L
Sbjct: 47 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 106
Query: 53 -DRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVP 111
D S + S ++L A+ A G++YL +H D+ NIL+ N+V
Sbjct: 107 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163
Query: 112 NVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++DFGL++ + +V + R + ++A E S N+ + SDV+ +G++L E+
Sbjct: 164 KIADFGLSR---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-13
Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E+ + ++H NVV+ + ++ EFM GSL+ E + L +V
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE--------QFLADV 173
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
A GI YLH I+H DIKP N+L++ ++DFG+++ + D + S
Sbjct: 174 ARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 135 RGTIGYIAPELISR--NFGTVS-CKSDVYGFGMVLLEMTGGR 173
GTI Y++PE I+ N G D++ G+ +LE GR
Sbjct: 230 -GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-13
Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 14/147 (9%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
LV + + G L H+ S+ S E++ +EYLH+ I+H DIKP
Sbjct: 77 LVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPD 129
Query: 102 NILLDHNFVPNVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160
NILLD +++DF +A K P ++T GT GY+APE++ R S D +
Sbjct: 130 NILLDEQGHVHITDFNIATKVTPDTL----TTSTSGTPGYMAPEVLCRQ--GYSVAVDWW 183
Query: 161 GFGMVLLEMTGGRRNSNLKATRSSKAY 187
G+ E G+R +
Sbjct: 184 SLGVTAYECLRGKRPYRGHSRTIRDQI 210
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 75/259 (28%), Positives = 110/259 (42%), Gaps = 70/259 (27%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR-HIFP---KESRGQSCSWEK 70
E+ + ++ H N+V L+ + LV+EF+ + LD +P ESR + ++
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI 109
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF--HPKE--N 126
L GIE+ H+ I+H DIKP NIL+ + V + DFG A+ P E
Sbjct: 110 LR--------GIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
Query: 127 DFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSS 184
D+V ATR Y APEL+ + +G D++ G ++ EM G
Sbjct: 159 DYV---ATR---WYRAPELLVGDTKYGR---AVDIWAVGCLVTEMLTG------------ 197
Query: 185 KAYFPSWVS-DQLNK----GGNL-----------------ELRNVTEIESMIAR--KLCV 220
+ FP DQL GNL L V EIE + R KL
Sbjct: 198 EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSG 257
Query: 221 IGL----WCIQVKPADRPS 235
+ L C+++ P DRPS
Sbjct: 258 LVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 5e-13
Identities = 54/174 (31%), Positives = 89/174 (51%), Gaps = 33/174 (18%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMP---NGSLDRHIFPKESRGQSCS 67
I E+ + ++ H N+V+L + K + +V+E+M G LD K + Q
Sbjct: 46 IREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKC 104
Query: 68 WEK-LHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
+ K L E G++YLH NG ILH DIK NIL++++ V ++DFGLA+ + K
Sbjct: 105 YMKQLLE-------GLQYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153
Query: 126 N--DFVS--ISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
N D+ + I T+ Y PEL+ + +G + D++ G +L E+ G+
Sbjct: 154 NSADYTNRVI-----TLWYRPPELLLGATRYGP---EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 5e-13
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 26/165 (15%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN---GSLDRHIFP-KESRGQSCSW 68
+ E+S + + H N+V+LL K LV+E+ LD+ P + +S +
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMY 105
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKEND 127
+ L G+ Y H ILH D+KP NIL++ + V ++DFGLA+ F
Sbjct: 106 QLLR--------GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154
Query: 128 FVSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEM 169
+ T+ Y APE++ S+++ T V D++ G + EM
Sbjct: 155 YTHEVV---TLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEM 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 5e-13
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 35/198 (17%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----FPKESRGQSCS 67
+NE + I H +V L G + S LV E++P G L H+ FP+
Sbjct: 49 LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP------- 101
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+ + A+ +EYLH+ D I++ D+KP N+LLD + ++DFG AK
Sbjct: 102 VARFY--AAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--- 153
Query: 128 FVSISATRGTIGYIAPELI-SRNFGTVSCKS-DVYGFGMVLLEMTGGR-----RNSNL-- 178
GT Y+APE+I S+ +G K+ D + G+++ EM G N
Sbjct: 154 --RTYTLCGTPEYLAPEIILSKGYG----KAVDWWALGILIYEMLAGYPPFFDDNPIQIY 207
Query: 179 KATRSSKAYFPSWVSDQL 196
+ K FPS+ S
Sbjct: 208 EKILEGKVRFPSFFSPDA 225
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 7e-13
Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 21/172 (12%)
Query: 11 EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIF 57
+F E+ + ++ HH N++ LLG C L E+ P+G+L D
Sbjct: 41 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100
Query: 58 PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
S + S ++L A+ A G++YL +H D+ NIL+ N+V ++DFG
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
L++ + +V + R + ++A E S N+ + SDV+ +G++L E+
Sbjct: 158 LSR---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-13
Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 45/188 (23%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+F E + + H N+V+LLG C+ G L++E+M G L+ + + S
Sbjct: 54 DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-------RHRSPRA 106
Query: 71 LHEVASGTAHGIEYLHNGCDVC----------------------ILHLDIKPHNILLDHN 108
++ T+ + N + +H D+ N L+ N
Sbjct: 107 QCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN 166
Query: 109 FVPNVSDFGLAK-------FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161
V ++DFGL++ + END + I ++ PE I + + +SDV+
Sbjct: 167 MVVKIADFGLSRNIYSADYYKASENDAIPIR-------WMPPESIF--YNRYTTESDVWA 217
Query: 162 FGMVLLEM 169
+G+VL E+
Sbjct: 218 YGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-13
Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 21/172 (12%)
Query: 11 EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----------FP 58
+F E+ + ++ HH N++ LLG C + E+ P G+L + F
Sbjct: 48 DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107
Query: 59 KE-SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
KE + + ++L + AS A G++YL + +H D+ N+L+ N ++DFG
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG 164
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
L++ E +V + R + ++A E S N+ + KSDV+ FG++L E+
Sbjct: 165 LSR---GEEVYVKKTMGRLPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-13
Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 50/248 (20%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKR------ALVYEFMPNGSLDRHIFPKESRG 63
E+F++E + H NV++L+G C + + ++ FM +G L H F SR
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDL--HSFLLYSRL 102
Query: 64 QSCSW----EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
C + L + + A G+EYL + +H D+ N +L+ N V+DFGL+
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 120 KFHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL 178
K + + + + +IA E L R + T KSDV+ FG+ + E+
Sbjct: 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTT---KSDVWSFGVTMWEI--------- 207
Query: 179 KATRSSKAYFP----SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW-----CIQVK 229
ATR Y P S + D L +G L+ C+ GL+ C +
Sbjct: 208 -ATRGQTPY-PGVENSEIYDYLRQGNRLK-----------QPPDCLDGLYSLMSSCWLLN 254
Query: 230 PADRPSMT 237
P DRPS
Sbjct: 255 PKDRPSFE 262
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 47/160 (29%), Positives = 87/160 (54%), Gaps = 13/160 (8%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+F++E + + H N+V+L+G C++ +V E +P G + K+ ++ ++
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT---KQ 94
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L + A A G+ YL + CI H D+ N L+ N V +SDFG+++ +E+D +
Sbjct: 95 LVKFALDAAAGMAYLES--KNCI-HRDLAARNCLVGENNVLKISDFGMSR---QEDDGIY 148
Query: 131 ISA--TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168
S+ + I + APE + N+G S +SDV+ +G++L E
Sbjct: 149 SSSGLKQIPIKWTAPEAL--NYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E NEV + H N+V++ G + +V EF+ G+L + +R E
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNE---E 115
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAKFHPKE 125
++ V + +LH ++H DIK +ILL + +SDFG ++K P+
Sbjct: 116 QIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172
Query: 126 NDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMTGG 172
V GT ++APE+ISR +GT + D++ G++++EM G
Sbjct: 173 KSLV------GTPYWMAPEVISRLPYGT---EVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-12
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 14/170 (8%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQ-SCSWE 69
EF E S + +HH N+V LLG ++ +++E++ G L + + CS +
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 70 KLHEVASGTAHGIEYLHNGCDVC----------ILHLDIKPHNILLDHNFVPNVSDFGLA 119
+ V S HG ++LH + +H D+ NIL+ +SD GL+
Sbjct: 113 EDGTVKSSLDHG-DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ + + + I ++ PE I +G S SD++ FG+VL E+
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-12
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 38/235 (16%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEK 70
++EV+ + + H N+V+ + S + L V E+ G L + I + + E
Sbjct: 47 VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF 106
Query: 71 LHEVASGTAHGIEYLHNGCDV--CILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
+ + + + HN D +LH D+KP NI LD N + DFGLAK ++ F
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR-----RNSNLKATRS 183
GT Y++PE ++ + KSD++ G ++ E+ RN A++
Sbjct: 167 AKTYV--GTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
Query: 184 SKAYFPSW---VSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
+ F S +LN+ VI + V P RPS
Sbjct: 223 KEGKFRRIPYRYSSELNE---------------------VIKS-MLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-12
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 23/177 (12%)
Query: 2 LENSKFSA-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
LE K A + + E+ + + H N+V+ +G ++ E+ NGSL + I
Sbjct: 35 LEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG 94
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHN-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
+S +++V G+ YLH G ++H DIK NIL + V ++DFG+A
Sbjct: 95 PFPESLVAVYVYQV----LQGLAYLHEQG----VIHRDIKAANILTTKDGVVKLADFGVA 146
Query: 120 ----KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TG 171
+ V GT ++APE+I S SD++ G ++E+ TG
Sbjct: 147 TKLNDVSKDDASVV------GTPYWMAPEVI--EMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-12
Identities = 59/173 (34%), Positives = 88/173 (50%), Gaps = 20/173 (11%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKESRGQS 65
E+F+ E + H NV+ LLG C SEGS +V +M +G L R+ E+ +
Sbjct: 39 EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSP-LVVLPYMKHGDL-RNFIRSETHNPT 96
Query: 66 CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPK 124
+ L A G+EYL + V H D+ N +LD +F V+DFGLA+ + K
Sbjct: 97 V--KDLIGFGLQVAKGMEYLASKKFV---HRDLAARNCMLDESFTVKVADFGLARDIYDK 151
Query: 125 ENDFVSISATRGT---IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLE-MTGG 172
E + S+ G + ++A E L ++ F T KSDV+ FG++L E MT G
Sbjct: 152 E--YYSVHNHTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRG 199
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-12
Identities = 54/184 (29%), Positives = 88/184 (47%), Gaps = 29/184 (15%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRALVY---EFMPNGSLDRHIF 57
L+ SKF+ + I E+ + + +V G F EG+ VY E+M GSLD+ ++
Sbjct: 38 LDESKFN--QIIMELDILHKAVSPYIVDFYGAFFIEGA----VYMCMEYMDAGSLDK-LY 90
Query: 58 PKESRGQSCSWEKLHEVASGTAHGIEYL---HNGCDVCILHLDIKPHNILLDHNFVPNVS 114
+ + L + G+++L HN I+H D+KP N+L++ N +
Sbjct: 91 AGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-----IIHRDVKPTNVLVNGNGQVKLC 145
Query: 115 DFGLAKFHPKENDFVSISATR-GTIGYIAPELIS----RNFGTVSCKSDVYGFGMVLLEM 169
DFG++ N S++ T G Y+APE I T + +SDV+ G+ +LEM
Sbjct: 146 DFGVSG-----NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
Query: 170 TGGR 173
GR
Sbjct: 201 ALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-12
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 25/188 (13%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
M ++ + +A+ NE + + H N+++ E +V E+ P G+L +I +
Sbjct: 38 MTKDERLAAQ---NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI---Q 91
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLA 119
R S E + + LH+ ILH D+K NILLD H V + DFG++
Sbjct: 92 KRCNSLLDED--TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149
Query: 120 KFHPKENDFVSISATRGTIG---YIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGRR- 174
K S S +G YI+PEL + + KSD++ G VL E+ +R
Sbjct: 150 KI------LSSKSKAYTVVGTPCYISPELCEGKPYNQ---KSDIWALGCVLYELASLKRA 200
Query: 175 --NSNLKA 180
+NL A
Sbjct: 201 FEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-12
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 9/165 (5%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP-KESRGQSCSWE 69
+F+ E + H N++Q LG C+E + LV EF P G L ++ +++ +
Sbjct: 41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L +A A G+ +LH +H D+ N LL + + D+GL+ KE+ +V
Sbjct: 101 TLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157
Query: 130 SISATRGTIGYIAPELISRNFGTV-----SCKSDVYGFGMVLLEM 169
+ + +IAPEL+ G + + +S+V+ G+ + E+
Sbjct: 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-12
Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 24/182 (13%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD-----RHIFPK 59
+K + +F+ EV + R+ N+++LLG C + ++ E+M NG L+ H+ K
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118
Query: 60 ESRGQSC----------SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF 109
E G S+ L VA A G++YL + + +H D+ N L+ N
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENL 175
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLL 167
++DFG+++ + D+ I R I ++A E I G + SDV+ FG+ L
Sbjct: 176 TIKIADFGMSR-NLYAGDYYRIQG-RAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLW 231
Query: 168 EM 169
E+
Sbjct: 232 EI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-12
Identities = 47/184 (25%), Positives = 93/184 (50%), Gaps = 24/184 (13%)
Query: 2 LENSKFSA-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF--- 57
L++ +A ++F E + + H ++V+ G C +G +V+E+M +G L++ +
Sbjct: 43 LKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHG 102
Query: 58 ----------PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH 107
P++++G+ + LH +AS A G+ YL + +H D+ N L+
Sbjct: 103 PDAMILVDGQPRQAKGELGLSQMLH-IASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158
Query: 108 NFVPNVSDFGLAKFHPKENDFVSISA-TRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMV 165
N + + DFG+++ D+ + T I ++ PE ++ R F T +SDV+ FG++
Sbjct: 159 NLLVKIGDFGMSR-DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT---ESDVWSFGVI 214
Query: 166 LLEM 169
L E+
Sbjct: 215 LWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 46/147 (31%), Positives = 67/147 (45%), Gaps = 27/147 (18%)
Query: 22 IHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-----DRHIFPKESRGQSCSWEKLHEVAS 76
+ H N++ LL S LV+EFM L D+ I + +S L
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL----- 112
Query: 77 GTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRG 136
G+EYLH+ ILH D+KP+N+L+ + V ++DFGLA+ N ++
Sbjct: 113 ---RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-- 164
Query: 137 TIGYIAPELISRNFGTVSCKSDVYGFG 163
T Y APEL+ FG + YG G
Sbjct: 165 TRWYRAPELL---FG---ARH--YGVG 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 25/179 (13%)
Query: 11 EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+ ++E+ + I H N++ LLG C++ +V E+ +G+L + + G+ S +
Sbjct: 61 DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120
Query: 70 KLHEV------------ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
A A G+E+L + CI H D+ N+L+ + V ++DFG
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFG 177
Query: 118 LAK-FHPKENDFVSISATRG--TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGG 172
LA+ H D+ T G + ++APE + T +SDV+ FG++L E T G
Sbjct: 178 LARDIH--HIDYYR-KTTNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLLWEIFTLG 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 22/168 (13%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
I E+S + + H N+V+L +K LV+E+M + L +++ ++ G + + +
Sbjct: 46 IREISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALD-PN 100
Query: 73 EVASGTAH---GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKEND 127
V S T GI + H N +LH D+KP N+L++ ++DFGLA+ F N
Sbjct: 101 TVKSFTYQLLKGIAFCHENR----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156
Query: 128 FVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
F S T+ Y AP+++ SR T S D++ G ++ EM GR
Sbjct: 157 F---SNEVVTLWYRAPDVLLGSR---TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+E I E+S + + +V+ G + + +V E+ GS+ + + ++ + E
Sbjct: 43 QEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEE 99
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ + T G+EYLH+ +H DIK NILL+ ++DFG++
Sbjct: 100 EIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSG------QLT 150
Query: 130 SISATRGT-IG---YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR-RNSNLKATR 182
A R T IG ++APE+I + K+D++ G+ +EM G+ S++ R
Sbjct: 151 DTMAKRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 40/236 (16%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKESR--GQSCSW 68
+ E+ + ++ H NV++ L E ++ +V E G L R I F K+ R + W
Sbjct: 50 LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
+ ++ S +E++H+ I+H DIKP N+ + V + D GL +F +
Sbjct: 110 KYFVQLCSA----LEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-- 160
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT-------GGRRNSNLKAT 181
+ + GT Y++PE I N + KSD++ G +L EM G + N
Sbjct: 161 TAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ K +P +D ++ ELR++ CI P RP ++
Sbjct: 219 KIEKCDYPPLPADHYSE----ELRDLVSR--------------CINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 40/236 (16%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKESR--GQSCSW 68
I E+ + +++H NV++ E ++ +V E G L R I F K+ R + W
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
+ ++ S +E++H+ ++H DIKP N+ + V + D GL +F +
Sbjct: 110 KYFVQLCSA----LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-- 160
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT-------GGRRNSNLKAT 181
+ + GT Y++PE I N + KSD++ G +L EM G + N
Sbjct: 161 TAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + +P SD ++ ELR + + CI P RP +T
Sbjct: 219 KIEQCDYPPLPSDHYSE----ELRQLVNM--------------CINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-11
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 31/193 (16%)
Query: 1 MLENSKFSAE--EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP 58
ML+ + S+E + ++E + + +++H +V++L G CS+ L+ E+ GSL F
Sbjct: 37 MLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS--FL 94
Query: 59 KESRGQSCSW----------------------EKLHEVASGTAHGIEYLHNGCDVCILHL 96
+ESR S+ L A + G++YL ++ ++H
Sbjct: 95 RESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHR 151
Query: 97 DIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 156
D+ N+L+ +SDFGL++ +E+ +V S R + ++A E + + T +
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT--Q 209
Query: 157 SDVYGFGMVLLEM 169
SDV+ FG++L E+
Sbjct: 210 SDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 25/184 (13%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD----RHIFPKE 60
S + E+F+ EV + R+ N+ +LLG C+ ++ E+M NG L+ +H+
Sbjct: 59 SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 61 SR---GQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSD 115
+S S+ L +A+ A G+ YL N +H D+ N L+ N+ ++D
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIAD 173
Query: 116 FGLAKFHPKENDFVSISATRGT----IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MT 170
FG+++ + +D+ + +G I ++A E + G + KSDV+ FG+ L E +T
Sbjct: 174 FGMSR-NLYSSDYYRV---QGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILT 227
Query: 171 GGRR 174
R
Sbjct: 228 LCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-11
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 18/161 (11%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73
E+ + + H +VQ G + ++ E+MP GS+ + + ++ + + +
Sbjct: 53 CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ 112
Query: 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK----FHPKENDFV 129
+ G+EYLH I+H DIK NIL D + DFG +K
Sbjct: 113 IL----EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165
Query: 130 SISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEM 169
S++ GT +++PE+IS +G K+DV+ G ++EM
Sbjct: 166 SVT---GTPYWMSPEVISGEGYGR---KADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC---- 66
EF+NE S + + +VV+LLG S+G ++ E M G L ++ ++
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 67 --SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
S +K+ ++A A G+ YL+ +H D+ N ++ +F + DFG+ +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIY 170
Query: 125 ENDFVSISATRG--TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
E D+ +G + +++PE S G + SDV+ FG+VL E+
Sbjct: 171 ETDYYR-KGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 26/194 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E NEV + HH NVV + G + +V EF+ G+L + +R E
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNE---E 118
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAKFHPKE 125
++ V + YLHN ++H DIK +ILL + +SDFG ++K PK
Sbjct: 119 QIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175
Query: 126 NDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMTGGR----RNSNLKA 180
V GT ++APE+ISR +GT + D++ G++++EM G L+A
Sbjct: 176 KSLV------GTPYWMAPEVISRLPYGT---EVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
Query: 181 TRSSKAYFPSWVSD 194
R + P V D
Sbjct: 227 MRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-11
Identities = 46/131 (35%), Positives = 68/131 (51%), Gaps = 16/131 (12%)
Query: 45 EFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNIL 104
EFM GSLDR I+ K G E L ++A G+ YL+N I+H DIKP NIL
Sbjct: 83 EFMDCGSLDR-IYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNIL 136
Query: 105 LDHNFVPNVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162
++ + DFG++ + + FV GT Y++PE I G + KSDV+
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMSPERIQG--GKYTVKSDVWSL 188
Query: 163 GMVLLEMTGGR 173
G+ ++E+ G+
Sbjct: 189 GISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 41/196 (20%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG---SLDRHIFP-KESRGQSCSW 68
+ E+ + ++H N+++LL LV+EFM + ES +S +
Sbjct: 46 LREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLY 105
Query: 69 EKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKEN 126
+ L G+ + H +G ILH D+KP N+L++ V ++DFGLA+ F
Sbjct: 106 QLLQ--------GLAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153
Query: 127 DFVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSS 184
+ TR Y APEL+ + + T D++ G + E+ R
Sbjct: 154 PYTHYVVTR---WYRAPELLLGDKGYST---PVDIWSVGCIFAELLSRR----------- 196
Query: 185 KAYFP--SWVSDQLNK 198
FP S + DQL K
Sbjct: 197 -PLFPGKSEI-DQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-11
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG------QS 65
F+ EV ++H NV+Q LG C E LV EF P G L ++ + +RG Q
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQK 99
Query: 66 CSWEKL-HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
+++ EVASG LH +H D+ N L + + D+GLA
Sbjct: 100 DVLQRMACEVASGLLW----LHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152
Query: 125 ENDFVSISATRGTIGYIAPELIS---RNFGTV--SCKSDVYGFGMVLLEM 169
E+ +++ + ++APEL+ ++ + KS+++ G+ + E+
Sbjct: 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-11
Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 21/164 (12%)
Query: 19 IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE--------- 69
IG+ H N++ LLG C++ ++ E+ G+L ++ + G S++
Sbjct: 77 IGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 70 KLHEVASGT---AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
++ S T A G+EYL CI H D+ N+L+ N V ++DFGLA+ +
Sbjct: 135 TFKDLVSCTYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 127 DFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 169
+ + R + ++APE L R + + +SDV+ FG+++ E+
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-10
Identities = 60/244 (24%), Positives = 108/244 (44%), Gaps = 54/244 (22%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E E+ + R++H +++++LG E S L E+M GS+ + + ++
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN 107
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDF 128
++ G + YLH + I+H D+K N+L+D ++DFG A
Sbjct: 108 YTEQLLRGLS----YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA-------R 153
Query: 129 VSISATR---------GTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGR----- 173
++ T GTI ++APE++ +G SC DV+ G V++EM +
Sbjct: 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGR-SC--DVWSVGCVIIEMATAKPPWNA 210
Query: 174 -RNSNLKAT--RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKP 230
++SN A + + A + + L+ G LR+VT L C++++P
Sbjct: 211 EKHSNHLALIFKIASATTAPSIPEHLSPG----LRDVT--------------LRCLELQP 252
Query: 231 ADRP 234
DRP
Sbjct: 253 EDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 21/187 (11%)
Query: 1 MLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFC--SEGSKR----ALVYEFMPNGS 51
ML+ FS+ EEF+ E + + H NV++L+G S R ++ FM +G
Sbjct: 34 MLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGD 93
Query: 52 LDRHIFPKESR-GQ---SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH 107
L H F SR G+ + + L A G+EYL + +H D+ N +L+
Sbjct: 94 L--HTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNE 148
Query: 108 NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167
N V+DFGL+K + + A++ + ++A E ++ N T SDV+ FG+ +
Sbjct: 149 NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT--HSDVWAFGVTMW 206
Query: 168 E-MTGGR 173
E MT G+
Sbjct: 207 EIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+NE+ + + H N++ + + + E+ G+L I +GQ E +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVL 104
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
+ Y+H ILH DIK NI L + + DFG++K S++
Sbjct: 105 WYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISK---ILGSEYSMA 158
Query: 133 AT-RGTIGYIAPEL---ISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF 188
T GT Y++PEL + NF KSD++ G VL E+ L R+ A
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNF-----KSDIWALGCVLYEL--------LTLKRTFDA-- 203
Query: 189 PSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
++ LN + N T + S+ + +L + +Q P RP+
Sbjct: 204 ----TNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 44/174 (25%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD----RHIFPK- 59
+K + +F+ E+ + R+ N+++LL C ++ E+M NG L+ RH +
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118
Query: 60 --ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
++ + S+ L +A+ A G++YL + + +H D+ N L+ N+ ++DFG
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFG 175
Query: 118 LAKFHPKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+++ + D+ I R I +++ E I G + SDV+ FG+ L E+
Sbjct: 176 MSR-NLYSGDYYRIQG-RAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 52/184 (28%), Positives = 75/184 (40%), Gaps = 41/184 (22%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMP------NGSLDRHIFPKESRG 63
E+ + ++ H NVV L+ E KR VY P +G L+
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH- 122
C +L E GI YLH + ILH DIK NIL+D+ + ++DFGLA+ +
Sbjct: 117 IKCYMLQLLE-------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 123 -----------PKENDFVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 169
+ ++ TR Y PEL+ R + T D++G G V EM
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTR---WYRPPELLLGERRYTT---AVDIWGIGCVFAEM 220
Query: 170 TGGR 173
R
Sbjct: 221 FTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 48/180 (26%), Positives = 70/180 (38%), Gaps = 22/180 (12%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHV-----NVVQLLGFCSEGSKRALVYEFMPNGSLDRH 55
+L+ S A+ + V I + V +L LV E++ G
Sbjct: 28 VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASL 87
Query: 56 IFPKESRGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVS 114
I K G W K + + G+E LH G I+H DIKP N+L+D ++
Sbjct: 88 I--KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG----IIHRDIKPENLLIDQTGHLKLT 139
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
DFGL++ + FV GT Y+APE I D + G V+ E G
Sbjct: 140 DFGLSRNGLENKKFV------GTPDYLAPETILGVGDDKMS--DWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 12/168 (7%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK-ES 61
EN K +E + E + ++ + +V+++G C E LV E G L++ + K +
Sbjct: 33 ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE 91
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK- 120
S E +H+V+ G ++YL V H D+ N+LL + +SDFGL+K
Sbjct: 92 ITVSNVVELMHQVSMG----MKYLEGKNFV---HRDLAARNVLLVNQHYAKISDFGLSKA 144
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168
++ + + SA + + + APE I NF S +SDV+ +G+ + E
Sbjct: 145 LGADDSYYKARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 26/176 (14%)
Query: 12 FINEVSTIGRIHHVNVVQLL--GFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
F E + R++H N+V LL G G A V+E++P +L R + + G + E
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYVPGRTL-REVLAAD--GALPAGE 80
Query: 70 KLH---EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFV-PN--VSDFGLAKFHP 123
+V A HN I+H D+KP NI++ V P+ V DFG+ P
Sbjct: 81 TGRLMLQVLDALACA----HNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLP 133
Query: 124 KENDFVSISATR-----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
D + TR GT Y APE + R V+ SD+Y +G++ LE G+R
Sbjct: 134 GVRDADVATLTRTTEVLGTPTYCAPEQL-RG-EPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 40/162 (24%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E+ + ++H N+V+ G C+E L+ EF+P+GSL ++ P+ + ++
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNK--NKINLKQQL 112
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
+ A G++YL + V H D+ N+L++ + DFGL K + ++ ++
Sbjct: 113 KYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 133 ATRGT-IGYIAPELISRNFGTVSCK----SDVYGFGMVLLEM 169
+ + + APE + + K SDV+ FG+ L E+
Sbjct: 170 DDLDSPVFWYAPECL------IQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 48/160 (30%), Positives = 87/160 (54%), Gaps = 13/160 (8%)
Query: 14 NEVSTIGRIHHVNVVQL-LGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E + ++H +V+L F +EG K L+ +F+ G L F + S+ + E +
Sbjct: 47 MERDILAEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVK 101
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
+ A +++LH+ + I++ D+KP NILLD ++DFGL+K +++ + S
Sbjct: 102 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYS 157
Query: 133 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
GT+ Y+APE+++R T S +D + FG+++ EM G
Sbjct: 158 FC-GTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+NE + +++ VV L LV M G L HI+ + G E+
Sbjct: 48 LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERAL 105
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
A+ G+E LH ++ D+KP NILLD +SD GLA P+ SI
Sbjct: 106 FYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIR 159
Query: 133 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
GT+GY+APE+++ T+S D +G G ++ EM G+
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLS--PDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-10
Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 27/170 (15%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS----LDRHIFPKESRGQSCSWEK 70
E++ + + H N+VQ LG + + E++P GS L+ + +E+ ++ +
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI 115
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L G+ YLHN I+H DIK NIL+D+ +SDFG++K K
Sbjct: 116 L--------KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSL 161
Query: 131 ISATR-------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ T G++ ++APE++ + T K+D++ G +++EM G+
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTR--KADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-10
Identities = 43/132 (32%), Positives = 62/132 (46%), Gaps = 10/132 (7%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
LV M G L HI+ RG E++ ++ GI +LH + I++ D+KP
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLH---SMDIVYRDMKPE 124
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161
N+LLD +SD GLA D +I+ GT GY+APE++ S D +
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKEE--PYSYPVDWFA 179
Query: 162 FGMVLLEMTGGR 173
G + EM GR
Sbjct: 180 MGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 51/163 (31%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+NE + +++ VV L LV M G L HI+ G +E+
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGR 103
Query: 73 EV--ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
V A+ G+E LH I++ D+KP NILLD + +SD GLA P+ +
Sbjct: 104 AVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T 157
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
I GT+GY+APE++ T S D + G +L EM G+
Sbjct: 158 IKGRVGTVGYMAPEVVKNERYTFS--PDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 53/182 (29%), Positives = 77/182 (42%), Gaps = 35/182 (19%)
Query: 1 MLENSKFSAEEF---INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS----LD 53
M + K S E++ I EV + ++ H N ++ G LV E+ GS L+
Sbjct: 48 MSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILE 106
Query: 54 RHIFPKESRGQSCSWEKLHEV-----ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN 108
H P L EV G G+ YLH+ +H DIK NILL
Sbjct: 107 VHKKP------------LQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEP 151
Query: 109 FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLL 167
++DFG A N FV GT ++APE+I + + G K DV+ G+ +
Sbjct: 152 GTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 168 EM 169
E+
Sbjct: 206 EL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-10
Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKESR--GQS 65
++ + E+ + +++H NV++ L E ++ +V E G L + I F K+ R +
Sbjct: 47 QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPER 106
Query: 66 CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
W+ ++ S +E++H+ ++H DIKP N+ + V + D GL +F +
Sbjct: 107 TVWKYFVQLCSA----VEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 126 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ + GT Y++PE I N + KSD++ G +L EM
Sbjct: 160 T--TAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-10
Identities = 41/132 (31%), Positives = 57/132 (43%), Gaps = 10/132 (7%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
LV M G L HI+ G + + A+ G+E+LH I++ D+KP
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFY--AAQIICGLEHLHQ---RRIVYRDLKPE 124
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161
N+LLD + +SD GLA I GT GY+APE++ D +
Sbjct: 125 NVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG--EVYDFSVDWFA 179
Query: 162 FGMVLLEMTGGR 173
G L EM GR
Sbjct: 180 LGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-10
Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+NE + +++ VV L + E +K AL V M G L HI+ + G E+
Sbjct: 48 LNEKQILEKVNSRFVVSL-AYAYE-TKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEER 103
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
A+ G+E LH I++ D+KP NILLD +SD GLA E + +
Sbjct: 104 AVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE--T 157
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
I GT+GY+APE++ T S D +G G ++ EM G+
Sbjct: 158 IRGRVGTVGYMAPEVVKNERYTFS--PDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-10
Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 11 EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG------ 63
+ I+E+ + I H N++ LLG C++ ++ E+ G+L ++ + G
Sbjct: 69 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128
Query: 64 ------QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
+ S++ L A A G+EYL CI H D+ N+L+ + V ++DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFG 185
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 169
LA+ + + + R + ++APE L R + + +SDV+ FG++L E+
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 21/164 (12%)
Query: 19 IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK-------- 70
IG+ H N++ LLG C++ ++ E+ G+L ++ + G S++
Sbjct: 74 IGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 71 ----LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
L A A G+EYL CI H D+ N+L+ + V ++DFGLA+ +
Sbjct: 132 TFKDLVSCAYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 127 DFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 169
+ + R + ++APE L R + + +SDV+ FG++L E+
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 9e-10
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 19/164 (11%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG--SLDRHIFPKESRGQSCSWEKLH 72
E+ + H VV+LL GS LV E+MP+ + R Q S+ ++
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM- 107
Query: 73 EVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI 131
G+ Y+H NG I+H D+KP N+L+ + V ++DFGLA+ +E
Sbjct: 108 -----LLKGVAYMHANG----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157
Query: 132 SATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
S T Y APEL+ +R + D++ G + E+ G
Sbjct: 158 SHQVATRWYRAPELLYGARKYDP---GVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E NEV + H NVV++ G + +V EF+ G+L + +R E
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNE---E 116
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAKFHPKE 125
++ V + LH ++H DIK +ILL H+ +SDFG ++K P+
Sbjct: 117 QIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173
Query: 126 NDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMTGG 172
V GT ++APELISR +G + D++ G++++EM G
Sbjct: 174 KSLV------GTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 49/168 (29%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E NEV + H NVV++ G + ++ EF+ G+L + ++R + E
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQTR---LNEE 117
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAKFHPKE 125
++ V + YLH+ ++H DIK +ILL + +SDFG ++K PK
Sbjct: 118 QIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174
Query: 126 NDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMTGG 172
V GT ++APE+ISR +GT + D++ G++++EM G
Sbjct: 175 KSLV------GTPYWMAPEVISRTPYGT---EVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-09
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKESRGQSCS 67
EF+NE S + +VV+LLG S+G +V E M +G L R + P+
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 68 WEKLHEV---ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
L E+ A+ A G+ YL+ V H D+ N ++ H+F + DFG+ +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR-DIY 170
Query: 125 ENDFVSISATRG--TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170
E D+ +G + ++APE S G + SD++ FG+VL E+T
Sbjct: 171 ETDYYR-KGGKGLLPVRWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-09
Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 24/177 (13%)
Query: 6 KF-SAEEFIN--EVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
KF S EE +N EV ++ ++ H N+V+L E + V+E+M G+L + K+
Sbjct: 35 KFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNL--YQLMKDR 91
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+G+ S + + G+ ++H +G H D+KP N+L+ V ++DFGLA+
Sbjct: 92 KGKPFSESVIRSIIYQILQGLAHIHKHG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147
Query: 121 FHPKEN----DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ D+VS TR Y APE++ R+ + S D++ G ++ E+ R
Sbjct: 148 -EIRSRPPYTDYVS---TR---WYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-09
Identities = 65/253 (25%), Positives = 98/253 (38%), Gaps = 52/253 (20%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKES 61
S+ +F+ E + + +H N+V+L+G E R ++ E M G L R P+
Sbjct: 49 SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE 108
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDH---NFVPNVSDFG 117
R S + + L A A G +YL N +H DI N LL V ++DFG
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFG 164
Query: 118 LAKFHPKENDFVSISATRG------TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG 171
+A+ D S R I ++ PE G + K+DV+ FG++L E+
Sbjct: 165 MAR------DIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFS 216
Query: 172 -------GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224
GR N V + + GG L+ + R I
Sbjct: 217 LGYMPYPGRTNQE--------------VMEFVTGGGRLD--PPKGCPGPVYR----IMTD 256
Query: 225 CIQVKPADRPSMT 237
C Q P DRP+
Sbjct: 257 CWQHTPEDRPNFA 269
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 41/162 (25%), Positives = 81/162 (50%), Gaps = 15/162 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+E + E + + ++ + +V+++G C E LV E G L++ + + + + +
Sbjct: 41 DELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEK 95
Query: 70 KLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKEN 126
+ E+ + G++YL N +H D+ N+LL +SDFGL+K EN
Sbjct: 96 NITELVHQVSMGMKYLEETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150
Query: 127 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168
+ + + + + + APE + N+ S KSDV+ FG+++ E
Sbjct: 151 YYKAKTHGKWPVKWYAPECM--NYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
EF E+ ++ H NVV+LLG C E ++ E+ G L + + +S+ +
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 71 L---HEVASGT--AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK----- 120
L +VA T A G+++L N +H D+ N L+ VS L+K
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 121 -FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++ N + + ++APE + + S KSDV+ FG+++ E+
Sbjct: 171 EYYKLRNALIPLR-------WLAPEAVQED--DFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-09
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73
EV + ++ H N+V E + +V E+ G L + I RG S +++
Sbjct: 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILS 105
Query: 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSIS 132
+ G++++H D ILH DIK NI L N V + DFG+A+ + ND + ++
Sbjct: 106 WFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELA 159
Query: 133 AT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
T GT Y++PE+ + K+D++ G VL E+
Sbjct: 160 YTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 24 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-------------FPKESRGQSCSWEK 70
H N++ LLG C++ ++ E+ G+L + K Q ++
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS-FKD 135
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L A A G+EYL + CI H D+ N+L+ + V ++DFGLA+ + +
Sbjct: 136 LVSCAYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 131 ISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 169
S R + ++APE L R + + +SDV+ FG+++ E+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-09
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E INE+ + H N+V L G + +V E++ GSL + ++C E
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDE 114
Query: 70 -KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL-AKFHPKEND 127
++ V +E+LH+ ++H DIK NILL + ++DFG A+ P+++
Sbjct: 115 GQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170
Query: 128 FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMTGG 172
S GT ++APE+++R +G K D++ G++ +EM G
Sbjct: 171 --KRSTMVGTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 5e-09
Identities = 41/138 (29%), Positives = 60/138 (43%), Gaps = 25/138 (18%)
Query: 42 LVYEFMPNG---SLDRHI--FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHL 96
LV E++P G SL ++ ++ + +EYLH+ I+H
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDV---------ARIYIAEIVLALEYLHS---NGIIHR 117
Query: 97 DIKPHNILLDHNFVPNVSDFGLAKF------HPKENDFVSISATRGTIGYIAPELISRNF 150
D+KP NIL+D N ++DFGL+K +D GT YIAPE+I
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI-LGQ 176
Query: 151 GTVSCKSDVYGFGMVLLE 168
G S D + G +L E
Sbjct: 177 GH-SKTVDWWSLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 41/165 (24%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 13 INEVSTIGRIH---HVNVVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKESRGQ 64
+ EV+ + R+ H N+V+L+ C+ +K LV+E + D + +
Sbjct: 47 VREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPP 103
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
E + ++ G+++LH C I+H D+KP NIL+ ++DFGLA+ +
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC 160
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ ++++ T+ Y APE++ ++ T + D++ G + EM
Sbjct: 161 Q---MALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-09
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------------ 57
++F E + + H ++V+ G C EG +V+E+M +G L++ +
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 58 -PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
QS + LH +A A G+ YL + +H D+ N L+ N + + DF
Sbjct: 112 NRPAELTQS---QMLH-IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 164
Query: 117 GLAKFHPKENDFVSISA-TRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 169
G+++ D+ + T I ++ PE ++ R F T +SDV+ G+VL E+
Sbjct: 165 GMSR-DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT---ESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-09
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 10/170 (5%)
Query: 15 EVSTIGRIHHVNVVQLL-GFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73
E + ++ H N+V + E +V F G L + KE +G+ ++ E
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVE 106
Query: 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISA 133
A ++YLH + ILH D+K N+ L + V D G+A+ + D S
Sbjct: 107 WFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--ST 161
Query: 134 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183
GT Y++PEL S + KSDV+ G + EM + N K S
Sbjct: 162 LIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
E+F+ E + + H ++V+L+G +E + +V E P G L ++ + S
Sbjct: 51 REKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDL 106
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
L + + + YL + V H DI N+L+ + DFGL+++ ++ +
Sbjct: 107 ASLILYSYQLSTALAYLESKRFV---HRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESY 162
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
S + I ++APE I NF + SDV+ FG+ + E+
Sbjct: 163 YKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-09
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI 138
A G+E+L CI H D+ NILL N V + DFGLA+ K+ D+V R +
Sbjct: 183 ARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 139 GYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 169
++APE I F V + +SDV+ FG++L E+
Sbjct: 240 KWMAPESI---FDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 9e-09
Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 50/162 (30%)
Query: 42 LVYEFMPNGSL-----DRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN-GCDVCILH 95
LV E+MP G L + +FP+E + + +A ++ +H G +H
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEE-------TARFY-IAELVL-ALDSVHKLGF----IH 124
Query: 96 LDIKPHNILLDHNFVPNVSDFGLAK---------------------------FHPKENDF 128
DIKP NIL+D + ++DFGL K +
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 129 VSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 169
V ++T GT YIAPE L +G + D + G++L EM
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEM 223
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKESRGQSCSWEK 70
I E+S + + H N+V L + S+ L++EF+ + L +++ PK GQ E
Sbjct: 47 IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPK---GQYMDAEL 102
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-----FHPKE 125
+ GI + H+ +LH D+KP N+L+D+ V ++DFGLA+
Sbjct: 103 VKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159
Query: 126 NDFVSISATRGTIGYIAPELISRNFGTV--SCKSDVYGFGMVLLEM 169
++ V T+ Y APE++ G+ S D++ G + EM
Sbjct: 160 HEVV-------TLWYRAPEVL---LGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 1e-08
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E INE+ + + + N+V L G + +V E++ GSL + ++C E
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV------TETCMDE 114
Query: 70 -KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL-AKFHPKEND 127
++ V +E+LH ++H DIK N+LL + ++DFG A+ P+++
Sbjct: 115 AQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
S GT ++APE+++R K D++ G++ +EM G
Sbjct: 171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 7/92 (7%)
Query: 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI 138
A G+E+L CI H D+ NILL N V + DFGLA+ K+ D+V + R +
Sbjct: 184 ARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 139 GYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 169
++APE I F V + +SDV+ FG++L E+
Sbjct: 241 KWMAPESI---FDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKESRGQSCSWEK 70
I E+S + ++H N+V+LL +K LV+EF+ + L +++ P
Sbjct: 46 IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
L+++ GI Y H+ +LH D+KP N+L+D ++DFGLA+
Sbjct: 105 LYQLL----QGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALV-YEFMPNGSLDRHIFPKESR------GQ 64
+ E + + H N++ +L C E + V Y +M G+L +F ++ R Q
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQ 112
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHP 123
+ S ++L +A A G+ YLH ++H DI N ++D ++D L++ P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170
+ + + R + ++A E + S SDV+ FG++L E+
Sbjct: 170 MDYHCLGDNENR-PVKWMALESLVNKE--YSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 56/191 (29%), Positives = 80/191 (41%), Gaps = 48/191 (25%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP--NG----SLDRHIFPKESRGQS 65
F+ E + H +V + CS+G VY MP G SL + ++ KES +
Sbjct: 49 FLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSK- 104
Query: 66 CSWEKLHEVASGTA---------HGIEYLHN-GCDVCILHLDIKPHNILLDHNFVPNVSD 115
+L E S A IEY+H+ G +LH D+KP NILL + D
Sbjct: 105 ----ELAEKTSVGAFLSIFHKICATIEYVHSKG----VLHRDLKPDNILLGLFGEVVILD 156
Query: 116 FGLAKF-HPKENDFVSISATR---------------GTIGYIAPELISRNFGT-VSCKSD 158
+G A F +E D + I GT Y+APE R G S +D
Sbjct: 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTD 213
Query: 159 VYGFGMVLLEM 169
+Y G++L +M
Sbjct: 214 IYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 14/161 (8%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
++ I EV + ++ H N ++ G + LV E+ + D E +
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDL----LEVHKKPLQEV 121
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ + G G+ YLH+ ++H DIK NILL ++DFG A N FV
Sbjct: 122 EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV 178
Query: 130 SISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEM 169
GT ++APE+I + + G K DV+ G+ +E+
Sbjct: 179 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 36/95 (37%), Positives = 47/95 (49%), Gaps = 15/95 (15%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK---FHPKENDFVSISATRGTI 138
EYLHN I++ D+KP N+LLD N + DFG AK K F GT
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTP 156
Query: 139 GYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGG 172
Y+APE+I N G D + G++L E +TG
Sbjct: 157 EYVAPEIIL-NKGY-DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 23/167 (13%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E + I+H +++QL G + L+ +P D + + R + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC--DIL 185
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
+ I+YLH I+H DIK NI ++H + DFG A F V I+
Sbjct: 186 AIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP------VDIN 236
Query: 133 ATR-----GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMTGGR 173
A + GTI APEL++R+ +G D++ G+VL EM
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND-------FVSISA 133
G++Y+H +V LH D+KP N+LL+ N + DFGLA+ E+D +V A
Sbjct: 118 GLKYIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV---A 171
Query: 134 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
TR Y APE I N + D++ G +L EM R
Sbjct: 172 TR---WYRAPE-IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 21 RIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF-PKESRGQSCSWEKLHEVASGTA 79
++H +V+++ G+ +V +P+ S D + + K SR ++ +
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSR--PLPIDQALIIEKQIL 167
Query: 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIG 139
G+ YLH I+H D+K NI ++ + D G A+F F+ ++ GT+
Sbjct: 168 EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA---GTVE 221
Query: 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
APE+++R+ + K+D++ G+VL EM
Sbjct: 222 TNAPEVLARD--KYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSISATR-GTI 138
G+ Y+H ILH D+K NIL+ + + ++DFGLA+ F +N + R T+
Sbjct: 131 GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 139 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 169
Y PEL+ R++G D++G G ++ EM
Sbjct: 188 WYRPPELLLGERDYGP---PIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 42/133 (31%), Positives = 68/133 (51%), Gaps = 21/133 (15%)
Query: 22 IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH-----IFPKESRGQSCSWEKLHEVAS 76
+ H +V L+ G K L+ E++ G L H IF +++ +C + L E++
Sbjct: 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT---ACFY--LSEISL 111
Query: 77 GTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR- 135
+E+LH I++ D+KP NILLD ++DFGL K E +++ T
Sbjct: 112 A----LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFC 161
Query: 136 GTIGYIAPELISR 148
GTI Y+APE++ R
Sbjct: 162 GTIEYMAPEILMR 174
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 20/181 (11%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+F+ E+ + H N+V L +K ++ EF G+LD I + RG +
Sbjct: 47 EDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALD-SIMLELERGLTEP-- 103
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAKFHPKE 125
++ V + +LH+ ++H D+K NILL + ++DFG K
Sbjct: 104 QIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160
Query: 126 NDFVSISATRGTIGYIAPELIS-RNFGT--VSCKSDVYGFGMVLLEMTGGR-RNSNLKAT 181
+ F+ GT ++APE+++ F K+D++ G+ L+E+ + L
Sbjct: 161 DTFI------GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214
Query: 182 R 182
R
Sbjct: 215 R 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI 138
A G+E+L CI H D+ NILL N V + DFGLA+ K+ D+V R +
Sbjct: 189 AKGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 139 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++APE I T+ +SDV+ FG++L E+
Sbjct: 246 KWMAPETIFDRVYTI--QSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 28/167 (16%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN---GSLDRHIFPK---ESRGQSCSW 68
E+ + ++ H N+V L+ K LV+E+ + L+++ P+ E + W
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIW 107
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF-HPKEND 127
+ L V H CI H D+KP NIL+ + DFG A+ +D
Sbjct: 108 QTLQAVNFCHKHN----------CI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 128 FVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGG 172
+ ATR Y APEL+ +G DV+ G V E+ G
Sbjct: 157 YTDYVATR---WYRAPELLVGDTQYGP---PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 47/177 (26%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC---- 66
EF+ E + +H N+V+LLG C + ++ E M G L ++ +++R +
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPL 102
Query: 67 -SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL-----DHNFVPNVSDFGLAK 120
+ ++L ++ A G YL + +H D+ N L+ D + V + DFGLA+
Sbjct: 103 LTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
Query: 121 FHPKENDFVSISATRG-TIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
K +D+ + ++APE L+ F T +SDV+ FG+++ E +T G++
Sbjct: 160 DIYK-SDYYRKEGEGLLPVRWMAPESLLDGKFTT---QSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
G++YLH+ ILH DIKP N+L++ N V + DFGLA+ + ++ ++ T Y
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQYY 170
Query: 141 IAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
APE++ SR++ + D++ G + E+ G R
Sbjct: 171 RAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-08
Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EE EV+ + + H N+VQ E +V ++ G L + I RG +
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPED 101
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ + ++++H D ILH DIK NI L + + DFG+A+ N V
Sbjct: 102 QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTV 155
Query: 130 SISAT-RGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMT--------GGRRNSNLK 179
++ T GT Y++PE+ +R + KSD++ G VL EM G +N LK
Sbjct: 156 ELARTCIGTPYYLSPEICENRPYNN---KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212
Query: 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
R S S S +LRN+ + + R P DRPS+
Sbjct: 213 IIRGSYPPVSSHYS--------YDLRNL--VSQLFKR------------NPRDRPSV 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 39/186 (20%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK-- 70
I E+S + ++H N+V+LL +K LV+EF+ + L + + G K
Sbjct: 47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSY 105
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-----FHPKE 125
L ++ G+ + H+ +LH D+KP N+L++ ++DFGLA+
Sbjct: 106 LFQLL----QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158
Query: 126 NDFVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183
++ V T+ Y APE++ + + T D++ G + EM TR
Sbjct: 159 HEVV-------TLWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMV----------TR- 197
Query: 184 SKAYFP 189
+A FP
Sbjct: 198 -RALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-08
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 23/159 (14%)
Query: 22 IHHVNVVQLLGFC----SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASG 77
+H N ++GF S+G + ++ E M GSLD+ + KE++ E L +V+
Sbjct: 57 LHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL--KEAK--RIPEEILGKVSIA 111
Query: 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK--FHPKENDFVSISATR 135
G+ YL I+H D+KP NIL++ + DFG++ N FV
Sbjct: 112 VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 163
Query: 136 GTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMTGGR 173
GT Y++PE + GT S +SD++ G+ L+E+ GR
Sbjct: 164 GTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 51 SLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFV 110
SLD+ +G + + L ++A +EYLH+ V +H D+KP N+L++ N
Sbjct: 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQ 142
Query: 111 PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS--RNFGTVSCKSDVYGFGMVLLE 168
+ DFG++ + D V+ + G Y+APE I+ N KSDV+ G+ ++E
Sbjct: 143 VKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199
Query: 169 MTGGR 173
+ GR
Sbjct: 200 LATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+NE + +++ VV L + E +K AL V M G L HI+ + G ++
Sbjct: 48 LNEKRILEKVNSRFVVSL-AYAYE-TKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQR 103
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
A+ G+E L I++ D+KP NILLD +SD GLA P+ +
Sbjct: 104 AIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---T 157
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ GT+GY+APE+I+ T S D +G G ++ EM G+
Sbjct: 158 VRGRVGTVGYMAPEVINNEKYTFS--PDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 16/131 (12%)
Query: 45 EFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNIL 104
E M GSLD+ + K R L +++ G+ YL I+H D+KP NIL
Sbjct: 79 EHMDGGSLDQ-VLKKAGR---IPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNIL 132
Query: 105 LDHNFVPNVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162
++ + DFG++ N FV GT Y++PE + TV SD++
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQ--SDIWSL 184
Query: 163 GMVLLEMTGGR 173
G+ L+EM GR
Sbjct: 185 GLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 5e-08
Identities = 36/130 (27%), Positives = 53/130 (40%), Gaps = 38/130 (29%)
Query: 81 GIEYLH--NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF----HPKENDFVSISAT 134
G++YLH N ++H D+KP NIL++ N + DFGLA+ ++ T
Sbjct: 115 GLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 135 RGTIGYIAPELISRNFGTVSCKS-----DVYGFGMVLLEMTGGRRNSNLKATRSSKAYFP 189
R Y APEL+ +S D++ G + E+ K FP
Sbjct: 170 R---WYRAPELL------LSSSRYTKAIDIWSVGCIFAELLTR------------KPLFP 208
Query: 190 -SWVSDQLNK 198
DQLN
Sbjct: 209 GRDYIDQLNL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-08
Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E INE+ + + N+V L G + +V E++ GSL + ++C E
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDE 115
Query: 70 -KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL-AKFHPKEND 127
++ V +E+LH+ ++H DIK NILL + ++DFG A+ P+++
Sbjct: 116 GQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
S GT ++APE+++R K D++ G++ +EM G
Sbjct: 172 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 39 KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDI 98
K + + + M G L H+ S+ S ++ A+ G+E++HN +++ D+
Sbjct: 71 KLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDL 123
Query: 99 KPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158
KP NILLD + +SD GLA K+ S+ GT GY+APE++ + S +D
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYDS-SAD 178
Query: 159 VYGFGMVLLEMTGGRRNSNLKATRSS 184
+ G +L ++ G T+
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
++ I EV + RI H N ++ G LV E+ + D E +
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEV 125
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ + G G+ YLH+ ++H DIK NILL ++DFG A N FV
Sbjct: 126 EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV 182
Query: 130 SISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEM 169
GT ++APE+I + + G K DV+ G+ +E+
Sbjct: 183 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-08
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALV--YEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E+ + + H +VQ G + +++ L E+MP GS+ + + +S + +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSI 131
++ G+ YLH+ I+H DIK NIL D + DFG +K I
Sbjct: 114 QIL----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 132 SATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEM 169
+ GT +++PE+IS +G K+DV+ G ++EM
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGR---KADVWSLGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 13/133 (9%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
V E++ G L H+ SR + S ++ + ++YLH+G I++ D+K
Sbjct: 72 FVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLE 124
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVY 160
N++LD + ++DFGL K D ++ GT Y+APE++ N +G D +
Sbjct: 125 NLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRA---VDWW 179
Query: 161 GFGMVLLEMTGGR 173
G G+V+ EM GR
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 9e-08
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E INE+ + + N+V L G + +V E++ GSL + ++C E
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDE 114
Query: 70 -KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL-AKFHPKEND 127
++ V +++LH+ ++H DIK NILL + ++DFG A+ P+++
Sbjct: 115 GQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
S GT ++APE+++R K D++ G++ +EM G
Sbjct: 171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 38/118 (32%), Positives = 58/118 (49%), Gaps = 19/118 (16%)
Query: 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIA 142
EYLH+ D I++ D+KP N+LLD+ V+DFG AK P + F GT Y+A
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFTLC----GTPEYLA 183
Query: 143 PELI-SRNFGTVSCKSDVYGFGMVLLEMTGGR----RNSNLKATR---SSKAYFPSWV 192
PE+I S+ G D + G++L E G ++ + + + FP+W
Sbjct: 184 PEVIQSKGHGKA---VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238
|
Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 42/131 (32%), Positives = 61/131 (46%), Gaps = 21/131 (16%)
Query: 45 EFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNIL 104
EFM GSLD + + L +A G+ YL + + ILH D+KP N+L
Sbjct: 79 EFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNML 127
Query: 105 LDHNFVPNVSDFGLAKFHPKENDFV-SISATR-GTIGYIAPELISRNFGTVSCKSDVYGF 162
++ + DFG++ V SI+ T GT Y+APE IS SDV+
Sbjct: 128 VNTRGQVKLCDFGVST------QLVNSIAKTYVGTNAYMAPERISGE--QYGIHSDVWSL 179
Query: 163 GMVLLEMTGGR 173
G+ +E+ GR
Sbjct: 180 GISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 42/167 (25%), Positives = 84/167 (50%), Gaps = 19/167 (11%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+++ E+ + +H +V+LLG K ++ EF P G++D I + RG +
Sbjct: 54 EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA-IMLELDRG--LTEP 110
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA----KFHPKE 125
++ + ++YLH+ + I+H D+K N+LL + ++DFG++ K +
Sbjct: 111 QIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167
Query: 126 NDFVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLLEM 169
+ F+ GT ++APE++ + K+D++ G+ L+EM
Sbjct: 168 DSFI------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 60/236 (25%), Positives = 104/236 (44%), Gaps = 29/236 (12%)
Query: 3 ENSKFSA-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
EN+ A +E ++E + + V +LLG C S LV + MP G L ++ +E+
Sbjct: 46 ENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYV--REN 102
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
+ + S + L+ A G+ YL +V ++H D+ N+L+ ++DFGLA+
Sbjct: 103 KDRIGSQDLLNWCVQ-IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
Query: 122 HPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNLK 179
+ + I ++A E ++ R F + +SDV+ +G+ + E MT G + +
Sbjct: 159 LDIDETEYHADGGKVPIKWMALESILHRRF---THQSDVWSYGVTVWELMTFGAKPYDGI 215
Query: 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIES-MIARKLCVIGLWCIQVKPADRP 234
R + D L KG L + I+ MI K C + RP
Sbjct: 216 PARE--------IPDLLEKGERLPQPPICTIDVYMIMVK-------CWMIDSECRP 256
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-07
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
EF++E + + H ++V+LLG C + + LV + MP+G L ++ + S +
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGS---QL 110
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L A G+ YL + ++H D+ N+L+ ++DFGLA+ + +
Sbjct: 111 LLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNLKATRSSKAYFP 189
+ I ++A E I ++ + +SDV+ +G+ + E MT G + + TR
Sbjct: 168 ADGGKMPIKWMALECI--HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------ 219
Query: 190 SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229
+ D L KG E + +C I ++ + VK
Sbjct: 220 --IPDLLEKG-----------ERLPQPPICTIDVYMVMVK 246
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
++ I EV + ++ H N +Q G LV E+ + D E +
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEV 115
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ V G G+ YLH+ ++H D+K NILL + + DFG A N FV
Sbjct: 116 EIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 172
Query: 130 SISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEM 169
GT ++APE+I + + G K DV+ G+ +E+
Sbjct: 173 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 14/135 (10%)
Query: 39 KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDI 98
K + + M G L H+ S+ S +++ A+ G+E++HN +++ D+
Sbjct: 71 KLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDL 123
Query: 99 KPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV-SCKS 157
KP NILLD + +SD GLA K+ S+ GT GY+APE++ + GT +
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQK--GTAYDSSA 177
Query: 158 DVYGFGMVLLEMTGG 172
D + G +L ++ G
Sbjct: 178 DWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI 138
A G+E+L C+ H D+ N+LL + + DFGLA+ ++++VS +T +
Sbjct: 247 ARGMEFL--ASKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 139 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++APE I N T SDV+ +G++L E+
Sbjct: 304 KWMAPESIFDNLYTT--LSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 28/179 (15%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS----LDRHIF 57
LE ++ E+ E+ + + + + G +GSK ++ E+ GS L
Sbjct: 36 LEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL 95
Query: 58 PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
+ L EV G+EYLH + H DIK NILL ++DFG
Sbjct: 96 DETYIA-----FILREV----LLGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFG 143
Query: 118 ----LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
L K N FV GT ++APE+I + K+D++ G+ +E+ G
Sbjct: 144 VSGQLTSTMSKRNTFV------GTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 10/106 (9%)
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
L ++A T + YL ++ I+H D+KP NILLD N + DFG++ + S
Sbjct: 109 LGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVD----S 161
Query: 131 ISATR--GTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMTGGR 173
I+ TR G Y+APE I + +SDV+ G+ L E+ G+
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 38 SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH---GIEYLHNGCDVCIL 94
+K L+ +++ G L H++ +E EV A +++LH + I+
Sbjct: 78 TKLHLILDYVNGGELFTHLYQREHF-------TESEVRVYIAEIVLALDHLHQ---LGII 127
Query: 95 HLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154
+ DIK NILLD ++DFGL+K E + + S GTI Y+APE+I G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGGSGGHD 186
Query: 155 CKSDVYGFGMVLLE-MTG-------GRRNSNLKATR---SSKAYFPSWVS 193
D + G++ E +TG G +NS + +R SK FP +S
Sbjct: 187 KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+E ++E + + + +V +LLG C S L+ + MP G L ++ +E + S
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQY 110
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L+ A G+ YL + ++H D+ N+L+ ++DFGLAK +
Sbjct: 111 LLNWCVQ-IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY-- 187
+ I ++A E I + +SDV+ +G+ + E+ T SK Y
Sbjct: 167 HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELM----------TFGSKPYDG 214
Query: 188 FP-SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234
P S +S L KG L + I+ + +I + C + RP
Sbjct: 215 IPASEISSILEKGERLPQPPICTID------VYMIMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 22/163 (13%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEKL 71
NE + + H +++L F +E +R L + E++P G L ++ + S S S
Sbjct: 50 NEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLF 105
Query: 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI 131
+ AS +EYLH+ I++ D+KP NILLD ++DFG AK
Sbjct: 106 Y--ASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDR 154
Query: 132 SATR-GTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGG 172
+ T GT Y+APE+I S+ D + G+++ EM G
Sbjct: 155 TWTLCGTPEYLAPEVIQSKGHNKA---VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 36/178 (20%)
Query: 33 FCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV---ASGTAHGIEYLHN 87
+C+ +K L V E++ G L HI QSC L A+ G+++LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI-------QSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH----PKENDFVSISATRGTIGYIAP 143
I++ D+K NILLD + ++DFG+ K + K F GT YIAP
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC------GTPDYIAP 165
Query: 144 E-LISRNFGTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
E L+ + + T D + FG++L EM G+ ++ R +P W++
Sbjct: 166 EILLGQKYNT---SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLT 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 21/174 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EEF +E R+ H N+V LLG ++ ++++ + + L + + S +
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 70 KLHEVASG------------TAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSD 115
V S A G+E+L H+ H D+ N+L+ +SD
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISD 167
Query: 116 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
GL + + + + + I +++PE I +G S SD++ +G+VL E+
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 36/178 (20%)
Query: 33 FCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSC---SWEKLHEVASGTAHGIEYLH- 86
FC+ +K L V E++ G L HI QS + A+ G+++LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH----PKENDFVSISATRGTIGYIA 142
G I++ D+K N+LLD + ++DFG+ K + K + F GT YIA
Sbjct: 115 KG----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------GTPDYIA 164
Query: 143 PELISRNFGTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
PE++ S D + FG++L EM G+ + + + + +FP W+S
Sbjct: 165 PEILKGQKYNESV--DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWIS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 12/133 (9%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
V E+ G L H+ SR + S ++ + ++YLH+ +V ++ D+K
Sbjct: 72 FVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLE 125
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVY 160
N++LD + ++DFGL K K D ++ GT Y+APE++ N +G D +
Sbjct: 126 NLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRA---VDWW 180
Query: 161 GFGMVLLEMTGGR 173
G G+V+ EM GR
Sbjct: 181 GLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-07
Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 22 IHHVNVVQLLGFC----SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASG 77
+H N ++GF S+G + ++ E M GSLD+ + K R + L +V+
Sbjct: 57 LHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIA 111
Query: 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK--FHPKENDFVSISATR 135
G+ YL I+H D+KP NIL++ + DFG++ N FV
Sbjct: 112 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 163
Query: 136 GTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMTGGR 173
GT Y++PE + GT S +SD++ G+ L+EM GR
Sbjct: 164 GTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 20/167 (11%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKESRGQSCSWEK 70
I E+S + + H N+V+L + LV+E++ + L +H+ P ++
Sbjct: 49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAK-FHPKENDF 128
L+++ G A Y H+ +LH D+KP N+L+D ++DFGLA+ F F
Sbjct: 108 LYQILRGIA----YCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
Query: 129 VSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
T+ Y APE++ SR++ T D++ G + EM +
Sbjct: 161 THEVV---TLWYRAPEILLGSRHYST---PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 7e-07
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 25/177 (14%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLG-FCSEG-----SKRALVYEFMPNGSLDRHIFPKESR 62
EE E++ + + HH N+ G F + + LV EF GS+ I K ++
Sbjct: 47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTK 104
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----L 118
G + E + + G+ +LH ++H DIK N+LL N + DFG L
Sbjct: 105 GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMTGG 172
+ + N F+ GT ++APE+I+ + T KSD++ G+ +EM G
Sbjct: 162 DRTVGRRNTFI------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-07
Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 22 IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR---GQSCSWEKLH-EVASG 77
+ H N++Q LG C E LV+E+ G L ++ ++ Q +++ E+A+G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGT 137
H + HN LH D+ N L + V D+G+ KE+ +
Sbjct: 112 VTH--MHKHN-----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 138 IGYIAPELI-SRNFGTVSCK----SDVYGFGMVLLEM 169
+ ++APEL+ + G ++ + S+V+ G+ L E+
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-07
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 34/203 (16%)
Query: 33 FCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90
+C+ +K L V EF+ G L HI + +G+ + A+ G+++LH+
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDLYRATF-YAAEIVCGLQFLHSKG- 116
Query: 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISR 148
I++ D+K N++LD + ++DFG+ KEN F A+ GT YIAPE++
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMC----KENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 149 NFGTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVSDQLNKGGN 201
T S D + FG++L EM G+ + ++ R ++P W++
Sbjct: 171 LKYTFSV--DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWIT-------- 220
Query: 202 LELRNVTE--IESMIARKLCVIG 222
E +++ E E R+L V+G
Sbjct: 221 KESKDILEKLFERDPTRRLGVVG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 23/187 (12%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-LDRHIFPKE 60
LE ++ E+ E++ + + V + G +G+K ++ E++ GS LD
Sbjct: 39 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDL------ 92
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA- 119
R ++ + G++YLH+ + H DIK N+LL ++DFG+A
Sbjct: 93 LRAGPFDEFQIATMLKEILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 120 ---KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR-RN 175
K N FV GT ++APE+I ++ K+D++ G+ +E+ G N
Sbjct: 150 QLTDTQIKRNTFV------GTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPN 201
Query: 176 SNLKATR 182
S++ R
Sbjct: 202 SDMHPMR 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 44/239 (18%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
+E F S + ++ H ++V G C G + +V E++ GSLD ++ K + SW
Sbjct: 43 SESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW 101
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN---------FVPNVSDFGLA 119
KL EVA A + +L D + H ++ N+LL F+ +SD G++
Sbjct: 102 -KL-EVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGIS 155
Query: 120 -KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRN-S 176
PKE I R I ++ PE I N +S +D + FG L E+ +GG + S
Sbjct: 156 ITVLPKE-----ILLER--IPWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207
Query: 177 NLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
L + + + Y D+ L TE+ ++I + C+ +P RPS
Sbjct: 208 ALDSQKKLQFY-----EDRH----QLPAPKWTELANLINQ--------CMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 20/166 (12%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
I EVS + + H N+V L LV+E+ LD+ + K+ + +H
Sbjct: 52 IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY-----LDKDL--KQYMDDCGNIMSMH 104
Query: 73 EVA---SGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
V G+ Y H +LH D+KP N+L++ ++DFGLA+ K
Sbjct: 105 NVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTK 159
Query: 130 SISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ S T+ Y P+++ S + T + D++G G + EM GR
Sbjct: 160 TYSNEVVTLWYRPPDVLLGSSEYST---QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 17/165 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E E+S + H N+V G K +V E+ GSL I+ + +RG S
Sbjct: 45 EIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-DIY-QVTRG-PLSEL 101
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA----KFHPKE 125
++ V T G+ YLH +H DIK NILL + ++DFG++ K
Sbjct: 102 QIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158
Query: 126 NDFVSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEM 169
F+ GT ++APE+ + G K D++ G+ +E+
Sbjct: 159 KSFI------GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 40/133 (30%), Positives = 66/133 (49%), Gaps = 13/133 (9%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
V E+ G L H+ SR + + E+ + +EYLH+ +++ DIK
Sbjct: 72 FVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLE 124
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVY 160
N++LD + ++DFGL K +D ++ GT Y+APE++ N +G D +
Sbjct: 125 NLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA---VDWW 179
Query: 161 GFGMVLLEMTGGR 173
G G+V+ EM GR
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF---HPKENDFVSIS--ATR 135
G++Y+H+ ++H D+KP N+L++ + + DFG+A+ P E+ + ATR
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 136 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APEL+ + + D++ G + EM G R
Sbjct: 176 ---WYRAPELL-LSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV--ASGTAHGIEYLHNGCDVCILHLDIK 99
V E++ G L I Q +++ H V A+ A G+ +LH+ I++ D+K
Sbjct: 78 FVMEYVNGGDLMYQI------QQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLK 128
Query: 100 PHNILLDHNFVPNVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSCKS 157
N++LD ++DFG+ KEN D V+ GT YIAPE+I+ +
Sbjct: 129 LDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFCGTPDYIAPEIIA--YQPYGKSV 182
Query: 158 DVYGFGMVLLEMTGGR 173
D + FG++L EM G+
Sbjct: 183 DWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 38 SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH---GIEYLHNGCDVCIL 94
+K L+ +++ G L H+ +E + EV + +E+LH + I+
Sbjct: 78 TKLHLILDYINGGELFTHLSQRERFKE-------QEVQIYSGEIVLALEHLHK---LGII 127
Query: 95 HLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRNFGTV 153
+ DIK NILLD N ++DFGL+K FH E + + GTI Y+AP+++ G
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 154 SCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
D + G+++ E+ G + ++S+A
Sbjct: 186 DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 21/186 (11%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE ++ E+ E++ + + + + G +G+K ++ E++ GS + P
Sbjct: 39 LEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPL 98
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA-- 119
++ L E+ G ++YLH+ + H DIK N+LL ++DFG+A
Sbjct: 99 E-ETYIATILREILKG----LDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQ 150
Query: 120 --KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR-RNS 176
K N FV GT ++APE+I ++ K+D++ G+ +E+ G NS
Sbjct: 151 LTDTQIKRNTFV------GTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNS 202
Query: 177 NLKATR 182
+L R
Sbjct: 203 DLHPMR 208
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYI 141
+E LH +++ D+KP NILLD+ + DFGL K + K++D + GT Y+
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYL 160
Query: 142 APELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
APEL+ G D + G++L EM G
Sbjct: 161 APELLL-GHGYTKA-VDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 32 GFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW----EKLHEVASGTAHGIEYLH 86
GF S+GS + E P S + K+ SW + L +S A G+++L
Sbjct: 172 GFSSQGSDTYV--EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL- 228
Query: 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 146
CI H D+ N+LL V + DFGLA+ ++++V R + ++APE I
Sbjct: 229 -ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286
Query: 147 SRNFGTVSCKSDVYGFGMVLLEM 169
TV +SDV+ +G++L E+
Sbjct: 287 FDCVYTV--QSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 25/83 (30%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 93 ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--F 150
++H D+KP NILLD + + DFG++ D + + + G Y+APE I
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 151 GTVSCKSDVYGFGMVLLEMTGGR 173
++DV+ G+ L+E+ G+
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 32/167 (19%)
Query: 43 VYEFMPNGSLDRHI-----FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLD 97
V E++ G L HI F E R + + E+ G +++LH + I++ D
Sbjct: 74 VMEYVNGGDLMFHIQRSGRFD-EPRARFYA----AEIVLG----LQFLH---ERGIIYRD 121
Query: 98 IKPHNILLDHNFVPNVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSC 155
+K N+LLD ++DFG+ KE V+ S GT YIAPE++S +
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMC----KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177
Query: 156 KSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVSDQ 195
D + G++L EM G+ + ++ + +P W+S +
Sbjct: 178 --DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 43/168 (25%), Positives = 81/168 (48%), Gaps = 21/168 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLL-GFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
E+++ E+ + H N+V+LL F E + L+ EF G++D + E + +
Sbjct: 47 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELE---RPLTE 102
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP----K 124
++ V T + YLH + I+H D+K NIL + ++DFG++ + +
Sbjct: 103 PQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159
Query: 125 ENDFVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLLEM 169
+ F+ GT ++APE++ + K+DV+ G+ L+EM
Sbjct: 160 RDSFI------GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 16/100 (16%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE-------NDFVSISA 133
++Y+H + H D+KP NIL + + + DFGLA+ + D+V A
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV---A 168
Query: 134 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
TR Y APEL F + D++ G + E+ G+
Sbjct: 169 TR---WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
I EVS + + H N+V L LV+E++ + L +++ + G S + +
Sbjct: 52 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVK 107
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
G+ Y H +LH D+KP N+L++ ++DFGLA+ K + S
Sbjct: 108 LFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYS 162
Query: 133 ATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
T+ Y P+++ S ++ T + D++G G + EM+ GR
Sbjct: 163 NEVVTLWYRPPDILLGSTDYST---QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 43 VYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHN 102
V E+ G L H+ SR + S ++ + + YLH+ CD +++ D+K N
Sbjct: 73 VMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALGYLHS-CD--VVYRDLKLEN 125
Query: 103 ILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYG 161
++LD + ++DFGL K + ++ GT Y+APE++ N +G D +G
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA---VDWWG 180
Query: 162 FGMVLLEMTGGR 173
G+V+ EM GR
Sbjct: 181 LGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
I EVS + + H N+V L LV+E++ + L +++ ++ G S +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVK 106
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
G+ Y H ILH D+KP N+L++ ++DFGLA+ K + S
Sbjct: 107 IFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYS 161
Query: 133 ATRGTIGYIAPELISRNFGTV--SCKSDVYGFGMVLLEMTGGR 173
T+ Y P+++ G+ S D++G G +L EM GR
Sbjct: 162 NEVVTLWYRPPDVL---LGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 38 SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLD 97
S+ V EF+ G L H+ R + E ++ + + +LH I++ D
Sbjct: 69 SRLFFVIEFVSGGDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHERG---IIYRD 121
Query: 98 IKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157
+K N+LLD ++D+G+ K + D S GT YIAPE++ +
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEIL---------RG 170
Query: 158 DVYGF-------GMVLLEMTGGR 173
+ YGF G+++ EM GR
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E+ + + H +VQ G + ++ L E+MP GS+ + + ++ +
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSI 131
++ G+ YLH+ I+H DIK NIL D + DFG +K I
Sbjct: 114 QIL----QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 132 SATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEM 169
+ GT +++PE+IS +G K+DV+ ++EM
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGR---KADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
A+ A + YLH+ + I++ D+KP NILLD ++DFGL K + + + S
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTF 156
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
GT Y+APE++ + + D + G VL EM G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTV--DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-06
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E+ + + H +VQ G + +R L E MP GS+ + + ++ + +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSI 131
++ G+ YLH+ I+H DIK NIL D + DFG +K +
Sbjct: 114 QIL----EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 132 SATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEM 169
+ GT +++PE+IS +G K+D++ G ++EM
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGR---KADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYI 141
+E+LH I++ D+KP NILLD + DFGL+K + +N + GT Y+
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEYL 163
Query: 142 APELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
APE++ G D + G+++ EM G
Sbjct: 164 APEVLLDEKGYTK-HVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 32/162 (19%)
Query: 18 TIGRIHHVNVVQLLGFCSEGSKRA-LVYEFMPNGSLDRHI----FPKESRGQSCSWEKLH 72
T H +V L C + V E+ G L HI F E R
Sbjct: 55 TANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVF------- 105
Query: 73 EVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK----FHPKEND 127
A+ G++YLH N I++ D+K N+LLD ++DFGL K F + +
Sbjct: 106 -YAACVVLGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
F GT ++APE+++ T + D +G G+++ EM
Sbjct: 161 FC------GTPEFLAPEVLTETSYTRAV--DWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 16/138 (11%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
LV E GS+ + +G+ E + + T G+ YLH ++H DIK
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQ 142
Query: 102 NILLDHNFVPNVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNFG---TVS 154
NILL N + DFG L + N F+ GT ++APE+I+ + +
Sbjct: 143 NILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMAPEVIACDEQPDASYD 196
Query: 155 CKSDVYGFGMVLLEMTGG 172
+SDV+ G+ +E+ G
Sbjct: 197 ARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 38/132 (28%), Positives = 56/132 (42%), Gaps = 37/132 (28%)
Query: 81 GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK------------------- 120
+EYLH G I++ D+KP NILL + +SDF L+K
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 121 --FHPKENDFVS-ISATR-----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
+ ++ S + R GT YIAPE+IS + + D + G++L EM G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
Query: 173 R---RNSNLKAT 181
+ SN T
Sbjct: 229 TTPFKGSNRDET 240
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-06
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+L + + F S + ++ H ++V+L G C + +V E++ G LD + +E
Sbjct: 37 VLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HRE 94
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL-----DHNFVPNV-- 113
S W KL +VA A + YL D ++H ++ NIL+ + +VP +
Sbjct: 95 KNNVSLHW-KL-DVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149
Query: 114 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
SD G+ + V I +IAPE I +++ +D + FG LLE+
Sbjct: 150 SDPGIPITVLSREERVE------RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 25/138 (18%)
Query: 43 VYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV--ASGTAHGIEYLHNGCDVCILHLDIKP 100
V E++ G L HI Q +++ H V A+ A G+ +LH+ I++ D+K
Sbjct: 79 VMEYVNGGDLMYHI------QQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKL 129
Query: 101 HNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELIS-RNFGTVSCK 156
N++LD ++DFG+ K + TR GT YIAPE+I+ + +G K
Sbjct: 130 DNVMLDAEGHIKIADFGMCKENIFGGK-----TTRTFCGTPDYIAPEIIAYQPYG----K 180
Query: 157 S-DVYGFGMVLLEMTGGR 173
S D + FG++L EM G+
Sbjct: 181 SVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 13/162 (8%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E + ++H +V L + LV M G L HI+ + +
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
+ G+E+LH I++ D+KP N+LLD++ +SD GLA K+ S T
Sbjct: 103 TAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQ----SKT 154
Query: 135 R---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ GT G++APEL+ S D + G+ L EM R
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSV--DYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 15/96 (15%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH-PKENDFVSISATRGTIG 139
G++Y+H+ ++H D+KP NIL++ N + DFGLA+ P+ +VS T
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRY 170
Query: 140 YIAPE--LISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE L + + + D++ G + EM G+
Sbjct: 171 YRAPEIMLTWQKYDV---EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 12/97 (12%)
Query: 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSISATRGTI 138
G++YLH + I+H D+K N+LL ++DFGLA+ + ++ T+
Sbjct: 119 RGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVVTL 172
Query: 139 GYIAPELISRNFG-TVSCKS-DVYGFGMVLLEMTGGR 173
Y APEL+ G T + D++ G +L E+ +
Sbjct: 173 WYRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 7/92 (7%)
Query: 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI 138
A G+ +L CI H D+ NILL H + + DFGLA+ ++++V R +
Sbjct: 224 AKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 139 GYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 169
++APE I F V + +SDV+ +G++L E+
Sbjct: 281 KWMAPESI---FNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 16/172 (9%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRAL--VYEFMPNGSLDRHIFPKES 61
S+ A+ E++ + + H NV+ LL F S S Y MP D ++
Sbjct: 54 SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL----QKI 109
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
G S +K+ + G++Y+H+ I+H D+KP N+ ++ + + DFGLA+
Sbjct: 110 MGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
E TR Y APE+I N+ + D++ G ++ EM G+
Sbjct: 167 ADAE--MTGYVVTR---WYRAPEVI-LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 34/160 (21%)
Query: 23 HHVNVVQLLG--FCSEGSKRALVYEFMPNGSL------DRHIFPKESRGQSCSWEKLHEV 74
H N+++L+ F + + ALV+E M + +L + P E R +S ++ L
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP-EKRVKSYMYQLLK-- 111
Query: 75 ASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK---FHPKENDFVS 130
++++H NG I H DIKP NIL+ + + ++DFG + P +++S
Sbjct: 112 ------SLDHMHRNG----IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS 160
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170
TR Y APE + + G K D++ G V E+
Sbjct: 161 ---TR---WYRAPECLLTD-GYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 41/154 (26%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 38 SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLD 97
+K L+ +++ G + H++ + + S +++ + +E+LH + I++ D
Sbjct: 78 AKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHK---LGIVYRD 130
Query: 98 IKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELISRNFGT 152
IK NILLD ++DFGL+K +F+S R GTI Y+APE+I R G
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYMAPEII-RGKGG 183
Query: 153 VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
D + G+++ E+ G L+ R++++
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-06
Identities = 36/133 (27%), Positives = 54/133 (40%), Gaps = 46/133 (34%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL---------AKF-----HPKEND 127
IE +H + +H DIKP NIL+D + ++DFGL +K+ H +++
Sbjct: 114 IESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 128 F------VSISATR---------------------GTIGYIAPELISRNFGTVSCKSDVY 160
I R GT YIAPE++ R T C D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWW 228
Query: 161 GFGMVLLEMTGGR 173
G++L EM G+
Sbjct: 229 SVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 6e-06
Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 25/104 (24%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK---------FHPKENDFVSIS 132
++Y+H+G ++H D+KP NILL+ + ++DFGLA+ +P D+V
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV--- 173
Query: 133 ATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMTGGR 173
ATR Y APE++ S + V D++ G +L EM G+
Sbjct: 174 ATR---WYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIG 139
G++Y+H+ +LH D+KP N+LL+ N + DFGLA+ ++ DF++ TR
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173
Query: 140 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APEL+ + T DV+ G + E+ G +
Sbjct: 174 YRAPELLLNCSEYTTA---IDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-06
Identities = 41/175 (23%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE ++ E+ E++ + + V + G + +K ++ E++ GS + P
Sbjct: 39 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-- 96
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA-- 119
++ + G++YLH+ + H DIK N+LL + ++DFG+A
Sbjct: 97 ---PLDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQ 150
Query: 120 --KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
K N FV GT ++APE+I ++ K+D++ G+ +E+ G
Sbjct: 151 LTDTQIKRNTFV------GTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-06
Identities = 39/165 (23%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 13 INEVSTIGRIH---HVNVVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKESRGQ 64
I EV+ + + H NVV+L C+ +K LV+E + D + +
Sbjct: 49 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEP 105
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
E + ++ G+++LH+ ++H D+KP NIL+ + ++DFGLA+ +
Sbjct: 106 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 162
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ +++++ T+ Y APE++ ++ + + D++ G + EM
Sbjct: 163 Q---MALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 8/155 (5%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E + ++ H +V+ E ++ E+ LD + + G++ S ++ E
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
G+ Y+H ILH D+K NI L +N + + DFG+++ D +
Sbjct: 112 FIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA--TTF 165
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
GT Y++PE + KSD++ G +L EM
Sbjct: 166 TGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 42 LVYEFMPNGSLDRHIFPKESR----GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLD 97
V EF+ G L HI ++SR ++ + E+ S + +LH D I++ D
Sbjct: 73 FVMEFVNGGDLMFHI--QKSRRFDEARARFYAA--EITSA----LMFLH---DKGIIYRD 121
Query: 98 IKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157
+K N+LLDH ++DFG+ K + S GT YIAPE++ S
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSV-- 177
Query: 158 DVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
D + G++L EM G + +A + + +P+W+S
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
A+ A I YLH+ + I++ D+KP NILLD ++DFGL K + + + S
Sbjct: 102 AAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTF 156
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
GT Y+APE++ + D + G VL EM G
Sbjct: 157 CGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 27 VVQLLGFCSEGSKRAL--VYEFMPNGSL----DRHIFPKESRGQSCSWEKLHEVASGTAH 80
VVQL FC+ + L V E+MP G L + P++ W K + TA
Sbjct: 105 VVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-------WAKFY-----TAE 150
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
+ L + ++H D+KP N+LLD + ++DFG E V GT Y
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDY 209
Query: 141 IAPELISRNFGT--VSCKSDVYGFGMVLLEMTGG 172
I+PE++ G + D + G+ L EM G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-05
Identities = 58/255 (22%), Positives = 109/255 (42%), Gaps = 54/255 (21%)
Query: 11 EFINEVSTIGRIHHVNVVQLLG-FCSEGSKRA-LVYEFMPNGSLDRHIFPKESRGQSC-- 66
+ + EV+ + + H N+V+ + F ++ +++ ++ EF G L R+I Q C
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI-------QKCYK 110
Query: 67 SWEKLHE-----VASGTAHGIEYLHNGCD----VCILHLDIKPHNILLDHNF-------- 109
+ K+ E + H + Y HN D +LH D+KP NI L
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 110 ---------VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160
+ + DFGL+K E+ + GT Y +PEL+ + KSD++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCV 220
G ++ E+ G+ T KA S + +L +G +L ++ ++ +++ + L
Sbjct: 228 ALGCIIYELCSGK-------TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNL-- 278
Query: 221 IGLWCIQVKPADRPS 235
+ + +RPS
Sbjct: 279 -----LNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 8/96 (8%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FH--PKENDFVSISATRGT 137
G++Y+H+ +V LH D+KP N+L++ + + DFGLA+ F P EN ++ T
Sbjct: 117 GLKYIHSA-NV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-GFMTEYVAT 172
Query: 138 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE I +F + + DV+ G +L E+ G +
Sbjct: 173 RWYRAPE-IMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 25/177 (14%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA------LVYEFMPNGSLDRHIFPKESR 62
EE E++ + + HH N+ G + S LV EF GS+ + K ++
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTK 114
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----L 118
G + + + + G+ +LH ++H DIK N+LL N + DFG L
Sbjct: 115 GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMTGG 172
+ + N F+ GT ++APE+I+ + T +SD++ G+ +EM G
Sbjct: 172 DRTVGRRNTFI------GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQ-SCS 67
A F S + ++ H+++ + G C GS+ +V EF+ +G LD + ++ +G+ +
Sbjct: 60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCLRKEKGRVPVA 117
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
W+ VA A + YL D ++H ++ NILL + G + F +
Sbjct: 118 WKIT--VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE----GTSPFIKLSDP 168
Query: 128 FVSISATR-----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
VS +A I +IAPE + ++S +D + FG LLE+
Sbjct: 169 GVSFTALSREERVERIPWIAPECV-PGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 29/91 (31%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI 138
A+G+E+L C+ H D+ N+L+ + + DFGLA+ ++++++S +T +
Sbjct: 249 ANGMEFL--ASKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 139 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
++APE I N T SDV+ FG++L E+
Sbjct: 306 KWMAPESIFNNLYTTL--SDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 30/151 (19%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKESRGQSCS--- 67
E++ + + H NVV L+ E + ++ L++++ + I + + S
Sbjct: 50 CREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPP 107
Query: 68 -------WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL----DHNFVPNVSDF 116
W+ L +G+ YLH+ +LH D+KP NIL+ V + D
Sbjct: 108 SMVKSLLWQIL--------NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156
Query: 117 GLA-KFHPKENDFVSISATRGTIGYIAPELI 146
GLA F+ + TI Y APEL+
Sbjct: 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 38/174 (21%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMP----------NGSLDRHIFPKESRGQ 64
E+ + + H N+V+L K LV+E+ NG +D I +
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV------K 102
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH-- 122
S ++ L G+ + H+ +LH D+KP N+L++ N ++DFGLA+
Sbjct: 103 SFMFQLLK--------GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMVLLEMTGGRR 174
P SA T+ Y P+++ FG S D++ G + E+ R
Sbjct: 152 PVR----CYSAEVVTLWYRPPDVL---FGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
A+ A + YLH+ + I++ D+KP NILLD ++DFGL K + + N + S
Sbjct: 102 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTF 156
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
GT Y+APE++ + D + G VL EM G
Sbjct: 157 CGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 13/137 (9%)
Query: 38 SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLD 97
S+ LV E++ G L H+ R + E A+ + +LH + I++ D
Sbjct: 69 SRLFLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRD 121
Query: 98 IKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCK 156
+K N+LLD + ++D+G+ K D + S GT YIAPE++ +G
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGF---S 176
Query: 157 SDVYGFGMVLLEMTGGR 173
D + G+++ EM GR
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 30/115 (26%), Positives = 43/115 (37%), Gaps = 38/115 (33%)
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAK--------------FHPKENDFVSISA------ 133
+H DIKP N+LLD +SDFGL H ++F+ +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 134 ----------------TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
T GT YIAPE+ + C D + G+++ EM G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
A+ + G+ +LH I++ D+K N++LD ++DFG+ K H + V+
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTF 161
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
GT YIAPE+I+ + D + +G++L EM G+
Sbjct: 162 CGTPDYIAPEIIA--YQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 42/164 (25%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
L+ EF+P G + + K++ S E + T I+ +H + +H DIKP
Sbjct: 78 LIMEFLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPD 130
Query: 102 NILLDHNFVPNVSDFGLA----KFH------------PKENDFVSISATR---------- 135
N+LLD +SDFGL K H P + F ++++ R
Sbjct: 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR 190
Query: 136 -------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
GT YIAPE+ + C D + G+++ EM G
Sbjct: 191 QLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 39 KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDI 98
K V +F+ G L H+ + S + + E+AS + YLH+ + I++ D+
Sbjct: 70 KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASA----LGYLHS---INIVYRDL 122
Query: 99 KPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELISRNFGTVS 154
KP NILLD ++DFGL K + ++ S T GT Y+APE+I +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVIRKQ--PYD 174
Query: 155 CKSDVYGFGMVLLEMTGG 172
D + G VL EM G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-05
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLL-GFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L S + E+ E + ++ H N+V F ++G +V E+ G L + I K
Sbjct: 35 LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-HLYIVMEYCDGGDLMQKI--KL 91
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
RG+ + + + G++++H + +LH DIK NI L N + DFG A+
Sbjct: 92 QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
Query: 121 F--HPKENDFVSISATR-GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-------- 169
P + + T GT Y+ PE I N + KSD++ G +L E+
Sbjct: 149 LLTSP-----GAYACTYVGTPYYVPPE-IWENM-PYNNKSDIWSLGCILYELCTLKHPFQ 201
Query: 170 TGGRRNSNLKATRSSKAYFPSWVSDQL 196
+N LK + S PS S +L
Sbjct: 202 ANSWKNLILKVCQGSYKPLPSHYSYEL 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 42/164 (25%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
L+ EF+P G + + K++ + E+ + T I+ +H + +H DIKP
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTE----EETQFYIAETVLAIDSIHQ---LGFIHRDIKPD 130
Query: 102 NILLDHNFVPNVSDFGLA----KFH------------PKENDFVSISATR---------- 135
N+LLD +SDFGL K H P + F ++++ R
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 136 -------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
GT YIAPE+ + C D + G+++ EM G
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 9/84 (10%)
Query: 93 ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND--FVSISATRGTIGYIAPELISRNF 150
I+H DIKP N+L+ HN V + DFG A+ + ++ + ATR Y +PEL+
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR---WYRSPELL---L 174
Query: 151 GTVSCKS-DVYGFGMVLLEMTGGR 173
G K+ D++ G +L E++ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 13/137 (9%)
Query: 38 SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLD 97
S+ V E++ G L H+ R + E ++ + + YLH + I++ D
Sbjct: 69 SRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRD 121
Query: 98 IKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCK 156
+K N+LLD ++D+G+ K + D + S GT YIAPE++ ++G
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGF---S 176
Query: 157 SDVYGFGMVLLEMTGGR 173
D + G+++ EM GR
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 8/81 (9%)
Query: 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI---SATRGTIGYIAPELISR 148
++H D+K NI L + + DFG +K + +D VS+ S+ GT Y+APEL R
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 149 NFGTVSCKSDVYGFGMVLLEM 169
S K+D++ G++L E+
Sbjct: 246 K--RYSKKADMWSLGVILYEL 264
|
Length = 478 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 5e-05
Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 31/147 (21%)
Query: 13 INEVSTIGRI---HHVNVVQLLGFC-----SEGSKRALVYEFMP---NGSLDRHIFPK-- 59
+ E++ + ++ H N+V+LL C K LV+E + L + PK
Sbjct: 46 LREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPG 103
Query: 60 --ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
+ + L G+++LH+ I+H D+KP NIL+ + ++DFG
Sbjct: 104 LPPETIKDLMRQLL--------RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPE 144
LA+ + E S+ T+ Y APE
Sbjct: 153 LARIYSFEMALTSVVV---TLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 8/85 (9%)
Query: 93 ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRN 149
++H DIK NILL N + + DFG +K + VS R GT Y+APE+ R
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYVAPEIWRRK 220
Query: 150 FGTVSCKSDVYGFGMVLLEMTGGRR 174
S K+D++ G++L E+ +R
Sbjct: 221 --PYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 46/181 (25%), Positives = 77/181 (42%), Gaps = 35/181 (19%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG---SLDRH---I 56
E + F+A I E S + + H N+V L LV+E++ +D+H +
Sbjct: 44 EGTPFTA---IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGL 100
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
P E + G+ Y+H ILH D+KP N+L+ ++DF
Sbjct: 101 HP----------ENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADF 147
Query: 117 GLAKF-----HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG 171
GLA+ H N+ V T+ Y P+++ + +C D++G G + +EM
Sbjct: 148 GLARAKSVPSHTYSNEVV-------TLWYRPPDVLLGSTEYSTC-LDMWGVGCIFVEMIQ 199
Query: 172 G 172
G
Sbjct: 200 G 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 11/148 (7%)
Query: 27 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86
VVQL + +V E+MP G L + + + W + + TA + L
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFY-----TAEVVLALD 156
Query: 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 146
+ +H D+KP N+LLD + ++DFG KE V GT YI+PE++
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVL 215
Query: 147 SRNFGT--VSCKSDVYGFGMVLLEMTGG 172
G + D + G+ L EM G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 23 HHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASG 77
+H NVV+ G + G + LV E GS+ + GQ + + G
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR-- 135
G+++LHN I+H D+K +NILL + DFG++ +++TR
Sbjct: 137 ALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLR 184
Query: 136 -----GTIGYIAPELIS---RNFGTVSCKSDVYGFGMVLLEMTGG 172
GT ++APE+I+ + + + DV+ G+ +E+ G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 10/96 (10%)
Query: 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIG 139
H I LH +H DIKP N+LLD N ++DFG + ++ V S GT
Sbjct: 116 HSIHQLH------YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPD 168
Query: 140 YIAPELISR---NFGTVSCKSDVYGFGMVLLEMTGG 172
YI+PE++ G + D + G+ + EM G
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 33/181 (18%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-------F 57
S+ A+ E+ + + H NV+ LL F P+ SLDR F
Sbjct: 54 SELFAKRAYRELRLLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPF 101
Query: 58 PKESRGQSCSWEKLHE-----VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN 112
G+ EKL E + G++Y+H I+H D+KP N+ ++ +
Sbjct: 102 MGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELK 158
Query: 113 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
+ DFGLA+ +++ TR Y APE+I N+ + D++ G ++ EM G
Sbjct: 159 ILDFGLAR--QTDSEMTGYVVTR---WYRAPEVI-LNWMHYTQTVDIWSVGCIMAEMLTG 212
Query: 173 R 173
+
Sbjct: 213 K 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 26/173 (15%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS---LDRHIFPKESRGQSCSWEK 70
NEV H N++ + GS ++ FM GS L + FP + S
Sbjct: 48 NEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP-----EGMSEAL 102
Query: 71 LHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN--- 126
+ + G G+ YLH NG +H +IK +IL+ + + ++S GL+ +
Sbjct: 103 IGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQ 156
Query: 127 ------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
DF S + + +++PEL+ ++ + KSD+Y G+ E+ GR
Sbjct: 157 KAKVVYDFPQFSTS--VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 37/127 (29%), Positives = 54/127 (42%), Gaps = 34/127 (26%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-----FHPKENDFVSISATR 135
G+ Y H +LH D+KP N+L+ ++DFGLA+ N+ V
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV------ 165
Query: 136 GTIGYIAPE--LISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFP--SW 191
T+ Y P+ L S + T D++G G + EM GR FP +
Sbjct: 166 -TLWYRPPDVLLGSTEYST---SLDMWGVGCIFYEMATGR------------PLFPGSTD 209
Query: 192 VSDQLNK 198
V DQL+K
Sbjct: 210 VEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
G++Y+H+ I+H D+KP N+ ++ + + DFGLA+ +++ ATR Y
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WY 183
Query: 141 IAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
APE I N+ + D++ G ++ E+ GR
Sbjct: 184 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 13/102 (12%)
Query: 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISA 133
+A + H + Y+H DIKP NIL+D N ++DFG + E+ V S
Sbjct: 113 IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV 162
Query: 134 TRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMTGG 172
GT YI+PE++ G + D + G+ + EM G
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
GI++LH+ I+H D+KP NI++ + + DFGLA+ ++ T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183
Query: 141 IAPELISRNFGT-VSCKSDVYGFGMVLLEMTGGR 173
APE+I G D++ G ++ EM G
Sbjct: 184 RAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR----GT 137
++Y+H V ++H DIK NIL+ + + DFG+A S+ R GT
Sbjct: 114 LKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVGT 164
Query: 138 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKATR 182
++APE+I K+D++ G+ + EM TG S++ A R
Sbjct: 165 PYWMAPEVI-TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 40/141 (28%), Positives = 58/141 (41%), Gaps = 21/141 (14%)
Query: 42 LVYEFMPNGSL----DRHIFP-KESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHL 96
LV E+ P G L +R+ E Q E + +A + H + Y+H
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV--LAIHSVHQMGYVHR--------- 126
Query: 97 DIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 156
DIKP N+L+D ++DFG A S GT YIAPE+++ G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGT 185
Query: 157 SDV----YGFGMVLLEMTGGR 173
V + G++ EM GR
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 18/95 (18%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA-KF-HPKENDFVSISATRG-- 136
G+ +LH D ILH D+K N+LL++ + + DFGLA ++ P + T+
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP------YTQLVV 168
Query: 137 TIGYIAPELISRNFGT--VSCKSDVYGFGMVLLEM 169
T+ Y APEL+ G S D++ G + E+
Sbjct: 169 TLWYRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 17/173 (9%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
E F+A I E S + + H N+V L V+E+M + L +++
Sbjct: 44 EGVPFTA---IREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGG 99
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ + G+ Y+H ILH D+KP N+L+ + ++DFGLA+
Sbjct: 100 LHPYN---VRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR-- 151
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTV--SCKSDVYGFGMVLLEMTGGR 173
K + S+ T+ Y P+++ G S D++G G + +EM G+
Sbjct: 152 AKSIPSQTYSSEVVTLWYRPPDVL---LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 35/109 (32%), Positives = 49/109 (44%), Gaps = 20/109 (18%)
Query: 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF-----------HPKEN 126
T +EYLHN I+H D+KP N+L+ ++DFGL+K E
Sbjct: 110 TVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 127 DFVSISATR--GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMTGG 172
D + GT YIAPE+I R +G D + G++L E G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 43/180 (23%), Positives = 85/180 (47%), Gaps = 30/180 (16%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRAL-------VYEFMPNGSLD 53
++ +A + NE+ +GR++H N++++ SE + + +Y FM + + D
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD 259
Query: 54 RHIFP--KESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVP 111
P K++R + +EY+H D ++H DIK NI L+ +
Sbjct: 260 WKDRPLLKQTR----------AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKI 306
Query: 112 NVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELISRNFGTVSCK-SDVYGFGMVLLEM 169
+ DFG A P E + + GT+ +PE+++ + C+ +D++ G++LL+M
Sbjct: 307 VLGDFGTAM--PFEKEREAFDYGWVGTVATNSPEILAGD---GYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 41/179 (22%), Positives = 72/179 (40%), Gaps = 37/179 (20%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL----DRHIFPKESRGQSCSWEK 70
E+ + I H N++ L+ EG LV + M L DR I ES+ + +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK------FHPK 124
L+ G+ LH +H D+ P NI ++ + ++DFGLA+ +
Sbjct: 129 LN--------GLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 125 ENDFVSISATRG------TIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMTGGR 173
+ ++ T+ Y APEL+ G + D++ G + E+ G+
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELL---MGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 30/142 (21%)
Query: 2 LENSKFSAEEF----INEVSTIGRIHHVNVVQL----------LGFCSEGSKRALVYEFM 47
L+N K E F I E+ + +++H N+V L L F + LV+E+M
Sbjct: 42 LDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM 98
Query: 48 PN---GSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNIL 104
+ G L ES S + + G+ Y H LH DIK NIL
Sbjct: 99 DHDLMGLL-------ESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNIL 148
Query: 105 LDHNFVPNVSDFGLAKFHPKEN 126
L++ ++DFGLA+ + E
Sbjct: 149 LNNKGQIKLADFGLARLYNSEE 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 11/94 (11%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE-NDFVSISATRGTIG 139
G++Y+H+ I+H D+KP NI ++ + + DFGLA+ E +V ATR
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV---ATR---W 180
Query: 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE++ N+ + D++ G ++ E+ G+
Sbjct: 181 YRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 8e-04
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 28/165 (16%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR--HIFPKESRGQSCSWEKLH 72
E+ + H N+V G K + EF GSL H+ S Q +
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IA 109
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
V+ T G+ YLH+ + H DIK NILL N ++DFG++ I+
Sbjct: 110 YVSRETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVS---------AQIT 157
Query: 133 ATR-------GTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEM 169
AT GT ++APE+ + G + D++ G+ +E+
Sbjct: 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 27/93 (29%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
G++Y+H+ I+H D+KP N+ ++ + + DFGLA+ +++ ATR Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATR---WY 181
Query: 141 IAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
APE I N+ + D++ G ++ E+ G+
Sbjct: 182 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 38/141 (26%), Positives = 59/141 (41%), Gaps = 27/141 (19%)
Query: 42 LVYEFMPNGSL----DRHIFPKESRGQSCSWEKLH--EV--ASGTAHGIEYLHNGCDVCI 93
+V E+MP G L + P++ W + + EV A H + ++H
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEK-------WARFYTAEVVLALDAIHSMGFIHR------ 166
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNFG 151
D+KP N+LLD + ++DFG N V GT YI+PE++ G
Sbjct: 167 ---DVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 152 TVSCKSDVYGFGMVLLEMTGG 172
+ D + G+ L EM G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 34/173 (19%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----FPKESRGQ 64
+ +E + I+H V L G + S LV EF+ G + FP +
Sbjct: 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDV--- 132
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
C + A+ EYL + + I++ D+KP N+LLD + ++DFG AK
Sbjct: 133 GCFY------AAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK---- 179
Query: 125 ENDFVSISATR-----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
+ TR GT YIAPE++ N G +D + G+ + E+ G
Sbjct: 180 ------VVDTRTYTLCGTPEYIAPEIL-LNVGHGKA-ADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 43/176 (24%), Positives = 69/176 (39%), Gaps = 22/176 (12%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E+ + I H ++ L+ S +V MP D +F R E+ +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCD--LFTYVDRSGPLPLEQAITI 190
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA------KFHPKENDF 128
+ YLH I+H D+K NI LD + DFG A P+ +
Sbjct: 191 QRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSS 184
GT+ +PEL++ + K+D++ G+VL EM+ K +SS
Sbjct: 248 S------GTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 24/101 (23%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
GI++LH+ I+H D+KP NI++ + + DFGLA+ T GT
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTSFM 181
Query: 141 IAPELISRNFGTVSC--------KSDVYGFGMVLLEMTGGR 173
+ P +++R + D++ G ++ EM G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 20/53 (37%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 146
+H DIKP N+LLD N ++DFG + + V + GT YI+PE++
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDR--HIFPKESRGQSCSWEKLH 72
E+ + H N+V G K + E+ GSL H+ S Q +
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ------IA 109
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS 132
V T G+ YLH+ +H DIK NILL N ++DFG+A I+
Sbjct: 110 YVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA---------AKIT 157
Query: 133 ATR-------GTIGYIAPEL--ISRNFGTVSCKSDVYGFGMVLLEM 169
AT GT ++APE+ + +N G + D++ G+ +E+
Sbjct: 158 ATIAKRKSFIGTPYWMAPEVAAVEKN-GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 24 HVNVVQLLGF-----CSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78
H NVV+ G G + LV E GS+ + RG+ + +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR--- 135
G+++LH + H D+K +NILL + DFG++ +++TR
Sbjct: 134 LMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRR 181
Query: 136 ----GTIGYIAPELIS---RNFGTVSCKSDVYGFGMVLLEMTGG 172
GT ++APE+I+ + T + DV+ G+ +E+ G
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 238 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.6 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.44 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.09 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.79 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.13 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.65 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.31 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.27 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.2 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.04 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.43 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.29 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.19 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.77 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.11 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.82 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.43 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.32 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.28 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.77 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.38 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.2 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.17 | |
| PLN02236 | 344 | choline kinase | 92.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.83 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 91.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.03 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 90.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.0 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.28 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=306.90 Aligned_cols=209 Identities=25% Similarity=0.385 Sum_probs=172.6
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
....+|+++|++|+|||||+++++|++....|||+||++||.|.+.+ -.++.+.+..-+.++.|++.|+.|||+.
T Consensus 221 ~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~- 295 (475)
T KOG0615|consen 221 RDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQ- 295 (475)
T ss_pred hhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHc-
Confidence 34579999999999999999999999999999999999999999998 4567888888899999999999999999
Q ss_pred CCceeeeccCCCcEEEccC---CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc-cccCceehHHHH
Q 037755 90 DVCILHLDIKPHNILLDHN---FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMV 165 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~~~Di~slG~~ 165 (238)
||+||||||+|||++.+ ..+||+|||+++..+... .....+||+.|.|||++.+..... ..+.|+||+||+
T Consensus 296 --GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcv 370 (475)
T KOG0615|consen 296 --GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCV 370 (475)
T ss_pred --CcccccCCcceEEeccCCcceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccce
Confidence 99999999999999865 778999999998776332 345567999999999998763333 347899999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|-+++|.+||.....+.. ..+++..++ ....+.....++++..+||.+||..||++|||++|
T Consensus 371 LfvcLsG~pPFS~~~~~~s-------l~eQI~~G~---y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e 433 (475)
T KOG0615|consen 371 LFVCLSGYPPFSEEYTDPS-------LKEQILKGR---YAFGPLQWDRISEEALDLINWMLVVDPENRPSADE 433 (475)
T ss_pred EEEEeccCCCcccccCCcc-------HHHHHhcCc---ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence 9999999999975544331 112222211 11223456778999999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=299.67 Aligned_cols=214 Identities=23% Similarity=0.364 Sum_probs=175.0
Q ss_pred CcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe-eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+.+.++.+|+++++..+|||||++||.|..... ..++||||.+|||.+++ ...+.+++..+..++.++++|
T Consensus 115 ~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~----k~~g~i~E~~L~~ia~~VL~G 190 (364)
T KOG0581|consen 115 NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDIL----KRVGRIPEPVLGKIARAVLRG 190 (364)
T ss_pred cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHH
Confidence 4566777899999999999999999999999988884 99999999999999998 334789999999999999999
Q ss_pred HHHhHc-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHN-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|.|||+ . +|+||||||+|||++..|.|||+|||++...... ......||..|+|||.+.+. .++.++|||
T Consensus 191 L~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIW 261 (364)
T KOG0581|consen 191 LSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGE--SYSVKSDIW 261 (364)
T ss_pred HHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCC--cCCccccee
Confidence 999996 5 9999999999999999999999999998754443 23445699999999999997 888999999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHH-HHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIES-MIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||++++|+++|+.|+........ .+-......... ..+.++. .+++++.+|+..||++||.+|||+.|
T Consensus 262 SLGLsllE~a~GrfP~~~~~~~~~--~~~~Ll~~Iv~~-------ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~q 331 (364)
T KOG0581|consen 262 SLGLSLLELAIGRFPYPPPNPPYL--DIFELLCAIVDE-------PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQ 331 (364)
T ss_pred cccHHHHHHhhCCCCCCCcCCCCC--CHHHHHHHHhcC-------CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 999999999999999977611111 111111111111 1112223 48999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=312.27 Aligned_cols=208 Identities=24% Similarity=0.372 Sum_probs=177.9
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+++++.+|+++.++|+|||||+++++|++.+++|+|.|+|..++|..++ ...+++++..+++++.||+.|+.|
T Consensus 58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkY 133 (592)
T KOG0575|consen 58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKY 133 (592)
T ss_pred CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999999988 457899999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +|+|||||..|+|++++.+|||+|||++....... ......+||+.|.|||++... .++..+||||+||
T Consensus 134 LH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGc 206 (592)
T KOG0575|consen 134 LHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGC 206 (592)
T ss_pred HHhc---CceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccC--CCCCchhhhhhhh
Confidence 9999 99999999999999999999999999997665332 122345699999999999976 8889999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|.|++|++||..+...+....+ ..... ..+..++.+..+||.++|+.||.+|||+++
T Consensus 207 vmYtLL~G~PPFetk~vkety~~I---k~~~Y------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~ 265 (592)
T KOG0575|consen 207 VMYTLLVGRPPFETKTVKETYNKI---KLNEY------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDE 265 (592)
T ss_pred HHHhhhhCCCCcccchHHHHHHHH---HhcCc------------ccccccCHHHHHHHHHHhcCCcccCCCHHH
Confidence 999999999999876555432211 11100 123457788899999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=293.49 Aligned_cols=210 Identities=31% Similarity=0.469 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCC-eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
+++|.+|+.+|++++|||||+++|++.+.. .+++||||+++|+|.+++... ....++...+..++.||+.|+.|||+
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~ 160 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS 160 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 679999999999999999999999999887 799999999999999999443 46799999999999999999999999
Q ss_pred CCCCc-eeeeccCCCcEEEccCC-ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 88 GCDVC-ILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 88 ~~~~~-i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+ + |+||||||+|||++.++ ++||+|||+++...... .......||..|+|||++.+....++.++||||||++
T Consensus 161 ~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIv 235 (362)
T KOG0192|consen 161 E---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIV 235 (362)
T ss_pred C---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHH
Confidence 8 8 99999999999999997 99999999998665532 1122245999999999998421268999999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|||+||+.||.......... ....... ....+..+++.+..++.+||+.||+.||++.|
T Consensus 236 lWEl~t~~~Pf~~~~~~~~~~-------~v~~~~~------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 236 LWELLTGEIPFEDLAPVQVAS-------AVVVGGL------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLE 295 (362)
T ss_pred HHHHHHCCCCCCCCCHHHHHH-------HHHhcCC------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence 999999999997655422111 1111111 11222337888999999999999999999753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=279.68 Aligned_cols=225 Identities=21% Similarity=0.285 Sum_probs=178.3
Q ss_pred CcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
+.-..+.+.+.+|++.|+.++||||++++..|..+..+|+||++|.+||+.+.+.. .....+.+..+..++.++++||
T Consensus 62 Ekc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~--~~~~Gl~E~~Ia~iLre~LkaL 139 (516)
T KOG0582|consen 62 EKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKT--YYPDGLEEASIATILREVLKAL 139 (516)
T ss_pred hhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHH--HccccccHHHHHHHHHHHHHHH
Confidence 44455578999999999999999999999999999999999999999999999833 3345699999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccc--cccCCccccCCcceeecCCCcccccCcee
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI--SATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
.|||.+ |.+|||+|+.|||++++|.|+|+|||.+...-..+..... ....|++.|+|||++......|+.++|||
T Consensus 140 ~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIw 216 (516)
T KOG0582|consen 140 DYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIW 216 (516)
T ss_pred HHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhh
Confidence 999999 9999999999999999999999999987655444322111 33459999999999766556899999999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCcc-ccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLE-LRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||++..|+.+|..||....+... .........-.+. .....+....++.++..++..||+.||++|||+++
T Consensus 217 SfGITA~ELA~G~aPf~k~pPmkv------Ll~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 217 SFGITACELAHGHAPFSKYPPMKV------LLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred hhhHHHHHHhcCCCCcccCChHHH------HHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 999999999999999965332211 0111111111111 01223344567779999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=290.94 Aligned_cols=209 Identities=25% Similarity=0.381 Sum_probs=177.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
+..++-+.+|+.+|+..+|+|||.+++.|-.++.+|+||||++||+|.+.+ ....+++.++..++.++++||+||
T Consensus 311 Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fL 385 (550)
T KOG0578|consen 311 QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFL 385 (550)
T ss_pred CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHH
Confidence 345677889999999999999999999998889999999999999999988 345699999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|.+ +|+|||||.+|||++.+|.+||+|||.|........ ......||+.|+|||++... .|+++.||||||++
T Consensus 386 H~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIM 458 (550)
T KOG0578|consen 386 HAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIM 458 (550)
T ss_pred Hhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhc--ccCccccchhhhhH
Confidence 999 999999999999999999999999999976655442 23344699999999999887 88999999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++||+.|++||........ ...+.....+.+... ..+++.+.+|+.+||+.|+++|+||.|
T Consensus 459 aIEMveGEPPYlnE~PlrA--------lyLIa~ng~P~lk~~----~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 459 AIEMVEGEPPYLNENPLRA--------LYLIATNGTPKLKNP----EKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred HHHHhcCCCCccCCChHHH--------HHHHhhcCCCCcCCc----cccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 9999999999976443322 223333333333333 457889999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=282.99 Aligned_cols=213 Identities=28% Similarity=0.478 Sum_probs=174.5
Q ss_pred CcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
+....+.++|.+|+++|++|+|+|||++++++..+..+++|||||..|||.+++.. ..+..+.......++.|||+|+
T Consensus 239 k~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM 316 (468)
T KOG0197|consen 239 KEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGM 316 (468)
T ss_pred eccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHH
Confidence 34456778999999999999999999999999998899999999999999999933 4567899999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+||+++ ++|||||...||||+++..+||+|||+++...+.. ........-+..|.|||.+.-. ..+.++|||||
T Consensus 317 ~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~--~FS~kSDVWSF 390 (468)
T KOG0197|consen 317 AYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYG--KFSSKSDVWSF 390 (468)
T ss_pred HHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCHHHHhhC--Ccccccceeeh
Confidence 999999 99999999999999999999999999999443322 2222333367789999999865 78999999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|++++|++| |+.|+...... .+...+.++... ..+..+++++.++|..||+.+|++|||++
T Consensus 391 GVlL~E~fT~G~~py~~msn~--------ev~~~le~GyRl------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 391 GVLLWELFTYGRVPYPGMSNE--------EVLELLERGYRL------PRPEGCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred hhhHHHHhccCCCCCCCCCHH--------HHHHHHhccCcC------CCCCCCCHHHHHHHHHHhhCCcccCCCHH
Confidence 999999987 66666543322 233333333322 23345888999999999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=270.59 Aligned_cols=214 Identities=23% Similarity=0.339 Sum_probs=173.8
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeee-EEEeCCe-eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSK-RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~-~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
+...+++...|+.+|++|+|||||++++ .+.+++. ++++||+|.+|+|...+.......+.+++..+|+++.|++.||
T Consensus 58 d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL 137 (375)
T KOG0591|consen 58 DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRAL 137 (375)
T ss_pred cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999 4555444 8999999999999998865556678999999999999999999
Q ss_pred HHhHcCCCC-ceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 83 EYLHNGCDV-CILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 83 ~~Lh~~~~~-~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
.++|+.-.+ -+.||||||.||+++.+|.|||+|||++++...... ......||+.|++||.+... .+..++||||
T Consensus 138 ~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~--~Y~~kSDiWs 213 (375)
T KOG0591|consen 138 YHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHES--GYNFKSDIWS 213 (375)
T ss_pred HHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcC--CCCcchhHHH
Confidence 999983211 299999999999999999999999999987755432 22334599999999999987 8899999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHH-HHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIE-SMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+||++|||+.-.+||.++.-.+. -..+.++ ..+.++ ..++.++..+|..|+.+||+.||+.
T Consensus 214 lGCllyEMcaL~~PF~g~n~~~L--------~~KI~qg------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 214 LGCLLYEMCALQSPFYGDNLLSL--------CKKIEQG------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHHhcCCCcccccHHHH--------HHHHHcC------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999999999999976522111 1112221 122223 6688999999999999999999973
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=277.22 Aligned_cols=166 Identities=27% Similarity=0.440 Sum_probs=147.7
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.+...+.+..|+.+|+.++|||||.+++++..++.+|+|||||.||+|.+++ ...+.+++..++..+.||+.|+++
T Consensus 49 ~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~ 124 (429)
T KOG0595|consen 49 NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQF 124 (429)
T ss_pred CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHH
Confidence 4567788899999999999999999999999999999999999999999999 345689999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccC------CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHN------FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
||++ +|+||||||+|||++.. -.+||+|||.++....... .+..+|++.|||||++... .|+.++|
T Consensus 125 L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~--~YdAKAD 196 (429)
T KOG0595|consen 125 LHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQ--QYDAKAD 196 (429)
T ss_pred HHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhc--cccchhh
Confidence 9999 99999999999999864 4579999999997765443 3445699999999999765 8899999
Q ss_pred eehHHHHHHHHhcCCCCCCccccc
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATR 182 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~ 182 (238)
+||+|+++|++++|+.||......
T Consensus 197 LWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 197 LWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred HHHHHHHHHHHHhCCCCccccCHH
Confidence 999999999999999999755444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=281.49 Aligned_cols=222 Identities=43% Similarity=0.787 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCC-eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+|.+|+.++.+++|||+|+++|||.+++ ..++|+||+..|+|.+++...... .++|..+.+|+.++++||+|||+
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~ 192 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHE 192 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHcc
Confidence 455999999999999999999999999988 599999999999999999543322 88999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCC-CCcccccccc-CCccccCCcceeecCCCcccccCceehHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK-ENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
.|.+.|+||||||+|||+|++...||+|||++...+. .... ... .||.+|+|||+.... ..+.++||||||++
T Consensus 193 ~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g--~lt~KsDVySFGVv 267 (361)
T KOG1187|consen 193 GCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTG--KLTEKSDVYSFGVV 267 (361)
T ss_pred CCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce---eeecCCCCccCChhhhccC--CcCcccccccchHH
Confidence 9888899999999999999999999999999976554 2221 111 599999999998764 78899999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchh----HHHH-HHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVT----EIES-MIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+.|+++|+.+....... ....+..|....+.+....+..+.. .... .....+..++.+|++.+|.+||+|.|
T Consensus 268 llElitgr~~~d~~~~~-~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~ 344 (361)
T KOG1187|consen 268 LLELITGRKAVDQSRPR-GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ 344 (361)
T ss_pred HHHHHhCCcccCCCCCc-ccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence 99999999887654422 1222556655555554333332221 1121 45666899999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=275.63 Aligned_cols=204 Identities=23% Similarity=0.296 Sum_probs=171.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+...+|..+|+.++||.||+++-.|++..++|+|+||+.||.|..++ .+.+.+++..++-++.+|+.||.|||
T Consensus 67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH 142 (357)
T KOG0598|consen 67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLH 142 (357)
T ss_pred hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHH
Confidence 35677889999999999999999999999999999999999999999999 45678999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. ||+|||+||+|||++.+|+++|+|||+|+.....+.. ....+||+.|+|||++.+. .++..+|.||||+++
T Consensus 143 ~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~--t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGill 215 (357)
T KOG0598|consen 143 SK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA--TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILL 215 (357)
T ss_pred hC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc--cccccCCccccChHHHhcC--CCCcccchHhHHHHH
Confidence 99 9999999999999999999999999999855444322 2345699999999999987 889999999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|+|++|.+||........ ....... . ....+...+.+..++++++|..||++|.-
T Consensus 216 YeML~G~pPF~~~~~~~~-------~~~I~~~-k------~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 216 YEMLTGKPPFYAEDVKKM-------YDKILKG-K------LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred HHHhhCCCCCcCccHHHH-------HHHHhcC-c------CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 999999999976554332 1111111 1 11222336778899999999999999963
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=278.03 Aligned_cols=207 Identities=25% Similarity=0.333 Sum_probs=169.6
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|+.++++++ ||||+++++++......++||||+.||+|.+.+ ...+++.+..+..++.|++.|++|+|
T Consensus 62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i----~~~g~l~E~~ar~~F~Qlisav~y~H 137 (370)
T KOG0583|consen 62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYI----VNKGRLKEDEARKYFRQLISAVAYCH 137 (370)
T ss_pred cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHH----HHcCCCChHHHHHHHHHHHHHHHHHH
Confidence 3566778999999998 999999999999999999999999999999999 33678899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccC-CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+. ||+||||||+|||++.+ +++||+|||++.... ..........|++.|.|||++.+.....+.++||||+|++
T Consensus 138 ~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GVi 212 (370)
T KOG0583|consen 138 SR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVI 212 (370)
T ss_pred hC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHH
Confidence 99 99999999999999999 999999999998663 1112234556999999999999863244688999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHH-HHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMI-ARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|.|++|..||...... ..... +... .-..+..+ ++++.+++.+||..||.+|+|+.|
T Consensus 213 Ly~ml~G~~PF~d~~~~-------~l~~k-i~~~-------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 213 LYVLLCGRLPFDDSNVP-------NLYRK-IRKG-------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred HHHHHhCCCCCCCccHH-------HHHHH-HhcC-------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 99999999999863222 11111 1111 11122233 788999999999999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=265.96 Aligned_cols=219 Identities=22% Similarity=0.300 Sum_probs=171.2
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+-..+|++.|++++|+|+|.++++|.....+++|||||.. ++.+.+ +.....++...+..+++|++.|+.|+|++
T Consensus 46 KIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eL---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~- 120 (396)
T KOG0593|consen 46 KIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHEL---ERYPNGVPSELVKKYLYQLLKAIHFCHKN- 120 (396)
T ss_pred HHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHH---HhccCCCCHHHHHHHHHHHHHHhhhhhhc-
Confidence 4456999999999999999999999999999999999965 655555 45567899999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++||||||+|||++.+|.+||+|||.++.....+... .....|.+|+|||++.+. ..|++..|||++||++.||
T Consensus 121 --n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y--TDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl 195 (396)
T KOG0593|consen 121 --NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY--TDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAEL 195 (396)
T ss_pred --CeecccCChhheEEecCCcEEeccchhhHhhcCCcchh--hhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHH
Confidence 99999999999999999999999999998665433222 233489999999999986 5889999999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhh-------hhcc-----C-CCccccchhHH---HHHHHHHHHHHHhhhccCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSD-------QLNK-----G-GNLELRNVTEI---ESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~-----~-~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~R 233 (238)
++|.+.|.+.+......-+.....+ .... + ..+++.....+ -+.++.-+.+|++.||+.||++|
T Consensus 196 ~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 196 LTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred hcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 9999999877665432222111111 1000 0 11112222222 23456678999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
+|-+|
T Consensus 276 ~sc~q 280 (396)
T KOG0593|consen 276 LSCEQ 280 (396)
T ss_pred ccHHH
Confidence 98654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=273.43 Aligned_cols=211 Identities=27% Similarity=0.375 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCC--eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.+.+.+|+.+|++++|||||+++|...... .++++|||+.+|+|.+++. .. +..+++..+..+..||+.||+|||
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~--~~-g~~l~E~~v~~ytr~iL~GL~ylH 134 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIK--RY-GGKLPEPLVRRYTRQILEGLAYLH 134 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHH--Hc-CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 667899999999999999999999854443 6999999999999999992 22 227999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
++ |++|+||||+|||++. ++.+||+|||++......... .......||+.|+|||++... ....+.+|||||||
T Consensus 135 s~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGC 210 (313)
T KOG0198|consen 135 SK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGC 210 (313)
T ss_pred hC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCC-CcCCccchhhhcCC
Confidence 99 9999999999999999 799999999988755431111 112234599999999999842 23346899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++.||+||..||... . ............. ..+.++..++.+..+|+.+|++.||++||||+|
T Consensus 211 tVvEM~Tg~~PW~~~-~-----~~~~~~~~ig~~~------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 211 TVVEMLTGKPPWSEF-F-----EEAEALLLIGRED------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred EEEeccCCCCcchhh-c-----chHHHHHHHhccC------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 999999999999653 0 0011111111111 112455668889999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=287.79 Aligned_cols=208 Identities=25% Similarity=0.338 Sum_probs=177.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
++.....+.+|+-+|+.+.|||+++++++|++..++|+|.||+.||.|.+++ ...+++++..+...+.||+.|+.|
T Consensus 52 s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~y 127 (786)
T KOG0588|consen 52 SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSY 127 (786)
T ss_pred ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999999999999999999999999999999 456899999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+|.. +|+|||+||+|+|++..+++||+|||.+........ ....+|++.|.|||++.|. +..+.++||||.|+
T Consensus 128 CH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGV 200 (786)
T KOG0588|consen 128 CHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGV 200 (786)
T ss_pred Hhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcc---ccccCCCcccCCchhhcCC-CCCCCccccchhHH
Confidence 9999 999999999999999998999999999976555443 3445699999999999997 56788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|.+++|+-||+.+.... ...+ +. .+.-.++.+++.+..+|+.+||.+||++|.|++|
T Consensus 201 ILfALLtG~LPFdDdNir~-------LLlK-V~-------~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~e 259 (786)
T KOG0588|consen 201 ILFALLTGKLPFDDDNIRV-------LLLK-VQ-------RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEE 259 (786)
T ss_pred HHHHHHhCCCCCCCccHHH-------HHHH-HH-------cCcccCCCcCCHHHHHHHHHHhccCccccccHHH
Confidence 9999999999998544332 1111 11 1122345678899999999999999999999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=268.21 Aligned_cols=210 Identities=26% Similarity=0.360 Sum_probs=165.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCC-CCHHHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQS-CSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~ 84 (238)
..++..+|+.+|++++|||||+++++..+ ..++|||+|||..|.+...- ..++ +++.+++.++.+++.||.|
T Consensus 151 ~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEY 225 (576)
T KOG0585|consen 151 PIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEY 225 (576)
T ss_pred cHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHH
Confidence 34789999999999999999999999854 57899999999998885432 3444 9999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCC---ccccccccCCccccCCcceeecC--CCcccccCce
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELISRN--FGTVSCKSDV 159 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Di 159 (238)
||.+ ||+||||||+|+|++++|+|||+|||++....... .........||+.|+|||.+.+. ....+.+.||
T Consensus 226 LH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~Di 302 (576)
T KOG0585|consen 226 LHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDI 302 (576)
T ss_pred HHhc---CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhh
Confidence 9999 99999999999999999999999999987553331 11122335699999999998773 2345778999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+|+++|.++.|+.||........ .....++. +.. +. ..++.+.+.+||.+||+.||+.|.++.|
T Consensus 303 WalGVTLYCllfG~~PF~~~~~~~l-------~~KIvn~p----L~f-P~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ 368 (576)
T KOG0585|consen 303 WALGVTLYCLLFGQLPFFDDFELEL-------FDKIVNDP----LEF-PE-NPEINEDLKDLIKRLLEKDPEQRITLPD 368 (576)
T ss_pred hhhhhhHHHhhhccCCcccchHHHH-------HHHHhcCc----ccC-CC-cccccHHHHHHHHHHhhcChhheeehhh
Confidence 9999999999999999976543322 11111111 111 11 1246778999999999999999998754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=271.64 Aligned_cols=215 Identities=21% Similarity=0.315 Sum_probs=169.8
Q ss_pred HHHHHHHhhcC-CCcceeeeeEEEeCC-eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 13 INEVSTIGRIH-HVNVVQLLGFCSEGS-KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 13 ~~e~~~l~~l~-h~ni~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
.+|++.|++|+ ||||+++.+++.+.. .+++|||||. .+|.+.+.. .+..+++..++.|+.||++||+|+|++
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~-- 129 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH-- 129 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc--
Confidence 47999999998 999999999987766 9999999995 599999832 368999999999999999999999999
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHh
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll 170 (238)
|++|||+||+|||+.....+||+|||+|+......... ....|++|+|||++... +.|+.+.|+|++||+++|+.
T Consensus 130 -GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT---eYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~ 204 (538)
T KOG0661|consen 130 -GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT---EYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELY 204 (538)
T ss_pred -CcccccCChhheEecccceeEecccccccccccCCCcc---hhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHH
Confidence 99999999999999999999999999999776655433 23489999999998875 57899999999999999999
Q ss_pred cCCCCCCcccccccCCc---------chhhhh-hhhcc--CCCc---cccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 171 GGRRNSNLKATRSSKAY---------FPSWVS-DQLNK--GGNL---ELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 171 ~g~~p~~~~~~~~~~~~---------~~~~~~-~~~~~--~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+-++.|.+......... ...|.. ..+.. .... .......+-+..+.+..++|.+||+.||.+|||
T Consensus 205 sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT 284 (538)
T KOG0661|consen 205 SLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT 284 (538)
T ss_pred HhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc
Confidence 99999976654432111 111111 00000 0011 111223334457889999999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
|+|
T Consensus 285 A~~ 287 (538)
T KOG0661|consen 285 ASQ 287 (538)
T ss_pred HHH
Confidence 975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=272.99 Aligned_cols=206 Identities=23% Similarity=0.340 Sum_probs=174.0
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
++.+...+.+|++|++.++||||+.++++|++..++|+|+||+.| +|..++ .+.+.++++.+..++.++++||.|
T Consensus 41 ~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~y 115 (808)
T KOG0597|consen 41 NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYY 115 (808)
T ss_pred chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHH
Confidence 344456689999999999999999999999999999999999976 999999 678899999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +|.|||+||.|||++.+|.+|++|||+++.+.... .......||+.|+|||++.+. .++..+|.||+||
T Consensus 116 Lhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~--pyd~~sDlWslGc 188 (808)
T KOG0597|consen 116 LHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGC 188 (808)
T ss_pred HHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCC--CccchhhHHHHHH
Confidence 9999 99999999999999999999999999998665533 333445699999999999976 7788899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++||+++|++||.... +.+.++... .+....+.+.+.++.+|+...|.+||..|.|..
T Consensus 189 ilYE~~~G~PPF~a~s-----------i~~Lv~~I~----~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~ 246 (808)
T KOG0597|consen 189 ILYELYVGQPPFYARS-----------ITQLVKSIL----KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWT 246 (808)
T ss_pred HHHHHhcCCCCchHHH-----------HHHHHHHHh----cCCCCCcccccHHHHHHHHHHhhcChhhcccHH
Confidence 9999999999995432 222222211 112223347788999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=251.34 Aligned_cols=209 Identities=24% Similarity=0.342 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
++.-.+|+.||+++. ||+|+++.++++.....++|||.|+.|.|.+++ +....+++.....++.|+..++.|||.
T Consensus 66 ~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa 141 (411)
T KOG0599|consen 66 REATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHA 141 (411)
T ss_pred HHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHH
Confidence 456678999999995 999999999999999999999999999999999 556789999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC----CCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~slG 163 (238)
. +|||||+||+|||++++.+++|+|||.+.......... ..+||++|+|||.+... .+.++...|+|++|
T Consensus 142 ~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~G 215 (411)
T KOG0599|consen 142 R---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACG 215 (411)
T ss_pred h---hhhhcccChhheeeccccceEEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHH
Confidence 9 99999999999999999999999999987665554433 34599999999998653 34678889999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|.++.|-+||--..... ....+.. ...+. ..+-..+++...++||.+||++||.+|.|++|
T Consensus 216 VImyTLLaGcpPFwHRkQml--------MLR~Ime-GkyqF--~speWadis~~~KdLIsrlLqVdp~~Ritake 279 (411)
T KOG0599|consen 216 VIMYTLLAGCPPFWHRKQML--------MLRMIME-GKYQF--RSPEWADISATVKDLISRLLQVDPTKRITAKE 279 (411)
T ss_pred HHHHHHHcCCCchhHHHHHH--------HHHHHHh-ccccc--CCcchhhccccHHHHHHHHHeeCchhcccHHH
Confidence 99999999999882111100 0011111 11111 12233567888999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=251.46 Aligned_cols=199 Identities=25% Similarity=0.303 Sum_probs=171.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.+.++..+|..+|+.+.||.++++++.+.+.+.++|||||++||.|.+++ .+.+++++..++.++.+|+.|+.|||
T Consensus 86 KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH 161 (355)
T KOG0616|consen 86 KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLH 161 (355)
T ss_pred HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHH
Confidence 35678889999999999999999999999999999999999999999999 55679999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|++||+||+|||+|.+|.+||+|||.++..... ....+||+.|+|||++.+. .+.+++|.|+||+++
T Consensus 162 ~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLI 231 (355)
T KOG0616|consen 162 SL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLI 231 (355)
T ss_pred hc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHH
Confidence 99 9999999999999999999999999999866443 2334599999999999987 888999999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
|||+.|.+||........ +...+...+ ..++.++.++.+|+...|++|-.+|.
T Consensus 232 YEMlaG~pPF~~~~~~~i---Y~KI~~~~v------------~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 232 YEMLAGYPPFYDDNPIQI---YEKILEGKV------------KFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHHcCCCCCcCCChHHH---HHHHHhCcc------------cCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 999999999977655221 222222211 23455788899999999999999983
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=268.79 Aligned_cols=204 Identities=24% Similarity=0.308 Sum_probs=168.1
Q ss_pred HHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 11 EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 11 ~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
-+..|-.+|.+| .||.|++++--|.++..+|+|+||+++|+|.+++ .+.+.+++...+.++.+|+.||.|||++
T Consensus 119 YV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~- 193 (604)
T KOG0592|consen 119 YVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN- 193 (604)
T ss_pred hhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc-
Confidence 455788999999 7999999999999999999999999999999999 5668999999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-----------ccccccCCccccCCcceeecCCCcccccCc
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-----------VSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|||||||||+|||++++++++|+|||.++........ .......||-.|.+||++... ..++++|
T Consensus 194 --GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sD 269 (604)
T KOG0592|consen 194 --GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSD 269 (604)
T ss_pred --CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccc
Confidence 9999999999999999999999999998766554322 011234599999999999986 7788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|||++|+|+.|.+||.....-... +.+..... +.+...++...+|+.+.|..||.+|+|++|
T Consensus 270 iWAlGCilyQmlaG~PPFra~NeyliF--------qkI~~l~y-------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~q 334 (604)
T KOG0592|consen 270 LWALGCILYQMLAGQPPFRAANEYLIF--------QKIQALDY-------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQ 334 (604)
T ss_pred hHHHHHHHHHHhcCCCCCccccHHHHH--------HHHHHhcc-------cCCCCCCHHHHHHHHHHHccCccccccHHH
Confidence 999999999999999999754432211 11111000 122335578899999999999999999754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=282.17 Aligned_cols=214 Identities=21% Similarity=0.247 Sum_probs=169.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
......+.+|+.+++.++||||+++++++..+...++||||+.+|+|.+++.........+++..+..++.|++.||.||
T Consensus 106 ~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l 185 (478)
T PTZ00267 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185 (478)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 34456778899999999999999999999999999999999999999988744333456788999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +|+||||||+||+++.++.++|+|||++................||+.|+|||.+.+. .++.++|||||||+
T Consensus 186 H~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~ 260 (478)
T PTZ00267 186 HSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVI 260 (478)
T ss_pred HhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHH
Confidence 998 9999999999999999999999999998765443222222334589999999998775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||....... ....... .... ..+..++.++.+++.+||+.||++|||++|
T Consensus 261 l~el~tg~~Pf~~~~~~~-------~~~~~~~-~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~ 319 (478)
T PTZ00267 261 LYELLTLHRPFKGPSQRE-------IMQQVLY-GKYD------PFPCPVSSGMKALLDPLLSKNPALRPTTQQ 319 (478)
T ss_pred HHHHHhCCCCCCCCCHHH-------HHHHHHh-CCCC------CCCccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 999999999986432211 1111111 1100 112235678999999999999999999753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=271.51 Aligned_cols=211 Identities=24% Similarity=0.329 Sum_probs=177.6
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe-eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
+...++...+|+.+++++.|||||.+.+.|.+++. ++++|+||+||++.+.+.. .++..++++.+..|+.|++.|+.
T Consensus 43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ 120 (426)
T KOG0589|consen 43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVN 120 (426)
T ss_pred CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHH
Confidence 45556688999999999999999999999988877 9999999999999999943 33789999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||++ .|+|||+|+.|||++.++.|+|+|||+++....... ......||+.|++||++.+. .+..++||||||
T Consensus 121 ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLG 193 (426)
T KOG0589|consen 121 YLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDI--PYNEKSDIWSLG 193 (426)
T ss_pred HHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCC--CCCccCcchhhc
Confidence 99998 999999999999999999999999999987665541 22344599999999999997 889999999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++|||++-+++|.......- +...... ....++..++.++..++..||+.+|+.|||+.|
T Consensus 194 C~~yEm~~lk~aF~a~~m~~L-------i~ki~~~-------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~ 254 (426)
T KOG0589|consen 194 CCLYEMCTLKPAFKASNMSEL-------ILKINRG-------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALE 254 (426)
T ss_pred chHHHHHhcccccCccchHHH-------HHHHhhc-------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHH
Confidence 999999999999975443321 2221111 123455678899999999999999999999854
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=262.78 Aligned_cols=222 Identities=22% Similarity=0.293 Sum_probs=172.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..--..+||.||++|.||||+++.++..+. ..+|||||||+. +|.-++ ...+-.+++.+++.++.|++.||.|+
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl---~~p~vkft~~qIKc~mkQLl~Gl~~c 234 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLL---SSPGVKFTEPQIKCYMKQLLEGLEYC 234 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhh---cCCCcccChHHHHHHHHHHHHHHHHH
Confidence 344567999999999999999999998776 689999999965 898887 33456899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|.. |+.|||||.+|||++.+|.+||+|||+++++....... .....-|.+|+|||++.|. ..|+...|+||.|||
T Consensus 235 H~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCI 309 (560)
T KOG0600|consen 235 HSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCI 309 (560)
T ss_pred hhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCC-cccccceeehhhhHH
Confidence 999 99999999999999999999999999999776654322 2223478999999999996 689999999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcc---------hhhh---hhhhccCCCcc--ccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYF---------PSWV---SDQLNKGGNLE--LRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
+.||+.|++.|.+.........+ ..|- ........... .+...+....++....+|+..||..||+
T Consensus 310 l~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~ 389 (560)
T KOG0600|consen 310 LAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD 389 (560)
T ss_pred HHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc
Confidence 99999999999776554422111 1111 00000000011 1122333455678889999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|.||.+
T Consensus 390 kR~tA~~ 396 (560)
T KOG0600|consen 390 KRGTASS 396 (560)
T ss_pred ccccHHH
Confidence 9999853
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=247.08 Aligned_cols=223 Identities=25% Similarity=0.304 Sum_probs=172.9
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
.+..+.+...+|++..++++|||+++++++...+ ...|++++|...|||.+.+.....++..+++.++..++..|
T Consensus 57 ~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gi 136 (302)
T KOG2345|consen 57 HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGI 136 (302)
T ss_pred cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHH
Confidence 4568889999999999999999999999986332 35899999999999999997777778899999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-------ccccccCCccccCCcceeecC-C
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-------VSISATRGTIGYIAPELISRN-F 150 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~-~ 150 (238)
++||.+||+. .++++||||||.||++++++.++++|||.+...+-.-.. ......+.|..|+|||++... .
T Consensus 137 c~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~ 215 (302)
T KOG2345|consen 137 CRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH 215 (302)
T ss_pred HHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC
Confidence 9999999997 223999999999999999999999999988644332111 112334589999999998753 2
Q ss_pred CcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCC
Q 037755 151 GTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 151 ~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
...+.++|||||||++|.||.|..||...-. .++.-.-+.....+. .+.. .-++..+.+++++||++||
T Consensus 216 ~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaLAv~n~q~s-----~P~~-----~~yse~l~~lik~mlqvdP 284 (302)
T KOG2345|consen 216 CTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLALAVQNAQIS-----IPNS-----SRYSEALHQLIKSMLQVDP 284 (302)
T ss_pred cccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEEeeeccccc-----cCCC-----CCccHHHHHHHHHHhcCCc
Confidence 3568999999999999999999999964333 111111111111111 1111 1177889999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
.+||++.|
T Consensus 285 ~qRP~i~~ 292 (302)
T KOG2345|consen 285 NQRPTIPE 292 (302)
T ss_pred ccCCCHHH
Confidence 99999753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=258.30 Aligned_cols=206 Identities=18% Similarity=0.277 Sum_probs=162.7
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.+.+.+|+.+|++++||||+++++++.+ ....++++||+.+|+|.+++. ..+.+++.....++.+++.|+.|
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~ 137 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYN 137 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHH
Confidence 4778899999999999999999999866 457899999999999999983 34578889999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. .+++||||||+||++++++.++|+|||++....... ....++..|+|||.+.+....++.++||||||+
T Consensus 138 lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv 210 (283)
T PHA02988 138 LYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210 (283)
T ss_pred HHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence 9973 178899999999999999999999999987543221 123478899999998764347789999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||....... ............. .+..+++.+.+++.+||+.||++|||++|
T Consensus 211 il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~e 271 (283)
T PHA02988 211 VLWEIFTGKIPFENLTTKE-------IYDLIINKNNSLK------LPLDCPLEIKCIVEACTSHDSIKRPNIKE 271 (283)
T ss_pred HHHHHHHCCCCCCCCCHHH-------HHHHHHhcCCCCC------CCCcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence 9999999999996532211 1111111111111 11235678999999999999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=257.37 Aligned_cols=225 Identities=20% Similarity=0.254 Sum_probs=175.6
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEe-----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
+....++..+|+++|+.++|+||+.+.+++.. -+.+|+|+|+|+ .+|...+ ..++.++...+...+.|++
T Consensus 61 ~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~ii----k~~~~L~d~H~q~f~YQiL 135 (359)
T KOG0660|consen 61 NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQII----KSQQDLTDDHAQYFLYQIL 135 (359)
T ss_pred chHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHH----HcCccccHHHHHHHHHHHH
Confidence 45667888999999999999999999999854 457999999994 4898888 4556699999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.|++|+|+. +++|||+||+|++++.+..+||+|||+++................|.+|.|||++... ..++...||
T Consensus 136 rgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDi 211 (359)
T KOG0660|consen 136 RGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDI 211 (359)
T ss_pred Hhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcc-ccccchhhh
Confidence 999999998 9999999999999999999999999999866543112222334589999999998664 588999999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcch-------h---------hhhhhhccCCCccccchhHHHHHHHHHHHHHHh
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFP-------S---------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 223 (238)
||.||++.||++|++.|.+.........+. . ....-+..............-....+...+|+.
T Consensus 212 WSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle 291 (359)
T KOG0660|consen 212 WSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE 291 (359)
T ss_pred hhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH
Confidence 999999999999999998765443221110 0 011111112222233333444567888999999
Q ss_pred hhccCCCCCCCCCCC
Q 037755 224 WCIQVKPADRPSMTK 238 (238)
Q Consensus 224 ~cl~~dp~~Rps~~e 238 (238)
+||..||.+|+|++|
T Consensus 292 kmL~fdP~kRita~e 306 (359)
T KOG0660|consen 292 KMLVFDPKKRITAEE 306 (359)
T ss_pred HHhccCccccCCHHH
Confidence 999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=264.94 Aligned_cols=204 Identities=23% Similarity=0.262 Sum_probs=165.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.....+.+|+.++++++||||+++++++.+....++||||+.+|+|.+++. ....+++..+..++.|++.||.|||
T Consensus 35 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH 110 (312)
T cd05585 35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ----REGRFDLSRARFYTAELLCALENLH 110 (312)
T ss_pred hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999999999999999999999999999883 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++||||||+++
T Consensus 111 ~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil 183 (312)
T cd05585 111 KF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLL 183 (312)
T ss_pred hC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCC--CCCCccceechhHHH
Confidence 99 999999999999999999999999999864322211 12233589999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+|++|..||...... .......... ...+..+++.+.+++.+||+.||++||++
T Consensus 184 ~el~tg~~pf~~~~~~-------~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 184 YEMLTGLPPFYDENVN-------EMYRKILQEP--------LRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred HHHHhCCCCcCCCCHH-------HHHHHHHcCC--------CCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 9999999999643221 1111111110 11123456788999999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=259.52 Aligned_cols=207 Identities=25% Similarity=0.344 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|++++++++|+||+++++.+.+++..++++||+.+|+|.+.+.. .....+++..+..++.|++.|++|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05631 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34678899999999999999999999999999999999999999887732 2234688999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++||||||+||++++++.++|+|||++........ .....|+..|+|||.+.+. .++.++||||||+++|+
T Consensus 122 ---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~e 193 (285)
T cd05631 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYE 193 (285)
T ss_pred ---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHH
Confidence 999999999999999999999999999875433221 1233589999999999875 67889999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|++|+.||......... .......... .......+++.+.+|+.+||+.||++|||+
T Consensus 194 l~~g~~pf~~~~~~~~~----~~~~~~~~~~-------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 194 MIQGQSPFRKRKERVKR----EEVDRRVKED-------QEEYSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred HHhCCCCCCCCCcchhH----HHHHHHhhcc-------cccCCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 99999999754332110 0011111110 011223457788999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=268.02 Aligned_cols=202 Identities=21% Similarity=0.275 Sum_probs=163.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|+.++++++||||+++++++.++...++||||+.+++|.+++ .....+++..+..++.||+.||+|||+
T Consensus 38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~ 113 (323)
T cd05571 38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALGYLHS 113 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456788999999999999999999999999999999999999998888 345678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +|+||||||+||+++.++.++|+|||+++....... ......|++.|+|||.+.+. .++.++|||||||++|
T Consensus 114 ~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ 186 (323)
T cd05571 114 C---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMY 186 (323)
T ss_pred C---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCC--CCCccccCcccchhhh
Confidence 9 999999999999999999999999999864322211 11233589999999999875 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+|++|..||....... ......... ...+..+++++.+++.+||+.||++||+
T Consensus 187 elltg~~Pf~~~~~~~-------~~~~~~~~~--------~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 187 EMMCGRLPFYNQDHEK-------LFELILMEE--------IRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred hhhcCCCCCCCCCHHH-------HHHHHHcCC--------CCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999996432211 111111100 0112345778899999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=256.65 Aligned_cols=206 Identities=20% Similarity=0.340 Sum_probs=172.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
+.+.-++.+|++||+.|+||||+.++++|++.+...+||||..+|.|.+++ ...+.+++..+..++.||++|+.|+
T Consensus 94 eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYC 169 (668)
T KOG0611|consen 94 EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYC 169 (668)
T ss_pred HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHH
Confidence 344557889999999999999999999999999999999999999999999 5567999999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|.+ +++|||+|.+|||++.++++||.|||++..+....-.. ..+|++.|.+||++++. +..++..|.||||++
T Consensus 170 Hkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvL 242 (668)
T KOG0611|consen 170 HKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVL 242 (668)
T ss_pred hhc---cceecccchhheeecCCCCeeeeccchhhhhccccHHH---HhcCCcccCCccccCCC-CCCCCccchhhHHHH
Confidence 999 99999999999999999999999999998776655433 34599999999999996 566888999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|.+..|..||.+.... . ...++..+...++.. +.+..-||+|||-+||++|-|+.+
T Consensus 243 LYtLVyGtMPFDG~Dhk-------~-lvrQIs~GaYrEP~~--------PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 243 LYTLVYGTMPFDGRDHK-------R-LVRQISRGAYREPET--------PSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred HHHHhhcccccCCchHH-------H-HHHHhhcccccCCCC--------CchHHHHHHHHHhcCcccchhHHH
Confidence 99999999999754322 1 122222322222222 344566999999999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=264.72 Aligned_cols=161 Identities=25% Similarity=0.382 Sum_probs=140.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++..+...+++|||+.+++|.+++ .....+++..+..++.+++.|+.|||
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH 120 (331)
T cd06649 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLR 120 (331)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34578999999999999999999999999999999999999999999988 23456889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. .+++||||||+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|+||||+++
T Consensus 121 ~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il 192 (331)
T cd06649 121 EK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSL 192 (331)
T ss_pred hc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHH
Confidence 74 169999999999999999999999999986443321 1223589999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcc
Q 037755 167 LEMTGGRRNSNLK 179 (238)
Q Consensus 167 ~~ll~g~~p~~~~ 179 (238)
|+|++|+.||...
T Consensus 193 ~el~tg~~p~~~~ 205 (331)
T cd06649 193 VELAIGRYPIPPP 205 (331)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=262.22 Aligned_cols=213 Identities=28% Similarity=0.435 Sum_probs=162.5
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeC-CeeeEEEEeCCCCChhhhccCCCC------------------------
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG-SKRALVYEFMPNGSLDRHIFPKES------------------------ 61 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~------------------------ 61 (238)
..+.+.+|+.+++++ +||||+++++++... ..++++|||+++|+|.+++.....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (338)
T cd05102 53 EHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132 (338)
T ss_pred HHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhc
Confidence 346788999999999 899999999988654 468999999999999988743211
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEcc
Q 037755 62 ----------------------------------RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH 107 (238)
Q Consensus 62 ----------------------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~ 107 (238)
....++...+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~ 209 (338)
T cd05102 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSE 209 (338)
T ss_pred cccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcC
Confidence 023577888899999999999999998 9999999999999999
Q ss_pred CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc-CCCCCCcccccccCC
Q 037755 108 NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKA 186 (238)
Q Consensus 108 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~ 186 (238)
++.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|+|++ |..||.......
T Consensus 210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--- 284 (338)
T cd05102 210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--- 284 (338)
T ss_pred CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---
Confidence 999999999998754332222222233466789999998765 67889999999999999996 999986533211
Q ss_pred cchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 187 YFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
............. .+..+++.+.+++.+||+.||++|||+.|
T Consensus 285 ----~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 285 ----EFCQRLKDGTRMR------APENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred ----HHHHHHhcCCCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111111111111 11235677899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=267.19 Aligned_cols=212 Identities=22% Similarity=0.323 Sum_probs=178.1
Q ss_pred CCcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
|+..+.+.+++++|+.+|.+++++||.++|+.+..+..+|++||||.||++.+.+ ..+..+.+..+..++.+++.|
T Consensus 48 Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~ 123 (467)
T KOG0201|consen 48 LEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKG 123 (467)
T ss_pred hhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhh----ccCCCCccceeeeehHHHHHH
Confidence 4566778899999999999999999999999999999999999999999999988 334455888889999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+.|||.. +.+|||||+.||++..+|.++++|||++....... .......||+.|+|||++.+. .|..++||||
T Consensus 124 l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~--~Y~~KADIWS 196 (467)
T KOG0201|consen 124 LDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQS--GYDTKADIWS 196 (467)
T ss_pred hhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhccc--cccchhhhhh
Confidence 9999999 99999999999999999999999999986554432 222455699999999999975 8899999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||++++||++|.+|+....+......++ ...++.+...+++.+++|+..||..||+.||||.+
T Consensus 197 LGITaiEla~GePP~s~~hPmrvlflIp--------------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 197 LGITAIELAKGEPPHSKLHPMRVLFLIP--------------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred hhHHHHHHhcCCCCCcccCcceEEEecc--------------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 9999999999999997655532222121 12223334467888999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=257.58 Aligned_cols=211 Identities=21% Similarity=0.289 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+..|++++++++||||+++.+++..+...+++|||+++|+|.+.+.........+++..+..++.|++.||.|||+.
T Consensus 37 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35677899999999999999999999999999999999999999887744444456799999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++||||||+||+++.++.++|+|||.+......... .....|+..|+|||.+.+. .++.++|+||||+++|+
T Consensus 117 ---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~e 189 (280)
T cd05608 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYE 189 (280)
T ss_pred ---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHH
Confidence 9999999999999999999999999998654332211 1223588999999999875 67889999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|++|+.||.......... . ....... .....+..+++.+.+++.+||+.||++||+++
T Consensus 190 l~~g~~pf~~~~~~~~~~---~-~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 190 MIAARGPFRARGEKVENK---E-LKQRILN-------DSVTYPDKFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred HHhCCCCCCCCCcchhHH---H-HHHhhcc-------cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 999999996533221100 0 0000000 00112234677889999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.31 Aligned_cols=219 Identities=22% Similarity=0.345 Sum_probs=162.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC---------------CCCCCCCHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE---------------SRGQSCSWEKL 71 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~~~~~ 71 (238)
..+.++.+|++++++++||||+++++++.+....+++|||+.+|+|.+++.... .....++...+
T Consensus 61 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05096 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL 140 (304)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHH
Confidence 345679999999999999999999999999999999999999999988873321 11235677889
Q ss_pred HHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC
Q 037755 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 151 (238)
Q Consensus 72 ~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 151 (238)
..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus 141 ~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-- 215 (304)
T cd05096 141 LHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-- 215 (304)
T ss_pred HHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--
Confidence 99999999999999999 9999999999999999999999999998754333222222233467889999998765
Q ss_pred cccccCceehHHHHHHHHhcC--CCCCCcccccccCCcchhhhhhhhccCC-CccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 152 TVSCKSDVYGFGMVLLEMTGG--RRNSNLKATRSSKAYFPSWVSDQLNKGG-NLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 152 ~~~~~~Di~slG~~l~~ll~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
.++.++||||||+++|+|+++ ..||........ ............ ..... .+..++..+.+++.+||+.
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~ 287 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV----IENAGEFFRDQGRQVYLF----RPPPCPQGLYELMLQCWSR 287 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHH----HHHHHHHhhhcccccccc----CCCCCCHHHHHHHHHHccC
Confidence 678899999999999999874 455543222111 011111111000 00000 1123456789999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||++|
T Consensus 288 ~p~~RPs~~~ 297 (304)
T cd05096 288 DCRERPSFSD 297 (304)
T ss_pred CchhCcCHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=263.79 Aligned_cols=200 Identities=22% Similarity=0.287 Sum_probs=163.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++.+.++...+++|||+.+|+|.+++ .....+++..+..++.|++.||+|||+
T Consensus 61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~ 136 (329)
T PTZ00263 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVLAFEYLHS 136 (329)
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999988 234578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +++||||||+||+++.++.++|+|||++....... ....|++.|+|||.+.+. .++.++|+||||+++|
T Consensus 137 ~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ 206 (329)
T PTZ00263 137 K---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLY 206 (329)
T ss_pred C---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHH
Confidence 9 99999999999999999999999999987553322 123489999999999876 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|++|..||....... .......... ..+..++..+.+|+.+||+.||.+||+.
T Consensus 207 elltg~~pf~~~~~~~--------~~~~i~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 207 EFIAGYPPFFDDTPFR--------IYEKILAGRL-------KFPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred HHHcCCCCCCCCCHHH--------HHHHHhcCCc-------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 9999999996433211 0011111110 0112245678899999999999999984
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=262.26 Aligned_cols=199 Identities=23% Similarity=0.239 Sum_probs=162.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.++...++||||+.+|+|.+++ ...+.+++..+..++.|++.||+|||+
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~ 119 (291)
T cd05612 44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCALEYLHS 119 (291)
T ss_pred HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999988 234578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +++||||||+||+++.++.++|+|||++....... ....|++.|+|||.+.+. .++.++||||||+++|
T Consensus 120 ~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ 189 (291)
T cd05612 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIY 189 (291)
T ss_pred C---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHH
Confidence 9 99999999999999999999999999987543321 123489999999998875 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+|++|+.||........ ......... ..+..+++.+.+++.+||+.||.+||+
T Consensus 190 ~l~~g~~pf~~~~~~~~--------~~~i~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 190 EMLVGYPPFFDDNPFGI--------YEKILAGKL-------EFPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred HHHhCCCCCCCCCHHHH--------HHHHHhCCc-------CCCccCCHHHHHHHHHHcCCCHHHccC
Confidence 99999999965332110 111111110 112234667899999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=257.77 Aligned_cols=222 Identities=20% Similarity=0.241 Sum_probs=166.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++++.++...++||||+.++.+.... .....+++..++.++.|++.||.|||
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH 117 (287)
T cd07848 42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCH 117 (287)
T ss_pred cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44577889999999999999999999999999999999999887765544 22457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||||+++
T Consensus 118 ~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil 191 (287)
T cd07848 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCIL 191 (287)
T ss_pred HC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHH
Confidence 98 9999999999999999999999999998755332211 11223488999999998775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCc-------chhhhhhh-hccC-----CCccccc----hhHHHHHHHHHHHHHHhhhccCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAY-------FPSWVSDQ-LNKG-----GNLELRN----VTEIESMIARKLCVIGLWCIQVK 229 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~-~~~~-----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~d 229 (238)
|+|++|+.||........... .+...... .... ....... .......++..+.+|+.+||+.|
T Consensus 192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~ 271 (287)
T cd07848 192 GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN 271 (287)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCC
Confidence 999999999975432211000 00000000 0000 0000000 01122346778999999999999
Q ss_pred CCCCCCCCC
Q 037755 230 PADRPSMTK 238 (238)
Q Consensus 230 p~~Rps~~e 238 (238)
|++|||++|
T Consensus 272 P~~R~s~~~ 280 (287)
T cd07848 272 PTDRYLTEQ 280 (287)
T ss_pred cccCCCHHH
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=265.37 Aligned_cols=205 Identities=23% Similarity=0.298 Sum_probs=164.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|++++++++||||+++++++.++...++|+||+.+|+|.+++ .....+++..+..++.||+.||+|||+
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~ 116 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHS 116 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999888 334578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++||||||+++|
T Consensus 117 ~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ 189 (318)
T cd05582 117 L---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMF 189 (318)
T ss_pred C---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCC--CCCCccceeccceEee
Confidence 9 999999999999999999999999999865433211 11223489999999998875 6688999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|+.||........ ..... .... ..+..+++.+.+++.+||+.||++|||+.+
T Consensus 190 el~tg~~p~~~~~~~~~-------~~~i~-~~~~-------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 190 EMLTGSLPFQGKDRKET-------MTMIL-KAKL-------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred eeccCCCCCCCCCHHHH-------HHHHH-cCCC-------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 99999999965332111 11111 1000 112235678899999999999999999754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=277.68 Aligned_cols=213 Identities=26% Similarity=0.446 Sum_probs=175.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC----------CCCCCHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR----------GQSCSWEKLHEVAS 76 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~----------~~~~~~~~~~~~~~ 76 (238)
..+++|++|++++..++|||||+++|++.+++.++||||||..|+|.+++.....+ ..+++..+.+.++.
T Consensus 531 ~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~ 610 (774)
T KOG1026|consen 531 QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIAT 610 (774)
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHH
Confidence 36899999999999999999999999999999999999999999999999443322 23488999999999
Q ss_pred HHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccccc
Q 037755 77 GTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 77 ~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
||+.|+.||-++ ..|||||-..|+||+++-.|||+|||+++..-..+-....+...-+.+|++||.+.-. .++..
T Consensus 611 QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~--kFTte 685 (774)
T KOG1026|consen 611 QIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG--KFTTE 685 (774)
T ss_pred HHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC--cccch
Confidence 999999999999 9999999999999999999999999999855444333333355578899999988754 88999
Q ss_pred CceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 157 ~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+||||+|+++||+++ |+.|+.+...++. .+.+.++.. -+.+.+++.++++||..||+.+|++|||
T Consensus 686 SDVWs~GVvLWEIFsyG~QPy~glSn~EV--------Ie~i~~g~l------L~~Pe~CP~~vY~LM~~CW~~~P~~RPs 751 (774)
T KOG1026|consen 686 SDVWSFGVVLWEIFSYGKQPYYGLSNQEV--------IECIRAGQL------LSCPENCPTEVYSLMLECWNENPKRRPS 751 (774)
T ss_pred hhhhhhhhhhhhhhccccCcccccchHHH--------HHHHHcCCc------ccCCCCCCHHHHHHHHHHhhcCcccCCC
Confidence 999999999999985 7778766554432 122222211 1244678899999999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
++|
T Consensus 752 F~e 754 (774)
T KOG1026|consen 752 FKE 754 (774)
T ss_pred HHH
Confidence 875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=263.98 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=161.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|+.++++++||||+++++.+..+...+++|||+.+++|.+++ ...+.+++..+..++.|++.||+|||+
T Consensus 43 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (323)
T cd05584 43 DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQ 118 (323)
T ss_pred hHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999988 334567888999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++||||||+++|
T Consensus 119 ~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ 191 (323)
T cd05584 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMY 191 (323)
T ss_pred C---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCC--CCCCcceecccHHHHH
Confidence 9 999999999999999999999999999864322221 11223489999999999875 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+|++|..||....... .... ...... ..+..+++.+.+++.+||+.||++||+
T Consensus 192 ell~G~~pf~~~~~~~-------~~~~-~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 192 DMLTGAPPFTAENRKK-------TIDK-ILKGKL-------NLPPYLTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred HHhcCCCCCCCCCHHH-------HHHH-HHcCCC-------CCCCCCCHHHHHHHHHHcccCHhHcCC
Confidence 9999999996533211 1111 111110 112234677899999999999999994
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=240.48 Aligned_cols=218 Identities=21% Similarity=0.282 Sum_probs=170.7
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
...+|++.|+.++|+||+.+.++|...+.+.+|+||++. +|+..+ ..+...++...++.++.++++|++|||++
T Consensus 47 talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vI---kd~~i~l~pa~iK~y~~m~LkGl~y~H~~-- 120 (318)
T KOG0659|consen 47 TALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVI---KDKNIILSPADIKSYMLMTLKGLAYCHSK-- 120 (318)
T ss_pred HHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHh---cccccccCHHHHHHHHHHHHHHHHHHHhh--
Confidence 457899999999999999999999999999999999976 999988 34456889999999999999999999999
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHh
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll 170 (238)
.|.|||+||.|+|++++|.+|++|||+++.......... ...-|.+|+|||++.|. ..|+...|+||.||++.||+
T Consensus 121 -~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 121 -WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred -hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc--cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHH
Confidence 999999999999999999999999999998877654332 12478999999999886 47888999999999999999
Q ss_pred cCCCCCCcccccccCCcc-hhhhh------------hhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 171 GGRRNSNLKATRSSKAYF-PSWVS------------DQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 171 ~g~~p~~~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
-|.+.|.+.+..+....+ ...-. ....+....+.......-+..+.+..+|+.+||..||.+|+|++
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 999888766544321110 00000 00000010111111113344567789999999999999999987
Q ss_pred C
Q 037755 238 K 238 (238)
Q Consensus 238 e 238 (238)
|
T Consensus 277 q 277 (318)
T KOG0659|consen 277 Q 277 (318)
T ss_pred H
Confidence 5
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=262.79 Aligned_cols=203 Identities=22% Similarity=0.285 Sum_probs=163.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....++.+|+.+++.++||||+++++.+..+...++||||+.+|+|.+.+ .....+++..+..++.||+.||+|||
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH 112 (328)
T cd05593 37 DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLH 112 (328)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999998887 33457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+|||++.++.++|+|||++....... .......|++.|+|||.+.+. .++.++||||||+++
T Consensus 113 ~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil 185 (328)
T cd05593 113 SG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVM 185 (328)
T ss_pred hC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCC--CCCccCCccccchHH
Confidence 99 99999999999999999999999999986432211 111233589999999999775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|+|++|+.||........ ....... . ...+..+++++.+++.+||+.||++||+
T Consensus 186 ~elltG~~Pf~~~~~~~~-------~~~~~~~-~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 186 YEMMCGRLPFYNQDHEKL-------FELILME-D-------IKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred HHHhhCCCCCCCCCHHHH-------HHHhccC-C-------ccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999999964322111 1111100 0 0112335678899999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=241.62 Aligned_cols=210 Identities=21% Similarity=0.283 Sum_probs=169.4
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+.+++.+|+.|-+.|+||||+++.+.+.+....|+|||++.|+.|-.-+.+ ....++..+-....||+.||.|+
T Consensus 51 ~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yC 126 (355)
T KOG0033|consen 51 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYC 126 (355)
T ss_pred cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH
Confidence 34778999999999999999999999999999999999999999999766632 25667788889999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEc---cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|.+ +|||||+||+|+++. .+.-+||+|||++.... .........||+.|+|||++... .+++.+|||+.
T Consensus 127 H~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~c 198 (355)
T KOG0033|consen 127 HSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWAC 198 (355)
T ss_pred Hhc---CceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcC--CCCCcchhhhh
Confidence 999 999999999999995 34468999999997665 22345666799999999999987 88999999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|-++.|..||-+...... ... +..+.- .-....-++++++.++|+++||..||++|+|+.|
T Consensus 199 GViLfiLL~G~~PF~~~~~~rl-------ye~-I~~g~y---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 199 GVILYILLVGYPPFWDEDQHRL-------YEQ-IKAGAY---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred hHHHHHHHhCCCCCCCccHHHH-------HHH-Hhcccc---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence 9999999999999965332211 111 111000 0011123567889999999999999999999875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=265.14 Aligned_cols=199 Identities=22% Similarity=0.235 Sum_probs=162.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++||||+++++++.++...++||||+.+|+|.+++ ...+.+++..+..++.|++.||.|||
T Consensus 73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~aL~~LH 148 (340)
T PTZ00426 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLIFEYLQ 148 (340)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999988 33457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+|||++.++.++|+|||++....... ....||+.|+|||.+.+. .++.++|+|||||++
T Consensus 149 ~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil 218 (340)
T PTZ00426 149 SL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFI 218 (340)
T ss_pred HC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHH
Confidence 99 99999999999999999999999999987543221 223489999999999775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
|+|++|..||....... .......... ..+..+++.+.+++.+||+.||++|+
T Consensus 219 ~ell~G~~Pf~~~~~~~--------~~~~i~~~~~-------~~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 219 YEILVGCPPFYANEPLL--------IYQKILEGII-------YFPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred HHHhcCCCCCCCCCHHH--------HHHHHhcCCC-------CCCCCCCHHHHHHHHHHcccCHHHcC
Confidence 99999999996533211 0111111110 01123456788999999999999996
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=260.68 Aligned_cols=210 Identities=17% Similarity=0.178 Sum_probs=166.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|++++++++||||+++++++.++...++||||+++++|.+++ .....+++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~ 119 (333)
T cd05600 44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALHE 119 (333)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4467889999999999999999999999999999999999999999998 334578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||++..... ......|++.|+|||.+.+. .++.++||||||+++|
T Consensus 120 ~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ 189 (333)
T cd05600 120 L---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLY 189 (333)
T ss_pred C---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCC--CCCCccceecchHHHh
Confidence 9 999999999999999999999999999864433 11233589999999999876 7788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||.......... ....................++.++.+++.+||+.+|.+|||+.|
T Consensus 190 ell~g~~pf~~~~~~~~~~-------~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 190 EFLCGFPPFSGSTPNETWE-------NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred hhhhCCCCCCCCCHHHHHH-------HHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 9999999996543221100 000000000000000011345778899999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=260.87 Aligned_cols=161 Identities=25% Similarity=0.373 Sum_probs=139.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++.++...+++|||+.+++|.+++. ..+.++...+..++.+++.|+.|||
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH 120 (333)
T cd06650 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 120 (333)
T ss_pred HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345778999999999999999999999999999999999999999999882 3456889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. .+++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|+|||||++
T Consensus 121 ~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il 192 (333)
T cd06650 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSL 192 (333)
T ss_pred hc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHH
Confidence 73 179999999999999999999999999986443221 1223488999999999775 678889999999999
Q ss_pred HHHhcCCCCCCcc
Q 037755 167 LEMTGGRRNSNLK 179 (238)
Q Consensus 167 ~~ll~g~~p~~~~ 179 (238)
|+|++|+.||...
T Consensus 193 ~~l~~g~~p~~~~ 205 (333)
T cd06650 193 VEMAIGRYPIPPP 205 (333)
T ss_pred HHHHHCCCCCCCc
Confidence 9999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=255.91 Aligned_cols=221 Identities=20% Similarity=0.252 Sum_probs=163.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|+.++++++||||+++++++.++...++|+||+.+ +|.+++. ..+..++...+..++.||+.||+|||+
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~~~~qi~~aL~~LH~ 121 (288)
T cd07871 46 APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD---NCGNLMSMHNVKIFMFQLLRGLSYCHK 121 (288)
T ss_pred cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346778999999999999999999999999999999999975 8988773 223467889999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +|+||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+. ..++.++|+||+|+++|
T Consensus 122 ~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~ 195 (288)
T cd07871 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILY 195 (288)
T ss_pred C---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHH
Confidence 9 999999999999999999999999999865433221 12233478999999988653 35678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhh-------hhhhhccC------CCcc--ccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSW-------VSDQLNKG------GNLE--LRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+|++|+.||...........+... ........ .... ..........++.++.+|+.+||+.||.+
T Consensus 196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~ 275 (288)
T cd07871 196 EMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS 275 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCccc
Confidence 999999999654432211000000 00000000 0000 00001111234677899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 276 R~t~~~ 281 (288)
T cd07871 276 RISAEA 281 (288)
T ss_pred CCCHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=263.07 Aligned_cols=219 Identities=21% Similarity=0.224 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|++++++++||||+++++++..+...+++++++. ++|..++ .....++...++.++.||+.||.|||++
T Consensus 127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~ylH~~ 201 (391)
T PHA03212 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYL----AAKRNIAICDILAIERSVLRAIQYLHEN 201 (391)
T ss_pred hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567899999999999999999999999999999999985 6888877 2345688999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+|+||||||+||+++.++.++|+|||++......... ......||+.|+|||++.+. .++.++||||||+++|+
T Consensus 202 ---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~e 275 (391)
T PHA03212 202 ---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFE 275 (391)
T ss_pred ---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-ccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999998643222111 11223589999999999775 67889999999999999
Q ss_pred HhcCCCCCCcccccccCCcchh----h------------------hh----hhhcc-CCCccccchhHHHHHHHHHHHHH
Q 037755 169 MTGGRRNSNLKATRSSKAYFPS----W------------------VS----DQLNK-GGNLELRNVTEIESMIARKLCVI 221 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~----~------------------~~----~~~~~-~~~~~~~~~~~~~~~~~~~l~~l 221 (238)
|++|..||.............. . .. ..... ...............++.++.+|
T Consensus 276 lltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L 355 (391)
T PHA03212 276 MATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYL 355 (391)
T ss_pred HHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHH
Confidence 9999987754322111100000 0 00 00000 00000011111223457789999
Q ss_pred HhhhccCCCCCCCCCCC
Q 037755 222 GLWCIQVKPADRPSMTK 238 (238)
Q Consensus 222 i~~cl~~dp~~Rps~~e 238 (238)
+.+||+.||++|||++|
T Consensus 356 i~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 356 ICKMLAFDAHHRPSAEA 372 (391)
T ss_pred HHHHhcCChhhCCCHHH
Confidence 99999999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=256.55 Aligned_cols=212 Identities=21% Similarity=0.284 Sum_probs=165.1
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|..+++.+ +||||+++++++.+....++||||+++|+|.+++ ...+.+++..+..++.|++.||.||
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~l 112 (329)
T cd05588 37 EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM----QRQRKLPEEHARFYSAEISLALNFL 112 (329)
T ss_pred hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3446688999999998 6999999999999999999999999999998887 2346799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||||++
T Consensus 113 H~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~ 185 (329)
T cd05588 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVL 185 (329)
T ss_pred HHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccccccCCccccCHHHHcCC--CCCCccceechHHH
Confidence 999 999999999999999999999999998864222111 11233589999999999875 67889999999999
Q ss_pred HHHHhcCCCCCCccccccc-CCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSS-KAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||........ ......+.......... ..+..++..+.+++.+||+.||++|||+
T Consensus 186 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 186 MFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-------RIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 9999999999964332221 11111111111111110 1122356778999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=261.14 Aligned_cols=202 Identities=22% Similarity=0.279 Sum_probs=162.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|+++++.++||||+++++.+......++||||+.+|+|..++ .....+++..++.++.||+.||+|||+
T Consensus 38 ~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~ 113 (323)
T cd05595 38 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS 113 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4466788999999999999999999999999999999999999998877 334578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++|+||||+++|
T Consensus 114 ~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ 186 (323)
T cd05595 114 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMY 186 (323)
T ss_pred C---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCC--CCCchhchhhhHHHHH
Confidence 9 999999999999999999999999998864322111 11234589999999999765 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+|++|+.||........ ......... ..+..+++++.+++.+||+.||++||+
T Consensus 187 ell~g~~Pf~~~~~~~~-------~~~~~~~~~--------~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 187 EMMCGRLPFYNQDHERL-------FELILMEEI--------RFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHhCCCCCCCCCHHHH-------HHHHhcCCC--------CCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 99999999964322111 111111000 011235678899999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=261.94 Aligned_cols=224 Identities=19% Similarity=0.256 Sum_probs=161.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....++.+|+.++++++||||+++++++... ...+++|||+. ++|.+++ .....+++..+..++.||+.|
T Consensus 41 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l----~~~~~~~~~~~~~i~~qi~~a 115 (338)
T cd07859 41 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI----KANDDLTPEHHQFFLYQLLRA 115 (338)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHH----HhcccCCHHHHHHHHHHHHHH
Confidence 3456788999999999999999999987533 35899999995 6898887 234578999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|.|||+. +++||||||+||+++.++.++|+|||++......... .......++..|+|||++.+....++.++|||
T Consensus 116 L~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dvw 192 (338)
T cd07859 116 LKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192 (338)
T ss_pred HHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHH
Confidence 9999999 9999999999999999999999999998744322211 11123358999999999865323678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcc--------hhhhh--------hhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYF--------PSWVS--------DQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|||+++|+|++|+.||...........+ ..... ....................+++.+.+++.+
T Consensus 193 SlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 272 (338)
T cd07859 193 SIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER 272 (338)
T ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHH
Confidence 9999999999999999654321110000 00000 0000000000111111112345678899999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 273 ~l~~~P~~Rpt~~e 286 (338)
T cd07859 273 LLAFDPKDRPTAEE 286 (338)
T ss_pred HcCcCcccCCCHHH
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=260.74 Aligned_cols=210 Identities=23% Similarity=0.297 Sum_probs=164.2
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+.+++.+ +||||+++++++..+...+++|||+.+|+|.+++. ....+++..+..++.||+.||+|||
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH 122 (332)
T cd05614 47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLH 122 (332)
T ss_pred HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 346788999999999 59999999999999999999999999999999882 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+|||++.++.++|+|||++.......... .....|+..|+|||.+.+. ..++.++||||||+++
T Consensus 123 ~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il 197 (332)
T cd05614 123 KL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILI 197 (332)
T ss_pred HC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCC-CCCCCccccccchhhh
Confidence 99 99999999999999999999999999987543322111 1223489999999998764 2467889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||.......... .+........ ...+..+++.+.+++.+||+.||++||++.
T Consensus 198 ~elltg~~pf~~~~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 198 FELLTGASPFTLEGERNTQS----EVSRRILKCD-------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred hhhhcCCCCCCCCCCCCCHH----HHHHHHhcCC-------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 99999999996433222111 1111111100 111223567789999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=256.22 Aligned_cols=212 Identities=21% Similarity=0.290 Sum_probs=164.5
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|+.++.++ +||||+++++++..+...++||||+.+|+|..++ .....+++..+..++.+++.||.||
T Consensus 37 ~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~----~~~~~l~~~~~~~i~~qi~~~l~~l 112 (329)
T cd05618 37 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYL 112 (329)
T ss_pred hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456678899998887 7999999999999999999999999999998877 2346789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||||++
T Consensus 113 H~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 185 (329)
T cd05618 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVL 185 (329)
T ss_pred HHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCC--CCCCccceecccHH
Confidence 999 999999999999999999999999999864322211 11233589999999999875 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccC-CcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSK-AYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||......... .....+.......... ..+..++..+.+++.+||+.||++|||+
T Consensus 186 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 186 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 99999999999643222111 1111111111111111 1123356678899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=252.22 Aligned_cols=209 Identities=24% Similarity=0.317 Sum_probs=163.2
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
..+..|++++++++||||+++++++.++...+++|||+.+++|.+++.. .....++...+..++.|++.|++|||+.
T Consensus 38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~- 114 (277)
T cd05607 38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM- 114 (277)
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4556799999999999999999999999999999999999999887732 2234688899999999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++||||||+||+++.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++|+|
T Consensus 115 --~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el 187 (277)
T cd05607 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEM 187 (277)
T ss_pred --CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHH
Confidence 999999999999999999999999999875543221 1223488999999998876 578899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|..||.......... ......... ... .....+++++.+++.+||+.||++||++.|
T Consensus 188 ~~g~~p~~~~~~~~~~~---~~~~~~~~~----~~~---~~~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 188 VAGRTPFKDHKEKVAKE---ELKRRTLED----EVK---FEHQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred HhCCCCCCCCcchhhHH---HHHHHhhcc----ccc---cccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 99999986432211100 000000100 000 011245778899999999999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=251.08 Aligned_cols=213 Identities=23% Similarity=0.408 Sum_probs=165.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC---------CCCCCCCHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE---------SRGQSCSWEKLHEVASG 77 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~~~~~~~~~~~ 77 (238)
...+.+.+|++++++++||||+++++++..+...++++||+.+++|.+++.... .....+++..+..++.|
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 128 (288)
T cd05093 49 NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128 (288)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999998884322 12345899999999999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccC
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
++.||+|||+. +++||||||+||++++++.++|+|||.+................++..|+|||.+.+. .++.++
T Consensus 129 l~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~s 203 (288)
T cd05093 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTES 203 (288)
T ss_pred HHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchh
Confidence 99999999998 9999999999999999999999999998755333222222223357789999998765 678899
Q ss_pred ceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 158 DVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 158 Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+||||+++|+|++ |..||....... ............ ....++.++.+++.+||+.||.+|||+
T Consensus 204 DiwslG~il~~l~t~g~~p~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~ 269 (288)
T cd05093 204 DVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIECITQGRVLQ------RPRTCPKEVYDLMLGCWQREPHMRLNI 269 (288)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCcCC------CCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999999999998 888875432211 111111111111 112345679999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
.|
T Consensus 270 ~~ 271 (288)
T cd05093 270 KE 271 (288)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=254.75 Aligned_cols=212 Identities=21% Similarity=0.272 Sum_probs=165.2
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|+.+++++ +||||+++++++.+...+++||||+.+|+|...+ ...+.+++..+..++.||+.|++||
T Consensus 37 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~qi~~al~~l 112 (327)
T cd05617 37 EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIALNFL 112 (327)
T ss_pred hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456688999999998 6999999999999999999999999999998877 2345799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++|+||||++
T Consensus 113 H~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvi 185 (327)
T cd05617 113 HER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVL 185 (327)
T ss_pred HHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCC--CCCchheeehhHHH
Confidence 999 999999999999999999999999998864322111 11234589999999998775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+|+|++|..||............ ........... ...+..++..+.+++.+||+.||++|+++.
T Consensus 186 l~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 186 MFEMMAGRSPFDIITDNPDMNTE-DYLFQVILEKP-------IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHhCCCCCCccCCCcccccH-HHHHHHHHhCC-------CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 99999999999643322211111 11111111110 011223566788999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=253.65 Aligned_cols=212 Identities=22% Similarity=0.403 Sum_probs=166.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHEVA 75 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~~ 75 (238)
..+++.+|++++++++||||+++++++......++++||+.+++|.+++..... ....++...+..++
T Consensus 51 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (283)
T cd05048 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHH
Confidence 456789999999999999999999999998999999999999999988843211 11467889999999
Q ss_pred HHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc
Q 037755 76 SGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 76 ~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
.+++.|+.|||+. +++|+||||+||++++++.++|+|||++................++..|+|||.+... .++.
T Consensus 131 ~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~ 205 (283)
T cd05048 131 IQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTT 205 (283)
T ss_pred HHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCch
Confidence 9999999999999 9999999999999999999999999998654332221222233467889999988765 6788
Q ss_pred cCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
++|+||||+++|+|++ |..||....... ....+.... ....+..+++++.+++.+||+.||++||
T Consensus 206 ~sDv~slG~il~el~~~g~~p~~~~~~~~--------~~~~i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp 271 (283)
T cd05048 206 ESDIWSFGVVLWEIFSYGLQPYYGFSNQE--------VIEMIRSRQ------LLPCPEDCPARVYALMIECWNEIPARRP 271 (283)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCC------cCCCcccCCHHHHHHHHHHccCChhhCc
Confidence 9999999999999997 988886432211 111111111 1112345678899999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|++|
T Consensus 272 ~~~~ 275 (283)
T cd05048 272 RFKD 275 (283)
T ss_pred CHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=250.46 Aligned_cols=212 Identities=23% Similarity=0.429 Sum_probs=166.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHEVA 75 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~~ 75 (238)
..+.+.+|+.++++++||||+++++++.++...++||||+.+++|.+++..... ....+++..++.++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 346789999999999999999999999999999999999999999998843221 22458899999999
Q ss_pred HHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc
Q 037755 76 SGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 76 ~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
.+|+.|++|||++ +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+. .++.
T Consensus 130 ~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~ 204 (291)
T cd05094 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTT 204 (291)
T ss_pred HHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCc
Confidence 9999999999999 9999999999999999999999999998755443222222233467889999998775 6788
Q ss_pred cCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
++||||||+++|+|++ |..||....... ............ ....++..+.+++.+||+.||++||
T Consensus 205 ~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rp 270 (291)
T cd05094 205 ESDVWSFGVILWEIFTYGKQPWFQLSNTE--------VIECITQGRVLE------RPRVCPKEVYDIMLGCWQREPQQRL 270 (291)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhCCCCCC------CCccCCHHHHHHHHHHcccChhhCc
Confidence 8999999999999998 998885433221 111111111111 1122466789999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|+.|
T Consensus 271 t~~~ 274 (291)
T cd05094 271 NIKE 274 (291)
T ss_pred CHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=258.92 Aligned_cols=204 Identities=22% Similarity=0.255 Sum_probs=163.4
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|..+++.+ +||||+++++++.+...+++||||+.+|+|.+++ .....+++..+..++.|++.||+||
T Consensus 37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i----~~~~~l~~~~~~~~~~ql~~~L~~l 112 (320)
T cd05590 37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFL 112 (320)
T ss_pred cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456777899999887 6999999999999999999999999999999887 3345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++|+||||++
T Consensus 113 H~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 185 (320)
T cd05590 113 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVL 185 (320)
T ss_pred HHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCC--CCCCccchhhhHHH
Confidence 999 999999999999999999999999999864322211 12233589999999998765 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||........ ..... .... ..+..++.++.+++.+||+.||++||++
T Consensus 186 l~el~~g~~Pf~~~~~~~~-------~~~i~-~~~~-------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 186 LYEMLCGHAPFEAENEDDL-------FEAIL-NDEV-------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHhhCCCCCCCCCHHHH-------HHHHh-cCCC-------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 9999999999965432211 11111 1100 1112356788999999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=256.47 Aligned_cols=220 Identities=21% Similarity=0.256 Sum_probs=160.0
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|+.+++.++||||+++++++.++...++||||+. ++|.+++. .....++...+..++.|++.||+|||+.
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~ 122 (303)
T cd07869 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR 122 (303)
T ss_pred chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567899999999999999999999999999999999995 57877763 2235688899999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..++.++|+||+|+++|+
T Consensus 123 ---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ 196 (303)
T cd07869 123 ---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVE 196 (303)
T ss_pred ---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999864432221 11234478999999998654 356778999999999999
Q ss_pred HhcCCCCCCcccccccCC-c------------chhhhhhhhccCCCccccchhHHH-----HHHHHHHHHHHhhhccCCC
Q 037755 169 MTGGRRNSNLKATRSSKA-Y------------FPSWVSDQLNKGGNLELRNVTEIE-----SMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~-~------------~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp 230 (238)
|++|..||.......... . .+...................... ...++++.+|+.+||+.||
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp 276 (303)
T cd07869 197 MIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFP 276 (303)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCc
Confidence 999999997532211000 0 000000000000000000000000 1134678899999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||+.|
T Consensus 277 ~~R~s~~~ 284 (303)
T cd07869 277 KNRLSAQA 284 (303)
T ss_pred hhccCHHH
Confidence 99999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=258.17 Aligned_cols=203 Identities=23% Similarity=0.302 Sum_probs=160.1
Q ss_pred cHHHHHHHHHHH---hhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTI---GRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 8 ~~~~~~~e~~~l---~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
..+++.+|+.++ +.++||||+++++++..+...|+||||+.+++|...+ ....+++..+..++.|++.|++|
T Consensus 42 ~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~-----~~~~l~~~~~~~~~~qi~~al~~ 116 (324)
T cd05589 42 EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGLQY 116 (324)
T ss_pred HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHH
Confidence 346677777665 4567999999999999999999999999999998877 23578999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++|+||||+
T Consensus 117 lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~ 189 (324)
T cd05589 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGV 189 (324)
T ss_pred HHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHH
Confidence 9999 999999999999999999999999998864322211 12234589999999999875 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++|+|++|+.||........ ..... .... ..+..+++.+.+++.+||+.||++||+.+
T Consensus 190 il~el~~G~~pf~~~~~~~~-------~~~i~-~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 190 LIYEMLVGESPFPGDDEEEV-------FDSIV-NDEV-------RYPRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred HHHHHHhCCCCCCCCCHHHH-------HHHHH-hCCC-------CCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 99999999999965432211 11111 1110 01123567788999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=256.39 Aligned_cols=208 Identities=23% Similarity=0.280 Sum_probs=170.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.+.+.+..|-.+|....+|+||+++-.|.+...+|+||||++||++..++ .....+++..++.++.+++.|+..||
T Consensus 183 ~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH 258 (550)
T KOG0605|consen 183 NQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIH 258 (550)
T ss_pred hhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHH
Confidence 45678889999999999999999999999999999999999999999999 55679999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCC---------------------cccc----c----------
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN---------------------DFVS----I---------- 131 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---------------------~~~~----~---------- 131 (238)
+. |++||||||+|+|||..|++||+|||+|....... .... .
T Consensus 259 ~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (550)
T KOG0605|consen 259 QL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQ 335 (550)
T ss_pred Hc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHH
Confidence 99 99999999999999999999999999984221100 0000 0
Q ss_pred ----------cccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCC
Q 037755 132 ----------SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGN 201 (238)
Q Consensus 132 ----------~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (238)
-...|||-|+|||++.+. .++..+|.|||||++|||+.|.+||....+...-..+..|.....
T Consensus 336 ~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~----- 408 (550)
T KOG0605|consen 336 TWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK----- 408 (550)
T ss_pred HHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----
Confidence 002399999999999998 788999999999999999999999998877765443333322111
Q ss_pred ccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 202 LELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 202 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
... ...++++..+||.+||. ||++|.-
T Consensus 409 --fP~----~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 409 --FPE----EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred --CCC----cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 111 12234889999999999 9999975
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=261.98 Aligned_cols=202 Identities=21% Similarity=0.279 Sum_probs=161.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|+++++.++||||+++++++......++||||+.+|+|.+++ .....+++..+..++.||+.||+|||+
T Consensus 38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~ 113 (325)
T cd05594 38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHS 113 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4467788999999999999999999999999999999999999998887 334578999999999999999999997
Q ss_pred -CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 88 -GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 -~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
. +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++||||||+++
T Consensus 114 ~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il 186 (325)
T cd05594 114 EK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVM 186 (325)
T ss_pred cC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccC--CCCCcccccccccee
Confidence 6 999999999999999999999999999864322211 11233489999999999775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|+|++|..||........ ........ . ..+..+++++.+++.+||+.||++|++
T Consensus 187 ~el~tG~~Pf~~~~~~~~-------~~~i~~~~-~-------~~p~~~~~~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 187 YEMMCGRLPFYNQDHEKL-------FELILMEE-I-------RFPRTLSPEAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred eeeccCCCCCCCCCHHHH-------HHHHhcCC-C-------CCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence 999999999964332111 00100000 0 011235678899999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=256.69 Aligned_cols=204 Identities=21% Similarity=0.262 Sum_probs=161.3
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+..|..++..+ +||||+++++++..+...++||||+.+|+|.+++ .....+++..+..++.|++.||.|||
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH 113 (316)
T cd05592 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLH 113 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345566777777765 7999999999999999999999999999999888 23457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +|+||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+. .++.++||||||+++
T Consensus 114 ~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il 186 (316)
T cd05592 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLL 186 (316)
T ss_pred HC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCC--CCCCcccchhHHHHH
Confidence 99 99999999999999999999999999986433222 112233589999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||........ ... ..... ...+..++.++.+++.+||+.||++||++.
T Consensus 187 ~ell~G~~Pf~~~~~~~~-------~~~-i~~~~-------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 187 YEMLIGQSPFHGEDEDEL-------FDS-ILNDR-------PHFPRWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHhCCCCCCCCCHHHH-------HHH-HHcCC-------CCCCCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 999999999965432111 111 11100 111223567788999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=260.41 Aligned_cols=218 Identities=20% Similarity=0.196 Sum_probs=164.4
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
...+|++++++++||||+++++++......+++|+++. ++|.+++ .....+++..+..++.||+.||.|||+.
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~-- 204 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR-- 204 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45689999999999999999999999999999999985 5888877 3346789999999999999999999999
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHh
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll 170 (238)
+|+||||||+|||++.++.++|+|||++................||..|+|||.+.+. .++.++|||||||++|+|+
T Consensus 205 -givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~ 281 (392)
T PHA03207 205 -GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMS 281 (392)
T ss_pred -CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999998655443322222234589999999999875 6788999999999999999
Q ss_pred cCCCCCCcccccccCCcchhhhh------------------hhhccC---CCccccchh-HHHHHHHHHHHHHHhhhccC
Q 037755 171 GGRRNSNLKATRSSKAYFPSWVS------------------DQLNKG---GNLELRNVT-EIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 171 ~g~~p~~~~~~~~~~~~~~~~~~------------------~~~~~~---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~ 228 (238)
+|+.||...........+..... ...... ......... .....++.++.+++.+||+.
T Consensus 282 ~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~ 361 (392)
T PHA03207 282 VKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTF 361 (392)
T ss_pred HCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhcc
Confidence 99999976544321111111000 000000 000000000 01123456788999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||+.|
T Consensus 362 dp~~Rpsa~e 371 (392)
T PHA03207 362 DQEFRPSAQD 371 (392)
T ss_pred ChhhCCCHHH
Confidence 9999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=254.93 Aligned_cols=204 Identities=21% Similarity=0.259 Sum_probs=161.8
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+..|..+++.. +||||+++++++.+++.+++||||+.+|+|.+++ .....++...+..++.|++.||+|||
T Consensus 38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~~l~~lH 113 (316)
T cd05620 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLH 113 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445677888888765 8999999999999999999999999999999888 23457889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||+|+++
T Consensus 114 ~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil 186 (316)
T cd05620 114 SK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLL 186 (316)
T ss_pred HC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHH
Confidence 99 999999999999999999999999998863322111 11233489999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||........ . ....... ...+..++.++.+++.+||+.||++||++.
T Consensus 187 ~el~~g~~Pf~~~~~~~~-------~-~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 187 YEMLIGQSPFHGDDEDEL-------F-ESIRVDT-------PHYPRWITKESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHHhCCCCCCCCCHHHH-------H-HHHHhCC-------CCCCCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 999999999965432211 1 1111110 011122567788999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=256.44 Aligned_cols=204 Identities=23% Similarity=0.266 Sum_probs=163.1
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|..+++.+ +||||+++++++.+....++||||+.+|+|.+.+ .....+++..+..++.|++.||+||
T Consensus 37 ~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~L 112 (318)
T cd05570 37 DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHI----QRSGRFDEPRARFYAAEIVLGLQFL 112 (318)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456678899999988 6999999999999999999999999999998887 3345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||||++
T Consensus 113 H~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvi 185 (318)
T cd05570 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVL 185 (318)
T ss_pred HhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCC--CCCcchhhhhHHHH
Confidence 999 999999999999999999999999998864322211 11223488999999999875 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||........ ....... .. ..+..+++.+.+++.+||+.||++|||+
T Consensus 186 l~~l~~G~~pf~~~~~~~~-------~~~i~~~-~~-------~~~~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 186 LYEMLAGQSPFEGDDEDEL-------FQSILED-EV-------RYPRWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHhhCCCCCCCCCHHHH-------HHHHHcC-CC-------CCCCcCCHHHHHHHHHHccCCHHHcCCC
Confidence 9999999999964332111 1111111 00 1112356788999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=261.93 Aligned_cols=213 Identities=23% Similarity=0.443 Sum_probs=163.4
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC--------------------------
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE-------------------------- 60 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------------------- 60 (238)
..+.+.+|+.+++.+ +||||+++++.+......+++|||+.+|+|.+++....
T Consensus 84 ~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (374)
T cd05106 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163 (374)
T ss_pred HHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchh
Confidence 456788999999999 89999999999999999999999999999988873211
Q ss_pred ----------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCC
Q 037755 61 ----------------------------------------SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKP 100 (238)
Q Consensus 61 ----------------------------------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p 100 (238)
....+++...+..++.||+.||.|||++ +++||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp 240 (374)
T cd05106 164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAA 240 (374)
T ss_pred cccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCch
Confidence 0123577888999999999999999998 999999999
Q ss_pred CcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc-CCCCCCcc
Q 037755 101 HNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLK 179 (238)
Q Consensus 101 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~ 179 (238)
+||+++.++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..||...
T Consensus 241 ~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 241 RNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred heEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999998754333222222223356789999998765 67889999999999999997 99998643
Q ss_pred cccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
..... ............ .+..+++++.+++.+||+.||++|||+.|
T Consensus 319 ~~~~~-------~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~~ 364 (374)
T cd05106 319 LVNSK-------FYKMVKRGYQMS------RPDFAPPEIYSIMKMCWNLEPTERPTFSQ 364 (374)
T ss_pred cccHH-------HHHHHHcccCcc------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 22110 111111110000 11124678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=257.14 Aligned_cols=202 Identities=25% Similarity=0.281 Sum_probs=159.5
Q ss_pred HHHHHHHH-HHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 10 EEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 10 ~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.++..|.. +++.++||||+++++.+.+....++||||+.+|+|..++ .....+++..+..++.||+.||.|||++
T Consensus 40 ~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 115 (323)
T cd05575 40 KHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSL 115 (323)
T ss_pred HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44555554 567889999999999999999999999999999998888 3345788999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++||||||+++|+
T Consensus 116 ---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~e 188 (323)
T cd05575 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYE 188 (323)
T ss_pred ---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCC--CCCccccccccchhhhh
Confidence 999999999999999999999999998864322211 12233589999999998775 67889999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|++|..||....... .......... .....+++.+.+++.+||+.||++||++.
T Consensus 189 ll~g~~pf~~~~~~~-------~~~~i~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 189 MLYGLPPFYSRDTAE-------MYDNILNKPL--------RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred hhcCCCCCCCCCHHH-------HHHHHHcCCC--------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 999999996533211 1111111100 11123467889999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=257.40 Aligned_cols=213 Identities=24% Similarity=0.410 Sum_probs=163.6
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-------------------------
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------------------- 61 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------------------- 61 (238)
..+.+.+|+.+++.+ +||||+++++++..+...++||||+.+|+|.+++.....
T Consensus 81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (375)
T cd05104 81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM 160 (375)
T ss_pred HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence 456788999999999 899999999999999999999999999999888743210
Q ss_pred ----------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceee
Q 037755 62 ----------------------------------------------RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILH 95 (238)
Q Consensus 62 ----------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H 95 (238)
....+++..+..++.+|+.||+|||+. +++|
T Consensus 161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH 237 (375)
T cd05104 161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIH 237 (375)
T ss_pred cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 112577888999999999999999998 9999
Q ss_pred eccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc-CCC
Q 037755 96 LDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG-GRR 174 (238)
Q Consensus 96 ~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~ 174 (238)
|||||+||+++.++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..
T Consensus 238 ~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~ 315 (375)
T cd05104 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSS 315 (375)
T ss_pred cCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999998755443322222223356789999999775 67889999999999999997 788
Q ss_pred CCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 175 NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 175 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||....... ............. .+...+.++.+++.+||+.||++|||+.|
T Consensus 316 p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~e 366 (375)
T cd05104 316 PYPGMPVDS-------KFYKMIKEGYRML------SPECAPSEMYDIMKSCWDADPLKRPTFKQ 366 (375)
T ss_pred CCCCCCchH-------HHHHHHHhCccCC------CCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 875432211 0111111111111 11123567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=249.45 Aligned_cols=219 Identities=21% Similarity=0.305 Sum_probs=160.3
Q ss_pred HHHHHHHHHHHhhc---CCCcceeeeeEEE-----eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRI---HHVNVVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 9 ~~~~~~e~~~l~~l---~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+|+.+++++ .||||+++++++. .....++++||+. ++|.+++.. .....+++..+..++.|++.
T Consensus 45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~ 121 (290)
T cd07862 45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLR 121 (290)
T ss_pred hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHH
Confidence 45667788888776 6999999999885 3456899999996 589888732 22346889999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||.|||+. +++||||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|||
T Consensus 122 aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Diw 193 (290)
T cd07862 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLW 193 (290)
T ss_pred HHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCC--CCCCccchH
Confidence 99999999 99999999999999999999999999987544331 11233488999999998765 678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhh--------hhhhhc---c-CCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSW--------VSDQLN---K-GGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~---~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
|||+++|+|++|.+||...........+... ...... . ...............+++.+.+++.+||+.
T Consensus 194 slG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (290)
T cd07862 194 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 273 (290)
T ss_pred HHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhcc
Confidence 9999999999999999754332110000000 000000 0 000011111222334677889999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||+.|
T Consensus 274 ~P~~R~s~~~ 283 (290)
T cd07862 274 NPAKRISAYS 283 (290)
T ss_pred CchhcCCHHH
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=258.86 Aligned_cols=207 Identities=26% Similarity=0.420 Sum_probs=158.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+++++.++|+||+++++++..+...++|+||+.+++|.+.. ...+..+..++.||+.||.|||+
T Consensus 115 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 186 (353)
T PLN00034 115 VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHR 186 (353)
T ss_pred HHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999999999999999999999999986532 34567788999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC---CcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~slG~ 164 (238)
+ +++||||||+|||++.++.++|+|||++........ ......|+..|+|||.+.... ...+.++|||||||
T Consensus 187 ~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGv 261 (353)
T PLN00034 187 R---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261 (353)
T ss_pred C---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHH
Confidence 9 999999999999999999999999999875433211 112335899999999875321 13456899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|+.||....... +...... .... ........++.++.+|+.+||+.||++|||++|
T Consensus 262 il~el~~g~~pf~~~~~~~----~~~~~~~-~~~~------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e 324 (353)
T PLN00034 262 SILEFYLGRFPFGVGRQGD----WASLMCA-ICMS------QPPEAPATASREFRHFISCCLQREPAKRWSAMQ 324 (353)
T ss_pred HHHHHHhCCCCCCCCCCcc----HHHHHHH-Hhcc------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999997322111 1000000 0000 011112345678999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=260.45 Aligned_cols=200 Identities=26% Similarity=0.409 Sum_probs=166.4
Q ss_pred HHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCc
Q 037755 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVC 92 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 92 (238)
..+++=|++|+||||+.+.|+|.....+|+|||||..|-|...+ ..+..++......|..+|+.|+.|||.+ .
T Consensus 160 ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---K 232 (904)
T KOG4721|consen 160 ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---K 232 (904)
T ss_pred hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---h
Confidence 35788899999999999999999999999999999999999999 5577899999999999999999999999 9
Q ss_pred eeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcC
Q 037755 93 ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172 (238)
Q Consensus 93 i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g 172 (238)
|+|||||.-||||+.+..|||+|||-++..... ...-...||..|+|||++... ..+.+.||||||+|||||+||
T Consensus 233 IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~ 307 (904)
T KOG4721|consen 233 IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTG 307 (904)
T ss_pred HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhc
Confidence 999999999999999999999999988755443 223345699999999999886 788999999999999999999
Q ss_pred CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 173 RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 173 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
..|+..-........+ -.+ .. .-..+.++++-++-|+++||+..|..|||+.
T Consensus 308 EiPYkdVdssAIIwGV-------GsN---sL---~LpvPstcP~GfklL~Kqcw~sKpRNRPSFr 359 (904)
T KOG4721|consen 308 EIPYKDVDSSAIIWGV-------GSN---SL---HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFR 359 (904)
T ss_pred CCCccccchheeEEec-------cCC---cc---cccCcccCchHHHHHHHHHHhcCCCCCccHH
Confidence 9998543222211111 000 00 1124567888899999999999999999974
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=255.85 Aligned_cols=204 Identities=19% Similarity=0.229 Sum_probs=162.0
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+..|.++++.+ +||||+++++++..+...++||||+++++|...+ .....+++..+..++.|++.||.||
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~L 112 (321)
T cd05591 37 DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFL 112 (321)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3446677899999876 7999999999999999999999999999998888 3345788999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||||++
T Consensus 113 H~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~i 185 (321)
T cd05591 113 HRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVL 185 (321)
T ss_pred HHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCC--CCCCccceechhHH
Confidence 999 999999999999999999999999998864322221 11233489999999998765 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||........ ....... .. ..+..+++++.+++.+||+.||++||+.
T Consensus 186 l~el~tg~~Pf~~~~~~~~-------~~~i~~~-~~-------~~p~~~~~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 186 MYEMMAGQPPFEADNEDDL-------FESILHD-DV-------LYPVWLSKEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred HHHHhcCCCCCCCCCHHHH-------HHHHHcC-CC-------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 9999999999975432211 1111111 00 0112245778999999999999999943
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=242.63 Aligned_cols=211 Identities=27% Similarity=0.446 Sum_probs=164.2
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+++.+|+.++++++||||+++++++.++...+++|||+.+|+|.+++... ...+++..+..++.+++.|+.|
T Consensus 39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~ 115 (256)
T cd05114 39 GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEY 115 (256)
T ss_pred CCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHH
Confidence 3445678999999999999999999999999999999999999999999988321 2368899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+. .++.++|+||||+
T Consensus 116 lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~ 189 (256)
T cd05114 116 LERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGV 189 (256)
T ss_pred HHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccC--ccchhhhhHHHHH
Confidence 9999 9999999999999999999999999988754332211 11122355689999998765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++ |+.||........ . ........... +...+..+.+++.+||+.||++|||++|
T Consensus 190 ~l~el~~~g~~p~~~~~~~~~-------~-~~i~~~~~~~~------~~~~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 190 LMWEVFTEGKMPFEKKSNYEV-------V-EMISRGFRLYR------PKLASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred HHHHHHcCCCCCCCCCCHHHH-------H-HHHHCCCCCCC------CCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 9999999 8888854332111 1 11111111100 1123467899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=247.26 Aligned_cols=212 Identities=29% Similarity=0.430 Sum_probs=165.2
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+.+.+|++++++++||||+++++++..+...++++||+.+++|.+++.. .....++...++.++.|++.+++|
T Consensus 42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~ 119 (263)
T cd05052 42 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEY 119 (263)
T ss_pred CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 344567889999999999999999999999999999999999999999998832 224568899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++||||||+||++++++.++|+|||.+......... .......+..|+|||.+.+. ..+.++||||||+
T Consensus 120 lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~ 193 (263)
T cd05052 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGV 193 (263)
T ss_pred HHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccC--CCCchhHHHHHHH
Confidence 9998 9999999999999999999999999998755432211 11112245689999988765 6788899999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |..||........ . ......... ..+..++.++.+++.+||+.||++|||+.|
T Consensus 194 il~el~t~g~~p~~~~~~~~~-------~-~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 194 LLWEIATYGMSPYPGIDLSQV-------Y-ELLEKGYRM------ERPEGCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred HHHHHHcCCCCCCCCCCHHHH-------H-HHHHCCCCC------CCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 9999998 8888854322111 0 111111111 111235678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=250.21 Aligned_cols=211 Identities=32% Similarity=0.528 Sum_probs=160.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++.+++++||||++++|++......++|+||+.+|+|.+++... ....+++..+..++.||+.||+|||
T Consensus 43 ~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh 120 (259)
T PF07714_consen 43 EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLH 120 (259)
T ss_dssp HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHH
T ss_pred ccceeeeeccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccc
Confidence 34789999999999999999999999999888899999999999999998433 2467899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|++|+++||++++++.+||+|||++....................|+|||.+... .++.++||||||+++
T Consensus 121 ~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l 195 (259)
T PF07714_consen 121 SN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLL 195 (259)
T ss_dssp HT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHH
T ss_pred cc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc
Confidence 99 9999999999999999999999999998766332222222334477899999999876 688999999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++ |+.||....... +.....+..... .+..++..+.+++.+||+.||++|||+.|
T Consensus 196 ~ei~~~~~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~C~~~~p~~RPs~~~ 254 (259)
T PF07714_consen 196 YEILTLGKFPFSDYDNEE--------IIEKLKQGQRLP------IPDNCPKDIYSLIQQCWSHDPEKRPSFQE 254 (259)
T ss_dssp HHHHTTSSGTTTTSCHHH--------HHHHHHTTEETT------SBTTSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred cccccccccccccccccc--------ccccccccccce------eccchhHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999 677764432111 111112211111 11235677889999999999999999753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=251.34 Aligned_cols=206 Identities=25% Similarity=0.344 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|+.+++.++||||+++++.+.++...+++|||+.+|+|.+++... ....+++..+..++.|++.|+.|||++
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 355778999999999999999999999999999999999999998877322 235689999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|+||||+||++++++.++|+|||.+........ .....|+..|+|||.+.+. .++.++|+||+|+++|+
T Consensus 122 ---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~e 193 (285)
T cd05605 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYE 193 (285)
T ss_pred ---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHH
Confidence 999999999999999999999999999875433221 1223488999999998765 67888999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+++|..||......... ..+...... ........++..+.+++.+||+.||++||+
T Consensus 194 l~~g~~pf~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 194 MIEGKSPFRQRKEKVKR----EEVERRVKE-------DQEEYSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred HHHCCCCCCCCchhhHH----HHHHHHhhh-------cccccCcccCHHHHHHHHHHccCCHHHhcC
Confidence 99999999753321110 001111110 011122346778899999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=246.02 Aligned_cols=212 Identities=24% Similarity=0.414 Sum_probs=166.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC----------CCCCCCCHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE----------SRGQSCSWEKLHEVASG 77 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------~~~~~~~~~~~~~~~~~ 77 (238)
..+++.+|+++++.+.||||+++++++..+...+++|||+++++|.+++.... .....++...+..++.+
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 45789999999999999999999999999999999999999999999884332 12345788899999999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccC
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
++.|+.+||++ +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+. .++.++
T Consensus 131 i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~ 205 (280)
T cd05049 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTES 205 (280)
T ss_pred HHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC--Ccchhh
Confidence 99999999999 9999999999999999999999999988644322211111223356789999998775 678899
Q ss_pred ceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 158 DVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 158 Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
||||||+++|+|++ |..||....... ........... .....++..+.+++.+||+.||++|||+
T Consensus 206 Di~slG~il~e~~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 271 (280)
T cd05049 206 DVWSFGVVLWEIFTYGKQPWYGLSNEE--------VIECITQGRLL------QRPRTCPSEVYDIMLGCWKRDPQQRINI 271 (280)
T ss_pred hHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCcC------CCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 99999999999998 999885433221 11111111111 1112356788999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
.|
T Consensus 272 ~e 273 (280)
T cd05049 272 KD 273 (280)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=247.33 Aligned_cols=210 Identities=22% Similarity=0.385 Sum_probs=162.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....++.+|++++++++||||+++++++..+...++|+||+.+++|.+++. ..+..+++..++.++.|++.||.|||
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH 111 (252)
T cd05084 35 DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE 111 (252)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999883 22346889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+. ..+.++|+||||+++
T Consensus 112 ~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il 186 (252)
T cd05084 112 SK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILL 186 (252)
T ss_pred hC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCC--CCChHHHHHHHHHHH
Confidence 99 9999999999999999999999999998644322111111111234579999998765 678889999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++ |..||....... ........... ..+..++..+.+++.+||+.||++|||+.|
T Consensus 187 ~e~~~~~~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 245 (252)
T cd05084 187 WEAFSLGAVPYANLSNQQ--------TREAIEQGVRL------PCPELCPDAVYRLMERCWEYDPGQRPSFST 245 (252)
T ss_pred HHHHhCCCCCccccCHHH--------HHHHHHcCCCC------CCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99997 888875432211 11111111111 112234668899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.81 Aligned_cols=210 Identities=23% Similarity=0.275 Sum_probs=166.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+++++.++||||+++++.+.++...++||||+.+++|.+++. ....++...+..++.||+.||+|||
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH 118 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI----RKDVFPEETARFYIAELVLALDSVH 118 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445678899999999999999999999999999999999999999999883 3367899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCC---------------------------ccccccccCCccc
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN---------------------------DFVSISATRGTIG 139 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---------------------------~~~~~~~~~~~~~ 139 (238)
+. |++||||||+||+++.++.++|+|||++....... .........|++.
T Consensus 119 ~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 195 (350)
T cd05573 119 KL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPD 195 (350)
T ss_pred HC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCcc
Confidence 98 99999999999999999999999999987554332 0011223358999
Q ss_pred cCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHH
Q 037755 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLC 219 (238)
Q Consensus 140 ~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 219 (238)
|+|||.+.+. .++.++|||||||++|+|++|+.||........ ................ ..+++.+.
T Consensus 196 y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~~~~p~~----~~~~~~~~ 262 (350)
T cd05573 196 YIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-------YNKIINWKESLRFPPD----PPVSPEAI 262 (350)
T ss_pred ccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCHHHH-------HHHHhccCCcccCCCC----CCCCHHHH
Confidence 9999999876 778899999999999999999999975442211 1111110000011110 11577899
Q ss_pred HHHhhhccCCCCCCCC-CC
Q 037755 220 VIGLWCIQVKPADRPS-MT 237 (238)
Q Consensus 220 ~li~~cl~~dp~~Rps-~~ 237 (238)
+++.+||+ ||.+||+ ++
T Consensus 263 ~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 263 DLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred HHHHHHcc-ChhhcCCCHH
Confidence 99999998 9999999 54
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=244.34 Aligned_cols=208 Identities=25% Similarity=0.409 Sum_probs=162.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++..+...++||||+.+|+|.+++.. ....+++..++.++.+++.|++|||+
T Consensus 49 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~ 125 (266)
T cd05064 49 QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE 125 (266)
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346788999999999999999999999999999999999999999998832 23578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++++|||.+......... ......++..|+|||.+.+. .++.++||||||+++|
T Consensus 126 ~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ 199 (266)
T cd05064 126 M---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMW 199 (266)
T ss_pred C---CEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHH
Confidence 8 9999999999999999999999999986543222111 11122356789999998765 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++ |..||....... ......+.... ..+..++..+.+++.+||+.+|++|||++|
T Consensus 200 ell~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~ 257 (266)
T cd05064 200 EVMSYGERPYWDMSGQD--------VIKAVEDGFRL------PAPRNCPNLLHQLMLDCWQKERGERPRFSQ 257 (266)
T ss_pred HHhcCCCCCcCcCCHHH--------HHHHHHCCCCC------CCCCCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 9775 999986432211 11111111111 112345678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=254.12 Aligned_cols=202 Identities=25% Similarity=0.286 Sum_probs=159.0
Q ss_pred HHHHHHH-HHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 11 EFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 11 ~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
++..|.. +++.+.||||+++++++.++...++||||+.+++|.+.+ .....++...+..++.||+.||.|||++
T Consensus 41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 115 (325)
T cd05602 41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL- 115 (325)
T ss_pred HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4444444 567889999999999999999999999999999999888 3345678889999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
|++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++||||||+++|+|
T Consensus 116 --giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el 189 (325)
T cd05602 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEM 189 (325)
T ss_pred --CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHH
Confidence 999999999999999999999999999864322111 11233489999999999875 678899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|..||........ ......... .....++..+.+++.+||+.||.+||++.+
T Consensus 190 ~~g~~pf~~~~~~~~-------~~~i~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 190 LYGLPPFYSRNTAEM-------YDNILNKPL--------QLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred hcCCCCCCCCCHHHH-------HHHHHhCCc--------CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 999999964332211 111111100 111235678899999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=254.10 Aligned_cols=225 Identities=16% Similarity=0.208 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|+++++.++||||+++++++..++..++|+||+++|+|.+++... ....+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~ 120 (327)
T cd08227 43 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM 120 (327)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456778999999999999999999999999999999999999999988322 234688999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
+++||||||+||+++.++.+++.||+............ ......++..|+|||.+.+....++.++||||||
T Consensus 121 ---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG 197 (327)
T cd08227 121 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 197 (327)
T ss_pred ---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHH
Confidence 99999999999999999999999997643222111100 0112236678999999876433578899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCc-----chhhhh------hh-------------hccCC-------CccccchhHHHH
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAY-----FPSWVS------DQ-------------LNKGG-------NLELRNVTEIES 212 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~-----~~~~~~------~~-------------~~~~~-------~~~~~~~~~~~~ 212 (238)
|++|+|++|..||........... .+.... .. ..... ............
T Consensus 198 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (327)
T cd08227 198 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNR 277 (327)
T ss_pred HHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccccc
Confidence 999999999999964322110000 000000 00 00000 000000111233
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 213 MIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 213 ~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+++.+.+|+.+||+.||++|||++|
T Consensus 278 ~~~~~~~~li~~~l~~dP~~Rpt~~e 303 (327)
T cd08227 278 TFSPHFHHFVEQCLQRNPDARPSAST 303 (327)
T ss_pred ccCHHHHHHHHHHHhhCchhcCCHHH
Confidence 46778999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=254.83 Aligned_cols=203 Identities=24% Similarity=0.283 Sum_probs=159.0
Q ss_pred HHHHHHHHH-HHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..++.+|.. +++.++||||+++++.+.+....++||||+++++|...+ .....+++..+..++.||+.||.|||+
T Consensus 39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~ 114 (321)
T cd05603 39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS 114 (321)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 344555554 578899999999999999999999999999999998877 234678899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++||||||+++|
T Consensus 115 ~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ 187 (321)
T cd05603 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLY 187 (321)
T ss_pred C---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhh
Confidence 8 999999999999999999999999999864322111 12233589999999998765 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+|++|..||....... ......... ...+...+..+.+++.+||+.||.+||++.
T Consensus 188 el~~g~~pf~~~~~~~-------~~~~i~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 188 EMLYGLPPFYSRDVSQ-------MYDNILHKP--------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hhhcCCCCCCCCCHHH-------HHHHHhcCC--------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 9999999996543211 111111110 011122456788999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=253.22 Aligned_cols=204 Identities=22% Similarity=0.256 Sum_probs=161.4
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+..|..+++.+ +||||+++++++.+....++||||+.+|+|.+++. ....++...+..++.|++.||+|||
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH 113 (316)
T cd05619 38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLH 113 (316)
T ss_pred hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345667788888865 89999999999999999999999999999999882 3457889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||+|+++
T Consensus 114 ~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il 186 (316)
T cd05619 114 SK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLL 186 (316)
T ss_pred hC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHH
Confidence 99 999999999999999999999999998864322111 11233489999999998775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||........ ......... ..+..++.++.+++.+||+.||++||++.
T Consensus 187 ~el~~G~~pf~~~~~~~~--------~~~i~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 187 YEMLIGQSPFHGHDEEEL--------FQSIRMDNP-------CYPRWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHhCCCCCCCCCHHHH--------HHHHHhCCC-------CCCccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 999999999965332111 111111000 01123566788999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=242.37 Aligned_cols=211 Identities=23% Similarity=0.397 Sum_probs=165.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++|+||+++++.+..+...++++||+.+++|.+++.. ..+..++...+..++.+++.|++||
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~L 119 (261)
T cd05072 42 TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYI 119 (261)
T ss_pred chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998833 2345788889999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. ..+.++|+||||++
T Consensus 120 H~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~ 193 (261)
T cd05072 120 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGIL 193 (261)
T ss_pred HHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccC--CCChhhhhhhhHHH
Confidence 998 9999999999999999999999999998755432211 11222356789999998765 67788999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |..||....... ............ ....++..+.+++.+||+.||++|||+++
T Consensus 194 l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (261)
T cd05072 194 LYEIVTYGKIPYPGMSNSD--------VMSALQRGYRMP------RMENCPDELYDIMKTCWKEKAEERPTFDY 253 (261)
T ss_pred HHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 999998 888885432211 111111111111 11224567889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=245.13 Aligned_cols=214 Identities=23% Similarity=0.412 Sum_probs=165.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-----------CCCCCCHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-----------RGQSCSWEKLHEV 74 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~ 74 (238)
....+.+.+|+++++.++|+||+++++++..+...++++||+.+++|.+++..... ....+++..+..+
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 127 (280)
T cd05092 48 ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127 (280)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHH
Confidence 34467899999999999999999999999999999999999999999988843221 1135788999999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+.|++.|++|||+. +++|+||||+||++++++.++|+|||++................++..|+|||.+.+. .++
T Consensus 128 ~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~ 202 (280)
T cd05092 128 ASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFT 202 (280)
T ss_pred HHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcC
Confidence 99999999999998 9999999999999999999999999998644332211112222356789999998775 678
Q ss_pred ccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
.++|+||||+++|+|++ |..||........ . .......... ....+++.+.+++.+||+.||++|
T Consensus 203 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~-~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~P~~R 268 (280)
T cd05092 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------I-ECITQGRELE------RPRTCPPEVYAIMQGCWQREPQQR 268 (280)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------H-HHHHcCccCC------CCCCCCHHHHHHHHHHccCChhhC
Confidence 89999999999999998 8888854322111 1 1111111111 112356778999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||++|
T Consensus 269 p~~~~ 273 (280)
T cd05092 269 MVIKD 273 (280)
T ss_pred CCHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=241.81 Aligned_cols=210 Identities=24% Similarity=0.376 Sum_probs=168.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+++++.++||||+++++.+.+++..++++||+.+++|.+++... ....++...++.++.+++.|+.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~l 117 (256)
T cd08529 40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHL 117 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 456788899999999999999999999999999999999999999999988432 246788999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. ..+.++|+||||++
T Consensus 118 H~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~i 190 (256)
T cd08529 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVV 190 (256)
T ss_pred HHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCC--CCCCccchHHHHHH
Confidence 998 9999999999999999999999999988755433221 1223478899999998775 67789999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|++|+.||....... ......... .......++..+.+++.+||+.+|++||++.|
T Consensus 191 l~~l~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 191 LYECCTGKHPFDANNQGA--------LILKIIRGV------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred HHHHHhCCCCCCCCCHHH--------HHHHHHcCC------CCCCccccCHHHHHHHHHHccCCcccCcCHHH
Confidence 999999999996543211 111111110 11122246778999999999999999999854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=242.33 Aligned_cols=221 Identities=22% Similarity=0.269 Sum_probs=167.3
Q ss_pred HHHHHHHHHHhhcCCCc-ceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 10 EEFINEVSTIGRIHHVN-VVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
....+|+.+|+.++|+| |+.+++++...+ .+++||||+.. +|..++.........++...++.++.||+.||
T Consensus 55 ~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl 133 (323)
T KOG0594|consen 55 STAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGL 133 (323)
T ss_pred chhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHH
Confidence 45689999999999999 999999997766 89999999965 99888855443335677799999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+|||++ +|+||||||.||+++++|.+||+|||+++...-.... ......|.+|.|||++.+. ..++...||||+
T Consensus 134 ~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~ 207 (323)
T KOG0594|consen 134 AFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSL 207 (323)
T ss_pred HHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCC-CcCCCCcchHhH
Confidence 999999 9999999999999999999999999999855433322 2344589999999999986 358889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhh-------hhhhhc---cCC-Ccc----ccchhHHHHHHHHHHHHHHhhhcc
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSW-------VSDQLN---KGG-NLE----LRNVTEIESMIARKLCVIGLWCIQ 227 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~~---~~~-~~~----~~~~~~~~~~~~~~l~~li~~cl~ 227 (238)
||++.||+++++.|.+.........+-.. .++... +.. ... ............++..+++.+||+
T Consensus 208 GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~ 287 (323)
T KOG0594|consen 208 GCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQ 287 (323)
T ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhc
Confidence 99999999999998776553221111000 000000 000 000 111122223334588999999999
Q ss_pred CCCCCCCCCC
Q 037755 228 VKPADRPSMT 237 (238)
Q Consensus 228 ~dp~~Rps~~ 237 (238)
.+|++|.|++
T Consensus 288 y~p~~R~Sa~ 297 (323)
T KOG0594|consen 288 YDPAKRISAK 297 (323)
T ss_pred cCcccCcCHH
Confidence 9999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=258.63 Aligned_cols=217 Identities=24% Similarity=0.427 Sum_probs=177.0
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+++..+.|++|+..+++-+|-||+-++|++.+... .+|+.+|+|-+|..++...+ ..+...+...|+.||++|+.
T Consensus 427 pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~ 502 (678)
T KOG0193|consen 427 PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMD 502 (678)
T ss_pred CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhh
Confidence 355678999999999999999999999999998776 99999999999999995433 57888899999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeec-CCCcccccCceehH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGF 162 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~sl 162 (238)
|||.+ +|+|+|||..|||+.+++.|+|+|||++................|...|+|||++.- ....++..+|||||
T Consensus 503 YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF 579 (678)
T KOG0193|consen 503 YLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF 579 (678)
T ss_pred hhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence 99999 999999999999999999999999999876555544444555668899999999753 22357899999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|+|||++|..||.....++....+ ++.............+++++++|+..||..++++||.+.
T Consensus 580 GiV~YELltg~lPysi~~~dqIifmV----------GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~ 644 (678)
T KOG0193|consen 580 GIVWYELLTGELPYSIQNRDQIIFMV----------GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFP 644 (678)
T ss_pred hHHHHHHHhCcCCcCCCChhheEEEe----------cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHH
Confidence 99999999999999743333321111 111122233445567888999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=259.39 Aligned_cols=205 Identities=22% Similarity=0.313 Sum_probs=171.8
Q ss_pred cccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
..+.+....|..|+.... ||.++.++..|.+..++++||||+.||++..+. ....+++..+..+++.|+.||.|
T Consensus 409 ~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~f 483 (694)
T KOG0694|consen 409 RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQF 483 (694)
T ss_pred cccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHH
Confidence 345677788888888885 999999999999999999999999999965555 45789999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ ||++||||.+|||+|..|++||+|||+|+..-..+. ..+..+||+.|+|||++.+. .|+.+.|.||||+
T Consensus 484 LH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGV 556 (694)
T KOG0694|consen 484 LHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGV 556 (694)
T ss_pred HHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC--ccccccCChhhcChhhhccC--cccchhhHHHHHH
Confidence 9999 999999999999999999999999999975432222 33566799999999999987 8999999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++|+|+.|..||.++..++....+ +. +....+..++.+..+++.++|.+||++|.-+.
T Consensus 557 LlyeML~Gq~PF~gddEee~FdsI-------~~--------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~ 614 (694)
T KOG0694|consen 557 LLYEMLVGESPFPGDDEEEVFDSI-------VN--------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSG 614 (694)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHH-------hc--------CCCCCCCcccHHHHHHHHHHhccCcccccCCC
Confidence 999999999999877665432111 11 11223445788899999999999999998763
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=248.34 Aligned_cols=216 Identities=23% Similarity=0.388 Sum_probs=162.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|+++++.++||||+++++++.. ....+++|||+.+++|.+++. ...+++..+..++.+++.|+.|
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~ 122 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAY 122 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999998755 346889999999999999882 2468999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||++ +++||||||+||+++.++.++|+|||++........... .....++..|+|||.+... ..+.++||||||
T Consensus 123 lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG 197 (283)
T cd05080 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFG 197 (283)
T ss_pred HHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHH
Confidence 9999 999999999999999999999999999875543322111 1122356679999988765 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCc---c----hhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAY---F----PSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+++|+|++|..|+........... . .....+....... ...+..++..+.+++.+||+.||++|||+
T Consensus 198 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 271 (283)
T cd05080 198 VTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTF 271 (283)
T ss_pred HHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCH
Confidence 999999999998754332110000 0 0000000000000 01123356789999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
++
T Consensus 272 ~~ 273 (283)
T cd05080 272 RS 273 (283)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=244.57 Aligned_cols=212 Identities=24% Similarity=0.383 Sum_probs=162.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC------CCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR------GQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~ 81 (238)
...++.+|+.+++.++||||+++++++..+...++++||+.+++|.+++...... ...++...+..++.+++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999887432211 2345778899999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+.|||+. +++|+||||+||++++++.++++|||.+................++..|+|||.+.+. .++.++|+||
T Consensus 132 l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s 206 (277)
T cd05062 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWS 206 (277)
T ss_pred HHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHH
Confidence 9999998 9999999999999999999999999988654332221111222357789999998765 6788999999
Q ss_pred HHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++ |..||....... .. .......... .+..++..+.+++.+||+.||++|||+.|
T Consensus 207 lG~~l~el~~~~~~p~~~~~~~~-------~~-~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e 270 (277)
T cd05062 207 FGVVLWEIATLAEQPYQGMSNEQ-------VL-RFVMEGGLLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLE 270 (277)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHH-------HH-HHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999998 677875432211 11 1111111111 11234567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=245.97 Aligned_cols=208 Identities=21% Similarity=0.285 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|++++++++||||+++++++.++...++++||+++++|.+.+ .....++...+..++.+++.|+.|||+.
T Consensus 48 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 123 (263)
T cd06625 48 VNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSN 123 (263)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 467889999999999999999999999999999999999999999988 2345688999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+++|+||+|+||++++++.++|+|||.+........... .....++..|+|||.+.+. ..+.++|+||||+++|
T Consensus 124 ---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ 198 (263)
T cd06625 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVV 198 (263)
T ss_pred ---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHH
Confidence 999999999999999999999999999864432211111 0123477899999999876 5788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++|+.||........ ......... ....+..++..+.+++.+||+.||.+|||+.|
T Consensus 199 el~~g~~p~~~~~~~~~-------~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 199 EMLTEKPPWAEFEAMAA-------IFKIATQPT------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred HHHhCCCCccccchHHH-------HHHHhccCC------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 99999999854321110 001110000 01122346678899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=248.38 Aligned_cols=212 Identities=24% Similarity=0.388 Sum_probs=163.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-------------CCCCCCHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-------------RGQSCSWEKLHEV 74 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~~ 74 (238)
..+++.+|+.+++.++||||+++++++..+...+++|||+.+++|.+++..... ....++...+..+
T Consensus 50 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 129 (283)
T cd05090 50 QWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129 (283)
T ss_pred HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHH
Confidence 346788999999999999999999999999999999999999999988732211 1235788889999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+.+++.|+.|||++ +++|+||||+||+++.++.++|+|||++................++..|+|||.+.+. .++
T Consensus 130 ~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~ 204 (283)
T cd05090 130 AIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFS 204 (283)
T ss_pred HHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC--CCC
Confidence 99999999999999 9999999999999999999999999998755433222222233356789999998765 678
Q ss_pred ccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
.++|+||||+++|+|++ |..||....... ........... ..+..+++.+.+++.+||+.||++|
T Consensus 205 ~~~Dv~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05090 205 SDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--------VIEMVRKRQLL------PCSEDCPPRMYSLMTECWQEGPSRR 270 (283)
T ss_pred chhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCcC------CCCCCCCHHHHHHHHHHcccCcccC
Confidence 89999999999999998 888885422111 11111111100 1112356778999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
|++.+
T Consensus 271 p~~~~ 275 (283)
T cd05090 271 PRFKD 275 (283)
T ss_pred cCHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=241.11 Aligned_cols=210 Identities=26% Similarity=0.446 Sum_probs=163.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++||||+++++++.+....+++|||+.+++|.+++.. ....+++..++.++.+++.|++||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~l 116 (256)
T cd05113 40 SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYL 116 (256)
T ss_pred cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34467899999999999999999999999988899999999999999998832 123689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||||++
T Consensus 117 H~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~ 190 (256)
T cd05113 117 ESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVL 190 (256)
T ss_pred HhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcC--cccchhHHHHHHHH
Confidence 999 9999999999999999999999999988754332211 11122356789999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |..||....... ............. ....+..+.+++.+||+.||++|||+.+
T Consensus 191 l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 250 (256)
T cd05113 191 MWEVYSLGKMPYERFNNSE--------TVEKVSQGLRLYR------PHLASEKVYAIMYSCWHEKAEERPTFQQ 250 (256)
T ss_pred HHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999998 888885432211 1111111111110 1123578899999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=240.21 Aligned_cols=212 Identities=28% Similarity=0.456 Sum_probs=169.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC-----CCCCCHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR-----GQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l 82 (238)
..+++.+|++.++.++|+|++++++++.++...++++||+.+++|.+++...... ...+++..++.++.+++.|+
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 3688999999999999999999999999999999999999999999998433211 47899999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
++||++ +++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+. .++.++|+|||
T Consensus 119 ~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~sl 193 (262)
T cd00192 119 EYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSF 193 (262)
T ss_pred HHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC--CcchhhccHHH
Confidence 999999 9999999999999999999999999998766554322222334478899999998775 67889999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++ |..||....... .......... ...+..++.++.+++.+||+.||++|||+.|
T Consensus 194 G~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (262)
T cd00192 194 GVLLWEIFTLGATPYPGLSNEE--------VLEYLRKGYR------LPKPEYCPDELYELMLSCWQLDPEDRPTFSE 256 (262)
T ss_pred HHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC------CCCCccCChHHHHHHHHHccCCcccCcCHHH
Confidence 999999998 588886542111 1111111111 1112334778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=241.49 Aligned_cols=210 Identities=27% Similarity=0.434 Sum_probs=164.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....++.+|+.++++++||||+++++++.++...++++||+.+++|.+++.. ....++...+..++.+++.|+.|||
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh 123 (266)
T cd05033 47 KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLS 123 (266)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999998832 2347889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||+|+||++++++.++++|||++................++..|+|||.+.+. .++.++|+||||+++
T Consensus 124 ~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l 198 (266)
T cd05033 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVM 198 (266)
T ss_pred hC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHH
Confidence 98 9999999999999999999999999998866422222112222356789999998765 678899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++ |..||....... ............. ...++..+.+++.+||+.||++|||+.|
T Consensus 199 ~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~e 257 (266)
T cd05033 199 WEVMSYGERPYWDMSNQD--------VIKAVEDGYRLPP------PMDCPSALYQLMLDCWQKDRNERPTFSQ 257 (266)
T ss_pred HHHHccCCCCCCCCCHHH--------HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99997 888885322111 1111111111111 1234667899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=246.07 Aligned_cols=219 Identities=22% Similarity=0.381 Sum_probs=162.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-------RGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~ 80 (238)
..+++.+|+.+++.++|+||+++++++..+...++++||+.+++|.+++..... ....+++..+..++.+++.
T Consensus 62 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05095 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence 457889999999999999999999999999999999999999999988843221 1234778899999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|++|||+. +++|+||||+||+++.++.++|+|||.+................++..|++||...+. .++.++|+|
T Consensus 142 al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Diw 216 (296)
T cd05095 142 GMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVW 216 (296)
T ss_pred HHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--Cccchhhhh
Confidence 99999999 9999999999999999999999999998754332211111222346789999987664 678899999
Q ss_pred hHHHHHHHHhc--CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTG--GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++|+|++ |..||................... ...... ..+..+++.+.+++.+||+.||++|||+.|
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQ---GRQVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhc---cccccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 99999999998 666765332221100000000000 000000 011224578899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=247.44 Aligned_cols=220 Identities=22% Similarity=0.371 Sum_probs=164.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC-------CCCCCCCHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE-------SRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------~~~~~~~~~~~~~~~~~i~ 79 (238)
...+.+.+|++++++++||||+++++++..+...++++|++.+++|.+++.... .....++...++.++.+++
T Consensus 61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05051 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999884322 1123689999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.||+|||+. +++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+. .++.++||
T Consensus 141 ~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv 215 (296)
T cd05051 141 SGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDV 215 (296)
T ss_pred HHHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchh
Confidence 999999998 9999999999999999999999999998654333222222233467789999998765 67889999
Q ss_pred ehHHHHHHHHhc--CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTG--GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 160 ~slG~~l~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
||||+++|++++ |..||........ -............... ......++.++.+++.+||+.||++|||+.
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQV----IENAGHFFRDDGRQIY---LPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHH----HHHHHhcccccccccc---CCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 999999999998 5666643321111 0000000000000000 011123457899999999999999999986
Q ss_pred C
Q 037755 238 K 238 (238)
Q Consensus 238 e 238 (238)
|
T Consensus 289 e 289 (296)
T cd05051 289 E 289 (296)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=258.65 Aligned_cols=220 Identities=19% Similarity=0.215 Sum_probs=161.1
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
..+.+|+++|++++||||+++++++..+...+++++++. ++|.+++.. ....+++..+..++.|++.||.|||+.
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~- 279 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE- 279 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456789999999999999999999999999999999995 688887732 234789999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+|+||||||+|||++.++.++|+|||++................||..|+|||.+.+. .++.++|||||||++|+|
T Consensus 280 --gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El 355 (461)
T PHA03211 280 --GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEA 355 (461)
T ss_pred --CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHH
Confidence 9999999999999999999999999998754332221111223489999999999876 678899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCC----cc---------------------ccchhHH--HHHHHHHHHHHH
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGN----LE---------------------LRNVTEI--ESMIARKLCVIG 222 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~---------------------~~~~~~~--~~~~~~~l~~li 222 (238)
++|..++...............+...+..... .. ....... ...++..+.+|+
T Consensus 356 ~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 435 (461)
T PHA03211 356 AVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLV 435 (461)
T ss_pred HHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHH
Confidence 99886654322211111111111111110000 00 0000000 113455789999
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||.+|||+.|
T Consensus 436 ~~mL~~DP~~RPsa~e 451 (461)
T PHA03211 436 CRALTFDGARRPSAAE 451 (461)
T ss_pred HHHcccChhhCcCHHH
Confidence 9999999999999865
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=244.46 Aligned_cols=212 Identities=23% Similarity=0.403 Sum_probs=164.2
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC------------CCCCCCCHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------------SRGQSCSWEKLHEV 74 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~~~ 74 (238)
...++.+|+++++++ +||||+++++++..+...+++|||+.+|+|.+++.... .....+++..++.+
T Consensus 58 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 137 (293)
T cd05053 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137 (293)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHH
Confidence 446788999999999 79999999999999999999999999999998884321 23457889999999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+.|++.|++|||++ +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+. .++
T Consensus 138 ~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~ 212 (293)
T cd05053 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYT 212 (293)
T ss_pred HHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcC
Confidence 99999999999998 9999999999999999999999999998755433221112222356789999988765 678
Q ss_pred ccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
.++||||||+++|++++ |..||....... ............ .+..++..+.+|+.+||+.||++|
T Consensus 213 ~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 213 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------LFKLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred cccceeehhhHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccC
Confidence 89999999999999997 888875432211 111111111111 112345678899999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+.|
T Consensus 279 ps~~e 283 (293)
T cd05053 279 PTFKQ 283 (293)
T ss_pred cCHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=245.73 Aligned_cols=214 Identities=21% Similarity=0.322 Sum_probs=167.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....++.+|+++++.++||||+++++++.+.+..++++||+.+++|.+++.........++...+..++.+++.|+.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08228 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999999999999999999999998887443334456889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. ..+.++|+||+|+++
T Consensus 124 ~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l 196 (267)
T cd08228 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLL 196 (267)
T ss_pred hC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999998875543221 11223478899999998765 667889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|+.||....... .. ......... ........++..+.+++.+||+.+|++|||++|
T Consensus 197 ~el~~g~~p~~~~~~~~-----~~-~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 257 (267)
T cd08228 197 YEMAALQSPFYGDKMNL-----FS-LCQKIEQCD-----YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGY 257 (267)
T ss_pred HHHhcCCCCCccccccH-----HH-HHHHHhcCC-----CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHH
Confidence 99999999985432211 01 111111111 011112345678999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=245.07 Aligned_cols=210 Identities=22% Similarity=0.308 Sum_probs=166.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.+++.++||||+++++.+.++..+++++||+++++|.+++.. ..+..++...+..++.+++.|+.+|
T Consensus 39 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~l 116 (255)
T cd08219 39 SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHI 116 (255)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567888999999999999999999999999999999999999999888732 2345688999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++|+||+|+||++++++.++++|||.+........ ......++..|+|||.+.+. ..+.++|+||||++
T Consensus 117 H~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i 189 (255)
T cd08219 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCI 189 (255)
T ss_pred hhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccC--CcCchhhhhhhchh
Confidence 999 999999999999999999999999999865433221 11223478889999998775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||....... .... ....... ..+..++..+.+++.+||+.||++|||+.|
T Consensus 190 ~~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 190 LYELCTLKHPFQANSWKN-------LILK-VCQGSYK------PLPSHYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred heehhhccCCCCCCCHHH-------HHHH-HhcCCCC------CCCcccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 999999999996432211 1111 1111110 112235667899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=248.71 Aligned_cols=218 Identities=21% Similarity=0.320 Sum_probs=163.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|++++++++||||+++++.+.++..+++++||+.+++|.+++. ....++...+..++.+++.||.|||+
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~ 117 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLRE 117 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34678899999999999999999999999999999999999999999982 34678999999999999999999997
Q ss_pred -CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 88 -GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 -~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
. +++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+. .++.++|+||||+++
T Consensus 118 ~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l 188 (308)
T cd06615 118 KH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSL 188 (308)
T ss_pred hC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCC--CCCccchHHHHHHHH
Confidence 5 89999999999999999999999999876443221 1223578899999998765 678889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhcc--------CCCc--cccch------------hH-HHHHHHHHHHHHHh
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNK--------GGNL--ELRNV------------TE-IESMIARKLCVIGL 223 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~------------~~-~~~~~~~~l~~li~ 223 (238)
|+|++|+.||...........+.......... .... ..... .. ....++.++.+++.
T Consensus 189 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (308)
T cd06615 189 VEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVD 268 (308)
T ss_pred HHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHH
Confidence 99999999986433221111000000000000 0000 00000 00 00125667999999
Q ss_pred hhccCCCCCCCCCCC
Q 037755 224 WCIQVKPADRPSMTK 238 (238)
Q Consensus 224 ~cl~~dp~~Rps~~e 238 (238)
+||+.||++|||+.|
T Consensus 269 ~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 269 KCLKKNPKERADLKE 283 (308)
T ss_pred HHccCChhhCcCHHH
Confidence 999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=251.00 Aligned_cols=204 Identities=22% Similarity=0.239 Sum_probs=161.3
Q ss_pred ccHHHHHHHHHHHhhcCC-CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+..|..+++.+.| ++|+++++++.+.+..++||||+.+|+|.+.+ .....+++..+..++.||+.||+||
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~l 117 (324)
T cd05587 42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGKFKEPHAVFYAAEIAIGLFFL 117 (324)
T ss_pred hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678889999999975 56888999999999999999999999999888 2345688999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+|||++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||+|++
T Consensus 118 H~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvi 190 (324)
T cd05587 118 HSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVL 190 (324)
T ss_pred HHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHH
Confidence 999 999999999999999999999999998864322211 11233489999999999875 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||........ . ........ ..+..+++++.+++.+||+.||++|++.
T Consensus 191 l~elltG~~pf~~~~~~~~-------~-~~i~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 191 LYEMLAGQPPFDGEDEDEL-------F-QSIMEHNV-------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHhCCCCCCCCCHHHH-------H-HHHHcCCC-------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 9999999999964332111 1 11111110 1112356788999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=248.67 Aligned_cols=216 Identities=25% Similarity=0.273 Sum_probs=163.3
Q ss_pred HHHHHHhhcCCCcceeeeeEEEeC--C---eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 14 NEVSTIGRIHHVNVVQLLGFCSEG--S---KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 14 ~e~~~l~~l~h~ni~~~~~~~~~~--~---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
+|+++|+++.|||||++.-+|... + .+.+||||++. +|.+.+......+..++...++-+.+||++|++|||+.
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~ 144 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH 144 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence 699999999999999999888432 2 34579999976 99988844334467899999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccC-CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+|+||||||.|+|+|.+ |.+||+|||.++........ .....++.|+|||++.+. ..++.+.||||.|||+.
T Consensus 145 ---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~a 217 (364)
T KOG0658|consen 145 ---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMA 217 (364)
T ss_pred ---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHH
Confidence 99999999999999954 89999999999765444332 123488899999999986 57899999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhh----hhhc-------cCCCccccch---hHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVS----DQLN-------KGGNLELRNV---TEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~-------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
||+-|++.|.+++.......+-..+. +.+. ....+..... .......+++..+|+.++|+.+|.+|
T Consensus 218 ELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 218 ELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred HHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhc
Confidence 99999999987655433222111000 0000 0000111111 11445678899999999999999999
Q ss_pred CCCC
Q 037755 234 PSMT 237 (238)
Q Consensus 234 ps~~ 237 (238)
.|+.
T Consensus 298 ~~~~ 301 (364)
T KOG0658|consen 298 LSAL 301 (364)
T ss_pred CCHH
Confidence 9874
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=244.47 Aligned_cols=212 Identities=23% Similarity=0.394 Sum_probs=164.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC--------------------CCCCCCC
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE--------------------SRGQSCS 67 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~--------------------~~~~~~~ 67 (238)
..+++.+|+.+++.++||||+++++.+..+...++++||+.+++|.+++.... .....++
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 125 (290)
T cd05045 46 ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125 (290)
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccC
Confidence 35678999999999999999999999999999999999999999998874321 1123578
Q ss_pred HHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceee
Q 037755 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 147 (238)
Q Consensus 68 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 147 (238)
...+..++.+++.|+.|||+. +++||||||+||++++++.++|+|||.+................++..|+|||.+.
T Consensus 126 ~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 899999999999999999998 99999999999999999999999999986543332211122233567899999887
Q ss_pred cCCCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhc
Q 037755 148 RNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 148 ~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 226 (238)
+. .++.++||||||+++|+|++ |..||....... ............ .+..++.++.+++.+||
T Consensus 203 ~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~~i~~cl 266 (290)
T cd05045 203 DH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--------LFNLLKTGYRME------RPENCSEEMYNLMLTCW 266 (290)
T ss_pred cC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCCCC------CCCCCCHHHHHHHHHHc
Confidence 65 67889999999999999998 888885432211 111111111111 11234568889999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||++|||++|
T Consensus 267 ~~~P~~Rp~~~~ 278 (290)
T cd05045 267 KQEPDKRPTFAD 278 (290)
T ss_pred cCCcccCCCHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=257.40 Aligned_cols=207 Identities=21% Similarity=0.246 Sum_probs=161.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|+++++.++||||+++++++.++...++||||+.+|+|.+++. ....+++..+..++.|++.||+|||+
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~ 119 (364)
T cd05599 44 QVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK 119 (364)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999882 34578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc------------------------------------cc
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV------------------------------------SI 131 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~------------------------------------~~ 131 (238)
. +++||||||+|||++.++.++|+|||++.......... ..
T Consensus 120 ~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (364)
T cd05599 120 L---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA 196 (364)
T ss_pred C---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccc
Confidence 9 99999999999999999999999999886432211000 00
Q ss_pred cccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHH
Q 037755 132 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIE 211 (238)
Q Consensus 132 ~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (238)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ............... .
T Consensus 197 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~----~ 263 (364)
T cd05599 197 YSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET-------YRKIINWKETLQFPD----E 263 (364)
T ss_pred cccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH-------HHHHHcCCCccCCCC----C
Confidence 012489999999998775 678899999999999999999999965432211 111111100000000 0
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCC
Q 037755 212 SMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 212 ~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
..+++.+.+++.+|+. +|.+|++
T Consensus 264 ~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 264 VPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCHHHHHHHHHHcc-CHhhcCC
Confidence 1346778899999997 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=239.94 Aligned_cols=206 Identities=21% Similarity=0.426 Sum_probs=161.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.+.||||+++++++.. ...++++||+.+++|.+++ .....+++..+..++.|++.|+.|||+
T Consensus 39 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~ 113 (257)
T cd05116 39 LKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEE 113 (257)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45788999999999999999999998864 5678999999999999988 234578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+ +++||||||+||+++.++.++|+|||.+........... .....++..|+|||.+... ..+.++|+||||+++
T Consensus 114 ~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l 188 (257)
T cd05116 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLM 188 (257)
T ss_pred C---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHH
Confidence 9 999999999999999999999999999875544332111 1112245789999988654 677899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++ |..||....... ............ .+..+++++.+++.+||+.||++|||++
T Consensus 189 ~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 189 WEAFSYGQKPYKGMKGNE--------VTQMIESGERME------CPQRCPPEMYDLMKLCWTYGVDERPGFA 246 (257)
T ss_pred HHHHhCCCCCCCCCCHHH--------HHHHHHCCCCCC------CCCCCCHHHHHHHHHHhccCchhCcCHH
Confidence 99997 999986432211 111111111111 1123567889999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=266.21 Aligned_cols=213 Identities=18% Similarity=0.201 Sum_probs=166.3
Q ss_pred CCcccccHHHHHHHHHHHhhcC-CCcceeeee-EEEe------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIH-HVNVVQLLG-FCSE------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~-~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~ 73 (238)
+.++..+...+.+|+++|++|+ |+|||.++| .... .-.+.++||||.||+|-+++.++. ...+++..+++
T Consensus 71 ~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLk 148 (738)
T KOG1989|consen 71 YVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLK 148 (738)
T ss_pred ecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHH
Confidence 3456677788999999999997 999999999 3311 135778999999999999995444 33599999999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc-ccc---c---cccCCccccCCccee
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND-FVS---I---SATRGTIGYIAPELI 146 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~---~---~~~~~~~~~~aPE~~ 146 (238)
|+.+++.|+++||.. .++|+|||||-+|||++.+|..||||||.+...-.... ... . -...-|+.|+|||.+
T Consensus 149 If~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 149 IFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI 227 (738)
T ss_pred HHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence 999999999999984 67799999999999999999999999998753332221 100 0 122378999999986
Q ss_pred ecCC-CcccccCceehHHHHHHHHhcCCCCCCccccccc---CCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHH
Q 037755 147 SRNF-GTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSS---KAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 147 ~~~~-~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 222 (238)
.-.. -..++++|||+|||+||-|+....||+..+.... ...++. .+.++..|.+||
T Consensus 228 Dlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P~--------------------~p~ys~~l~~LI 287 (738)
T KOG1989|consen 228 DLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFPP--------------------FPNYSDRLKDLI 287 (738)
T ss_pred hhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCCC--------------------CccHHHHHHHHH
Confidence 4321 1578999999999999999999999976533322 111111 145788999999
Q ss_pred hhhccCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMT 237 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~ 237 (238)
..||+.||.+||++.
T Consensus 288 ~~mL~~nP~~RPnI~ 302 (738)
T KOG1989|consen 288 RTMLQPNPDERPNIY 302 (738)
T ss_pred HHHhccCcccCCCHH
Confidence 999999999999974
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=256.04 Aligned_cols=211 Identities=19% Similarity=0.238 Sum_probs=163.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++||||+++++++.++...++||||+.+|+|.+++. ...+++..+..++.|++.||+|||+
T Consensus 86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~ 160 (370)
T cd05596 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHS 160 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999882 2457888999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC--CcccccCceehHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMV 165 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~ 165 (238)
. +|+||||||+|||++.++.++|+|||.+........ .......|++.|+|||.+.+.. ..++.++|+|||||+
T Consensus 161 ~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvi 236 (370)
T cd05596 161 M---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred C---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHH
Confidence 9 999999999999999999999999999875433221 1112345899999999986531 236789999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC--CCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD--RPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~e 238 (238)
+|+|++|..||....... ................ ...++.++.+++.+||+.+|.+ |+|++|
T Consensus 237 lyelltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~e 300 (370)
T cd05596 237 LYEMLVGDTPFYADSLVG-------TYSKIMDHKNSLTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDE 300 (370)
T ss_pred HHHHHhCCCCcCCCCHHH-------HHHHHHcCCCcCCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHH
Confidence 999999999996543211 1111111100011111 1135678899999999999988 998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=244.88 Aligned_cols=211 Identities=24% Similarity=0.403 Sum_probs=164.3
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|+.+++++ +||||+++++++......++++||+.+|+|.+++.. .....++..++..++.+++.|+.|||
T Consensus 81 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH 158 (302)
T cd05055 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLA 158 (302)
T ss_pred HHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356789999999999 799999999999999999999999999999998832 22344899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||||+||+++.++.++++|||.+................++..|+|||.+.+. .++.++||||+|+++
T Consensus 159 ~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil 233 (302)
T cd05055 159 SK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILL 233 (302)
T ss_pred HC---CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHH
Confidence 99 9999999999999999999999999998755433221112223467789999998765 678899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++ |..||....... ............. .+...++.+.+++.+||+.+|++|||+.|
T Consensus 234 ~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 293 (302)
T cd05055 234 WEIFSLGSNPYPGMPVDS-------KFYKLIKEGYRMA------QPEHAPAEIYDIMKTCWDADPLKRPTFKQ 293 (302)
T ss_pred HHHHhCCCCCcCCCCchH-------HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 99998 888885432211 1111111111100 11124567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=241.71 Aligned_cols=209 Identities=22% Similarity=0.311 Sum_probs=162.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++.+......++++||+++++|..+ ..+++..+..++.+++.|+.|||
T Consensus 41 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH 112 (279)
T cd06619 41 ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW 112 (279)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999988543 34678889999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|+||||+++
T Consensus 113 ~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l 183 (279)
T cd06619 113 SL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISF 183 (279)
T ss_pred HC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHH
Confidence 99 99999999999999999999999999986543321 1233588999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||................. .......... .....++++.+++.+||+.||++||+++|
T Consensus 184 ~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 184 MELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDEDPPVL-----PVGQFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred HHHHhCCCCchhhcccccccchHHHHH-HHhccCCCCC-----CCCcCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 999999999865332221111111111 1100000000 11224567899999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=238.91 Aligned_cols=211 Identities=27% Similarity=0.424 Sum_probs=164.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++||||+++++++..++..++++||+.+++|.+++... .+..++...+..++.+++.|+.+|
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~l 119 (261)
T cd05068 42 TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYL 119 (261)
T ss_pred cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999998332 245789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||||+||+++.++.++|+|||.+........ ........+..|+|||.+.+. ..+.++|+||||++
T Consensus 120 H~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~ 193 (261)
T cd05068 120 EAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGIL 193 (261)
T ss_pred HhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcCceeccCccccccC--CCCchhhHHHHHHH
Confidence 999 999999999999999999999999999876543211 111112234579999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |+.||....... ............ ....++..+.+++.+||+.||++||++.+
T Consensus 194 l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 253 (261)
T cd05068 194 LTEIVTYGRMPYPGMTNAE--------VLQQVDQGYRMP------CPPGCPKELYDIMLDCWKEDPDDRPTFET 253 (261)
T ss_pred HHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCcCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 999998 888885432111 111111111100 11234678899999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=239.71 Aligned_cols=209 Identities=29% Similarity=0.467 Sum_probs=163.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++.+....++++||+++++|.+++.. ....+++..+..++.|++.|++|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH 117 (256)
T cd05059 41 MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLE 117 (256)
T ss_pred CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3556889999999999999999999999999999999999999999998832 2247889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||||+||+++.++.++++|||.++........ ......++..|+|||.+.+. .++.++|+||||+++
T Consensus 118 ~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il 191 (256)
T cd05059 118 SN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLM 191 (256)
T ss_pred HC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccC--CCCchhhHHHHHHHH
Confidence 99 9999999999999999999999999988755332211 11112244579999998875 678899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++ |..||........ . ......... ..+..++..+.+++.+||+.+|++|||+.|
T Consensus 192 ~~l~~~g~~p~~~~~~~~~-------~-~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 192 WEVFSEGKMPYERFSNSEV-------V-ESVSAGYRL------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred HHHhccCCCCCCCCCHHHH-------H-HHHHcCCcC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 99998 7888864322211 0 111111000 011225678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=242.09 Aligned_cols=212 Identities=25% Similarity=0.394 Sum_probs=164.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------CCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------RGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+.+|+.+++.++||||+++++++..+...++++||+.+++|.+++..... ....+++..+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (277)
T cd05032 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHH
Confidence 356788999999999999999999999999999999999999999998843221 12347788999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+.|||+. +++|+||||+||+++.++.++|+|||.++...............++..|+|||.+... ..+.++|+||
T Consensus 132 l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s 206 (277)
T cd05032 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWS 206 (277)
T ss_pred HHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHH
Confidence 9999998 9999999999999999999999999988654333221112223467789999998765 6788999999
Q ss_pred HHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|++++ |..||........ ........... .+..++..+.+++.+||+.+|++|||+.|
T Consensus 207 lG~il~el~t~g~~p~~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 270 (277)
T cd05032 207 FGVVLWEMATLAEQPYQGLSNEEV--------LKFVIDGGHLD------LPENCPDKLLELMRMCWQYNPKMRPTFLE 270 (277)
T ss_pred HHHHHHHhhccCCCCCccCCHHHH--------HHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9999999998 8888854322211 11111111111 11223678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=261.77 Aligned_cols=213 Identities=21% Similarity=0.246 Sum_probs=166.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC--------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
....++.+|+..+..++|+||+++++.+.... .+++||||+.+|+|.+++.........+++..+..++.|+
T Consensus 73 ~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ql 152 (496)
T PTZ00283 73 ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152 (496)
T ss_pred HHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHH
Confidence 44567889999999999999999988764322 3679999999999999885544445689999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+.||+|||+. +|+||||||+||+++.++.++|+|||+++...............||+.|+|||.+.+. .++.++|
T Consensus 153 l~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~D 227 (496)
T PTZ00283 153 LLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKAD 227 (496)
T ss_pred HHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHH
Confidence 9999999999 9999999999999999999999999998755433222222334589999999999875 6788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||||+++|+|++|+.||....... ........ .. ...+..+++++.+++.+||+.||.+|||+.|
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~-------~~~~~~~~-~~------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~e 293 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEE-------VMHKTLAG-RY------DPLPPSISPEMQEIVTALLSSDPKRRPSSSK 293 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhcC-CC------CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 9999999999999999996433211 11111111 00 1122345778999999999999999999753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=248.35 Aligned_cols=221 Identities=20% Similarity=0.274 Sum_probs=163.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|+.++++++||||+++++++..+...+++|||+.+ +|.+.+. ..+..++...+..++.|++.||+|||+
T Consensus 47 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~lH~ 122 (309)
T cd07872 47 APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMD---DCGNIMSMHNVKIFLYQILRGLAYCHR 122 (309)
T ss_pred cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999975 8877762 223467889999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..++.++||||||+++|
T Consensus 123 ~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 196 (309)
T cd07872 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFF 196 (309)
T ss_pred C---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHH
Confidence 9 999999999999999999999999999865433221 11223478899999988653 35678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhh-------hhhhhc------cCCCc--cccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSW-------VSDQLN------KGGNL--ELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~~------~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+|++|+.||...........+... ...... ..... ...........+++++.+++.+||+.||.+
T Consensus 197 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 276 (309)
T cd07872 197 EMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKK 276 (309)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhh
Confidence 999999999654432210000000 000000 00000 000001112245778899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 277 R~t~~e 282 (309)
T cd07872 277 RISAEE 282 (309)
T ss_pred CCCHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=253.24 Aligned_cols=203 Identities=25% Similarity=0.263 Sum_probs=159.4
Q ss_pred HHHHHHHHH-HHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..++..|.. +++.++||||+++++.+..+...++||||+.+|+|...+ .....+++..+..++.||+.||+|||+
T Consensus 39 ~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~ 114 (325)
T cd05604 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS 114 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345555655 467789999999999999999999999999999998887 345678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. |++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++||||||+++|
T Consensus 115 ~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ 187 (325)
T cd05604 115 I---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLY 187 (325)
T ss_pred C---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCC--CCCCcCccccccceeh
Confidence 9 999999999999999999999999999864322211 11233489999999999875 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+|++|..||....... .......... . .....+..+.+++.+||+.||.+||++.
T Consensus 188 el~~G~~pf~~~~~~~-------~~~~~~~~~~----~----~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 188 EMLYGLPPFYCRDVAE-------MYDNILHKPL----V----LRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred hhhcCCCCCCCCCHHH-------HHHHHHcCCc----c----CCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 9999999996533211 1111111100 0 1112456788899999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=245.56 Aligned_cols=220 Identities=22% Similarity=0.371 Sum_probs=162.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC--------CCCCCCHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES--------RGQSCSWEKLHEVASGT 78 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~~i 78 (238)
...+.+.+|++++++++|||++++++++......+++|||+.+++|.+++..... ....++...++.++.++
T Consensus 59 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 138 (295)
T cd05097 59 TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI 138 (295)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999998743211 11246788999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+.|++|||+. +++|+||||+||+++.++.++|+|||++................++..|+|||.+... .++.++|
T Consensus 139 ~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~D 213 (295)
T cd05097 139 ASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASD 213 (295)
T ss_pred HHHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhh
Confidence 9999999999 9999999999999999999999999998754333222222223356789999988765 6788999
Q ss_pred eehHHHHHHHHhc--CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTG--GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 159 i~slG~~l~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+||||+++|+|++ |..||.......... . ............. .......++.+.+++.+||+.||++|||+
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~---~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 286 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIE---N-TGEFFRNQGRQIY---LSQTPLCPSPVFKLMMRCWSRDIKDRPTF 286 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHH---H-HHHhhhhcccccc---CCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 9999999999988 445654322211100 0 0000000000000 00111245689999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
++
T Consensus 287 ~~ 288 (295)
T cd05097 287 NK 288 (295)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=250.83 Aligned_cols=208 Identities=24% Similarity=0.292 Sum_probs=172.3
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
.+.+.+.+|+.+|++++ ||||+.+++.+++...+++|||++.||.|.+.+... .+++..+..++.+++.+++||
T Consensus 77 ~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~l 151 (382)
T KOG0032|consen 77 EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYL 151 (382)
T ss_pred ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHH
Confidence 36689999999999998 999999999999999999999999999999999443 399999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccC----CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 86 HNGCDVCILHLDIKPHNILLDHN----FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|+. |++|||+||+|+|+... +.++++|||++....... ......||+.|+|||++... .++..+|+||
T Consensus 152 H~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS 223 (382)
T KOG0032|consen 152 HSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWS 223 (382)
T ss_pred HhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc---eEeeecCCccccCchhhcCC--CCCcccchhH
Confidence 998 99999999999999633 479999999998776622 23445699999999999875 8889999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+++|.|++|..||...........+ ... ...........++..+.+++..||..||.+|+|+++
T Consensus 224 ~Gvi~yiLL~G~~PF~~~~~~~~~~~i--------~~~---~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 224 IGVILYILLSGVPPFWGETEFEIFLAI--------LRG---DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred HHHHHHHHhhCCCCCcCCChhHHHHHH--------HcC---CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHH
Confidence 999999999999999766544321111 000 011122233456889999999999999999999864
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=243.99 Aligned_cols=223 Identities=21% Similarity=0.241 Sum_probs=163.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.++...++|+||+. ++|.+++.... .+..++...++.++.|++.||.|||+
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~ 119 (285)
T cd07861 42 VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS 119 (285)
T ss_pred chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 34678899999999999999999999999999999999997 58887763222 24678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. ..++.++|+||||+++|
T Consensus 120 ~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ 193 (285)
T cd07861 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFA 193 (285)
T ss_pred C---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHH
Confidence 9 999999999999999999999999999864433211 11223468899999988653 24678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcc--------hhhhh-----hhhcc-CCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYF--------PSWVS-----DQLNK-GGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~--------~~~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
+|++|+.||............ ..... ..... ...............+++++.+++.+||+.||++|
T Consensus 194 ~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 273 (285)
T cd07861 194 EMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKR 273 (285)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhC
Confidence 999999999654322110000 00000 00000 00000000111122357788999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+.|
T Consensus 274 pt~~~ 278 (285)
T cd07861 274 ISAKK 278 (285)
T ss_pred CCHHH
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=242.63 Aligned_cols=217 Identities=21% Similarity=0.348 Sum_probs=159.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR-GQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...+.+|+.+++.++||||+++++.+......+++|||+.+|+|.+++...... ....+...+..++.|++.|++|||+
T Consensus 39 ~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (269)
T cd05042 39 QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118 (269)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 456789999999999999999999999999999999999999999988443221 2345677888999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-----CCcccccCceehH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-----FGTVSCKSDVYGF 162 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~sl 162 (238)
. +++||||||+||+++.++.++|+|||++................++..|+|||.+... ....+.++|||||
T Consensus 119 ~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05042 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195 (269)
T ss_pred c---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHH
Confidence 9 9999999999999999999999999998644332211111223356789999987431 1245788999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++ |..||....... ............ ...+.....+++.+.+++..|| .||++|||++|
T Consensus 196 G~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 196 GVTMWELFTAADQPYPDLSDEQ-------VLKQVVREQDIK--LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred HHHHHHHHhCCCCCCCcCCHHH-------HHHHHhhccCcc--CCCCcccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence 999999998 677775432111 011111111110 0111223346677788999998 59999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=254.69 Aligned_cols=212 Identities=20% Similarity=0.219 Sum_probs=164.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++||||+++++++.++...++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+
T Consensus 44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~ 120 (330)
T cd05601 44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ 120 (330)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999998832 23578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC----CCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~slG 163 (238)
. +++||||||+||+++.++.++|+|||.+......... ......|++.|+|||.+... ...++.++||||||
T Consensus 121 ~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 196 (330)
T cd05601 121 M---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196 (330)
T ss_pred C---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeeccc
Confidence 9 9999999999999999999999999998755433221 11223589999999998632 12467889999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ............... ...+++.+.+|+.+||+ ||++|||+++
T Consensus 197 ~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~ 259 (330)
T cd05601 197 VIAYEMIYGRSPFHEGTSAKT-------YNNIMNFQRFLKFPE----DPKVSSDFLDLIQSLLC-GQKERLGYEG 259 (330)
T ss_pred ceeeeeccCCCCCCCCCHHHH-------HHHHHcCCCccCCCC----CCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence 999999999999965332211 111111111000000 12356778899999998 9999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=246.69 Aligned_cols=211 Identities=20% Similarity=0.342 Sum_probs=163.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC------------CCCCCCCHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------------SRGQSCSWEKLHEVAS 76 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~~~~~ 76 (238)
.+.+.+|+.++++++||||+++++++......+++++|+.+++|.+++.... .....++...+..++.
T Consensus 52 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (283)
T cd05091 52 REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131 (283)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 5678899999999999999999999999999999999999999988873211 1123578888999999
Q ss_pred HHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccccc
Q 037755 77 GTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 77 ~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
|++.||.|||+. +++||||||+||++++++.++|+|||++................+++.|+|||.+.+. .++.+
T Consensus 132 ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~ 206 (283)
T cd05091 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSID 206 (283)
T ss_pred HHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcc
Confidence 999999999998 9999999999999999999999999998755433222222333467789999998764 67889
Q ss_pred CceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 157 ~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+||||||+++|+|++ |..||....... ........... ..+..++..+.+++.+||+.+|++|||
T Consensus 207 ~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~i~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RP~ 272 (283)
T cd05091 207 SDIWSYGVVLWEVFSYGLQPYCGYSNQD--------VIEMIRNRQVL------PCPDDCPAWVYTLMLECWNEFPSRRPR 272 (283)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCcC------CCCCCCCHHHHHHHHHHhCCCcccCCC
Confidence 999999999999998 777775422111 11111111111 112345677899999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
++|
T Consensus 273 ~~~ 275 (283)
T cd05091 273 FKD 275 (283)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=237.92 Aligned_cols=209 Identities=22% Similarity=0.406 Sum_probs=161.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.. ...++|+||+++++|.+++.. ....+++..++.++.+++.|+.|||
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH 112 (257)
T cd05115 37 SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLE 112 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999998864 578999999999999998832 2357899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
++ +++||||||+||+++.++.++|+|||.+........... .....++..|+|||.+... .++.++|+||||++
T Consensus 113 ~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~ 187 (257)
T cd05115 113 GK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGIT 187 (257)
T ss_pred hc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHH
Confidence 98 999999999999999999999999999875433322111 1112245689999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++ |..||....... ........... ..+..+++++.+++.+||+.||++||++.+
T Consensus 188 l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~ 247 (257)
T cd05115 188 MWEAFSYGQKPYKKMKGPE--------VMSFIEQGKRL------DCPAECPPEMYALMKDCWIYKWEDRPNFAK 247 (257)
T ss_pred HHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999996 998886432211 11111111111 112335678899999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=246.43 Aligned_cols=209 Identities=22% Similarity=0.377 Sum_probs=162.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.+++.++||||+++++++... ..+++++|+.+|+|.+++.. ....++...+..++.||+.||+|||
T Consensus 51 ~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH 126 (316)
T cd05108 51 KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE 126 (316)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH
Confidence 4467889999999999999999999998764 57799999999999998832 2346888999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||++.................+..|+|||.+.+. .++.++||||||+++
T Consensus 127 ~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l 201 (316)
T cd05108 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTV 201 (316)
T ss_pred hc---CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHH
Confidence 99 9999999999999999999999999999765443322222222346789999998765 678899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++ |..||....... ............. +..++.++.+++.+||+.||++|||+.|
T Consensus 202 ~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~~ 260 (316)
T cd05108 202 WELMTFGSKPYDGIPASE--------ISSILEKGERLPQ------PPICTIDVYMIMVKCWMIDADSRPKFRE 260 (316)
T ss_pred HHHHcCCCCCCCCCCHHH--------HHHHHhCCCCCCC------CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99997 999886432111 1111111111111 1123457889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=256.07 Aligned_cols=207 Identities=21% Similarity=0.251 Sum_probs=159.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++.+.++...++||||+.+|+|.+++. ....+++..+..++.||+.||+|||+
T Consensus 44 ~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~ 119 (382)
T cd05625 44 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHK 119 (382)
T ss_pred HHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45678899999999999999999999999999999999999999999882 33568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc----------------------------------------
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND---------------------------------------- 127 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---------------------------------------- 127 (238)
. +|+||||||+|||++.++.++|+|||++........
T Consensus 120 ~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (382)
T cd05625 120 M---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRA 196 (382)
T ss_pred C---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 9 999999999999999999999999998742210000
Q ss_pred -----cccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCc
Q 037755 128 -----FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNL 202 (238)
Q Consensus 128 -----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (238)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ...........
T Consensus 197 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~ 267 (382)
T cd05625 197 ARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET-------QMKVINWQTSL 267 (382)
T ss_pred ccccccccccccccCcccCCHHHhcCC--CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHH-------HHHHHccCCCc
Confidence 0000112488999999999875 678899999999999999999999965432211 11111111111
Q ss_pred cccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 203 ELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 203 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
... ....+++++.+++.+|+ .||++|++
T Consensus 268 ~~p----~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 268 HIP----PQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred CCC----CcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 110 11235677888888876 59999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=242.92 Aligned_cols=212 Identities=22% Similarity=0.333 Sum_probs=167.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.+++.++||||+++++++.++...++++||+++++|.+++.........+++..++.++.+++.|+.|||+
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08229 45 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124 (267)
T ss_pred HHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45688899999999999999999999999999999999999999998874333345678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+. ..+.++|+||||+++|
T Consensus 125 ~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~ 197 (267)
T cd08229 125 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLY 197 (267)
T ss_pred C---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHH
Confidence 9 9999999999999999999999999988655432211 1223488899999998765 6778899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+|++|..||....... .... ....... ........+++.+.+++.+||+.||++|||+.
T Consensus 198 ~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 198 EMAALQSPFYGDKMNL-----YSLC-KKIEQCD-----YPPLPSDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred HHHhCCCCcccccchH-----HHHh-hhhhcCC-----CCCCCcccccHHHHHHHHHhcCCCcccCCCHH
Confidence 9999999985432210 0000 0010000 00111134677899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=256.78 Aligned_cols=206 Identities=22% Similarity=0.245 Sum_probs=158.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+++++++.||||+++++++.+....|+||||+.+|+|.+++ .....+++..+..++.|++.||+|||+
T Consensus 44 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~ 119 (377)
T cd05629 44 QLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML----IKYDTFSEDVTRFYMAECVLAIEAVHK 119 (377)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3467889999999999999999999999999999999999999999988 234678899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc------------c--------------------------
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF------------V-------------------------- 129 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~------------~-------------------------- 129 (238)
. +|+||||||+||+++.++.++|+|||+++........ .
T Consensus 120 ~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (377)
T cd05629 120 L---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIAT 196 (377)
T ss_pred C---CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 9 9999999999999999999999999988532111000 0
Q ss_pred -------cccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCc
Q 037755 130 -------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNL 202 (238)
Q Consensus 130 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (238)
......||+.|+|||.+.+. .++.++|||||||++|+|++|..||........ ...........
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~ 267 (377)
T cd05629 197 WKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGAIMFECLIGWPPFCSENSHET-------YRKIINWRETL 267 (377)
T ss_pred hhhcccccccccCCCccccCHHHHccC--CCCCceeeEecchhhhhhhcCCCCCCCCCHHHH-------HHHHHccCCcc
Confidence 00012489999999998775 678899999999999999999999964332211 01111111111
Q ss_pred cccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 203 ELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 203 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
.... ...++.++.+|+.+||+ +|.+|+
T Consensus 268 ~~p~----~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 268 YFPD----DIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred CCCC----CCCCCHHHHHHHHHHhc-CHhhcC
Confidence 1110 01246778999999998 777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=240.66 Aligned_cols=207 Identities=25% Similarity=0.406 Sum_probs=160.2
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
..++..|+..++.+.||||+++++++.. ...++++||+.+|+|.+++.. ....+++..+..++.|++.|+.|||+.
T Consensus 53 ~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T cd05111 53 FQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH 128 (279)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4677888889999999999999998754 567889999999999999832 235789999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+. .++.++|+||||+++|+
T Consensus 129 ---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~e 203 (279)
T cd05111 129 ---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWE 203 (279)
T ss_pred ---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHH
Confidence 9999999999999999999999999998755433222222233467789999998765 67889999999999999
Q ss_pred Hhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 169 MTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 169 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++ |..||....... ..+........... ..++..+.+++.+||..||++|||+.|
T Consensus 204 l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 204 MMSYGAEPYAGMRPHE--------VPDLLEKGERLAQP------QICTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred HHcCCCCCCCCCCHHH--------HHHHHHCCCcCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 998 998886433211 11112221111111 113456788999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=254.96 Aligned_cols=211 Identities=19% Similarity=0.220 Sum_probs=159.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++.+.++...++||||+++|+|.+++. ....+++..+..++.||+.||.|||+
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~ 119 (381)
T cd05626 44 QVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK 119 (381)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45678899999999999999999999999999999999999999999882 34568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc---------------------------------------
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--------------------------------------- 128 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------------------------------- 128 (238)
. +|+||||||+||+++.++.++|+|||++.........
T Consensus 120 ~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (381)
T cd05626 120 M---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRA 196 (381)
T ss_pred C---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccc
Confidence 9 9999999999999999999999999987532110000
Q ss_pred ------ccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCc
Q 037755 129 ------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNL 202 (238)
Q Consensus 129 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (238)
.......||..|+|||.+.+. .++.++|||||||++|+|++|..||......... ..........
T Consensus 197 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-------~~i~~~~~~~ 267 (381)
T cd05626 197 TKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ-------LKVINWENTL 267 (381)
T ss_pred cccccccccccccCCccccCHHHHcCC--CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH-------HHHHcccccc
Confidence 000112489999999998875 6788999999999999999999999654322110 0111100000
Q ss_pred cccchhHHHHHHHHHHHHHHhhhc--cCCCCCCCCCCC
Q 037755 203 ELRNVTEIESMIARKLCVIGLWCI--QVKPADRPSMTK 238 (238)
Q Consensus 203 ~~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rps~~e 238 (238)
... ....+++++.+++.+|+ ..+|..|||++|
T Consensus 268 ~~~----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 268 HIP----PQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred CCC----CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 000 01135677888998854 556666999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=249.27 Aligned_cols=208 Identities=18% Similarity=0.312 Sum_probs=174.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+..++.+|+.-|+.++|||||++|++...+.++|+|+|.=.+|+|.+++.+ ....+.+....+++.||+.|+.|+
T Consensus 58 ~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YC 134 (864)
T KOG4717|consen 58 TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYC 134 (864)
T ss_pred hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999999999999999999999999999943 346889999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEE-ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILL-DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. .+||||+||+|+.+ ..-|.|||+|||.+-.+...... ...+|+..|.|||++.|. ....++.||||||+
T Consensus 135 HqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGV 207 (864)
T KOG4717|consen 135 HQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGV 207 (864)
T ss_pred hhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcchh---hcccchhhccCchhhhcC-ccCCcchhhhHHHH
Confidence 998 99999999999766 57899999999998776665543 334599999999999997 34467899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|-+.+|++||......+....+. ... -..+..++.++.+||.+||..||.+|.|.+|
T Consensus 208 ILyMLVCGq~PFqeANDSETLTmIm---DCK------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEe 266 (864)
T KOG4717|consen 208 ILYMLVCGQPPFQEANDSETLTMIM---DCK------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEE 266 (864)
T ss_pred HHHHHHhCCCccccccchhhhhhhh---ccc------------ccCchhhhHHHHHHHHHHHhcCchhhccHHH
Confidence 9999999999997655444322221 110 1245778999999999999999999998754
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=240.90 Aligned_cols=218 Identities=22% Similarity=0.365 Sum_probs=159.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-RGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....+.+|+.++++++||||+++++.+.+....++||||+.+|+|.+++..... .....+...+..++.|++.|++|||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999999988899999999999999998843221 2235567788889999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC-----CcccccCceeh
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF-----GTVSCKSDVYG 161 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~~Di~s 161 (238)
+. +++|+||||+||+++.++.++++|||.+................++..|+|||.+.+.. ..++.++|+||
T Consensus 118 ~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 118 KN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred HC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 98 99999999999999999999999999986443322211122234678899999886421 13577899999
Q ss_pred HHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++ |..||........ ... ..... .. ...........++.+.+++.+|| .+|++|||++|
T Consensus 195 lG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~-~~-~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~ 262 (269)
T cd05087 195 LGVTIWELFELGSQPYRHLSDEQV---LTY----TVREQ-QL-KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEE 262 (269)
T ss_pred HHHHHHHHHhCCCCCCCCCChHHH---HHH----Hhhcc-cC-CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHH
Confidence 9999999996 9999864322211 000 00000 00 00001111224556888999999 68999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=248.94 Aligned_cols=203 Identities=21% Similarity=0.239 Sum_probs=161.3
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+..|..+++.+ +|++|+++++++......++||||+.+|+|.+.+ .....+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH 118 (323)
T cd05616 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFFLH 118 (323)
T ss_pred HHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345567788888887 5899999999999999999999999999998888 23456889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+|||++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++|+|||||++
T Consensus 119 ~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil 191 (323)
T cd05616 119 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLL 191 (323)
T ss_pred HC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHH
Confidence 98 999999999999999999999999999864322211 11233589999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+|++|..||........ . ........ ..+..++.++.+++.+||+.||++|++.
T Consensus 192 ~elltg~~Pf~~~~~~~~-------~-~~i~~~~~-------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 192 YEMLAGQAPFEGEDEDEL-------F-QSIMEHNV-------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHhCCCCCCCCCHHHH-------H-HHHHhCCC-------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 999999999965432211 1 11111110 1112356788999999999999999986
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=256.52 Aligned_cols=213 Identities=23% Similarity=0.389 Sum_probs=164.0
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------------------
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------------------ 61 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------------------ 61 (238)
...+.+.+|+++++++. ||||+++++++.+....++||||+.+|+|.+++.....
T Consensus 82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (400)
T cd05105 82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE 161 (400)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence 34578999999999996 99999999999999999999999999999887743210
Q ss_pred --------------------------------------------------------------------CCCCCCHHHHHH
Q 037755 62 --------------------------------------------------------------------RGQSCSWEKLHE 73 (238)
Q Consensus 62 --------------------------------------------------------------------~~~~~~~~~~~~ 73 (238)
....++...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~ 241 (400)
T cd05105 162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS 241 (400)
T ss_pred cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence 113477888899
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++................++..|+|||.+.+. .+
T Consensus 242 ~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~ 316 (400)
T cd05105 242 FTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LY 316 (400)
T ss_pred HHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CC
Confidence 999999999999998 9999999999999999999999999998754333222222223467789999998765 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++||||||+++|+|++ |..||........ ........... .....++..+.+++.+||+.||++
T Consensus 317 ~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~ 383 (400)
T cd05105 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-------FYNKIKSGYRM------AKPDHATQEVYDIMVKCWNSEPEK 383 (400)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCcccchhHH-------HHHHHhcCCCC------CCCccCCHHHHHHHHHHCccCHhH
Confidence 889999999999999996 8888864322110 11111111111 111345678899999999999999
Q ss_pred CCCCC
Q 037755 233 RPSMT 237 (238)
Q Consensus 233 Rps~~ 237 (238)
|||+.
T Consensus 384 RPt~~ 388 (400)
T cd05105 384 RPSFL 388 (400)
T ss_pred CcCHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=261.48 Aligned_cols=221 Identities=17% Similarity=0.193 Sum_probs=157.6
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeC--------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEG--------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+|+.+++.++||||+++++++... ..++++|||+.+ +|.+++.........++...++.++.||+.|
T Consensus 104 ~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~g 182 (440)
T PTZ00036 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182 (440)
T ss_pred chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence 3446799999999999999999976432 246789999975 7766663333445689999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCC-ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|+|||+. +|+||||||+||+++.++ .++|+|||+++........ ....+++.|+|||++.+. ..++.++|||
T Consensus 183 L~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~Diw 255 (440)
T PTZ00036 183 LAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGA-TNYTTHIDLW 255 (440)
T ss_pred HHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHHHH
Confidence 9999999 999999999999998654 6999999999755332221 123478999999998653 3578899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhh----hhh-------hccCCCcccc---chhHHHHHHHHHHHHHHhhhc
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWV----SDQ-------LNKGGNLELR---NVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~----~~~-------~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl 226 (238)
||||++|+|++|.+||...........+.... ... .......... .....+...++++.+|+.+||
T Consensus 256 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L 335 (440)
T PTZ00036 256 SLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFL 335 (440)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHC
Confidence 99999999999999997654321110000000 000 0000000000 001122234678999999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||.+|||+.|
T Consensus 336 ~~dP~~R~ta~e 347 (440)
T PTZ00036 336 KYEPLKRLNPIE 347 (440)
T ss_pred CCChhHCcCHHH
Confidence 999999999864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=238.45 Aligned_cols=208 Identities=30% Similarity=0.472 Sum_probs=165.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++||||+++++++.++...++++||+.+++|.+++... .+..++...+..++.+++.|+.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~ 122 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE 122 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999999998432 34578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+... .++.++|+||||+++|
T Consensus 123 ~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~ 195 (261)
T cd05148 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLY 195 (261)
T ss_pred C---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHH
Confidence 8 9999999999999999999999999998755332211 1123356789999998765 6778899999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++ |..||........ . ......... ..+..+++.+.+++.+||+.||.+|||++|
T Consensus 196 ~l~~~g~~p~~~~~~~~~-------~-~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (261)
T cd05148 196 EMFTYGQVPYPGMNNHEV-------Y-DQITAGYRM------PCPAKCPQEIYKIMLECWAAEPEDRPSFKA 253 (261)
T ss_pred HHHcCCCCCCCcCCHHHH-------H-HHHHhCCcC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9998 8888864332111 1 111111000 111334677899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=255.40 Aligned_cols=169 Identities=23% Similarity=0.311 Sum_probs=145.8
Q ss_pred CCCcccccHHHHHHHHHHHhhcC-C-----CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHH
Q 037755 1 MLENSKFSAEEFINEVSTIGRIH-H-----VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74 (238)
Q Consensus 1 ~l~~~~~~~~~~~~e~~~l~~l~-h-----~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~ 74 (238)
|+++...-..+...|+.+|..|+ | -|+|+++++|..++++|+|+|.+. .+|.+++ +.++...++...++.+
T Consensus 218 IiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYell--K~n~f~Glsl~~ir~~ 294 (586)
T KOG0667|consen 218 IIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELL--KNNKFRGLSLPLVRKF 294 (586)
T ss_pred eeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHH--HhcCCCCCCHHHHHHH
Confidence 56777788888899999999996 4 389999999999999999999984 5999999 4455667999999999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEcc--CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH--NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
+.||+.||.+||+. +|+|+||||+|||+.+ ...+||+|||.+....... .....++.|+|||++.|. .
T Consensus 295 ~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGl--p 364 (586)
T KOG0667|consen 295 AQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGL--P 364 (586)
T ss_pred HHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccC--C
Confidence 99999999999999 9999999999999964 3478999999987554432 244588999999999997 8
Q ss_pred ccccCceehHHHHHHHHhcCCCCCCccccc
Q 037755 153 VSCKSDVYGFGMVLLEMTGGRRNSNLKATR 182 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~g~~p~~~~~~~ 182 (238)
++.+.||||||||+.||.+|.+.|.+....
T Consensus 365 Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 365 YDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 899999999999999999998888766443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=239.98 Aligned_cols=214 Identities=25% Similarity=0.404 Sum_probs=161.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe------CCeeeEEEEeCCCCChhhhccCC--CCCCCCCCHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALVYEFMPNGSLDRHIFPK--ESRGQSCSWEKLHEVASG 77 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~~~~~~ 77 (238)
....+.+.+|+.+++.++||||+++++++.. ....++++||+.+|+|.+++... ......++...+..++.|
T Consensus 41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 3456788999999999999999999997632 12568999999999998876322 123346889999999999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccC
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
++.|++|||++ +++||||||+||+++.++.++|+|||.+................++..|+|||...+. .++.++
T Consensus 121 i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~ 195 (272)
T cd05075 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKS 195 (272)
T ss_pred HHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCC--CcChHH
Confidence 99999999998 9999999999999999999999999998765443221111222366789999998775 678899
Q ss_pred ceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 158 DVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 158 Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+||||+++|+|++ |..||....... ............ ....++..+.+++.+||+.||++|||+
T Consensus 196 Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~ 261 (272)
T cd05075 196 DVWSFGVTMWEIATRGQTPYPGVENSE--------IYDYLRQGNRLK------QPPDCLDGLYSLMSSCWLLNPKDRPSF 261 (272)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 99999999999999 788885422111 111111111111 112345678999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
.|
T Consensus 262 ~~ 263 (272)
T cd05075 262 ET 263 (272)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=256.63 Aligned_cols=206 Identities=22% Similarity=0.263 Sum_probs=158.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+++++++.||||+++++.+.+++..++||||+++|+|.+++ .....+++..+..++.||+.||+|||+
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~ 119 (376)
T cd05598 44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRLGIFEEDLARFYIAELTCAIESVHK 119 (376)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999998 234578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc----------------------------------------
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND---------------------------------------- 127 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---------------------------------------- 127 (238)
+ +|+||||||+||+++.++.++|+|||++........
T Consensus 120 ~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (376)
T cd05598 120 M---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQH 196 (376)
T ss_pred C---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhc
Confidence 9 999999999999999999999999998742210000
Q ss_pred -cccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccc
Q 037755 128 -FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRN 206 (238)
Q Consensus 128 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (238)
........||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.......... ............
T Consensus 197 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~~~~~~- 266 (376)
T cd05598 197 QRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL-------KVINWETTLHIP- 266 (376)
T ss_pred ccccccccCCCccccCHHHHcCC--CCCcceeeeeccceeeehhhCCCCCCCCCHHHHHH-------HHhccCccccCC-
Confidence 0000123489999999999876 67889999999999999999999996543221100 111000000000
Q ss_pred hhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 207 VTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 207 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
....+++.+.+++.+|+ .+|.+|+
T Consensus 267 ---~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 267 ---SQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred ---CCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 01234667788898876 5999999
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=246.50 Aligned_cols=208 Identities=23% Similarity=0.318 Sum_probs=164.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.+.|||++++++.+..+...++|+||+.+++|.+++. ...++...+..++.+++.|+.|||
T Consensus 59 ~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH 133 (296)
T cd06654 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133 (296)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH
Confidence 345778899999999999999999999999999999999999999999882 245788999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..+.++|+||||+++
T Consensus 134 ~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil 206 (296)
T cd06654 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMA 206 (296)
T ss_pred HC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCC--CCCccchHHHHHHHH
Confidence 99 999999999999999999999999998865433221 11223488899999998765 567899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|+.||......... ...... ..... ..+..++..+.+++.+||..||++|||+.|
T Consensus 207 ~~l~~g~~pf~~~~~~~~~-------~~~~~~-~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 266 (296)
T cd06654 207 IEMIEGEPPYLNENPLRAL-------YLIATN-GTPEL----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (296)
T ss_pred HHHHhCCCCCCCCCHHHhH-------HHHhcC-CCCCC----CCccccCHHHHHHHHHHCcCCcccCcCHHH
Confidence 9999999999654321110 000000 00011 112345677899999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=244.28 Aligned_cols=208 Identities=24% Similarity=0.322 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|++++++++|+||+++.+.+..++..++++||+.+++|.+++... ....++...+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~ 121 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE 121 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 455788999999999999999999999999999999999999998887322 234689999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+|+||||||+||++++++.++|+|||.+........ .....|+..|+|||.+.+. .++.++|+||+|+++|+
T Consensus 122 ---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~ 193 (285)
T cd05632 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYE 193 (285)
T ss_pred ---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHH
Confidence 999999999999999999999999998865433221 1223588999999998765 67889999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+++|..||......... ........... ......++..+.+|+.+||+.||++|||+.
T Consensus 194 l~~g~~P~~~~~~~~~~----~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 194 MIEGQSPFRGRKEKVKR----EEVDRRVLETE-------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred HHhCCCCCCCCCHHHHH----HHHHHhhhccc-------cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 99999999643221110 00111111100 011233566788999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=240.29 Aligned_cols=208 Identities=22% Similarity=0.301 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+++.+|++++++++||||+++++.+.++...++++||+.+++|.+++. .....+++..+..++.+++.|+.|||+.
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~~ 118 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN 118 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 6789999999999999999999999999999999999999999999882 2246789999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..+.++|+||||+++|+
T Consensus 119 ---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~ 191 (256)
T cd06612 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIE 191 (256)
T ss_pred ---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHH
Confidence 999999999999999999999999999875543321 11223378899999998775 67888999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++|+.||............ . ... .........++.++.+++.+||+.||++|||+.|
T Consensus 192 l~~g~~p~~~~~~~~~~~~~-------~-~~~----~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 249 (256)
T cd06612 192 MAEGKPPYSDIHPMRAIFMI-------P-NKP----PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249 (256)
T ss_pred HHhCCCCCCCcchhhhhhhh-------c-cCC----CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHH
Confidence 99999998653322111000 0 000 0001112345678999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=242.78 Aligned_cols=213 Identities=22% Similarity=0.384 Sum_probs=164.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES---RGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.....+.+|+.+++.++||||+++++++......++++||+.+++|.+++..... ....+++..+..++.+++.|++
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 3467888999999999999999999999998999999999999999998843221 2345788999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCC-----ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNF-----VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~-----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|||+. +++|+|++|+||+++.++ .++++|||++................++..|+|||.+.+. ..+.++|
T Consensus 121 ~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~D 195 (269)
T cd05044 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSD 195 (269)
T ss_pred HHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC--Ccccchh
Confidence 99998 999999999999999877 8999999998654332221112223456789999998765 6788999
Q ss_pred eehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 159 i~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||||+++|+|++ |..||........ ......... ......++..+.+++.+||+.+|++|||++
T Consensus 196 v~slG~il~ellt~g~~p~~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 261 (269)
T cd05044 196 VWSFGVLMWEILTLGQQPYPALNNQEV--------LQHVTAGGR------LQKPENCPDKIYQLMTNCWAQDPSERPTFD 261 (269)
T ss_pred HHHHHHHHHHHHHcCCCCCcccCHHHH--------HHHHhcCCc------cCCcccchHHHHHHHHHHcCCCcccCCCHH
Confidence 9999999999998 8988854322110 011111100 011233567889999999999999999986
Q ss_pred C
Q 037755 238 K 238 (238)
Q Consensus 238 e 238 (238)
|
T Consensus 262 ~ 262 (269)
T cd05044 262 R 262 (269)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=239.58 Aligned_cols=219 Identities=20% Similarity=0.319 Sum_probs=160.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++||||+++++.+.+....+++|||+.+|+|.+++..........+...+..++.||+.||+|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 34578999999999999999999999999999999999999999999998543333456777888999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-----CCcccccCceeh
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-----FGTVSCKSDVYG 161 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~s 161 (238)
+. +++|+||||+||+++.++.++|+|||++................++..|+|||.+... ....+.++||||
T Consensus 117 ~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 98 9999999999999999999999999987533222111112233478899999987532 113467899999
Q ss_pred HHHHHHHHhcC-CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGG-RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|+++ ..||...... ............... .+.....+++.+.+++..|| .+|++|||++|
T Consensus 194 lG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~ 261 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLSDR-------EVLNHVIKDQQVKLF--KPQLELPYSERWYEVLQFCW-LSPEKRATAEE 261 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhhcccccC--CCccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence 99999999974 5566432211 111111111110000 01111225567888999999 68999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=245.65 Aligned_cols=221 Identities=21% Similarity=0.301 Sum_probs=163.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|+.+++.++||||+++++++..+...++|+||+. ++|.+.+.. ....++...+..++.|++.||.|||+
T Consensus 47 ~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~ 122 (301)
T cd07873 47 APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR 122 (301)
T ss_pred chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 44577899999999999999999999999999999999996 588887732 23568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+. ..++.++||||||+++|
T Consensus 123 ~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~ 196 (301)
T cd07873 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFY 196 (301)
T ss_pred C---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHH
Confidence 9 999999999999999999999999999865433221 11223478899999988653 35678899999999999
Q ss_pred HHhcCCCCCCcccccccCCc------------chhhhhhhh-ccCCCccc--cchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAY------------FPSWVSDQL-NKGGNLEL--RNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~------------~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+|++|+.||........... .+....... ........ .........+++.+.+|+.+||+.||.+
T Consensus 197 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 276 (301)
T cd07873 197 EMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRK 276 (301)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCccc
Confidence 99999999975433211000 000000000 00000000 0011122345778899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 277 R~t~~e 282 (301)
T cd07873 277 RISAEE 282 (301)
T ss_pred CcCHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=243.26 Aligned_cols=213 Identities=22% Similarity=0.409 Sum_probs=164.8
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHE 73 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~ 73 (238)
...+++.+|+.+++.+ +||||+++++++......++++||+.+++|.+++..... ....++...+..
T Consensus 62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05101 62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141 (304)
T ss_pred HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence 3456789999999999 799999999999999999999999999999998854321 124578888999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.|++.|+.|||++ +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+. .+
T Consensus 142 ~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~ 216 (304)
T cd05101 142 CTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VY 216 (304)
T ss_pred HHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CC
Confidence 999999999999999 9999999999999999999999999998765443322222223356789999998765 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++||||||+++|++++ |..||....... .. .......... .+..++..+.+++.+||+.+|++
T Consensus 217 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~-~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~ 282 (304)
T cd05101 217 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LF-KLLKEGHRMD------KPANCTNELYMMMRDCWHAIPSH 282 (304)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HH-HHHHcCCcCC------CCCCCCHHHHHHHHHHcccChhh
Confidence 888999999999999998 677774332211 11 1111111110 11235678899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 283 Rps~~e 288 (304)
T cd05101 283 RPTFKQ 288 (304)
T ss_pred CCCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=242.57 Aligned_cols=221 Identities=20% Similarity=0.263 Sum_probs=165.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++|||++++++++..+...++++||+++++|..+. .....+++..+..++.|++.+|.|||+
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH~ 118 (286)
T cd07847 43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCHK 118 (286)
T ss_pred ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3466789999999999999999999999999999999999998887766 234568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..++.++|+||||+++|
T Consensus 119 ~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~ 192 (286)
T cd07847 119 H---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFA 192 (286)
T ss_pred C---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHH
Confidence 8 999999999999999999999999999875544321 11223477889999998653 24678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhh----------------hccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQ----------------LNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
+|++|..||................... ..................++..+.+|+.+||+.||+
T Consensus 193 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 272 (286)
T cd07847 193 ELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPT 272 (286)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcc
Confidence 9999999996543321110000000000 000000000111122234578899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||+.|
T Consensus 273 ~Rp~~~e 279 (286)
T cd07847 273 ERLSCEE 279 (286)
T ss_pred ccCCHHH
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=240.43 Aligned_cols=214 Identities=22% Similarity=0.339 Sum_probs=167.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++|+|++++++.+..+...++++||+.+++|.+++.........++...+..++.+++.|+.|||
T Consensus 44 ~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 123 (267)
T cd08224 44 KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123 (267)
T ss_pred hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999887543344566899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++++|||.+........ ......++..|.|||.+.+. .++.++|+||||+++
T Consensus 124 ~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il 196 (267)
T cd08224 124 SK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLL 196 (267)
T ss_pred hC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc--ccceecCCccccCHHHhccC--CCCchhcHHHHHHHH
Confidence 98 999999999999999999999999998865433221 11223478889999998765 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||...... ..... ........ .. .....++..+.+++.+||+.+|++|||+.|
T Consensus 197 ~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~-~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 197 YEMAALQSPFYGDKMN-----LYSLC-KKIEKCDY-PP----LPADHYSEELRDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred HHHHHCCCCcccCCcc-----HHHHH-hhhhcCCC-CC----CChhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999999998543311 00000 11111000 00 011245678899999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=242.29 Aligned_cols=219 Identities=25% Similarity=0.313 Sum_probs=165.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...++.+|++++++++||||+++++++.+ ...++++|||+++++|.+++.........++...+..++.+++.||+||
T Consensus 42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45778999999999999999999998854 3478999999999999887643333456789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+|++|+||+++.++.++|+|||++........ ....++..|+|||.+.+. .++.++|+||||++
T Consensus 122 H~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~i 192 (287)
T cd06621 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLT 192 (287)
T ss_pred HHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCC--CCCchhhHHHHHHH
Confidence 998 999999999999999999999999999764432211 123377889999998765 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||......... ..........................++.+.+++.+||+.||++|||+.|
T Consensus 193 l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 262 (287)
T cd06621 193 LLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262 (287)
T ss_pred HHHHHhCCCCCCcccCCCCC---hHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHH
Confidence 99999999999755331110 00011111111111111111111224677899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=242.65 Aligned_cols=217 Identities=24% Similarity=0.334 Sum_probs=165.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....++.+|+++++.++||||+++++.+.....+++++||+++++|.+++ ...+.++...+..++.+++.++.|||
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH 120 (284)
T cd06620 45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLY 120 (284)
T ss_pred hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999999999999999999999998887 23457899999999999999999999
Q ss_pred c-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 N-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+ . +++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+. ..+.++|+||||++
T Consensus 121 ~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~ 191 (284)
T cd06620 121 NVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGIS 191 (284)
T ss_pred Hhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccC--CCCccchHHHHHHH
Confidence 6 5 89999999999999999999999999875432211 1123488999999998765 77889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++|..||...............+............... ....++..+.+|+.+||+.||++|||++|
T Consensus 192 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred HHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 999999999997544332111111111111110000000000 01125677899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=239.69 Aligned_cols=201 Identities=22% Similarity=0.334 Sum_probs=154.9
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|+.+++.++||||+++++++......++++||+.+++|..++.. ....++...+..++.||+.|++|||+.
T Consensus 48 ~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (262)
T cd05077 48 SLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK 124 (262)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 35778899999999999999999999998899999999999999887732 235689999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCc-------cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 89 CDVCILHLDIKPHNILLDHNFV-------PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+++||||||+||+++.++. ++++|||.+...... ....++..|+|||.+... ..++.++||||
T Consensus 125 ---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~Diws 194 (262)
T cd05077 125 ---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWS 194 (262)
T ss_pred ---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHH
Confidence 9999999999999986654 789999987644322 122377889999987632 35788899999
Q ss_pred HHHHHHHHh-cCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMT-GGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|+ +|..|+........ ........ .. .....+++.+++.+||+.||.+||++.|
T Consensus 195 lG~~l~el~~~~~~p~~~~~~~~~--------~~~~~~~~--~~------~~~~~~~~~~li~~cl~~dp~~Rp~~~~ 256 (262)
T cd05077 195 FGTTLWEICYNGEIPLKDKTLAEK--------ERFYEGQC--ML------VTPSCKELADLMTHCMNYDPNQRPFFRA 256 (262)
T ss_pred HHHHHHHHHhCCCCCCCCcchhHH--------HHHHhcCc--cC------CCCChHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999998 57777654321110 00000000 00 0112457889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=253.01 Aligned_cols=163 Identities=25% Similarity=0.303 Sum_probs=140.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++.+.++..+++||||+.+|+|.+++ .....+++..+..++.|++.||+|||+
T Consensus 44 ~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~ 119 (363)
T cd05628 44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAIDSIHQ 119 (363)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3467889999999999999999999999999999999999999999988 334678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc---------------------------------cccccc
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF---------------------------------VSISAT 134 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---------------------------------~~~~~~ 134 (238)
+ +|+||||||+|||++.++.++|+|||++......... ......
T Consensus 120 ~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (363)
T cd05628 120 L---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFST 196 (363)
T ss_pred C---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence 9 9999999999999999999999999998643221100 000123
Q ss_pred CCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcc
Q 037755 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLK 179 (238)
Q Consensus 135 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~ 179 (238)
.||+.|+|||.+.+. .++.++|+|||||++|+|++|..||...
T Consensus 197 ~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 197 VGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 589999999999875 6788999999999999999999999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=237.94 Aligned_cols=217 Identities=18% Similarity=0.204 Sum_probs=165.4
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
..+|+.+|.+++|||||.+-+++... +..|+|||||+. +|.+.+.. -.+++...+++.+..|+++|++|||.+
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~- 196 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN- 196 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc-
Confidence 46899999999999999999988543 579999999965 99888833 236899999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
.|+|||+|++|+|++..|.+||+|||+++.++...... ....-|.+|+|||++.+. ..++.+.|+||+||++.|+
T Consensus 197 --wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~--T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~ 271 (419)
T KOG0663|consen 197 --WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY--TPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAEL 271 (419)
T ss_pred --eeEecccchhheeeccCCcEEecccchhhhhcCCcccC--cceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHH
Confidence 99999999999999999999999999999877653221 223478899999999986 5789999999999999999
Q ss_pred hcCCCCCCcccccccCCcchhh-------hhhhhcc---------CCCccccchhHHHHH-HHHHHHHHHhhhccCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSW-------VSDQLNK---------GGNLELRNVTEIESM-IARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~ 232 (238)
+++++.|.+.+.......+-.. +++.... .....-......... +++.-.+|++.+|..||.+
T Consensus 272 l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~k 351 (419)
T KOG0663|consen 272 LTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGK 351 (419)
T ss_pred HhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccc
Confidence 9999999876554322111000 0000000 000000000111111 5577889999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|.||+|
T Consensus 352 R~tA~~ 357 (419)
T KOG0663|consen 352 RITAED 357 (419)
T ss_pred cccHHH
Confidence 999875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=242.61 Aligned_cols=206 Identities=22% Similarity=0.362 Sum_probs=163.7
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+.+.+|+.++++++||||+++++++.+....++++||+++++|.+++ .....++...+..++.+++.|+.|||++
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~l~~~l~~lH~~- 125 (267)
T cd06628 51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYLHNR- 125 (267)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHH----HhccCccHHHHHHHHHHHHHHHHHHHhc-
Confidence 57889999999999999999999999999999999999999999988 3345788899999999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccc----cccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+++||||+|+||++++++.++|+|||.+.......... ......++..|+|||.+.+. ..+.++|+||+|++
T Consensus 126 --~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~i 201 (267)
T cd06628 126 --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCL 201 (267)
T ss_pred --CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHH
Confidence 99999999999999999999999999887554321111 11123478899999998765 66788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ ...... . .....+..++..+.+++.+||+.||.+|||++|
T Consensus 202 l~~l~~g~~p~~~~~~~~~-------~~~~~~-~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 202 VVEMLTGKHPFPDCTQLQA-------IFKIGE-N------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred HHHHhhCCCCCCCccHHHH-------HHHHhc-c------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 9999999999964322110 001000 0 011122345678899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=244.48 Aligned_cols=229 Identities=17% Similarity=0.204 Sum_probs=168.6
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+++.+|++++++++||||+++++++.+....++++||+.+++|.+++... ....+++..+..++.+++.||.|
T Consensus 39 ~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~ 116 (314)
T cd08216 39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDY 116 (314)
T ss_pred chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHH
Confidence 3455678999999999999999999999999999999999999999999988322 23468899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-----ccccccCCccccCCcceeecCCCcccccCce
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
||++ +|+||||||+||+++.++.++++||+.+......... .......++..|+|||.+.+....++.++|+
T Consensus 117 LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (314)
T cd08216 117 IHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193 (314)
T ss_pred HHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhH
Confidence 9999 9999999999999999999999999987543322110 0112223677899999987643357789999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCC-----cchhhhh----hh----hcc------CCCccccchhHHHHHHHHHHHH
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKA-----YFPSWVS----DQ----LNK------GGNLELRNVTEIESMIARKLCV 220 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~-----~~~~~~~----~~----~~~------~~~~~~~~~~~~~~~~~~~l~~ 220 (238)
||+|+++|+|++|..||.......... ..+.... .. ... ...............++.++.+
T Consensus 194 ws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (314)
T cd08216 194 YSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQ 273 (314)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHH
Confidence 999999999999999997533211000 0000000 00 000 0000011112233456778999
Q ss_pred HHhhhccCCCCCCCCCCC
Q 037755 221 IGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 221 li~~cl~~dp~~Rps~~e 238 (238)
|+.+||+.||++|||++|
T Consensus 274 li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 274 FVELCLQRDPESRPSASQ 291 (314)
T ss_pred HHHHHhhcCCCcCcCHHH
Confidence 999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=242.90 Aligned_cols=213 Identities=23% Similarity=0.420 Sum_probs=162.9
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHE 73 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~ 73 (238)
...+++.+|+.+++++ .||||+++++++..+...++++||+.+|+|.+++..... ....++...+..
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (314)
T cd05099 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138 (314)
T ss_pred HHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHH
Confidence 3456788999999999 599999999999998999999999999999998844221 124588899999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||.++...............++..|+|||.+.+. .+
T Consensus 139 ~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~ 213 (314)
T cd05099 139 CAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VY 213 (314)
T ss_pred HHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--Cc
Confidence 999999999999998 9999999999999999999999999998755432211111112245679999998765 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++|+||||+++|++++ |..||....... ........... .....++.++.+++.+||+.||++
T Consensus 214 ~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~ 279 (314)
T cd05099 214 THQSDVWSFGILMWEIFTLGGSPYPGIPVEE--------LFKLLREGHRM------DKPSNCTHELYMLMRECWHAVPTQ 279 (314)
T ss_pred CccchhhHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCCCccc
Confidence 889999999999999998 788875432111 11111111111 111234567889999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 280 Rps~~~ 285 (314)
T cd05099 280 RPTFKQ 285 (314)
T ss_pred CcCHHH
Confidence 999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=232.50 Aligned_cols=214 Identities=19% Similarity=0.239 Sum_probs=171.1
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
+.++..+|+++--+.+ |||||.++++|++ ...+.+|||.++||.|.+.+. ......+++..+..|..||+.|+
T Consensus 97 Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq--~~g~~afTErea~eI~~qI~~Av 174 (400)
T KOG0604|consen 97 DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQ--DRGDQAFTEREASEIMKQIGLAV 174 (400)
T ss_pred cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHH--HcccccchHHHHHHHHHHHHHHH
Confidence 4567789999888875 9999999999855 346778999999999999983 33456899999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEc---cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.|||+. +|.|||+||+|+|+. .+..+||+|||.++....... .....-|+.|.|||++-.. .+++..|+
T Consensus 175 ~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~e--Kydkscdm 246 (400)
T KOG0604|consen 175 RYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPE--KYDKSCDM 246 (400)
T ss_pred HHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCcc---ccCCcccccccCHHHhCch--hcCCCCCc
Confidence 999999 999999999999996 355789999999986554332 3445589999999999876 78999999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+|+++|-|++|.+||....-... +......+..+.-. .+.+-.+.+++..+++|+.+|..+|++|.|+.|
T Consensus 247 wSlgVimYIlLCGyPPFYS~hg~ai----spgMk~rI~~gqy~---FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 247 WSLGVIMYILLCGYPPFYSNHGLAI----SPGMKRRIRTGQYE---FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred cchhHHHHHhhcCCCcccccCCccC----ChhHHhHhhccCcc---CCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 9999999999999999976554333 33333333222221 223344678999999999999999999999864
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=248.19 Aligned_cols=209 Identities=25% Similarity=0.431 Sum_probs=161.0
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC------------CCCCCCCHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------------SRGQSCSWEKLHEV 74 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~~~ 74 (238)
..+++.+|+.+++++ +||||+++++++..++..++++||+.+++|.+++.... .....++...++.+
T Consensus 50 ~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (303)
T cd05088 50 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129 (303)
T ss_pred HHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHH
Confidence 456788999999999 89999999999999999999999999999999884322 12346889999999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+.|++.|++|||+. +++||||||+||+++.++.++|+|||++....... .......+..|+|||.+.+. .++
T Consensus 130 ~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~ 201 (303)
T cd05088 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYT 201 (303)
T ss_pred HHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhcc--CCc
Confidence 99999999999998 99999999999999999999999999885322111 11111245679999988765 578
Q ss_pred ccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
.++||||||+++|+|++ |..||........ . .......... ....+++.+.+++.+||+.||++|
T Consensus 202 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~-~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R 267 (303)
T cd05088 202 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y-EKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYER 267 (303)
T ss_pred ccccchhhhhHHHHHHhcCCCCcccCChHHH-------H-HHHhcCCcCC------CCCCCCHHHHHHHHHHcCCChhhC
Confidence 89999999999999998 9988854322110 1 1111110000 112245678999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+++
T Consensus 268 p~~~~ 272 (303)
T cd05088 268 PSFAQ 272 (303)
T ss_pred cCHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=252.68 Aligned_cols=211 Identities=20% Similarity=0.259 Sum_probs=161.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++||||+++++.+.++...++||||+.+|+|.+++. ...+++..+..++.||+.||+|||+
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~ 160 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHS 160 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999882 2457889999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC--CcccccCceehHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMV 165 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~ 165 (238)
. +|+||||||+|||++.++.++|+|||++........ .......||+.|+|||.+.+.. ..++.++|+||+|++
T Consensus 161 ~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~i 236 (370)
T cd05621 161 M---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred C---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHH
Confidence 9 999999999999999999999999999875533221 1122345999999999987542 136789999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC--CCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD--RPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~e 238 (238)
+|+|++|..||........ ............... ...++..+.+++.+||+.++.+ |+|++|
T Consensus 237 lyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~~~p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 237 LFEMLVGDTPFYADSLVGT-------YSKIMDHKNSLNFPE----DVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred HHHHHhCCCCCCCCCHHHH-------HHHHHhCCcccCCCC----cccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 9999999999965432111 111111111111100 1235677889999999855543 777653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=244.28 Aligned_cols=167 Identities=20% Similarity=0.289 Sum_probs=133.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCC-----CCCCCCCCHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPK-----ESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
...+.+|+.++++++||||+++++++.. +...++++||+. ++|.+++... ......++...+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 3567899999999999999999998854 457899999985 4887765221 1123468999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEE----ccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCccccc
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILL----DHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
|+|||++ +++||||||+|||+ +.++.++|+|||.+......... .......+|+.|+|||.+.+. ..++.+
T Consensus 121 l~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 196 (317)
T cd07868 121 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKA 196 (317)
T ss_pred HHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCC-CCcCch
Confidence 9999999 99999999999999 45678999999998765433211 111233588999999998764 357888
Q ss_pred CceehHHHHHHHHhcCCCCCCccc
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
+|+||+||++|+|++|++||....
T Consensus 197 ~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 197 IDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred hhHHHHHHHHHHHHhCCCCccCCc
Confidence 999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=249.85 Aligned_cols=158 Identities=25% Similarity=0.311 Sum_probs=132.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
....++.+|+.+++.++||||+++++++.... ..+++|||+.+ +|.+.+ ...++...+..++.|++.
T Consensus 62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~ 134 (359)
T cd07876 62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI------HMELDHERMSYLLYQMLC 134 (359)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHH------hccCCHHHHHHHHHHHHH
Confidence 44567889999999999999999999985443 57999999965 666655 235788899999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||.|||++ +|+||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+. .++.++|||
T Consensus 135 ~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~Diw 206 (359)
T cd07876 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGM--GYKENVDIW 206 (359)
T ss_pred HHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCC--CCCcchhhH
Confidence 99999999 999999999999999999999999999864432211 1223488999999999875 678899999
Q ss_pred hHHHHHHHHhcCCCCCCcc
Q 037755 161 GFGMVLLEMTGGRRNSNLK 179 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~ 179 (238)
|||+++|+|++|..||...
T Consensus 207 SlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 207 SVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=236.67 Aligned_cols=211 Identities=27% Similarity=0.434 Sum_probs=162.8
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+++.+|+.++++++|||++++++++.. ...+++|||+.+++|.+++.. .....++...++.++.+++.|++|
T Consensus 41 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~ 117 (260)
T cd05070 41 GTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAY 117 (260)
T ss_pred CCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999998854 568999999999999998832 224568899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +++|+||+|+||++++++.++|+|||.+......... ......++..|+|||...+. .++.++|+||||+
T Consensus 118 lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ 191 (260)
T cd05070 118 IERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGI 191 (260)
T ss_pred HHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcC--CCcchhhhHHHHH
Confidence 9999 9999999999999999999999999998755432211 11122356689999988765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++ |..||....... ........... ..+...+..+.+++.+||+.||++|||+++
T Consensus 192 ~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 252 (260)
T cd05070 192 LLTELVTKGRVPYPGMNNRE--------VLEQVERGYRM------PCPQDCPISLHELMLQCWKKDPEERPTFEY 252 (260)
T ss_pred HHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC------CCCCcCCHHHHHHHHHHcccCcccCcCHHH
Confidence 9999999 888885432111 11111111111 111234567999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=236.09 Aligned_cols=210 Identities=24% Similarity=0.353 Sum_probs=167.4
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
.....++.+|++++++++|+||+++++++.++...++++||+.+++|.+++... .+..++...+..++.+++.++.||
T Consensus 40 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~l 117 (256)
T cd08221 40 EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYI 117 (256)
T ss_pred hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 345577889999999999999999999999999999999999999999988322 245689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+........ ......++..|.|||.+.+. ..+.++|+||||++
T Consensus 118 h~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i 190 (256)
T cd08221 118 HKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCV 190 (256)
T ss_pred HhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCC--CCCCcchhHHHHHH
Confidence 998 999999999999999999999999998875533321 12234588999999998765 56788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||....... ...... .... ......++.++.+++.+||+.||++|||+.|
T Consensus 191 ~~~l~~g~~~~~~~~~~~-------~~~~~~-~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 191 LYELLTLKRTFDATNPLN-------LVVKIV-QGNY------TPVVSVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred HHHHHHCCCCCCCCCHHH-------HHHHHH-cCCC------CCCccccCHHHHHHHHHHcccCcccCCCHHH
Confidence 999999999985432211 111111 1100 0111445678999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=242.57 Aligned_cols=212 Identities=21% Similarity=0.281 Sum_probs=163.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+++++.++|||++++++++..+...++++||+.+++|...+.. ....+++..+..++.+++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH 120 (282)
T cd06643 44 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLH 120 (282)
T ss_pred HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3457788999999999999999999999999999999999999999887632 2357899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG 163 (238)
+. +++||||+|+||+++.++.++++|||++........ ......++..|+|||.+... ...++.++|+||+|
T Consensus 121 ~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 195 (282)
T cd06643 121 EN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 195 (282)
T ss_pred HC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHH
Confidence 98 999999999999999999999999999865432211 12233588899999987431 12456789999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ... ......... ..+..++.++.+++.+||+.||.+|||++|
T Consensus 196 vil~el~~g~~p~~~~~~~~~-------~~~-~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 196 ITLIEMAQIEPPHHELNPMRV-------LLK-IAKSEPPTL----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred HHHHHHccCCCCccccCHHHH-------HHH-HhhcCCCCC----CCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999999854321110 000 000000000 112235678899999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=239.64 Aligned_cols=212 Identities=21% Similarity=0.234 Sum_probs=163.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|+.++++++||||+++++.+..+...++++||+.+++|.+++. ....++...+..++.|++.|+.|||+
T Consensus 49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~ 124 (267)
T cd06646 49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS 124 (267)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999999999999872 34578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 166 (238)
. +++|||++|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ....+.++|+||+|+++
T Consensus 125 ~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il 199 (267)
T cd06646 125 K---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199 (267)
T ss_pred C---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHH
Confidence 8 999999999999999999999999999875532211 11233478899999987532 12467789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||............ ... ...... ......++..+.+++.+||+.||++|||++|
T Consensus 200 ~el~~g~~p~~~~~~~~~~~~~--------~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 200 IELAELQPPMFDLHPMRALFLM--------SKS-NFQPPK-LKDKTKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred HHHHhCCCCccccchhhhheee--------ecC-CCCCCC-CccccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 9999999998543322111000 000 000000 0011235678899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=238.16 Aligned_cols=213 Identities=26% Similarity=0.431 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe------eeEEEEeCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------RALVYEFMPNGSLDRHIFPKE--SRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~~i 78 (238)
...+.+.+|++.++.++||||+++++++..... .++++||+.+++|...+.... .....++...+..++.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i 122 (273)
T cd05035 43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122 (273)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence 345688999999999999999999998865443 799999999999988873322 223478999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+.||.|||+. +++||||||+||++++++.++|+|||.++...............++..|+|||.+.+. .++.++|
T Consensus 123 ~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~D 197 (273)
T cd05035 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSD 197 (273)
T ss_pred HHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccC--CCCcccc
Confidence 9999999998 9999999999999999999999999998755433222111222356789999998765 6788999
Q ss_pred eehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 159 i~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||||+++|+|++ |..||....... ........... ..+..++.++.+++.+||+.||++|||+.
T Consensus 198 v~SlG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 263 (273)
T cd05035 198 VWAFGVTMWEIATRGQTPYPGVENHE--------IYDYLRHGNRL------KQPEDCLDELYDLMYSCWRADPKDRPTFT 263 (273)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------CCCcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999999998 888875432111 11111111111 11224567899999999999999999986
Q ss_pred C
Q 037755 238 K 238 (238)
Q Consensus 238 e 238 (238)
|
T Consensus 264 e 264 (273)
T cd05035 264 K 264 (273)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=259.82 Aligned_cols=215 Identities=25% Similarity=0.351 Sum_probs=176.3
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCC--CHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC--SWEKLHEVASGTAHG 81 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~ 81 (238)
.++...+-+..|+.+-++|+|.|||+++|.+.+++..-+.||-++||||.+.+.+++ +++ .+.++-.+..||+.|
T Consensus 611 kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeG 687 (1226)
T KOG4279|consen 611 KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEG 687 (1226)
T ss_pred ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHH
Confidence 445556677899999999999999999999999999999999999999999995444 555 678899999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|.|||++ .|||||||.+|+|++ -+|.+||.|||-++....-. ...+...||.-|+|||++......|++++|||
T Consensus 688 LkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIW 762 (1226)
T KOG4279|consen 688 LKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIW 762 (1226)
T ss_pred hhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccchhhhChHhhccCCcCCCchhhhh
Confidence 9999999 999999999999998 57899999999886443322 22345569999999999987656899999999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||++.||.||++||...+..+..... --.....+.++..++.+.+.||.+|+.+||.+||||++
T Consensus 763 S~GCT~vEMATGrPPF~ElgspqAAMFk------------VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~ 828 (1226)
T KOG4279|consen 763 SFGCTMVEMATGRPPFVELGSPQAAMFK------------VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKD 828 (1226)
T ss_pred hccceeEeeccCCCCeeecCChhHhhhh------------hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHH
Confidence 9999999999999999644333221111 01122345677889999999999999999999999864
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=239.61 Aligned_cols=211 Identities=26% Similarity=0.383 Sum_probs=164.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.++++++||||+++++.+.. ...++++||+.+++|.+++.... ...+++..++.++.|++.||+|||
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH 114 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLE 114 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999999999988 88999999999999999884322 157889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccc-cccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
++ +++|+||+|+||+++.++.++|+|||.+............ ....++..|+|||.+.+. .++.++|+||||++
T Consensus 115 ~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~ 189 (257)
T cd05040 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVT 189 (257)
T ss_pred hC---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHH
Confidence 99 9999999999999999999999999998765443222111 123467789999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |..||....... . ............ .+..++..+.+++.+||+.+|++|||+.|
T Consensus 190 l~el~t~g~~p~~~~~~~~----~---~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 250 (257)
T cd05040 190 LWEMFTYGEEPWAGLSGSQ----I---LKKIDKEGERLE------RPEACPQDIYNVMLQCWAHNPADRPTFAA 250 (257)
T ss_pred HHHHHhCCCCCCCCCCHHH----H---HHHHHhcCCcCC------CCccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 999998 999985332211 0 001110110000 11234678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=243.56 Aligned_cols=206 Identities=24% Similarity=0.329 Sum_probs=162.1
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+.+.+|+.++++++|+|++++++.+.++...+++|||+.+++|.+.+.. .....+++..+..++.|++.|+.|||+.
T Consensus 45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~- 121 (285)
T cd05630 45 SMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE- 121 (285)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4577899999999999999999999999999999999999999888732 2234688999999999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++|+||||+||+++.++.++|+|||++........ .....|+..|+|||.+.+. .++.++|+||+|+++|+|
T Consensus 122 --~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l 194 (285)
T cd05630 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEM 194 (285)
T ss_pred --CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHH
Confidence 999999999999999999999999998865433221 1223588999999998765 678899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
++|..||......... .......... .......+++++.+|+.+||+.||++|||+
T Consensus 195 ~~g~~Pf~~~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 195 IAGQSPFQQRKKKIKR----EEVERLVKEV-------QEEYSEKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred HhCCCCCCCCCccchH----HHHHhhhhhh-------hhhcCccCCHHHHHHHHHHhhcCHHHccCC
Confidence 9999999653221100 0000000000 011123456778999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=248.35 Aligned_cols=204 Identities=21% Similarity=0.254 Sum_probs=161.4
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+..|..+++.+. |++|+++++++.+....++||||+.+|+|.+++ .....+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH 118 (323)
T cd05615 43 DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLH 118 (323)
T ss_pred HHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999998885 677889999999999999999999999999888 33457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++|+||+|+++
T Consensus 119 ~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil 191 (323)
T cd05615 119 RR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLL 191 (323)
T ss_pred HC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHH
Confidence 98 999999999999999999999999999864322211 11233489999999998765 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||........ ....... .. ..+..++.++.+++.+||+.||++|++..
T Consensus 192 ~elltG~~pf~~~~~~~~-------~~~i~~~-~~-------~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 192 YEMLAGQPPFDGEDEDEL-------FQSIMEH-NV-------SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHHhCCCCCCCCCHHHH-------HHHHHhC-CC-------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 999999999965432111 1111111 00 11123466788999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=252.94 Aligned_cols=209 Identities=27% Similarity=0.403 Sum_probs=168.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+..+..+|.+|++++++++|||||+++|+...+..+++|||+|.||+|.+++. ..++.++..+...++.+++.||+|
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~---k~~~~v~~~ek~~~~~~AA~Gl~Y 277 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLK---KNKKSLPTLEKLRFCYDAARGLEY 277 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHhHHHH
Confidence 45677899999999999999999999999999999999999999999999992 223369999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +++||||-.+|+|++.++.+||+|||+++...... . ......-+..|+|||.+... .++.++||||||+
T Consensus 278 Lh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~-~-~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV 350 (474)
T KOG0194|consen 278 LHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV-M-KKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGV 350 (474)
T ss_pred HHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee-e-ccccccCcceecChhhhccC--ccccccchhheee
Confidence 9999 99999999999999999999999999987554111 1 11122467899999999876 8899999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhh-ccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQL-NKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++||+++ |..|+......+. ...+ ........ +...+..+..++.+||..||++|||+.
T Consensus 351 ~~~Eif~~g~~Py~g~~~~~v--------~~kI~~~~~r~~~------~~~~p~~~~~~~~~c~~~~p~~R~tm~ 411 (474)
T KOG0194|consen 351 LLWEIFENGAEPYPGMKNYEV--------KAKIVKNGYRMPI------PSKTPKELAKVMKQCWKKDPEDRPTMS 411 (474)
T ss_pred eEEeeeccCCCCCCCCCHHHH--------HHHHHhcCccCCC------CCCCHHHHHHHHHHhccCChhhccCHH
Confidence 9999987 7778865544421 1111 11111111 124566778888999999999999985
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=235.72 Aligned_cols=211 Identities=27% Similarity=0.422 Sum_probs=162.7
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+++.+|++++++++|||++++++++.. ...+++|||+.+++|.+++.. .....++...+..++.+++.||.|
T Consensus 41 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~ 117 (260)
T cd05069 41 GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAY 117 (260)
T ss_pred CCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999998854 568899999999999998833 234467889999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++|+||+|+||++++++.++|+|||.+......... ......++..|+|||...+. ..+.++|+||||+
T Consensus 118 lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~ 191 (260)
T cd05069 118 IERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGI 191 (260)
T ss_pred HHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccC--CcChHHHHHHHHH
Confidence 9998 9999999999999999999999999998755332211 11222356789999988765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |..||....... ........... ......+..+.+++.+||+.||++|||+++
T Consensus 192 ~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05069 192 LLTELVTKGRVPYPGMVNRE--------VLEQVERGYRM------PCPQGCPESLHELMKLCWKKDPDERPTFEY 252 (260)
T ss_pred HHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------CCCcccCHHHHHHHHHHccCCcccCcCHHH
Confidence 9999999 888886432211 11111111000 111235678999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=245.49 Aligned_cols=208 Identities=23% Similarity=0.338 Sum_probs=164.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++||||+++++++..+...++|+||+.+++|..++. ...+++..+..++.+++.|+.|||
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH 132 (296)
T cd06655 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLH 132 (296)
T ss_pred chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH
Confidence 345788899999999999999999999999999999999999999999872 346889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..+.++|+||||+++
T Consensus 133 ~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil 205 (296)
T cd06655 133 AN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMA 205 (296)
T ss_pred HC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999998764433221 11223478899999998765 677899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++|..||......... .. .......... ....+++.+.+++.+||+.||++|||+.|
T Consensus 206 ~~lltg~~pf~~~~~~~~~-------~~-~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 265 (296)
T cd06655 206 IEMVEGEPPYLNENPLRAL-------YL-IATNGTPELQ----NPEKLSPIFRDFLNRCLEMDVEKRGSAKE 265 (296)
T ss_pred HHHHhCCCCCCCCCHHHHH-------HH-HHhcCCcccC----CcccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 9999999999654322110 00 0000010111 12335667889999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=245.96 Aligned_cols=209 Identities=23% Similarity=0.409 Sum_probs=161.1
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHEV 74 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~ 74 (238)
..+.+.+|+.+++++ +||||+++++++.+....++++||+++++|.+++..... ....++...+..+
T Consensus 45 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 124 (297)
T cd05089 45 DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124 (297)
T ss_pred HHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHH
Confidence 456789999999999 799999999999999999999999999999998843211 1235888999999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+.|++.|++|||+. +++||||||+||+++.++.++|+|||++........ ......+..|+|||...+. .++
T Consensus 125 ~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~ 196 (297)
T cd05089 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYS--VYT 196 (297)
T ss_pred HHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccC--CCC
Confidence 99999999999998 999999999999999999999999998853221111 1111235579999998765 678
Q ss_pred ccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
.++||||||+++|+|++ |..||....... .... ....... ..+..++..+.+|+.+||+.||.+|
T Consensus 197 ~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~~-~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R 262 (297)
T cd05089 197 TKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYEK-LPQGYRM------EKPRNCDDEVYELMRQCWRDRPYER 262 (297)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH-HhcCCCC------CCCCCCCHHHHHHHHHHcCCChhhC
Confidence 89999999999999997 999985433221 1111 1111000 1112356788999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||++|
T Consensus 263 p~~~~ 267 (297)
T cd05089 263 PPFAQ 267 (297)
T ss_pred cCHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=236.07 Aligned_cols=206 Identities=22% Similarity=0.248 Sum_probs=167.2
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.+.+.|-+||+.+.||.++.+|..++.+...|++||||.||+|..... ...++.+++..++.++.+++-||.|||..
T Consensus 122 ~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml- 198 (459)
T KOG0610|consen 122 KRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML- 198 (459)
T ss_pred HHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh-
Confidence 466779999999999999999999999999999999999999988773 34478999999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-------------------------------c---------
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-------------------------------V--------- 129 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------------------------~--------- 129 (238)
|||+|||||+|||+.++|++-|+||.++......... .
T Consensus 199 --GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~ 276 (459)
T KOG0610|consen 199 --GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESA 276 (459)
T ss_pred --ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccc
Confidence 9999999999999999999999999886422110000 0
Q ss_pred --------------cccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhh
Q 037755 130 --------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQ 195 (238)
Q Consensus 130 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 195 (238)
......||-.|+|||++.|. ..+.+.|.|+||+++|||+.|.-||.+....+...++
T Consensus 277 ~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI------- 347 (459)
T KOG0610|consen 277 SRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI------- 347 (459)
T ss_pred cccchhhhcCCCCccccccccccccccceeeecC--CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-------
Confidence 00112388899999999997 8899999999999999999999999887766553222
Q ss_pred hccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 196 LNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+.+. +..+.. .+++..+++||++.|-.||.+|.-
T Consensus 348 v~~~----l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 348 VGQP----LKFPEE--PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred hcCC----CcCCCC--CcchhHHHHHHHHHhccChhhhhc
Confidence 2111 111111 156788999999999999999976
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=253.91 Aligned_cols=221 Identities=22% Similarity=0.300 Sum_probs=162.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCC-----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
...++.+|+.+++.++||||+++++++.... ..++|+||+. ++|.+.+ .....++...+..++.||+.||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL 116 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKII----VSPQPLSSDHVKVFLYQILRGL 116 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHH----hcCCCCCHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999997766 7899999996 5787777 3346789999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
.|||+. +++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+. ..++.++||||+
T Consensus 117 ~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Diwsl 191 (372)
T cd07853 117 KYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSV 191 (372)
T ss_pred HHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhH
Confidence 999999 999999999999999999999999999875433221 111223478899999998764 246788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchh---------------hhhhhh-ccCCCcc-ccchhHHHHHHHHHHHHHHhhh
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPS---------------WVSDQL-NKGGNLE-LRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~---------------~~~~~~-~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 225 (238)
||++|+|++|+.||...........+.. .....+ ....... ...........++++.+|+.+|
T Consensus 192 G~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 271 (372)
T cd07853 192 GCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRM 271 (372)
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHh
Confidence 9999999999999965433211100000 000000 0000000 0000001122367889999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||++|||+.|
T Consensus 272 L~~dP~~R~t~~e 284 (372)
T cd07853 272 LVFDPDKRISAAD 284 (372)
T ss_pred CCCChhhCcCHHH
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=235.44 Aligned_cols=207 Identities=28% Similarity=0.485 Sum_probs=161.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+++++++.||||+++++++. +...++++||+.+++|.+++. ....+++..+..++.|++.|++|||+
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~ 113 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLES 113 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 4567899999999999999999999876 456899999999999999983 33478999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
. +++|+||||+||+++.++.++|+|||.+........... .....++..|+|||.+.+. .++.++|+||||+++
T Consensus 114 ~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l 188 (257)
T cd05060 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTL 188 (257)
T ss_pred c---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCC--CCCccchHHHHHHHH
Confidence 8 999999999999999999999999999875544332111 1111234679999988765 678899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++ |..||....... + .......... ..+..++..+.+++.+||+.||++|||+.|
T Consensus 189 ~~~~~~g~~p~~~~~~~~----~----~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~ 247 (257)
T cd05060 189 WEAFSYGAKPYGEMKGAE----V----IAMLESGERL------PRPEECPQEIYSIMLSCWKYRPEDRPTFSE 247 (257)
T ss_pred HHHHcCCCCCcccCCHHH----H----HHHHHcCCcC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 99997 899986432211 1 1111111111 111234578899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=241.24 Aligned_cols=218 Identities=22% Similarity=0.335 Sum_probs=158.0
Q ss_pred HHHHHHHHHHhhc---CCCcceeeeeEEEe-----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 10 EEFINEVSTIGRI---HHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 10 ~~~~~e~~~l~~l---~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
..+.+|+.+++.+ .||||+++++++.. ....++++|++.+ +|.+++.. .....+++..+..++.|++.|
T Consensus 44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~a 120 (288)
T cd07863 44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK--VPPPGLPAETIKDLMRQFLRG 120 (288)
T ss_pred hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHh--cCCCCCCHHHHHHHHHHHHHH
Confidence 4566788887776 69999999998754 3468999999974 88887732 223458999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|.|||+. +++||||||+||+++.++.++|+|||.+........ .....++..|+|||.+.+. .++.++||||
T Consensus 121 l~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws 192 (288)
T cd07863 121 LDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWS 192 (288)
T ss_pred HHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCC--CCCCcchhhh
Confidence 9999999 999999999999999999999999999875533221 1223478899999998765 6788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhh----hhh----c----cCCCccccchhHHHHHHHHHHHHHHhhhccCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVS----DQL----N----KGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~----~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 229 (238)
+|+++|+|++|.+||...........+..... ..+ . ................++..+.+++.+||+.|
T Consensus 193 lG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 272 (288)
T cd07863 193 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFN 272 (288)
T ss_pred HHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccC
Confidence 99999999999999865432211000000000 000 0 00000011112223346778899999999999
Q ss_pred CCCCCCCCC
Q 037755 230 PADRPSMTK 238 (238)
Q Consensus 230 p~~Rps~~e 238 (238)
|++|||+.|
T Consensus 273 P~~R~t~~~ 281 (288)
T cd07863 273 PHKRISAFR 281 (288)
T ss_pred cccCCCHHH
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=246.49 Aligned_cols=213 Identities=23% Similarity=0.413 Sum_probs=163.1
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHE 73 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~ 73 (238)
...+++.+|+.+++.+ +||||+++++++..+...++++||+.+|+|.+++..... ....++...+..
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (307)
T cd05098 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144 (307)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3456788999999999 799999999999999999999999999999999844321 123588899999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.|++.||+|||++ +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+. .+
T Consensus 145 ~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~ 219 (307)
T cd05098 145 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IY 219 (307)
T ss_pred HHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CC
Confidence 999999999999998 9999999999999999999999999998655332211111112245689999998765 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++|+||||+++|+|++ |..||....... ........... ..+..++.++.+++.+||+.+|++
T Consensus 220 ~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~ 285 (307)
T cd05098 220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQ 285 (307)
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHHcCCCC------CCCCcCCHHHHHHHHHHcccChhh
Confidence 889999999999999998 778875322111 11111111110 111234678889999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 286 Rps~~e 291 (307)
T cd05098 286 RPTFKQ 291 (307)
T ss_pred CcCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=268.29 Aligned_cols=215 Identities=23% Similarity=0.343 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|+.++++|+||||+++++++.. ...+|+||||+.+++|.+++.........+++..++.++.||+.||.|
T Consensus 54 ~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaY 133 (1021)
T PTZ00266 54 REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133 (1021)
T ss_pred HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 446788999999999999999999998844 457899999999999999885433334679999999999999999999
Q ss_pred hHcCCC----CceeeeccCCCcEEEcc-----------------CCccccccccccccCCCCCccccccccCCccccCCc
Q 037755 85 LHNGCD----VCILHLDIKPHNILLDH-----------------NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAP 143 (238)
Q Consensus 85 Lh~~~~----~~i~H~dl~p~nil~~~-----------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aP 143 (238)
||+... .+|+||||||+|||++. .+.++|+|||++........ .....|++.|+||
T Consensus 134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAP 210 (1021)
T PTZ00266 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSP 210 (1021)
T ss_pred HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCH
Confidence 998410 25999999999999964 23489999999875433221 1233589999999
Q ss_pred ceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHh
Q 037755 144 ELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223 (238)
Q Consensus 144 E~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 223 (238)
|++.+....++.++|||||||++|+|++|..||...... ... ...+....... ....+.++.+||.
T Consensus 211 EvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~------~ql-i~~lk~~p~lp-------i~~~S~eL~dLI~ 276 (1021)
T PTZ00266 211 ELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF------SQL-ISELKRGPDLP-------IKGKSKELNILIK 276 (1021)
T ss_pred HHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH------HHH-HHHHhcCCCCC-------cCCCCHHHHHHHH
Confidence 998654335788999999999999999999999532211 111 11111111110 1124677899999
Q ss_pred hhccCCCCCCCCCCC
Q 037755 224 WCIQVKPADRPSMTK 238 (238)
Q Consensus 224 ~cl~~dp~~Rps~~e 238 (238)
+||+.+|.+|||+.|
T Consensus 277 ~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 277 NLLNLSAKERPSALQ 291 (1021)
T ss_pred HHhcCChhHCcCHHH
Confidence 999999999999754
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=235.95 Aligned_cols=213 Identities=23% Similarity=0.247 Sum_probs=165.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++.+.++..+++++||+.+++|.+++.. ....++...+..++.|++.|+.|||+
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~ 119 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE 119 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 567899999999999999999999999999999999999999999988732 22578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 166 (238)
. +++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ....+.++|+||||+++
T Consensus 120 ~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l 194 (262)
T cd06613 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITA 194 (262)
T ss_pred C---CceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHH
Confidence 8 999999999999999999999999998865433211 11223478889999998652 12456789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||......... .. ..... .. ..........+.++.+++.+||+.||.+|||++|
T Consensus 195 ~~~~tg~~p~~~~~~~~~~-------~~-~~~~~-~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (262)
T cd06613 195 IELAELQPPMFDLHPMRAL-------FL-ISKSN-FP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256 (262)
T ss_pred HHHHhCCCCCCCCCHHHHH-------HH-HHhcc-CC-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHH
Confidence 9999999998643321110 00 00000 00 0001122345678999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=241.98 Aligned_cols=210 Identities=25% Similarity=0.413 Sum_probs=160.9
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHE 73 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~ 73 (238)
...+.+.+|+++++++ +||||+++++++...+..+++|||+.+++|.+++..... ....++...+..
T Consensus 37 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 116 (270)
T cd05047 37 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116 (270)
T ss_pred HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHH
Confidence 3456888999999999 799999999999999999999999999999998843221 123578899999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.+++.|++|||+. +++|+||||+||++++++.++++|||++....... .......+..|+|||.+... .+
T Consensus 117 ~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~--~~ 188 (270)
T cd05047 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VY 188 (270)
T ss_pred HHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccC--CC
Confidence 999999999999998 99999999999999999999999999875222111 11112245679999988765 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++|+||||+++|+|++ |..||....... .... ........ ....++..+.+++.+||+.||.+
T Consensus 189 ~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~-~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~ 254 (270)
T cd05047 189 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEK-LPQGYRLE------KPLNCDDEVYDLMRQCWREKPYE 254 (270)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHH-HhCCCCCC------CCCcCCHHHHHHHHHHcccChhh
Confidence 889999999999999996 999985432111 1111 11110000 11224567889999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 255 Rps~~~ 260 (270)
T cd05047 255 RPSFAQ 260 (270)
T ss_pred CCCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=246.99 Aligned_cols=203 Identities=23% Similarity=0.255 Sum_probs=157.8
Q ss_pred HHHHHHHHHHhhc---CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 10 EEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 10 ~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.++.+|..+++.. .||||+++++.+.+....++||||+.+|+|.+++ .....+++..+..++.||+.||+|||
T Consensus 38 ~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qil~al~~LH 113 (330)
T cd05586 38 AHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAELVLALEHLH 113 (330)
T ss_pred HHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3455677777665 6999999999999999999999999999998887 33567899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. ..++.++||||||+++
T Consensus 114 ~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil 187 (330)
T cd05586 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLV 187 (330)
T ss_pred HC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCC-CCCCCccceeccccEE
Confidence 99 999999999999999999999999999864322211 11233589999999998653 2468899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+|++|..||........ . ........... ...+++++.+++.+||+.||.+||++
T Consensus 188 ~elltG~~Pf~~~~~~~~-------~-~~i~~~~~~~~------~~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 188 FEMCCGWSPFYAEDTQQM-------Y-RNIAFGKVRFP------KNVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred EEeccCCCCCCCCCHHHH-------H-HHHHcCCCCCC------CccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 999999999865332110 1 11111100000 01256778899999999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=235.37 Aligned_cols=210 Identities=29% Similarity=0.435 Sum_probs=162.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|++++++++||||+++++.+.+ ...++++||+.+|+|.+++.. ..+..++...+..++.+++.||+||
T Consensus 42 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~l 118 (262)
T cd05071 42 TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYV 118 (262)
T ss_pred ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998754 568999999999999998832 2234678899999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||...+. .++.++|+||||++
T Consensus 119 H~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~ 192 (262)
T cd05071 119 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGIL 192 (262)
T ss_pred HHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccC--CCCchhhHHHHHHH
Confidence 999 9999999999999999999999999998755433221 11223366789999988765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++ |..||....... ........... .....++..+.+++.+||+.||++|||+++
T Consensus 193 l~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 252 (262)
T cd05071 193 LTELTTKGRVPYPGMVNRE--------VLDQVERGYRM------PCPPECPESLHDLMCQCWRKEPEERPTFEY 252 (262)
T ss_pred HHHHHcCCCCCCCCCChHH--------HHHHHhcCCCC------CCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 999999 777875432211 11111111100 112345678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=240.21 Aligned_cols=202 Identities=21% Similarity=0.290 Sum_probs=155.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++||||+++++++..+...++||||+.+|+|.+++.. ....+++..+..++.||+.|++|||+
T Consensus 42 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (258)
T cd05078 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED 118 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346788999999999999999999999998999999999999999999832 23468889999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCc--------cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 88 GCDVCILHLDIKPHNILLDHNFV--------PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
. +++||||||+||+++.++. ++++|||.+...... ....++..|+|||.+.+. ..++.++|+
T Consensus 119 ~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~Di 188 (258)
T cd05078 119 K---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENP-QNLSLAADK 188 (258)
T ss_pred C---CeecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCC-CCCCchhhH
Confidence 9 9999999999999987665 588999987544321 123477889999998753 246788999
Q ss_pred ehHHHHHHHHhcCC-CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTGGR-RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||+++|++++|. .|+....... ......... ..+...+.++.+++.+||+.||++|||++|
T Consensus 189 wslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 252 (258)
T cd05078 189 WSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYEDRH--------QLPAPKWTELANLINQCMDYEPDFRPSFRA 252 (258)
T ss_pred HHHHHHHHHHHcCCCCChhhccHHH--------HHHHHHccc--------cCCCCCcHHHHHHHHHHhccChhhCCCHHH
Confidence 99999999999995 4443221111 000111100 111123467899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=248.79 Aligned_cols=154 Identities=22% Similarity=0.356 Sum_probs=131.5
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
....|+.++++++||||+++++++..+...++|++++. ++|.+++. .....+++..+..++.||+.||.|||+.
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~-- 176 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ-- 176 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34679999999999999999999999999999999995 58888773 2346789999999999999999999999
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHh
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll 170 (238)
+|+||||||+||+++.++.++|+|||.+........ .....|+..|+|||.+.+. .++.++||||||+++|+|+
T Consensus 177 -~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 177 -RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEML 250 (357)
T ss_pred -CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999874332221 1223489999999999875 6788999999999999999
Q ss_pred cCCCCC
Q 037755 171 GGRRNS 176 (238)
Q Consensus 171 ~g~~p~ 176 (238)
++..++
T Consensus 251 ~~~~~~ 256 (357)
T PHA03209 251 AYPSTI 256 (357)
T ss_pred HcCCcc
Confidence 866554
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=235.32 Aligned_cols=213 Identities=28% Similarity=0.484 Sum_probs=165.5
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+....+++.+|+.++++++||||+++++++..+...++++||+.+++|.+++.. ..+..++...+..++.+++.|+.
T Consensus 40 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~ 117 (261)
T cd05034 40 PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMA 117 (261)
T ss_pred CCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999998999999999999999998833 23457899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||++ +++|+||+|+||++++++.++++|||.+....... .........+..|+|||.+.+. ..+.++|+||+|
T Consensus 118 ~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG 191 (261)
T cd05034 118 YLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFG 191 (261)
T ss_pred HHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccC--CcCchhHHHHHH
Confidence 99999 99999999999999999999999999987554321 1111122355689999998765 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|++++ |+.||....... ............ .+...+..+.+++.+||+.||++|||++|
T Consensus 192 ~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 253 (261)
T cd05034 192 ILLTEIVTYGRVPYPGMTNRE--------VLEQVERGYRMP------RPPNCPEELYDLMLQCWDKDPEERPTFEY 253 (261)
T ss_pred HHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999998 898885432111 111111110000 01123567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=237.51 Aligned_cols=213 Identities=25% Similarity=0.374 Sum_probs=164.9
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+.+.+|+.++++++|||++++++++......++|+||+.+++|.+++. ....++...+..++.+++.|+.|||++
T Consensus 53 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~- 127 (272)
T cd06629 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLHSK- 127 (272)
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 568889999999999999999999999999999999999999999882 335788999999999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++||||+|+||+++.++.++++|||.+................++..|+|||.+......++.++|+||||+++|++
T Consensus 128 --~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 128 --GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred --CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHH
Confidence 999999999999999999999999999865433221111222347889999999876422478899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|..||....... .. ....... ............++..+.+++.+||+.||++|||++|
T Consensus 206 ~~g~~p~~~~~~~~------~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 206 FAGRRPWSDEEAIA------AM-FKLGNKR--SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred HhCCCCCcCcchHH------HH-HHhhccc--cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 99999985322110 00 0100000 0011111222346788999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=241.65 Aligned_cols=212 Identities=25% Similarity=0.396 Sum_probs=161.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES---RGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....+.+|+.++++++|+||+++++++.+....++++||+.+++|.+++..... ....+++..+..++.+|+.|++|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 52 DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 346789999999999999999999999888899999999999999998843221 12368899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCC---ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNF---VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
||+. +++|+||||+||+++.++ .++|+|||.++................+..|+|||.+.+. .++.++||||
T Consensus 132 LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diws 206 (277)
T cd05036 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWS 206 (277)
T ss_pred HHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHH
Confidence 9999 999999999999998654 5899999998755322211111122245689999998765 6889999999
Q ss_pred HHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++ |..||....... .. .......... .+..++..+.+++.+||+.||++|||++|
T Consensus 207 lG~il~el~~~g~~pf~~~~~~~-------~~-~~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~ 270 (277)
T cd05036 207 FGVLLWEIFSLGYMPYPGRTNQE-------VM-EFVTGGGRLD------PPKGCPGPVYRIMTDCWQHTPEDRPNFAT 270 (277)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHH-------HH-HHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 9999999996 888886433221 11 1111111111 11234667899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=239.70 Aligned_cols=207 Identities=21% Similarity=0.280 Sum_probs=165.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+++++.++||||+++++++.++...++++||+.+++|.+++. ...++...++.++.|++.|+.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~l 114 (274)
T cd06609 40 EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLEYL 114 (274)
T ss_pred chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999999999999999999999882 23789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||++++++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||||++
T Consensus 115 h~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~i 187 (274)
T cd06609 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGIT 187 (274)
T ss_pred HhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccC--CCCchhhHHHHHHH
Confidence 998 999999999999999999999999999876544321 12233478889999999876 57889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHH-HHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESM-IARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ .......... ..... ++..+.+++.+||+.||++|||++|
T Consensus 188 l~~l~tg~~p~~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 188 AIELAKGEPPLSDLHPMRV--------LFLIPKNNPP------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred HHHHHhCCCCcccCchHHH--------HHHhhhcCCC------CCcccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 9999999999964331110 0111111010 11111 5678899999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=250.53 Aligned_cols=209 Identities=23% Similarity=0.246 Sum_probs=161.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++.+++||||+++++.+.++...++||||+++|+|.+++ .....+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~~L~~lH 118 (360)
T cd05627 43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDAIH 118 (360)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999988 33457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc---------------------------------ccccc
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF---------------------------------VSISA 133 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---------------------------------~~~~~ 133 (238)
+. +|+||||||+||+++.++.++|+|||++......... .....
T Consensus 119 ~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (360)
T cd05627 119 QL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYS 195 (360)
T ss_pred HC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccc
Confidence 99 9999999999999999999999999987643221100 00012
Q ss_pred cCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHH
Q 037755 134 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESM 213 (238)
Q Consensus 134 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (238)
..||+.|+|||++.+. .++.++|+|||||++|+|++|..||........ ............... ...
T Consensus 196 ~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~-------~~~i~~~~~~~~~p~----~~~ 262 (360)
T cd05627 196 TVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET-------YRKVMNWKETLVFPP----EVP 262 (360)
T ss_pred cCCCccccCHHHHcCC--CCCCcceeccccceeeecccCCCCCCCCCHHHH-------HHHHHcCCCceecCC----CCC
Confidence 3489999999999876 678899999999999999999999965433211 111111100010000 012
Q ss_pred HHHHHHHHHhhhccCCCCCCCCC
Q 037755 214 IARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 214 ~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+++++.+++.+|+. ||.+|++.
T Consensus 263 ~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 263 ISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCHHHHHHHHHhcc-ChhhcCCC
Confidence 46678889998774 99999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=237.07 Aligned_cols=210 Identities=23% Similarity=0.372 Sum_probs=162.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.+++.++||||+++++++.. ...+++++|+++|+|.+++.. ....++...+..++.|++.||+||
T Consensus 50 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~l 125 (279)
T cd05109 50 PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYL 125 (279)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3345788899999999999999999999875 457799999999999998832 235689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++||||||+||+++.++.++|+|||+++...............++..|+|||...+. .++.++||||||++
T Consensus 126 H~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~ 200 (279)
T cd05109 126 EEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVT 200 (279)
T ss_pred HHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHH
Confidence 999 9999999999999999999999999998765433222112222356789999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++ |..||....... ............. ...++.++.+++.+||+.||++|||+.|
T Consensus 201 l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 260 (279)
T cd05109 201 VWELMTFGAKPYDGIPARE--------IPDLLEKGERLPQ------PPICTIDVYMIMVKCWMIDSECRPRFRE 260 (279)
T ss_pred HHHHHcCCCCCCCCCCHHH--------HHHHHHCCCcCCC------CccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999998 888885422111 1111111111111 1234667899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=247.20 Aligned_cols=213 Identities=28% Similarity=0.453 Sum_probs=161.8
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEE-eCCeeeEEEEeCCCCChhhhccCCCCC-----------------------
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCS-EGSKRALVYEFMPNGSLDRHIFPKESR----------------------- 62 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~----------------------- 62 (238)
..+.+.+|+.+++++ +||||+++++++. .+...++++||+.+++|.+++......
T Consensus 53 ~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (337)
T cd05054 53 EYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132 (337)
T ss_pred HHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccc
Confidence 345678899999999 7999999999875 456788999999999998887432110
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccC
Q 037755 63 ----------------------------------GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN 108 (238)
Q Consensus 63 ----------------------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~ 108 (238)
...+++..+..++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~ 209 (337)
T cd05054 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSEN 209 (337)
T ss_pred cccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCC
Confidence 13678899999999999999999999 99999999999999999
Q ss_pred CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCc
Q 037755 109 FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAY 187 (238)
Q Consensus 109 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~ 187 (238)
+.++|+|||++................++..|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus 210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---- 283 (337)
T cd05054 210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---- 283 (337)
T ss_pred CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----
Confidence 99999999998755333222222233466789999998775 78889999999999999997 998885422111
Q ss_pred chhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 188 FPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
............. .+...++++.+++.+||+.+|++|||+.|
T Consensus 284 ---~~~~~~~~~~~~~------~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 325 (337)
T cd05054 284 ---EFCRRLKEGTRMR------APEYATPEIYSIMLDCWHNNPEDRPTFSE 325 (337)
T ss_pred ---HHHHHHhccCCCC------CCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0111111111110 11234567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=234.66 Aligned_cols=211 Identities=26% Similarity=0.440 Sum_probs=163.7
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+++.+|+.++++++||||+++++++.. ...++++||+.+++|.+++.. ..+..++...+..++.+++.||+|
T Consensus 41 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~ 117 (260)
T cd05067 41 GSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAF 117 (260)
T ss_pred CCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Confidence 34556789999999999999999999998754 578999999999999998732 234578899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+. .++.++|+||||+
T Consensus 118 LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~ 191 (260)
T cd05067 118 IERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 191 (260)
T ss_pred HhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccC--CcCcccchHHHHH
Confidence 9998 999999999999999999999999999865542221 111222356789999998765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++ |+.||....... ........... ......+.++.+++.+||+.||++|||+++
T Consensus 192 ~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05067 192 LLTEIVTYGRIPYPGMTNPE--------VIQNLERGYRM------PRPDNCPEELYELMRLCWKEKPEERPTFEY 252 (260)
T ss_pred HHHHHHhCCCCCCCCCChHH--------HHHHHHcCCCC------CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999998 999986433211 11111111111 111234567999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=243.24 Aligned_cols=212 Identities=26% Similarity=0.413 Sum_probs=162.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC------------------CCCCCCCHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------------------SRGQSCSWE 69 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------------~~~~~~~~~ 69 (238)
..+++.+|+.+++++.||||+++++++.++...++++||+.+++|.+++.... .....+++.
T Consensus 51 ~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 130 (288)
T cd05050 51 MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130 (288)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHH
Confidence 35678899999999999999999999999999999999999999998884221 112347788
Q ss_pred HHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC
Q 037755 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 149 (238)
Q Consensus 70 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 149 (238)
.++.++.+++.||.|||+. +++||||+|+||+++.++.++++|||.+.................+..|+|||.+.+.
T Consensus 131 ~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (288)
T cd05050 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN 207 (288)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence 9999999999999999998 9999999999999999999999999988644332211112222356679999988765
Q ss_pred CCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 150 FGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 150 ~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
.++.++|+||||+++|+|++ |..||....... ........... ..+..++.++.+++.+||+.
T Consensus 208 --~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~ 271 (288)
T cd05050 208 --RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE--------VIYYVRDGNVL------SCPDNCPLELYNLMRLCWSK 271 (288)
T ss_pred --CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCC------CCCCCCCHHHHHHHHHHccc
Confidence 67889999999999999997 777775322111 11111111111 01123567899999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||+.|
T Consensus 272 ~p~~Rpt~~e 281 (288)
T cd05050 272 LPSDRPSFAS 281 (288)
T ss_pred CcccCCCHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=240.74 Aligned_cols=215 Identities=22% Similarity=0.293 Sum_probs=164.4
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
...+++.+|+.+++++ .|+||+++++++.+.. ..++++||+.+++|.+++......+..++...+..++.|++
T Consensus 44 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~ 123 (275)
T cd06608 44 DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123 (275)
T ss_pred hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHH
Confidence 3457899999999999 6999999999986544 58999999999999988744333356889999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC---Cccccc
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCK 156 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~ 156 (238)
.|+.|||+. +++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+.. ..++.+
T Consensus 124 ~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 198 (275)
T cd06608 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDAR 198 (275)
T ss_pred HHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCcccc
Confidence 999999999 999999999999999999999999998865433221 122334888999999875421 245678
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+||||+++|++++|..||........ ... ........ .......+..+.+++.+||+.||++|||+
T Consensus 199 ~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~-~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~ 266 (275)
T cd06608 199 SDVWSLGITAIELADGKPPLCDMHPMRA-------LFK-IPRNPPPT----LKSPENWSKKFNDFISECLIKNYEQRPFM 266 (275)
T ss_pred ccHHHhHHHHHHHHhCCCCccccchHHH-------HHH-hhccCCCC----CCchhhcCHHHHHHHHHHhhcChhhCcCH
Confidence 9999999999999999999863221110 001 11110101 11123366789999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
.|
T Consensus 267 ~~ 268 (275)
T cd06608 267 EE 268 (275)
T ss_pred HH
Confidence 64
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=238.62 Aligned_cols=212 Identities=25% Similarity=0.339 Sum_probs=162.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCC--CHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC--SWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|+.++++++|+||+++++++..+...++++||+.+++|.+++... ...+ +...+..++.|++.|++|
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~ 123 (268)
T cd06624 47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKY 123 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999988322 1334 788889999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||+. +++||||||+||+++. ++.++|+|||.+........ ......++..|+|||.+......++.++|+||+|
T Consensus 124 lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG 198 (268)
T cd06624 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG 198 (268)
T ss_pred HHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHH
Confidence 9998 9999999999999976 67899999998864432221 1122347889999999865433467899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|++++|..||......... .+... ........+..+++++.+++.+||+.+|++|||+.|
T Consensus 199 vvl~~l~~g~~p~~~~~~~~~~----~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 199 CTIVEMATGKPPFIELGEPQAA----MFKVG--------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred HHHHHHHhCCCCCccccChhhh----Hhhhh--------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 9999999999998542211100 00000 000111223346778999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=235.81 Aligned_cols=208 Identities=24% Similarity=0.398 Sum_probs=162.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|++++++++||||+++++++......++++||+.+++|.+++.. ....+++..+..++.+++.++.|||+
T Consensus 35 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~ 111 (250)
T cd05085 35 LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES 111 (250)
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345788999999999999999999999999999999999999999998732 23467899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+. .++.++|+||||+++|
T Consensus 112 ~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~ 185 (250)
T cd05085 112 K---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLW 185 (250)
T ss_pred C---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccC--CCCchhHHHHHHHHHH
Confidence 8 999999999999999999999999998864332211 111122345679999998765 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++ |..||........ .......... .....++..+.+++.+||+.+|++|||+.|
T Consensus 186 ~~~~~g~~p~~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 243 (250)
T cd05085 186 ETFSLGVCPYPGMTNQQA--------REQVEKGYRM------SCPQKCPDDVYKVMQRCWDYKPENRPKFSE 243 (250)
T ss_pred HHhcCCCCCCCCCCHHHH--------HHHHHcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9998 8888864322211 1111111110 011224678899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=237.06 Aligned_cols=206 Identities=27% Similarity=0.415 Sum_probs=160.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEE-EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|+.++++++|+|++++++++ .++...++++||+.+++|.+++.. .....+++..+..++.+++.|++||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~l 118 (256)
T cd05082 41 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL 118 (256)
T ss_pred chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4457889999999999999999999975 556778999999999999998832 2234588899999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++||||||+||+++.++.++++|||.+....... ....++..|+|||.+.+. .++.++|+||||++
T Consensus 119 H~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i 188 (256)
T cd05082 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK--KFSTKSDVWSFGIL 188 (256)
T ss_pred HhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccC--CCCchhhhHHHHHH
Confidence 998 99999999999999999999999999886443322 112255689999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |+.||....... ........... .....+++.+.+++.+||+.||++|||++|
T Consensus 189 ~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 248 (256)
T cd05082 189 LWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKM------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQ 248 (256)
T ss_pred HHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 999997 888875332111 11111111110 111245678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=243.06 Aligned_cols=167 Identities=20% Similarity=0.299 Sum_probs=133.0
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEE--eCCeeeEEEEeCCCCChhhhccCC-----CCCCCCCCHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPK-----ESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
...+.+|+.++++++||||+++++++. .+...++++||+.+ +|.+.+... ......+++..+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 356789999999999999999999884 45678999999864 776665211 1123468889999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEE----ccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCccccc
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILL----DHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~----~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
|.|||+. +++||||||+||++ +.++.++|+|||++.......... ......++..|+|||.+.+. ..++.+
T Consensus 121 L~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 196 (317)
T cd07867 121 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKA 196 (317)
T ss_pred HHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCC-CccCcH
Confidence 9999999 99999999999999 456789999999987554332111 11223478899999998763 356888
Q ss_pred CceehHHHHHHHHhcCCCCCCccc
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
+||||||+++|+|++|..||....
T Consensus 197 ~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 197 IDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHhHHHHHHHHHhCCCCccccc
Confidence 999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=233.81 Aligned_cols=211 Identities=29% Similarity=0.505 Sum_probs=163.7
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+++.+|++++++++|||++++++++......++++||+.+++|.+++.. ....++...+..++.+++.++++
T Consensus 39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~ 115 (256)
T cd05112 39 GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAY 115 (256)
T ss_pred CCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999999999999999988732 23467889999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++|+||||+
T Consensus 116 lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~ 189 (256)
T cd05112 116 LESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGV 189 (256)
T ss_pred HHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccC--CcChHHHHHHHHH
Confidence 9998 999999999999999999999999998865433211 111122356789999998765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++ |..||....... .............. ...+..+.+++.+||+.+|++|||+.|
T Consensus 190 ~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 190 LMWEVFSEGKTPYENRSNSE--------VVETINAGFRLYKP------RLASQSVYELMQHCWKERPEDRPSFSL 250 (256)
T ss_pred HHHHHHcCCCCCCCcCCHHH--------HHHHHhCCCCCCCC------CCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 9999998 888886433211 11111111111111 113567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=237.56 Aligned_cols=206 Identities=20% Similarity=0.296 Sum_probs=165.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+++++++.||||+++++.+.++...++|+||+.+++|.+++. ...++...+..++.+++.|+.+||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh 118 (277)
T cd06640 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLH 118 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999999999999999999999999999882 246888999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++++|||.+........ ......++..|.|||.+.+. ..+.++|+||||+++
T Consensus 119 ~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il 191 (277)
T cd06640 119 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITA 191 (277)
T ss_pred hC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccC--CCccHHHHHHHHHHH
Confidence 98 999999999999999999999999999865433221 11223477889999998765 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||......... ..... .........++..+.+++.+||+.+|++|||++|
T Consensus 192 ~el~tg~~p~~~~~~~~~~--------~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06640 192 IELAKGEPPNSDMHPMRVL--------FLIPK------NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKE 249 (277)
T ss_pred HHHHHCCCCCCCcChHhHh--------hhhhc------CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHH
Confidence 9999999998643221110 00000 0112233456788999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=250.82 Aligned_cols=210 Identities=20% Similarity=0.311 Sum_probs=168.9
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe--eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK--RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
.+....++|..|+.+|+.|+||||++++++|.+... ..+|+|.+..|+|..+. .+.+.+....++.|+.||++|
T Consensus 80 q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkG 155 (632)
T KOG0584|consen 80 QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKG 155 (632)
T ss_pred cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHH
Confidence 345566999999999999999999999999976554 77899999999999998 567789999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|.|||++ +++|+|||||-+||||+ .-|.|||+|+|++.......... ..|||.|+|||.+.- .|....|||
T Consensus 156 L~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks----vIGTPEFMAPEmYEE---~YnE~VDVY 227 (632)
T KOG0584|consen 156 LVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS----VIGTPEFMAPEMYEE---NYNELVDVY 227 (632)
T ss_pred hhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccccce----eccCccccChHHHhh---hcchhhhhh
Confidence 9999996 78899999999999998 46899999999998665543222 359999999999873 678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+.+.||.|+..|+.-+...... =..+..+..+ ..+..--.+++++||.+||.. .++|||+.|
T Consensus 228 aFGMCmLEMvT~eYPYsEC~n~AQI-------YKKV~SGiKP-----~sl~kV~dPevr~fIekCl~~-~~~R~sa~e 292 (632)
T KOG0584|consen 228 AFGMCMLEMVTSEYPYSECTNPAQI-------YKKVTSGIKP-----AALSKVKDPEVREFIEKCLAT-KSERLSAKE 292 (632)
T ss_pred hhhHHHHHHHhccCChhhhCCHHHH-------HHHHHcCCCH-----HHhhccCCHHHHHHHHHHhcC-chhccCHHH
Confidence 9999999999999998655543221 1111111111 111112267899999999999 999999864
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=237.38 Aligned_cols=212 Identities=21% Similarity=0.225 Sum_probs=162.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....+.+|+.+++.++||||+++++.+..+...++++||+++++|.+++ ...+.+++..+..++.+++.|+.|||+
T Consensus 49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~ 124 (267)
T cd06645 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHS 124 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999987 234578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 166 (238)
. +++|+||||+||+++.++.++|+|||.+....... .......|+..|+|||.+... ...++.++|+||||+++
T Consensus 125 ~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il 199 (267)
T cd06645 125 K---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITA 199 (267)
T ss_pred C---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHH
Confidence 9 99999999999999999999999999886443221 112234588999999987421 12467889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ ..... ........... ...++..+.+++.+||+.||++|||++|
T Consensus 200 ~~l~~~~~p~~~~~~~~~---~~~~~---~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 200 IELAELQPPMFDLHPMRA---LFLMT---KSNFQPPKLKD----KMKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred HHHhcCCCCcccccchhh---HHhhh---ccCCCCCcccc----cCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 999999999854322110 00000 00000000000 1124567889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=234.78 Aligned_cols=210 Identities=27% Similarity=0.439 Sum_probs=163.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.++...++++||+++++|.+++.. ....++...+..++.+++.|+++||
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH 123 (267)
T cd05066 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLS 123 (267)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999998832 2346889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+. +++|+||||+||+++.++.++++|||.+........... .....++..|+|||.+.+. .++.++|+||||++
T Consensus 124 ~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~ 198 (267)
T cd05066 124 DM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIV 198 (267)
T ss_pred HC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHH
Confidence 99 999999999999999999999999999876544322111 1111235679999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++ |..||....... ............ ....+++.+.+++.+||+.+|.+|||+.|
T Consensus 199 l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (267)
T cd05066 199 MWEVMSYGERPYWEMSNQD--------VIKAIEEGYRLP------APMDCPAALHQLMLDCWQKDRNERPKFEQ 258 (267)
T ss_pred HHHHhcCCCCCcccCCHHH--------HHHHHhCCCcCC------CCCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence 999886 998885432211 011111111110 11234677899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=239.77 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=155.3
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
..++.+|+.++++++||||+++++++.++...++||||+.+|+|..++.. ....++...+..++.|++.||+|||+.
T Consensus 60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (274)
T cd05076 60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK 136 (274)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 45788899999999999999999999999999999999999999888732 245788999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCC-------ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 89 CDVCILHLDIKPHNILLDHNF-------VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+++||||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+. ..++.++|+||
T Consensus 137 ---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~s 206 (274)
T cd05076 137 ---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWS 206 (274)
T ss_pred ---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHH
Confidence 999999999999997543 3789999987533221 112367889999988653 35788999999
Q ss_pred HHHHHHHHh-cCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMT-GGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+++ +|..||........ .. ........ +....+.+.+++.+||+.+|++|||+.|
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~~----~~----~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~ 268 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSEK----ER----FYEKKHRL--------PEPSCKELATLISQCLTYEPTQRPSFRT 268 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHHH----HH----HHHhccCC--------CCCCChHHHHHHHHHcccChhhCcCHHH
Confidence 999999985 68888854322111 00 00000000 0112346889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=239.43 Aligned_cols=209 Identities=25% Similarity=0.396 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+++.+|++++++++|+||+++++++.+....++++||+.+++|.+++. ....++...+..++.|++.|++|||+.
T Consensus 46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (265)
T cd06631 46 YEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN 121 (265)
T ss_pred HHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678899999999999999999999999999999999999999999882 335688999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc----ccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+++|+||+|+||++++++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+
T Consensus 122 ---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~ 196 (265)
T cd06631 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGC 196 (265)
T ss_pred ---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHH
Confidence 9999999999999999999999999988654321111 111223478899999998775 6778899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++|..||........ ... ....... ....+..++..+.+++.+||+.||++|||+.|
T Consensus 197 ~~~~l~~g~~p~~~~~~~~~------~~~--~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 197 TVFEMATGKPPLASMDRLAA------MFY--IGAHRGL----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred HHHHHHhCCCccccCChHHH------HHH--hhhccCC----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 99999999999964221110 000 0000000 01122345678899999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=236.55 Aligned_cols=218 Identities=21% Similarity=0.354 Sum_probs=162.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+++.+|+++++++.|||++++.+++... ...++++||+++++|.+++.. ....+++..+..++.+++.||+|
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~ 124 (284)
T cd05079 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDY 124 (284)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999988764 568999999999999998832 23468899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||++ +++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. .++.++|+||||
T Consensus 125 lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG 199 (284)
T cd05079 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFG 199 (284)
T ss_pred HHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhh
Confidence 9999 99999999999999999999999999987554332211 11223366789999988765 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccC-------CcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSK-------AYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+++|+++++..|.......... ................. .....++..+.+|+.+||+.||++|||+
T Consensus 200 ~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 273 (284)
T cd05079 200 VTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL------PRPPNCPEEVYQLMRKCWEFQPSKRTTF 273 (284)
T ss_pred hhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC------CCCCCCCHHHHHHHHHHccCCcccCcCH
Confidence 9999999987654322111000 00000111111111111 1112356789999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
+|
T Consensus 274 ~~ 275 (284)
T cd05079 274 QN 275 (284)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=241.84 Aligned_cols=208 Identities=23% Similarity=0.328 Sum_probs=164.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++||||+++++++..+...++|+||+++++|.+++. ...++...+..++.+++.|+.|||
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH 132 (297)
T cd06656 58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLH 132 (297)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345778899999999999999999999999999999999999999999882 246788999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..+.++|+||||+++
T Consensus 133 ~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil 205 (297)
T cd06656 133 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMA 205 (297)
T ss_pred HC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHH
Confidence 98 999999999999999999999999998865433221 11223478899999998775 677899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++|..||............ ........ ..+..++..+.+++.+||+.||++|||++|
T Consensus 206 ~~l~tg~~pf~~~~~~~~~~~~--------~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 206 IEMVEGEPPYLNENPLRALYLI--------ATNGTPEL----QNPERLSAVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred HHHHhCCCCCCCCCcchheeee--------ccCCCCCC----CCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999653322111000 00000000 112345677889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=240.56 Aligned_cols=222 Identities=19% Similarity=0.233 Sum_probs=163.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++++.++...++++||+. ++|.+++.. .....+++..+..++.+++.|++|||+
T Consensus 42 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~ 118 (284)
T cd07860 42 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS 118 (284)
T ss_pred cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999996 588887732 224578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+. ...+.++|+||||+++|
T Consensus 119 ~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ 192 (284)
T cd07860 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFA 192 (284)
T ss_pred C---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHH
Confidence 8 999999999999999999999999998865433221 11222367889999988764 24577899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhh-----------hh---hhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWV-----------SD---QLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~-----------~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
+|++|+.||................ .. ...................+++++.+++.+||+.||++|
T Consensus 193 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07860 193 EMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272 (284)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccC
Confidence 9999999996543221100000000 00 000000000111112223456788999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||++|
T Consensus 273 pt~~~ 277 (284)
T cd07860 273 ISAKA 277 (284)
T ss_pred CCHHH
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=234.91 Aligned_cols=211 Identities=27% Similarity=0.428 Sum_probs=162.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....++|.+|+.++++++||||+++++++.++...++++||+.+++|.+++.. ..+.++...++.++.|++.|++||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~l 122 (269)
T cd05065 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYL 122 (269)
T ss_pred HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33467899999999999999999999999999999999999999999998832 235688999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccC---CccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|+. +++|+||+|+||+++.++.++++|||.+................ .+..|+|||.+.+. .++.++|||||
T Consensus 123 H~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dvwsl 197 (269)
T cd05065 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSY 197 (269)
T ss_pred HHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccC--cccchhhhhhh
Confidence 999 99999999999999999999999999886543322211111111 24579999998765 67889999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|++++ |..||....... ............ ....++..+.+++.+||+.+|++||++.+
T Consensus 198 G~~l~e~l~~g~~p~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (269)
T cd05065 198 GIVMWEVMSYGERPYWDMSNQD--------VINAIEQDYRLP------PPMDCPTALHQLMLDCWQKDRNARPKFGQ 260 (269)
T ss_pred HHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCCcCC------CcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999886 888885432211 111111110000 11234567889999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=256.62 Aligned_cols=225 Identities=17% Similarity=0.195 Sum_probs=158.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR-GQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
.....+.+|+.+|++++||||+++++++......+++++++. ++|..++...... ........+..++.||+.||.||
T Consensus 205 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL 283 (501)
T PHA03210 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI 283 (501)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999985 4776666322211 22334567788999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.++.++|+|||++.......... .....|+..|+|||.+.+. .++.++|||||||+
T Consensus 284 H~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvi 357 (501)
T PHA03210 284 HDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLI 357 (501)
T ss_pred HhC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHH
Confidence 999 99999999999999999999999999987554332211 1223589999999999876 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchh-----------------hhhhhhccCCCc-cccchhH-H-HHHHHHHHHHHHhhh
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPS-----------------WVSDQLNKGGNL-ELRNVTE-I-ESMIARKLCVIGLWC 225 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~-~~~~~~~-~-~~~~~~~l~~li~~c 225 (238)
+|+|++|..++...........+.. ...+.+...... ....... + ...++.++.+++.+|
T Consensus 358 l~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~km 437 (501)
T PHA03210 358 LLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKM 437 (501)
T ss_pred HHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHH
Confidence 9999998754432211110000000 000000000000 0000000 0 112456788899999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||.+|||+.|
T Consensus 438 L~~DP~~Rpsa~e 450 (501)
T PHA03210 438 LTFDWHLRPGAAE 450 (501)
T ss_pred hccCcccCcCHHH
Confidence 9999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=243.47 Aligned_cols=216 Identities=20% Similarity=0.291 Sum_probs=163.5
Q ss_pred cccccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
-+....+-|.+|+.+|.+|+ |.+|+.+++|-..++.+|||||+ ...+|..++.+ +...++.-.++.++.|++.|+
T Consensus 398 ~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~-Gd~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV 473 (677)
T KOG0596|consen 398 ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC-GDIDLNKILKK---KKSIDPDWFLKFYWKQMLLAV 473 (677)
T ss_pred cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec-ccccHHHHHHh---ccCCCchHHHHHHHHHHHHHH
Confidence 45566788999999999996 99999999999999999999996 46699998832 223334347889999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc---------c
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT---------V 153 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---------~ 153 (238)
.++|++ ||||.||||.|+|+- .|.+||+|||++.-..............||+.|++||.+...... .
T Consensus 474 ~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki 549 (677)
T KOG0596|consen 474 KTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKI 549 (677)
T ss_pred HHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceee
Confidence 999999 999999999999987 468999999999877666555555666799999999998653222 5
Q ss_pred cccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
+.++|||||||++|+|+.|+.||..-.... ..+.....-....+....+.. .++.++++.||++||.+|
T Consensus 550 ~r~SDvWSLGCILYqMvYgktPf~~~~n~~------aKl~aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdPkkR 618 (677)
T KOG0596|consen 550 SRKSDVWSLGCILYQMVYGKTPFGQIINQI------AKLHAITDPNHEIEFPDIPEN-----DELIDVMKCCLARDPKKR 618 (677)
T ss_pred cCccchhhhhhHHHHHHhcCCchHHHHHHH------HHHHhhcCCCccccccCCCCc-----hHHHHHHHHHHhcCcccC
Confidence 678999999999999999999996422110 001111111111122221111 128899999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+.|
T Consensus 619 ~si~e 623 (677)
T KOG0596|consen 619 WSIPE 623 (677)
T ss_pred CCcHH
Confidence 99864
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=237.26 Aligned_cols=209 Identities=24% Similarity=0.329 Sum_probs=163.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|++++++++|||++++++.+.. +..+++++||+++++|.+++.. .....+++..+..++.+++.++.+|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~l 118 (257)
T cd08223 41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYL 118 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999998764 4568999999999999988832 2345689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. ..+.++|+||+|++
T Consensus 119 H~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i 191 (257)
T cd08223 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCC 191 (257)
T ss_pred HhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHH
Confidence 999 999999999999999999999999999865533221 11233478899999998775 67788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++++|+.||....... .... ...... ...+..+++.+.+++.+||+.||++|||+.|
T Consensus 192 l~~l~~g~~~~~~~~~~~-------~~~~-~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 192 VYEMATLKHAFNAKDMNS-------LVYR-IIEGKL------PPMPKDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred HHHHHcCCCCCCCCCHHH-------HHHH-HHhcCC------CCCccccCHHHHHHHHHHhccCcccCCCHHH
Confidence 999999999986432111 1111 111110 1122346778999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=239.14 Aligned_cols=210 Identities=23% Similarity=0.285 Sum_probs=164.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++.+......|+|+||+++++|.+++... ....+++..+..++.|++.|+.|||+
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~ 113 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ 113 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3556778999999999999999999999999999999999999999988322 22478999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|
T Consensus 114 ~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~ 185 (277)
T cd05577 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLY 185 (277)
T ss_pred C---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHH
Confidence 9 99999999999999999999999999886543211 11223477889999998765 5788899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|+.||.......... ........ .....+..+++.+.+++.+||+.||++||++.|
T Consensus 186 ~l~~g~~p~~~~~~~~~~~----~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 186 EMIAGRSPFRQRKEKVEKE----ELKRRTLE-------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHhhCCCCCCCCcccccHH----HHHhcccc-------ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 9999999986433211100 00000000 011122335778899999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=232.32 Aligned_cols=209 Identities=24% Similarity=0.424 Sum_probs=162.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+++++++.||||+++++++.+....++++||+.+++|.+++.. ....++...+..++.+++.++.|||+
T Consensus 35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~ 111 (251)
T cd05041 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES 111 (251)
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999999999999999999999999999998832 23467889999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +++||||+|+||+++.++.++|+|||.+.................+..|+|||.+.+. .++.++|+||||+++|
T Consensus 112 ~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~ 186 (251)
T cd05041 112 K---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLW 186 (251)
T ss_pred C---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccC--CCCcchhHHHHHHHHH
Confidence 9 9999999999999999999999999998754322211111122245679999998765 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++ |..||....... ........... ..+...+..+.+++.+||+.+|.+|||+.|
T Consensus 187 ~l~t~~~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 244 (251)
T cd05041 187 ETFSLGDTPYPGMSNQQ--------TRERIESGYRM------PAPQLCPEEIYRLMLQCWAYDPENRPSFSE 244 (251)
T ss_pred HHHhccCCCCccCCHHH--------HHHHHhcCCCC------CCCccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 9998 777775433211 01111111000 011234668999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=246.76 Aligned_cols=216 Identities=19% Similarity=0.255 Sum_probs=157.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
..+++.+|+.++++++||||+++++++... ...+++++++ +++|.+.+ ....++...+..++.|++.|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRG 130 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHH
Confidence 346678999999999999999999987543 3568999988 67998877 23568999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|.|||+. +|+||||||+||+++.++.++|+|||++....... ....++..|+|||.+.+. ..++.++||||
T Consensus 131 L~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~Diws 201 (343)
T cd07878 131 LKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWS 201 (343)
T ss_pred HHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCC-ccCCchhhhHh
Confidence 9999999 99999999999999999999999999987543321 223488999999998763 35778899999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcc--------hhhhhh--------hhccCCCccccchhHHHHHHHHHHHHHHhhh
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYF--------PSWVSD--------QLNKGGNLELRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 225 (238)
||+++|+|++|..||...........+ +..... .....................+.+.+|+.+|
T Consensus 202 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 281 (343)
T cd07878 202 VGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence 999999999999999653321110000 000000 0000000000000111112345688999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||++|||+.|
T Consensus 282 L~~dp~~R~s~~e 294 (343)
T cd07878 282 LVLDSDKRISASE 294 (343)
T ss_pred cCCChhhCCCHHH
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=240.29 Aligned_cols=209 Identities=26% Similarity=0.395 Sum_probs=162.0
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
...+|+.++++++||||+++++++..+...+++|+++.+++|.+++. ....++...+..++.+++.||.+||+.
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~-- 117 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK-- 117 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhhhhhhcccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccc--
Confidence 34569999999999999999999999999999999999999999883 457889999999999999999999999
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceee-cCCCcccccCceehHHHHHHHH
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++|+||||+||+++.++.++|+|||.+...... ........++..|.|||.+. +. ..+.++|+||+|+++|+|
T Consensus 118 -~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l 192 (260)
T PF00069_consen 118 -GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGK--KYTRKSDIWSLGIILYEL 192 (260)
T ss_dssp -TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTS--SBSTHHHHHHHHHHHHHH
T ss_pred -cccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccc
Confidence 9999999999999999999999999998753111 12223445889999999987 44 778899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|..||...........+.......... ...........+.+++.+||+.||++|||+.|
T Consensus 193 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 193 LTGKLPFEESNSDDQLEIIEKILKRPLPS--------SSQQSREKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp HHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred cccccccccccchhhhhhhhhcccccccc--------cccccchhHHHHHHHHHHHccCChhHCcCHHH
Confidence 99999987541111111111110000000 00000011278999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=244.25 Aligned_cols=208 Identities=24% Similarity=0.331 Sum_probs=163.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++.+..+...++++||+.+++|.+++. ...++...+..++.+|+.|+.|||
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH 135 (292)
T cd06658 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLH 135 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999998872 245889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. ..+.++|+||||+++
T Consensus 136 ~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil 208 (292)
T cd06658 136 NQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMV 208 (292)
T ss_pred HC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999998864432221 11223478899999998765 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++|..||........ . ............ ....++..+.+++.+||+.||++|||++|
T Consensus 209 ~el~~g~~p~~~~~~~~~-------~-~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 209 IEMIDGEPPYFNEPPLQA-------M-RRIRDNLPPRVK----DSHKVSSVLRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred HHHHhCCCCCCCCCHHHH-------H-HHHHhcCCCccc----cccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999864322110 0 001000000000 11234667889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=239.12 Aligned_cols=206 Identities=19% Similarity=0.291 Sum_probs=164.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++.+..+...++|+||+.+++|.+++. ...++...+..++.+++.|+.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH 118 (277)
T cd06642 44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLH 118 (277)
T ss_pred HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh
Confidence 345678999999999999999999999999999999999999999998872 356889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||||+++
T Consensus 119 ~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il 191 (277)
T cd06642 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITA 191 (277)
T ss_pred cC---CeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHH
Confidence 98 999999999999999999999999999865433221 11223478889999998775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..|+......... ....... .......++..+.+++.+||+.+|++|||+.|
T Consensus 192 ~el~tg~~p~~~~~~~~~~--------~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 192 IELAKGEPPNSDLHPMRVL--------FLIPKNS------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred HHHHhCCCCCcccchhhHH--------hhhhcCC------CCCCCcccCHHHHHHHHHHccCCcccCcCHHH
Confidence 9999999998643221110 0011110 01112345677899999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=234.76 Aligned_cols=210 Identities=28% Similarity=0.424 Sum_probs=162.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++|||++++.+++......+++|||+.+++|.+++.. ....++...+..++.+++.|++|||
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH 124 (268)
T cd05063 48 KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLS 124 (268)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999998832 2356889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccc-cccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+. +++|+|+||+||+++.++.++++|||++............ .....+..|+|||.+.+. .++.++|+||||++
T Consensus 125 ~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~i 199 (268)
T cd05063 125 DM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIV 199 (268)
T ss_pred HC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHH
Confidence 98 9999999999999999999999999998655433221111 111234579999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++ |..||...... . ............. ...++..+.+++.+||+.||++||++.|
T Consensus 200 l~ell~~g~~p~~~~~~~-------~-~~~~i~~~~~~~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 259 (268)
T cd05063 200 MWEVMSFGERPYWDMSNH-------E-VMKAINDGFRLPA------PMDCPSAVYQLMLQCWQQDRARRPRFVD 259 (268)
T ss_pred HHHHHhCCCCCCCcCCHH-------H-HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 999997 99998543211 1 1111111111110 1134567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=232.94 Aligned_cols=209 Identities=25% Similarity=0.443 Sum_probs=162.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|++++++++|+||+++++.+.+ ...++++||+.+++|.+++.. ..+..++...+..++.+++.|+.||
T Consensus 42 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~l 118 (260)
T cd05073 42 SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFI 118 (260)
T ss_pred hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999887 778999999999999999833 2345678889999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+. ..+.++|+||||++
T Consensus 119 H~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~ 192 (260)
T cd05073 119 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGIL 192 (260)
T ss_pred HhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccC--CcCccccchHHHHH
Confidence 998 999999999999999999999999998865433221 111223356779999998765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+|++++ |..||....... ............ .....+.++.+++.+||+.||++|||+.
T Consensus 193 l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 193 LMEIVTYGRIPYPGMSNPE--------VIRALERGYRMP------RPENCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred HHHHHhcCCCCCCCCCHHH--------HHHHHhCCCCCC------CcccCCHHHHHHHHHHcccCcccCcCHH
Confidence 999998 888886432111 111111111111 1123566789999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=248.70 Aligned_cols=208 Identities=22% Similarity=0.252 Sum_probs=159.4
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|+.+++.++||||+++++.+.++...++||||+.+|+|.+++. ...++...+..++.||+.||+|||+.
T Consensus 87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~ 161 (371)
T cd05622 87 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM 161 (371)
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567889999999999999999999999999999999999999999882 24578889999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC--CcccccCceehHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVL 166 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~l 166 (238)
+|+||||||+||+++.++.++|+|||++........ .......||+.|+|||.+.+.. ..++.++|||||||++
T Consensus 162 ---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvil 237 (371)
T cd05622 162 ---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (371)
T ss_pred ---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHH
Confidence 999999999999999999999999999875533221 1122345899999999987532 2367899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC---CCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD---RPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~---Rps~~ 237 (238)
|+|++|..||....... ................ ...++..+.+++.+||+ +|.. |++++
T Consensus 238 yell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ 299 (371)
T cd05622 238 YEMLVGDTPFYADSLVG-------TYSKIMNHKNSLTFPD----DNDISKEAKNLICAFLT-DREVRLGRNGVE 299 (371)
T ss_pred HHHHhCCCCCCCCCHHH-------HHHHHHcCCCcccCCC----cCCCCHHHHHHHHHHcC-ChhhhcCCCCHH
Confidence 99999999997543221 1111111111111111 12457788999999998 5555 55543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=245.78 Aligned_cols=159 Identities=25% Similarity=0.305 Sum_probs=133.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....+++.+|+.+++.++||||+++++++... ..+++||||+.+ +|.+.+ ...++...+..++.|++
T Consensus 64 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~ 136 (364)
T cd07875 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI------QMELDHERMSYLLYQML 136 (364)
T ss_pred chhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHH------HhcCCHHHHHHHHHHHH
Confidence 34457788999999999999999999987543 457999999965 777766 23578889999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.||+|||++ +|+||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+. .++.++||
T Consensus 137 ~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~Di 208 (364)
T cd07875 137 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDI 208 (364)
T ss_pred HHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCC--CCCchhhH
Confidence 999999999 999999999999999999999999999875433221 1223588999999999875 67889999
Q ss_pred ehHHHHHHHHhcCCCCCCcc
Q 037755 160 YGFGMVLLEMTGGRRNSNLK 179 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~ 179 (238)
|||||++|+|++|+.||...
T Consensus 209 wSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 209 WSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred HhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=240.04 Aligned_cols=212 Identities=21% Similarity=0.294 Sum_probs=162.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.+++.+.||||+++++.+..+...++||||+.+++|...+.+ ....++...+..++.|++.++.|||
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH 127 (292)
T cd06644 51 EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLH 127 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 3457788999999999999999999999999999999999999999887622 2356889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG 163 (238)
+. +++|||++|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. ...++.++|+||||
T Consensus 128 ~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 202 (292)
T cd06644 128 SM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 202 (292)
T ss_pred cC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHH
Confidence 98 99999999999999999999999999876432221 111233478899999998532 12357789999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||....... .... ......... ..+..++.++.+++.+||+.||++||+++|
T Consensus 203 ~il~el~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 203 ITLIEMAQIEPPHHELNPMR-------VLLK-IAKSEPPTL----SQPSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred HHHHHHhcCCCCCccccHHH-------HHHH-HhcCCCccC----CCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 99999999999985432111 0111 111100000 112235567899999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=235.06 Aligned_cols=201 Identities=22% Similarity=0.324 Sum_probs=156.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|+.++++++||||+++++++.. ...++++||+.+++|.+++.. ....++...+..++.||+.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~ 120 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDK 120 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 6788999999999999999999999887 778999999999999998832 122788999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCC-------ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 89 CDVCILHLDIKPHNILLDHNF-------VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+++|+||||+||+++.++ .++++|||.+...... ....++..|+|||.+.+....++.++|+||
T Consensus 121 ---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s 191 (259)
T cd05037 121 ---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWS 191 (259)
T ss_pred ---CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHH
Confidence 999999999999999877 7999999998754331 223366789999998764346788899999
Q ss_pred HHHHHHHHhcC-CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGG-RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|++++| ..||........ ... ....... ... ....+.+++.+||..||.+|||+.|
T Consensus 192 lG~~~~~l~~~~~~p~~~~~~~~~---~~~-----~~~~~~~---~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 192 FGTTLLEICSNGEEPLSTLSSSEK---ERF-----YQDQHRL---PMP-----DCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred HHHHHHHHHhCCCCCcccCCchhH---HHH-----HhcCCCC---CCC-----CchHHHHHHHHHhccChhhCCCHHH
Confidence 99999999994 666654321111 000 0000000 000 0167889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=246.76 Aligned_cols=158 Identities=25% Similarity=0.306 Sum_probs=133.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|+.+++.++||||+++++++... ...+++|||+.+ ++.+.+ ...++...+..++.|++.
T Consensus 58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~l~~~~~~~~~~qi~~ 130 (355)
T cd07874 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI------QMELDHERMSYLLYQMLC 130 (355)
T ss_pred HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHH------hhcCCHHHHHHHHHHHHH
Confidence 3456788999999999999999999988543 357999999965 676666 235788899999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||.|||+. +++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+|
T Consensus 131 aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~Diw 202 (355)
T cd07874 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIW 202 (355)
T ss_pred HHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCC--CCCchhhHH
Confidence 99999999 999999999999999999999999999875433221 1223588999999999875 678899999
Q ss_pred hHHHHHHHHhcCCCCCCcc
Q 037755 161 GFGMVLLEMTGGRRNSNLK 179 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~ 179 (238)
|||+++|+|++|+.||...
T Consensus 203 slG~il~el~~g~~pf~~~ 221 (355)
T cd07874 203 SVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=239.37 Aligned_cols=223 Identities=22% Similarity=0.240 Sum_probs=165.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++..+...++|+||+ +++|.+++.. ....+++..++.++.+++.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH 116 (286)
T cd07832 41 GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMH 116 (286)
T ss_pred hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999999999999999999 9999998732 2367899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+. ...+.++||||+|+++
T Consensus 117 ~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l 191 (286)
T cd07832 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIF 191 (286)
T ss_pred HC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeecc-ccCCchhHHHHHHHHH
Confidence 98 999999999999999999999999998875543321 112233588899999998653 2457889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhh-------hhhhh---ccCCCc-c----ccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSW-------VSDQL---NKGGNL-E----LRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~-~----~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
|+|++|.++|...........+... ..... .+.... . ...........+..+.+++.+||+.||+
T Consensus 192 ~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 271 (286)
T cd07832 192 AELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPS 271 (286)
T ss_pred HHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChh
Confidence 9999998777543321100000000 00000 000000 0 0001112234568899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 272 ~R~~~~~ 278 (286)
T cd07832 272 KRLSAAE 278 (286)
T ss_pred hCCCHHH
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=232.43 Aligned_cols=207 Identities=23% Similarity=0.266 Sum_probs=164.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++.+.++...++++||+.+++|.+++ .+...++...+..++.+++.|++|||
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lH 110 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL----RDRGLFDEYTARFYIACVVLAFEYLH 110 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34578999999999999999999999999999999999999999999988 23356899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++|+|||.+........ .....++..|++||.+.+. .++.++|+||+|+++
T Consensus 111 ~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il 182 (262)
T cd05572 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILL 182 (262)
T ss_pred hC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cccccCCcCccChhHhcCC--CCCChhhhhhhHHHH
Confidence 98 999999999999999999999999999875544321 1122478899999998765 678889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|++++|..||....... ............. ...+...++++.+++.+||+.||++|||+
T Consensus 183 ~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 183 YELLTGRPPFGEDDEDP-----MEIYNDILKGNGK------LEFPNYIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred HHHHhCCCCcCCCCCCH-----HHHHHHHhccCCC------CCCCcccCHHHHHHHHHHccCChhhCcCC
Confidence 99999999996543211 0111111100000 01112236789999999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=235.67 Aligned_cols=214 Identities=22% Similarity=0.336 Sum_probs=163.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCCC----CCCCCHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKESR----GQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~----~~~~~~~~~~~~~~~i~~ 80 (238)
....+.+.+|+.+++.++||||+++++++.. +...+++++|+.+++|.+++...... +..++...++.++.+++.
T Consensus 49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 128 (280)
T cd05043 49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence 3446778899999999999999999998755 56789999999999999988433221 256899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||++ +++|+||+|+||++++++.++++|||+++...............++..|+|||.+.+. .++.++|||
T Consensus 129 ~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~ 203 (280)
T cd05043 129 GMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVW 203 (280)
T ss_pred HHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHH
Confidence 99999998 9999999999999999999999999998754332211111223366789999998765 678899999
Q ss_pred hHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++|++++ |+.||....... +. .......... ....+++++.+++.+||+.||++|||+.|
T Consensus 204 slG~~l~el~~~g~~p~~~~~~~~----~~----~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 268 (280)
T cd05043 204 SFGVLLWELMTLGQTPYVEIDPFE----MA----AYLKDGYRLA------QPINCPDELFAVMACCWALDPEERPSFSQ 268 (280)
T ss_pred HhHHHHHHHhcCCCCCcCcCCHHH----HH----HHHHcCCCCC------CCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99999999998 999886432211 11 1111111100 11224567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=236.32 Aligned_cols=218 Identities=26% Similarity=0.417 Sum_probs=159.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEE--eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|++++++++||||+++++++. +....++++||+.+++|.+++.. ....++...+..++.+++.||.|
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~ 123 (284)
T cd05081 47 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEY 123 (284)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999764 34568999999999999998832 23468899999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccc-cccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||+. +++||||||+||++++++.++|+|||++............ ....++..|+|||.+.+. .++.++|+||||
T Consensus 124 LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 198 (284)
T cd05081 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFG 198 (284)
T ss_pred HHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHH
Confidence 9999 9999999999999999999999999998765433221111 111234569999998765 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccC---C-----cchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSK---A-----YFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+++|+|++|..++......... . ................ .....++..+.+++.+||+.+|++|||
T Consensus 199 ~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt 272 (284)
T cd05081 199 VVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL------PAPPGCPAEIYAIMKECWNNDPSQRPS 272 (284)
T ss_pred HHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcC------CCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999987665432211100 0 0000000111111000 011234567999999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
+.|
T Consensus 273 ~~e 275 (284)
T cd05081 273 FSE 275 (284)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=238.18 Aligned_cols=214 Identities=21% Similarity=0.274 Sum_probs=161.5
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEE-----eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
..+.+.+|+.+++.+ +||||+++++++. .+...+++|||+++++|.+++.........+++..+..++.+++.|
T Consensus 57 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~ 136 (286)
T cd06638 57 IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136 (286)
T ss_pred hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHH
Confidence 346788999999999 6999999999873 4457899999999999998774333345678899999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCc
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSD 158 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~D 158 (238)
+.|||+. +++|||+||+||+++.++.++++|||.+........ ......++..|+|||.+... ...++.++|
T Consensus 137 l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 211 (286)
T cd06638 137 LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211 (286)
T ss_pred HHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhh
Confidence 9999998 999999999999999999999999999875433221 11223488999999987532 124678899
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+||+|+++|+|++|+.||.......... . .......... .+..++..+.+++.+||+.||++|||+.|
T Consensus 212 v~slGvi~~el~~g~~p~~~~~~~~~~~-------~-~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e 279 (286)
T cd06638 212 VWSLGITAIELGDGDPPLADLHPMRALF-------K-IPRNPPPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSD 279 (286)
T ss_pred hhhHHHHHHHHhcCCCCCCCCchhHHHh-------h-ccccCCCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHH
Confidence 9999999999999999986433211100 0 0000000000 11224567899999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=238.85 Aligned_cols=213 Identities=23% Similarity=0.282 Sum_probs=161.5
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
....+++.+|+.+++++ +||||+++++++... ...++++||+.+++|.+++.. .....+++..+..++.|+
T Consensus 43 ~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi 120 (272)
T cd06637 43 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREI 120 (272)
T ss_pred CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHH
Confidence 34567889999999999 699999999998652 468999999999999998832 234568899999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSC 155 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~ 155 (238)
+.|++|||+. +++|+|++|+||+++.++.++|+|||++........ ......|+..|+|||.+.+. ...++.
T Consensus 121 ~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~ 195 (272)
T cd06637 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDF 195 (272)
T ss_pred HHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCc
Confidence 9999999998 999999999999999999999999999865432211 12234488899999998632 124677
Q ss_pred cCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
++|+||+|+++|+|++|..||......... . ....... .......++..+.+|+.+||+.||.+|||
T Consensus 196 ~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~-~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 196 KSDLWSLGITAIEMAEGAPPLCDMHPMRAL------F-LIPRNPA------PRLKSKKWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred hhhHHHHHHHHHHHHhCCCCccccCHHHHH------H-HHhcCCC------CCCCCCCcCHHHHHHHHHHcCCChhhCCC
Confidence 899999999999999999998533211110 0 0000000 00011224567899999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
++|
T Consensus 263 ~~~ 265 (272)
T cd06637 263 TEQ 265 (272)
T ss_pred HHH
Confidence 864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=237.11 Aligned_cols=200 Identities=26% Similarity=0.325 Sum_probs=163.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++.++...++++||+.+++|.+++ .....++...+..++.|++.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~qil~~l~~lH 118 (290)
T cd05580 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLALEYLH 118 (290)
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34577889999999999999999999999999999999999999999988 33467899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+. ..+.++|+||||+++
T Consensus 119 ~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il 188 (290)
T cd05580 119 SL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILI 188 (290)
T ss_pred HC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHH
Confidence 98 9999999999999999999999999998755433 1223488899999998765 667889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|+|++|..||....... ......... ...+..++..+.+++.+||+.||.+|++
T Consensus 189 ~~l~~g~~p~~~~~~~~--------~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~R~~ 242 (290)
T cd05580 189 YEMLAGYPPFFDDNPIQ--------IYEKILEGK-------VRFPSFFSPDAKDLIRNLLQVDLTKRLG 242 (290)
T ss_pred HHHHhCCCCCCCCCHHH--------HHHHHhcCC-------ccCCccCCHHHHHHHHHHccCCHHHccC
Confidence 99999999986433111 011111111 0112234678899999999999999993
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=241.60 Aligned_cols=220 Identities=18% Similarity=0.216 Sum_probs=161.1
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|++++++++||||+++++++.++...++++||+. ++|.+++.. ....+++..++.++.||+.||.|||+.
T Consensus 43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~ 118 (284)
T cd07839 43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH 118 (284)
T ss_pred ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567889999999999999999999999999999999996 478777632 235689999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..++.++|+||||+++|+
T Consensus 119 ---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ 192 (284)
T cd07839 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAE 192 (284)
T ss_pred ---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999875433221 11223478899999988663 246788999999999999
Q ss_pred HhcCCCCCCcccccccC-Ccc-------hhhhhhhhc---cCC-Ccccc---chhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSK-AYF-------PSWVSDQLN---KGG-NLELR---NVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~-~~~-------~~~~~~~~~---~~~-~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
|++|..|+......... ..+ ......... ... ..... ........+++++.+++.+||+.||.+|
T Consensus 193 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07839 193 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQR 272 (284)
T ss_pred HHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhc
Confidence 99999886432221100 000 000000000 000 00000 0011223467789999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||++|
T Consensus 273 ~t~~~ 277 (284)
T cd07839 273 ISAEE 277 (284)
T ss_pred CCHHH
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=236.94 Aligned_cols=212 Identities=24% Similarity=0.399 Sum_probs=161.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------CCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------RGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~ 81 (238)
...++.+|+.+++.++||||+++++++.+....+++|||+.+|+|.+++..... .....+...+..++.+++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence 345688999999999999999999999998999999999999999999843221 12345667889999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+.|||++ +++||||||+||++++++.++++|||.++...............++..|+|||.+.+. .++.++|+||
T Consensus 132 l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dvws 206 (288)
T cd05061 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWS 206 (288)
T ss_pred HHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHH
Confidence 9999999 9999999999999999999999999998754333222112222356789999998765 6788999999
Q ss_pred HHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||+.|
T Consensus 207 lG~~l~el~~~~~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 270 (288)
T cd05061 207 FGVVLWEITSLAEQPYQGLSNEQ--------VLKFVMDGGYLD------QPDNCPERVTDLMRMCWQFNPKMRPTFLE 270 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999998 677775322111 111111111111 11223578999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=263.46 Aligned_cols=213 Identities=26% Similarity=0.431 Sum_probs=171.6
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCC---CCCCCCCCHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK---ESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
+.....+|.+|..+|+.++|||||+++|++-+....++++|||++|+|..++... ..+...++......++.+|++|
T Consensus 735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G 814 (1025)
T KOG1095|consen 735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG 814 (1025)
T ss_pred CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence 4566789999999999999999999999998899999999999999999999443 2225678999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccccccc-CCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
+.||+++ +.|||||..+|+|++....|||+|||+++..-... ....... .-+..|+|||.+... ..+.++|||
T Consensus 815 ~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~-yyr~~~~a~lPvkWm~PEsl~d~--iFtskSDvW 888 (1025)
T KOG1095|consen 815 MNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKD-YYRKHGEAMLPVKWMPPESLKDG--IFTSKSDVW 888 (1025)
T ss_pred hHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhch-heeccCccccceecCCHHHHhhc--ccccccchh
Confidence 9999999 99999999999999999999999999998332222 2222222 456799999999874 789999999
Q ss_pred hHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 161 GFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 161 slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||+++||+++ |..||........ ......+. +-..+..++..+.++|.+||+.+|++||++.
T Consensus 889 sFGVllWEifslG~~PY~~~~n~~v--------~~~~~~gg------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 889 SFGVLLWEIFSLGATPYPSRSNFEV--------LLDVLEGG------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred hhHHHHHHHHhCCCCCCCCcchHHH--------HHHHHhCC------ccCCCCCCChHHHHHHHHHccCChhhCccHH
Confidence 99999999997 5677765443321 12111111 1223355788899999999999999999974
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=240.03 Aligned_cols=212 Identities=21% Similarity=0.301 Sum_probs=164.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++.+..+...+++|||+.+++|.+++.. ....+++..+..++.|++.|+.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh 120 (280)
T cd06611 44 EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLH 120 (280)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999998732 2357899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG 163 (238)
+. +++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+... ....+.++|+||||
T Consensus 121 ~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG 195 (280)
T cd06611 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG 195 (280)
T ss_pred HC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHH
Confidence 99 999999999999999999999999998764433221 11233478899999987532 12356789999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ... ......... ..+..++.++.+++.+||+.||++|||+.+
T Consensus 196 ~il~~l~~g~~p~~~~~~~~~-------~~~-~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (280)
T cd06611 196 ITLIELAQMEPPHHELNPMRV-------LLK-ILKSEPPTL----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAE 258 (280)
T ss_pred HHHHHHHhCCCCcccCCHHHH-------HHH-HhcCCCCCc----CCcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 999999999999864322110 011 111110000 112235667889999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=236.33 Aligned_cols=209 Identities=20% Similarity=0.312 Sum_probs=163.9
Q ss_pred cccHHHHHHHHHHHhhcC---CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
....+++.+|+.+++++. |||++++++++.++...++++||+.+++|.+++. ...+++..+..++.+++.++
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l 114 (277)
T cd06917 40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVAL 114 (277)
T ss_pred chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHH
Confidence 345678889999999996 9999999999999999999999999999998872 23788999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
.|||+. +++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||.+.+. ..++.++|+|||
T Consensus 115 ~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~sl 188 (277)
T cd06917 115 KYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSL 188 (277)
T ss_pred HHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccC-CccccchhHHHH
Confidence 999998 999999999999999999999999998875544321 12233588899999987643 246788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||.......... ........... ....+.++.+++.+||+.||++|||+.|
T Consensus 189 G~~l~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 251 (277)
T cd06917 189 GITIYEMATGNPPYSDVDAFRAMM--------LIPKSKPPRLE-----DNGYSKLLREFVAACLDEEPKERLSAEE 251 (277)
T ss_pred HHHHHHHHhCCCCCCCCChhhhhh--------ccccCCCCCCC-----cccCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 999999999999996432221100 00000000000 1125678899999999999999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=238.47 Aligned_cols=219 Identities=21% Similarity=0.260 Sum_probs=158.9
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
..+.+|++++++++||||+++++++.++...++|+||+.+ +|.+++.. ....++...+..++.|++.||.|||+.
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~- 122 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR- 122 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4567899999999999999999999999999999999975 89887732 234788999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. ..++.++|+||+|+++|+|
T Consensus 123 --~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l 197 (291)
T cd07844 123 --RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEM 197 (291)
T ss_pred --CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998644322211 1222367889999988653 2467889999999999999
Q ss_pred hcCCCCCCcccccccCCc---------chhhhhhhhcc----CCCccccchhHHH---HHHH--HHHHHHHhhhccCCCC
Q 037755 170 TGGRRNSNLKATRSSKAY---------FPSWVSDQLNK----GGNLELRNVTEIE---SMIA--RKLCVIGLWCIQVKPA 231 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~---------~~~~~~~~~~~----~~~~~~~~~~~~~---~~~~--~~l~~li~~cl~~dp~ 231 (238)
++|..||........... ........... ............. ..+. ..+.+++.+||+.||+
T Consensus 198 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 277 (291)
T cd07844 198 ATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPK 277 (291)
T ss_pred HhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcc
Confidence 999999964431100000 00000000000 0000000001111 1122 6788999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 278 ~Rps~~e 284 (291)
T cd07844 278 KRISAAE 284 (291)
T ss_pred cccCHHH
Confidence 9999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=236.07 Aligned_cols=212 Identities=24% Similarity=0.346 Sum_probs=165.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+++++++.||||+++++.+..+...++++||+.+++|.+++... ...++...+..++.+++.|++|||
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH 117 (265)
T cd06605 41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLH 117 (265)
T ss_pred HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHc
Confidence 45578899999999999999999999999999999999999999999988321 167889999999999999999999
Q ss_pred c-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 N-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+ . +++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+. .++.++|+||||++
T Consensus 118 ~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~ 188 (265)
T cd06605 118 EKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLS 188 (265)
T ss_pred CCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCC--CCCchhhHHHHHHH
Confidence 9 8 999999999999999999999999998764432211 114578899999998776 77889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++|..||........ ............ .. ... ....++..+.++|.+||..||++|||+.|
T Consensus 189 l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~-~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (265)
T cd06605 189 LIELATGRFPYPPENDPPD--GIFELLQYIVNE-PP--PRL---PSGKFSPDFQDFVNLCLIKDPRERPSYKE 253 (265)
T ss_pred HHHHHhCCCCCCccccccc--cHHHHHHHHhcC-CC--CCC---ChhhcCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9999999999865432111 000111111111 00 000 01126778999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.43 Aligned_cols=212 Identities=23% Similarity=0.420 Sum_probs=162.6
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHEV 74 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~ 74 (238)
..+++.+|+++++++ .||||+++++++..+...++++||+.+|+|.+++..... ....++...+..+
T Consensus 60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (334)
T cd05100 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139 (334)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 457889999999999 799999999999999999999999999999998844221 1235788889999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+.|++.||.|||++ +++||||||+||+++.++.++|+|||.++...............++..|+|||.+.+. .++
T Consensus 140 ~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~ 214 (334)
T cd05100 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYT 214 (334)
T ss_pred HHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcC
Confidence 99999999999999 9999999999999999999999999998754332211111122345679999998765 678
Q ss_pred ccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
.++||||||+++|+|++ |..||....... .. .......... .+..++..+.+++.+||+.+|++|
T Consensus 215 ~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~-~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~R 280 (334)
T cd05100 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LF-KLLKEGHRMD------KPANCTHELYMIMRECWHAVPSQR 280 (334)
T ss_pred chhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HH-HHHHcCCCCC------CCCCCCHHHHHHHHHHcccChhhC
Confidence 88999999999999998 778775432111 11 1111111111 112345678899999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+.|
T Consensus 281 ps~~e 285 (334)
T cd05100 281 PTFKQ 285 (334)
T ss_pred cCHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=231.39 Aligned_cols=209 Identities=28% Similarity=0.466 Sum_probs=164.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+..++.++|+||+++++++.+.+..++++||+.+++|.+++.... ...+++..+..++.|++.|+++||+
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~ 121 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES 121 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc
Confidence 57789999999999999999999999999999999999999999999883211 1228999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++++|||.+.......... .....++..|+|||.+.+. .++.++|+||+|+++|
T Consensus 122 ~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~ 195 (258)
T smart00219 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-KKGGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLW 195 (258)
T ss_pred C---CeeecccccceEEEccCCeEEEcccCCceecccccccc-cccCCCcccccChHHhccC--CCCcchhHHHHHHHHH
Confidence 9 99999999999999999999999999987665442221 1122367889999988654 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++ |..||...... .... ......... ....++..+.+++.+||+.||++|||+.|
T Consensus 196 ~l~~~g~~p~~~~~~~-------~~~~-~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 196 EIFTLGESPYPGMSNE-------EVLE-YLKKGYRLP------KPENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred HHHhCCCCCCCCCCHH-------HHHH-HHhcCCCCC------CCCcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 9998 77777542111 1111 111111111 11225778999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=236.29 Aligned_cols=211 Identities=23% Similarity=0.392 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+++.+|++++++++|+||+++++++.+....++++||+.+++|.+++. ....+++..+..++.|++.|+.|||+.
T Consensus 47 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~ 122 (268)
T cd06630 47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN 122 (268)
T ss_pred HHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4788999999999999999999999999999999999999999999882 345788999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCC-ccccccccccccCCCCCcc--ccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+++|+||+|+||+++.++ .++|+|||.+......... .......++..|+|||.+.+. .++.++|+||+|++
T Consensus 123 ---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~ 197 (268)
T cd06630 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCV 197 (268)
T ss_pred ---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHH
Confidence 999999999999998765 5899999998655433111 011223478899999998765 66788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++|..||........ . ........ .......+..+++++.+++.+||+.||++|||+.|
T Consensus 198 l~~l~~g~~p~~~~~~~~~---~-~~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 198 IIEMATAKPPWNAEKHSNH---L-ALIFKIAS------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred HHHHHhCCCCCCCCCCcch---H-HHHHHHhc------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 9999999999864322111 0 00000000 01112233456788999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=275.68 Aligned_cols=211 Identities=24% Similarity=0.317 Sum_probs=171.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.....+.+|..++..+.|||+|+++|+=..+..+++.||||.+|+|.+.+ ..+.-.++.....+..|++.|++|||
T Consensus 1276 k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH 1351 (1509)
T KOG4645|consen 1276 KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLH 1351 (1509)
T ss_pred ccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHH
Confidence 34466789999999999999999999999999999999999999999988 45667788888889999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCC-CcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNF-GTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG 163 (238)
++ |||||||||.||+++.+|.+|++|||.+........+. ......||+.|+|||++.+.. -....+.||||||
T Consensus 1352 ~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslG 1428 (1509)
T KOG4645|consen 1352 EH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLG 1428 (1509)
T ss_pred hc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhccc
Confidence 99 99999999999999999999999999998665543221 122345999999999998754 2466789999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
||..||+||+.||........ +...+.. ...+.++..++.+-.+|+..||+.||++|.++.
T Consensus 1429 CVVlEM~tGkrPW~~~dne~a-------IMy~V~~------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1429 CVVLEMATGKRPWAELDNEWA-------IMYHVAA------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred ceEEEeecCCCchhhccchhH-------HHhHHhc------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 999999999999964333221 1111111 222334455888889999999999999998874
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=233.46 Aligned_cols=208 Identities=24% Similarity=0.402 Sum_probs=161.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++++.. ...++++||+.+|+|.+++.. ....+++..+..++.|++.|++|||+
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~ 127 (279)
T cd05057 52 ANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45788899999999999999999999887 788999999999999998832 23468999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||.+................++..|+|||.+... .++.++|+||||+++|
T Consensus 128 ~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~ 202 (279)
T cd05057 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVW 202 (279)
T ss_pred C---CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHH
Confidence 8 9999999999999999999999999998765433222211112245679999988654 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++ |..||....... +............ +...+..+.+++.+||..||++|||+.+
T Consensus 203 el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~ 260 (279)
T cd05057 203 ELMTFGAKPYEGIPAVE--------IPDLLEKGERLPQ------PPICTIDVYMVLVKCWMIDAESRPTFKE 260 (279)
T ss_pred HHhcCCCCCCCCCCHHH--------HHHHHhCCCCCCC------CCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9998 999986533221 1111111111111 1123456888999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=228.00 Aligned_cols=204 Identities=20% Similarity=0.367 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
..++.+|++|-+.|+||||++++++|.+....|+++||...|++...+ +......+++.....+..|++.|+.|+|..
T Consensus 66 ~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L--~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k 143 (281)
T KOG0580|consen 66 EHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDL--QEGRMKRFDEQRAATYIKQLANALLYCHLK 143 (281)
T ss_pred hhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHH--HhcccccccccchhHHHHHHHHHHHHhccC
Confidence 456789999999999999999999999999999999999999999988 333567888999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++||||||+|+|++..+..+++|||-+.-.+... ....+||..|++||...+. ..+...|+|++|++.||
T Consensus 144 ---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~ye 214 (281)
T KOG0580|consen 144 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYE 214 (281)
T ss_pred ---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHH
Confidence 99999999999999999999999999886544322 2344599999999999987 78899999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++.|.+||........ +.... ... ...++.++....++|.+|+..+|.+|.+..|
T Consensus 215 flvg~ppFes~~~~et---YkrI~--------k~~----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~ 269 (281)
T KOG0580|consen 215 FLVGLPPFESQSHSET---YKRIR--------KVD----LKFPSTISGGAADLISRLLVKNPIERLALTE 269 (281)
T ss_pred HHhcCCchhhhhhHHH---HHHHH--------Hcc----ccCCcccChhHHHHHHHHhccCccccccHHH
Confidence 9999999976552221 11110 001 1123667888999999999999999988653
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=242.69 Aligned_cols=208 Identities=24% Similarity=0.334 Sum_probs=164.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.+.||||+++++++..+...++++||+++++|.+.+ ....+++..++.++.|++.|+.|||
T Consensus 60 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH 134 (297)
T cd06659 60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLH 134 (297)
T ss_pred chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHH-----hhcCCCHHHHHHHHHHHHHHHHHHH
Confidence 34677889999999999999999999999999999999999999998877 2356889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++
T Consensus 135 ~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il 207 (297)
T cd06659 135 SQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMV 207 (297)
T ss_pred hC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999998864432211 11223488899999998765 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ ............ .....++..+.+++.+||+.||++|||++|
T Consensus 208 ~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~----~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 208 IEMVDGEPPYFSDSPVQA--------MKRLRDSPPPKL----KNAHKISPVLRDFLERMLTREPQERATAQE 267 (297)
T ss_pred HHHHhCCCCCCCCCHHHH--------HHHHhccCCCCc----cccCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 999999999864322111 001111000000 011234567889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=239.43 Aligned_cols=213 Identities=22% Similarity=0.310 Sum_probs=163.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++.+......++++||+.+++|..++.... ....+++..+..++.+++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH 119 (286)
T cd06622 41 SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLK 119 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 335688899999999999999999999999999999999999999988873221 1347899999999999999999999
Q ss_pred c-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC----cccccCceeh
Q 037755 87 N-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG----TVSCKSDVYG 161 (238)
Q Consensus 87 ~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~~~Di~s 161 (238)
+ . +++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+... .++.++|+||
T Consensus 120 ~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diws 192 (286)
T cd06622 120 EEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192 (286)
T ss_pred hcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHh
Confidence 6 5 899999999999999999999999998865432211 22347788999999865311 3478899999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++|..||........ ...... .... .....+..++.++.+++.+||+.||++||+++|
T Consensus 193 lG~il~~l~~g~~pf~~~~~~~~----~~~~~~-~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (286)
T cd06622 193 LGLSILEMALGRYPYPPETYANI----FAQLSA-IVDG------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ 258 (286)
T ss_pred HHHHHHHHHhCCCCCCCcchhhH----HHHHHH-Hhhc------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999999999999854321110 000000 0000 011122347788999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=231.36 Aligned_cols=208 Identities=24% Similarity=0.334 Sum_probs=164.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++|||++++++.+..+...++|+||+++++|.+++.. ..+..+++..+..++.+++.+++|||
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh 118 (256)
T cd08220 41 DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVH 118 (256)
T ss_pred HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999999833 22456899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccC-CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
++ +++|+||+|+||+++.+ +.++++|||.+......... ....++..|+|||.+.+. ..+.++|+||+|++
T Consensus 119 ~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~ 190 (256)
T cd08220 119 TK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGK--PYNQKSDIWALGCV 190 (256)
T ss_pred hC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc---cccccCCcccCchhccCC--CCCcccchHHHHHH
Confidence 98 99999999999999855 45799999998755433211 223478899999998775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||...... ........... ......+++.+.+++.+||+.||++|||+.|
T Consensus 191 l~~l~~~~~~~~~~~~~-------~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 191 LYELASLKRAFEAANLP-------ALVLKIMSGTF-------APISDRYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred HHHHHhCCCCcccCchH-------HHHHHHHhcCC-------CCCCCCcCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999998543221 11111111100 0111235678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=262.88 Aligned_cols=213 Identities=24% Similarity=0.306 Sum_probs=162.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-------RGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~~~~~~~~~~~~~i~ 79 (238)
...+++.+|++++++++||||+++++++.+++..+++|||++|++|.+++..... ....++...+..++.||+
T Consensus 44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa 123 (932)
T PRK13184 44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123 (932)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999988743211 123456678889999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc----------------cccccccCCccccCCc
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND----------------FVSISATRGTIGYIAP 143 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~----------------~~~~~~~~~~~~~~aP 143 (238)
.||+|||+. +++||||||+||+++.++.++|+|||++........ ........||+.|+||
T Consensus 124 ~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred HHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 999999999 999999999999999999999999999875521110 0001123489999999
Q ss_pred ceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHh
Q 037755 144 ELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223 (238)
Q Consensus 144 E~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 223 (238)
|.+.+. .++.++|||||||++|+|++|..||......... ....... .... .....+++.+.+++.
T Consensus 201 E~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~------~~~~i~~-----P~~~-~p~~~iP~~L~~LI~ 266 (932)
T PRK13184 201 ERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRKIS------YRDVILS-----PIEV-APYREIPPFLSQIAM 266 (932)
T ss_pred HHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh------hhhhccC-----hhhc-cccccCCHHHHHHHH
Confidence 998876 6788999999999999999999999652221100 0000000 0000 001245677889999
Q ss_pred hhccCCCCCCCCC
Q 037755 224 WCIQVKPADRPSM 236 (238)
Q Consensus 224 ~cl~~dp~~Rps~ 236 (238)
+||+.||++||+.
T Consensus 267 rcL~~DP~kR~ss 279 (932)
T PRK13184 267 KALAVDPAERYSS 279 (932)
T ss_pred HHccCChhhCcCH
Confidence 9999999999874
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=241.57 Aligned_cols=226 Identities=19% Similarity=0.245 Sum_probs=163.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++||||+++++++..+...++++||+.++++.+++... ....+++..+..++.|++.||.|||+
T Consensus 42 ~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~ 119 (328)
T cd08226 42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ 119 (328)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4578899999999999999999999999999999999999999999887332 23468899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCcccccCceehH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
. +++||||||+||+++.++.+++.||+.+.......... ......++..|+|||.+.+....++.++|+||+
T Consensus 120 ~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (328)
T cd08226 120 N---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196 (328)
T ss_pred C---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence 8 99999999999999999999999997543221111100 001122456799999987653457889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccC------Ccchhh--------hhh---------------hhccC---CCccccchhHH
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSK------AYFPSW--------VSD---------------QLNKG---GNLELRNVTEI 210 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~------~~~~~~--------~~~---------------~~~~~---~~~~~~~~~~~ 210 (238)
|+++|+|++|..||......... .....+ ... ..... ...........
T Consensus 197 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (328)
T cd08226 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276 (328)
T ss_pred HHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchh
Confidence 99999999999999654321100 000000 000 00000 00000001122
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 211 ESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 211 ~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
...+++.+.+|+.+||+.||++|||++|
T Consensus 277 ~~~~~~~~~~li~~~l~~dP~~Rpta~e 304 (328)
T cd08226 277 SKTFSPAFQNLVELCLQQDPEKRPSASS 304 (328)
T ss_pred hhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence 3457788999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=238.81 Aligned_cols=209 Identities=20% Similarity=0.194 Sum_probs=161.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+++++.++||||+++++.+..+...++++||+.+++|.+++ .....+++..+..++.+++.|++|||+
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~ 119 (305)
T cd05609 44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL----KNIGALPVDMARMYFAETVLALEYLHN 119 (305)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999998 233568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-------------ccccccCCccccCCcceeecCCCccc
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-------------VSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
. +++||||+|+||+++.++.++++|||.+......... .......++..|+|||.+... ..+
T Consensus 120 ~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~ 194 (305)
T cd05609 120 Y---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYG 194 (305)
T ss_pred C---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCC--CCC
Confidence 8 9999999999999999999999999987632111100 000112367789999998765 678
Q ss_pred ccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
.++|+||||+++|++++|..||....... .. ..........+. ....++..+.+++.+||+.||++||
T Consensus 195 ~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~-~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~ 262 (305)
T cd05609 195 KPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LF-GQVISDDIEWPE----GDEALPADAQDLISRLLRQNPLERL 262 (305)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HH-HHHHhcccCCCC----ccccCCHHHHHHHHHHhccChhhcc
Confidence 89999999999999999999986432111 01 111110000001 1123567789999999999999999
Q ss_pred CCC
Q 037755 235 SMT 237 (238)
Q Consensus 235 s~~ 237 (238)
|..
T Consensus 263 ~~~ 265 (305)
T cd05609 263 GTG 265 (305)
T ss_pred Ccc
Confidence 853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=232.75 Aligned_cols=209 Identities=23% Similarity=0.352 Sum_probs=161.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++||||+++++++.+ ...++++||+.+++|.+++.. ....++...+..++.+++.|++||
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~l 123 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYL 123 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998876 457899999999999999832 234689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+... .++.++|+||||++
T Consensus 124 H~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~i 197 (270)
T cd05056 124 ESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVC 197 (270)
T ss_pred HhC---CeeccccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccC--CCCchhhhHHHHHH
Confidence 998 999999999999999999999999998865433321 111222345679999988765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++ |..||........ ........... .+..++..+.+++.+||..+|++|||+.|
T Consensus 198 l~el~~~g~~pf~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 257 (270)
T cd05056 198 MWEILMLGVKPFQGVKNNDV--------IGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSKRPRFTE 257 (270)
T ss_pred HHHHHHcCCCCCCCCCHHHH--------HHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999885 9999864432211 11111111111 11235678999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=231.34 Aligned_cols=205 Identities=29% Similarity=0.471 Sum_probs=162.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.+++.++|+||+++++++.++...++++||+++++|.+++.. .....+++..+..++.|++.|+.|||+
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~ 120 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEE 120 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999999999999999988999999999999999998832 222378999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||.+........ ....+..|+|||.+.+. ..+.++|+||||+++|
T Consensus 121 ~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~ 190 (256)
T cd05039 121 K---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLW 190 (256)
T ss_pred C---CccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHH
Confidence 9 999999999999999999999999999875532211 12245679999988764 6778899999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++ |..||....... ........... ..+..+++.+.+++.+||+.+|++|||++|
T Consensus 191 ~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 191 EIYSFGRVPYPRIPLKD--------VVPHVEKGYRM------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred HHHhcCCCCCCCCCHHH--------HHHHHhcCCCC------CCccCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 9997 888885332111 11111111010 111235678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=239.74 Aligned_cols=221 Identities=21% Similarity=0.301 Sum_probs=164.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+++++.++||||+++++++..+...++++||+.+++|..+. .....++...+..++.+++.|++|||+
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~ 118 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLE----KYPNGLDESRVRKYLFQILRGIEFCHS 118 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999999999999999999998888766 233458999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+|++|+||++++++.++|+|||++........ ......++..|+|||.+.+. ...+.++||||||+++|
T Consensus 119 ~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~ 192 (286)
T cd07846 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVT 192 (286)
T ss_pred C---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHH
Confidence 8 999999999999999999999999999875433221 11223478899999998653 24677899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchh-------hhhhhh---------ccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPS-------WVSDQL---------NKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
+|++|..||...........+.. ...... .................++..+.+++.+||+.||+
T Consensus 193 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 272 (286)
T cd07846 193 EMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPD 272 (286)
T ss_pred HHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcc
Confidence 99999988864432110000000 000000 00000000011111234577899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 273 ~Rp~~~~ 279 (286)
T cd07846 273 DRPSSSQ 279 (286)
T ss_pred cchhHHH
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=237.61 Aligned_cols=208 Identities=23% Similarity=0.326 Sum_probs=163.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++||||+++++++..+...++++||+.+++|.+++. ...++...+..++.+++.|+++||
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH 132 (285)
T cd06648 58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLAVLKALSFLH 132 (285)
T ss_pred hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999882 256889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++||||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+. .++.++|+||+|+++
T Consensus 133 ~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l 205 (285)
T cd06648 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMV 205 (285)
T ss_pred hC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCC--CCCCcccHHHHHHHH
Confidence 99 99999999999999999999999999876443221 111223488899999998765 578899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ . ............ ....++..+.+++.+||+.||++|||+.|
T Consensus 206 ~ell~g~~p~~~~~~~~~-------~-~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 206 IEMVDGEPPYFNEPPLQA-------M-KRIRDNLPPKLK----NLHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred HHHHhCCCCCcCCCHHHH-------H-HHHHhcCCCCCc----ccccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 999999999864322110 0 011111000110 11225678999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=238.04 Aligned_cols=214 Identities=23% Similarity=0.282 Sum_probs=161.9
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
..+.+.+|+.+++++ +|||++++++++... ...++|+||+.+++|.+++......+..+++..++.++.+++.|
T Consensus 61 ~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 140 (291)
T cd06639 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140 (291)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Confidence 346778999999999 799999999988643 36899999999999998874333345678999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC---CcccccCc
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSD 158 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~D 158 (238)
++|||+. +++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.... ...+.++|
T Consensus 141 l~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 215 (291)
T cd06639 141 LQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCD 215 (291)
T ss_pred HHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccc
Confidence 9999998 999999999999999999999999998875433221 112234788999999876431 13578999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+||||+++|+|++|+.||........ ... ........... .......+.+++.+||+.||++|||+.|
T Consensus 216 i~slGvi~~el~~g~~p~~~~~~~~~-------~~~-~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 216 VWSLGITAIELGDGDPPLFDMHPVKT-------LFK-IPRNPPPTLLH----PEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred hHHHHHHHHHHhhCCCCCCCCcHHHH-------HHH-HhcCCCCCCCc----ccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 99999999999999999864322111 001 11111111111 1234557899999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=236.69 Aligned_cols=210 Identities=24% Similarity=0.388 Sum_probs=163.9
Q ss_pred cHHHHHHHHHHHhh-cCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...++.+|+.++.+ ++||||+++++++.++...++++||+.+++|.+.+.........++...++.++.+++.++.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 44667789988875 68999999999999999999999999999998887433334567899999999999999999999
Q ss_pred c-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 N-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+ . +++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. ..+.++|+||||++
T Consensus 131 ~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~l 202 (269)
T cd08528 131 KEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCI 202 (269)
T ss_pred cCC---ceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHH
Confidence 6 5 89999999999999999999999999987544332 22334588899999999765 57889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++|..||....... .... ......... ....+++.+.+++.+||+.||++|||+.|
T Consensus 203 l~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 262 (269)
T cd08528 203 LYQMCTLQPPFYSTNMLS-------LATK-IVEAVYEPL-----PEGMYSEDVTDVITSCLTPDAEARPDIIQ 262 (269)
T ss_pred HHHHHhCCCcccccCHHH-------HHHH-HhhccCCcC-----CcccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence 999999999985432211 0111 111100000 01234678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=237.79 Aligned_cols=212 Identities=22% Similarity=0.280 Sum_probs=161.1
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEE------eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCS------EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....++..|+.+++++ .||||+++++++. .+...+++|||+.+|+|.+++.. .....+++..++.++.|++
T Consensus 54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~ 131 (282)
T cd06636 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN--TKGNALKEDWIAYICREIL 131 (282)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHH
Confidence 4456788999999999 6999999999884 34678999999999999998832 2345688888999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCccccc
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCK 156 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~ 156 (238)
.|+.|||+. +++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+... ...++.+
T Consensus 132 ~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~ 206 (282)
T cd06636 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYR 206 (282)
T ss_pred HHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcc
Confidence 999999998 999999999999999999999999998764432211 11233488899999987532 1246778
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+||||+++|+|++|..||.......... ..... .........++.++.+++.+||+.||.+|||+
T Consensus 207 ~DvwslG~~l~el~~g~~p~~~~~~~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (282)
T cd06636 207 SDIWSLGITAIEMAEGAPPLCDMHPMRALF--------LIPRN-----PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST 273 (282)
T ss_pred cchhHHHHHHHHHHhCCCCccccCHHhhhh--------hHhhC-----CCCCCcccccCHHHHHHHHHHhCCChhhCcCH
Confidence 999999999999999999985432211100 00000 00111123456789999999999999999997
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
.|
T Consensus 274 ~e 275 (282)
T cd06636 274 EQ 275 (282)
T ss_pred HH
Confidence 54
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=235.11 Aligned_cols=209 Identities=24% Similarity=0.336 Sum_probs=165.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.++++++||||+++.+++.++...++++||+.+++|.+.+.. .....+++..+..++.+++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (256)
T cd08218 41 KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH 118 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999988732 22346788999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+. ..+.++|+||||+++
T Consensus 119 ~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~ 191 (256)
T cd08218 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVL 191 (256)
T ss_pred hC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHH
Confidence 98 9999999999999999999999999988654332211 1223478889999998775 677889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++++|..||...... ......... .. ...+..++.++.+++.+||+.+|++|||+.|
T Consensus 192 ~~l~~g~~~~~~~~~~-------~~~~~~~~~-~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 192 YEMCTLKHAFEAGNMK-------NLVLKIIRG-SY------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred HHHHcCCCCccCCCHH-------HHHHHHhcC-CC------CCCcccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 9999999998543211 111111111 11 1122345778999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=234.64 Aligned_cols=205 Identities=23% Similarity=0.298 Sum_probs=166.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|++++++++||||+++++.+.++...++++||+.+++|.+++. ....++...+..++.+++.|+.|||+
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~ 118 (258)
T cd05578 43 SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHS 118 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 45788999999999999999999999999999999999999999999882 23578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +++|+||+|+||++++++.++|+|||.+....... ......++..|+|||.+... ..+.++|+||||+++|
T Consensus 119 ~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~ 190 (258)
T cd05578 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAY 190 (258)
T ss_pred C---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHccc--CCCCcccchhhHHHHH
Confidence 9 99999999999999999999999999887554432 11233478899999998775 5788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|++|..||....... .......... .....+...+..+.+++.+||+.||.+||++
T Consensus 191 ~l~~g~~p~~~~~~~~-----~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 191 ECLRGKRPYRGHSRTI-----RDQIRAKQET-------ADVLYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred HHHhCCCCCCCCCccH-----HHHHHHHhcc-------ccccCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 9999999987544321 1111111111 1111223356889999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=238.93 Aligned_cols=208 Identities=25% Similarity=0.271 Sum_probs=163.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+++++.++||||+++++.+..+...++++||+.+++|.+++.. ..+..+++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~ 121 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL 121 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999998732 234678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc---------------------------cccccCCcccc
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV---------------------------SISATRGTIGY 140 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~ 140 (238)
. +++|+||||+||+++.++.++|+|||.+.......... ......|+..|
T Consensus 122 ~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y 198 (316)
T cd05574 122 L---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEY 198 (316)
T ss_pred C---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCC
Confidence 8 99999999999999999999999999876443321110 01122478889
Q ss_pred CCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHH
Q 037755 141 IAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCV 220 (238)
Q Consensus 141 ~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 220 (238)
+|||.+.+. ..+.++||||||+++|+|++|..||........ .......... ... ...+++.+.+
T Consensus 199 ~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~--~~~----~~~~~~~~~~ 263 (316)
T cd05574 199 IAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-------FSNILKKEVT--FPG----SPPVSSSARD 263 (316)
T ss_pred cCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-------HHHHhcCCcc--CCC----ccccCHHHHH
Confidence 999999875 678899999999999999999999864432211 0111111000 000 1116788999
Q ss_pred HHhhhccCCCCCCCC
Q 037755 221 IGLWCIQVKPADRPS 235 (238)
Q Consensus 221 li~~cl~~dp~~Rps 235 (238)
++.+||+.||++|||
T Consensus 264 li~~~l~~~p~~R~s 278 (316)
T cd05574 264 LIRKLLVKDPSKRLG 278 (316)
T ss_pred HHHHHccCCHhHCCC
Confidence 999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=234.49 Aligned_cols=208 Identities=23% Similarity=0.301 Sum_probs=159.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+.+.+|+.++++++||||+++++++.+ +...++++||+.+++|.+++. ....++...++.++.|++.|++||
T Consensus 47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~L 122 (266)
T cd06651 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYL 122 (266)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999998865 467889999999999999882 334688899999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+. ..+.++|+||+|+
T Consensus 123 H~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~ 197 (266)
T cd06651 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGC 197 (266)
T ss_pred HhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHH
Confidence 998 9999999999999999999999999988644321111 111223478899999998765 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++|+.||....... .......... ....+..+++.+.+++ +||..||++|||++|
T Consensus 198 i~~el~~g~~pf~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 198 TVVEMLTEKPPWAEYEAMA-------AIFKIATQPT------NPQLPSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred HHHHHHHCCCCccccchHH-------HHHHHhcCCC------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 9999999999986321111 0111111100 1122344566777888 688899999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=234.75 Aligned_cols=208 Identities=25% Similarity=0.357 Sum_probs=165.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+++++.++||||+++++++.++...++++||+++++|.+++. ....++...+..++.+++.|++|||
T Consensus 44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH 119 (258)
T cd06632 44 EAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLH 119 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999999999999999999999999999882 3356889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.... ..+.++|+||||+++
T Consensus 120 ~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l 192 (258)
T cd06632 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTV 192 (258)
T ss_pred HC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHH
Confidence 99 99999999999999999999999999886543322 112334788899999986641 378889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++|..||....... ......... .....+..+++.+.+++.+||+.||++|||++|
T Consensus 193 ~~l~~g~~pf~~~~~~~-------~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 251 (258)
T cd06632 193 LEMATGKPPWSQLEGVA-------AVFKIGRSK------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251 (258)
T ss_pred HHHHhCCCCcccCcHHH-------HHHHHHhcc------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHH
Confidence 99999999986433111 000000000 011122345778899999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=252.02 Aligned_cols=205 Identities=23% Similarity=0.332 Sum_probs=168.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
+--+++.+||..|+++.|||++.+-|+|-.+...|+|||||- ||..|.+ .-..+++.+-.+..|+.+.+.||+|||
T Consensus 68 EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLH 143 (948)
T KOG0577|consen 68 EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLH 143 (948)
T ss_pred HHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHH
Confidence 334678899999999999999999999999999999999995 5888877 334688999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeec-CCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~slG~~ 165 (238)
+. +.+|||||..|||+++.|.|||+|||.+........ ..||+.|+|||++.. ..+.|+-++||||||++
T Consensus 144 S~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns------FvGTPywMAPEVILAMDEGqYdgkvDvWSLGIT 214 (948)
T KOG0577|consen 144 SH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 214 (948)
T ss_pred Hh---hHHhhhccccceEecCCCeeeeccccchhhcCchhc------ccCCccccchhHheeccccccCCccceeeccch
Confidence 99 999999999999999999999999999876655443 349999999999765 23467889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+.++...++|......... ...+.....+-+. ..+-+..+.+|+-+||+.-|.+|||.+
T Consensus 215 CIELAERkPPlFnMNAMSA--------LYHIAQNesPtLq-----s~eWS~~F~~Fvd~CLqKipqeRptse 273 (948)
T KOG0577|consen 215 CIELAERKPPLFNMNAMSA--------LYHIAQNESPTLQ-----SNEWSDYFRNFVDSCLQKIPQERPTSE 273 (948)
T ss_pred hhhhhhcCCCccCchHHHH--------HHHHHhcCCCCCC-----CchhHHHHHHHHHHHHhhCcccCCcHH
Confidence 9999999999865443321 1222222222222 245677899999999999999999975
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=238.48 Aligned_cols=220 Identities=21% Similarity=0.264 Sum_probs=162.3
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|++++++++|+||+++++++.++...++|+||+ +++|.+++.. ....+++..+..++.||+.||.|||++
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456778999999999999999999999999999999999 8899998832 113789999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..++.++|+||||+++|+
T Consensus 122 ---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e 195 (298)
T cd07841 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAE 195 (298)
T ss_pred ---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999875544321 11223467789999988553 256788999999999999
Q ss_pred HhcCCCCCCcccccccCCcc--------hhhhhhh--hccC---CCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYF--------PSWVSDQ--LNKG---GNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~--------~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|++|.++|............ ....... .... ...............+..+.+++.+||+.||++|||
T Consensus 196 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 275 (298)
T cd07841 196 LLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275 (298)
T ss_pred HHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC
Confidence 99997777543321100000 0000000 0000 000001111222345678999999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
++|
T Consensus 276 ~~e 278 (298)
T cd07841 276 ARQ 278 (298)
T ss_pred HHH
Confidence 864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=239.06 Aligned_cols=171 Identities=22% Similarity=0.306 Sum_probs=138.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKE-SRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
...+.+.+|+.++++++||||+++++++.+. ...++|+||+++ ++.+.+.... .....+++..++.++.|++.|+.
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 122 (316)
T cd07842 44 GISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122 (316)
T ss_pred CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999887 789999999965 6766653222 22347899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEcc----CCccccccccccccCCCCCc-cccccccCCccccCCcceeecCCCcccccCc
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDH----NFVPNVSDFGLAKFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~----~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|||+. +++||||||+||+++. ++.++|+|||++........ ........++..|+|||.+.+. ..++.++|
T Consensus 123 ~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 198 (316)
T cd07842 123 YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAID 198 (316)
T ss_pred HHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHH
Confidence 99999 9999999999999999 89999999999876544332 1112223478889999987653 24678899
Q ss_pred eehHHHHHHHHhcCCCCCCccccc
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATR 182 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~ 182 (238)
+||||+++|+|++|+.||......
T Consensus 199 v~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 199 IWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred HHHHHHHHHHHHhcCCCCcCCccc
Confidence 999999999999999999765444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=230.20 Aligned_cols=209 Identities=25% Similarity=0.381 Sum_probs=156.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEE-eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|+.+++.++||||+++++++. .+...++++||+.+++|.+++.. .....+...+..++.+++.|++|||
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH 115 (262)
T cd05058 39 EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLA 115 (262)
T ss_pred HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4568889999999999999999999764 45678899999999999998832 2234667788899999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc--cccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+. +++||||||+||++++++.++|+|||.+........ ........++..|+|||.+.+. .++.++||||||+
T Consensus 116 ~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ 190 (262)
T cd05058 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGV 190 (262)
T ss_pred hC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC--ccchHHHHHHHHH
Confidence 98 999999999999999999999999999864432211 0111122356789999988765 6788999999999
Q ss_pred HHHHHhcCC-CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGR-RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|. +||...... .... ......... .+...++.+.+++.+||+.+|++|||+.|
T Consensus 191 ~l~el~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 251 (262)
T cd05058 191 LLWELMTRGAPPYPDVDSF-------DITV-YLLQGRRLL------QPEYCPDPLYEVMLSCWHPKPEMRPTFSE 251 (262)
T ss_pred HHHHHHcCCCCCCCCCCHH-------HHHH-HHhcCCCCC------CCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 999999964 455332111 1111 111111110 01224567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=236.06 Aligned_cols=212 Identities=24% Similarity=0.373 Sum_probs=162.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC-----CCCCCHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR-----GQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l 82 (238)
..+.+.+|++++++++||||+++++++.+....++++||+++++|.+++...... ...++...+..++.+++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 3578999999999999999999999999989999999999999999988432211 12689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+|||++ +++|+||||+||+++.++.++++|||.+....... ........++..|+|||.+.+. ..+.++|+|||
T Consensus 131 ~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~sl 204 (275)
T cd05046 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQED--DFSTKSDVWSF 204 (275)
T ss_pred HHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccC--CCCchhhHHHH
Confidence 999999 99999999999999999999999999876432221 1112223467789999988765 56788999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|++++ |..||....... .. ........... ....++..+.+++.+||+.||++|||+.|
T Consensus 205 G~~l~~l~~~~~~p~~~~~~~~-------~~-~~~~~~~~~~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 268 (275)
T cd05046 205 GVLMWEVFTQGELPFYGLSDEE-------VL-NRLQAGKLELP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSE 268 (275)
T ss_pred HHHHHHHHhCCCCCccccchHH-------HH-HHHHcCCcCCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999999998 777875322111 01 11111000000 01234567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=233.12 Aligned_cols=210 Identities=24% Similarity=0.314 Sum_probs=173.1
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.+.+.+.+.+|+.+++++..|++|++||.|-....+|+|||||..||+.+.+. ..+++++++.+..++...++||.|
T Consensus 68 V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~Y 144 (502)
T KOG0574|consen 68 VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQY 144 (502)
T ss_pred ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHH
Confidence 45678999999999999999999999999988899999999999999999983 456899999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||.. .-+|||||..|||++.+|..||.|||++....+... ....-.||+.|+|||++..- .|...+||||||+
T Consensus 145 LH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGI 217 (502)
T KOG0574|consen 145 LHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGI 217 (502)
T ss_pred HHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhCccccCcccccHHHHHHh--ccchhhhHhhhcc
Confidence 9998 899999999999999999999999999865444321 12334599999999999876 7788899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+..||..|++|+..-++......++.. +.+. -.-+..-+.++.+|+++||-.+|++|-|+
T Consensus 218 TaIEMAEG~PPYsDIHPMRAIFMIPT~----------PPPT--F~KPE~WS~~F~DFi~~CLiK~PE~R~TA 277 (502)
T KOG0574|consen 218 TAIEMAEGRPPYSDIHPMRAIFMIPTK----------PPPT--FKKPEEWSSEFNDFIRSCLIKKPEERKTA 277 (502)
T ss_pred hhhhhhcCCCCcccccccceeEeccCC----------CCCC--CCChHhhhhHHHHHHHHHhcCCHHHHHHH
Confidence 999999999998655444332222221 1111 11234457789999999999999999876
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=228.63 Aligned_cols=204 Identities=29% Similarity=0.470 Sum_probs=159.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++|||++++++++... ..++++||+.+++|.+++... ....++...+..++.|++.|+.|||+
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~ 118 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES 118 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457889999999999999999999998664 579999999999999988332 23468899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|||++|+||+++.++.++|+|||.+....... .....+..|.|||.+.+. .++.++|+||||+++|
T Consensus 119 ~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ 188 (254)
T cd05083 119 K---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLW 188 (254)
T ss_pred C---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHH
Confidence 8 99999999999999999999999999886443221 112345689999988765 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++ |..||....... ............ ....++..+.+++.+||+.+|++|||++|
T Consensus 189 el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 189 EVFSYGRAPYPKMSLKE--------VKECVEKGYRME------PPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred HHHhCCCCCCccCCHHH--------HHHHHhCCCCCC------CCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9997 888885433211 111111111111 11235678899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=235.33 Aligned_cols=212 Identities=22% Similarity=0.341 Sum_probs=167.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEE--eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+++.+|++++++++||||+++++++. .+...++++||+.+++|.+++.........+++..++.++.+++.|+.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~ 119 (265)
T cd08217 40 EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119 (265)
T ss_pred HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 344677889999999999999999999775 345789999999999999988544444568899999999999999999
Q ss_pred HhH-----cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 84 YLH-----NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 84 ~Lh-----~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+|| +. +++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+. ..+.++|
T Consensus 120 ~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~D 192 (265)
T cd08217 120 ECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSD 192 (265)
T ss_pred HHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCC--CCCchhH
Confidence 999 76 9999999999999999999999999998755443321 1223488899999998775 5778899
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+||||+++|+|++|..||....... ......... ....+...+..+.+++.+||+.+|++|||+.|
T Consensus 193 v~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 193 IWSLGCLIYELCALSPPFTARNQLQ--------LASKIKEGK------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred HHHHHHHHHHHHHCCCcccCcCHHH--------HHHHHhcCC------CCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 9999999999999999986533111 111111111 11223346678999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=232.56 Aligned_cols=217 Identities=25% Similarity=0.455 Sum_probs=163.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+.+.+|+++++.+.||||+++++++.. +...++++||+++++|.+++.. ....++...+..++.+++.||.||
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~l 125 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYL 125 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999999877 6689999999999999999832 223689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccc-cccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|++ +++|+||+|+||+++.++.++|+|||.+............ ....++..|.|||.+.+. ..+.++|+||||+
T Consensus 126 H~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~ 200 (284)
T cd05038 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGV 200 (284)
T ss_pred HhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhh
Confidence 999 9999999999999999999999999998766533222111 112355679999988765 6788899999999
Q ss_pred HHHHHhcCCCCCCcccccccCC-------cchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKA-------YFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++|+|++|..|+.......... ................. ....++.++.+++.+||+.||++|||+.
T Consensus 201 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 274 (284)
T cd05038 201 TLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP------RPPSCPDEVYDLMKLCWEAEPQDRPSFA 274 (284)
T ss_pred hhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCC------CCccCCHHHHHHHHHHhccChhhCCCHH
Confidence 9999999998875433222110 00011111111111100 1123456789999999999999999986
Q ss_pred C
Q 037755 238 K 238 (238)
Q Consensus 238 e 238 (238)
|
T Consensus 275 e 275 (284)
T cd05038 275 D 275 (284)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=231.60 Aligned_cols=217 Identities=23% Similarity=0.312 Sum_probs=167.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+++++.++|+|++++++.+..+...++++|++.+++|.+.+..... ...+++..+..++.|++.|+++||+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~ 120 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS 120 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 567899999999999999999999999999999999999999999998833221 2568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
. +++|+|++|+||++++++.++|+|||.+.......... ......++..|+|||.+... ...+.++|+||||++
T Consensus 121 ~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i 196 (267)
T cd06610 121 N---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGIT 196 (267)
T ss_pred C---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHH
Confidence 8 99999999999999999999999999886554433221 11222478899999988654 356788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ + ....... ............+++.+.+++.+||+.||++|||++|
T Consensus 197 ~~~l~~g~~p~~~~~~~~~---~----~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 197 AIELATGAAPYSKYPPMKV---L----MLTLQND--PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred HHHHHhCCCCccccChhhh---H----HHHhcCC--CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999864332210 1 1111110 0000000112345678899999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=237.66 Aligned_cols=213 Identities=17% Similarity=0.178 Sum_probs=159.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++|+||+++++++.++...++||||+.+|+|.+++.. ....+++..+..++.||+.||+|||+
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~ 120 (331)
T cd05597 44 ETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ 120 (331)
T ss_pred hHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346688999999999999999999999999999999999999999998832 24578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~ 164 (238)
. +++||||||+||+++.++.++|+|||++......... ......|++.|+|||.+... ...++.++||||+|+
T Consensus 121 ~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 196 (331)
T cd05597 121 L---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGV 196 (331)
T ss_pred C---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhh
Confidence 9 9999999999999999999999999998644332211 11223489999999998642 124677899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC--CCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD--RPSMT 237 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ 237 (238)
++|+|++|+.||........ ............. ......+++.+.+++.+||..++++ ||++.
T Consensus 197 ~l~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~~~~---~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~ 261 (331)
T cd05597 197 CMYEMLYGETPFYAESLVET-------YGKIMNHKEHFQF---PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQ 261 (331)
T ss_pred HHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCcccC---CCccCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999965332211 1111111000000 1111226778899999988754433 66653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=236.65 Aligned_cols=205 Identities=24% Similarity=0.306 Sum_probs=159.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+++++.++||||+++.+++.++...++|+||+. |++.+.+. .....++...+..++.|++.|+.|||+
T Consensus 58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~ 133 (307)
T cd06607 58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYLHS 133 (307)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44678899999999999999999999999999999999996 57766662 123568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 166 (238)
. +++|+||+|+||+++.++.++|+|||.+....... ...++..|+|||.+.+. ....+.++||||||+++
T Consensus 134 ~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 134 H---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred C---CceecCCCcccEEECCCCCEEEeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 8 99999999999999999999999999886543321 22477889999987531 13567889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ ........... ......+..+.+++.+||+.||++|||+.+
T Consensus 205 ~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 263 (307)
T cd06607 205 IELAERKPPLFNMNAMSA--------LYHIAQNDSPT-----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263 (307)
T ss_pred HHHHcCCCCCCCccHHHH--------HHHHhcCCCCC-----CCchhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence 999999999854322110 00000000000 011235678999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=234.41 Aligned_cols=224 Identities=20% Similarity=0.259 Sum_probs=165.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|++++++++|+||+++++++..+...++++||+.++.+.... .....++...++.++.+++.|++||
T Consensus 41 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~L 116 (288)
T cd07833 41 EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYC 116 (288)
T ss_pred ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334578999999999999999999999999999999999999886666554 2345689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++|+|++|+||++++++.++|+|||.+......... ......++..|+|||.+.+. ..++.++|+||||++
T Consensus 117 H~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~ 191 (288)
T cd07833 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCI 191 (288)
T ss_pred HHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHH
Confidence 999 9999999999999999999999999998765443321 11223477889999998764 356789999999999
Q ss_pred HHHHhcCCCCCCcccccccCCc-------chhhhhhhhcc-----C-CCccccchh----HHHHHHHHHHHHHHhhhccC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAY-------FPSWVSDQLNK-----G-GNLELRNVT----EIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~-----~-~~~~~~~~~----~~~~~~~~~l~~li~~cl~~ 228 (238)
+|+|++|..||........... .+......... . ......... ..+..++.++.+|+.+||+.
T Consensus 192 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 271 (288)
T cd07833 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM 271 (288)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhcc
Confidence 9999999999864432210000 00000000000 0 000000111 11223478899999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||++|
T Consensus 272 ~p~~Rps~~~ 281 (288)
T cd07833 272 DPKERLTCDE 281 (288)
T ss_pred CchhcccHHH
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=234.39 Aligned_cols=207 Identities=24% Similarity=0.417 Sum_probs=158.9
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|+.+++.++||||+++++++... ..+++++|+.+|+|.+++.. ....++...+..++.|++.||.|||++
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~ 128 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER 128 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 34688999999999999999999988654 56789999999999998832 234688899999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+. ..+.++||||||+++|+
T Consensus 129 ---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~e 203 (303)
T cd05110 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWE 203 (303)
T ss_pred ---CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHH
Confidence 9999999999999999999999999998755433222122223356789999998765 67889999999999999
Q ss_pred Hhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 169 MTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 169 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++ |..||....... .............. ..++..+.+++.+||..||++|||++|
T Consensus 204 l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 204 LMTFGGKPYDGIPTRE--------IPDLLEKGERLPQP------PICTIDVYMVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred HHhCCCCCCCCCCHHH--------HHHHHHCCCCCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 997 888885432111 11111111111111 123457889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=240.92 Aligned_cols=212 Identities=23% Similarity=0.393 Sum_probs=161.7
Q ss_pred HHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC--------------------------
Q 037755 9 AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-------------------------- 61 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------------------- 61 (238)
.+.+.+|+++|+++. ||||+++++.+......++|+||+.+|+|.+++.....
T Consensus 84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (401)
T cd05107 84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ 163 (401)
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence 457889999999997 99999999999998999999999999999988843211
Q ss_pred --------------------------------------------------------------------CCCCCCHHHHHH
Q 037755 62 --------------------------------------------------------------------RGQSCSWEKLHE 73 (238)
Q Consensus 62 --------------------------------------------------------------------~~~~~~~~~~~~ 73 (238)
....++...+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 243 (401)
T cd05107 164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG 243 (401)
T ss_pred cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence 112456677888
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.+++.||.|||+. +++||||||+||++++++.++|+|||++................++..|+|||.+.+. .+
T Consensus 244 ~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~ 318 (401)
T cd05107 244 FSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LY 318 (401)
T ss_pred HHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CC
Confidence 999999999999998 9999999999999999999999999998754332221112223467889999998765 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++|+||||+++|+|++ |..||....... ............. .+..++..+.+++.+||+.||.+
T Consensus 319 ~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-------~~~~~~~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~ 385 (401)
T cd05107 319 TTLSDVWSFGILLWEIFTLGGTPYPELPMNE-------QFYNAIKRGYRMA------KPAHASDEIYEIMQKCWEEKFEI 385 (401)
T ss_pred CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-------HHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhH
Confidence 888999999999999998 888875432111 0111111111110 11234678999999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 386 RPs~~e 391 (401)
T cd05107 386 RPDFSQ 391 (401)
T ss_pred CcCHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=239.84 Aligned_cols=223 Identities=18% Similarity=0.231 Sum_probs=163.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEE----eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
...+.+.+|+.++++++||||+++++++. .....++|+||+. ++|.+++ .....+++..+..++.|++.||
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL 120 (334)
T cd07855 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGL 120 (334)
T ss_pred cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999875 3457899999995 5898887 2345689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCCCcccccCcee
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
.|||++ +++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. ..++.++|+|
T Consensus 121 ~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~ 196 (334)
T cd07855 121 KYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMW 196 (334)
T ss_pred HHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCC-cccccccchH
Confidence 999998 99999999999999999999999999986543332211 11223578899999997653 3578899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCc-------chh---------hhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAY-------FPS---------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|||+++|+|++|+.||........... .+. ........................+.++.+++.+
T Consensus 197 slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 276 (334)
T cd07855 197 SVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ 276 (334)
T ss_pred HHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHH
Confidence 999999999999999965432110000 000 0000000001111111122223457889999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 277 ~l~~~P~~Rpt~~~ 290 (334)
T cd07855 277 MLQFDPEERITVEQ 290 (334)
T ss_pred HccCChhhCcCHHH
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=234.64 Aligned_cols=208 Identities=24% Similarity=0.338 Sum_probs=164.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++|||++++++.+..+...++|+||+.+++|.+++. ...++...+..++.+++.|++|||
T Consensus 58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH 132 (293)
T cd06647 58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 132 (293)
T ss_pred hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHH
Confidence 345778999999999999999999999999999999999999999999882 245788899999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+... ..+.++|+||||+++
T Consensus 133 ~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll 205 (293)
T cd06647 133 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMA 205 (293)
T ss_pred hC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999998764433221 11223478889999998765 668899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++|..||............ ........ .....++..+.+++.+||+.+|++||++.|
T Consensus 206 ~~ll~g~~pf~~~~~~~~~~~~--------~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 265 (293)
T cd06647 206 IEMVEGEPPYLNENPLRALYLI--------ATNGTPEL----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265 (293)
T ss_pred HHHHhCCCCCCCCChhhheeeh--------hcCCCCCC----CCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999654322111000 00000000 112235667889999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=229.34 Aligned_cols=211 Identities=22% Similarity=0.331 Sum_probs=168.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|++++++++||||+++++.+... ...++++||+.+++|.+++. ....+++..+..++.+++.++.|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~ 116 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAY 116 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHH
Confidence 3468899999999999999999999999888 89999999999999999882 23488999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++|+|++|+||+++.++.++|+|||.+................++..|.|||.+.+. ..+.++|+||||+
T Consensus 117 lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~ 191 (260)
T cd06606 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGC 191 (260)
T ss_pred HHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHH
Confidence 9998 9999999999999999999999999998765554321112234588899999998775 5788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++|..||....... ... ..... .......+...+..+.+++.+||+.||++|||+.|
T Consensus 192 il~~l~~g~~p~~~~~~~~------~~~-~~~~~-----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 253 (260)
T cd06606 192 TVIEMATGKPPWSELGNPM------AAL-YKIGS-----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253 (260)
T ss_pred HHHHHHhCCCCCCCCCchH------HHH-Hhccc-----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence 9999999999986544110 000 00100 01111222344788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=235.81 Aligned_cols=219 Identities=18% Similarity=0.212 Sum_probs=160.9
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+|+.++++++||||+++++++... ...++++||+.+ +|.+.+.. ....++...+..++.|++.||+|||+
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~ 124 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD 124 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999998776 899999999974 88887732 23468999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. ...+.++|+||+|+++|
T Consensus 125 ~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~ 198 (293)
T cd07843 125 N---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFA 198 (293)
T ss_pred C---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHH
Confidence 9 999999999999999999999999998875544321 11223477889999988764 24578899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhh-------hhhhcc---C--CCccccch----hHHHHH-HHHHHHHHHhhhccCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWV-------SDQLNK---G--GNLELRNV----TEIESM-IARKLCVIGLWCIQVKP 230 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~---~--~~~~~~~~----~~~~~~-~~~~l~~li~~cl~~dp 230 (238)
+|++|..||...........+.... ...... . ........ ...+.. +++.+.+++.+||+.||
T Consensus 199 ~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 278 (293)
T cd07843 199 ELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDP 278 (293)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCc
Confidence 9999999997544322111000000 000000 0 00000000 011111 47778999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||+.|
T Consensus 279 ~~R~t~~e 286 (293)
T cd07843 279 AKRISAED 286 (293)
T ss_pred cccCCHHH
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=244.38 Aligned_cols=198 Identities=22% Similarity=0.301 Sum_probs=159.3
Q ss_pred HHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 10 ~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+-.+|+.++... .||||++..+.+.++.+.|+|||.+.|+-+.+.+. . .+.....+..|+.+|+.|+.|||++
T Consensus 360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~----~-~~~~~~e~~~w~~~lv~Av~~LH~~ 434 (612)
T KOG0603|consen 360 DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIR----S-KPEFCSEASQWAAELVSAVDYLHEQ 434 (612)
T ss_pred cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHH----h-cchhHHHHHHHHHHHHHHHHHHHhc
Confidence 3456678777777 69999999999999999999999999988877772 2 2333377788999999999999999
Q ss_pred CCCceeeeccCCCcEEE-ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 89 CDVCILHLDIKPHNILL-DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
|+||||+||+|||+ ++.++++|+|||.+...... ...++-|..|.|||++... .++.++|+||||+++|
T Consensus 435 ---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy 504 (612)
T KOG0603|consen 435 ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLY 504 (612)
T ss_pred ---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccC--CCCcchhhHHHHHHHH
Confidence 99999999999999 68899999999988654443 2344578899999999965 8999999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||.....+ ..+...+.. ......+++..++|+.+||++||.+||+++|
T Consensus 505 ~ML~G~tp~~~~P~~-------~ei~~~i~~---------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~ 559 (612)
T KOG0603|consen 505 EMLTGRTLFAAHPAG-------IEIHTRIQM---------PKFSECVSDEAKDLLQQLLQVDPALRLGADE 559 (612)
T ss_pred HHHhCCCccccCCch-------HHHHHhhcC---------CccccccCHHHHHHHHHhccCChhhCcChhh
Confidence 999999999654443 001111111 1111668899999999999999999999875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=233.46 Aligned_cols=221 Identities=22% Similarity=0.238 Sum_probs=162.7
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|+++++.++|||++++++++.++...++++||+. ++|.+++... ....+++..+..++.+++.||.|||++
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~ 118 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH 118 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4678899999999999999999999999999999999995 6898887321 224689999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|||++|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. ..++.++|+||||+++|+
T Consensus 119 ---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~ 192 (283)
T cd07835 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAE 192 (283)
T ss_pred ---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999998654332211 1222367889999988653 245778999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhh-------hh-------hhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSW-------VS-------DQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~-------~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
|++|..||...........+... .. ....................++..+.+++.+||+.||++||
T Consensus 193 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 272 (283)
T cd07835 193 MVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI 272 (283)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc
Confidence 99999998654332110000000 00 00000000000111122234567899999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|++|
T Consensus 273 t~~~ 276 (283)
T cd07835 273 SAKA 276 (283)
T ss_pred CHHH
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=229.52 Aligned_cols=208 Identities=23% Similarity=0.261 Sum_probs=164.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++.+..+...++++||+.+++|.+++. ....+++..+..++.|++.||+|||
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~lH 110 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLH 110 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999883 2347899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc------ccccccCCccccCCcceeecCCCcccccCcee
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF------VSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
+. +++|+||+|+||+++.++.++|+|||++......... .......++..|++||..... ..+.++|+|
T Consensus 111 ~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~ 185 (265)
T cd05579 111 SN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWW 185 (265)
T ss_pred Hc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCC--CCCcchhhH
Confidence 98 9999999999999999999999999987644332210 111223477889999998765 578889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|||+++|++++|..||....... .... ........... ...+..+.+++.+||+.+|++|||+
T Consensus 186 slG~~~~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (265)
T cd05579 186 SLGCILYEFLVGIPPFHGETPEE-------IFQN-ILNGKIEWPED-----VEVSDEAIDLISKLLVPDPEKRLGA 248 (265)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HhcCCcCCCcc-----ccCCHHHHHHHHHHhcCCHhhcCCC
Confidence 99999999999999986443221 1111 11111100000 1146788999999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=227.62 Aligned_cols=210 Identities=24% Similarity=0.363 Sum_probs=167.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+..+++++|+|++++++++.....+++++||+.+++|.+++. ....++...+..++.+++.++.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lh 116 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLH 116 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 346789999999999999999999999999999999999999999999983 3367899999999999999999999
Q ss_pred c-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 N-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+ . +++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+... ..+.++|+||||++
T Consensus 117 ~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~i 189 (264)
T cd06623 117 TKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLT 189 (264)
T ss_pred ccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCC--CCCchhhHHHHHHH
Confidence 9 8 9999999999999999999999999988755332221 1123477889999998775 67888999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHH-HHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESM-IARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++++|..||...... .......... .... ...... ++..+.+++.+||+.+|++|||+.|
T Consensus 190 l~~l~tg~~p~~~~~~~----~~~~~~~~~~-~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ 252 (264)
T cd06623 190 LLECALGKFPFLPPGQP----SFFELMQAIC-DGPP------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252 (264)
T ss_pred HHHHHhCCCCCcccccc----CHHHHHHHHh-cCCC------CCCCcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999998654421 0111111111 1000 111122 6778999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=229.38 Aligned_cols=213 Identities=24% Similarity=0.380 Sum_probs=165.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+++.++|+||+++++++.+....++++||+.+++|.+++ ..+..++...+..++.+++.|+.|||+
T Consensus 42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~ 117 (264)
T cd06626 42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHS 117 (264)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHH----hhcCCCChHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999999988 234567889999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc--ccccCCccccCCcceeecCC-CcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG~ 164 (238)
. +++|+||+|+||++++++.++|+|||.+........... .....++..|+|||.+.+.. ...+.++|+||||+
T Consensus 118 ~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194 (264)
T ss_pred C---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence 9 999999999999999999999999999876544332111 11234788999999987652 23788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++|..||........ . ............. ....+++.+.+++.+||+.||.+|||+.|
T Consensus 195 il~~l~~g~~pf~~~~~~~~---~----~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (264)
T cd06626 195 VVLEMATGKRPWSELDNEFQ---I----MFHVGAGHKPPIP----DSLQLSPEGKDFLDRCLESDPKKRPTASE 257 (264)
T ss_pred HHHHHHhCCCCccCCcchHH---H----HHHHhcCCCCCCC----cccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 99999999999964321100 0 0000000000000 01234677889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=230.75 Aligned_cols=208 Identities=20% Similarity=0.238 Sum_probs=160.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+.+.+|+.++++++||||+++++++.+ ...+++++||+++++|.+++. ....++...+..++.+++.||.||
T Consensus 47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~l 122 (265)
T cd06652 47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYL 122 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34688899999999999999999998865 356889999999999999882 334678889999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. ..+.++|+||||+
T Consensus 123 H~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~ 197 (265)
T cd06652 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGC 197 (265)
T ss_pred HhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHH
Confidence 998 9999999999999999999999999988644321111 011223478899999998765 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++|+.||....... ......... .....+..++..+.+++.+||. +|++|||++|
T Consensus 198 il~el~~g~~p~~~~~~~~-------~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 198 TVVEMLTEKPPWAEFEAMA-------AIFKIATQP------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred HHHHHhhCCCCCCccchHH-------HHHHHhcCC------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 9999999999986421111 011111110 0112234566778899999995 9999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=243.49 Aligned_cols=207 Identities=21% Similarity=0.289 Sum_probs=174.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...++++.+|+++|+.|+|||||+++.+.+.+..+|+||||+.+|.+.+++ .+.+.+.+..+..++.|+++|++|+
T Consensus 96 ~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYc 171 (596)
T KOG0586|consen 96 PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYC 171 (596)
T ss_pred hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHH
Confidence 344577899999999999999999999999999999999999999999999 4567777789999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|||||||.+|+|++.+.+++|+|||.+.+....... ...+|++.|.|||++.+. ...++..|+||+|++
T Consensus 172 H~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l---qt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 172 HSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML---QTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVV 244 (596)
T ss_pred hhc---ceeccccchhhcccccccceeeeccccceeecccccc---cccCCCCCccChHhhcCc-ccCCcceehhhhhhh
Confidence 999 9999999999999999999999999999877654433 334599999999999997 367889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|.++.|.-||.+..........- ...-.++.-++-++.++|+++|-.+|.+|+++++
T Consensus 245 ly~LV~GsLPFDG~~lk~Lr~rvl---------------~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dq 302 (596)
T KOG0586|consen 245 LYALVEGSLPFDGQNLKELRPRVL---------------RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQ 302 (596)
T ss_pred heeeeecccccCCcccccccchhe---------------eeeecccceeechhHHHHHHhhccCccccCCHHH
Confidence 999999999998655544332211 1111233445678889999999999999999864
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=233.49 Aligned_cols=209 Identities=26% Similarity=0.344 Sum_probs=164.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++|+|++++++.+..+...++++||+.+++|.+++... ...++...+..++.+++.|+.|||+
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~ 134 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS 134 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4678899999999999999999999999999999999999999999998321 1378999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. |++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..+.++|+||||+++|
T Consensus 135 ~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~ 207 (286)
T cd06614 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCI 207 (286)
T ss_pred C---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHH
Confidence 8 999999999999999999999999998754433221 11223477889999998765 5788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||........ ....... .... ......++..+.+++.+||+.+|.+|||+.|
T Consensus 208 ~l~~g~~p~~~~~~~~~-------~~~~~~~-~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 266 (286)
T cd06614 208 EMAEGEPPYLREPPLRA-------LFLITTK-GIPP----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266 (286)
T ss_pred HHHhCCCCCCCCCHHHH-------HHHHHhc-CCCC----CcchhhCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999999864322211 0000000 0000 0112235678999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=237.50 Aligned_cols=212 Identities=18% Similarity=0.180 Sum_probs=159.6
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|+.+++.++|+||+++++.+.+....++||||+.+|+|.+++.. ....+++..+..++.|++.|+.|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~ 121 (332)
T cd05623 45 TACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL 121 (332)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45578899999999999999999999999999999999999999999832 235688999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceehHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMV 165 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~ 165 (238)
+++||||||+||+++.++.++|+|||++........ .......|++.|+|||++.+. ...++.++|+||||++
T Consensus 122 ---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvi 197 (332)
T cd05623 122 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVC 197 (332)
T ss_pred ---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHH
Confidence 999999999999999999999999998864322221 111233589999999998631 1256788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC--CCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD--RPSMT 237 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ 237 (238)
+|+|++|+.||........ ........... ..+.....+++++.+++.+||..++.+ |+|++
T Consensus 198 l~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~~---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~ 261 (332)
T cd05623 198 MYEMLYGETPFYAESLVET-------YGKIMNHKERF---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIE 261 (332)
T ss_pred HHHHhcCCCCCCCCCHHHH-------HHHHhCCCccc---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence 9999999999964332111 11111111000 011112345778899999999765544 55553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=232.14 Aligned_cols=223 Identities=20% Similarity=0.257 Sum_probs=164.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++++..++..++|+||+.+ +|.+++.... ....+++..+..++.|++.|+.|||+
T Consensus 41 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (284)
T cd07836 41 TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE 118 (284)
T ss_pred chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999975 8888773322 23568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||+|+||++++++.++++|||.+........ ......++..|++||.+.+. ..++.++|+||||+++|
T Consensus 119 ~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~ 192 (284)
T cd07836 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMA 192 (284)
T ss_pred C---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHH
Confidence 8 999999999999999999999999999865433221 11223467889999988653 35678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhh-------hhhhhccC----CCccc---cchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSW-------VSDQLNKG----GNLEL---RNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~----~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
++++|..||...........+... ....+... ..... .........++..+.+++.+||+.||++|
T Consensus 193 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 272 (284)
T cd07836 193 EMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272 (284)
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccC
Confidence 999999998754432110000000 00000000 00000 01112223457789999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||++|
T Consensus 273 ~~~~~ 277 (284)
T cd07836 273 ISAHD 277 (284)
T ss_pred CCHHH
Confidence 99754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=247.28 Aligned_cols=215 Identities=22% Similarity=0.315 Sum_probs=170.3
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+.+..+++.-|++||..+.||+||++++.|..++.+|++.|+|.||.+...+. .-+..+++.++..++++++.||.
T Consensus 68 kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn 144 (1187)
T KOG0579|consen 68 KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALN 144 (1187)
T ss_pred cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHH---HhccccchHHHHHHHHHHHHHHH
Confidence 345667889999999999999999999999988899999999999999988773 23578999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC---CcccccCcee
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVY 160 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~ 160 (238)
|||++ +|+|||||..|||+.-+|.++|.|||++....... .......||+.|+|||+..... ..|+.++|||
T Consensus 145 ~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiW 219 (1187)
T KOG0579|consen 145 WLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIW 219 (1187)
T ss_pred HHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHH
Confidence 99999 99999999999999999999999999986433321 2234456999999999976531 2578899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++.+|..+.+|-..-.+. .+.-.+.....+-+. .++.-+.++.+|+.+||..||..||+++|
T Consensus 220 SlGITLIEMAqiEPPHhelnpM--------RVllKiaKSePPTLl----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaq 285 (1187)
T KOG0579|consen 220 SLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTLL----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQ 285 (1187)
T ss_pred hhhhHHHHHhccCCCccccchH--------HHHHHHhhcCCCccc----CcchhhhHHHHHHHHHHhcCCccCCCHHH
Confidence 9999999999999886432211 111111111111111 23456778899999999999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=227.41 Aligned_cols=208 Identities=25% Similarity=0.394 Sum_probs=165.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+..+++++|||++++++++......++++||+.+++|.+++.. ....++...+..++.+++.++.+||+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 116 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS 116 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc
Confidence 567899999999999999999999999999999999999999999998832 12578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+. ..+.++|+||||+++|
T Consensus 117 ~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~ 188 (253)
T cd05122 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAI 188 (253)
T ss_pred C---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHH
Confidence 8 999999999999999999999999998875544321 1233478899999998775 5788899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||........ ... .......... ....++..+.+++.+||+.||++|||+.|
T Consensus 189 ~l~~g~~p~~~~~~~~~-------~~~-~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 189 ELAEGKPPYSELPPMKA-------LFK-IATNGPPGLR----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred HHHhCCCCCCCCchHHH-------HHH-HHhcCCCCcC----cccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999864321111 000 0000000000 01113677999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=231.88 Aligned_cols=221 Identities=20% Similarity=0.235 Sum_probs=166.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|++++++++|+||+++++++..+...++++||+.+ ++.+++.. ....++...+..++.+++.|+.|||+
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~ 116 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS 116 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999999999999999999965 88887732 23578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||.+........ ......++..|.|||.+.+. ...+.++|+||||+++|
T Consensus 117 ~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~ 190 (283)
T cd05118 117 H---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFA 190 (283)
T ss_pred C---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHH
Confidence 9 999999999999999999999999998865544321 11223477889999988653 35788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcc--------hhh-------hhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYF--------PSW-------VSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~--------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
++++|+.||............ +.. ......................++.++.+++.+||+.||.+
T Consensus 191 ~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 270 (283)
T cd05118 191 ELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270 (283)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCccc
Confidence 999999988654321100000 000 00000000001111123344567889999999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 271 Rp~~~~ 276 (283)
T cd05118 271 RITAEQ 276 (283)
T ss_pred CcCHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=231.83 Aligned_cols=219 Identities=20% Similarity=0.233 Sum_probs=157.3
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
..+.+|+.+++.++|+||+++++++.++...++|+||+. +++.+.+.. ....++...+..++.|++.||.|||+.
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~- 122 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ- 122 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 467899999999999999999999999999999999995 677766622 234577888899999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+. ..++.++|+||||+++|+|
T Consensus 123 --~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l 197 (291)
T cd07870 123 --HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEM 197 (291)
T ss_pred --CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988644332211 1223478899999998753 2467789999999999999
Q ss_pred hcCCCCCCcccccccC-Cc------chh-hhhhhhc---cC-----CCccccchhHHHH--HHHHHHHHHHhhhccCCCC
Q 037755 170 TGGRRNSNLKATRSSK-AY------FPS-WVSDQLN---KG-----GNLELRNVTEIES--MIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~-~~------~~~-~~~~~~~---~~-----~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~ 231 (238)
++|..||......... .. .+. ....... .. ............. ..+..+.+++.+||+.||+
T Consensus 198 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~ 277 (291)
T cd07870 198 LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK 277 (291)
T ss_pred HhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence 9999998643321000 00 000 0000000 00 0000000000000 1246788999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 278 ~R~t~~~ 284 (291)
T cd07870 278 DRISAQD 284 (291)
T ss_pred cCcCHHH
Confidence 9999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=234.09 Aligned_cols=208 Identities=25% Similarity=0.309 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++|+|++++++.+..+...++++||+++++|.+++. ...+++..+..++.+++.+++|||
T Consensus 59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH 133 (292)
T cd06657 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLH 133 (292)
T ss_pred hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999988762 245788999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..+.++|+||+|+++
T Consensus 134 ~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil 206 (292)
T cd06657 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMV 206 (292)
T ss_pred HC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999998765433221 11223478899999988764 567899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||......... ............ ....++..+.+++.+||+.||.+|||+.|
T Consensus 207 ~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 207 IEMVDGEPPYFNEPPLKAM--------KMIRDNLPPKLK----NLHKVSPSLKGFLDRLLVRDPAQRATAAE 266 (292)
T ss_pred HHHHhCCCCCCCCCHHHHH--------HHHHhhCCcccC----CcccCCHHHHHHHHHHHhCCcccCcCHHH
Confidence 9999999998643221110 000000000000 11234667889999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=232.46 Aligned_cols=210 Identities=21% Similarity=0.243 Sum_probs=162.2
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+++++++ +|+||+++++.+..+...++++||+.+++|.+++. ....++...+..++.|++.||.|||
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH 122 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLH 122 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 457788999999999 59999999999999999999999999999999883 3456889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||+|+||+++.++.++|+|||++........ .......++..|+|||.+.......+.++|+||||+++
T Consensus 123 ~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l 198 (290)
T cd05613 123 KL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198 (290)
T ss_pred hC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHH
Confidence 98 999999999999999999999999998865433221 11122347889999999875423567889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+|++|..||........ ........... . ...+..+++.+.+++.+||+.||++||+.
T Consensus 199 ~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~-~-------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 199 YELLTGASPFTVDGEKNS---QAEISRRILKS-E-------PPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred HHHhcCCCCCCcCCcccc---HHHHHHHhhcc-C-------CCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 999999999864322111 11111111110 0 01122356778999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=230.33 Aligned_cols=205 Identities=20% Similarity=0.311 Sum_probs=163.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++.+.++...++|+||+.+++|.+++. ...++...+..++.+++.++.+||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (277)
T cd06641 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS 119 (277)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc
Confidence 45678899999999999999999999999999999999999999998872 3468899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. ..+.++|+||||+++|
T Consensus 120 ~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~ 192 (277)
T cd06641 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAI 192 (277)
T ss_pred C---CeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccC--CCCchhhHHHHHHHHH
Confidence 8 999999999999999999999999998865433211 11223478889999998764 6678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++|..||....... ......... .......++.++.+++.+||+.+|.+||+++|
T Consensus 193 ~l~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 193 ELAKGEPPHSELHPMK--------VLFLIPKNN------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred HHHcCCCCCCccchHH--------HHHHHhcCC------CCCCCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999985422111 001111111 11122345678899999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=237.96 Aligned_cols=222 Identities=21% Similarity=0.262 Sum_probs=159.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....++.+|+.++++++||||+++++++... ...++++||+. ++|.+.+ ....+++..++.++.|++.|
T Consensus 45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~a 118 (336)
T cd07849 45 TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRG 118 (336)
T ss_pred hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHH
Confidence 3456788999999999999999999987543 35799999996 4887776 23578999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|++||+. +++||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+. ..++.++|+|
T Consensus 119 L~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dvw 194 (336)
T cd07849 119 LKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIW 194 (336)
T ss_pred HHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHH
Confidence 9999999 99999999999999999999999999987544322211 11223478899999987542 2567889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcc--------hhhhh--------hhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYF--------PSWVS--------DQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|+|+++|+|++|+.||...........+ ..... .....................+.++.+++.+
T Consensus 195 slGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (336)
T cd07849 195 SVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDK 274 (336)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHH
Confidence 9999999999999999643221100000 00000 0000000000001111223456789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||+.|
T Consensus 275 ~l~~dP~~Rpt~~e 288 (336)
T cd07849 275 MLTFNPHKRITVEE 288 (336)
T ss_pred HcCCChhhCcCHHH
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=233.04 Aligned_cols=211 Identities=21% Similarity=0.263 Sum_probs=163.4
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+++++++ +||||+++++.+..+...++|+||+.+++|.+++. ....+++..+..++.|++.+|.|||
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH 122 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH 122 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHH
Confidence 446788999999999 59999999999999999999999999999998882 3456889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||+|+||+++.++.++++|||++......... ......++..|+|||.+.+.....+.++|+||||+++
T Consensus 123 ~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il 198 (288)
T cd05583 123 QL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198 (288)
T ss_pred HC---CeeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHH
Confidence 98 9999999999999999999999999987654332211 1122347889999999876533467889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||......... ........ ... ...+..++..+.+++.+||+.||++|||+.
T Consensus 199 ~el~tg~~p~~~~~~~~~~---~~~~~~~~-~~~-------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~ 258 (288)
T cd05583 199 FELLTGASPFTVDGEQNSQ---SEISRRIL-KSK-------PPFPKTMSAEARDFIQKLLEKDPKKRLGAN 258 (288)
T ss_pred HHHHhCCCCcccCcccchH---HHHHHHHH-ccC-------CCCCcccCHHHHHHHHHHhcCCHhhccCcc
Confidence 9999999998643222111 11111111 110 111223567789999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=248.79 Aligned_cols=157 Identities=17% Similarity=0.285 Sum_probs=127.8
Q ss_pred HHHHHHHHHHHhhcCCC------cceeeeeEEEeC-CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHV------NVVQLLGFCSEG-SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
...+..|+++++.+.|. +++++++++..+ .+.|+|++++ +++|.+++. ....+++..+..++.||+.|
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~a 243 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVA 243 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHH
Confidence 44567788888887554 588898988654 5788999988 678888872 34578999999999999999
Q ss_pred HHHhHc-CCCCceeeeccCCCcEEEccCC----------------ccccccccccccCCCCCccccccccCCccccCCcc
Q 037755 82 IEYLHN-GCDVCILHLDIKPHNILLDHNF----------------VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 144 (238)
Q Consensus 82 l~~Lh~-~~~~~i~H~dl~p~nil~~~~~----------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 144 (238)
|.|||+ . +|+||||||+|||++.++ .+||+|||.+...... .....||..|+|||
T Consensus 244 L~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE 315 (467)
T PTZ00284 244 LDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPE 315 (467)
T ss_pred HHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcH
Confidence 999996 6 999999999999998665 4899999987533221 12235899999999
Q ss_pred eeecCCCcccccCceehHHHHHHHHhcCCCCCCccc
Q 037755 145 LISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 145 ~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
++.+. .++.++|||||||++|+|++|+.||....
T Consensus 316 ~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 316 VVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred HhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876 67889999999999999999999996543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=231.28 Aligned_cols=209 Identities=25% Similarity=0.382 Sum_probs=167.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....++.+|++++++++||||+++.+++.++...++++||+++++|.+++.........++...++.++.+++.|++|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh 120 (256)
T cd08530 41 KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 44567889999999999999999999999999999999999999999988443334567899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++++|||++....... .....++..|++||.+.+. .++.++|+||||+++
T Consensus 121 ~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~ 191 (256)
T cd08530 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLL 191 (256)
T ss_pred hC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCC--CCCchhhHHHHHHHH
Confidence 99 99999999999999999999999999987554431 1223478899999998765 667889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++|..||....... ....... .........++.++.+++.+||+.+|++|||+.|
T Consensus 192 ~~l~~g~~p~~~~~~~~--------~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 192 YEMATFAPPFEARSMQD--------LRYKVQR------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred HHHHhCCCCCCCCCHHH--------HHHHHhc------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 99999999986433211 0011111 1111122356778999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=228.59 Aligned_cols=201 Identities=21% Similarity=0.221 Sum_probs=156.5
Q ss_pred HHHHHHHHHh-hcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 11 EFINEVSTIG-RIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 11 ~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.+..|..++. +..|||++++++.+..+...++++||+.+++|.+++ .....++...+..++.|++.||.|||+.
T Consensus 42 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~- 116 (260)
T cd05611 42 NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQR- 116 (260)
T ss_pred HHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3445555444 458999999999999999999999999999999988 2345789999999999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++|+||+|+||+++.++.++|+|||.+...... ....++..|+|||.+.+. .++.++|+||+|+++|++
T Consensus 117 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l 186 (260)
T cd05611 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEF 186 (260)
T ss_pred --CeecCCCCHHHeEECCCCcEEEeecccceecccc------ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHH
Confidence 9999999999999999999999999987643321 223478899999998875 478899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++|..||........ ... ...... .........+++.+.+++.+||+.||++|||+.
T Consensus 187 ~~g~~p~~~~~~~~~-------~~~-~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 187 LFGYPPFHAETPDAV-------FDN-ILSRRI---NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred HHCCCCCCCCCHHHH-------HHH-HHhccc---CCCCcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence 999999964322110 011 101000 001112224678899999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=243.90 Aligned_cols=220 Identities=22% Similarity=0.335 Sum_probs=170.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....+.+|.+|+++|.+|+||||+.++++|..+..+++|+||++.|+|.+++.+.+... +.......++.||++|++|
T Consensus 575 ~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaY 652 (807)
T KOG1094|consen 575 TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAY 652 (807)
T ss_pred chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHH
Confidence 34556899999999999999999999999999999999999999999999995443222 3445566799999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|.+. ++||||+.+.|+|+++++++||+|||.++..-...-....+...-+.+|+|||.+.-. ..+.++|+|+||+
T Consensus 653 Les~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg--kFttaSDvWafgv 727 (807)
T KOG1094|consen 653 LESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG--KFTTASDVWAFGV 727 (807)
T ss_pred HHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc--cccchhhhhhhHH
Confidence 9998 9999999999999999999999999998754443333333444467899999987654 7889999999999
Q ss_pred HHHHHh--cCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMT--GGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++||++ +...||.....++.-.. .-..............+..++..+.+++.+||+.|-++|||+++
T Consensus 728 TlwE~~~~C~e~Py~~lt~e~vven-------~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~ 796 (807)
T KOG1094|consen 728 TLWEVFMLCREQPYSQLTDEQVVEN-------AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQ 796 (807)
T ss_pred HHHHHHHHHhhCchhhhhHHHHHHh-------hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHH
Confidence 999975 56777765444332111 11111111122223345668889999999999999999999863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=223.51 Aligned_cols=213 Identities=19% Similarity=0.268 Sum_probs=166.2
Q ss_pred ccccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
++++-.++...++++.+.+ +|+||+.+|+|..+..+++-||.|.. .+..++. .-.+++++..+-++...+++||.
T Consensus 130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlk---rik~piPE~ilGk~tva~v~AL~ 205 (391)
T KOG0983|consen 130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLK---RIKGPIPERILGKMTVAIVKALY 205 (391)
T ss_pred CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHH---HhcCCchHHhhhhhHHHHHHHHH
Confidence 4455678888888888775 99999999999999999999998843 5555441 12467999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGF 162 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~sl 162 (238)
||.++ .+|+|||+||+|||+|+.|.+|++|||++....+.... ....|.+.|+|||.+... .+.|+.++|||||
T Consensus 206 YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 206 YLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred HHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 99987 49999999999999999999999999998765554432 334589999999998654 5678999999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|++++|+.||+.||.....+-. +...+.+...+.+... ..+++.+.+|+..||+.|+.+||.-.
T Consensus 281 GITlveLaTg~yPy~~c~tdFe-------~ltkvln~ePP~L~~~----~gFSp~F~~fv~~CL~kd~r~RP~Y~ 344 (391)
T KOG0983|consen 281 GITLVELATGQYPYKGCKTDFE-------VLTKVLNEEPPLLPGH----MGFSPDFQSFVKDCLTKDHRKRPKYN 344 (391)
T ss_pred ccchhhhhcccCCCCCCCccHH-------HHHHHHhcCCCCCCcc----cCcCHHHHHHHHHHhhcCcccCcchH
Confidence 9999999999999976554421 1111212111111111 22789999999999999999999743
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=230.72 Aligned_cols=223 Identities=17% Similarity=0.215 Sum_probs=160.5
Q ss_pred HHHHHHHHHHHhhcC-CCcceeeeeEEEeCCe-----eeEEEEeCCCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK-----RALVYEFMPNGSLDRHIFPKESR-GQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~ 81 (238)
...+.+|+.+++++. ||||+++++++..... .++++||+.+ +|.+++...... ...+++..++.++.||+.|
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 467889999999995 6999999999876655 8999999975 888877443322 4578999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|.|||+. +++||||+|+||+++. ++.++|+|||.+......... .....+++.|+|||.+.+. ..++.++|+|
T Consensus 123 L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~ 196 (295)
T cd07837 123 VAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGS-THYSTPVDIW 196 (295)
T ss_pred HHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCC-CCCCchHHHH
Confidence 9999999 9999999999999998 889999999988644322111 1122367889999988653 2567899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhh--------hhhhcc-----CCCccccchhHHHHHHHHHHHHHHhhhcc
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWV--------SDQLNK-----GGNLELRNVTEIESMIARKLCVIGLWCIQ 227 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 227 (238)
|||+++|+|++|..||...........+.... ...... ...............++..+.++|.+||+
T Consensus 197 slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 276 (295)
T cd07837 197 SVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLR 276 (295)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHcc
Confidence 99999999999999986543221100000000 000000 00000001111223467889999999999
Q ss_pred CCCCCCCCCCC
Q 037755 228 VKPADRPSMTK 238 (238)
Q Consensus 228 ~dp~~Rps~~e 238 (238)
.||++|||++|
T Consensus 277 ~~P~~R~~~~e 287 (295)
T cd07837 277 YDPAKRISAKA 287 (295)
T ss_pred CChhhcCCHHH
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=227.39 Aligned_cols=213 Identities=23% Similarity=0.377 Sum_probs=158.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKE--SRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~~i 78 (238)
...+++.+|++++++++||||+++++++.... ..+++++|+.+|+|.+++.... .....++...+..++.++
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i 122 (273)
T cd05074 43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122 (273)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence 34567889999999999999999999885432 2468899999999987763221 122357889999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+.|++|||+. +++|+||||+||+++.++.++++|||.++...............++..|++||.+.+. ..+.++|
T Consensus 123 ~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sD 197 (273)
T cd05074 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSD 197 (273)
T ss_pred HHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhh
Confidence 9999999998 9999999999999999999999999998755433222122223356789999988765 6678899
Q ss_pred eehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 159 i~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||||+++|+|++ |..||....... . . ........... ....++.+.+++.+||+.+|++|||+.
T Consensus 198 i~slG~il~el~~~g~~p~~~~~~~~----~---~-~~~~~~~~~~~------~~~~~~~~~~l~~~~l~~~p~~Rps~~ 263 (273)
T cd05074 198 VWAFGVTMWEIMTRGQTPYAGVENSE----I---Y-NYLIKGNRLKQ------PPDCLEDVYELMCQCWSPEPKCRPSFQ 263 (273)
T ss_pred hHHHHHHHHHHhhCCCCCCCCCCHHH----H---H-HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9999999999998 788875432211 0 0 01111111100 122456889999999999999999986
Q ss_pred C
Q 037755 238 K 238 (238)
Q Consensus 238 e 238 (238)
|
T Consensus 264 ~ 264 (273)
T cd05074 264 H 264 (273)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=226.52 Aligned_cols=209 Identities=25% Similarity=0.338 Sum_probs=163.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+++++.++|+||+++++.+..+...++++||+.+++|.+++.. ..+..+++..+..++.+++.|+.|||
T Consensus 41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (257)
T cd08225 41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIH 118 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456888999999999999999999999999999999999999999998832 22346789999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCc-cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFV-PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+. +++|+|++|+||++++++. ++++|||.+........ ......++..|+|||.+.+. ..+.++|+||||++
T Consensus 119 ~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~i 191 (257)
T cd08225 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCV 191 (257)
T ss_pred HC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCC--CCCchhhHHHHHHH
Confidence 98 9999999999999998764 59999998865543221 11223488899999988765 67789999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++++|..||...... ........... .......+..+.+++.+||+.+|++|||+.|
T Consensus 192 l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 192 LYELCTLKHPFEGNNLH-------QLVLKICQGYF-------APISPNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred HHHHHhCCCCCCCccHH-------HHHHHHhcccC-------CCCCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999999998543211 11111111110 0111234567899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=235.13 Aligned_cols=213 Identities=28% Similarity=0.439 Sum_probs=158.8
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCC------------------------
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKES------------------------ 61 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~------------------------ 61 (238)
..+.+.+|+.+++++ +||||+++++++.. +...++++||+.+|+|.+++.....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (343)
T cd05103 53 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132 (343)
T ss_pred HHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence 346788999999999 68999999998754 4567899999999999988743211
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCc
Q 037755 62 ---------------------------------------RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHN 102 (238)
Q Consensus 62 ---------------------------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~n 102 (238)
....++...+..++.|++.||+|||++ +++||||||+|
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~N 209 (343)
T cd05103 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARN 209 (343)
T ss_pred hhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCe
Confidence 012467788889999999999999999 99999999999
Q ss_pred EEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc-CCCCCCcccc
Q 037755 103 ILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKAT 181 (238)
Q Consensus 103 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~ 181 (238)
|+++.++.++|+|||++................++..|+|||.+.+. .++.++|+||||+++|++++ |..||.....
T Consensus 210 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 210 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred EEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 99999999999999998754332222222223356789999998765 67889999999999999996 8888754321
Q ss_pred cccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.. .............. +...++++.+++.+||+.||++|||+.|
T Consensus 288 ~~-------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 288 DE-------EFCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred cH-------HHHHHHhccCCCCC------CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 11 11111111111111 1123567899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=224.49 Aligned_cols=211 Identities=26% Similarity=0.377 Sum_probs=169.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+++++.++|||++++.+.+..+...++++|++++++|.+.+......+..++...+..++.+++.|+.+||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 120 (258)
T cd08215 41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 56678899999999999999999999999999999999999999999988544334578999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||...+. ..+.++|+||+|+++
T Consensus 121 ~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~ 193 (258)
T cd08215 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVL 193 (258)
T ss_pred hC---CEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccC--CCCccccHHHHHHHH
Confidence 99 99999999999999999999999999887554432 112233578899999988765 578889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++|..||...... ......... .. ...+..++..+.+++.+||..+|++|||+.|
T Consensus 194 ~~l~~g~~p~~~~~~~-------~~~~~~~~~-~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 194 YELCTLKHPFEGENLL-------ELALKILKG-QY------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred HHHHcCCCCCCCCcHH-------HHHHHHhcC-CC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999998543311 111111111 10 1111245678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=236.36 Aligned_cols=207 Identities=18% Similarity=0.163 Sum_probs=157.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|+.+++.++|+||+++++++.+++..|+||||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 45 TACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45578899999999999999999999999999999999999999998832 235788999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC---CcccccCceehHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMV 165 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Di~slG~~ 165 (238)
+|+||||||+||+++.++.++|+|||++......... ......|+..|+|||.+.+.. ..++.++|+||+|++
T Consensus 122 ---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvi 197 (331)
T cd05624 122 ---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 197 (331)
T ss_pred ---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehh
Confidence 9999999999999999999999999998654332211 112335899999999886521 246788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+|+|++|+.||....... ............. .+.....+++++.+++.+||+.++++
T Consensus 198 l~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~~---~p~~~~~~~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 198 MYEMLYGETPFYAESLVE-------TYGKIMNHEERFQ---FPSHITDVSEEAKDLIQRLICSRERR 254 (331)
T ss_pred hhhhhhCCCCccCCCHHH-------HHHHHHcCCCccc---CCCccccCCHHHHHHHHHHccCchhh
Confidence 999999999996433211 1111111111010 01111235678899999999876544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=231.28 Aligned_cols=205 Identities=23% Similarity=0.329 Sum_probs=172.0
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.-..+|-++|++++.+.||.+--.|++.+.+|+|+..|+||+|.-++++.. +..+++..+..++.+|+.||.+||+.
T Consensus 230 ~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~- 306 (591)
T KOG0986|consen 230 TMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR- 306 (591)
T ss_pred HHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc-
Confidence 345689999999999999999999999999999999999999999996544 36899999999999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
.||.||+||+|||+|+.|+++|+|+|++...+...... ...||.+|+|||++... .|+...|.|||||++|+|
T Consensus 307 --~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYem 379 (591)
T KOG0986|consen 307 --RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEM 379 (591)
T ss_pred --ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc---cccCcccccCHHHHcCC--cccCCccHHHHHhHHHHH
Confidence 99999999999999999999999999998776655432 23599999999999987 688899999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+.|..||...........+...+ +....+.....+++.+++....|+.||++|.-
T Consensus 380 i~G~sPFr~~KeKvk~eEvdrr~-----------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 380 IAGHSPFRQRKEKVKREEVDRRT-----------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HcccCchhhhhhhhhHHHHHHHH-----------hcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 99999996544443222222111 11223455778899999999999999999964
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=236.05 Aligned_cols=222 Identities=20% Similarity=0.249 Sum_probs=161.2
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.....+.+|+.+++++ +||||+++++++.. +...++|+||+. ++|..++. ...+++..+..++.+++.||+
T Consensus 48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~ 121 (337)
T cd07852 48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIR-----ANILEDVHKRYIMYQLLKALK 121 (337)
T ss_pred hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHH
Confidence 3456678899999999 99999999998854 346899999996 59988872 227788889999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc---ccccccCCccccCCcceeecCCCcccccCcee
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|||++ +++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. ...+.++|+|
T Consensus 122 ~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~ 197 (337)
T cd07852 122 YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMW 197 (337)
T ss_pred HHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecc-ccccccchHH
Confidence 99998 9999999999999999999999999998755443221 111223478899999988653 3567889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhh----------------hhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSW----------------VSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|||+++|+|++|+.||...........+... ......................++..+.+++.+
T Consensus 198 slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (337)
T cd07852 198 SVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKK 277 (337)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHH
Confidence 9999999999999998654322110000000 000000000011111112222357789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||+.|
T Consensus 278 ~l~~~P~~Rps~~~ 291 (337)
T cd07852 278 LLVFNPNKRLTAEE 291 (337)
T ss_pred hccCCcccccCHHH
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=233.03 Aligned_cols=205 Identities=24% Similarity=0.315 Sum_probs=158.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+++++.++|+|++++.+++..+...++|+||+. |++.+.+. .....++...+..++.+++.|+.|||+
T Consensus 58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~ 133 (308)
T cd06634 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS 133 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34678899999999999999999999999999999999996 58877662 223568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 166 (238)
. +++||||+|+||+++.++.++++|||.+....... ...++..|+|||.+.+. ....+.++||||||+++
T Consensus 134 ~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il 204 (308)
T cd06634 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (308)
T ss_pred C---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHH
Confidence 8 99999999999999999999999999886543321 22478899999987531 12467789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ .......... ......++..+.+++.+||+.+|++|||++|
T Consensus 205 ~el~~g~~p~~~~~~~~~--------~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 205 IELAERKPPLFNMNAMSA--------LYHIAQNESP-----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred HHHHcCCCCCccccHHHH--------HHHHhhcCCC-----CcCcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 999999998854221110 0001111110 0112345677899999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=233.56 Aligned_cols=219 Identities=19% Similarity=0.211 Sum_probs=158.7
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+|+.++++++|+||+++++++.+. ...++|+||+. ++|.+++.. ....+++..+..++.|++.|++|||+
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~ 126 (309)
T cd07845 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHE 126 (309)
T ss_pred chhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999999999998654 56899999996 488887732 23578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. ..++.++|+||||+++|
T Consensus 127 ~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~ 200 (309)
T cd07845 127 N---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILA 200 (309)
T ss_pred C---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHH
Confidence 9 9999999999999999999999999998755433211 1222357789999998653 25678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhh-------hhhhhcc------C--CCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSW-------VSDQLNK------G--GNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~------~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+|++|..||...........+... ....... . ...............++++.+++.+||+.||++
T Consensus 201 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 280 (309)
T cd07845 201 ELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280 (309)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhh
Confidence 999999999654332211000000 0000000 0 000000001111224778899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 281 R~t~~~ 286 (309)
T cd07845 281 RATAEE 286 (309)
T ss_pred CcCHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=235.65 Aligned_cols=220 Identities=20% Similarity=0.269 Sum_probs=161.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
...++.+|+.+++.++||||+++++++... ...++++||+. ++|.+++ .....++...+..++.|++.|+
T Consensus 47 ~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL 121 (337)
T cd07858 47 DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQII----RSSQTLSDDHCQYFLYQLLRGL 121 (337)
T ss_pred hhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHH
Confidence 456778899999999999999999987543 35899999995 6888877 3346799999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
.|||++ +++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+... ...+.++|+|||
T Consensus 122 ~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Diwsl 195 (337)
T cd07858 122 KYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSV 195 (337)
T ss_pred HHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHH
Confidence 999999 999999999999999999999999999875543321 11223478899999987642 247788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcch----------------hhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhc
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFP----------------SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 226 (238)
|+++|+|++|..||...........+. ........................+++++.+++.+||
T Consensus 196 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 275 (337)
T cd07858 196 GCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKML 275 (337)
T ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHh
Confidence 999999999999996542211000000 0000000000000001111222346788999999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||++|||++|
T Consensus 276 ~~~P~~Rps~~e 287 (337)
T cd07858 276 VFDPSKRITVEE 287 (337)
T ss_pred cCChhhccCHHH
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=229.37 Aligned_cols=221 Identities=19% Similarity=0.265 Sum_probs=159.0
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|++++++++||||+++++++.++...++|+||+. ++|.+++.. .....++...+..++.+|+.||+|||++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 121 (294)
T PLN00009 45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH 121 (294)
T ss_pred hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678899999999999999999999999999999999995 588777622 2233467888899999999999999999
Q ss_pred CCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+++|+||+|+||+++. ++.++++|||++........ ......++..|+|||.+.+. ..++.++|+||+|+++|
T Consensus 122 ---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~ 195 (294)
T PLN00009 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFA 195 (294)
T ss_pred ---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHH
Confidence 9999999999999985 55789999999875433211 11223467899999987653 24678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhh----hhh---------hccCC-CccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWV----SDQ---------LNKGG-NLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~----~~~---------~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
+|++|..||................ ... ..... .............+++.+.+++.+||+.||++|
T Consensus 196 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (294)
T PLN00009 196 EMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275 (294)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhC
Confidence 9999999996543211100000000 000 00000 000011111123356778999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+.|
T Consensus 276 ps~~~ 280 (294)
T PLN00009 276 ITARA 280 (294)
T ss_pred cCHHH
Confidence 99753
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=232.59 Aligned_cols=205 Identities=23% Similarity=0.305 Sum_probs=158.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|++++++++|||++++++++.++...++++||+.+ ++.+.+. .....+++..+..++.+++.|+.|||+
T Consensus 68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~ 143 (317)
T cd06635 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHS 143 (317)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346788999999999999999999999999999999999965 7777662 224568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 166 (238)
. +++||||+|+||+++.++.++|+|||.+...... ....++..|+|||.+... ....+.++|+||||+++
T Consensus 144 ~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil 214 (317)
T cd06635 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214 (317)
T ss_pred C---CcccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHH
Confidence 9 9999999999999999999999999987644332 223478899999987431 12567889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ ........... .....+++.+.+++.+||+.+|.+|||+.|
T Consensus 215 ~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 215 IELAERKPPLFNMNAMSA--------LYHIAQNESPT-----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred HHHHhCCCCCCCccHHHH--------HHHHHhccCCC-----CCCccccHHHHHHHHHHccCCcccCcCHHH
Confidence 999999999854321110 00111100000 011235667899999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=230.45 Aligned_cols=201 Identities=23% Similarity=0.278 Sum_probs=154.7
Q ss_pred HHHHHHHHHhh---cCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 11 EFINEVSTIGR---IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 11 ~~~~e~~~l~~---l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
.+.+|...++. ..||||+.+++.+..++..++||||+.+++|.+++ ...+.+++..+..++.|++.|+.|||+
T Consensus 40 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~ 115 (279)
T cd05633 40 LALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHN 115 (279)
T ss_pred HHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34455544444 37999999999999989999999999999998887 234579999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||||+||++++++.++++|||++....... .....++..|+|||.+... ..++.++|+||+|+++|
T Consensus 116 ~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~ 187 (279)
T cd05633 116 R---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLF 187 (279)
T ss_pred C---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHH
Confidence 9 99999999999999999999999999886443221 1223489999999987642 25678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+|++|..||........ ........ ......+..++.++.+++.+||+.||++||+
T Consensus 188 ~l~~g~~pf~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 188 KLLRGHSPFRQHKTKDK-----HEIDRMTL-------TVNVELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred HHHhCCCCcCCCCCcCH-----HHHHHHhh-------cCCcCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 99999999964322110 01111100 0011123346778999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=225.75 Aligned_cols=188 Identities=17% Similarity=0.236 Sum_probs=150.4
Q ss_pred CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCc
Q 037755 23 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHN 102 (238)
Q Consensus 23 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~n 102 (238)
+||||+++++.+...+..++||||+++++|.+++ .....+++..+..++.|+++|+.|||+. +++||||+|+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~n 139 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLEN 139 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHH
Confidence 6999999999999999999999999999999988 2334889999999999999999999999 99999999999
Q ss_pred EEEccCC-ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccc
Q 037755 103 ILLDHNF-VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKAT 181 (238)
Q Consensus 103 il~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 181 (238)
|+++.++ .++++|||.+....... ...++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.....
T Consensus 140 il~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 140 VLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred EEEeCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 9999888 99999999886553322 22478899999999775 677889999999999999999999974332
Q ss_pred cccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
... ....+... . . ........+++.+.+++.+||+.||.+||+.
T Consensus 212 ~~~--~~~~~~~~-~-~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 212 EEL--DLESLLKR-Q-Q-------KKLPFIKNVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred chh--hHHHHHHh-h-c-------ccCCcccccCHHHHHHHHHHhccChhhCCch
Confidence 211 11111110 0 0 0011122577889999999999999999964
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=235.85 Aligned_cols=158 Identities=25% Similarity=0.307 Sum_probs=132.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|+.++++++||||+++++++... ...++|+||+. ++|.+.+. ..++...+..++.|++.
T Consensus 57 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~ 129 (353)
T cd07850 57 THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLC 129 (353)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHH
Confidence 3456778999999999999999999988543 35799999995 48888771 23888999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||+. +++||||||+||+++.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+|
T Consensus 130 aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dvw 201 (353)
T cd07850 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIW 201 (353)
T ss_pred HHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhH
Confidence 99999999 999999999999999999999999999875433221 1223478899999998775 678899999
Q ss_pred hHHHHHHHHhcCCCCCCcc
Q 037755 161 GFGMVLLEMTGGRRNSNLK 179 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~ 179 (238)
|||+++|+|++|+.||...
T Consensus 202 slG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 202 SVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred hHHHHHHHHHHCCCCCCCC
Confidence 9999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=221.32 Aligned_cols=227 Identities=21% Similarity=0.236 Sum_probs=172.6
Q ss_pred cccccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
....++.++.+|++++.+.+ |+||+.++++|+++...|+|||.|.||+|..++ .+.+.+++..+..+..+|+.||
T Consensus 114 q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI----~~~~~F~E~EAs~vvkdia~aL 189 (463)
T KOG0607|consen 114 QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHI----QKRKHFNEREASRVVKDIASAL 189 (463)
T ss_pred CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHH----HHhhhccHHHHHHHHHHHHHHH
Confidence 34457899999999999996 999999999999999999999999999999999 4567899999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCc---cccccccccccCCCCCcc-----ccccccCCccccCCccee---ecCCC
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFV---PNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELI---SRNFG 151 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~---~~~~~ 151 (238)
.|||.+ ||.|||+||+|||..+.+. |||+||.+.......... ...-.+.|+..|+|||+. .+...
T Consensus 190 dFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~ 266 (463)
T KOG0607|consen 190 DFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQAT 266 (463)
T ss_pred HHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccc
Confidence 999999 9999999999999976554 699999887544333322 122334588899999975 33434
Q ss_pred cccccCceehHHHHHHHHhcCCCCCCcccccccCCc---chhhhhhhhccCCCcccc-chhHHHHHHHHHHHHHHhhhcc
Q 037755 152 TVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY---FPSWVSDQLNKGGNLELR-NVTEIESMIARKLCVIGLWCIQ 227 (238)
Q Consensus 152 ~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~ 227 (238)
.|+++.|.||||+++|-|+.|.+||.+.....=+.. .=....+.+......... .+.+-...++.+.++++...|-
T Consensus 267 ~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlv 346 (463)
T KOG0607|consen 267 FYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLV 346 (463)
T ss_pred cccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHh
Confidence 789999999999999999999999976544321111 000011111111111111 1222345688899999999999
Q ss_pred CCCCCCCCCC
Q 037755 228 VKPADRPSMT 237 (238)
Q Consensus 228 ~dp~~Rps~~ 237 (238)
.||..|.++.
T Consensus 347 rda~~rlsa~ 356 (463)
T KOG0607|consen 347 RDAKQRLSAA 356 (463)
T ss_pred ccHHhhhhhh
Confidence 9999998875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=227.54 Aligned_cols=223 Identities=22% Similarity=0.242 Sum_probs=163.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|++++++++|||++++++++... ...++++||+.+ +|.+++.. ....+++..++.++.+++.|++|
T Consensus 40 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~ 115 (287)
T cd07840 40 GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQY 115 (287)
T ss_pred cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999887 899999999964 88887732 22578999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++|+||+|+||++++++.++++|||.+......... ......++..|+|||.+.+. ..++.++|+||||+
T Consensus 116 LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~ 190 (287)
T cd07840 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGC 190 (287)
T ss_pred HHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEcc-ccCChHHHHHHHHH
Confidence 9998 9999999999999999999999999998755443311 11223467889999987653 25678899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhh-------hhhhcc-----CCCcc---ccchhHHHHH-HHHHHHHHHhhhccC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWV-------SDQLNK-----GGNLE---LRNVTEIESM-IARKLCVIGLWCIQV 228 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~-----~~~~~---~~~~~~~~~~-~~~~l~~li~~cl~~ 228 (238)
++|+|++|..||...........+.... ...... ..... .......... ++..+.+++.+||+.
T Consensus 191 ~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 270 (287)
T cd07840 191 ILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL 270 (287)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCC
Confidence 9999999999986443221100000000 000000 00000 0000111112 377899999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||++|
T Consensus 271 ~P~~Rp~~~~ 280 (287)
T cd07840 271 DPKKRISADQ 280 (287)
T ss_pred ChhhCcCHHH
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=228.96 Aligned_cols=216 Identities=19% Similarity=0.231 Sum_probs=158.5
Q ss_pred HHHHHHHHHHhhcC-CCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 10 EEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 10 ~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....+|+.+++++. |||++++++++.++ +..++|+||+. +++.+.+.. ....+++..+..++.+++.||+|||
T Consensus 42 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH 117 (282)
T cd07831 42 VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH 117 (282)
T ss_pred hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34457999999995 99999999999877 88999999996 488777732 2357899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||+|+||+++. +.++|+|||.+......... ....++..|+|||.+.+. ...+.++|+||+|+++
T Consensus 118 ~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l 189 (282)
T cd07831 118 RN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVF 189 (282)
T ss_pred HC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHH
Confidence 99 9999999999999999 99999999998755332221 123478899999976543 2467889999999999
Q ss_pred HHHhcCCCCCCcccccccCCc--------chhhhhhhhccCCCcc-------ccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAY--------FPSWVSDQLNKGGNLE-------LRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
|+|++|..||........... ...+ ........... ..........++..+.+++.+||+.||+
T Consensus 190 ~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 268 (282)
T cd07831 190 FEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPD 268 (282)
T ss_pred HHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcc
Confidence 999999999965432211000 0000 00000000000 0011122335678999999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 269 ~R~~~~~ 275 (282)
T cd07831 269 ERITAKQ 275 (282)
T ss_pred cccCHHH
Confidence 9999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=229.29 Aligned_cols=222 Identities=20% Similarity=0.258 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCC--------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+|++++++++||||+++++++.... ..++++||+. ++|.+.+. .....+++..++.++.|++.
T Consensus 55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~ 130 (310)
T cd07865 55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLS---NKNVKFTLSEIKKVMKMLLN 130 (310)
T ss_pred hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHH---hcccCCCHHHHHHHHHHHHH
Confidence 345678999999999999999999886543 4599999996 48877762 22347899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc--ccccccCCccccCCcceeecCCCcccccCc
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|+.|||++ +++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. ...+.++|
T Consensus 131 al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 206 (310)
T cd07865 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPID 206 (310)
T ss_pred HHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhh
Confidence 99999999 9999999999999999999999999998755433221 111223477889999988654 24577899
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcc-------hhhhhhhh-----ccCCCccccchhHHH-----HHHHHHHHHH
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYF-------PSWVSDQL-----NKGGNLELRNVTEIE-----SMIARKLCVI 221 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~-----~~~~~~~~~~~~~~~-----~~~~~~l~~l 221 (238)
+||||+++|+|++|..||...........+ +....... ............... ...+..+.++
T Consensus 207 i~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dl 286 (310)
T cd07865 207 MWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDL 286 (310)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHH
Confidence 999999999999999988654322110000 00000000 000000000000000 1124567899
Q ss_pred HhhhccCCCCCCCCCCC
Q 037755 222 GLWCIQVKPADRPSMTK 238 (238)
Q Consensus 222 i~~cl~~dp~~Rps~~e 238 (238)
+.+||+.||++|||++|
T Consensus 287 i~~~l~~~P~~R~t~~e 303 (310)
T cd07865 287 IDKLLVLDPAKRIDADT 303 (310)
T ss_pred HHHHhcCChhhccCHHH
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=230.40 Aligned_cols=217 Identities=23% Similarity=0.288 Sum_probs=159.0
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccC-CCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP-KESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....++.+|+.+++++. ||||+++++++..+...++++||+. +++.++... .......+++..+..++.+++.|++|
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 34567889999999996 9999999999988889999999985 466543311 11224678999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC-CcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG 163 (238)
||+. .+++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ..++.++|+||+|
T Consensus 123 lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG 197 (288)
T cd06616 123 LKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG 197 (288)
T ss_pred Hhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence 9963 2899999999999999999999999999864432211 12224788899999986531 2467889999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|+.||...... . ....... ... ...........++.++.+|+.+||+.||++|||++|
T Consensus 198 ~il~el~~g~~p~~~~~~~-----~-~~~~~~~-~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 263 (288)
T cd06616 198 ITLYEVATGKFPYPKWNSV-----F-DQLTQVV-KGD--PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263 (288)
T ss_pred HHHHHHHhCCCCchhcchH-----H-HHHhhhc-CCC--CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999998643210 0 0000000 000 000011111336778999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=224.98 Aligned_cols=207 Identities=22% Similarity=0.321 Sum_probs=166.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++|||++++++++.+++..+++++++.+++|.+++. ....+++..+..++.+++.++.+||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH 116 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLH 116 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHh
Confidence 356789999999999999999999999999999999999999999999882 2367899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++||||+|+||+++.++.++|+|||.+......... .....++..|+|||...+. ..+.++|+||+|+++
T Consensus 117 ~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l 189 (254)
T cd06627 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTV 189 (254)
T ss_pred hC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHH
Confidence 99 9999999999999999999999999998766543321 1223478899999998765 477889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++++|..||...... ..... .. ... ....+..++..+.+++.+||+.+|++|||++|
T Consensus 190 ~~l~~g~~p~~~~~~~------~~~~~-~~-~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 190 IELLTGNPPYYDLNPM------AALFR-IV-QDD------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred HHHHhCCCCCCCccHH------HHHHH-Hh-ccC------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 9999999998643211 11100 00 000 01112234678899999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=231.18 Aligned_cols=205 Identities=22% Similarity=0.317 Sum_probs=158.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+++++.++|||++++++++.++...++++||+. +++.+.+. .....++...+..++.+++.++.|||+
T Consensus 64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~ 139 (313)
T cd06633 64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHS 139 (313)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999999999999996 57777662 224568899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~l 166 (238)
. +++|+||+|+||+++.++.++|+|||.+...... ....++..|+|||.+... ....+.++|+||||+++
T Consensus 140 ~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil 210 (313)
T cd06633 140 H---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 210 (313)
T ss_pred C---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHH
Confidence 9 9999999999999999999999999987643221 233478899999997531 12567789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||......... .. ........ .....++..+.+++.+||+.+|.+|||++|
T Consensus 211 ~el~~g~~p~~~~~~~~~~-------~~-~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~ 269 (313)
T cd06633 211 IELAERKPPLFNMNAMSAL-------YH-IAQNDSPT-----LQSNEWTDSFRGFVDYCLQKIPQERPASAE 269 (313)
T ss_pred HHHHhCCCCCCCCChHHHH-------HH-HHhcCCCC-----CCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999998653221110 00 00000000 011224567889999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=234.55 Aligned_cols=219 Identities=18% Similarity=0.245 Sum_probs=161.6
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
.+.+|++++++++||||+++++++..+...++++||+. ++|.+++ .....++...+..++.|++.|++|||+.
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~-- 138 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV----DRKIRLTESQVKCILLQILNGLNVLHKW-- 138 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 57899999999999999999999999999999999996 5898887 2345689999999999999999999998
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCCCCc------------cccccccCCccccCCcceeecCCCcccccCc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND------------FVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+++|+||+|+||+++.++.++++|||.+........ ........++..|+|||.+.+. ...+.++|
T Consensus 139 -~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 216 (335)
T PTZ00024 139 -YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVD 216 (335)
T ss_pred -CeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHH
Confidence 999999999999999999999999998875541110 0111222367789999998764 24678899
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhh--------hh-----hccCCCccccchhHHHHHHHHHHHHHHhhh
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVS--------DQ-----LNKGGNLELRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--------~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 225 (238)
+||||+++|+|++|..||...........+..... .. ...................+.++.+++.+|
T Consensus 217 v~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (335)
T PTZ00024 217 MWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296 (335)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHH
Confidence 99999999999999999965443211000000000 00 000000001111112233467889999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||++|||++|
T Consensus 297 l~~~P~~R~s~~~ 309 (335)
T PTZ00024 297 LKLNPLERISAKE 309 (335)
T ss_pred cCCCchhccCHHH
Confidence 9999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=223.66 Aligned_cols=193 Identities=20% Similarity=0.180 Sum_probs=152.7
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDV 91 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~ 91 (238)
+.+|...+....||||+++++++.++...+++|||+.+|+|.+++. ....+++..+..++.|++.|+.|||+.
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~--- 104 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS----KFLNIPEECVKRWAAEMVVALDALHRE--- 104 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH----HhcCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 4455566666679999999999999999999999999999999883 234689999999999999999999998
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG 171 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~ 171 (238)
+++||||||+||+++.++.++++|||.+....... ....++..|+|||...+. .++.++|+||+|+++|+|++
T Consensus 105 ~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~ 177 (237)
T cd05576 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGIS--EETEACDWWSLGAILFELLT 177 (237)
T ss_pred CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCC--CCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999999999775443321 223356789999988764 66788999999999999999
Q ss_pred CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 172 GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 172 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|..|+........ .... ...+..+++.+.+++.+||+.||++|||+.
T Consensus 178 g~~~~~~~~~~~~-------------~~~~------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 178 GKTLVECHPSGIN-------------THTT------LNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CcchhhcCchhcc-------------cccc------cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 9987643211100 0000 012233567889999999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=238.53 Aligned_cols=211 Identities=22% Similarity=0.354 Sum_probs=174.2
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
++..+.+.|..|+-+|++++||||++++|++.+ ...|+|||.++.|.|..++. .....++......++.||+.|++
T Consensus 430 ~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~tala 505 (974)
T KOG4257|consen 430 CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALA 505 (974)
T ss_pred CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHH
Confidence 345668999999999999999999999999987 58899999999999999993 33468888999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. ..|||||...|||+.+.-.||++|||+++...+..-. ..+...-+..|+|||.++=. ..+.++|||-||
T Consensus 506 YLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY-kaS~~kLPIKWmaPESINfR--rFTtASDVWMFg 579 (974)
T KOG4257|consen 506 YLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY-KASRGKLPIKWMAPESINFR--RFTTASDVWMFG 579 (974)
T ss_pred HHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchh-hccccccceeecCccccchh--cccchhhHHHHH
Confidence 99999 9999999999999999999999999999977665432 23334467899999998754 889999999999
Q ss_pred HHHHHHh-cCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMT-GGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+.+||++ .|..||.+-..... .-.+. ...+...++++++.+..++.+||..||.+||++.|
T Consensus 580 VCmWEIl~lGvkPfqgvkNsDV--------I~~iE------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrfte 641 (974)
T KOG4257|consen 580 VCMWEILSLGVKPFQGVKNSDV--------IGHIE------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTE 641 (974)
T ss_pred HHHHHHHHhcCCccccccccce--------EEEec------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence 9999986 68899865433221 11122 22334456778999999999999999999998754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=221.54 Aligned_cols=204 Identities=27% Similarity=0.342 Sum_probs=164.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++.+..+...+++|||+.+++|.+++ .....+++..+..++.|++.|+.|||+
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lh~ 111 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLALEYLHS 111 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999988 233478999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++++|||.+....... .......++..|.|||...+. ..+.++|+||||+++|
T Consensus 112 ~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~ 184 (250)
T cd05123 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLY 184 (250)
T ss_pred C---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHH
Confidence 8 99999999999999999999999999886554332 112233478899999998765 5778899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++++|..||...... ........ .. . ..+...+..+.+++.+||..||++|||+.
T Consensus 185 ~l~~g~~p~~~~~~~-------~~~~~~~~-~~-~------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 185 EMLTGKPPFYAEDRK-------EIYEKILK-DP-L------RFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHCCCCCCCCCHH-------HHHHHHhc-CC-C------CCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 999999998543321 11111111 00 0 11122367788999999999999999983
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=224.39 Aligned_cols=212 Identities=21% Similarity=0.353 Sum_probs=157.6
Q ss_pred HHHHHHHHHH-HhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..++..|+.+ ++.++||||+++++++..+...++++||++ ++|.+++.........+++..++.++.|++.|++|||+
T Consensus 43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 121 (283)
T cd06617 43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121 (283)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3456667665 566689999999999999999999999996 58877764433344678999999999999999999998
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC--CcccccCceehHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMV 165 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG~~ 165 (238)
++ +++||||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+.. ..++.++|+||||++
T Consensus 122 ~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~ 196 (283)
T cd06617 122 KL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGIT 196 (283)
T ss_pred cC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHH
Confidence 42 79999999999999999999999999987543221 112234788899999886521 245788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||...... ... ....... ..... ....++.++.+++.+||+.+|++|||++|
T Consensus 197 l~~l~~g~~p~~~~~~~-----~~~-~~~~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 257 (283)
T cd06617 197 MIELATGRFPYDSWKTP-----FQQ-LKQVVEE-PSPQL-----PAEKFSPEFQDFVNKCLKKNYKERPNYPE 257 (283)
T ss_pred HHHHHhCCCCCCccccC-----HHH-HHHHHhc-CCCCC-----CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999998532111 000 0111100 00000 01235678999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=232.86 Aligned_cols=224 Identities=19% Similarity=0.244 Sum_probs=165.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC-----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
....+.+.+|+.++++++||||+++.+++.... ..+++++|+. ++|.+++ .....+++..++.++.+++.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~~l~~ 114 (330)
T cd07834 40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVI----KSPQPLTDDHIQYFLYQILR 114 (330)
T ss_pred chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHH----hCCCCCCHHHHHHHHHHHHH
Confidence 345578899999999999999999999987664 7899999997 4888887 23448999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCce
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
|+++||+. +++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+. ...+.++|+
T Consensus 115 ~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi 190 (330)
T cd07834 115 GLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDI 190 (330)
T ss_pred HHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecc-cCCCcchhH
Confidence 99999999 9999999999999999999999999998765443210 112233478889999998774 267888999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcchh----------------hhhhhhccCCCccccchhHHHHHHHHHHHHHHh
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFPS----------------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 223 (238)
||||+++|+|++|..||...........+.. .......................++..+.+++.
T Consensus 191 ~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 270 (330)
T cd07834 191 WSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLE 270 (330)
T ss_pred HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHH
Confidence 9999999999999999965543211000000 000000000000011111122335788999999
Q ss_pred hhccCCCCCCCCCCC
Q 037755 224 WCIQVKPADRPSMTK 238 (238)
Q Consensus 224 ~cl~~dp~~Rps~~e 238 (238)
+||+.||++|||++|
T Consensus 271 ~~l~~~P~~Rpt~~~ 285 (330)
T cd07834 271 KMLVFDPKKRITADE 285 (330)
T ss_pred HHccCChhhCCCHHH
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=223.27 Aligned_cols=219 Identities=20% Similarity=0.278 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHhhc---CCCcceeeeeEEEeCCe-----eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRI---HHVNVVQLLGFCSEGSK-----RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 9 ~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+|+.+++++ .|||++++++++..... .++++||+.+ +|.+++... ....+++..++.++.+++.
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~ 118 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLR 118 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHH
Confidence 45677888888777 59999999999977666 9999999964 888877321 2236899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||.|||+. +++|+|++|+||+++.++.++|+|||.+......... ....++..|+|||.+.+. ..+.++|+|
T Consensus 119 al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~ 190 (287)
T cd07838 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMW 190 (287)
T ss_pred HHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccC--CCCCcchhh
Confidence 99999999 9999999999999999999999999988755333211 122367889999998775 678889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhh---------hhh---hccCCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWV---------SDQ---LNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
|||+++|+|++|..||...........+.... ... ..................++..+.+++.+||+.
T Consensus 191 s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 270 (287)
T cd07838 191 SVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTF 270 (287)
T ss_pred hHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhcc
Confidence 99999999999998886543221100000000 000 000000001111223345678889999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||+.|
T Consensus 271 dp~~Rp~~~~ 280 (287)
T cd07838 271 NPHKRISAFE 280 (287)
T ss_pred CCccCCCHHH
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=230.73 Aligned_cols=217 Identities=19% Similarity=0.234 Sum_probs=159.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|++++++++||||+++.+++.. +...++++||+ +++|.+.+ ....++...+..++.|++.|++||
T Consensus 51 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~-----~~~~~~~~~~~~~~~ql~~aL~~L 124 (328)
T cd07856 51 VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLL-----TSRPLEKQFIQYFLYQILRGLKYV 124 (328)
T ss_pred chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 345788899999999999999999998865 56789999998 56898877 234678888899999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+....... ....++..|+|||.+.+. ..++.++|+||||++
T Consensus 125 H~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~i 195 (328)
T cd07856 125 HSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCI 195 (328)
T ss_pred HhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCcccccccCceeeecc-CCcCcHHHHHHHHHH
Confidence 999 99999999999999999999999999986432211 122467889999987652 257889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcc--------hhhhh--------hhhccCCCccccchhHHHHHHHHHHHHHHhhhccCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYF--------PSWVS--------DQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 229 (238)
+|+|++|..||...........+ ..+.. ....................+++.+.+++.+||+.+
T Consensus 196 l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 275 (328)
T cd07856 196 FAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFD 275 (328)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCC
Confidence 99999999999654321110000 00000 000000000111111122235678999999999999
Q ss_pred CCCCCCCCC
Q 037755 230 PADRPSMTK 238 (238)
Q Consensus 230 p~~Rps~~e 238 (238)
|++|||++|
T Consensus 276 P~~R~t~~e 284 (328)
T cd07856 276 PQKRISAAE 284 (328)
T ss_pred hhhCCCHHH
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=224.35 Aligned_cols=208 Identities=20% Similarity=0.240 Sum_probs=160.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+.+|++++++++||||+++++++.+. ...++++||+.+++|.+.+. ....++...+..++.+++.|+.|
T Consensus 46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~ 121 (264)
T cd06653 46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSY 121 (264)
T ss_pred HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHH
Confidence 3446888999999999999999999998653 56889999999999999882 23458889999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||+. +++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. ..+.++|+||||
T Consensus 122 LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 196 (264)
T cd06653 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVA 196 (264)
T ss_pred HHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHH
Confidence 9998 9999999999999999999999999998754321110 111123478899999998775 678889999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+++|++++|..||...... ....+..... .....+..+++.+.+++.+||+ +|..|||+.
T Consensus 197 ~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~ 256 (264)
T cd06653 197 CTVVEMLTEKPPWAEYEAM-------AAIFKIATQP------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAE 256 (264)
T ss_pred HHHHHHHhCCCCCCccCHH-------HHHHHHHcCC------CCCCCCcccCHHHHHHHHHHhc-CcccCccHH
Confidence 9999999999998643211 1111111110 1112334567889999999999 579999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=225.61 Aligned_cols=199 Identities=23% Similarity=0.293 Sum_probs=153.2
Q ss_pred HHHHHHH---HhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 12 FINEVST---IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 12 ~~~e~~~---l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
+.+|..+ ++...||||+++.+.+.+....++|+||+.+++|.+++ .....+++..+..++.|++.|+.|||+.
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l----~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 116 (278)
T cd05606 41 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNR 116 (278)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3444444 34457999999999999999999999999999998887 2345799999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++||||+|+||+++.++.++|+|||.+........ ....|+..|+|||.+.+. ..++.++|+||+|+++|+
T Consensus 117 ---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~ 188 (278)
T cd05606 117 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFK 188 (278)
T ss_pred ---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHH
Confidence 999999999999999999999999998864432221 223488999999998643 246788999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
|++|+.||.......... ....... . ....+..++..+.+++.+||+.||++||
T Consensus 189 l~~g~~p~~~~~~~~~~~-----~~~~~~~-~------~~~~~~~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 189 LLRGHSPFRQHKTKDKHE-----IDRMTLT-M------AVELPDSFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred HHhCCCCCCCCCccchHH-----HHHHhhc-c------CCCCCCcCCHHHHHHHHHHhhcCHHhcc
Confidence 999999996542221100 0000000 0 0111223467899999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=247.43 Aligned_cols=213 Identities=26% Similarity=0.418 Sum_probs=171.7
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.++.++.+|..|+.||-+++||||+++.|++.....+.+|+|||+.|+|..++.. ..+.++..++..++..|+.|++
T Consensus 669 ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMk 745 (996)
T KOG0196|consen 669 YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMK 745 (996)
T ss_pred ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhH
Confidence 3467788999999999999999999999999999999999999999999999932 3356889999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCC-ccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN-DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
||.+. ++|||||...|||++.+-.+|+.|||+++...+.. .........-+.+|.|||.+.-. ..+.++||||+
T Consensus 746 YLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~R--KFTsASDVWSy 820 (996)
T KOG0196|consen 746 YLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR--KFTSASDVWSY 820 (996)
T ss_pred HHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhc--ccCchhhcccc
Confidence 99998 99999999999999999999999999998664433 22222223356899999999755 78999999999
Q ss_pred HHHHHHHh-cCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMT-GGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|+||.| .|+.|+-....+. +.+.+.++..++ .+..++..|..|+..||++|-.+||+++|
T Consensus 821 GIVmWEVmSyGERPYWdmSNQd--------VIkaIe~gyRLP------pPmDCP~aL~qLMldCWqkdR~~RP~F~q 883 (996)
T KOG0196|consen 821 GIVMWEVMSYGERPYWDMSNQD--------VIKAIEQGYRLP------PPMDCPAALYQLMLDCWQKDRNRRPKFAQ 883 (996)
T ss_pred ceEEEEecccCCCcccccchHH--------HHHHHHhccCCC------CCCCCcHHHHHHHHHHHHHHhhcCCCHHH
Confidence 99999976 6887764333222 222222222222 22347788899999999999999999754
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=227.15 Aligned_cols=222 Identities=21% Similarity=0.236 Sum_probs=159.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCC----------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASG 77 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (238)
....+.+|++++++++||||+++++++.+.. ..++++||+.+ ++.+.+.. ....++...+..++.|
T Consensus 49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~q 124 (302)
T cd07864 49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQ 124 (302)
T ss_pred chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHH
Confidence 3457789999999999999999999886644 78999999976 77666622 2347899999999999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccC
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
++.||+|||+. +++|+||+|+||++++++.++|+|||.+......... ......++..|+|||.+.+. ...+.++
T Consensus 125 i~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~ 199 (302)
T cd07864 125 LLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAI 199 (302)
T ss_pred HHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCC-CCCCchh
Confidence 99999999999 9999999999999999999999999998755433211 11122357789999987653 2467889
Q ss_pred ceehHHHHHHHHhcCCCCCCcccccccCCcchhhhh-------hhhccC--------CCccccchhHHHHHHHHHHHHHH
Q 037755 158 DVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVS-------DQLNKG--------GNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 158 Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li 222 (238)
||||||+++|+|++|+.||...........+..... ...... ..............++..+.+++
T Consensus 200 Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (302)
T cd07864 200 DVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLL 279 (302)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHH
Confidence 999999999999999999864332211000000000 000000 00000000111123467899999
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||++|||++|
T Consensus 280 ~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 280 DHMLTLDPSKRCTAEE 295 (302)
T ss_pred HHHccCChhhCCCHHH
Confidence 9999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=226.43 Aligned_cols=209 Identities=22% Similarity=0.320 Sum_probs=163.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++..|+.+++.++||||+++++++.+....++++||+.+++|.+.+.........+++..++.++.+++.|+.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999998899999999999999988874433345689999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+|++|+||+++. +.++++|||.+........ ......++..|+|||.+.+. ..+.++|+||+|+++|
T Consensus 125 ~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~ 196 (260)
T cd08222 125 R---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILY 196 (260)
T ss_pred c---CccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHH
Confidence 8 9999999999999975 5699999998865433221 12233478899999988654 5677899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++++|..||...... ....... .. .....+..++.++.+++.+||+.||++||++.|
T Consensus 197 ~l~~~~~~~~~~~~~-------~~~~~~~-~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (260)
T cd08222 197 EMCCLAHAFEGQNFL-------SVVLRIV-EG------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAE 253 (260)
T ss_pred HHHhCCCCCCCccHH-------HHHHHHH-cC------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHH
Confidence 999999998532211 1111111 10 011123456778999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=224.48 Aligned_cols=205 Identities=23% Similarity=0.317 Sum_probs=164.0
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|+++++++. ||||+++++++..+...+++||++.+++|.+++ .....++...++.++.+++.|+.+||
T Consensus 44 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~ql~~~l~~Lh 119 (280)
T cd05581 44 KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLH 119 (280)
T ss_pred HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999998 999999999999999999999999999999988 23447999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc------------------ccccccCCccccCCcceeec
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF------------------VSISATRGTIGYIAPELISR 148 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~ 148 (238)
+. +++|+|++|+||+++.++.++++|||.+......... .......++..|+|||....
T Consensus 120 ~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred HC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 98 9999999999999999999999999988755433211 11122347789999998876
Q ss_pred CCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 149 NFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 149 ~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
. ..+.++|+||||++++++++|..||........ ... ...... ..+..+++.+.+++.+||+.
T Consensus 197 ~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~-~~~~~~-------~~~~~~~~~~~~li~~~l~~ 259 (280)
T cd05581 197 K--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-------FQK-ILKLEY-------SFPPNFPPDAKDLIEKLLVL 259 (280)
T ss_pred C--CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-------HHH-HHhcCC-------CCCCccCHHHHHHHHHHhcC
Confidence 5 578889999999999999999999875432111 000 100000 11123367889999999999
Q ss_pred CCCCCCCC
Q 037755 229 KPADRPSM 236 (238)
Q Consensus 229 dp~~Rps~ 236 (238)
||.+|||+
T Consensus 260 ~p~~R~~~ 267 (280)
T cd05581 260 DPQDRLGV 267 (280)
T ss_pred CHhhCCCc
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=257.09 Aligned_cols=208 Identities=22% Similarity=0.487 Sum_probs=154.1
Q ss_pred HHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCc
Q 037755 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVC 92 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 92 (238)
..|++.+++++||||+++++++.+....++||||+++|+|.+++ ..+++..+..++.+++.|++|||..+..+
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 803 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPA 803 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH-------hcCCHHHHHHHHHHHHHHHHHhccCCCCC
Confidence 45789999999999999999999999999999999999999998 24788999999999999999999655569
Q ss_pred eeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcC
Q 037755 93 ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172 (238)
Q Consensus 93 i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g 172 (238)
++|||+||+||+++.++..++. ++........ ....++..|+|||.+.+. .++.++||||||+++|||++|
T Consensus 804 iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred eecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhC
Confidence 9999999999999988776664 4433211111 112478899999998775 678899999999999999999
Q ss_pred CCCCCcccccccCCcchhhhhhhhccC-----CCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 173 RRNSNLKATRSSKAYFPSWVSDQLNKG-----GNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 173 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+.||...... ......+........ .................++.+++.+||+.||++|||++|
T Consensus 875 ~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 943 (968)
T PLN00113 875 KSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943 (968)
T ss_pred CCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence 9998432211 111222222111110 000111111122334567889999999999999999864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=231.99 Aligned_cols=222 Identities=19% Similarity=0.277 Sum_probs=157.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--------------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--------------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ 72 (238)
...+.+.+|++++++++||||+++++.+... ...++++||+. ++|.+++ ....+++..++
T Consensus 44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~-----~~~~l~~~~~~ 117 (342)
T cd07854 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL-----EQGPLSEEHAR 117 (342)
T ss_pred chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHH-----HcCCCCHHHHH
Confidence 3456788999999999999999999876543 35789999996 5888877 23468899999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCC
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNF 150 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~ 150 (238)
.++.||+.|+.|||+. +++||||||+||+++ .++.++++|||.+.......... ......++..|+|||.+.+.
T Consensus 118 ~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 193 (342)
T cd07854 118 LFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP- 193 (342)
T ss_pred HHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCc-
Confidence 9999999999999998 999999999999997 45678999999986443221111 11222478889999987542
Q ss_pred CcccccCceehHHHHHHHHhcCCCCCCcccccccCCcc---------------hhhhhhhhccCCCccccchhHHHHHHH
Q 037755 151 GTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF---------------PSWVSDQLNKGGNLELRNVTEIESMIA 215 (238)
Q Consensus 151 ~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (238)
..++.++|+||||+++|+|++|+.||............ .........................++
T Consensus 194 ~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (342)
T cd07854 194 NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVN 273 (342)
T ss_pred cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCC
Confidence 25678899999999999999999999644321110000 000000000000011111112223466
Q ss_pred HHHHHHHhhhccCCCCCCCCCCC
Q 037755 216 RKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 216 ~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.++.+|+.+||+.||++|||++|
T Consensus 274 ~~~~~li~~~L~~dP~~R~t~~e 296 (342)
T cd07854 274 PEALDFLEQILTFNPMDRLTAEE 296 (342)
T ss_pred HHHHHHHHHHhCCCchhccCHHH
Confidence 78899999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=225.26 Aligned_cols=219 Identities=20% Similarity=0.299 Sum_probs=161.2
Q ss_pred HHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 10 EEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 10 ~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
....+|+..+++++ |||++++++++..+...++|+||+ +++|.+.+.... +..++...+..++.|++.++.|||++
T Consensus 42 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~ 118 (283)
T cd07830 42 CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH 118 (283)
T ss_pred HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567999999999 999999999999999999999999 779988873222 35789999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+. ...+.++|+||||+++++
T Consensus 119 ---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~e 191 (283)
T cd07830 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAE 191 (283)
T ss_pred ---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHH
Confidence 9999999999999999999999999998755432211 223478889999988653 356889999999999999
Q ss_pred HhcCCCCCCcccccccCCcc--------h-hhhhhh--hccC-CCcccc---chhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYF--------P-SWVSDQ--LNKG-GNLELR---NVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~--------~-~~~~~~--~~~~-~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
|++|..||............ . .+.... .... ...... .........+..+.+++.+||+.||++|
T Consensus 192 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 271 (283)
T cd07830 192 LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKR 271 (283)
T ss_pred HHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccC
Confidence 99999998655332110000 0 000000 0000 000000 0111111225779999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+.|
T Consensus 272 pt~~e 276 (283)
T cd07830 272 PTASQ 276 (283)
T ss_pred CCHHH
Confidence 99864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=224.82 Aligned_cols=225 Identities=22% Similarity=0.282 Sum_probs=169.0
Q ss_pred CCCcccccHHHHHHHHHHHhhcC--CCc----ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHH
Q 037755 1 MLENSKFSAEEFINEVSTIGRIH--HVN----VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74 (238)
Q Consensus 1 ~l~~~~~~~~~~~~e~~~l~~l~--h~n----i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~ 74 (238)
|+++-...++...-|+++|+++. -|+ ++.+.++|+-.++.|+|||.+ |-|+.+++ ..+...+++..++..+
T Consensus 121 Iik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFl--k~N~y~~fpi~~ir~m 197 (415)
T KOG0671|consen 121 IIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFL--KENNYIPFPIDHIRHM 197 (415)
T ss_pred HHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHh--ccCCccccchHHHHHH
Confidence 35566777888899999999993 333 788999999999999999988 66999999 4444568899999999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEcc--------------------CCccccccccccccCCCCCcccccccc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH--------------------NFVPNVSDFGLAKFHPKENDFVSISAT 134 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~--------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~ 134 (238)
..|+++++++||++ +++|.|+||+||++-+ +..++++|||.+++..... +..
T Consensus 198 ~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~i 269 (415)
T KOG0671|consen 198 GYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STI 269 (415)
T ss_pred HHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----cee
Confidence 99999999999999 9999999999999932 2357899999988665443 223
Q ss_pred CCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCc-------chhhhhhhh-----------
Q 037755 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY-------FPSWVSDQL----------- 196 (238)
Q Consensus 135 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~----------- 196 (238)
..|..|+|||++.+. .++.++||||+||+++|+.+|.-.|......+.... ++.......
T Consensus 270 VsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rl 347 (415)
T KOG0671|consen 270 VSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRL 347 (415)
T ss_pred eeccccCCchheecc--CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccc
Confidence 489999999999997 889999999999999999999988865553331111 111111111
Q ss_pred ccCCCc-------------cccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 197 NKGGNL-------------ELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 197 ~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+.... .+.......+.....|.+|+.+||..||++|+|+.|
T Consensus 348 dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 348 DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 000000 000111122345667999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=239.30 Aligned_cols=215 Identities=28% Similarity=0.432 Sum_probs=174.4
Q ss_pred CCcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
|+.+....++|..|+.+|+.++|||+|+++|+|..+...|+|+|||..|+|.+++ ++.....++.-.+++++.||.+|
T Consensus 300 LKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYL--Recnr~ev~avvLlyMAtQIsSa 377 (1157)
T KOG4278|consen 300 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYL--RECNRSEVPAVVLLYMATQISSA 377 (1157)
T ss_pred hhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHH--HHhchhhcchhHHHHHHHHHHHH
Confidence 4556677899999999999999999999999999999999999999999999999 44556788888999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+.||... +.+||||...|+|+.++..||+.|||+++++.... ........-+..|.|||.+.-. ..+.++|||+
T Consensus 378 MeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyN--tFSiKSDVWA 451 (1157)
T KOG4278|consen 378 MEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--TFSIKSDVWA 451 (1157)
T ss_pred HHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCccccccc--ccccchhhHH
Confidence 9999999 99999999999999999999999999998775432 2222223356789999998754 7789999999
Q ss_pred HHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++||+.| |-.|+.+-...+ +-..+ +..-+.+.+..+++.+++|++.||+.+|++||+++|
T Consensus 452 FGVLLWEIATYGMsPYPGidlSq--------VY~LL------EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 452 FGVLLWEIATYGMSPYPGIDLSQ--------VYGLL------EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAE 515 (1157)
T ss_pred HHHHHHHHHhcCCCCCCCccHHH--------HHHHH------hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHH
Confidence 9999999986 556664322111 00111 112233445668899999999999999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=231.73 Aligned_cols=217 Identities=20% Similarity=0.268 Sum_probs=159.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe------eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|+.+++++.|||++++.+++..... .+++++|+ +++|.+++. ...+++..+..++.+++.
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~ 129 (343)
T cd07851 56 IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILR 129 (343)
T ss_pred hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHH
Confidence 345677889999999999999999998765443 89999998 569988882 357899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|+.|||+. +++|+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+. ...+.++|+|
T Consensus 130 aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dvw 200 (343)
T cd07851 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIW 200 (343)
T ss_pred HHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCC-CCCCchHhHH
Confidence 99999998 9999999999999999999999999998754332 1223477889999988653 2567889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcc--------hhhhhhh--------hccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYF--------PSWVSDQ--------LNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|||+++|++++|+.||...........+ +...... ..................+++.+.+++.+
T Consensus 201 slGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~ 280 (343)
T cd07851 201 SVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK 280 (343)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHH
Confidence 9999999999999999643321100000 0000000 00000000000111112347789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||+.|
T Consensus 281 ~l~~~P~~Rpt~~e 294 (343)
T cd07851 281 MLVLDPDKRITAAE 294 (343)
T ss_pred hCCCChhhCCCHHH
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=228.00 Aligned_cols=222 Identities=20% Similarity=0.215 Sum_probs=157.9
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
..+++.+|+.+++++ .||||+++++.... ....+++++++. ++|.+.+ .....++...+..++.||+.||
T Consensus 44 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL 118 (332)
T cd07857 44 LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQII----RSGQPLTDAHFQSFIYQILCGL 118 (332)
T ss_pred hHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHH
Confidence 356788999999999 59999999987532 245788889885 6898887 3346789999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCCCcccccCcee
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
.|||+. +++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. ..++.++|+|
T Consensus 119 ~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~ 194 (332)
T cd07857 119 KYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVW 194 (332)
T ss_pred HHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHH
Confidence 999999 99999999999999999999999999987544322111 11223588899999987653 3567889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCC--------cchhhhhh--------hhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKA--------YFPSWVSD--------QLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|+|+++|++++|..||.......... ........ ...................++..+.+++.+
T Consensus 195 slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (332)
T cd07857 195 SVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEK 274 (332)
T ss_pred HHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHH
Confidence 99999999999999986533111000 00000000 000000000111111112246788999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||+.|
T Consensus 275 ~l~~~P~~R~t~~~ 288 (332)
T cd07857 275 LLAFDPTKRISVEE 288 (332)
T ss_pred HccCCcccCCCHHH
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.81 Aligned_cols=214 Identities=21% Similarity=0.276 Sum_probs=155.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
...+.+|+.++++++||||+++++++... ...+++++|+. .+|.... +..++...+..++.|++.|+
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL 130 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGL 130 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHH
Confidence 45688999999999999999999998654 34689999985 4776655 34688999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+|||+. +++||||+|+||+++.++.++|+|||++....... ....++..|+|||.+.+. ..++.++|+|||
T Consensus 131 ~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~sl 201 (342)
T cd07879 131 KYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSV 201 (342)
T ss_pred HHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHH
Confidence 999999 99999999999999999999999999986543221 123467889999998653 246788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcch-------hhhhhhhcc---------CCCccccchhHHHHHHHHHHHHHHhhhc
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFP-------SWVSDQLNK---------GGNLELRNVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl 226 (238)
|+++|+|++|+.||...........+. ....+.... ................++.+.+++.+||
T Consensus 202 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 281 (342)
T cd07879 202 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281 (342)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHc
Confidence 999999999999997543211000000 000000000 0000000111111234667899999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||++|||++|
T Consensus 282 ~~dP~~R~~~~e 293 (342)
T cd07879 282 ELDVDKRLTATE 293 (342)
T ss_pred CCChhhCcCHHH
Confidence 999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=227.29 Aligned_cols=222 Identities=22% Similarity=0.267 Sum_probs=156.6
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeC--------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEG--------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+|++++++++||||+++++++.+. ...+++++|+.+ ++...+. .....+++..+..++.|++.
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~ 126 (311)
T cd07866 51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLE 126 (311)
T ss_pred chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHH
Confidence 35678999999999999999999987443 346999999865 6766662 23457999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc---------ccccCCccccCCcceeecCCC
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS---------ISATRGTIGYIAPELISRNFG 151 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~ 151 (238)
||.|||+. +++|+|++|+||++++++.++|+|||++........... .....++..|+|||.+.+. .
T Consensus 127 al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~ 202 (311)
T cd07866 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-R 202 (311)
T ss_pred HHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-C
Confidence 99999999 999999999999999999999999998865433221111 0112357789999987653 2
Q ss_pred cccccCceehHHHHHHHHhcCCCCCCcccccccCCcc------------hhh--hhhhhc-cCCCccccchhHHHHHHHH
Q 037755 152 TVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF------------PSW--VSDQLN-KGGNLELRNVTEIESMIAR 216 (238)
Q Consensus 152 ~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~------------~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~ 216 (238)
.++.++|+||||+++|+|++|.+||...........+ +.+ ...... ..................+
T Consensus 203 ~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (311)
T cd07866 203 RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGP 282 (311)
T ss_pred ccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCCh
Confidence 4678899999999999999999998654332110000 000 000000 0000000011111123446
Q ss_pred HHHHHHhhhccCCCCCCCCCCC
Q 037755 217 KLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 217 ~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+.+++.+||+.||++|||+.|
T Consensus 283 ~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 283 EGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred hHHHHHHHHcccCcccCcCHHH
Confidence 7899999999999999999754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=217.41 Aligned_cols=170 Identities=22% Similarity=0.311 Sum_probs=141.0
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccC-CCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFP-KESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...-+|+.+++.++|||++.+..++-+ +..+++++||.+. +|...+.- .....+.++...++.+++||+.|++|||+
T Consensus 72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence 445789999999999999999998855 8899999999965 88877722 22334578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccC----CccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehH
Q 037755 88 GCDVCILHLDIKPHNILLDHN----FVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+ =|.|||+||.|||+..+ |+|||+|+|+++.....-.... ...-.-|.+|+|||++.|. -.+|++.|+|+.
T Consensus 151 N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAi 226 (438)
T KOG0666|consen 151 N---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAI 226 (438)
T ss_pred h---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHH
Confidence 8 89999999999999877 8999999999987766543332 1222378999999999986 468999999999
Q ss_pred HHHHHHHhcCCCCCCccccccc
Q 037755 163 GMVLLEMTGGRRNSNLKATRSS 184 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~ 184 (238)
||++.||++-++.|........
T Consensus 227 GCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 227 GCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred HHHHHHHHccCccccchhhhcc
Confidence 9999999999988866554443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.92 Aligned_cols=216 Identities=19% Similarity=0.241 Sum_probs=159.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
..+++.+|+.++++++||||+++++++.... ..++|++++ +++|.+++ ....+++..+..++.|++.|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM-----KHEKLSEDRIQFLVYQMLKG 130 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHH
Confidence 3467889999999999999999999986543 358999998 67998877 23578999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
++|||+. +++||||+|+||+++.++.++++|||.+....... ....++..|+|||.+.+. ...+.++|+||
T Consensus 131 l~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s 201 (343)
T cd07880 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWS 201 (343)
T ss_pred HHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHH
Confidence 9999999 99999999999999999999999999987543321 122478889999998753 24678899999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCc-------chhhhhhhhccC---------CCccccchhHHHHHHHHHHHHHHhhh
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAY-------FPSWVSDQLNKG---------GNLELRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~c 225 (238)
||+++|++++|..||........... .+......+... ..............+++.+.+++.+|
T Consensus 202 lG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 281 (343)
T cd07880 202 VGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKM 281 (343)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHH
Confidence 99999999999999965432110000 000000000000 00000011112234567789999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||++|||+.|
T Consensus 282 l~~dP~~R~t~~~ 294 (343)
T cd07880 282 LVLDAESRITAAE 294 (343)
T ss_pred cCCChhhCCCHHH
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=219.99 Aligned_cols=202 Identities=23% Similarity=0.287 Sum_probs=167.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...+-..|-.+|+..+||.+..+--.|....++|+||||.+||.|.-++ .....+++.....+-.+|+.||.|||+
T Consensus 211 EVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs 286 (516)
T KOG0690|consen 211 EVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHS 286 (516)
T ss_pred HhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhh
Confidence 3445567889999999999999988999999999999999999998888 445688899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +||.||+|.+|++++.+|++||+|||+|+..-..+. .....+||+.|+|||++... .++...|.|.+|+|+|
T Consensus 287 ~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMY 359 (516)
T KOG0690|consen 287 R---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMY 359 (516)
T ss_pred C---CeeeeechhhhheeccCCceEeeecccchhcccccc--eeccccCChhhcCchhhccc--cccceeehhhhhHHHH
Confidence 8 999999999999999999999999999975544332 23556799999999999987 8899999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
||++|+.||........ +.... ...-..+..++++.+.|+...|..||.+|.-
T Consensus 360 EMmCGRLPFyn~dh~kL---FeLIl------------~ed~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 360 EMMCGRLPFYNKDHEKL---FELIL------------MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred HHHhccCcccccchhHH---HHHHH------------hhhccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 99999999965432211 11111 1111234567888999999999999999964
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=236.29 Aligned_cols=216 Identities=24% Similarity=0.279 Sum_probs=173.9
Q ss_pred cccccHHHHHHHHHHHhhc-CCCcceeeeeEEE-----eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASG 77 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (238)
-.....+.+.-|..+|+.+ .|||++.+++++. .++.+|+|||||.+||+.+.+. ...+..+.+..+.+|+..
T Consensus 54 ~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVK--n~~g~rl~E~~IaYI~re 131 (953)
T KOG0587|consen 54 PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVK--NTKGNRLKEEWIAYILRE 131 (953)
T ss_pred CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHh--hhcccchhhHHHHHHHHH
Confidence 3455567888999999999 5999999999984 3568999999999999999984 344889999999999999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC---Cccc
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVS 154 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~ 154 (238)
++.|+.+||++ .++|||+|-.|||++.++.||+.|||++....... .......||+.|+|||++.... +.++
T Consensus 132 ~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd 206 (953)
T KOG0587|consen 132 ILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYD 206 (953)
T ss_pred HHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcc
Confidence 99999999999 99999999999999999999999999986554432 2334556999999999997642 2467
Q ss_pred ccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
.++|+||||++..||.-|.+|+...++.-.. ..-..++.+... -+..=++++.+||..||..|...||
T Consensus 207 ~R~D~WsLGITaIEladG~PPl~DmHPmraL----------F~IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP 274 (953)
T KOG0587|consen 207 YRSDLWSLGITAIEMAEGAPPLCDMHPMRAL----------FLIPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRP 274 (953)
T ss_pred cccchhhccceeehhcCCCCCccCcchhhhh----------ccCCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCc
Confidence 8899999999999999999998765544221 111222222221 2345678899999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
++.+
T Consensus 275 ~~~~ 278 (953)
T KOG0587|consen 275 STEE 278 (953)
T ss_pred chhh
Confidence 9754
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=221.38 Aligned_cols=210 Identities=20% Similarity=0.323 Sum_probs=156.1
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....+.+|+.++.+.. ||||+++++++.++...++++||+. +++.+.... ....+++..+..++.+++.|++|||
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH 131 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLK 131 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456677887777775 9999999999999999999999985 477666522 2347889999999999999999999
Q ss_pred c-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC--CcccccCceehHH
Q 037755 87 N-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~~Di~slG 163 (238)
+ . +++||||+|+||++++++.++|+|||.+........ .....++..|+|||.+.+.. ...+.++|+||||
T Consensus 132 ~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG 205 (296)
T cd06618 132 EKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205 (296)
T ss_pred hhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHH
Confidence 6 5 899999999999999999999999998865433221 12224778899999987542 2467889999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|+.||....... .......... ...... ...++.++.+++.+||+.||.+|||++|
T Consensus 206 ~il~el~~g~~p~~~~~~~~------~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 206 ISLVELATGQFPYKNCKTEF------EVLTKILQEE-PPSLPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred HHHHHHHhCCCCCCcchhHH------HHHHHHhcCC-CCCCCC----CCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999999985422110 0000111110 000000 0135667899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=231.33 Aligned_cols=166 Identities=25% Similarity=0.381 Sum_probs=141.2
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
+...+++.-+|+++|++++|||||+++++=++.. ...++||||.||||...+.+.++ ...+++.++..++.++
T Consensus 51 ~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~ 129 (732)
T KOG4250|consen 51 SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDL 129 (732)
T ss_pred ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHH
Confidence 4567899999999999999999999999876544 57899999999999999965553 3589999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEc--cCC--ccccccccccccCCCCCccccccccCCccccCCcceeecCCCccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLD--HNF--VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~--~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+.|++|||++ +|+||||||.||++. .+| ..||+|||.++...+... .....||..|++||.+... ..++
T Consensus 130 ~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q-~~y~ 202 (732)
T KOG4250|consen 130 VSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSL---FTSLVGTEEYLHPELYERQ-KKYT 202 (732)
T ss_pred HHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCe---eeeecCchhhcChHHHhhc-cCcC
Confidence 9999999999 999999999999995 333 359999999986666542 2334599999999999841 2678
Q ss_pred ccCceehHHHHHHHHhcCCCCCCc
Q 037755 155 CKSDVYGFGMVLLEMTGGRRNSNL 178 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~g~~p~~~ 178 (238)
...|.||||+++|+++||..||..
T Consensus 203 ~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 203 ATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ceeehhhhhhHHHHHhccCCCCCc
Confidence 889999999999999999999953
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=222.78 Aligned_cols=221 Identities=22% Similarity=0.260 Sum_probs=163.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++|+|++++++++.+....++++||+. ++|.+++... ...++...+..++.+++.|+++||+
T Consensus 41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~ 116 (282)
T cd07829 41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS 116 (282)
T ss_pred ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34677899999999999999999999999999999999997 5999988321 2578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||+|+||++++++.++|+|||.+........ ......++..|+|||.+.+. ...+.++|+||||+++|
T Consensus 117 ~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~ 190 (282)
T cd07829 117 H---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFA 190 (282)
T ss_pred C---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHH
Confidence 9 999999999999999999999999999875543321 11223356789999988653 35678899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchh-------hhhhhhc-----c--CCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPS-------WVSDQLN-----K--GGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~-------~~~~~~~-----~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
++++|..||...........+.. ....... . ................+..+.+++.+||+.||++|
T Consensus 191 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 270 (282)
T cd07829 191 EMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKR 270 (282)
T ss_pred HHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccC
Confidence 99999999865442211000000 0000000 0 00000001111122346789999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
|+++|
T Consensus 271 p~~~~ 275 (282)
T cd07829 271 ISAKE 275 (282)
T ss_pred CCHHH
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=225.41 Aligned_cols=216 Identities=18% Similarity=0.246 Sum_probs=155.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
..+.+.+|+.++++++||||+++++++... ...+++++++ +++|.+.+ ....+++..+..++.|++.|
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~-----~~~~l~~~~~~~i~~qi~~a 132 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQILRG 132 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHH
Confidence 356788999999999999999999988543 3467888877 77998877 23468899999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
++|||+. +++||||||+||+++.++.++|+|||++....... ....++..|+|||.+.+. ...+.++|+||
T Consensus 133 L~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dvws 203 (345)
T cd07877 133 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWS 203 (345)
T ss_pred HHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCc-cCCCchhhHHH
Confidence 9999999 99999999999999999999999999986443221 223478889999987653 25677899999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcc-------hhhhhhhhccC---------CCccccchhHHHHHHHHHHHHHHhhh
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYF-------PSWVSDQLNKG---------GNLELRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~c 225 (238)
||+++|+|++|+.||...........+ ........... ...............++.+.+++.+|
T Consensus 204 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 283 (345)
T cd07877 204 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 283 (345)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHH
Confidence 999999999999998643321100000 00000000000 00000000000112356789999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||.+|||+.|
T Consensus 284 L~~dp~~R~t~~e 296 (345)
T cd07877 284 LVLDSDKRITAAQ 296 (345)
T ss_pred cCCChhhcCCHHH
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=219.15 Aligned_cols=207 Identities=17% Similarity=0.196 Sum_probs=147.2
Q ss_pred HHHHHHhhcCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 14 NEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 14 ~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.+...++.+.|+|++++++...... ..+++++++. .++.+.+ ......+...+..++.|++.|+.|||+.
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~- 145 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIF----KRIKCKNKKLIKNIMKDMLTTLEYIHEH- 145 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHH----HhhccCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3445566778999999999765433 3466777763 3666655 1223457788899999999999999998
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+++||||||+||+++.++.++|+|||+++......... ......||+.|+|||...+. .++.++||||||+
T Consensus 146 --~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~ 221 (294)
T PHA02882 146 --GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGY 221 (294)
T ss_pred --CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHH
Confidence 99999999999999999999999999987553322111 11223589999999998876 6789999999999
Q ss_pred HHHHHhcCCCCCCcccccccC-CcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSK-AYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||......... ..........+.... ......++.+.+++..||+.+|++||++++
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~ 288 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK--------IKIKNANKFIYDFIECVTKLSYEEKPDYDA 288 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh--------hccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence 999999999999754221110 000011111111110 011234678999999999999999999753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-34 Score=227.92 Aligned_cols=205 Identities=20% Similarity=0.198 Sum_probs=175.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+.+++..|-.+|..++.|.||++|--|.++..+|++||-|-||.|...+ ...+.+...+...++.-++.|+.||
T Consensus 461 tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYL 536 (732)
T KOG0614|consen 461 TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYL 536 (732)
T ss_pred hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999988 5677899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+.||+||+|++++.+|-+||.|||.+++......+ ...+||+.|.|||++... ..+.+.|.||||++
T Consensus 537 H~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT---wTFcGTpEYVAPEIILnK--GHD~avDyWaLGIl 608 (732)
T KOG0614|consen 537 HRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNK--GHDRAVDYWALGIL 608 (732)
T ss_pred Hhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCce---eeecCCcccccchhhhcc--CcchhhHHHHHHHH
Confidence 999 9999999999999999999999999999988776654 445699999999999876 77888999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+||+++|.+||....+......+ ...+ +....+..+.+...+++++..+.+|.+|.-
T Consensus 609 i~ELL~G~pPFs~~dpmktYn~I----LkGi---------d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 609 IYELLTGSPPFSGVDPMKTYNLI----LKGI---------DKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHcCCCCCCCCchHHHHHHH----Hhhh---------hhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 99999999999765544321111 1111 112345667788889999999999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=233.00 Aligned_cols=214 Identities=25% Similarity=0.410 Sum_probs=168.3
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC---C-------CC--CCCCHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE---S-------RG--QSCSWEKLHE 73 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---~-------~~--~~~~~~~~~~ 73 (238)
.+.+.+..|+++|+.+ .|+||+.+.|.+.++..+++|.||+..|+|..++.... . .. ..++......
T Consensus 343 ~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLls 422 (609)
T KOG0200|consen 343 SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLS 422 (609)
T ss_pred HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHH
Confidence 5678999999999999 59999999999999999999999999999999995443 0 01 2388999999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccc-cccCCccccCCcceeecCCCc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~ 152 (238)
++.||+.|++||++. +++|||+-..|||+..+..+||+|||+++........... +...-+..|+|||.+... .
T Consensus 423 fa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ 497 (609)
T KOG0200|consen 423 FAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--V 497 (609)
T ss_pred HHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--c
Confidence 999999999999999 9999999999999999999999999999855444333211 111135679999999875 8
Q ss_pred ccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
++.++||||+|+++||+++ |..|+..-. ....+...+.++. ..+.+..+++++.++++.||+.+|+
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~-------~~~~l~~~l~~G~------r~~~P~~c~~eiY~iM~~CW~~~p~ 564 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGIP-------PTEELLEFLKEGN------RMEQPEHCSDEIYDLMKSCWNADPE 564 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCCC-------cHHHHHHHHhcCC------CCCCCCCCCHHHHHHHHHHhCCCcc
Confidence 8999999999999999986 566765411 0111112222222 2234455688899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+||+++|
T Consensus 565 ~RP~F~~ 571 (609)
T KOG0200|consen 565 DRPTFSE 571 (609)
T ss_pred cCCCHHH
Confidence 9999764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=226.10 Aligned_cols=208 Identities=23% Similarity=0.387 Sum_probs=171.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
.-++|.+|+.+|.+|+|||++++||++-+ ....||||.+..|||.+.+.+ .....+.......++.||+.|+.||.+
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes 230 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES 230 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh
Confidence 35899999999999999999999999988 788899999999999999944 345678888999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccc-cCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISA-TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+ ++||||+-..|+++.....|||+|||+.+-.+...+.+.... ..-...|.|||.+.-. ..+.++|+|++|+++
T Consensus 231 k---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTi 305 (1039)
T KOG0199|consen 231 K---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTI 305 (1039)
T ss_pred h---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhH
Confidence 9 999999999999999999999999999987777666554432 3366789999999765 778899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||++ |+.||.+...-. +.+.+.++..+. .+..+++++++++..||..+|++|||+.
T Consensus 306 WEMFtyGEePW~G~~g~q--------IL~~iD~~erLp------RPk~csedIY~imk~cWah~paDRptFs 363 (1039)
T KOG0199|consen 306 WEMFTYGEEPWVGCRGIQ--------ILKNIDAGERLP------RPKYCSEDIYQIMKNCWAHNPADRPTFS 363 (1039)
T ss_pred HhhhccCCCCCCCCCHHH--------HHHhccccccCC------CCCCChHHHHHHHHHhccCCccccccHH
Confidence 99996 678886544322 222222222222 2234788999999999999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=210.10 Aligned_cols=207 Identities=25% Similarity=0.313 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|++.+++++|+|++++++++......++++|++.+++|.+++.. ...++...+..++.+++.++.+||+.
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~ 106 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSN 106 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 68999999999999999999999999999999999999999999998832 22388999999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
+++|+|++|+||+++.++.++++|||.+....... ......++..|++||...+. ..+.++|+||+|+++++
T Consensus 107 ---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~ 178 (244)
T smart00220 107 ---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGK--GYGKAVDVWSLGVILYE 178 (244)
T ss_pred ---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccC--CCCchhhHHHHHHHHHH
Confidence 99999999999999999999999999987554432 11233478889999998754 66779999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|..||...... .. ............. .....++..+.+++.+||..||++||++.|
T Consensus 179 l~~~~~p~~~~~~~------~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 179 LLTGKPPFPGDDQL------LE-LFKKIGKPKPPFP----PPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred HHhCCCCCCCCCcH------HH-HHHHHhccCCCCc----cccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 99999988542111 01 1111111111100 000115568899999999999999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=235.26 Aligned_cols=179 Identities=26% Similarity=0.368 Sum_probs=128.0
Q ss_pred eeEEEEeCCCCChhhhccCCCCCCCCC-CHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccc
Q 037755 40 RALVYEFMPNGSLDRHIFPKESRGQSC-SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118 (238)
Q Consensus 40 ~~lv~e~~~~~sL~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~ 118 (238)
+|+-||||+...+.+++. .+... .....+.++.+|+.||+|+|+. |++||||||.|||+++++.|||+|||+
T Consensus 671 LYIQMEyCE~~ll~~iI~----~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIR----RNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGL 743 (1351)
T ss_pred EEEEHhhhhhhHHHHHHH----hcccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeeccccc
Confidence 577888887766666652 22222 4678899999999999999999 999999999999999999999999999
Q ss_pred cccCC------CC----------CccccccccCCccccCCcceeecCCC-cccccCceehHHHHHHHHhcCCCCCCcccc
Q 037755 119 AKFHP------KE----------NDFVSISATRGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMTGGRRNSNLKAT 181 (238)
Q Consensus 119 ~~~~~------~~----------~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~Di~slG~~l~~ll~g~~p~~~~~~ 181 (238)
+.... .. ..........||..|.|||++.+... .++.+.|+||||+|++||+. ||...-
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM- 819 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM- 819 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH-
Confidence 87511 00 00011223459999999999988632 58999999999999999983 332111
Q ss_pred cccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
-...+...+.++..+.. ........+.-.++|++|++.||++||||.|
T Consensus 820 ------ERa~iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 820 ------ERASILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ------HHHHHHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 11223334444333333 2223334556678999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=204.41 Aligned_cols=215 Identities=20% Similarity=0.244 Sum_probs=176.9
Q ss_pred CcccccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
.+.+++.+=.+.|-.+..+. +||.+|.++..|.+++.+++|.||++||+|.-++ .....+|++.+..+..+|+-|
T Consensus 288 ~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~la 363 (593)
T KOG0695|consen 288 VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLA 363 (593)
T ss_pred cCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHH
Confidence 46677777778888888887 5999999999999999999999999999998887 345689999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|.|||+. ||+.||+|.+|+|++..|++|++|+|.|+.....+.+ .+..+||+.|.|||++.+. .++...|.|+
T Consensus 364 l~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd~--tstfcgtpnyiapeilrge--eygfsvdwwa 436 (593)
T KOG0695|consen 364 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGE--EYGFSVDWWA 436 (593)
T ss_pred HHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCcc--cccccCCCcccchhhhccc--ccCceehHHH
Confidence 9999998 9999999999999999999999999999755444433 3566799999999999997 8888999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
||++++|||.|+.||.--..++.......+..+.+.....-.+ ..++-....+++.-|..||.+|.-
T Consensus 437 lgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip-------rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 437 LGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP-------RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc-------ceeehhhHHHHHHhhcCCcHHhcC
Confidence 9999999999999998777776666655555554433222212 223334455777889999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=201.52 Aligned_cols=221 Identities=19% Similarity=0.299 Sum_probs=163.0
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEe--------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSE--------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+|+++|+.++|+|++.+++++.. ....|+||++|+. +|...+ .+....++...+..++..+..|
T Consensus 61 italreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlL---sn~~vr~sls~Ikk~Mk~Lm~G 136 (376)
T KOG0669|consen 61 ITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLL---SNRKVRFSLSEIKKVMKGLMNG 136 (376)
T ss_pred HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHh---cCccccccHHHHHHHHHHHHHH
Confidence 455789999999999999999998833 3458999999964 888887 2334689999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccccc--ccCCccccCCcceeecCCCcccccCce
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS--ATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
|.|+|++ .|+|||+|+.|+|++.+|.++|+|||+++............ ...-|.+|++||.+.|. ..++++.|+
T Consensus 137 L~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDi 212 (376)
T KOG0669|consen 137 LYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDI 212 (376)
T ss_pred HHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchh
Confidence 9999999 99999999999999999999999999996554443322111 22258899999999986 578999999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcchhhhh-------hh------hccCCCc--cccchhHHHHHH-----HHHHH
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVS-------DQ------LNKGGNL--ELRNVTEIESMI-----ARKLC 219 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-------~~------~~~~~~~--~~~~~~~~~~~~-----~~~l~ 219 (238)
|..||++.+|++|.+.+.+.........+..... +. +...... ............ .++..
T Consensus 213 WgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~ 292 (376)
T KOG0669|consen 213 WGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEAL 292 (376)
T ss_pred HhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHH
Confidence 9999999999999998876655543222211111 10 1000000 001111111111 34778
Q ss_pred HHHhhhccCCCCCCCCCCC
Q 037755 220 VIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 220 ~li~~cl~~dp~~Rps~~e 238 (238)
+|+.++|..||.+|+.++|
T Consensus 293 dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 293 DLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred HHHHHHhccCcccCcchHh
Confidence 9999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=212.30 Aligned_cols=213 Identities=20% Similarity=0.282 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEE-eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....-+|.+|-+.|.||.||++|+++. +....|-|+|||+|.+|..++ ...+.+++..+..|..||+.||.||-+
T Consensus 511 hKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNE 586 (775)
T KOG1151|consen 511 HKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNE 586 (775)
T ss_pred HHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhc
Confidence 356678999999999999999999995 445678899999999998888 667899999999999999999999998
Q ss_pred CCCCceeeeccCCCcEEEc---cCCccccccccccccCCCCCcccc-----ccccCCccccCCcceeecC--CCcccccC
Q 037755 88 GCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKFHPKENDFVS-----ISATRGTIGYIAPELISRN--FGTVSCKS 157 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~--~~~~~~~~ 157 (238)
. .++|+|-||||.|||+- ..|.+||+|||+++.+........ .+...||.+|++||.+.-. .+..+.+.
T Consensus 587 i-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKV 665 (775)
T KOG1151|consen 587 I-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKV 665 (775)
T ss_pred c-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccce
Confidence 5 67899999999999995 457889999999987655433211 2344599999999977542 45678999
Q ss_pred ceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 158 DVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 158 Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
||||.|+++|..+.|+.||+..............+... ...+.. .+.++.+..+||++||+..-++|..
T Consensus 666 DVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt-----EVqFP~----KPvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 666 DVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT-----EVQFPP----KPVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred eeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce-----eccCCC----CCccCHHHHHHHHHHHHhhhhhhhh
Confidence 99999999999999999998655544322222221111 111111 1345678889999999887777653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=227.78 Aligned_cols=210 Identities=22% Similarity=0.232 Sum_probs=156.1
Q ss_pred HHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
.+...+|++.|+.- .|||||++++.-.+++..|+..|.|. .+|.+++.................++.|+++||++||+
T Consensus 546 ~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs 624 (903)
T KOG1027|consen 546 FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS 624 (903)
T ss_pred HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh
Confidence 35667999999999 59999999999999999999999995 59999995421111111114567889999999999999
Q ss_pred CCCCceeeeccCCCcEEEcc---C--CccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 88 GCDVCILHLDIKPHNILLDH---N--FVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~---~--~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
. +||||||||.||||+. + .+++|.|||+|+........ ...+...||.+|.|||.+... ..+.++||||
T Consensus 625 l---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFs 699 (903)
T KOG1027|consen 625 L---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFS 699 (903)
T ss_pred c---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcc--ccCcccchhh
Confidence 8 9999999999999975 2 46789999999876655432 223455699999999999876 5567899999
Q ss_pred HHHHHHHHhcC-CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGG-RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||++|+.++| .+||+..-..+.. + .........+.. ....+..+||.+|+++||..||||.+
T Consensus 700 lGCvfyYvltgG~HpFGd~~~R~~N--I------l~~~~~L~~L~~------~~d~eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 700 LGCVFYYVLTGGSHPFGDSLERQAN--I------LTGNYTLVHLEP------LPDCEAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred cCceEEEEecCCccCCCchHHhhhh--h------hcCccceeeecc------CchHHHHHHHHHhcCCCcccCCCHHH
Confidence 99999999887 7899754333210 0 000000001111 11117789999999999999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=217.46 Aligned_cols=198 Identities=20% Similarity=0.256 Sum_probs=159.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
+....+.|-+||....++=||++|-.|.+++.+|+||+|++||++..++. +.+-+.+..++.+..++..|+.+.|.
T Consensus 672 QvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHk 747 (1034)
T KOG0608|consen 672 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHK 747 (1034)
T ss_pred hhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHh
Confidence 45677889999999999999999999999999999999999999999883 45678889999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccC---CCC-----Ccc-------------------------------
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH---PKE-----NDF------------------------------- 128 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~---~~~-----~~~------------------------------- 128 (238)
. |.+||||||+|||||.+|++||+|||+|+-. ... +..
T Consensus 748 m---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~ 824 (1034)
T KOG0608|consen 748 M---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQ 824 (1034)
T ss_pred c---cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhh
Confidence 9 9999999999999999999999999998522 110 000
Q ss_pred -ccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccch
Q 037755 129 -VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNV 207 (238)
Q Consensus 129 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (238)
...-...||+.|+|||++... .++-.+|.||.|++||+|+.|+.||...........+..|..-..
T Consensus 825 r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~----------- 891 (1034)
T KOG0608|consen 825 RILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLH----------- 891 (1034)
T ss_pred hhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccc-----------
Confidence 000112399999999999886 778889999999999999999999998888877766655533211
Q ss_pred hHHHHHHHHHHHHHHhhh
Q 037755 208 TEIESMIARKLCVIGLWC 225 (238)
Q Consensus 208 ~~~~~~~~~~l~~li~~c 225 (238)
.....+++++..++|.++
T Consensus 892 ~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 892 IPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred cccccccCHHHHHHHHHH
Confidence 112344566666777664
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=207.58 Aligned_cols=217 Identities=22% Similarity=0.261 Sum_probs=161.5
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccC-CCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP-KESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.+..++..|.+...+- +.||||+++|..=.++.+|+-||.|. .||..+... -.-+...+++.-+-.+..-.+.||.|
T Consensus 104 keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~y 182 (361)
T KOG1006|consen 104 KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDY 182 (361)
T ss_pred HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHH
Confidence 4557788888887776 59999999998888889999999994 477544310 11235688999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|.+. ..|+|||+||+|||++..|.+||+|||+|.....+ .......|...|+|||.+......++.++|+||||+
T Consensus 183 LK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 183 LKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGI 257 (361)
T ss_pred HHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcc
Confidence 9976 48999999999999999999999999998533222 223334588999999999765346899999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++||+.||..|+......... + ..+..+..+.+. ...-..+++..+..++.-||..|-++||+..
T Consensus 258 TL~EvAtG~fPyr~w~svfeq------l-~~Vv~gdpp~l~-~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~ 322 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVFEQ------L-CQVVIGDPPILL-FDKECVHYSFSMVRFINTCLIKDRSDRPKYD 322 (361)
T ss_pred eEeeeecCCCCcchHHHHHHH------H-HHHHcCCCCeec-CcccccccCHHHHHHHHHHhhcccccCcchh
Confidence 999999999998543321110 0 011111111111 1112245788899999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=226.76 Aligned_cols=105 Identities=24% Similarity=0.315 Sum_probs=97.1
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|+.+++.++||||+++++.+......|+||||+.+++|.+++. ....++...++.++.||+.||.|||+.
T Consensus 48 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~ 123 (669)
T cd05610 48 VHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH 123 (669)
T ss_pred HHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4778899999999999999999999999999999999999999999882 335688899999999999999999998
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccc
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
+|+||||||+|||++.++.++|+|||+++
T Consensus 124 ---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 124 ---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred ---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=216.51 Aligned_cols=209 Identities=22% Similarity=0.251 Sum_probs=169.0
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+.+.+|+.||+++.||.||.+...+++..++++|||.+.| ++...+.+ ...+++++...+.+..||+.||+|
T Consensus 603 p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~ 679 (888)
T KOG4236|consen 603 PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILS--SEKGRLPERITKFLVTQILVALRY 679 (888)
T ss_pred CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHH
Confidence 345668899999999999999999999999999999999999965 66666633 335799999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccC---CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHN---FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
||-+ +|+|+|+||+|||+.+. ..+||+|||.++..+...-. ..-.||+.|+|||++... .+...-|+||
T Consensus 680 LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTPAYLaPEVLrnk--GyNrSLDMWS 751 (888)
T KOG4236|consen 680 LHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNK--GYNRSLDMWS 751 (888)
T ss_pred hhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCccccCHHHHhhc--ccccccccee
Confidence 9999 99999999999999743 47899999999977665421 223499999999999887 6777899999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
.|+++|.-+.|..||+.+..-.+ ++ .+....-++.-..++++...+||+..|++.-.+|-|.+
T Consensus 752 VGVIiYVsLSGTFPFNEdEdInd----------QI---QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 752 VGVIIYVSLSGTFPFNEDEDIND----------QI---QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred eeEEEEEEecccccCCCccchhH----------Hh---hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence 99999999999999975432221 11 11122223334467888999999999999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=229.12 Aligned_cols=208 Identities=21% Similarity=0.208 Sum_probs=165.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
+..-|+.|-++|..-..+=|+.++-.|.+..++|+||||++||+|-..+ .+...+|+..++.++.+|+-||.-||+
T Consensus 118 ~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH~ 193 (1317)
T KOG0612|consen 118 ETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLHS 193 (1317)
T ss_pred hHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHHh
Confidence 3456788999998888889999999999999999999999999999988 333489999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~ 164 (238)
. |+|||||||+|||+|..|+++|+|||.|-.....+. ...+...|||-|.+||++... .+.|++.+|.||+|+
T Consensus 194 m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV 269 (1317)
T KOG0612|consen 194 M---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGV 269 (1317)
T ss_pred c---cceeccCCcceeEecccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHH
Confidence 9 999999999999999999999999999977655443 344566799999999998642 246889999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
++|||+.|.-||..+....+...+ .... . .+..+. ...++++..+||.+.+. +|+.|..
T Consensus 270 ~~YEMlyG~TPFYadslveTY~KI---m~hk----~--~l~FP~--~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 270 FMYEMLYGETPFYADSLVETYGKI---MNHK----E--SLSFPD--ETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred HHHHHHcCCCcchHHHHHHHHHHH---hchh----h--hcCCCc--ccccCHHHHHHHHHHhc-Chhhhcc
Confidence 999999999999776655442211 1110 0 111111 12378888999988775 4555543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=192.66 Aligned_cols=216 Identities=16% Similarity=0.262 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHhhcC-CCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 9 AEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..++.+|++||+.|. ||||++++++..+ ...+.+||||++..+..... ..++...+..++.++++||.|+
T Consensus 76 kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyC 148 (338)
T KOG0668|consen 76 KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYC 148 (338)
T ss_pred HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHH
Confidence 468899999999997 9999999999855 45688999999887776665 6788889999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. ||.|||+||.|++++. .-..+|+|+|++.+......... ...+.-|--||++... ..++.+-|+|||||
T Consensus 149 HS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy-~~YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 149 HSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDY-QMYDYSLDMWSLGC 221 (338)
T ss_pred Hhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeec-hhccccHHHHHHHH
Confidence 999 9999999999999995 45689999999988877654322 2356667789998764 46788899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCc---------------------chhhhhhhhccCCCccc-cc-hhHHHHHHHHHHHHH
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAY---------------------FPSWVSDQLNKGGNLEL-RN-VTEIESMIARKLCVI 221 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~l~~l 221 (238)
++..|+..+.||.-.....++.. ++....+.+........ .. ..+....++++..+|
T Consensus 222 mlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDl 301 (338)
T KOG0668|consen 222 MLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDL 301 (338)
T ss_pred HHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHH
Confidence 99999999999964433322111 01111111111111110 00 111122346889999
Q ss_pred HhhhccCCCCCCCCCCC
Q 037755 222 GLWCIQVKPADRPSMTK 238 (238)
Q Consensus 222 i~~cl~~dp~~Rps~~e 238 (238)
+.+.|..|..+|+|+.|
T Consensus 302 ldklLrYDHqeRlTakE 318 (338)
T KOG0668|consen 302 LDKLLRYDHQERLTAKE 318 (338)
T ss_pred HHHHHhhccccccchHH
Confidence 99999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=205.59 Aligned_cols=198 Identities=22% Similarity=0.249 Sum_probs=160.5
Q ss_pred HHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC
Q 037755 13 INEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDV 91 (238)
Q Consensus 13 ~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~ 91 (238)
..|-++|... +-|.++.++..|.+-+++|+||||++||+|.-++ .+-+.+.+..+..++.+|+-||-|||+.
T Consensus 397 m~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k--- 469 (683)
T KOG0696|consen 397 MVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK--- 469 (683)
T ss_pred ehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---
Confidence 3455666655 4678889999999999999999999999999888 3456777888899999999999999999
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG 171 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~ 171 (238)
||+.||||.+||+++.+|++||.|||.|+..-....+ .....||+.|+|||++.-+ .++++.|.||+|+++|||+.
T Consensus 470 gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmla 545 (683)
T KOG0696|consen 470 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLA 545 (683)
T ss_pred CeeeeeccccceEeccCCceEeeecccccccccCCcc--eeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHc
Confidence 9999999999999999999999999999754443322 2455699999999999865 88999999999999999999
Q ss_pred CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 172 GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 172 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|++||.+...+.....+ .... ...+..++.+..++....|...|.+|.-.
T Consensus 546 GQpPFdGeDE~elF~aI---~ehn------------vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 546 GQPPFDGEDEDELFQAI---MEHN------------VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred CCCCCCCCCHHHHHHHH---HHcc------------CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 99999877655431111 1111 12344567788889999999999999643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=205.55 Aligned_cols=225 Identities=24% Similarity=0.332 Sum_probs=162.7
Q ss_pred cccHHHHHHHHHHHhhc--CCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI--HHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
..+.+.|++|-.|.+.. +|+||+++++.-..+. .+++|++|.+.|||.+++ +...+++.....++..++
T Consensus 243 ~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL-----~~ntisw~~~cria~Sma 317 (534)
T KOG3653|consen 243 EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL-----KANTISWNSLCRIAESMA 317 (534)
T ss_pred HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH-----HhccccHHHHHHHHHHHH
Confidence 35678899999999886 7999999999875554 899999999999999999 457899999999999999
Q ss_pred HHHHHhHcC------CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC--
Q 037755 80 HGIEYLHNG------CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-- 151 (238)
Q Consensus 80 ~~l~~Lh~~------~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-- 151 (238)
.||+|||+. .+++|+|||||..|||+.+++.+.|+|||++............-...||.+|+|||++.+...
T Consensus 318 rGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~ 397 (534)
T KOG3653|consen 318 RGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQ 397 (534)
T ss_pred HHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccc
Confidence 999999974 235699999999999999999999999999976655443333333569999999999987522
Q ss_pred --cccccCceehHHHHHHHHhcCCCCCCcccccccCCc----------chhhhhhhhccCCCccccchhHHHH-HHHHHH
Q 037755 152 --TVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY----------FPSWVSDQLNKGGNLELRNVTEIES-MIARKL 218 (238)
Q Consensus 152 --~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 218 (238)
..-.+.||||+|+|+||++++=.-+....+...... +.......+.+...+.... .... .-..-+
T Consensus 398 d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~--~W~~h~~~~~l 475 (534)
T KOG3653|consen 398 DRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD--AWRKHAGMAVL 475 (534)
T ss_pred cHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChh--hhhcCccHHHH
Confidence 123578999999999999986432221111111111 1111111122211111111 1111 234457
Q ss_pred HHHHhhhccCCCCCCCCCC
Q 037755 219 CVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 219 ~~li~~cl~~dp~~Rps~~ 237 (238)
++.+..||..||+-|.|+.
T Consensus 476 ~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 476 CETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHHHHcCCchhhhhhhH
Confidence 8889999999999999873
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=188.04 Aligned_cols=165 Identities=25% Similarity=0.369 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+..+|+++..+. .+|.+|.++|.+-....+|+.||.|. .||..+......+++.+++..+-+++..+++|+.|||+
T Consensus 88 q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~ 166 (282)
T KOG0984|consen 88 QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS 166 (282)
T ss_pred HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH
Confidence 35567788887776 69999999998888889999999995 48877765556778999999999999999999999998
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC--CCcccccCceehHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMV 165 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Di~slG~~ 165 (238)
+ ..++|||+||+|||++.+|+||++|||++....++- ......|...|+|||.+... ...|+.++||||||++
T Consensus 167 k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGIt 241 (282)
T KOG0984|consen 167 K--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGIT 241 (282)
T ss_pred H--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhh
Confidence 7 489999999999999999999999999985433321 22334588899999998653 1268899999999999
Q ss_pred HHHHhcCCCCCCcc
Q 037755 166 LLEMTGGRRNSNLK 179 (238)
Q Consensus 166 l~~ll~g~~p~~~~ 179 (238)
+.||.+++.|+...
T Consensus 242 miElA~lr~PY~~w 255 (282)
T KOG0984|consen 242 MIEMAILRFPYESW 255 (282)
T ss_pred hhhhhhcccccccc
Confidence 99999999998543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=201.64 Aligned_cols=222 Identities=22% Similarity=0.304 Sum_probs=158.1
Q ss_pred cccHHHHHHHHHHHhhc--CCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI--HHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
..+.+.+.+|.+|++.+ +|+||+.+++....++ .+|+|++|.+.|||.|++ ....++.....+++..++
T Consensus 244 srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~A 318 (513)
T KOG2052|consen 244 SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIA 318 (513)
T ss_pred ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHH-----hhccCCHHHHHHHHHHHh
Confidence 45678899999999875 8999999999875443 689999999999999999 347889999999999999
Q ss_pred HHHHHhHcC-----CCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc--ccccccCCccccCCcceeecCCC-
Q 037755 80 HGIEYLHNG-----CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFG- 151 (238)
Q Consensus 80 ~~l~~Lh~~-----~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~- 151 (238)
+||+|||.. .++.|.|||||+.|||+.+++.+.|+|+|++......... .......||.+|+|||++.....
T Consensus 319 sGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~ 398 (513)
T KOG2052|consen 319 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINM 398 (513)
T ss_pred hhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcCh
Confidence 999999962 2356999999999999999999999999999766554322 22334569999999999865311
Q ss_pred ---cccccCceehHHHHHHHHhcC----------CCCCCcccccccCCcchhhhhhhhccCCCccccchh-HHHHHHHHH
Q 037755 152 ---TVSCKSDVYGFGMVLLEMTGG----------RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVT-EIESMIARK 217 (238)
Q Consensus 152 ---~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 217 (238)
..-+.+||||||+|+||++-+ +.||. .....++.+... .+.+=. ....+..+. -........
T Consensus 399 ~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy--d~Vp~DPs~eeM-rkVVCv-~~~RP~ipnrW~s~~~l~~ 474 (513)
T KOG2052|consen 399 KHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY--DVVPSDPSFEEM-RKVVCV-QKLRPNIPNRWKSDPALRV 474 (513)
T ss_pred hhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc--cCCCCCCCHHHH-hcceee-cccCCCCCcccccCHHHHH
Confidence 223568999999999998753 13432 112222222111 010000 000000000 011234556
Q ss_pred HHHHHhhhccCCCCCCCCC
Q 037755 218 LCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 218 l~~li~~cl~~dp~~Rps~ 236 (238)
+.++|+.||..||+-|.|+
T Consensus 475 m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 475 MAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHHhhcCCchhhhHH
Confidence 7789999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=198.59 Aligned_cols=159 Identities=25% Similarity=0.327 Sum_probs=136.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
..+..+..+|...+..+.|+||++++.++.-. ...|+|||+|. ++|...+ .-.++-..+.+++.|++
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi------~~elDH~tis~i~yq~~ 128 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVI------LMELDHETISYILYQML 128 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHH------HHhcchHHHHHHHHHHH
Confidence 44567788999999999999999999999543 45799999994 5898887 25677788999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.|++|||+. +|+||||||+||++..++.+||.|||+++..... ........+..|.|||++.+. .+...+||
T Consensus 129 ~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~--~~ke~vdi 200 (369)
T KOG0665|consen 129 CGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGM--GYKENVDI 200 (369)
T ss_pred HHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheecc--CCcccchh
Confidence 999999999 9999999999999999999999999999755443 223444588999999999997 58889999
Q ss_pred ehHHHHHHHHhcCCCCCCcc
Q 037755 160 YGFGMVLLEMTGGRRNSNLK 179 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~ 179 (238)
||+||++.||++|...|.+.
T Consensus 201 wSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 201 WSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred hhhhhHHHHHhhceEEecCc
Confidence 99999999999999888643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=228.95 Aligned_cols=195 Identities=18% Similarity=0.209 Sum_probs=133.9
Q ss_pred HhhcCC-CcceeeeeEE-------EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 19 IGRIHH-VNVVQLLGFC-------SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 19 l~~l~h-~ni~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
.+.++| +||+++++++ ......+.++|++ +++|.+++.. ....++...++.++.||+.||.|||++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 455667 6888899987 2223567788887 5699999832 235689999999999999999999999
Q ss_pred CceeeeccCCCcEEEccCC-------------------ccccccccccccCCCCCc--------------cccccccCCc
Q 037755 91 VCILHLDIKPHNILLDHNF-------------------VPNVSDFGLAKFHPKEND--------------FVSISATRGT 137 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~-------------------~~~l~d~~~~~~~~~~~~--------------~~~~~~~~~~ 137 (238)
+|+||||||+|||++..+ .++++|||+++....... ........||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999996544 455666666543211000 0000112378
Q ss_pred cccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHH
Q 037755 138 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARK 217 (238)
Q Consensus 138 ~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (238)
+.|+|||++.+. .++.++|||||||++|||++|..|+...... ....... .. . ... ....+.
T Consensus 179 ~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---------~~~~~~~-~~----~-~~~-~~~~~~ 240 (793)
T PLN00181 179 SWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSRT---------MSSLRHR-VL----P-PQI-LLNWPK 240 (793)
T ss_pred cceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHHH---------HHHHHHh-hc----C-hhh-hhcCHH
Confidence 889999998876 6788999999999999999988776422110 0000000 00 0 000 111334
Q ss_pred HHHHHhhhccCCCCCCCCCCC
Q 037755 218 LCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 218 l~~li~~cl~~dp~~Rps~~e 238 (238)
..+++.+||+.||.+|||+.|
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred HHHHHHHhCCCChhhCcChHH
Confidence 567889999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=219.52 Aligned_cols=211 Identities=23% Similarity=0.387 Sum_probs=171.0
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+...-+.+..|+.+|.++.|||++++++++.... +.+|++|+++|+|.+++. .....+..+..+.|+.||++|+.|
T Consensus 738 ~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~Y 813 (1177)
T KOG1025|consen 738 SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKY 813 (1177)
T ss_pred CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHH
Confidence 3445688999999999999999999999997754 889999999999999993 245789999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ .+|||||-..|||+.+...+|+.|||+++.......-.......-.+.|+|-|.+... .++.++||||+|+
T Consensus 814 Le~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGV 888 (1177)
T KOG1025|consen 814 LEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGV 888 (1177)
T ss_pred HHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhh
Confidence 9998 9999999999999999999999999999866655443333333456788998888765 7899999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++||+|| |..|+......+. .+.++.+.. -..+..++.++..++.+||..|++.||+++|
T Consensus 889 tiWElmTFGa~Py~gi~~~eI--------~dlle~geR------LsqPpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 889 TIWELMTFGAKPYDGIPAEEI--------PDLLEKGER------LSQPPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred hHHHHHhcCCCccCCCCHHHh--------hHHHhcccc------CCCCCCccHHHHHHHHHHhccCcccCccHHH
Confidence 9999985 7778766554432 222222222 2233557788899999999999999999764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=179.40 Aligned_cols=219 Identities=21% Similarity=0.249 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.....+|+-+|+.++|.|||+++++...++++.+|||+|.. +|..++.+ -++.++.+.+...+.|+++++.|+|++
T Consensus 45 pssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh 120 (292)
T KOG0662|consen 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH 120 (292)
T ss_pred cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh
Confidence 35678999999999999999999999999999999999954 88877732 357899999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
++.|||+||.|++++.+|..|+.|||+++-.+-.- ...+...-|.+|.+|.++.+. --++...|+||.||++.|
T Consensus 121 ---nvlhrdlkpqnllin~ngelkladfglarafgipv--rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifae 194 (292)
T KOG0662|consen 121 ---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAE 194 (292)
T ss_pred ---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHH
Confidence 99999999999999999999999999997554432 223445578999999999886 256778999999999999
Q ss_pred Hhc-CCCCCCcccccccCCcchhhhh----------hhhccCCCccccchhH----HHHHHHHHHHHHHhhhccCCCCCC
Q 037755 169 MTG-GRRNSNLKATRSSKAYFPSWVS----------DQLNKGGNLELRNVTE----IESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 169 ll~-g~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
+.. |++.|.+.........+-.... ..+.+........... +.+.+...=.+++++.|.-+|..|
T Consensus 195 lanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qr 274 (292)
T KOG0662|consen 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQR 274 (292)
T ss_pred HhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccc
Confidence 985 5555655444332211100000 0011111111111111 222333345789999999999999
Q ss_pred CCCC
Q 037755 234 PSMT 237 (238)
Q Consensus 234 ps~~ 237 (238)
+|++
T Consensus 275 isae 278 (292)
T KOG0662|consen 275 ISAE 278 (292)
T ss_pred cCHH
Confidence 9985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=183.30 Aligned_cols=159 Identities=22% Similarity=0.237 Sum_probs=116.5
Q ss_pred CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc
Q 037755 50 GSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129 (238)
Q Consensus 50 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 129 (238)
|+|.+++. ..+..+++..++.++.|++.||+|||+. + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILE---VRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 58888882 2245799999999999999999999998 5 999999999999998 99887554322
Q ss_pred cccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhH
Q 037755 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTE 209 (238)
Q Consensus 130 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (238)
..|++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... ................. ..
T Consensus 64 ----~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~-~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILLNGMPADDPRD-RS 130 (176)
T ss_pred ----CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHHHHhccCCccc-cc
Confidence 1488999999999876 67889999999999999999999985432211 11111111111111111 11
Q ss_pred HHHHHHH--HHHHHHhhhccCCCCCCCCCCC
Q 037755 210 IESMIAR--KLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 210 ~~~~~~~--~l~~li~~cl~~dp~~Rps~~e 238 (238)
....+.. .+.+++.+||+.||++|||+.|
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 161 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANH 161 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHH
Confidence 1223333 6999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=191.20 Aligned_cols=215 Identities=21% Similarity=0.283 Sum_probs=165.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEE-EeCCeeeEEEEeCCCCChhhhccC----CCCCCCCCCHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFP----KESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~~~~~~i~ 79 (238)
++.+...+..|.-.+.-++|||+..+.++. ++...+++++.++.-|+|..++.. .....+.++..++..++.|++
T Consensus 327 S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla 406 (563)
T KOG1024|consen 327 SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLA 406 (563)
T ss_pred cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHH
Confidence 345567788888889999999999999987 556788999999999999999841 122345778889999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.|++|||+. +++|.||...|+++++.-+|||+|-.+++..=...-.--......+..|++||.+... .++.++|+
T Consensus 407 ~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDv 481 (563)
T KOG1024|consen 407 MAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDV 481 (563)
T ss_pred HHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhh
Confidence 999999999 9999999999999999999999998887633222211122344578899999999876 78899999
Q ss_pred ehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||+++|||+| |+-|+..-.+.+ +..-++++... ..+.++++++..++..||+.+|++|||.+|
T Consensus 482 WsfGVllWELmtlg~~PyaeIDPfE--------m~~ylkdGyRl------aQP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 482 WSFGVLLWELMTLGKLPYAEIDPFE--------MEHYLKDGYRL------AQPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred HHHHHHHHHHHhcCCCCccccCHHH--------HHHHHhcccee------cCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 999999999997 555553211111 11122222211 234568999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=179.85 Aligned_cols=175 Identities=32% Similarity=0.529 Sum_probs=150.3
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|++.++.+.|++++++++++......++++|++.+++|.+++... ...++...+..++.+++.++++||+.
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~ 111 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN 111 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 578999999999999999999999999989999999999989999988321 14688999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+++|+|++|.||+++. ++.++|+||+.+........ ......+...|.+||..... ...+.+.|+|++|++++
T Consensus 112 ---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~ 185 (215)
T cd00180 112 ---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILY 185 (215)
T ss_pred ---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHH
Confidence 9999999999999998 89999999999875544321 11223477889999988663 35677899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++ ..+.+++.+|++.||++||++.|
T Consensus 186 ~l----------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 186 EL----------------------------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HH----------------------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 98 67888999999999999999753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=208.26 Aligned_cols=199 Identities=18% Similarity=0.183 Sum_probs=124.6
Q ss_pred EeCCeeeEEEEeCCCCChhhhccCCCC----------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeecc
Q 037755 35 SEGSKRALVYEFMPNGSLDRHIFPKES----------------RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDI 98 (238)
Q Consensus 35 ~~~~~~~lv~e~~~~~sL~~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl 98 (238)
..+...++|++|+.+++|.+++..... .+.......+..++.|++.||.|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 455678999999999999888733210 001112345678999999999999998 9999999
Q ss_pred CCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCC--------------------cccccC
Q 037755 99 KPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG--------------------TVSCKS 157 (238)
Q Consensus 99 ~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--------------------~~~~~~ 157 (238)
||+|||++. ++.++|+|||++......... ......+++.|+|||.+..... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 578999999998744332211 1223458899999996532111 123456
Q ss_pred ceehHHHHHHHHhcCCCCCCccccc------ccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 158 DVYGFGMVLLEMTGGRRNSNLKATR------SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 158 Di~slG~~l~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
|||||||++|+|+++..++...... ........|..... ......................+|+.+||+.||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-cccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999876554321100 00000111110000 0000000000011111233456899999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||+.|
T Consensus 440 kR~ta~e 446 (566)
T PLN03225 440 QRISAKA 446 (566)
T ss_pred cCCCHHH
Confidence 9999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=203.08 Aligned_cols=172 Identities=20% Similarity=0.276 Sum_probs=141.2
Q ss_pred CCCcccccHHHHHHHHHHHhhcCC------CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHH
Q 037755 1 MLENSKFSAEEFINEVSTIGRIHH------VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74 (238)
Q Consensus 1 ~l~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~ 74 (238)
|+.++..-...=..|+++|++|.. -++++++-.|...+++|||||.+ ..+|.+.+.. ...+-.+...++..+
T Consensus 464 IIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKK-yG~nvGL~ikaVRsY 541 (752)
T KOG0670|consen 464 IIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKK-YGRNVGLHIKAVRSY 541 (752)
T ss_pred EeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHH-hCcccceeehHHHHH
Confidence 456666666777889999999942 37899999999999999999987 4589888732 223457888999999
Q ss_pred HHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCC-ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 75 ~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
+.|+.-||..|... |++|.||||+|||++++. .+||||||.+........+. ..-+..|.|||++.|. .|
T Consensus 542 aqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~--~y 612 (752)
T KOG0670|consen 542 AQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGL--PY 612 (752)
T ss_pred HHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccccH----HHHHHhccCcceeecC--cc
Confidence 99999999999998 999999999999999664 56999999987665554332 2256789999999997 77
Q ss_pred cccCceehHHHHHHHHhcCCCCCCcccccc
Q 037755 154 SCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 183 (238)
+...|+||.||++||+.||+..|.+.....
T Consensus 613 d~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 613 DYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred cCCccceeeceeeEEeeccceecCCCCcHH
Confidence 888999999999999999998887765443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=194.37 Aligned_cols=98 Identities=28% Similarity=0.502 Sum_probs=83.3
Q ss_pred CcccccHHHHHHHHHHHhhcC-----CC---cceeeeeEE----EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRIH-----HV---NVVQLLGFC----SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l~-----h~---ni~~~~~~~----~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~ 70 (238)
++.+...+....|+++|++++ |+ .||++++.| .++.++|||||++ |.+|..+|.. ...+.++...
T Consensus 112 KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~ 188 (590)
T KOG1290|consen 112 KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSC 188 (590)
T ss_pred ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHH
Confidence 344555677889999999993 22 589999998 4678999999998 6799888843 3456889999
Q ss_pred HHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEE
Q 037755 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL 105 (238)
Q Consensus 71 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~ 105 (238)
++.|+.||+.||.|||+.| ||+|.||||+|||+
T Consensus 189 VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 189 VKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999999999999999988 99999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=200.95 Aligned_cols=153 Identities=23% Similarity=0.328 Sum_probs=134.5
Q ss_pred HHHHHHHhhcC---CCcceeeeeEEEeCCeeeEEEEeC-CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 13 INEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEFM-PNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 13 ~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~-~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.-|++||..++ |+||+|++++|+++..+|+++|.. +|.+|.+++ .....+++..+..|+.|++.|+++||..
T Consensus 614 p~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~ 689 (772)
T KOG1152|consen 614 PSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ 689 (772)
T ss_pred chhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc
Confidence 45999999996 999999999999999999999986 456889988 4567899999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
||||||||-+|+.++++|.+||+|||.+.......- ....||..|.|||++.|. ...++.-|||+||+++|.
T Consensus 690 ---~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~-~y~gk~qdiwalgillyt 761 (772)
T KOG1152|consen 690 ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYT 761 (772)
T ss_pred ---CceecccccccEEEecCCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeE
Confidence 999999999999999999999999998875544332 234599999999999886 345777899999999999
Q ss_pred HhcCCCCCC
Q 037755 169 MTGGRRNSN 177 (238)
Q Consensus 169 ll~g~~p~~ 177 (238)
+...++||.
T Consensus 762 ivykenpyy 770 (772)
T KOG1152|consen 762 IVYKENPYY 770 (772)
T ss_pred EEeccCCCc
Confidence 999998874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-29 Score=188.19 Aligned_cols=167 Identities=24% Similarity=0.379 Sum_probs=138.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
.+..++.+|++.|...+|.|++..+++..-. ...|+++|.+.. +|...+ -....++.+.++..++||+.|
T Consensus 94 ~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRG 168 (449)
T KOG0664|consen 94 ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRG 168 (449)
T ss_pred HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhh
Confidence 4567899999999999999999998887443 246788898854 888877 456789999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|+|||+. +|.||||||.|+|++++...||+|||+++....... .......-|..|+|||++.|. ..++.+.||||
T Consensus 169 LKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWS 243 (449)
T KOG0664|consen 169 LKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWS 243 (449)
T ss_pred hHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh-hhhHHHHHHHHhccHHHhhcc-hhhcCccceeh
Confidence 9999998 999999999999999999999999999985544321 111222367889999999885 46889999999
Q ss_pred HHHHHHHHhcCCCCCCcccccc
Q 037755 162 FGMVLLEMTGGRRNSNLKATRS 183 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~ 183 (238)
.||++.|++.++..|...++.+
T Consensus 244 VGCIFaELLgRrILFQAq~Piq 265 (449)
T KOG0664|consen 244 VGCIFAELLQRKILFQAAGPIE 265 (449)
T ss_pred hhHHHHHHHhhhhhhhccChHH
Confidence 9999999999988886555443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=197.29 Aligned_cols=221 Identities=17% Similarity=0.116 Sum_probs=142.9
Q ss_pred HHHHHHHHhhcCCCcc-----eeeeeEEEe--------CCeeeEEEEeCCCCChhhhccCCCC-----------------
Q 037755 12 FINEVSTIGRIHHVNV-----VQLLGFCSE--------GSKRALVYEFMPNGSLDRHIFPKES----------------- 61 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni-----~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~----------------- 61 (238)
...|+..+.+++|.++ +++++++.. +...++|+||+.+++|.+++.....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3446777777766544 667776642 3568999999999999988843211
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCcc
Q 037755 62 ---RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI 138 (238)
Q Consensus 62 ---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 138 (238)
....+++..+..++.+++.++.|||+. +++||||||+||+++.++.++|+|||++......... ......+++
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp 374 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDP 374 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCc
Confidence 012345677889999999999999998 9999999999999999999999999998644332111 111123578
Q ss_pred ccCCcceeecCCC--------------------cccccCceehHHHHHHHHhcCCC-CCCcccccccCCcchhhhhhhhc
Q 037755 139 GYIAPELISRNFG--------------------TVSCKSDVYGFGMVLLEMTGGRR-NSNLKATRSSKAYFPSWVSDQLN 197 (238)
Q Consensus 139 ~~~aPE~~~~~~~--------------------~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~ 197 (238)
.|+|||.+..... ......|+||+||++|+|++|.. |+...................+.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 9999998753210 11234699999999999999874 55321111100000000000000
Q ss_pred cCCCccccchhHHHHHHHHHHHHHHhhhccCCC---CCCCCCCC
Q 037755 198 KGGNLELRNVTEIESMIARKLCVIGLWCIQVKP---ADRPSMTK 238 (238)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~e 238 (238)
...... ... ......++...+|+.+||..+| .+|+|++|
T Consensus 455 ~~~~~~-~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 455 MYKGQK-YDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred hhcccC-CCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 000000 011 1233457889999999999876 68999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=185.98 Aligned_cols=166 Identities=23% Similarity=0.331 Sum_probs=138.5
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+++.+|++.|..+. +.||+++.+.+..++.+++|+||++.....++. ..++...+..++..++.||+++
T Consensus 76 s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~ 148 (418)
T KOG1167|consen 76 SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHL 148 (418)
T ss_pred cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhh
Confidence 45678999999999995 999999999999999999999999988888877 5677889999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCC-------C--------------------------cccc-
Q 037755 86 HNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKE-------N--------------------------DFVS- 130 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~-------~--------------------------~~~~- 130 (238)
|.+ ||||||+||+|++++ ..++..|+|||++...... . ....
T Consensus 149 h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~ 225 (418)
T KOG1167|consen 149 HKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRR 225 (418)
T ss_pred hcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceec
Confidence 999 999999999999998 5678899999998611000 0 0000
Q ss_pred --------ccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccc
Q 037755 131 --------ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183 (238)
Q Consensus 131 --------~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 183 (238)
.-...||++|.|||++..+ +..+++.||||.|+++.-+++++.||.....+.
T Consensus 226 ~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~ 285 (418)
T KOG1167|consen 226 CNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDA 285 (418)
T ss_pred cCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccceeehhhccccccccCcccc
Confidence 0112399999999999886 677889999999999999999999997665443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-27 Score=174.47 Aligned_cols=207 Identities=19% Similarity=0.256 Sum_probs=151.4
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeee-EEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~-~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....+|.+|..--=.| .|.||+.-|+ .|+..+.+++++||++.|+|.+.+ ....+.+...+.++.|+++|+.|
T Consensus 62 tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~f 136 (378)
T KOG1345|consen 62 TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEF 136 (378)
T ss_pred hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHH
Confidence 4567888888876666 4999998777 578888889999999999999988 33678888999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEc--cCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCce
Q 037755 85 LHNGCDVCILHLDIKPHNILLD--HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDV 159 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di 159 (238)
||++ ++||||||.+|||+- +.-++||+|||..+..+..- .....+..|.+||.+... .....+.+|+
T Consensus 137 MHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~ 208 (378)
T KOG1345|consen 137 MHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDI 208 (378)
T ss_pred hhcc---chhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccc
Confidence 9999 999999999999995 44589999999987554432 222356678899976431 1245678999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
|.||+++|.++||..||.-.... +..+..| ..+...... ..+..-..+++.+..+.++-|..+|++|
T Consensus 209 WqfGIi~f~cltG~~PWQka~~~--d~~Y~~~--~~w~~rk~~---~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 209 WQFGIIFFYCLTGKFPWQKASIM--DKPYWEW--EQWLKRKNP---ALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hheeeeeeeeecCCCcchhhhcc--CchHHHH--HHHhcccCc---cCchhhcccCHHHHHHHHHhcCCccccc
Confidence 99999999999999999732222 1222222 122221111 1112223356677778888999999888
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-26 Score=190.27 Aligned_cols=209 Identities=20% Similarity=0.222 Sum_probs=161.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...-+++|+-+++-.+||||+.+++.+.....+|+.||||.+|+|.+.. .-.+++++.++.+++.+.+.+++|||+
T Consensus 55 d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs 130 (829)
T KOG0576|consen 55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHS 130 (829)
T ss_pred cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhc
Confidence 3455678999999999999999999999999999999999999999876 335789999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeec-CCCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Di~slG~~l 166 (238)
. +-+|||||-.||++++.|.+++.|||.+...+..- .......||+.|+|||+-.- ....+...+|+|++|++.
T Consensus 131 ~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitA 205 (829)
T KOG0576|consen 131 Q---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITA 205 (829)
T ss_pred C---CcccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccch
Confidence 9 99999999999999999999999999986544322 11234569999999998532 234677789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccC--CCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKG--GNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
.|+..-.+|.+....... .....+. ....+.+. ..-.+.+.+|++.+|-.+|++|||++
T Consensus 206 iel~eLqpplfdlhpmr~--------l~LmTkS~~qpp~lkDk----~kws~~fh~fvK~altknpKkRptae 266 (829)
T KOG0576|consen 206 IELGELQPPLFDLHPMRA--------LFLMTKSGFQPPTLKDK----TKWSEFFHNFVKGALTKNPKKRPTAE 266 (829)
T ss_pred hhhhhcCCcccccchHHH--------HHHhhccCCCCCcccCC----ccchHHHHHHHHHHhcCCCccCCChh
Confidence 999877776644333221 1111111 11111111 22345678899999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=168.72 Aligned_cols=162 Identities=28% Similarity=0.422 Sum_probs=136.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCC-CCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQS-CSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|++.++.++|+|++++++++......++++|++.+++|.+++.. ... ++...+..++.+++.++.+||
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh 115 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLH 115 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 578899999999999999999999999998999999999999999998832 223 788999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+|++|+||+++.++.++|+|||.+......... ......++..|++||.+. .....+.++|+|+||+++
T Consensus 116 ~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~ 190 (225)
T smart00221 116 SL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVIL 190 (225)
T ss_pred hC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHH
Confidence 98 9999999999999999999999999988755443200 112234777899999884 223666799999999999
Q ss_pred HHHhcCCCCCCc
Q 037755 167 LEMTGGRRNSNL 178 (238)
Q Consensus 167 ~~ll~g~~p~~~ 178 (238)
+++++|+.||..
T Consensus 191 ~~l~~g~~pf~~ 202 (225)
T smart00221 191 YELLWGPEPFSG 202 (225)
T ss_pred HHHHHCCCCccc
Confidence 999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-26 Score=192.93 Aligned_cols=212 Identities=19% Similarity=0.237 Sum_probs=163.8
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDV 91 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~ 91 (238)
+..|+.+-..++|||++.....+.+.....-.||||++ +|..++ .....+....+..++.|++.|++|+|..
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~--- 439 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM--- 439 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---
Confidence 55677777888999998887777665555555999998 998888 3345788899999999999999999999
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccCCCCCcc--ccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
|+.|||+|++|+++..+|.+||+|||.+......... .......|+..|+|||++.+. .......||||.|+++..|
T Consensus 440 GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~-~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 440 GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGK-EYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccc-ccCcchhhhhhccceEEEE
Confidence 9999999999999999999999999998765554433 334455699999999999886 2345568999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+|+.||........... ................+...++.....+|.+||+.||.+|.|+++
T Consensus 519 ~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~ 581 (601)
T KOG0590|consen 519 ILGRFPWKVAKKSDNSFK------TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQ 581 (601)
T ss_pred ecCCCccccccccccchh------hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence 999999965544433210 001111112233344566778888999999999999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-24 Score=174.21 Aligned_cols=209 Identities=22% Similarity=0.398 Sum_probs=157.6
Q ss_pred HhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCce-eeec
Q 037755 19 IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCI-LHLD 97 (238)
Q Consensus 19 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i-~H~d 97 (238)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++.........+|+.|+.|||+. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4678999999999999999999999999999999999932 456888889999999999999999987 54 9999
Q ss_pred cCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC--c---ccccCceehHHHHHHHHhcC
Q 037755 98 IKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG--T---VSCKSDVYGFGMVLLEMTGG 172 (238)
Q Consensus 98 l~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~---~~~~~Di~slG~~l~~ll~g 172 (238)
+++.|++++..-.+|++|||+.....................|.|||.+..... . .+.+.|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999875543111111111224567899999876311 1 46779999999999999999
Q ss_pred CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 173 RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 173 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
..||...........+... ++.......++......+..+.+..++..||..+|.+||+++
T Consensus 155 ~~~~~~~~~~~~~~eii~~----~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR----VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cCccccccccCChHHHHHH----HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 9999876555543222222 222122222221111125566899999999999999999975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=159.82 Aligned_cols=193 Identities=18% Similarity=0.186 Sum_probs=138.3
Q ss_pred CCCcceeeeeEEEe---------------------------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHH
Q 037755 23 HHVNVVQLLGFCSE---------------------------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVA 75 (238)
Q Consensus 23 ~h~ni~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~ 75 (238)
+|||||++.++|.+ ...+|+||.... .+|..++ .....+......++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl-----~~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYL-----WTRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHH-----hcCCCchHHHHHHH
Confidence 69999999998743 345789998774 4898888 33556677788899
Q ss_pred HHHHHHHHHhHcCCCCceeeeccCCCcEEEc--cCC--ccccccccccccCCCCCc-cccccc---cCCccccCCcceee
Q 037755 76 SGTAHGIEYLHNGCDVCILHLDIKPHNILLD--HNF--VPNVSDFGLAKFHPKEND-FVSISA---TRGTIGYIAPELIS 147 (238)
Q Consensus 76 ~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~--~~~--~~~l~d~~~~~~~~~~~~-~~~~~~---~~~~~~~~aPE~~~ 147 (238)
.|+++|+.|||++ |+.|||+|++|||+. +++ ...+.|||+|--....+. ....+. .-|+-..+|||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999995 333 457899998853322111 011111 12677889999986
Q ss_pred cCCCc----ccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHh
Q 037755 148 RNFGT----VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223 (238)
Q Consensus 148 ~~~~~----~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 223 (238)
.-.+. .-.++|.|+.|.+.||+++..+||........ +.........+.+++.+++.+.+++.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~~r~Yqe~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------DTRTYQESQLPALPSRVPPVARQLVF 491 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-------------chhhhhhhhCCCCcccCChHHHHHHH
Confidence 53111 13478999999999999999999965222111 01111122234456678888999999
Q ss_pred hhccCCCCCCCCCC
Q 037755 224 WCIQVKPADRPSMT 237 (238)
Q Consensus 224 ~cl~~dp~~Rps~~ 237 (238)
..|+.||++|+|..
T Consensus 492 ~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPN 505 (598)
T ss_pred HHhcCCccccCCcc
Confidence 99999999999963
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=152.23 Aligned_cols=206 Identities=17% Similarity=0.296 Sum_probs=155.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.-..+|..|.-.|+.+.||||..+++.+....++.+|..||+.|||...+. +..+...+..++.+.+.+++.+++|||
T Consensus 229 risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlh--e~t~vvvd~sqav~faldiargmaflh 306 (448)
T KOG0195|consen 229 RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLH--EQTSVVVDHSQAVRFALDIARGMAFLH 306 (448)
T ss_pred hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHh--cCccEEEecchHHHHHHHHHhhHHHHh
Confidence 334678899999999999999999999999999999999999999999983 333556778889999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccc--cccccccCCCCCccccccccCCccccCCcceeecCCCc-ccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVS--DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT-VSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~~Di~slG 163 (238)
+. .+-|----+++..++++++-+.+|. |--.+. ......-.+.|++||.+...... .-.++|+|||+
T Consensus 307 sl-ep~ipr~~lns~hvmidedltarismad~kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfa 376 (448)
T KOG0195|consen 307 SL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFA 376 (448)
T ss_pred hc-chhhhhhhcccceEEecchhhhheecccceeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHH
Confidence 86 2334444688899999998777664 322221 11122367899999998765222 23568999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+++||+-|++.||...+..+-...+. .......+++.+++.+..++.-|+..||.+||.++
T Consensus 377 illwel~trevpfadlspmecgmkia-------------leglrv~ippgis~hm~klm~icmnedpgkrpkfd 437 (448)
T KOG0195|consen 377 ILLWELNTREVPFADLSPMECGMKIA-------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD 437 (448)
T ss_pred HHHHHhhccccccccCCchhhhhhhh-------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc
Confidence 99999999999997655443322211 11122334566788999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-21 Score=152.13 Aligned_cols=222 Identities=27% Similarity=0.351 Sum_probs=161.5
Q ss_pred cHHHHHHHHHHHhhcCCC-cceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHV-NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....+.+|+.+++.+.|+ +++++.+.+......+++++++.++++.+.+...... ..++......++.+++.++.++|
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H 118 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH 118 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 467889999999999988 7999999998777789999999999998666211111 37889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCC-ccccccccccccCCCCCccc----cccccCCccccCCcceeecCC-CcccccCcee
Q 037755 87 NGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDFV----SISATRGTIGYIAPELISRNF-GTVSCKSDVY 160 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~ 160 (238)
+. +++|||+||+||+++..+ .++++|||.+.......... ......++..|.+||.+.+.. .......|+|
T Consensus 119 ~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~ 195 (384)
T COG0515 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195 (384)
T ss_pred hC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHH
Confidence 99 999999999999999888 79999999987444332211 124445999999999998731 3677889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCc--cccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNL--ELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++++++++|..||....... ............... ...............+.+++..|+..+|..|.+..
T Consensus 196 s~g~~~~~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 270 (384)
T COG0515 196 SLGITLYELLTGLPPFEGEKNSS----ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270 (384)
T ss_pred HHHHHHHHHHhCCCCCCCCCccc----cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHH
Confidence 99999999999999965444310 000111111111100 00000000023345678899999999999998754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-22 Score=170.99 Aligned_cols=210 Identities=20% Similarity=0.173 Sum_probs=148.4
Q ss_pred cccHHHHHHHHHHHhh--cCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
..+.+.|.++++-.+. .++||++++.-+.....-.|+|-+|.. .+|.|.+ ....-+..-+.+-++.|++.|+.
T Consensus 60 ~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRl----STRPFL~~iEKkWiaFQLL~al~ 134 (1431)
T KOG1240|consen 60 TISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRL----STRPFLVLIEKKWIAFQLLKALS 134 (1431)
T ss_pred CCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhh----ccchHHHHHHHHHHHHHHHHHHH
Confidence 3444555555544443 489999999998888888899999985 5999988 34455667777889999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-cc----ccccCCccccCCcceeecCC--------
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VS----ISATRGTIGYIAPELISRNF-------- 150 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~----~~~~~~~~~~~aPE~~~~~~-------- 150 (238)
.+|+. ||+|||||.+|||+++=+.+.|+||..-+..-...+. .. ......-.+|.|||.+....
T Consensus 135 qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~ 211 (1431)
T KOG1240|consen 135 QCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQD 211 (1431)
T ss_pred HHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCc
Confidence 99999 9999999999999999999999999865322111111 11 11222456899999875521
Q ss_pred -CcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchh-HHHHHHHHHHHHHHhhhcc
Q 037755 151 -GTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVT-EIESMIARKLCVIGLWCIQ 227 (238)
Q Consensus 151 -~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~ 227 (238)
+..+++.||||+||++.|+++ |+++|...+.-..... ...... .+..-.+..+.+++..|++
T Consensus 212 ~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~---------------~~~~~e~~Le~Ied~~~Rnlil~Mi~ 276 (1431)
T KOG1240|consen 212 APLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG---------------NADDPEQLLEKIEDVSLRNLILSMIQ 276 (1431)
T ss_pred ccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc---------------CccCHHHHHHhCcCccHHHHHHHHHc
Confidence 124678999999999999975 6788864433322111 000011 1222234578999999999
Q ss_pred CCCCCCCCCCC
Q 037755 228 VKPADRPSMTK 238 (238)
Q Consensus 228 ~dp~~Rps~~e 238 (238)
.||++|.||++
T Consensus 277 rdPs~RlSAed 287 (1431)
T KOG1240|consen 277 RDPSKRLSAED 287 (1431)
T ss_pred cCchhccCHHH
Confidence 99999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=145.68 Aligned_cols=123 Identities=20% Similarity=0.236 Sum_probs=95.4
Q ss_pred cHHHHHHHHHHHhhcCCCccee-eeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQ-LLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~-~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.++.+.+|+++|++++|+|+++ +++. ...++||||+.|++|.... .. . ...++.+++.+|.|||
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~~----~~-~------~~~~~~~i~~aL~~lH 128 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLAR----PH-G------DPAWFRSAHRALRDLH 128 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHhC----cc-c------hHHHHHHHHHHHHHHH
Confidence 4677999999999999999985 4432 4579999999999996321 10 1 1457889999999999
Q ss_pred cCCCCceeeecc-CCCcEEEccCCccccccccccccCCCCCcccc------ccccCCccccCCcceeec
Q 037755 87 NGCDVCILHLDI-KPHNILLDHNFVPNVSDFGLAKFHPKENDFVS------ISATRGTIGYIAPELISR 148 (238)
Q Consensus 87 ~~~~~~i~H~dl-~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~ 148 (238)
+. ||+|||| ||+||+++.++.++|+|||+++.......... .....+++.|.|||.+..
T Consensus 129 ~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 129 RA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred HC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99 9999999 99999999999999999999986654432111 123347778999998865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=155.56 Aligned_cols=190 Identities=22% Similarity=0.221 Sum_probs=154.5
Q ss_pred HHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 11 EFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 11 ~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+...|..++..++ ||.++++...+..+.++++++++..+|.|...+ .+.....+.........++-++.++|+.
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l- 116 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL- 116 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh-
Confidence 5567888899997 999999999999999999999999999998777 4556777888888999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++++|+|++||+++.+|++++.|||+++..-.... .+||..|+|||++.+ ...++|.||+|++.++|
T Consensus 117 --~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~g----h~~a~D~ws~gvl~fel 184 (612)
T KOG0603|consen 117 --GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIING----HLSAADWWSFGVLAFEL 184 (612)
T ss_pred --HHHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhhc----cCCcccchhhhhhHHHH
Confidence 999999999999999999999999999875433322 158999999999973 35679999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
++|--||..... ..+ +......+...+....+++..++..+|..|.-.
T Consensus 185 ltg~~pf~~~~~--------~~I-----------l~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 185 LTGTLPFGGDTM--------KRI-----------LKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhCCCCCchHHH--------HHH-----------hhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 999999865110 000 011122445667778889999999999888643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-20 Score=146.41 Aligned_cols=165 Identities=18% Similarity=0.234 Sum_probs=109.2
Q ss_pred eEEEEeCCCCChhhhcc---CCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCcccccccc
Q 037755 41 ALVYEFMPNGSLDRHIF---PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117 (238)
Q Consensus 41 ~lv~e~~~~~sL~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~ 117 (238)
+++|+-+ .++|.+.+. ........+.......+..|+++.+++||.. |++|+||+|+|++++.+|.+.|+||+
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcChH
Confidence 6677877 458877752 1122233455566777889999999999999 99999999999999999999999998
Q ss_pred ccccCCCCCccccccccCCccccCCcceeecC------CCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhh
Q 037755 118 LAKFHPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSW 191 (238)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 191 (238)
.....+.... . ...+..|.+||..... ...++.+.|.|+||+++|.+++|+.||...........
T Consensus 191 ~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 191 SLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 7654433221 1 2245678889876442 12467789999999999999999999986655443221
Q ss_pred hhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 192 VSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
....+. .+++.+..||.++|+.||.+|
T Consensus 262 --------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred --------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 112233 678889999999999999988
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.5e-19 Score=141.54 Aligned_cols=162 Identities=20% Similarity=0.226 Sum_probs=131.7
Q ss_pred HHHHHHHHHhhcCC----CcceeeeeEE-EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 11 EFINEVSTIGRIHH----VNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 11 ~~~~e~~~l~~l~h----~ni~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
.+..|+.++..+.. +++..+++.. ..+...++||+.+ |.+|.++... ...+.++..++..++.|++.+|.+|
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~--~~~~~fs~~T~l~ia~q~l~~l~~l 138 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKR--NPPGRFSRKTVLRIAIQNLNALEDL 138 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHh--CCCCCcCHhHHHHHHHHHHHHHHHH
Confidence 68889999999973 5888899888 5777889999987 7799997622 2267899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccC-----CccccccccccccCC--CCCcc----c-c-ccccCCccccCCcceeecCCCc
Q 037755 86 HNGCDVCILHLDIKPHNILLDHN-----FVPNVSDFGLAKFHP--KENDF----V-S-ISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~-----~~~~l~d~~~~~~~~--~~~~~----~-~-~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
|+. |++||||||.|+.++.. ..+.+.|||+++... ..... . . .....||..|.++....+. .
T Consensus 139 H~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e 213 (322)
T KOG1164|consen 139 HSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--E 213 (322)
T ss_pred Hhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--c
Confidence 999 99999999999999854 357899999998332 22110 1 1 1234599999999988876 7
Q ss_pred ccccCceehHHHHHHHHhcCCCCCCccc
Q 037755 153 VSCKSDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
.+.+.|+||++-++.++..|..||....
T Consensus 214 ~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 214 QGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred cCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 7889999999999999999998885433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.8e-19 Score=131.19 Aligned_cols=152 Identities=15% Similarity=0.092 Sum_probs=110.0
Q ss_pred HHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 11 EFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 11 ~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.+.+|+++|++|. |+++++++++ ...+++|+|+.|.+|.... .. . ...++.+++.++.++|+.
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~----~~-~------~~~~~~qi~~~L~~lH~~- 110 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRP----PR-G------DLAYFRAARRLLQQLHRC- 110 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhh----hh-h------hHHHHHHHHHHHHHHHHC-
Confidence 6889999999995 6889999886 3468999999998886543 11 1 134678999999999999
Q ss_pred CCceeeecc-CCCcEEEccCCccccccccccccCCCCCcc---cc--------ccccCCccccCCcceeecCCCcccccC
Q 037755 90 DVCILHLDI-KPHNILLDHNFVPNVSDFGLAKFHPKENDF---VS--------ISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 90 ~~~i~H~dl-~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
||+|||| ||+||+++.++.++|+|||.+......... .. ......++.+++|+...-....--.+.
T Consensus 111 --GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~ 188 (218)
T PRK12274 111 --GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRE 188 (218)
T ss_pred --cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHH
Confidence 9999999 799999999999999999999755443310 00 011124555666664322101112456
Q ss_pred ceehHHHHHHHHhcCCCCCCccc
Q 037755 158 DVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 158 Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
+.++.|.-+|.++|++.+.-.+.
T Consensus 189 ~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 189 LWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHhcchHHHHHhccCCccccC
Confidence 78899999999999997764443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=134.42 Aligned_cols=217 Identities=19% Similarity=0.226 Sum_probs=161.4
Q ss_pred CCcccccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
+|++..--.++..|.++.+.|+ ...|..+..+..++..-.+||+.. |.||++.+ +.....++..+++.++.|++.
T Consensus 47 ~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLf---nfC~R~ftmkTvLMLaDQml~ 122 (341)
T KOG1163|consen 47 LESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLF---NFCSRRFTMKTVLMLADQMLS 122 (341)
T ss_pred eecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHH---HHHhhhhhHHhHHHHHHHHHH
Confidence 4556666678889999999997 578888889999999999999988 78999987 345678999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEcc---CCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCc
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
-+.|+|.. +.+||||||+|+|+.- ...+.++|||+++...+..... ......||.+|.+--...+. .
T Consensus 123 RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--e 197 (341)
T KOG1163|consen 123 RIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI--E 197 (341)
T ss_pred HHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhh--h
Confidence 99999999 9999999999999974 4567899999998665543211 11223488899887666554 5
Q ss_pred ccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
.+.+-|+=|+|-++.++.-|..||.+-......+.+......... .....+....+-++...+..|-..--++
T Consensus 198 qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s-------~~ie~LC~G~P~EF~myl~Y~R~L~F~E 270 (341)
T KOG1163|consen 198 QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS-------TPIEVLCKGFPAEFAMYLNYCRGLGFEE 270 (341)
T ss_pred hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-------CCHHHHhCCCcHHHHHHHHHHhhcCCCC
Confidence 677889999999999999999999765554443333333222221 1223344455666777777776665555
Q ss_pred CC
Q 037755 233 RP 234 (238)
Q Consensus 233 Rp 234 (238)
-|
T Consensus 271 ~P 272 (341)
T KOG1163|consen 271 KP 272 (341)
T ss_pred CC
Confidence 54
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=133.73 Aligned_cols=217 Identities=20% Similarity=0.240 Sum_probs=163.3
Q ss_pred CCcccccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
+|...+.+.++..|...++.|. .++|..++-+..++.+-.+|+|.+ |.||+|++ .-.+..++..++..++.|++.
T Consensus 60 fEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~ 135 (449)
T KOG1165|consen 60 FEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMIT 135 (449)
T ss_pred eccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHH
Confidence 4667778889999999999995 899999999999999999999988 77998877 345789999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccC-----CccccccccccccCCCCCccc-----cccccCCccccCCcceeecCC
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHN-----FVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNF 150 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~-----~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~ 150 (238)
-+.++|++ .+|.|||||+|+||... +.+-++|||+++...+..... ......||.+|++--...+.
T Consensus 136 rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr- 211 (449)
T KOG1165|consen 136 RIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR- 211 (449)
T ss_pred HHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccc-
Confidence 99999999 99999999999999743 356799999998776653221 12223499999998887776
Q ss_pred CcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCC
Q 037755 151 GTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 151 ~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
..+.+-|.=|||-++.+.+-|..||.+-....-...+... +.....-....+...++.++...+...-+.+-
T Consensus 212 -EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI-------Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F 283 (449)
T KOG1165|consen 212 -EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI-------GETKRSTPIEVLCEGFPEEFATYLRYVRRLDF 283 (449)
T ss_pred -hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh-------ccccccCCHHHHHhcCHHHHHHHHHHHHhcCc
Confidence 6788899999999999999999999765544333222221 11222233344555556566555555444444
Q ss_pred CCCC
Q 037755 231 ADRP 234 (238)
Q Consensus 231 ~~Rp 234 (238)
.+-|
T Consensus 284 ~E~P 287 (449)
T KOG1165|consen 284 FETP 287 (449)
T ss_pred ccCC
Confidence 4433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.9e-20 Score=148.49 Aligned_cols=173 Identities=21% Similarity=0.305 Sum_probs=123.9
Q ss_pred eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccc
Q 037755 39 KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118 (238)
Q Consensus 39 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~ 118 (238)
.+++.|++|...+|.+++..+. .+...+......++.|++.++.| . +.+|+|+||.||+...+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999994322 34566778889999999999999 5 899999999999999999999999999
Q ss_pred cccCCCCCc----cccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcC-CCCCCcccccccCCcchhhhh
Q 037755 119 AKFHPKEND----FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG-RRNSNLKATRSSKAYFPSWVS 193 (238)
Q Consensus 119 ~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~ 193 (238)
......... ........||.+|++||.+.+. .++.++||||||++++|++.- .-.+. .....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~ 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFE-----------RIATL 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhh
Confidence 765444331 1112233499999999999997 889999999999999999862 11110 00011
Q ss_pred hhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 194 DQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
..+.++..+ +....+ .+.-..|+.+++++.|.+||++.
T Consensus 470 ~d~r~g~ip-----~~~~~d-~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 470 TDIRDGIIP-----PEFLQD-YPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhhhcCCCC-----hHHhhc-CcHHHHHHHHhcCCCcccCchHH
Confidence 111111111 011111 23345799999999999999753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-19 Score=135.72 Aligned_cols=168 Identities=23% Similarity=0.341 Sum_probs=129.2
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
+-....++...-+.-|-++-|.||++++.|+.+. ....+++||+..|++..++.......+.+......+|+.||
T Consensus 106 ~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqI 185 (458)
T KOG1266|consen 106 NPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQI 185 (458)
T ss_pred ChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 4445556666667777788899999999998543 45789999999999999998777778899999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc--ccccCCccccCCcceeecCCCccccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
+.||.|||+ |++.|+|+++.-+.|++..+|.++++--.-............ .+...+.++|.+||.-... ..+.+
T Consensus 186 lsal~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t--n~~~a 262 (458)
T KOG1266|consen 186 LSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT--NTTGA 262 (458)
T ss_pred Hhhhhhhhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc--ccccc
Confidence 999999999 689999999999999999998888764322111111111111 1222366788899975543 56778
Q ss_pred CceehHHHHHHHHhcCCC
Q 037755 157 SDVYGFGMVLLEMTGGRR 174 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~ 174 (238)
+|||++|+...+|..+..
T Consensus 263 ~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 263 SDIYKFGMCALEMAILEI 280 (458)
T ss_pred hhhhhhhHHHHHHHHhee
Confidence 999999999999988764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=131.11 Aligned_cols=127 Identities=16% Similarity=0.186 Sum_probs=96.3
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeC--------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEG--------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
+.+|+..+.++.||+|..+.+++... ...+++|||++|.+|.+.. .++. ....+++.++.
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~ 149 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIE 149 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHH
Confidence 68999999999999999999886532 3578999999999997764 1222 24569999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
.+|+. |++|||++|+||+++.+| ++++|||........... ...+... .+..++|+||||
T Consensus 150 ~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler--~y~~~~di~~lg 209 (232)
T PRK10359 150 SLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLER--HYGIKNEIKDLG 209 (232)
T ss_pred HHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHh--Hhccccccccee
Confidence 99999 999999999999999888 999999977533221110 0122222 344689999999
Q ss_pred HHHHHHh
Q 037755 164 MVLLEMT 170 (238)
Q Consensus 164 ~~l~~ll 170 (238)
+++..+.
T Consensus 210 ~~~~~~~ 216 (232)
T PRK10359 210 YYLLIYK 216 (232)
T ss_pred EeehHHH
Confidence 9876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-17 Score=122.21 Aligned_cols=100 Identities=15% Similarity=0.120 Sum_probs=80.2
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCC
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL-HNGCD 90 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~ 90 (238)
..+|++.++++.++++.....+... ..++||||++++++.... .....++...+..++.|++.++.++ |+.
T Consensus 66 ~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~----~~~~~~~~~~~~~i~~qi~~~L~~l~H~~-- 137 (190)
T cd05147 66 AEKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPR----LKDAPLSESKARELYLQVIQIMRILYQDC-- 137 (190)
T ss_pred HHHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchh----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 3459999999988877554443322 238999999887765443 1235788899999999999999999 788
Q ss_pred CceeeeccCCCcEEEccCCcccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~ 121 (238)
|++|||+||+||+++ ++.++|+|||++..
T Consensus 138 -giiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 138 -RLVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred -CcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 999999999999998 47899999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=121.31 Aligned_cols=101 Identities=17% Similarity=0.233 Sum_probs=80.3
Q ss_pred cHHHHHHHHHHHhhc-----CCCcceeeeeEEEeCC---eee-EEEEe--CCCCChhhhccCCCCCCCCCCHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-----HHVNVVQLLGFCSEGS---KRA-LVYEF--MPNGSLDRHIFPKESRGQSCSWEKLHEVAS 76 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~---~~~-lv~e~--~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~ 76 (238)
..+.+.+|+.+++.+ .||||++++++++++. .++ +|+|| +.+++|.+++.. ..+++. ..++.
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~ 111 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLR 111 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHH
Confidence 457899999999999 5799999999998863 333 78999 457899999922 235544 35577
Q ss_pred HHHHHH-HHhHcCCCCceeeeccCCCcEEEcc----CCccccccccc
Q 037755 77 GTAHGI-EYLHNGCDVCILHLDIKPHNILLDH----NFVPNVSDFGL 118 (238)
Q Consensus 77 ~i~~~l-~~Lh~~~~~~i~H~dl~p~nil~~~----~~~~~l~d~~~ 118 (238)
+++.++ +|||++ +|+||||||+||+++. +..++|+|++.
T Consensus 112 ~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 112 QLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred HHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 888777 899999 9999999999999974 33799999543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.7e-18 Score=146.40 Aligned_cols=215 Identities=25% Similarity=0.318 Sum_probs=164.9
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++..|..+-+.+. |+|++++++.....+..++++++..|+++.+-+. .......+....-.++.|+..++.|+|
T Consensus 63 ~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H 140 (601)
T KOG0590|consen 63 SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLH 140 (601)
T ss_pred hhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccC
Confidence 3455566888888887 9999999999999999999999999999977662 222225666777789999999999999
Q ss_pred -cCCCCceeeeccCCCcEEEccCC-ccccccccccccCCC-CCccccccccCC-ccccCCcceeecCCCcccccCceehH
Q 037755 87 -NGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPK-ENDFVSISATRG-TIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 87 -~~~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+. ++.|+|++|+|.+++.++ ..++.|||++..... .+.........| ++.|.|||...+. ....+..|+||.
T Consensus 141 ~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~ 216 (601)
T KOG0590|consen 141 PEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSL 216 (601)
T ss_pred ccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccc
Confidence 87 999999999999999999 999999999987776 444444445567 9999999999874 356778999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++..+++|.-|+......... +..+..... .........+.....+++.+++..+|..|.+.++
T Consensus 217 g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 217 GIVLSAMLTGELPWDFPSRKDGR--YSSWKSNKG--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred cccccccccCCCCcccccccccc--ceeeccccc--------ccccCccccCChhhhhcccccccCCchhcccccc
Confidence 99999999999998766555422 111111110 0001122345667778888999999999998764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=118.29 Aligned_cols=102 Identities=19% Similarity=0.147 Sum_probs=82.3
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CC
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN-GC 89 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~ 89 (238)
.+.+|.+.++++.|+++.....+... ..++||||++|+++..... ....++......++.+++.++.++|+ .
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~- 137 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA- 137 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 34689999999999988655554433 2489999998875543321 23467788899999999999999999 8
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
|++||||||+||+++ ++.++|+|||++...
T Consensus 138 --givHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 138 --GLVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred --CEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 999999999999999 789999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-17 Score=144.75 Aligned_cols=139 Identities=24% Similarity=0.254 Sum_probs=105.9
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-------------ccccCCccccCCcce
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-------------ISATRGTIGYIAPEL 145 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-------------~~~~~~~~~~~aPE~ 145 (238)
+.+++|||+. +|+|||+||+|.+|..-|++|++|||+++.......+.. .....||+.|.|||+
T Consensus 153 vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 7889999999 999999999999999999999999999865444322210 112259999999999
Q ss_pred eecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhh
Q 037755 146 ISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 146 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 225 (238)
+.-. .|++..|.|++|+++|+.+.|..||+.+...+....+ +.+...+.. -...+.++..+++.+.
T Consensus 230 ilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---isd~i~wpE---------~dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---ISDDIEWPE---------EDEALPPEAQDLIEQL 295 (1205)
T ss_pred hhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---hhhhccccc---------cCcCCCHHHHHHHHHH
Confidence 9876 8899999999999999999999999887655432111 111111111 1233567788899999
Q ss_pred ccCCCCCCC
Q 037755 226 IQVKPADRP 234 (238)
Q Consensus 226 l~~dp~~Rp 234 (238)
|+.+|.+|-
T Consensus 296 L~qnp~~Rl 304 (1205)
T KOG0606|consen 296 LRQNPLCRL 304 (1205)
T ss_pred HHhChHhhc
Confidence 999999884
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-15 Score=112.51 Aligned_cols=101 Identities=22% Similarity=0.280 Sum_probs=87.7
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
..++.+|+.++..+.|+++.....++......+++|||++|++|.+.+.. . .. ....++.+++.++.++|+.
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~ 114 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSA 114 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhC
Confidence 35688999999999999998877777777788999999999999988721 1 11 7788999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCcccccccccccc
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~ 121 (238)
+++|+|++|.||+++ ++.++++|||.+..
T Consensus 115 ---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 115 ---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999999 78899999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.8e-16 Score=135.35 Aligned_cols=140 Identities=21% Similarity=0.166 Sum_probs=117.9
Q ss_pred CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEE
Q 037755 25 VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNIL 104 (238)
Q Consensus 25 ~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil 104 (238)
+.|.++...+.-.+..++|++|.+.|+|.+++ +..+.+++..++.+..|++..+.+||.. +||||||||+|++
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfl 826 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFL 826 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeE
Confidence 45666666666677788999999999999999 4678999999999999999999999999 9999999999999
Q ss_pred Ec-------cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCC
Q 037755 105 LD-------HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173 (238)
Q Consensus 105 ~~-------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~ 173 (238)
+. .+..++|+|||.+--+..-.........++|-.+-++|...|. .++...|.|.|+.+++.|+.|+
T Consensus 827 l~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 827 LRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHH
Confidence 94 2346799999998544333333344555688889999999997 8999999999999999999997
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.7e-15 Score=125.90 Aligned_cols=98 Identities=18% Similarity=0.273 Sum_probs=86.7
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+++.+|++++++++|++++....+.......++||||+++++|.+++. ....++.+++.++.+||+.
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~ 447 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA 447 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC
Confidence 4678899999999999999888777777777899999999999998872 3467899999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
+++|||+||+||++ .++.++|+|||++...
T Consensus 448 ---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 448 ---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999 6778999999998643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=111.88 Aligned_cols=104 Identities=16% Similarity=0.183 Sum_probs=82.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcc--eeeeeEEEeC-C---eeeEEEEeCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNV--VQLLGFCSEG-S---KRALVYEFMPN-GSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~~-~---~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....++.+|+.+++++.|+++ +..+++...+ . ..++|+|+++| .+|.+.+. ...++.. .+.+++
T Consensus 82 ~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~ 152 (239)
T PRK01723 82 LERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIG 152 (239)
T ss_pred hhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHH
Confidence 345788999999999998775 6677764332 2 23599999987 68888772 2344443 357899
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
.++.+||+. ||+|+||||.|||++.++.++|+|||.+...
T Consensus 153 ~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 153 QLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 999999999 9999999999999998889999999988644
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=109.29 Aligned_cols=98 Identities=23% Similarity=0.351 Sum_probs=82.3
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+++.+|+++++.+.|+++.....+.......+++|||++|++|.+.+.. ... .++.+++.++.+||+.
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~ 109 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKA 109 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHC
Confidence 36778999999999988776655555666678899999999999887721 111 7899999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCcccccccccccc
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~ 121 (238)
+++|+|++|.||+++ ++.++++|||.+..
T Consensus 110 ---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 110 ---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=110.99 Aligned_cols=101 Identities=17% Similarity=0.136 Sum_probs=79.1
Q ss_pred HHHHHHHHHHhhcCCCc--ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 10 EEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+|+..++++.+.. +.+++++ . ..++||||+.+++|.... ..........+..++.+++.++++||+
T Consensus 95 ~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 95 LWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHh
Confidence 34678999999997533 3344432 2 358999999998886654 123345566678899999999999999
Q ss_pred CCCCc-eeeeccCCCcEEEccCCccccccccccccC
Q 037755 88 GCDVC-ILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 88 ~~~~~-i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
. + ++|||+||+||+++ ++.++++|||.+...
T Consensus 167 ~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 167 E---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred c---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 9 99999999999999 888999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-14 Score=120.57 Aligned_cols=149 Identities=16% Similarity=0.205 Sum_probs=116.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+...+-++.|+.++||||+++++.++.+...|+|+|-+. .|...+ +.++...+...+.||+.||.|||
T Consensus 51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~l-------k~l~~~~v~~Gl~qIl~AL~FL~ 121 (690)
T KOG1243|consen 51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVL-------KELGKEEVCLGLFQILAALSFLN 121 (690)
T ss_pred hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHH-------HHhHHHHHHHHHHHHHHHHHHHh
Confidence 345778899999999999999999999999999999999873 677766 44447778888999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
..| +++|++++-+.|+++..|..+|++|.++........ .........+|..|+..... +-..|.|-||+++
T Consensus 122 ~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s----~~s~D~~~Lg~li 193 (690)
T KOG1243|consen 122 DDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS----EWSIDSWGLGCLI 193 (690)
T ss_pred ccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc----ccchhhhhHHHHH
Confidence 654 999999999999999999999999988753322221 11112233455666654332 1347999999999
Q ss_pred HHHhcC
Q 037755 167 LEMTGG 172 (238)
Q Consensus 167 ~~ll~g 172 (238)
++++.|
T Consensus 194 ~el~ng 199 (690)
T KOG1243|consen 194 EELFNG 199 (690)
T ss_pred HHHhCc
Confidence 999999
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.1e-13 Score=94.73 Aligned_cols=102 Identities=23% Similarity=0.287 Sum_probs=86.9
Q ss_pred HHHHHHHHHHHhhcCC--CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 9 AEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..++.+|+..++.+++ .++++++++...++..++++||+.++++... +......++.+++.+++.||
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh 103 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLH 103 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHh
Confidence 4689999999999976 5899999988888899999999988777542 45666778999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCcccccccccccc
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~ 121 (238)
.....+++|+|++|.||+++..+.++++||+.+..
T Consensus 104 ~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 104 QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 85333799999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.4e-13 Score=100.67 Aligned_cols=96 Identities=20% Similarity=0.165 Sum_probs=77.3
Q ss_pred HHHHHHHHHHhhcCCCc--ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 10 EEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+|..++..+.|++ +...++ ....+++|||+.|++|..... ......++.+++.++.++|+
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHH
Confidence 35678999999998774 444443 235589999999999876541 02346788999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
. +++|+||+|+||++++++.++|+|||.+...
T Consensus 144 ~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 144 H---GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred C---CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 8 9999999999999999999999999998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4e-13 Score=111.48 Aligned_cols=201 Identities=20% Similarity=0.181 Sum_probs=147.1
Q ss_pred HHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHhHc
Q 037755 13 INEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH----GIEYLHN 87 (238)
Q Consensus 13 ~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~Lh~ 87 (238)
.+|+.....++ |+|.++.+..++.++..++-+|.+. .+|..+.. .....++...++..+.+... |+.++|+
T Consensus 165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs 240 (524)
T KOG0601|consen 165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS 240 (524)
T ss_pred cchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCC
Confidence 45677777774 9999999999999999999999985 68877772 33455778888888888888 9999999
Q ss_pred CCCCceeeeccCCCcEEEccC-CccccccccccccCCCCCccccc---cccCCccccCCcceeecCCCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSI---SATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
. +++|-|++|.||+...+ ..++++||+.........-.... -...+...|++||...+ .++...|+|++|
T Consensus 241 ~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ 314 (524)
T KOG0601|consen 241 N---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLG 314 (524)
T ss_pred C---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchh
Confidence 8 99999999999999988 88899999998766665422211 11247788999999987 567789999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
.++.+..++..+....... .|. ... ......+.....+.++...+.+|++.+|..|++++
T Consensus 315 ev~l~~~l~~~~~~~g~~~-------~W~-----~~r--~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNS-------SWS-----QLR--QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred hhhHhhHhhcccccCCCCC-------Ccc-----ccc--cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 9999998887554221100 000 000 00011222333445566688899999999998864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.4e-11 Score=85.40 Aligned_cols=100 Identities=19% Similarity=0.264 Sum_probs=78.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
.+++-.+|+.++.++.-..|....=+..+...-.++|||++|..|.+.+... ...++..+-.-+.-||.
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~ 110 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHK 110 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh
Confidence 3567788999999997555554444455555667999999998998888221 25577788888889999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
+ ||+|||++++||++++++ +.++|||++.+.
T Consensus 111 ~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 111 A---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred c---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9 999999999999998765 899999998643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=86.38 Aligned_cols=97 Identities=13% Similarity=0.169 Sum_probs=73.2
Q ss_pred HHHHHHhhcCC--CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCC
Q 037755 14 NEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL-HNGCD 90 (238)
Q Consensus 14 ~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~ 90 (238)
+|+..|+++.. -++.+++++ ..-++||||+.++.+..-. -+...++......+..+++.++..| |+.
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~-- 144 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK----LKDAKLNDEEMKNAYYQVLSMMKQLYKEC-- 144 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh----hhccccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 89999999953 466677765 4567999999764432211 1122344556677889999999988 888
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccC
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
+++|||+++.||++. ++.+.++||+.+...
T Consensus 145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999997 467899999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.7e-11 Score=87.59 Aligned_cols=97 Identities=19% Similarity=0.190 Sum_probs=69.5
Q ss_pred HHHHHHHhhcCCCc--ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CC
Q 037755 13 INEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN-GC 89 (238)
Q Consensus 13 ~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~ 89 (238)
..|...+..+.+.. +.++++. ...++++||++++.+...... .... ...+..++.+++.++.++|+ .
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~----~~~~-~~~~~~~~~~~~~~l~~lh~~~- 134 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLK----DVRL-LEDPEELYDQILELMRKLYREA- 134 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhh----hhhh-cccHHHHHHHHHHHHHHHhhcc-
Confidence 45666677765432 4444443 246899999988544221100 0000 15678899999999999999 7
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
+++|+|++|+||+++ ++.++++|||.+...
T Consensus 135 --~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 135 --GLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred --CcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 999999999999999 889999999988533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.7e-11 Score=106.52 Aligned_cols=193 Identities=19% Similarity=0.145 Sum_probs=136.7
Q ss_pred CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcE
Q 037755 24 HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNI 103 (238)
Q Consensus 24 h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~ni 103 (238)
+|-++...--+.-....+++++|..+++|...+. .....+..........+..+..+||.. .+.|+|++|.|.
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSL 935 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhccccc---hhhcccccccch
Confidence 3444433333445667899999999999987772 233455556666778889999999996 799999999999
Q ss_pred EEccCCccccccccccccCCCCCcc------------------------c-----cccccCCccccCCcceeecCCCccc
Q 037755 104 LLDHNFVPNVSDFGLAKFHPKENDF------------------------V-----SISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 104 l~~~~~~~~l~d~~~~~~~~~~~~~------------------------~-----~~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
+...++...+.+|+.....+..... . ......+|+.|.+||...+. ...
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hg 1013 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHG 1013 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCC
Confidence 9999999999998733222111000 0 01122389999999999987 778
Q ss_pred ccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
..+|.|+.|+++++.++|..||...........+. ......+ ..+...+++..+++...+..+|.+|.
T Consensus 1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~--------~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQQIFENIL--------NRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred CcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccc--------cCCCCCC----CCccccChhhhhhhhhhhccCchhcc
Confidence 88999999999999999999998766655432221 1111112 22244567778889999999999998
Q ss_pred CCC
Q 037755 235 SMT 237 (238)
Q Consensus 235 s~~ 237 (238)
.+.
T Consensus 1082 ~a~ 1084 (1205)
T KOG0606|consen 1082 GAK 1084 (1205)
T ss_pred Ccc
Confidence 764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.6e-10 Score=82.60 Aligned_cols=96 Identities=23% Similarity=0.171 Sum_probs=70.4
Q ss_pred HHHHHHHHHHhhcCCCcce-eeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 10 EEFINEVSTIGRIHHVNVV-QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
..+.+|+..++.+.+.+++ +++.+.. ...++||||++|.++...- . .....+.+++.+++.||+.
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~ 102 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLHSS 102 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHhCC
Confidence 4568899999999755544 4554433 3457999999998875421 0 1133567899999999997
Q ss_pred C--CCceeeeccCCCcEEEccCCccccccccccc
Q 037755 89 C--DVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 89 ~--~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
. ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 103 ~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 103 PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 1 11259999999999999 6688999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=88.41 Aligned_cols=192 Identities=14% Similarity=0.177 Sum_probs=122.4
Q ss_pred eeEEEEeCCCCC-hhhhccC--CCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccc
Q 037755 40 RALVYEFMPNGS-LDRHIFP--KESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116 (238)
Q Consensus 40 ~~lv~e~~~~~s-L~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~ 116 (238)
.-++|+.+.+.. +..+... +...-..+.++...+++..++.+.+.||+. |.+-||++++|+|+++++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 567888776542 2222211 112233577889999999999999999999 9999999999999999999999874
Q ss_pred cccccCCCCCccccccccCCccccCCcceee-cCC--CcccccCceehHHHHHHHHhcC-CCCCCcccccccCC-cchhh
Q 037755 117 GLAKFHPKENDFVSISATRGTIGYIAPELIS-RNF--GTVSCKSDVYGFGMVLLEMTGG-RRNSNLKATRSSKA-YFPSW 191 (238)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~--~~~~~~~Di~slG~~l~~ll~g-~~p~~~~~~~~~~~-~~~~~ 191 (238)
...... ..+ .......|...|.+||.-. +.+ ...+...|.|.||+++++++.| ++||.+-....... .+...
T Consensus 162 Dsfqi~-~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQIN-ANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeec-cCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 332211 111 1223345888999999754 211 1456779999999999999876 89986543332211 11111
Q ss_pred hhhh-----hccCCCccccchhHHHHHHHHHHHHHHhhhccCC--CCCCCCCC
Q 037755 192 VSDQ-----LNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK--PADRPSMT 237 (238)
Q Consensus 192 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--p~~Rps~~ 237 (238)
+... ..............-...+++++..+..+|+..- +.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1111 1111111111122233567888999999998754 56899874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.6e-11 Score=102.56 Aligned_cols=153 Identities=16% Similarity=0.214 Sum_probs=100.3
Q ss_pred HHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-------cccccCCccccCC
Q 037755 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-------SISATRGTIGYIA 142 (238)
Q Consensus 70 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------~~~~~~~~~~~~a 142 (238)
....-+.+++.|+.|+|+. .++||++|.|++|.++.++.+|++.|+.+.......... ..........|.|
T Consensus 100 ~~f~nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred HhhhhhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 3344466677899999987 489999999999999999999999998875433311110 0111124567999
Q ss_pred cceeecCCCcccccCceehHHHHHHHHhcCC-CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHH
Q 037755 143 PELISRNFGTVSCKSDVYGFGMVLLEMTGGR-RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVI 221 (238)
Q Consensus 143 PE~~~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 221 (238)
||++... ..+.++|+||+|+++|.+..|+ .-+........ ..+.....+ .. ..-...+++.++.+=
T Consensus 178 pE~~~~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~~~---------~~-~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 178 PEYLLGT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNLLN---------AG-AFGYSNNLPSELRES 244 (700)
T ss_pred chhhccc--cccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcccc---------cc-cccccccCcHHHHHH
Confidence 9999875 7788999999999999888444 33322111110 001000000 00 001115677788888
Q ss_pred HhhhccCCCCCCCCCC
Q 037755 222 GLWCIQVKPADRPSMT 237 (238)
Q Consensus 222 i~~cl~~dp~~Rps~~ 237 (238)
+.+++..++..||++.
T Consensus 245 l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLD 260 (700)
T ss_pred HHHHhcCCcccCcchh
Confidence 8889999999999653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.2e-10 Score=80.19 Aligned_cols=110 Identities=22% Similarity=0.288 Sum_probs=82.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN-GSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+..+.+-.+|+++|.++.--.|.-..=++.+...-.++|||+.| -++.+++...- ............+..|-..+.-
T Consensus 51 kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igk 128 (229)
T KOG3087|consen 51 KLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGK 128 (229)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHH
Confidence 45678889999999999766666555566666677799999966 36777773211 1222233346788899999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCC---ccccccccccc
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNF---VPNVSDFGLAK 120 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~---~~~l~d~~~~~ 120 (238)
||.+ +|+||||..+||++..++ .+.++|||++.
T Consensus 129 lH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 129 LHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred hhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999 999999999999997554 33789999975
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.1e-10 Score=97.12 Aligned_cols=194 Identities=20% Similarity=0.219 Sum_probs=131.3
Q ss_pred HHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC
Q 037755 13 INEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDV 91 (238)
Q Consensus 13 ~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~ 91 (238)
..|+.+...+ .|.+++.++..|......++-.|||+++++.... .-...+.+..++....+++.++.++|+.
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~--- 385 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK--- 385 (524)
T ss_pred hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---
Confidence 3577777777 4888998888777767777888999999887665 2345677888899999999999999998
Q ss_pred ceeeeccCCCcEEEccC-CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHh
Q 037755 92 CILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll 170 (238)
..+|+|++|+||++..+ +..+++||++.......... ....+..|-.+|++... ..+..+.|++|||....+.+
T Consensus 386 ~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~----~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~ 460 (524)
T KOG0601|consen 386 LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV----FHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAI 460 (524)
T ss_pred hhhcccccccceeeccchhhhhccccccccccceeccc----ccccccccccchhhccc-cccccccccccccccccccc
Confidence 99999999999999876 67789999987532222111 11133333124444332 36778899999999999999
Q ss_pred cCCCCCC-cccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 171 GGRRNSN-LKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 171 ~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++...-. +..... +..+. ..........+..+...+...++..||++.
T Consensus 461 ~~~~ls~~~~~~~~------------i~~~~-------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~ 509 (524)
T KOG0601|consen 461 TGSPLSESGVQSLT------------IRSGD-------TPNLPGLKLQLQVLLKVMINPDRKRRPSAV 509 (524)
T ss_pred cCcccCccccccee------------eeccc-------ccCCCchHHhhhhhhhhhcCCccccchhhh
Confidence 8874221 100000 00000 001111225566677778888888888764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.3e-10 Score=93.52 Aligned_cols=104 Identities=17% Similarity=0.175 Sum_probs=71.2
Q ss_pred HHHHHHHHHhhcC----CCcceeeeeEE-EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHH
Q 037755 11 EFINEVSTIGRIH----HVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH-GIEY 84 (238)
Q Consensus 11 ~~~~e~~~l~~l~----h~ni~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~ 84 (238)
+|.+|+..+.++. +.+-+.+-.++ ...+..+++|||++|++|.+...... .... ...++..++. .+..
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHH
Confidence 4666777777762 32223333333 33446789999999999988652111 1112 2345555555 4678
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCC
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~ 123 (238)
+|.. |++|+|++|.||+++.++.++++|||++....
T Consensus 273 l~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8888 99999999999999999999999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.7e-09 Score=83.34 Aligned_cols=105 Identities=19% Similarity=0.121 Sum_probs=79.6
Q ss_pred HHHHHHHHHhhcCCCcc--eeeeeEEEe-----CCeeeEEEEeCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 11 EFINEVSTIGRIHHVNV--VQLLGFCSE-----GSKRALVYEFMPNG-SLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni--~~~~~~~~~-----~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
.+.+|...+.++...+| +.++.+.+. ....++|+|++++. +|.+++.... ....+......++.+++..+
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i 151 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMV 151 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHH
Confidence 57899999998853333 344555543 23578999999875 7888772211 23445667778999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEcc-------CCccccccccccc
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDH-------NFVPNVSDFGLAK 120 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~-------~~~~~l~d~~~~~ 120 (238)
+-||.. |++|+|++++|||++. +..+.++||+.+.
T Consensus 152 ~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 152 RDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999999 9999999999999975 4578999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.7e-09 Score=79.95 Aligned_cols=101 Identities=25% Similarity=0.254 Sum_probs=67.2
Q ss_pred cHHHHHHHHHHHhhcCCC--cceeeeeEEEeCCeeeEEEEeCC--CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHV--NVVQLLGFCSEGSKRALVYEFMP--NGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~~~~~~lv~e~~~--~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+....+|++.|+++... ++.+++++. .-++||||+. |..+.... ...++......++.+++..+.
T Consensus 51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~------~~~~~~~~~~~~~~~il~~~~ 120 (188)
T PF01163_consen 51 IREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK------DVDLSPEEPKELLEEILEEII 120 (188)
T ss_dssp HHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH------HCGGGGSTHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH------hccccchhHHHHHHHHHHHHH
Confidence 456778999999999765 566666553 3469999998 55554433 112113445667788888555
Q ss_pred H-hHcCCCCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 84 Y-LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 84 ~-Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
. +|+. |++|||+++.||+++++ .+.++|||.+...
T Consensus 121 ~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 121 KMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHHhc---CceecCCChhhEEeecc-eEEEEecCcceec
Confidence 4 6788 99999999999999987 8999999987533
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.2e-09 Score=78.57 Aligned_cols=109 Identities=19% Similarity=0.249 Sum_probs=84.4
Q ss_pred ccHHHHHHHHHHHhhcCCC--cceeeeeEEEeCC----eeeEEEEeCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHV--NVVQLLGFCSEGS----KRALVYEFMPNG-SLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~~~----~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....+..+|...+.++... .+.+++++.+... ..++|+|++++. +|.+++.. ....+......++.+++
T Consensus 53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALA 128 (206)
T ss_pred ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHH
Confidence 3456788999998888533 3456666665532 458999999874 78888722 12256667788999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCC---ccccccccccccC
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNF---VPNVSDFGLAKFH 122 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~---~~~l~d~~~~~~~ 122 (238)
..++-||+. |++|+|+++.|||++.++ .+.++||+.+...
T Consensus 129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999 999999999999999877 7899999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.9e-08 Score=83.10 Aligned_cols=137 Identities=18% Similarity=0.284 Sum_probs=103.4
Q ss_pred HHHHHHHhhcCCCcceeeeeEEEe----CCeeeEEEEeCCC-CChhhhccCCCC-----------CCCCCCHHHHHHHHH
Q 037755 13 INEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFMPN-GSLDRHIFPKES-----------RGQSCSWEKLHEVAS 76 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~-~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~ 76 (238)
..-++.++++.|+|+|++.+++.. +..+++|++|.++ ++|.+..+.... .+...++..+|.++.
T Consensus 321 t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~ 400 (655)
T KOG3741|consen 321 TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYIS 400 (655)
T ss_pred hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHH
Confidence 445888999999999999998863 4578999999754 577666543222 234678899999999
Q ss_pred HHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCccccc
Q 037755 77 GTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 77 ~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
|+..||.++|+. |+..+-+.|.+|+++++.+++|..-|......... + +.+.+. .+
T Consensus 401 QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------~-------~~le~~-----Qq 456 (655)
T KOG3741|consen 401 QLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------T-------EPLESQ-----QQ 456 (655)
T ss_pred HHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCC---------C-------cchhHH-----hh
Confidence 999999999999 99999999999999998888887665543222211 0 122221 24
Q ss_pred CceehHHHHHHHHhcCC
Q 037755 157 SDVYGFGMVLLEMTGGR 173 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~ 173 (238)
-|.-.||.++..+.||.
T Consensus 457 ~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 457 NDLRDLGLLLLALATGT 473 (655)
T ss_pred hhHHHHHHHHHHHhhcc
Confidence 67888999999999995
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.7e-08 Score=74.45 Aligned_cols=108 Identities=24% Similarity=0.269 Sum_probs=81.8
Q ss_pred cHHHHHHHHHHHhhcCC--CcceeeeeEEEeCC---eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHH--VNVVQLLGFCSEGS---KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
...++.+|+++++.+.+ .++.+++.+..... ..++||||++|.++.+.+. ...++......++.+++.++
T Consensus 38 ~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l 112 (223)
T cd05154 38 SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL-----RPELSPEERRALARALADTL 112 (223)
T ss_pred ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHH
Confidence 35678999999999975 44577777776542 6789999999988877551 13466667777777888888
Q ss_pred HHhHcCC-----------------------------------------------------CCceeeeccCCCcEEEcc--
Q 037755 83 EYLHNGC-----------------------------------------------------DVCILHLDIKPHNILLDH-- 107 (238)
Q Consensus 83 ~~Lh~~~-----------------------------------------------------~~~i~H~dl~p~nil~~~-- 107 (238)
+.||+.. ...++|+|+.|.||+++.
T Consensus 113 ~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~ 192 (223)
T cd05154 113 AALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE 192 (223)
T ss_pred HHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC
Confidence 8887420 235899999999999998
Q ss_pred CCccccccccccc
Q 037755 108 NFVPNVSDFGLAK 120 (238)
Q Consensus 108 ~~~~~l~d~~~~~ 120 (238)
++.+.++||+.+.
T Consensus 193 ~~~~~iID~e~~~ 205 (223)
T cd05154 193 PRVVAVLDWELAT 205 (223)
T ss_pred CcEEEEEeccccc
Confidence 5667899999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.3e-09 Score=90.16 Aligned_cols=103 Identities=14% Similarity=0.131 Sum_probs=64.8
Q ss_pred HHHHHHHHhhc----CCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhc--cCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 12 FINEVSTIGRI----HHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHI--FPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 12 ~~~e~~~l~~l----~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+.+|+.-+.++ .+.+.+.+-.++.+ .+..+++|||+.|+++.+.. .+.......+....+..++.|++
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 44455555554 23344444444422 45678999999999997642 11111111344444444444444
Q ss_pred hHcCCCCceeeeccCCCcEEEccCC----ccccccccccccCCC
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNF----VPNVSDFGLAKFHPK 124 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~~ 124 (238)
.. |++|+|++|.||+++.+| +++++|||+......
T Consensus 278 --~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999887 999999998865533
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.8e-07 Score=69.83 Aligned_cols=110 Identities=16% Similarity=0.103 Sum_probs=81.9
Q ss_pred cccHHHHHHHHHHHhhcCCC--cceeeeeEEEe-----CCeeeEEEEeCCC-CChhhhccCCCCCCCCCCHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHV--NVVQLLGFCSE-----GSKRALVYEFMPN-GSLDRHIFPKESRGQSCSWEKLHEVASG 77 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~-----~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (238)
+..+..|.+|+..|+++... .+.++. ++.. ....++|+|-+.+ .+|.+++... .-.+.+......++.+
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~ 136 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKA 136 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHH
Confidence 34678899999999999533 344444 3321 1246789987643 5788877221 1235567777899999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCc--ccccccccccc
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFV--PNVSDFGLAKF 121 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~--~~l~d~~~~~~ 121 (238)
++..++-||.. |+.|+|+.+.||+++.++. +.++||..++.
T Consensus 137 va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 137 VALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999999999 9999999999999986666 89999987753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.6e-07 Score=70.89 Aligned_cols=98 Identities=20% Similarity=0.187 Sum_probs=73.5
Q ss_pred ccHHHHHHHHHHHhhcCCC--cceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHV--NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.++...++|.+.|++|.-. .+.+.+++ +..++|||+++|-.|...- +.......++..|+.-+..
T Consensus 151 ~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~ 217 (304)
T COG0478 151 VSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRK 217 (304)
T ss_pred hHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHH
Confidence 4677788999999999644 77777765 4567999999886664322 1333445556666666655
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccc
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
+-+. |+||||+++-||+++++|.+.++||--+.
T Consensus 218 ~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 218 AYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred HHHc---CccccCCchheEEEecCCCEEEEeCcccc
Confidence 5555 99999999999999999999999997665
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=3e-06 Score=63.66 Aligned_cols=67 Identities=22% Similarity=0.245 Sum_probs=52.1
Q ss_pred CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCcccccccc
Q 037755 38 SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117 (238)
Q Consensus 38 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~ 117 (238)
...++++||++|..|.+.. .+++ .+...+..++.-||+. |++|||..|.|++++.++ ++++|++
T Consensus 116 ~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECc
Confidence 3456899999998886643 1222 2456677889999999 999999999999999654 8999997
Q ss_pred ccc
Q 037755 118 LAK 120 (238)
Q Consensus 118 ~~~ 120 (238)
.-+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.7e-05 Score=56.49 Aligned_cols=103 Identities=21% Similarity=0.196 Sum_probs=80.7
Q ss_pred HHHHHHHhhcCC-CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC
Q 037755 13 INEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDV 91 (238)
Q Consensus 13 ~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~ 91 (238)
.+|.-+++.+++ +++++++|++.. .+++||...+++.... ....+....++..+.+++.+++..+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 468889999975 699999999954 4688998776664321 0001223568899999999999999999986444
Q ss_pred ceeeeccCCCcEEEccCCccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+.-.|++++|+-++++++++++|.....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 68889999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.2e-05 Score=60.16 Aligned_cols=112 Identities=13% Similarity=0.191 Sum_probs=65.4
Q ss_pred cHHHHHHHHHHHhhcCCCc--ceeeeeEEEeCCeeeEEEEeCCCCC-hhhhc---------------------cCCCCCC
Q 037755 8 SAEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEFMPNGS-LDRHI---------------------FPKESRG 63 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~~s-L~~~~---------------------~~~~~~~ 63 (238)
......+|.++++.+..-. +.+++++.+..+...++|+++.|.+ +...+ .+.....
T Consensus 35 ~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~ 114 (226)
T TIGR02172 35 DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT 114 (226)
T ss_pred CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 3566799999999996443 4678888888788889999998863 11111 1100001
Q ss_pred CCCCHHH--HHHHHH-------HHHHH-HHHhHcC-CCCceeeeccCCCcEEEccCCccccccccccc
Q 037755 64 QSCSWEK--LHEVAS-------GTAHG-IEYLHNG-CDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 64 ~~~~~~~--~~~~~~-------~i~~~-l~~Lh~~-~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
..++... ....+. .+... ..+|.+. ....++|+|+.|.||++++++ +.++||+.+.
T Consensus 115 ~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 115 STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 1111100 000000 01111 1122211 123579999999999999888 8999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.6e-06 Score=74.47 Aligned_cols=198 Identities=19% Similarity=0.190 Sum_probs=125.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
..+.-..-|...+.++.|+|++.++.+.-++. ...+..+++..-++...+ ..-...+....+.+..++..++
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL 299 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGL 299 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhH
Confidence 34445556777888889999999998874432 233456777777777776 3456788899999999999999
Q ss_pred HHhHcCCCCceeeeccCCC---cEEEccCCccccc--cccccccCCCCCccccccccCCccccCCcceeecCCCcccccC
Q 037755 83 EYLHNGCDVCILHLDIKPH---NILLDHNFVPNVS--DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
+++|+. ...|.-+..+ +--.+..+.+.++ ||+..+..+..... .....+..+.++|.............
T Consensus 300 ~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 300 AYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred HHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhh
Confidence 999997 5555555444 3333444555555 77766544333211 11224455677887765433344457
Q ss_pred ceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 158 DVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 158 Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|.+|.....+..|..+-..... +.. .........+.+...+|+..++++|+++.
T Consensus 374 dL~~lgll~~~~~~~~~i~~~~~~-------~~~-----------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDISEKSAV-------PVS-----------------LLDVLSTSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHHHHHhhhhhcCcccccccc-------hhh-----------------hhccccchhhhhhhhhhcchhhhhccchh
Confidence 999999999999887643211110 000 01111111566677789999999998875
Q ss_pred C
Q 037755 238 K 238 (238)
Q Consensus 238 e 238 (238)
|
T Consensus 430 ~ 430 (1351)
T KOG1035|consen 430 E 430 (1351)
T ss_pred h
Confidence 4
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.5e-06 Score=74.01 Aligned_cols=153 Identities=17% Similarity=0.143 Sum_probs=111.2
Q ss_pred HHHHHHHHHHhhcCCCc-ceeeeeEEEeCCeeeEEEEeCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 10 EEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEFMPNG-SLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
....-++++|++++||| .+..++-++.+...++.++++.++ +..... ....-.+...+..+.+..-..+++++|+
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~ 354 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHS 354 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccc
Confidence 34556899999999999 777777777788899999999876 332222 1122344555677788888889999998
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. .-+|+| ||+..+ +..+.++|+......... ......+++.|+|||+.... .+....|+|++|.-..
T Consensus 355 ~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~ 421 (829)
T KOG0576|consen 355 S---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAI 421 (829)
T ss_pred c---cccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccc--ccccCCCccCCCcchh
Confidence 6 568887 666554 577999998865443332 22344589999999987765 6667789999998888
Q ss_pred HHhcCCCCCCc
Q 037755 168 EMTGGRRNSNL 178 (238)
Q Consensus 168 ~ll~g~~p~~~ 178 (238)
++.-|.+|-..
T Consensus 422 ~~ap~~pPr~~ 432 (829)
T KOG0576|consen 422 QMAPGLPPRSS 432 (829)
T ss_pred hcCCCCCCCCC
Confidence 88888776544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.2e-05 Score=57.66 Aligned_cols=47 Identities=13% Similarity=0.201 Sum_probs=35.8
Q ss_pred HHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhh
Q 037755 9 AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRH 55 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~ 55 (238)
..++.+|+++++.+. +--+.+++++...+...++||++++|.++...
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 346788999999984 44456788877776678999999998777543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2e-05 Score=67.00 Aligned_cols=106 Identities=18% Similarity=0.211 Sum_probs=66.2
Q ss_pred HHHHHHHHHhhc----C-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 11 EFINEVSTIGRI----H-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 11 ~~~~e~~~l~~l----~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
++.+|..-+.++ + .|++.-..=+++-.+.-.++|||+.|..+.+...-. ....+...+...+.++. +..+
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~ 281 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQL 281 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHH
Confidence 455666666665 2 344332222334456778999999999888874111 12333333322222222 2222
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCC
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 124 (238)
=.. |.+|.|..|.||+++.+|++.+.|||+......
T Consensus 282 ~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred Hhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 234 999999999999999999999999998764444
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00024 Score=64.71 Aligned_cols=45 Identities=16% Similarity=0.360 Sum_probs=34.4
Q ss_pred cHHHHHHHHHHHhhcC-CCcc--eeeeeEEEeC---CeeeEEEEeCCCCCh
Q 037755 8 SAEEFINEVSTIGRIH-HVNV--VQLLGFCSEG---SKRALVYEFMPNGSL 52 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni--~~~~~~~~~~---~~~~lv~e~~~~~sL 52 (238)
....+.+|+++++.+. |+++ .+++.++.+. ...++|||++.|..+
T Consensus 81 ~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 81 SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 3457889999999995 6665 6777777654 467899999987543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00025 Score=54.70 Aligned_cols=29 Identities=31% Similarity=0.507 Sum_probs=25.1
Q ss_pred ceeeeccCCCcEEEccCCccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.++|+|+.+.||++++++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 59999999999999876656799999765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0004 Score=53.14 Aligned_cols=97 Identities=20% Similarity=0.223 Sum_probs=68.0
Q ss_pred HHHHHHhhcC--CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCC
Q 037755 14 NEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN-GCD 90 (238)
Q Consensus 14 ~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~ 90 (238)
+|+.-|+++. +=.+.+.+++..+ .+|||++.... . -+...+...+.......+..+++..+.-|-. .
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~n----VLvMEfIg~~g---~-pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRNN----VLVMEFIGDDG---L-PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecCC----eEEEEeccCCC---C-CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 5888888884 4445566655543 58999985531 1 1112223333444677778888888887766 5
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccC
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
++||+||+.=|||+. ++.+.++|++-+...
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 999999999999999 889999999977643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00078 Score=50.36 Aligned_cols=96 Identities=18% Similarity=0.253 Sum_probs=67.1
Q ss_pred cHHHHHHHHHHHhhcC------CCcceeeeeEEEeCCeeeEEEEeCCC------CChhhhccCCCCCCCCCCHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIH------HVNVVQLLGFCSEGSKRALVYEFMPN------GSLDRHIFPKESRGQSCSWEKLHEVA 75 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~~~~~lv~e~~~~------~sL~~~~~~~~~~~~~~~~~~~~~~~ 75 (238)
...+..+|+.-..++. +..|.+++|+.++..-+.+|+|.+.. .+|.+++ ....++. .....+
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~~L 127 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQAL 127 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHHHH
Confidence 3466677777777776 78899999999999989999988632 2567766 2234444 333333
Q ss_pred HHHHHHHHHhHcCCCCceeeeccCCCcEEEccC--C--cccccc
Q 037755 76 SGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN--F--VPNVSD 115 (238)
Q Consensus 76 ~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~--~--~~~l~d 115 (238)
. ....+|-++ +|+.+|++|.||++... + .+.++|
T Consensus 128 ~---~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 128 D---EFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred H---HHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEe
Confidence 3 344566666 89999999999999633 2 455665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.002 Score=51.60 Aligned_cols=111 Identities=23% Similarity=0.262 Sum_probs=70.8
Q ss_pred ccHHHHHHHHHHHhhcCC--CcceeeeeEEEeCC--eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGS--KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
.+..+..+|..+++.+.- --+...++++.++. ..+.||+|++|..+.+.... .......+ . ..+...|
T Consensus 63 ~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~-----~~~~~~~~-~--~~l~~~L 134 (321)
T COG3173 63 ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP-----ESLGRQFA-L--DALADFL 134 (321)
T ss_pred hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc-----ccchHHHH-H--HHHHHHH
Confidence 455667789999988843 23445666776666 78999999988644333310 00000011 0 2444444
Q ss_pred HHhHcCCC-------------------------------------------------------CceeeeccCCCcEEEcc
Q 037755 83 EYLHNGCD-------------------------------------------------------VCILHLDIKPHNILLDH 107 (238)
Q Consensus 83 ~~Lh~~~~-------------------------------------------------------~~i~H~dl~p~nil~~~ 107 (238)
+.||+-.. ..++|||+.+.|++++.
T Consensus 135 a~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~ 214 (321)
T COG3173 135 AELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDP 214 (321)
T ss_pred HHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeC
Confidence 44443211 45999999999999998
Q ss_pred CCccccccccccccCCCC
Q 037755 108 NFVPNVSDFGLAKFHPKE 125 (238)
Q Consensus 108 ~~~~~l~d~~~~~~~~~~ 125 (238)
++.+-|.||+.+......
T Consensus 215 ~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 215 GRPTGVLDWELATLGDPL 232 (321)
T ss_pred CCeeEEEeccccccCCcH
Confidence 888999999988754443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0018 Score=49.35 Aligned_cols=47 Identities=23% Similarity=0.366 Sum_probs=32.3
Q ss_pred cHHHHHHHHHHHhhcCCC--cceeeeeEE---EeCCeeeEEEEeCCCCChhh
Q 037755 8 SAEEFINEVSTIGRIHHV--NVVQLLGFC---SEGSKRALVYEFMPNGSLDR 54 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~--ni~~~~~~~---~~~~~~~lv~e~~~~~sL~~ 54 (238)
....+.+|..+++.+... .+.+++... ......+++++++.|..+..
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 467888999999999533 355666644 23345789999998877766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0021 Score=50.18 Aligned_cols=28 Identities=21% Similarity=0.362 Sum_probs=25.1
Q ss_pred ceeeeccCCCcEEEccCCccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.++|+|+.|.||++++++ +.++||+.+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999999876 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0011 Score=56.59 Aligned_cols=87 Identities=18% Similarity=0.141 Sum_probs=55.0
Q ss_pred ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HhHcCCCCceeeeccCCCcEEE
Q 037755 27 VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE-YLHNGCDVCILHLDIKPHNILL 105 (238)
Q Consensus 27 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~Lh~~~~~~i~H~dl~p~nil~ 105 (238)
|.+++..+. ....++|||+.|..+.+.-. -....++...+ +..+.++.. .+=.. |.+|+|=.|.||++
T Consensus 266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~---i~~~gi~~~~i---~~~l~~~~~~qIf~~---GffHaDPHPGNilv 334 (538)
T KOG1235|consen 266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDA---IDKRGISPHDI---LNKLVEAYLEQIFKT---GFFHADPHPGNILV 334 (538)
T ss_pred CCeehhhcC--cceEEEEEecCCccCCCHHH---HHHcCCCHHHH---HHHHHHHHHHHHHhc---CCccCCCCCCcEEE
Confidence 344443333 46789999999988766531 11234444443 333444322 22223 99999999999999
Q ss_pred cc----CCccccccccccccCCC
Q 037755 106 DH----NFVPNVSDFGLAKFHPK 124 (238)
Q Consensus 106 ~~----~~~~~l~d~~~~~~~~~ 124 (238)
.. ++.+.+.|+|+......
T Consensus 335 ~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 335 RPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ecCCCCCccEEEEcccccccccH
Confidence 84 56788999999864433
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0004 Score=58.46 Aligned_cols=47 Identities=19% Similarity=0.311 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeC-CeeeEEEEeCCCCChhhhc
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEG-SKRALVYEFMPNGSLDRHI 56 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~ 56 (238)
.-++...++.++.+.|+|...++++.... ....+|+|++ +.||++.+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~ 73 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDIL 73 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHH
Confidence 34566788889999999999999887543 4577899998 45999887
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0039 Score=49.73 Aligned_cols=30 Identities=30% Similarity=0.428 Sum_probs=26.4
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+++|+|+.|.|+++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999988777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.021 Score=45.66 Aligned_cols=45 Identities=13% Similarity=0.153 Sum_probs=34.9
Q ss_pred cHHHHHHHHHHHhhcCC---CcceeeeeEEEe---CCeeeEEEEeCCCCCh
Q 037755 8 SAEEFINEVSTIGRIHH---VNVVQLLGFCSE---GSKRALVYEFMPNGSL 52 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~---~~~~~lv~e~~~~~sL 52 (238)
....+.+|...|+.+.- -.+.++++++.. .+..++|||++++.++
T Consensus 50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 34688999999999953 357788887754 3668999999988655
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.00015 Score=68.10 Aligned_cols=159 Identities=11% Similarity=0.007 Sum_probs=108.2
Q ss_pred HHHHHHhhcCCCcceeeeeEEE--eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC--C
Q 037755 14 NEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG--C 89 (238)
Q Consensus 14 ~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--~ 89 (238)
.|.+.++...|+++.....-.. +....+..++|+.+|.+.+.+.+...+...+....+...-.+.+.+..-.|+. .
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 4555566678998887666543 33467888999999999999966555544544443333333324444444432 1
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
..--+|+++++.|.++..+..++++++|+.+.... .....+...+++-|+.|++...- ..+.++|+|..|+.+|..
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHH
Confidence 12378999999999999999999999999872211 11223344577777888877654 667779999999999999
Q ss_pred hcCCCCC
Q 037755 170 TGGRRNS 176 (238)
Q Consensus 170 l~g~~p~ 176 (238)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887666
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.014 Score=42.57 Aligned_cols=102 Identities=14% Similarity=0.118 Sum_probs=66.7
Q ss_pred cccccHHHHHHHHHHHhhcCCCcce-eeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVV-QLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
-.++.+..+..|+++|+.+.--++- +++.+..+. +.|||+.|-+|.+... ..+..++..+ +.+.
T Consensus 54 r~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L~~~~~-------~~~rk~l~~v----lE~a 118 (201)
T COG2112 54 RRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPLGKLEI-------GGDRKHLLRV----LEKA 118 (201)
T ss_pred cCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcchhhhhh-------cccHHHHHHH----HHHH
Confidence 3566788999999999999876665 344444332 4499999888877661 1133444443 3333
Q ss_pred HHhHcCCCCceeeeccCC-CcEEEccCCccccccccccccCC
Q 037755 83 EYLHNGCDVCILHLDIKP-HNILLDHNFVPNVSDFGLAKFHP 123 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p-~nil~~~~~~~~l~d~~~~~~~~ 123 (238)
--|-.. ||-|+.+.- ...++-.++.+.|+||..+++..
T Consensus 119 ~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 119 YKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred HHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 334444 899999864 44444445599999999887443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0059 Score=48.91 Aligned_cols=96 Identities=17% Similarity=0.101 Sum_probs=67.0
Q ss_pred cHHHHHHHHHHHhhcC-CC-cceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVSTIGRIH-HV-NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~-ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
++-...+|+..|+.|. |- -+.+.+++ +..++||+.+.|-.|...- ......+ +...+...+--|
T Consensus 153 SRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~-------~v~d~~~---ly~~lm~~Iv~l 218 (465)
T KOG2268|consen 153 SRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR-------HVEDPPT---LYDDLMGLIVRL 218 (465)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee-------ecCChHH---HHHHHHHHHHHH
Confidence 4455678999999884 32 23444443 4567899999887775433 1222222 444555556667
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccc
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.++ |++|||++-=||++.+++.++++||--+.
T Consensus 219 a~~---GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 219 ANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred HHc---CceecccchheeEEecCCCEEEeechHhh
Confidence 777 99999999999999999999999997554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.023 Score=46.33 Aligned_cols=75 Identities=15% Similarity=0.073 Sum_probs=57.6
Q ss_pred CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccc
Q 037755 37 GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116 (238)
Q Consensus 37 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~ 116 (238)
+...|++|++- |+++... +.-...++..++.+.+..++-+..+ ...-|||+...||+++ .|.|.|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEe
Confidence 34567788875 5566332 3344677888888888888888765 4789999999999999 999999999
Q ss_pred cccccCC
Q 037755 117 GLAKFHP 123 (238)
Q Consensus 117 ~~~~~~~ 123 (238)
.+++...
T Consensus 366 klsRl~~ 372 (488)
T COG5072 366 KLSRLSY 372 (488)
T ss_pred eeeeccc
Confidence 9998443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.024 Score=45.04 Aligned_cols=45 Identities=16% Similarity=0.301 Sum_probs=29.2
Q ss_pred cccHHHHHHHHHHHhhcC---CCcceeeeeEEEeCCeeeEEEEeCCCC
Q 037755 6 KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEFMPNG 50 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~~ 50 (238)
....+.|..|+.-|+.|. .-.+.+++++...++..++++||++.+
T Consensus 50 ~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 50 ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 334567889999999993 345778999888777889999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.02 Score=45.77 Aligned_cols=31 Identities=32% Similarity=0.306 Sum_probs=27.1
Q ss_pred CCceeeeccCCCcEEEccC----Cccccccccccc
Q 037755 90 DVCILHLDIKPHNILLDHN----FVPNVSDFGLAK 120 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~----~~~~l~d~~~~~ 120 (238)
...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4579999999999999974 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.023 Score=43.60 Aligned_cols=30 Identities=20% Similarity=0.307 Sum_probs=26.4
Q ss_pred CceeeeccCCCcEEEcc-CCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDH-NFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~ 120 (238)
..++|+|+.+.||++++ ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 36999999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.028 Score=45.16 Aligned_cols=30 Identities=37% Similarity=0.541 Sum_probs=26.8
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+++|+|+.+.|++++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 489999999999999988777899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.16 Score=38.86 Aligned_cols=50 Identities=22% Similarity=0.422 Sum_probs=38.9
Q ss_pred cccccHHHHHHHHHHHhhcCC---CcceeeeeEEEeCCeeeEEEEeCCCCChh
Q 037755 4 NSKFSAEEFINEVSTIGRIHH---VNVVQLLGFCSEGSKRALVYEFMPNGSLD 53 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~~~~~lv~e~~~~~sL~ 53 (238)
+..+..+-|..|+.-|..+.- -++.+++.+.....+.|+|++|++.+.+.
T Consensus 47 n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 47 NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 344455778889998888853 45778888888999999999999886654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.042 Score=44.34 Aligned_cols=30 Identities=23% Similarity=0.377 Sum_probs=25.8
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999976656899998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.057 Score=43.36 Aligned_cols=29 Identities=34% Similarity=0.334 Sum_probs=25.2
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+++|||+.+.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 37999999999999987 567899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.072 Score=41.98 Aligned_cols=48 Identities=21% Similarity=0.233 Sum_probs=35.1
Q ss_pred HHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccc
Q 037755 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 72 ~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
...+..+-.++.-.+.. ..-.+|+|+.|.|++.++.+.+.|+||..+.
T Consensus 135 ~~~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 135 RKKLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33444555555544431 0249999999999999999999999998875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.034 Score=42.26 Aligned_cols=87 Identities=17% Similarity=0.203 Sum_probs=53.5
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.-|.++..++.+++ .|+++.. .++..+-+|.|+|....... .. +..-=+++|.-.|+.
T Consensus 103 ~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i~~-------------~N----~i~agi~~L~~fH~~- 160 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKINF-------------SN----FITAGIKDLMDFHSE- 160 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcccch-------------hH----HHHHhHHHHHHhhcc-
Confidence 34455666655543 2344431 13445678888875422210 00 111114557778853
Q ss_pred CCceeeeccCCCcEEEccCCccccccccc
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGL 118 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~ 118 (238)
..+..|||..|+||+.++.|.+||.|-+.
T Consensus 161 ~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 161 NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCeecCCCChhheeecCCCCEEecChhh
Confidence 35799999999999999999999999664
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.023 Score=43.00 Aligned_cols=29 Identities=31% Similarity=0.469 Sum_probs=20.9
Q ss_pred ceeeeccCCCcEEE-ccCCccccccccccc
Q 037755 92 CILHLDIKPHNILL-DHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~-~~~~~~~l~d~~~~~ 120 (238)
..+|+|+.|.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 59999999999999 788999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.028 Score=41.53 Aligned_cols=28 Identities=21% Similarity=0.319 Sum_probs=24.9
Q ss_pred ceeeeccCCCcEEEccCCccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
..+|+|+.|.|+++++++ ++++||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 479999999999998777 8899999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.1 Score=42.03 Aligned_cols=32 Identities=19% Similarity=0.238 Sum_probs=28.1
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccC
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
.+++|+|+.++|+++++++.+.++||..+...
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 47999999999999999988999999887633
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.37 Score=40.08 Aligned_cols=28 Identities=29% Similarity=0.110 Sum_probs=23.8
Q ss_pred ceeeeccCCCcEEEccCCccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
..+|.|+.+.||+.++ +.+.++||..+.
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEecccc
Confidence 6899999999998764 468999998875
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.20 E-value=0.068 Score=39.98 Aligned_cols=29 Identities=24% Similarity=0.311 Sum_probs=24.4
Q ss_pred ceeeeccCCCcEEEccCC-----ccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNF-----VPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~-----~~~l~d~~~~~ 120 (238)
.++|||+.+.|+++..++ .+.++||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 699999999999997543 57899998775
|
subfamily of choline kinases |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.59 Score=38.61 Aligned_cols=99 Identities=17% Similarity=0.208 Sum_probs=69.0
Q ss_pred HHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCc
Q 037755 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVC 92 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 92 (238)
..|+.-|++++...|.-.--+.-. ..++||+++.... +. +...+...++...+..+-.+++.-+.-|-+.| +
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdg---w~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~ 285 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDG---WA-APKLKDASLSTSKARELYQQCVRIMRRLYQKC--R 285 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCC---Cc-CcccccccCChHHHHHHHHHHHHHHHHHHHHh--c
Confidence 468888888876665544333333 3468999985322 21 22234556777778888888888888887766 9
Q ss_pred eeeeccCCCcEEEccCCccccccccccc
Q 037755 93 ILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 93 i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
+||.||.-=|+|+-+ |.+.++|.+-+.
T Consensus 286 LVHADLSEfN~Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 286 LVHADLSEFNLLYHD-GKLYIIDVSQSV 312 (520)
T ss_pred eeccchhhhhheEEC-CEEEEEEccccc
Confidence 999999999998864 577888877654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.16 Score=41.66 Aligned_cols=29 Identities=24% Similarity=0.364 Sum_probs=25.7
Q ss_pred ceeeeccCCCcEEEcc-CCccccccccccc
Q 037755 92 CILHLDIKPHNILLDH-NFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~-~~~~~l~d~~~~~ 120 (238)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 6999999999999986 4679999999875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.24 Score=40.29 Aligned_cols=28 Identities=36% Similarity=0.570 Sum_probs=24.7
Q ss_pred eeeeccCCCcEEEccCCc-cccccccccc
Q 037755 93 ILHLDIKPHNILLDHNFV-PNVSDFGLAK 120 (238)
Q Consensus 93 i~H~dl~p~nil~~~~~~-~~l~d~~~~~ 120 (238)
++|+|+.|.||+++.+.. +-++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 7899998763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.52 E-value=0.088 Score=41.68 Aligned_cols=29 Identities=31% Similarity=0.529 Sum_probs=24.5
Q ss_pred ceeeeccCCCcEEEccCCc-cccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFV-PNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~-~~l~d~~~~~ 120 (238)
.++|+|+.|.||++++++. +-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 5899999999999997555 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=91.82 E-value=0.91 Score=34.13 Aligned_cols=87 Identities=24% Similarity=0.356 Sum_probs=56.7
Q ss_pred cHHHHHHHHHHHhhcC---CCcc--eeeeeEEEeC--C----------------eeeEEEEeCCCCChhhhccCCCCCCC
Q 037755 8 SAEEFINEVSTIGRIH---HVNV--VQLLGFCSEG--S----------------KRALVYEFMPNGSLDRHIFPKESRGQ 64 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~---h~ni--~~~~~~~~~~--~----------------~~~lv~e~~~~~sL~~~~~~~~~~~~ 64 (238)
..+-|..|.+...+|+ +.++ ++++||..=. . ...+|.||.....
T Consensus 97 y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------- 163 (207)
T PF13095_consen 97 YADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------- 163 (207)
T ss_pred hcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------
Confidence 3456788888888874 3355 8999987211 0 1234555543322
Q ss_pred CCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCcccccccccc
Q 037755 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119 (238)
Q Consensus 65 ~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~ 119 (238)
.+... -+.++.+-+..+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 164 ~~~~~----~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 164 PLQIR----DIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccchh----HHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 22222 345666778889998 9999999999986 4588898853
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.27 E-value=0.37 Score=45.35 Aligned_cols=30 Identities=33% Similarity=0.389 Sum_probs=24.9
Q ss_pred CceeeeccCCCcEEEccCC--ccc-cccccccc
Q 037755 91 VCILHLDIKPHNILLDHNF--VPN-VSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~--~~~-l~d~~~~~ 120 (238)
.+++|+|+++.||+++.++ ++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3799999999999999775 454 89999764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.03 E-value=0.15 Score=41.41 Aligned_cols=30 Identities=20% Similarity=0.317 Sum_probs=25.8
Q ss_pred ceeeeccCCCcEEEcc-CCcccccccccccc
Q 037755 92 CILHLDIKPHNILLDH-NFVPNVSDFGLAKF 121 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~ 121 (238)
-.+|+|+.+.||++++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4899999999999974 57899999998753
|
|
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=90.33 E-value=1.3 Score=33.84 Aligned_cols=102 Identities=17% Similarity=0.168 Sum_probs=68.4
Q ss_pred cHHHHHHHHHHHhhcCCC--cceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVSTIGRIHHV--NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+|...++-+.-. -+..+.++-.+.+.-|++|+-++|.++...- ..++.+. .+.-++.+|+.|
T Consensus 55 ~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~~~-------~~~~p~r---~v~~la~aLR~L 124 (266)
T COG3231 55 PAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASHPR-------YALDPKR---AVPLLAEALRRL 124 (266)
T ss_pred chhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccchh-------hcCCHHH---HHHHHHHHHHHH
Confidence 346788999999888432 3445556666678889999999997774432 1333333 345577778888
Q ss_pred HcCCC-------------------------------------------------------CceeeeccCCCcEEEccCCc
Q 037755 86 HNGCD-------------------------------------------------------VCILHLDIKPHNILLDHNFV 110 (238)
Q Consensus 86 h~~~~-------------------------------------------------------~~i~H~dl~p~nil~~~~~~ 110 (238)
|+... .-+.|||-+.-|++++....
T Consensus 125 H~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~d~L~~~rp~~edLVv~HGDACLPN~i~d~~rf 204 (266)
T COG3231 125 HELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELFDELEARRPAVEDLVVTHGDACLPNFILDGWRF 204 (266)
T ss_pred hcCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHHHHHHhcCCchhhceeecCcccCcceEecCCce
Confidence 87421 12788998989998887755
Q ss_pred ccccccccc
Q 037755 111 PNVSDFGLA 119 (238)
Q Consensus 111 ~~l~d~~~~ 119 (238)
.-++|+|..
T Consensus 205 ~GfIDlGrl 213 (266)
T COG3231 205 SGFIDLGRL 213 (266)
T ss_pred EEeeecCcc
Confidence 556666643
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.00 E-value=0.56 Score=39.22 Aligned_cols=33 Identities=24% Similarity=0.353 Sum_probs=26.9
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCC
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 124 (238)
..++|||+.+.||++..+ .++++|+..+...+.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~G~~ 255 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFYGPI 255 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccccCCh
Confidence 369999999999999876 589999987764433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.28 E-value=0.69 Score=37.56 Aligned_cols=28 Identities=36% Similarity=0.470 Sum_probs=23.7
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+++|+|+.+.||+++ + .+.++||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 4 57899999775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 238 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-30 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-85
Identities = 84/239 (35%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70
+F EV I H N+++L GFC ++R LVY +M NGS+ + + W K
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
+A G+A G+ YLH+ CD I+H D+K NILLD F V DFGLAK ++ V+
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 131 ISATR--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL-KATRSSKAY 187
T GTIG+IAPE +S G S K+DV+G+G++LLE+ G+R +L +
Sbjct: 193 ---TAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 188 FPSWVSDQLNKGGNLEL--------RNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
WV L + L E+E +I + L C Q P +RP M++
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ-----VALLCTQSSPMERPKMSE 301
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (598), Expect = 4e-77
Identities = 70/237 (29%), Positives = 109/237 (45%), Gaps = 25/237 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
++F E+ + + H N+V+LLGF S+G LVY +MPNGSL + + SW
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSWH 133
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND-F 128
++A G A+GI +LH +H DIK NILLD F +SDFGLA+ K
Sbjct: 134 MRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 129 VSISATR--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
++ +R GT Y+APE + G ++ KSD+Y FG+VLLE+ G +
Sbjct: 191 MT---SRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQ 241
Query: 187 YFPSWVSDQLNKGGNLE------LRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ ++ +E + + + + C+ K RP +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKRPDIK 295
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 9e-74
Identities = 82/233 (35%), Positives = 119/233 (51%), Gaps = 15/233 (6%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EEF E+ T+ H ++V L+GFC E ++ L+Y++M NG+L RH++ + S SWE
Sbjct: 80 EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND-F 128
+ E+ G A G+ YLH I+H D+K NILLD NFVP ++DFG++K + +
Sbjct: 140 QRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 129 VSISATR--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
+S T GT+GYI PE + T KSDVY FG+VL E+ R R
Sbjct: 197 LS---TVVKGTLGYIDPEYFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPR-EMV 250
Query: 187 YFPSWVSDQLNKGGNLEL---RNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
W + N G ++ +I RK + C+ + DRPSM
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-51
Identities = 57/260 (21%), Positives = 94/260 (36%), Gaps = 31/260 (11%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHI 56
+ + + EV ++ + H N++Q +G G+ L+ F GSL +
Sbjct: 54 IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYLH-------NGCDVCILHLDIKPHNILLDHNF 109
+ SW +L +A A G+ YLH +G I H DIK N+LL +N
Sbjct: 114 -----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT---VSCKSDVYGFGMVL 166
++DFGLA GT Y+APE++ + D+Y G+VL
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
Query: 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQ----------LNKGGNLELRNVTEIESMIAR 216
E+ ++ F + ++K LR+ + + +
Sbjct: 229 WELASRCTAADGPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM-A 286
Query: 217 KLCVIGLWCIQVKPADRPSM 236
LC C R S
Sbjct: 287 MLCETIEECWDHDAEARLSA 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-49
Identities = 64/238 (26%), Positives = 112/238 (47%), Gaps = 25/238 (10%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ EF+ EV+ + R+ H N+V +G ++ ++V E++ GSL R + +R
Sbjct: 72 DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR 131
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ + +A A G+ YLHN + I+H ++K N+L+D + V DFGL++
Sbjct: 132 -EQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL- 188
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKAT 181
K + F+S + GT ++APE++ + KSDVY FG++L E+ T + NL
Sbjct: 189 -KASTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPA 245
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVT--EIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ V+ K LE+ ++ ++I C +P RPS
Sbjct: 246 Q--------VVAAVGFKCKRLEIPRNLNPQVAAIIEG--------CWTNEPWKRPSFA 287
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-43
Identities = 54/236 (22%), Positives = 91/236 (38%), Gaps = 33/236 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+EF EV + ++H N+V+L G +V EF+P G L + + W
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKAHPIKWS 122
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLD-----HNFVPNVSDFGLAKFHPK 124
+ A GIEY+ N + I+H D++ NI L V+DFGL++
Sbjct: 123 VKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKATRS 183
S+S G ++APE I + + K+D Y F M+L + TG +
Sbjct: 182 -----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK- 235
Query: 184 SKAYFPSWVSDQLNKGGNLELRNVT--EIESMIARKLCVIGLWCIQVKPADRPSMT 237
+++ +G + + ++I C P RP +
Sbjct: 236 -----IKFINMIREEGLRPTIPEDCPPRLRNVIEL--------CWSGDPKKRPHFS 278
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-43
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 29/232 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+ FI E+ + R++H N+V+L G C LV E+ GSL + E +
Sbjct: 46 KAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAA 102
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDF 128
+ G+ YLH+ ++H D+KP N+LL V + DFG A
Sbjct: 103 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKATRSSKAY 187
++ +G+ ++APE+ + S K DV+ +G++L E+ T + +
Sbjct: 159 -HMTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGP------ 209
Query: 188 FPSWVSDQLNKGGNLEL-RNV-TEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ ++ G L +N+ IES++ R C P+ RPSM
Sbjct: 210 -AFRIMWAVHNGTRPPLIKNLPKPIESLMTR--------CWSKDPSQRPSME 252
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-43
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 20/178 (11%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
E+ + E E + H N++ L G C + LV EF G L+R +
Sbjct: 44 EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-----S 98
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN--------VS 114
G+ + L A A G+ YLH+ V I+H D+K NIL+ ++
Sbjct: 99 GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TG 171
DFGLA+ + + + G ++APE+I + S SDV+ +G++L E+ TG
Sbjct: 159 DFGLAREWHRT----TKMSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTG 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-43
Identities = 54/264 (20%), Positives = 96/264 (36%), Gaps = 44/264 (16%)
Query: 10 EEFINE--VSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKESR 62
+ FINE + + + H N+ + + + LV E+ PNGSL +++
Sbjct: 50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----S 104
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHN------GCDVCILHLDIKPHNILLDHNFVPNVSDF 116
+ W +A G+ YLH I H D+ N+L+ ++ +SDF
Sbjct: 105 LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164
Query: 117 GLAKFH----PKENDFVSISATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMV 165
GL+ +A GTI Y+APE++ R+ + + D+Y G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
Query: 166 LLEMTGGRRNSNLKATRSSKAY---FPSWVSDQ----------LNKGGNLELRNVTEIES 212
E+ R ++L S Y F + V + + + + S
Sbjct: 225 YWEIF--MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 213 MIARKLCVIGLWCIQVKPADRPSM 236
+ R L C R +
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTA 306
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-42
Identities = 60/235 (25%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+ F NEV + + HVN++ +G+ + + A+V ++ SL H+ + +
Sbjct: 65 QAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL---HASETKFEMK 120
Query: 70 KLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
KL ++A TA G++YLH I+H D+K +NI L + + DFGLA + +
Sbjct: 121 KLIDIARQTARGMDYLHAKS----IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176
Query: 129 VSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGRR----NSNLKATRS 183
G+I ++APE+I ++ S +SDVY FG+VL E+ G+ +N
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--- 233
Query: 184 SKAYFPSWVSDQLNKGGNLELR-NVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + + +G L +++++ S +++ + C++ K +RPS
Sbjct: 234 --------IIEMVGRGS---LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-40
Identities = 49/249 (19%), Positives = 88/249 (35%), Gaps = 36/249 (14%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+++ + F EV + H NVV +G C A++ +L +
Sbjct: 67 RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDA 123
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
K ++A G+ YLH ILH D+K N+ D+ V ++DFGL
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNGKV-VITDFGLFSIS 179
Query: 123 PKENDFV---SISATRGTIGYIAPELISRNFGTVSC-------KSDVYGFGMVLLEMTGG 172
+ G + ++APE+I + SDV+ G + E+
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 173 R---RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229
+ + Q+ G L + + +++ I L+C +
Sbjct: 240 EWPFKTQP-----------AEAIIWQMGTGMKPNL-----SQIGMGKEISDILLFCWAFE 283
Query: 230 PADRPSMTK 238
+RP+ TK
Sbjct: 284 QEERPTFTK 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-40
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 13/170 (7%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKE 60
+ S + +F E + H NV+ +LG C L+ +MP GSL + E
Sbjct: 45 DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HE 102
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ + A A G+ +LH + I + ++++D + +S +
Sbjct: 103 GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
Query: 121 FHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEM 169
++APE + + T +D++ F ++L E+
Sbjct: 162 SF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 34/242 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
F+ EV + + H NV++ +G + + + E++ G+L I +S W
Sbjct: 52 RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWS 108
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF-------- 121
+ A A G+ YLH + I+H D+ HN L+ N V+DFGLA+
Sbjct: 109 QRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 122 ----HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNS 176
K+ D G ++APE+I N + K DV+ FG+VL E + +
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNADP 223
Query: 177 NLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ Y P + LN G L+ I + C + P RPS
Sbjct: 224 D---------YLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSF 270
Query: 237 TK 238
K
Sbjct: 271 VK 272
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-36
Identities = 48/255 (18%), Positives = 93/255 (36%), Gaps = 35/255 (13%)
Query: 10 EEFINE--VSTIGRIHHVNVVQLLGFCSEGSKR----ALVYEFMPNGSLDRHIFPKESRG 63
+ E + + H N++ + +G+ L+ ++ NGSL ++ +
Sbjct: 74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KS 128
Query: 64 QSCSWEKLHEVASGTAHGIEYLH-----NGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
+ + + ++A + G+ +LH I H D+K NIL+ N ++D GL
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188
Query: 119 AKFHPKENDFVSISAT--RGTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMTGG 172
A + + V I GT Y+ PE++ + +D+Y FG++L E+
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA-- 246
Query: 173 RRNSNLKATRSSKAYFPSWVSDQ----------LNKGGNLELRNVTEIESMIARKLCVIG 222
RR + + + V K N + R++ +
Sbjct: 247 RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE-CLRQMGKLM 305
Query: 223 LWCIQVKPADRPSMT 237
C PA R +
Sbjct: 306 TECWAHNPASRLTAL 320
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-35
Identities = 46/254 (18%), Positives = 87/254 (34%), Gaps = 35/254 (13%)
Query: 10 EEFINE--VSTIGRIHHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHIFPKESRG 63
+ + E + + H N++ + + L+ + GSL ++ +
Sbjct: 45 KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QL 99
Query: 64 QSCSWEKLHEVASGTAHGIEYLH-----NGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
+ + A G+ +LH I H D+K NIL+ N ++D GL
Sbjct: 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159
Query: 119 AKFHPKENDFVSISAT--RGTIGYIAPELI----SRNFGTVSCKSDVYGFGMVLLEMTGG 172
A H + + + + GT Y+APE++ + + D++ FG+VL E+
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA-- 217
Query: 173 RRNSNLKATRSSKAYFPSWVSDQ----------LNKGGNLELRNVTEIESMIARKLCVIG 222
RR + K F V + + N + L +
Sbjct: 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP-TLTSLAKLM 276
Query: 223 LWCIQVKPADRPSM 236
C P+ R +
Sbjct: 277 KECWYQNPSARLTA 290
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 51/255 (20%), Positives = 95/255 (37%), Gaps = 35/255 (13%)
Query: 10 EEFINE--VSTIGRIHHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHIFPKESRG 63
+ E + + H N++ + ++ + LV ++ +GSL ++
Sbjct: 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NR 133
Query: 64 QSCSWEKLHEVASGTAHGIEYLH-----NGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
+ + E + ++A TA G+ +LH I H D+K NIL+ N ++D GL
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193
Query: 119 AKFHPKENDFVSISAT--RGTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMTGG 172
A H D + I+ GT Y+APE++ + ++D+Y G+V E+
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-- 251
Query: 173 RRNSNLKATRSSKAYFPSWVSDQ----------LNKGGNLELRNVTEIESMIARKLCVIG 222
RR S + + V + + N + + R + I
Sbjct: 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL-RVMAKIM 310
Query: 223 LWCIQVKPADRPSMT 237
C A R +
Sbjct: 311 RECWYANGAARLTAL 325
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 33/242 (13%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ EEF+ E + + I H N+VQLLG C+ ++ EFM G+L + +E
Sbjct: 252 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRE 309
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
Q S L +A+ + +EYL +H ++ N L+ N + V+DFGL++
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSR 366
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNLK 179
+ + + + + I + APE + + S KSDV+ FG++L E T G
Sbjct: 367 LM-TGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSP---- 419
Query: 180 ATRSSKAYFPSW----VSDQLNKGGNLEL-RNVTEIESMIARKLCVIGLWCIQVKPADRP 234
+P V + L K +E E K+ + C Q P+DRP
Sbjct: 420 --------YPGIDLSQVYELLEKDYRMERPEGCPE-------KVYELMRACWQWNPSDRP 464
Query: 235 SM 236
S
Sbjct: 465 SF 466
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-29
Identities = 69/247 (27%), Positives = 106/247 (42%), Gaps = 45/247 (18%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ EEF+ E + + I H N+VQLLG C+ ++ EFM G+L + +E
Sbjct: 45 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRE 102
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
Q S L +A+ + +EYL N I H D+ N L+ N + V+DFGL
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEKKN----FI-HRDLAARNCLVGENHLVKVADFGL 157
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSN 177
++ + + + + + I + APE + + S KSDV+ FG++L E T G
Sbjct: 158 SRLM-TGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSP-- 212
Query: 178 LKATRSSKAYFPSW----VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLWCIQV 228
+P V + L K +E V E+ M C Q
Sbjct: 213 ----------YPGIDLSQVYELLEKDYRMERPEGCPEKVYEL--M---------RACWQW 251
Query: 229 KPADRPS 235
P+DRPS
Sbjct: 252 NPSDRPS 258
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 51/175 (29%), Positives = 91/175 (52%), Gaps = 10/175 (5%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
++ S E F+ E + + + H +V+L ++ ++ EFM GSL F K
Sbjct: 219 TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD--FLKS 275
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
G KL + ++ A G+ ++ +H D++ NIL+ + V ++DFGLA+
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR 332
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
++N++ + + I + APE I NFG+ + KSDV+ FG++L+E +T GR
Sbjct: 333 -VIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-28
Identities = 53/177 (29%), Positives = 93/177 (52%), Gaps = 14/177 (7%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ S + F+ E + + ++ H +V+L ++ ++ E+M NGSL F K
Sbjct: 44 SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKT 100
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
G + KL ++A+ A G+ ++ N I H D++ NIL+ ++DFGL
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERN----YI-HRDLRAANILVSDTLSCKIADFGL 155
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
A+ ++N++ + + I + APE I N+GT + KSDV+ FG++L E +T GR
Sbjct: 156 ARLI-EDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 41/238 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+F+ E + + H N+V+L+G C++ +V E + G + + G +
Sbjct: 157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVK 213
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L ++ A G+EYL C +H D+ N L+ V +SDFG+++
Sbjct: 214 TLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNLKATRSSKAYF 188
S + + + APE + N+G S +SDV+ FG++L E + G +
Sbjct: 271 SGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWETFSLGASP------------Y 316
Query: 189 PSW----VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
P+ + + KGG L V + M C +P RPS +
Sbjct: 317 PNLSNQQTREFVEKGGRLPCPELCPDAVFRL--M---------EQCWAYEPGQRPSFS 363
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-28
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 46/247 (18%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
M++ S +EF E T+ ++ H +V+ G CS+ +V E++ NG L ++
Sbjct: 39 MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL---R 95
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
S G+ +L E+ G+ +L H I H D+ N L+D + VSDFG+
Sbjct: 96 SHGKGLEPSQLLEMCYDVCEGMAFLESHQ----FI-HRDLAARNCLVDRDLCVKVSDFGM 150
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSN 177
++ ++ +VS T+ + + APE+ ++ S KSDV+ FG+++ E + G+
Sbjct: 151 TRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYFKYSSKSDVWAFGILMWEVFSLGKMP-- 205
Query: 178 LKATRSSKAYFPSW----VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLWCIQV 228
+ + V ++++G L + +I M C
Sbjct: 206 ----------YDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI--M---------YSCWHE 244
Query: 229 KPADRPS 235
P RP+
Sbjct: 245 LPEKRPT 251
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ S E F+ E + ++ H +VQL SE +V E+M GSL F K
Sbjct: 215 TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD--FLKG 271
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
G+ +L ++A+ A G+ Y+ + +H D++ NIL+ N V V+DFGLA+
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNLK 179
++N++ + + I + APE +G + KSDV+ FG++L E T GR
Sbjct: 329 -LIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVP---- 381
Query: 180 ATRSSKAYFPSW----VSDQLNKGGNLEL-RNVTEIESMIARKLCVIGLWCIQVKPADRP 234
+P V DQ+ +G + E L + C + +P +RP
Sbjct: 382 --------YPGMVNREVLDQVERGYRMPCPPECPE-------SLHDLMCQCWRKEPEERP 426
Query: 235 S 235
+
Sbjct: 427 T 427
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
S + +E ++E + + + +V +LLG C S L+ + MP G L ++ +E +
Sbjct: 55 ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHK 111
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ L A G+ YL D ++H D+ N+L+ ++DFGLAK
Sbjct: 112 DN-IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
E + I ++A E I + +SDV+ +G+ + E MT G +
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ S E F+ E + ++ H +VQL SE +V E+M GSL F K
Sbjct: 298 TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD--FLKG 354
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
G+ +L ++A+ A G+ Y+ + +H D++ NIL+ N V V+DFGLA+
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR 411
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNLK 179
++N++ + + I + APE +G + KSDV+ FG++L E T GR
Sbjct: 412 -LIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVP---- 464
Query: 180 ATRSSKAYFPSW----VSDQLNKGGNLEL-RNVTEIESMIARKLCVIGLWCIQVKPADRP 234
+P V DQ+ +G + E L + C + +P +RP
Sbjct: 465 --------YPGMVNREVLDQVERGYRMPCPPECPE-------SLHDLMCQCWRKEPEERP 509
Query: 235 S 235
+
Sbjct: 510 T 510
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-27
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
S + + + IG + H ++V+LLG C S LV +++P GSL H+ ++ RG
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGA-LG 113
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+ L A G+ YL + ++H ++ N+LL V+DFG+A P ++
Sbjct: 114 PQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ S + I ++A E I +FG + +SDV+ +G+ + E MT G
Sbjct: 171 QLLYSEAKTPIKWMALESI--HFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-27
Identities = 51/250 (20%), Positives = 99/250 (39%), Gaps = 38/250 (15%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKE 60
E+ + E+ + ++H N+V+ G C+E L+ EF+P+GSL ++
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---P 117
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ ++ + A G++YL +H D+ N+L++ + DFGL K
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174
Query: 121 FHPKENDFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNS 176
+ ++ + + + APE + SDV+ FG+ L E +T +S
Sbjct: 175 AIETDKEY--YTVKDDRDSPVFWYAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDS 230
Query: 177 NLKATRSSKAYFPSW------VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLWC 225
+ A + + L +G L V ++ M + C W
Sbjct: 231 SPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQL--M---RKC----W- 280
Query: 226 IQVKPADRPS 235
+ +P++R S
Sbjct: 281 -EFQPSNRTS 289
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-26
Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+ S E+FI E + ++ H +VQL G C E + LV EFM +G L + +
Sbjct: 39 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD--YLRT 96
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
RG + E L + G+ YL I H D+ N L+ N V VSDFG+
Sbjct: 97 QRGL-FAAETLLGMCLDVCEGMAYLEEAC----VI-HRDLAARNCLVGENQVIKVSDFGM 150
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+F ++ + S + T+ + + +PE+ +F S KSDV+ FG+++ E + G+
Sbjct: 151 TRF-VLDDQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 55/171 (32%), Positives = 89/171 (52%), Gaps = 14/171 (8%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
+F+ E S +G+ H N+++L G ++ +V E+M NGSLD F ++ Q +
Sbjct: 89 QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FT 145
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+L + G A G++YL D+ +H D+ NIL++ N V VSDFGL + + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202
Query: 128 FVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
TRG I + +PE I + + SDV+ +G+VL E M+ G R
Sbjct: 203 AA--YTTRGGKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 57/170 (33%), Positives = 93/170 (54%), Gaps = 14/170 (8%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
+F+ E +G+ H N+++L G S+ ++ E+M NG+LD+ F +E G+ S
Sbjct: 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSV 146
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
+L + G A G++YL ++ +H D+ NIL++ N V VSDFGL++ E+D
Sbjct: 147 LQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDP 201
Query: 129 VSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ T G I + APE I ++ + SDV+ FG+V+ E MT G R
Sbjct: 202 EATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-26
Identities = 46/177 (25%), Positives = 89/177 (50%), Gaps = 14/177 (7%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
M++ S +EFI E + + H +VQL G C++ ++ E+M NG L + +E
Sbjct: 55 MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLRE 112
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
R + ++L E+ +EYL + H D+ N L++ V VSDFGL
Sbjct: 113 MRHR-FQTQQLLEMCKDVCEAMEYLESKQ----FL-HRDLAARNCLVNDQGVVKVSDFGL 166
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+++ ++++ S ++ + + PE++ + S KSD++ FG+++ E + G+
Sbjct: 167 SRY-VLDDEYTSSVGSKFPVRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-26
Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+E ++E + + + +V +LLG C S L+ + MP G L ++ +E + +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQ 117
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L A G+ YL D ++H D+ N+L+ ++DFGLAK E
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ I ++A E I + +SDV+ +G+ + E MT G +
Sbjct: 175 HAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-26
Identities = 59/171 (34%), Positives = 88/171 (51%), Gaps = 14/171 (8%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
+F++E S +G+ H N+++L G + G +V E+M NGSLD F + GQ +
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQ-FT 149
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+L + G G+ YL D+ +H D+ N+L+D N V VSDFGL++ + D
Sbjct: 150 IMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 128 FVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
T G I + APE I F T S SDV+ FG+V+ E + G R
Sbjct: 207 AA--YTTTGGKIPIRWTAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-26
Identities = 52/248 (20%), Positives = 98/248 (39%), Gaps = 36/248 (14%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKE 60
+ + E+ + ++H ++++ G C + + LV E++P GSL ++
Sbjct: 71 DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---- 126
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
S +L A G+ YLH +H D+ N+LLD++ + + DFGLAK
Sbjct: 127 -PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
Query: 121 FHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNSNL 178
P+ +++ + + APE + SDV+ FG+ L E +T + +
Sbjct: 183 AVPEGHEYYRVREDGDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240
Query: 179 KATRSSKAYFPSW------VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLWCIQ 227
+++ L +G L V + M K C W +
Sbjct: 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHL--M---KNC----W--E 289
Query: 228 VKPADRPS 235
+ + RP+
Sbjct: 290 TEASFRPT 297
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
EE + E + ++ + +V+L+G C LV E G L + F R +
Sbjct: 53 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK--FLVGKREEI-P 108
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+ E+ + G++YL + +H D+ N+LL + +SDFGL+K ++
Sbjct: 109 VSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
Query: 128 FVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ +A + + APE I NF S +SDV+ +G+ + E ++ G++
Sbjct: 166 Y--YTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-25
Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+F+ E T+ + H ++V+L+G +E + ++ E G L F + +
Sbjct: 61 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYS-LDLA 116
Query: 70 KLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
L A + + YL + H DI N+L+ N + DFGL+++ +++
Sbjct: 117 SLILYAYQLSTALAYLESKR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDST 170
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ S + I ++APE I NF + SDV+ FG+ + E + G +
Sbjct: 171 YYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 23 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82
H NV++ + + + E +L ++ E + + + + T G+
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGL 131
Query: 83 EYLH-NGCDVCILHLDIKPHNILL-----DHNFVPNVSDFGLAK-FHPKENDFVSISATR 135
+LH I+H D+KPHNIL+ +SDFGL K + F S
Sbjct: 132 AHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 136 GTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEM-TGGRRNSNLKATRSSKAYFPSWVS 193
GT G+IAPE++S + + D++ G V + + G P S
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG--------------SHPFGKS 233
Query: 194 DQ-----LNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
Q L +L+ + + E +IAR+L I I + P RPS
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIAREL--I-EKMIAMDPQKRPSAKH 280
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-25
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-LVYEFMPNGSLDRHIFPKESRGQSC 66
+A+ F+ E S + ++ H N+VQLLG E +V E+M GSL + +
Sbjct: 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVL 114
Query: 67 SWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
+ L + + +EYL +N + H D+ N+L+ + V VSDFGL K
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNN----FV-HRDLAARNVLVSEDNVAKVSDFGLTK---- 165
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ + + + APE + S KSDV+ FG++L E + GR
Sbjct: 166 -EASSTQDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-25
Identities = 57/251 (22%), Positives = 94/251 (37%), Gaps = 39/251 (15%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKE 60
+++ +F E+ + + H N+V+ G C +R L+ E++P GSL ++ +
Sbjct: 49 HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---Q 105
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ KL + S G+EYL +H D+ NIL+++ + DFGL K
Sbjct: 106 KHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 162
Query: 121 FHPKENDFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT--GGRRN 175
P++ +F I + APE + S SDV+ FG+VL E+ +
Sbjct: 163 VLPQDKEF--FKVKEPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSK 218
Query: 176 SNLKATRSSKAYFPSW------VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLW 224
S + + L G L + I M C W
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMI--M---TEC----W 269
Query: 225 CIQVKPADRPS 235
RPS
Sbjct: 270 --NNNVNQRPS 278
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-25
Identities = 51/251 (20%), Positives = 93/251 (37%), Gaps = 51/251 (20%)
Query: 6 KFSAEEFINEVSTIGRIHHVNVVQLLGF-------------CSEGSKRALVY---EFMPN 49
K++ E+ EV + ++ HVN+V G S SK ++ EF
Sbjct: 45 KYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDK 104
Query: 50 GSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF 109
G+L++ I ++ RG+ E+ G++Y+H +++ D+KP NI L
Sbjct: 105 GTLEQWI--EKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK 159
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
+ DFGL + ++GT+ Y++PE IS + D+Y G++L E+
Sbjct: 160 QVKIGDFGLVTSLKNDGKRTR---SKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAEL 214
Query: 170 -TGGRRNSNLKA--TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCI 226
T + +++ +
Sbjct: 215 LHVCDTAFETSKFFTDLRDGIISDIFDKKEK--------------TLLQ--------KLL 252
Query: 227 QVKPADRPSMT 237
KP DRP+ +
Sbjct: 253 SKKPEDRPNTS 263
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-25
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 15/175 (8%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+ + ++FI EV+ + + H N+++L G +V E P GSL + ++ +G
Sbjct: 60 SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQG 116
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
L A A G+ YL +H D+ N+LL + + DFGL + P
Sbjct: 117 H-FLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
Query: 124 KENDFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ +D + APE + T S SD + FG+ L E T G+
Sbjct: 173 QNDDHY--VMQEHRKVPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-24
Identities = 57/265 (21%), Positives = 96/265 (36%), Gaps = 63/265 (23%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-------------LVYEFMPNGS 51
++ ++EV + ++H VV+ E + E+ NG+
Sbjct: 42 TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT 101
Query: 52 LDRHIFPK---ESRGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDH 107
L I + + R + ++ + Y+H G I+H D+KP NI +D
Sbjct: 102 LYDLIHSENLNQQRDEYWRL--FRQILEA----LSYIHSQG----IIHRDLKPMNIFIDE 151
Query: 108 NFVPNVSDFGLAKFHPKENDFVSISATR------------GTIGYIAPELISRNFGTVSC 155
+ + DFGLAK + D + + + GT Y+A E++ G +
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNE 210
Query: 156 KSDVYGFGMVLLEM-----TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEI 210
K D+Y G++ EM TG R + LK RS FP D
Sbjct: 211 KIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDN--------------- 255
Query: 211 ESMIARKLCVIGLWCIQVKPADRPS 235
+ + +K+ I P RP
Sbjct: 256 KMKVEKKII---RLLIDHDPNKRPG 277
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-LVYEFMPNGSLDRHIFPKESRGQSC 66
+A+ F+ E S + ++ H N+VQLLG E +V E+M GSL + +
Sbjct: 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVL 286
Query: 67 SWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
+ L + + +EYL +N + H D+ N+L+ + V VSDFGL K
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNN----FV-HRDLAARNVLVSEDNVAKVSDFGLTK---- 337
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ + + + APE + S KSDV+ FG++L E + GR
Sbjct: 338 -EASSTQDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-24
Identities = 41/176 (23%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQ 64
+E + E + + ++ + +V+++G C LV E G L++++ + +
Sbjct: 58 DPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYL----QQNR 112
Query: 65 SCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ + E+ + G++YL N + H D+ N+LL +SDFGL+K
Sbjct: 113 HVKDKNIIELVHQVSMGMKYLEESN----FV-HRDLAARNVLLVTQHYAKISDFGLSKAL 167
Query: 123 PKENDFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ ++ A + + APE I N+ S KSDV+ FG+++ E + G++
Sbjct: 168 RADENY--YKAQTHGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-24
Identities = 53/245 (21%), Positives = 84/245 (34%), Gaps = 43/245 (17%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHI-- 56
+ +K + F E + + H N+V+ K LV E M +G+L ++
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN---- 112
F SW G+++LH I+H D+K NI +
Sbjct: 123 FKVMKIKVLRSW------CRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGP---TGSVK 172
Query: 113 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TG 171
+ D GLA A GT ++APE+ + DVY FGM +LEM T
Sbjct: 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEKYDE---SVDVYAFGMCMLEMATS 225
Query: 172 GRRNSNLKATRSS-KAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKP 230
S + + +K E++ + E CI+
Sbjct: 226 EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE--------------GCIRQNK 271
Query: 231 ADRPS 235
+R S
Sbjct: 272 DERYS 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-24
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEFMPNGSLDRHIFPKESRGQSCSW 68
E F+ E + ++H NV+ L+G + +M +G L + I S ++ +
Sbjct: 67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTV 123
Query: 69 EKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
+ L A G+EYL + H D+ N +LD +F V+DFGLA+ +
Sbjct: 124 KDLISFGLQVARGMEYLAEQK----FV-HRDLAARNCMLDESFTVKVADFGLARD-ILDR 177
Query: 127 DFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
++ S+ R + + A E S + KSDV+ FG++L E +T G
Sbjct: 178 EYYSVQQHRHARLPVKWTALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-24
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 38/250 (15%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKE 60
+ +F E+ + +H +V+ G +++ LV E++P+G L F +
Sbjct: 62 HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQR 119
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
R + +L +S G+EYL +H D+ NIL++ ++DFGLAK
Sbjct: 120 HRAR-LDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK 175
Query: 121 FHPKENDFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNS 176
P + D+ I + APE + + S +SDV+ FG+VL E T ++
Sbjct: 176 LLPLDKDY--YVVREPGQSPIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSC 231
Query: 177 NLKATRSSKAYFPSW------VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLWC 225
+ A + + L +G L V E+ M KLC W
Sbjct: 232 SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHEL--M---KLC----W- 281
Query: 226 IQVKPADRPS 235
P DRPS
Sbjct: 282 -APSPQDRPS 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-24
Identities = 57/251 (22%), Positives = 96/251 (38%), Gaps = 39/251 (15%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKE 60
+++ +F E+ + + H N+V+ G C +R L+ E++P GSL ++ +
Sbjct: 80 HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---Q 136
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ KL + S G+EYL +H D+ NIL+++ + DFGL K
Sbjct: 137 KHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 193
Query: 121 FHPKENDFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRRNS 176
P++ ++ I + APE + S SDV+ FG+VL E T ++
Sbjct: 194 VLPQDKEY--YKVKEPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSK 249
Query: 177 NLKATRSSKAYFPSW-------VSDQLNKGGNLEL-----RNVTEIESMIARKLCVIGLW 224
+ A + + L G L + I M C W
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMI--M---TEC----W 300
Query: 225 CIQVKPADRPS 235
RPS
Sbjct: 301 --NNNVNQRPS 309
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 9e-24
Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 11/174 (6%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
K EE + E + ++ + +V+L+G C LV E G L + F R
Sbjct: 374 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK--FLVGKR 430
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ + E+ + G++YL + +H ++ N+LL + +SDFGL+K
Sbjct: 431 EEI-PVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486
Query: 123 PKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
++ + + SA + + + APE I NF S +SDV+ +G+ + E ++ G++
Sbjct: 487 GADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 9e-24
Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+F+ E T+ + H ++V+L+G +E + ++ E G L F + +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKFS-LDLA 491
Query: 70 KLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
L A + + YL + H DI N+L+ N + DFGL+++ +++
Sbjct: 492 SLILYAYQLSTALAYLESKR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDST 545
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+ S + I ++APE I NF + SDV+ FG+ + E + G +
Sbjct: 546 YYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-23
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQ 64
+ + E+F++E + + H ++V+L+G E ++ E P G L ++ E
Sbjct: 53 TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL---ERNKN 108
Query: 65 SCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
S L + + YL N C+ H DI NIL+ + DFGL+++
Sbjct: 109 SLKVLTLVLYSLQICKAMAYLESIN----CV-HRDIAVRNILVASPECVKLGDFGLSRY- 162
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
++ D+ S TR I +++PE I NF + SDV+ F + + E ++ G++
Sbjct: 163 IEDEDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-23
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
+S+ ++ E++ + H N+VQ LG SE + E +P GSL + +
Sbjct: 57 ERDSR-YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL--RSK 113
Query: 62 RGQSCSWEKLHEVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFG 117
G E+ + T G++YLH D I+H DIK N+L++ ++ V +SDFG
Sbjct: 114 WGPLKDNEQT--IGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFG 168
Query: 118 LAKFHPKENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
+K + + T GT+ Y+APE+I + +D++ G ++EM G+
Sbjct: 169 TSK---RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-23
Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 21/237 (8%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73
NE+ I I + + G + + ++YE+M N S+ + ++ + +
Sbjct: 92 NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 74 VAS----GTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
V + Y+HN ++C H D+KP NIL+D N +SDFG +++ +
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--- 206
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR----RNSNLKAT---- 181
I +RGT ++ PE S K D++ G+ L M +L
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
R+ +P + L N + S + ++ PA+R +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF-LKLF--LRKNPAERITSED 319
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-23
Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEFMPNGSLDRHIFPKESRGQSCSW 68
+F+ E + H NV+ LLG C L V +M +G L I + + +
Sbjct: 71 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTV 127
Query: 69 EKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
+ L A G++YL + H D+ N +LD F V+DFGLA+ +
Sbjct: 128 KDLIGFGLQVAKGMKYLASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYDK 181
Query: 127 DFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
++ S+ G + ++A E S + KSDV+ FG++L E MT G
Sbjct: 182 EYYSVHNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-23
Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 39/234 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
EE EV+ + + H N+VQ E +V ++ G L + I +G +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQED 125
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
++ + ++++H D ILH DIK NI L + + DFG+A+ +
Sbjct: 126 QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR---NSNLKA-----T 181
GT Y++PE+ + KSD++ G VL E+ + ++K
Sbjct: 183 RACI--GTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
S S L S+++ + P DRPS
Sbjct: 239 SGSFPPVSLHYSYDLR--------------SLVS--------QLFKRNPRDRPS 270
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-23
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEG-SKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
+F+ E + H NV+ LLG C +V +M +G L I + + +
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTV 191
Query: 69 EKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
+ L A G+++L + H D+ N +LD F V+DFGLA+ +
Sbjct: 192 KDLIGFGLQVAKGMKFLASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYDK 245
Query: 127 DFVSISATRGT---IGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
+F S+ G + ++A E S + KSDV+ FG++L E MT G
Sbjct: 246 EFDSVHNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-22
Identities = 53/259 (20%), Positives = 92/259 (35%), Gaps = 47/259 (18%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHI 56
+L + + EE E +H N+++L+ +C L+ F G+L I
Sbjct: 62 ILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
+ +G + +++ + G G+E +H H D+KP NILL P + D
Sbjct: 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDL 178
Query: 117 GLAKFHPKENDFVS-------ISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE 168
G + +A R TI Y APEL S ++ + ++DV+ G VL
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238
Query: 169 MTGGR--------RNSNLKATRSSKAYFPSW--VSDQLNKGGNLELRNVTEIESMIARKL 218
M G + ++ ++ P S L ++
Sbjct: 239 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALW--------------QLLN--- 281
Query: 219 CVIGLWCIQVKPADRPSMT 237
+ V P RP +
Sbjct: 282 -----SMMTVDPHQRPHIP 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-22
Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL 71
F EV ++ H N+V ++ E LV E++ +L +I ES G S +
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGP-LSVDTA 113
Query: 72 HEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
+ GI++ H I+H DIKP NIL+D N + DFG+AK E
Sbjct: 114 INFTNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQ 168
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
+ GT+ Y +PE +D+Y G+VL EM G
Sbjct: 169 TNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEP 210
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-22
Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ + +E F S + ++ H ++V G C G + LV EF+ GSLD ++ +
Sbjct: 50 KAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKN 106
Query: 63 GQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPN-------- 112
+ EVA A + +L + I H ++ NILL
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENT----LI-HGNVCAKNILLIREEDRKTGNPPFIK 161
Query: 113 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTG 171
+SD G++ + + I ++ PE I N ++ +D + FG L E +G
Sbjct: 162 LSDPGISI------TVLPKDILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSG 214
Query: 172 GRR 174
G +
Sbjct: 215 GDK 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-22
Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 32/236 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+ I E+ + +++H NV++ E ++ +V E G L R I + + +
Sbjct: 77 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
+ + +E++H ++H DIKP N+ + V + D GL +F +
Sbjct: 137 TVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 193
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-----NSNLKA--TR 182
GT Y++PE I N + KSD++ G +L EM + NL + +
Sbjct: 194 HSLV--GTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
Query: 183 SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
+ +P SD ++ ELR + CI P RP +T
Sbjct: 250 IEQCDYPPLPSDHYSE----ELRQLVN--------------MCINPDPEKRPDVTY 287
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 37/172 (21%), Positives = 66/172 (38%), Gaps = 32/172 (18%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMPNGSLDRHIFPKESRGQSC 66
+ E + + H ++VQ+ F + +V E++ SL K S+GQ
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKL 179
Query: 67 SWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
+ + YLH G +++ D+KP NI+L + + D G
Sbjct: 180 PVAEAIAYLLEILPALSYLHSIG----LVYNDLKPENIMLTEEQL-KLIDLGAVS----- 229
Query: 126 NDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
I++ GT G+ APE++ + +D+Y G L +T
Sbjct: 230 ----RINSFGYLYGTPGFQAPEIVR---TGPTVATDIYTVGRTLAALTLDLP 274
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-22
Identities = 42/251 (16%), Positives = 80/251 (31%), Gaps = 57/251 (22%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
+ + EV + H +VV+ +E + E+ GSL I
Sbjct: 55 QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVS-------------- 114
+L ++ G+ Y+H + ++H+DIKP NI + +PN +
Sbjct: 115 AELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 115 -----DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
D G G ++A E++ N+ K+D++ + ++
Sbjct: 172 MFKIGDLGHVTRISSPQVEE------GDSRFLANEVLQENYT-HLPKADIFALALTVVCA 224
Query: 170 TGGR---RNSNL--KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224
G RN + + + P +S + ++
Sbjct: 225 AGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFT--------------ELLK--------V 262
Query: 225 CIQVKPADRPS 235
I P RPS
Sbjct: 263 MIHPDPERRPS 273
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-22
Identities = 62/245 (25%), Positives = 98/245 (40%), Gaps = 50/245 (20%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKESRGQSC 66
+F+ E I + +H N+V+ +G + R ++ E M G L R P+ S+ S
Sbjct: 78 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 67 SWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKF 121
+ L VA A G +YL ++ I H DI N LL V + DFG+A+
Sbjct: 138 AMLDLLHVARDIACGCQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGDFGMAR- 191
Query: 122 HPKENDFVSISATR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMTGGRRN 175
D S R G + PE + G + K+D + FG++L E+
Sbjct: 192 -----DIYRASYYRKGGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEI------ 238
Query: 176 SNLKATRSSKAYFPSW----VSDQLNKGGNLEL-RNVTEIESMIARKLCVIGLWCIQVKP 230
+ Y PS V + + GG ++ +N + I C Q +P
Sbjct: 239 ----FSLGYMPY-PSKSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQP 286
Query: 231 ADRPS 235
DRP+
Sbjct: 287 EDRPN 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-21
Identities = 53/238 (22%), Positives = 89/238 (37%), Gaps = 38/238 (15%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCS 67
+ ++EV+ + + H N+V+ + + L V E+ G L I Q
Sbjct: 50 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD 109
Query: 68 WEKLHEVASGTAHGIEYLH--NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
E + V + ++ H + +LH D+KP N+ LD + DFGLA+ +
Sbjct: 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169
Query: 126 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR---NSNLKA-- 180
F GT Y++PE ++R + + KSD++ G +L E+ + K
Sbjct: 170 TSFAKTFV--GTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225
Query: 181 ---TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
P SD EL + I M + +K RPS
Sbjct: 226 GKIREGKFRRIPYRYSD--------ELNEI--ITRM------------LNLKDYHRPS 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-21
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 28/180 (15%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKESRGQSC 66
+F+ E I + +H N+V+ +G + R ++ E M G L R P+ S+ S
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 67 SWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKF 121
+ L VA A G +YL ++ I H DI N LL V + DFG+A+
Sbjct: 179 AMLDLLHVARDIACGCQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGDFGMAR- 232
Query: 122 HPKENDFVSISATR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
D R G + PE + G + K+D + FG++L E + G
Sbjct: 233 -----DIYRAGYYRKGGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-21
Identities = 51/266 (19%), Positives = 95/266 (35%), Gaps = 60/266 (22%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG---------SKRALVY---EFMPN 49
L N + + E+ + EV + ++ H +V+ E S + +Y +
Sbjct: 40 LPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRK 99
Query: 50 GSLDRHIFPKESRGQ---SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLD 106
+L + + + + S ++A +E+LH ++H D+KP NI
Sbjct: 100 ENLKDWMNGRCTIEERERSVCLHIFLQIAEA----VEFLH---SKGLMHRDLKPSNIFFT 152
Query: 107 HNFVPNVSDFGLAKFHPKENDFVSISATR----------GTIGYIAPELISRNFGTVSCK 156
+ V V DFGL ++ + ++ GT Y++PE I N + S K
Sbjct: 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHK 210
Query: 157 SDVYGFGMVLLEM-----TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIE 211
D++ G++L E+ T R L R+ K FP + +
Sbjct: 211 VDIFSLGLILFELLYPFSTQMERVRTLTDVRNLK--FPPLFTQK---------------- 252
Query: 212 SMIARKLCVIGLWCIQVKPADRPSMT 237
+ + P +RP
Sbjct: 253 YPCEYVMV---QDMLSPSPMERPEAI 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 27/174 (15%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD------RHIFPKESRG 63
EF+NE S + + +VV+LLG S+G ++ E M G L R
Sbjct: 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 64 QSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
S K+ ++A A G+ YL + + H D+ N ++ +F + DFG+ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANK----FV-HRDLAARNCMVAEDFTVKIGDFGMTR- 186
Query: 122 HPKENDFVSISATR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEM 169
D R G G + +PE S G + SDV+ FG+VL E+
Sbjct: 187 -----DIYETDYYRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-21
Identities = 52/236 (22%), Positives = 84/236 (35%), Gaps = 48/236 (20%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
+ EV + ++ H V+L EG L E SL +H E+ G S
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPE 156
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF---HPKE 125
++ T + +LH ++HLD+KP NI L + DFGL
Sbjct: 157 AQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213
Query: 126 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR----NSNLKAT 181
G Y+APEL+ ++G +DV+ G+ +LE+ +
Sbjct: 214 EVQE------GDPRYMAPELLQGSYG---TAADVFSLGLTILEVACNMELPHGGEGWQQL 264
Query: 182 RSSKAY--FPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
R F + +S ELR+V + M ++ P R +
Sbjct: 265 RQGYLPPEFTAGLSS--------ELRSV--LVMM------------LEPDPKLRAT 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-21
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL----------DRHIFP 58
E ++E+ + + H N+V LLG C+ G ++ E+ G L
Sbjct: 94 EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 59 KESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
+ S L +S A G+ +L N CI H D+ N+LL + V + DF
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKN----CI-HRDVAARNVLLTNGHVAKIGDF 208
Query: 117 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
GLA+ +++++ R + ++APE S + +SDV+ +G++L E + G
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGL 264
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-21
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 26/181 (14%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHI 56
+F E+ + ++ HH N++ LLG C L E+ P+G+L D
Sbjct: 70 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVS 114
S + S ++L A+ A G++YL I H D+ NIL+ N+V ++
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FI-HRDLAARNILVGENYVAKIA 184
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
DFGL++ + +V + R + ++A E S N+ + SDV+ +G++L E ++ G
Sbjct: 185 DFGLSR---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 174 R 174
Sbjct: 240 T 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-21
Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 22/180 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD------------RHIF 57
EEF +E R+ H NVV LLG ++ ++++ + +G L
Sbjct: 57 EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 58 PKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSD 115
+ + + + A G+EYL H+ + H D+ N+L+ +SD
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH----VV-HKDLATRNVLVYDKLNVKISD 171
Query: 116 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGRR 174
GL + + + + + I ++APE I +G S SD++ +G+VL E + G +
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-21
Identities = 62/241 (25%), Positives = 100/241 (41%), Gaps = 41/241 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEFMPNGSLD---RHIFPKES 61
EEF++E + + H NV++LLG C E S + ++ FM G L + E+
Sbjct: 81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL-ET 139
Query: 62 RGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
+ + L + A G+EYL N + H D+ N +L + V+DFGL+
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRN----FL-HRDLAARNCMLRDDMTVCVADFGLS 194
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLK 179
K + + + + +IA E S + KSDV+ FG+ + E+
Sbjct: 195 KKIYSGDYYRQGRIAKMPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEI---------- 242
Query: 180 ATRSSKAYFPSW----VSDQLNKGGNLEL-RNVTEIESMIARKLCVIGLWCIQVKPADRP 234
ATR Y P + D L G L+ + + +L I C + P DRP
Sbjct: 243 ATRGMTPY-PGVQNHEMYDYLLHGHRLKQPEDCLD-------ELYEIMYSCWRTDPLDRP 294
Query: 235 S 235
+
Sbjct: 295 T 295
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-21
Identities = 54/241 (22%), Positives = 91/241 (37%), Gaps = 54/241 (22%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----FP-KESRG 63
E+ E+S + H +VV GF + +V E SL E+R
Sbjct: 86 EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR- 144
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
L ++ G +YLH ++H D+K N+ L+ + + DFGLA
Sbjct: 145 -----YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192
Query: 124 KENDFVSISATR-GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLK 179
+ + GT YIAPE++S+ S + DV+ G ++ + G+ S LK
Sbjct: 193 YDGERKK---VLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247
Query: 180 AT----RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
T + ++ P ++ S+I + L Q P RP+
Sbjct: 248 ETYLRIKKNEYSIPKHIN--------------PVAASLIQKML--------QTDPTARPT 285
Query: 236 M 236
+
Sbjct: 286 I 286
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-20
Identities = 44/197 (22%), Positives = 85/197 (43%), Gaps = 30/197 (15%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+ EV + H N+++L G+ + ++ L+ E+ P G++ R + + +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113
Query: 70 KLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
+ E+A+ + Y H ++H DIKP N+LL ++DFG + P
Sbjct: 114 YITELANA----LSYCHSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 160
Query: 129 VSISATR----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKAT 181
S+ R GT+ Y+ PE+I K D++ G++ E G+ + + T
Sbjct: 161 ---SSRRTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
Query: 182 ----RSSKAYFPSWVSD 194
+ FP +V++
Sbjct: 216 YKRISRVEFTFPDFVTE 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-20
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 40/241 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA------LVYEFMPNGSLD---RHIFPKE 60
EEF+ E + + H +V +L+G + ++ FM +G L E
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
+ + + L A G+EYL N I H D+ N +L + V+DFGL
Sbjct: 130 N-PFNLPLQTLVRFMVDIACGMEYLSSRN----FI-HRDLAARNCMLAEDMTVCVADFGL 183
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL 178
++ + + A++ + ++A E S + SDV+ FG+ + E+
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEI--------- 232
Query: 179 KATRSSKAYF---PSWVSDQLNKGGNLEL-RNVTEIESMIARKLCVIGLWCIQVKPADRP 234
TR Y + + + L G L+ E ++ + C P RP
Sbjct: 233 -MTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME-------EVYDLMYQCWSADPKQRP 284
Query: 235 S 235
S
Sbjct: 285 S 285
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-20
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 34/195 (17%)
Query: 1 ML-ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL------- 52
L E S+ + ++F E + + H ++V+ G C+EG +V+E+M +G L
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 53 ----DRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLD 106
++ +L VAS A G+ YL + + H D+ N L+
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH----FV-HRDLATRNCLVG 192
Query: 107 HNFVPNVSDFGLAKFHPKENDFVSISATR-GTIGYI-----APELISRNFGTVSCKSDVY 160
V + DFG+++ D S R G + PE I + + +SDV+
Sbjct: 193 QGLVVKIGDFGMSR------DIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVW 244
Query: 161 GFGMVLLE-MTGGRR 174
FG+VL E T G++
Sbjct: 245 SFGVVLWEIFTYGKQ 259
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-20
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 34/185 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHIF 57
++F E + + H ++V+ G C +G +V+E+M +G L
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 58 PKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVSD 115
++ +AS A G+ YL + + H D+ N L+ N + + D
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQH----FV-HRDLATRNCLVGANLLVKIGD 176
Query: 116 FGLAKFHPKENDFVSISATR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLE- 168
FG+++ D S R G + PE I + + +SDV+ FG++L E
Sbjct: 177 FGMSR------DVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEI 228
Query: 169 MTGGR 173
T G+
Sbjct: 229 FTYGK 233
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-20
Identities = 40/172 (23%), Positives = 60/172 (34%), Gaps = 27/172 (15%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC--SWEKL 71
E+ + +V L G EG + E + GSL L
Sbjct: 99 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-----------GQLIKQMGCL 147
Query: 72 HE--VASGTAH---GIEYLHNGCDVCILHLDIKPHNILLDHNFVP-NVSDFGLAKFHPKE 125
E G+EYLH ILH D+K N+LL + + DFG A +
Sbjct: 148 PEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 126 NDFVSISAT---RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
S+ GT ++APE++ K D++ ++L M G
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-20
Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 51/237 (21%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
EV ++ H ++++L + + + LV E NG ++R++ + E
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSEN 112
Query: 75 ASGT-----AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
+ G+ YLH+ ILH D+ N+LL N ++DFGLA ++
Sbjct: 113 EARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
Query: 130 SISATR-GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKAT---- 181
T GT YI+PE+ +R+ +SDV+ G + + GR +K T
Sbjct: 170 Y---TLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
+ PS++S E + +I + L + PADR S++
Sbjct: 225 VLADYEMPSFLSI--------------EAKDLIHQLL--------RRNPADRLSLSS 259
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-20
Identities = 54/240 (22%), Positives = 90/240 (37%), Gaps = 52/240 (21%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+ E+S + H +VV GF + +V E SL + R
Sbjct: 60 EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRK------ 110
Query: 70 KLHEVASGT-----AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
L E + G +YLH ++H D+K N+ L+ + + DFGLA
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167
Query: 125 ENDFVSISATR-GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKA 180
+ + GT YIAPE++S+ S + DV+ G ++ + G+ S LK
Sbjct: 168 DGERKK---VLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
Query: 181 T----RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
T + ++ P ++ S+I + L Q P RP++
Sbjct: 223 TYLRIKKNEYSIPKHINP--------------VAASLIQKML--------QTDPTARPTI 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-20
Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 12 FINEVSTIGRIHHVNVVQLL--GFCSEGSKRALVY---EFMPNGSLDRHIFPKESRGQSC 66
F E ++H +V + G +E L Y E++ +L +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPM 113
Query: 67 SWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
+ ++ EV + + + H NG I+H D+KP NI++ V DFG+A+
Sbjct: 114 TPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR--AIA 167
Query: 126 NDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
+ S++ T GT Y++PE +V +SDVY G VL E+ G
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEP 217
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-20
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 25/182 (13%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL--------------DR 54
E ++E+ + + +H+N+V LLG C+ G ++ E+ G L
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 55 HIFPKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPN 112
E + E L + A G+ +L N CI H D+ NILL H +
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN----CI-HRDLAARNILLTHGRITK 185
Query: 113 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTG 171
+ DFGLA+ ++++V R + ++APE S + +SDV+ +G+ L E +
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 172 GR 173
G
Sbjct: 244 GS 245
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-19
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----FP-KESRGQSCS 67
E+ + H N++++ + + + L+ EF P G L + + F + S
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA----- 117
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+ E+A + Y H ++H DIKP N+L+ + ++DFG + P
Sbjct: 118 -TFMEELADA----LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---- 165
Query: 128 FVSISATR----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKA 180
S R GT+ Y+ PE+I T K D++ G++ E G + +
Sbjct: 166 ----SLRRRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
Query: 181 T----RSSKAYFPSWVS 193
T + FP ++S
Sbjct: 220 THRRIVNVDLKFPPFLS 236
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-19
Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL---------------- 52
E ++E+ + ++ H N+V LLG C+ L++E+ G L
Sbjct: 93 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152
Query: 53 ---DRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF 109
++ +E ++E L A A G+E+L C+ H D+ N+L+ H
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV-HRDLAARNVLVTHGK 209
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE- 168
V + DFGLA+ ++++V R + ++APE S G + KSDV+ +G++L E
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEI 267
Query: 169 MTGGR 173
+ G
Sbjct: 268 FSLGV 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 3e-19
Identities = 42/211 (19%), Positives = 72/211 (34%), Gaps = 48/211 (22%)
Query: 45 EFMPNGSLDRHI---FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
+ +L + E R ++A +E+LH ++H D+KP
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH---SKGLMHRDLKPS 193
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATR----------GTIGYIAPELISRNFG 151
NI + V V DFGL ++ + ++ GT Y++PE I N
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-- 251
Query: 152 TVSCKSDVYGFGMVLLEM-----TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRN 206
S K D++ G++L E+ T R + R+ K FP +
Sbjct: 252 NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK--FPLLFTQ------------ 297
Query: 207 VTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + + P +RP T
Sbjct: 298 ----KYPQEHMMV---QDMLSPSPTERPEAT 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-19
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 23/180 (12%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHI 56
+ I+E+ + I H N++ LLG C++ ++ E+ G+L +
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVS 114
P + + S + L A A G+EYL CI H D+ N+L+ + V ++
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK----CI-HRDLAARNVLVTEDNVMKIA 233
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
DFGLA+ + + + R + ++APE + + +SDV+ FG++L E T G
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHI 56
+ ++E+ + I H N++ LLG C++ ++ E+ G+L +
Sbjct: 85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVS 114
+ +++ L A G+EYL CI H D+ N+L+ N V ++
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIA 199
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
DFGLA+ + + + R + ++APE + + +SDV+ FG+++ E T G
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-18
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 12/164 (7%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL 71
E T GR+ +VV + F + + + L + R + +
Sbjct: 81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRA 136
Query: 72 HEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS 130
+ ++ H G H D+KP NIL+ + + DFG+A +
Sbjct: 137 VAIVRQIGSALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQ 191
Query: 131 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
+ T GT+ Y+APE S + ++D+Y VL E G
Sbjct: 192 LGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSP 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-18
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCS-EGSKRALVYEFMPNGSL------------DRH 55
++E+ + I HH+NVV LLG C+ G ++ EF G+L
Sbjct: 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 56 IFPKESRGQSCSWEKLHEVASGTAHGIEYL-HNGCDVCILHLDIKPHNILLDHNFVPNVS 114
+ P++ + E L + A G+E+L C +H D+ NILL V +
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKIC 190
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
DFGLA+ K+ D+V R + ++APE + + +SDV+ FG++L E + G
Sbjct: 191 DFGLARDIYKDPDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL------------DRHI 56
+ ++E+ + I H N++ LLG C++ ++ E+ G+L +
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDHNFVPNVS 114
+ +++ L A G+EYL CI H D+ N+L+ N V ++
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIA 245
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MTGGR 173
DFGLA+ + + + R + ++APE + + +SDV+ FG+++ E T G
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-18
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 27/182 (14%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKESRGQ- 64
+ + E + +++H N+V+L E + R L+ EF P GSL + +
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 65 --SCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL----DHNFVPNVSDFG 117
S L +V G + +L NG I+H +IKP NI+ D V ++DFG
Sbjct: 110 PESEFLIVLRDVVGG----MNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV------SCKSDVYGFGMVLLEMTG 171
A+ + FVS+ GT Y+ P++ R D++ G+
Sbjct: 162 AARELEDDEQFVSL---YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 172 GR 173
G
Sbjct: 219 GS 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 43/185 (23%), Positives = 84/185 (45%), Gaps = 26/185 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL----------------- 52
+ ++E + + +++H +V++L G CS+ L+ E+ GSL
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 53 ---DRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF 109
++ + L A + G++YL ++ ++H D+ NIL+
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGR 187
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE- 168
+SDFGL++ +E+ +V S R + ++A E S + +SDV+ FG++L E
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEI 245
Query: 169 MTGGR 173
+T G
Sbjct: 246 VTLGG 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-18
Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 29/182 (15%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL----------------- 52
+F E + + + N+V+LLG C+ G L++E+M G L
Sbjct: 95 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154
Query: 53 ---DRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL--HNGCDVCILHLDIKPHNILLDH 107
S + +A A G+ YL + H D+ N L+
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----FV-HRDLATRNCLVGE 209
Query: 108 NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167
N V ++DFGL++ + + + I ++ PE S + + +SDV+ +G+VL
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLW 267
Query: 168 EM 169
E+
Sbjct: 268 EI 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 30/161 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
EE EVS + ++ H NV+ L + L+ E + G L D + KES
Sbjct: 60 EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDF-LAQKES------- 111
Query: 69 EKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGL 118
L E + + G+ YLH I H D+KP NI+L +P + DFGL
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
A ++ GT ++APE+++ + ++D+
Sbjct: 166 AHEI-EDGVEFKNIF--GTPEFVAPEIVNYEP--LGLEADM 201
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 27/182 (14%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKESRGQ- 64
+ + E + +++H N+V+L E + R L+ EF P GSL + +
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 65 --SCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL----DHNFVPNVSDFG 117
S L +V G + +L NG I+H +IKP NI+ D V ++DFG
Sbjct: 110 PESEFLIVLRDVVGG----MNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV------SCKSDVYGFGMVLLEMTG 171
A+ + FVS+ GT Y+ P++ R D++ G+
Sbjct: 162 AARELEDDEQFVSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 172 GR 173
G
Sbjct: 219 GS 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
EE EVS + ++ H N++ L + L+ E + G L D + KES
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDF-LAQKES------- 111
Query: 69 EKLHEV-ASGTAH----GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGL 118
L E A+ G+ YLH I H D+KP NI+L +P + DFGL
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
A +F +I GT ++APE+++ + ++D+
Sbjct: 166 AHEIEDGVEFKNIF---GTPEFVAPEIVNYEP--LGLEADM 201
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-17
Identities = 40/194 (20%), Positives = 74/194 (38%), Gaps = 29/194 (14%)
Query: 5 SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+ + E+ + H NV++ + + E N +L + K
Sbjct: 48 LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSD 106
Query: 64 QSCSWEKLHEVAS---GTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN-------- 112
++ +K + S A G+ +LH + I+H D+KP NIL+ +
Sbjct: 107 ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 113 -----VSDFGLAK-FHPKENDFVSISATR-GTIGYIAPELISRNFGTV-----SCKSDVY 160
+SDFGL K ++ F + GT G+ APEL+ + + D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 161 GFGMVLLEM-TGGR 173
G V + + G+
Sbjct: 224 SMGCVFYYILSKGK 237
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-17
Identities = 48/261 (18%), Positives = 93/261 (35%), Gaps = 64/261 (24%)
Query: 5 SKFSAEEFINEVSTIGRI--HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ + + NE++ + ++ H +++L + +V E N L+ + + +
Sbjct: 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKK 102
Query: 63 GQSCSWEKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
+ + + +H +G I+H D+KP N L+ + + DF
Sbjct: 103 K------SIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDF 151
Query: 117 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLL 167
G+A + V + GT+ Y+ PE I + +S KSDV+ G +L
Sbjct: 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211
Query: 168 EMTGGR--------RNSNLKATRSSKAY--FPSWVSDQLNKGGNLELRNVTEIESMIARK 217
MT G+ + S L A FP L + ++
Sbjct: 212 YMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL--------------QDVLKC- 256
Query: 218 LCVIGLWCIQVKPADRPSMTK 238
C++ P R S+ +
Sbjct: 257 -------CLKRDPKQRISIPE 270
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-17
Identities = 54/264 (20%), Positives = 90/264 (34%), Gaps = 54/264 (20%)
Query: 1 MLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA-------LVYEFMPNGSL 52
+L N + I EV + ++ H N+VQ S G + + L+ + G L
Sbjct: 61 LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120
Query: 53 DRHIFPKESRGQSCSWEKLHE-----VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH 107
+ ESRG L + T ++++H I+H D+K N+LL +
Sbjct: 121 VEFLKKMESRG------PLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN 173
Query: 108 NFVPNVSDFGLAKF---------HPKENDFVSISATR-GTIGYIAPELISRNFG-TVSCK 156
+ DFG A + V TR T Y PE+I + K
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 157 SDVYGFGMVLLEMTGGR---RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESM 213
D++ G +L + + + + K P + T S+
Sbjct: 234 QDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQY------------TVFHSL 281
Query: 214 IARKLCVIGLWCIQVKPADRPSMT 237
I +QV P +R S+
Sbjct: 282 IR--------AMLQVNPEERLSIA 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-17
Identities = 48/259 (18%), Positives = 92/259 (35%), Gaps = 64/259 (24%)
Query: 5 SKFSAEEFINEVSTIGRI--HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ + + NE++ + ++ H +++L + +V E N L+ + + +
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKK 121
Query: 63 GQSCSWEKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
+ + + +H +G I+H D+KP N L+ + + DF
Sbjct: 122 K------SIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDF 170
Query: 117 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLL 167
G+A + V + GT+ Y+ PE I + +S KSDV+ G +L
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230
Query: 168 EMTGGR--------RNSNLKATRSSKAY--FPSWVSDQLNKGGNLELRNVTEIESMIARK 217
MT G+ + S L A FP L + ++
Sbjct: 231 YMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL--------------QDVLKC- 275
Query: 218 LCVIGLWCIQVKPADRPSM 236
C++ P R S+
Sbjct: 276 -------CLKRDPKQRISI 287
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 7e-17
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
EE EV+ + I H N++ L + L+ E + G L D + KES
Sbjct: 53 EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDF-LAEKES------- 104
Query: 69 EKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGL 118
L E + G+ YLH I H D+KP NI+L VPN + DFG+
Sbjct: 105 --LTEDEATQFLKQILDGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
A N+F +I GT ++APE+++ + ++D+
Sbjct: 159 AHKIEAGNEFKNIF---GTPEFVAPEIVNYEP--LGLEADM 194
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-17
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 27/187 (14%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE + S +E + E+ + + HH N+V + LV + + GS+ I
Sbjct: 50 LEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIV 108
Query: 62 RGQSCSWEKLHE-----VASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSD 115
L E + G+EYLH NG +H D+K NILL + ++D
Sbjct: 109 AKGEHKSGVLDESTIATILREVLEGLEYLHKNG----QIHRDVKAGNILLGEDGSVQIAD 164
Query: 116 FGLAKF---------HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
FG++ F + FV GT ++APE++ + G K+D++ FG+
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFV------GTPCWMAPEVMEQVRG-YDFKADIWSFGITA 217
Query: 167 LEMTGGR 173
+E+ G
Sbjct: 218 IELATGA 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 8e-17
Identities = 33/193 (17%), Positives = 59/193 (30%), Gaps = 23/193 (11%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-FPKESRGQSCSWEKLH 72
+ + ++ + LV E G+L I K + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN-----------VSDFGLAKF 121
A + IE +H D I+H DIKP N +L + F+ + D G +
Sbjct: 176 SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR------RN 175
+A T G+ E++S + + D +G + M G
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 176 SNLKATRSSKAYF 188
K +
Sbjct: 291 GECKPEGLFRRLP 303
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-17
Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRG---QSCSWE 69
E++ + ++ H NVV+L+ + ++ L V+E + G + + + +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQARF 141
Query: 70 KLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
++ G IEYLH I+H DIKP N+L+ + ++DFG++ +
Sbjct: 142 YFQDLIKG----IEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 129 VSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMTGGR 173
+S + GT ++APE +S S DV+ G+ L G+
Sbjct: 194 LSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 9e-17
Identities = 46/259 (17%), Positives = 90/259 (34%), Gaps = 64/259 (24%)
Query: 5 SKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ + + NE++ + ++ +++L + +V E N L+ + + +
Sbjct: 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKK 149
Query: 63 GQSCSWEKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
+ + + +H +G I+H D+KP N L+ + + DF
Sbjct: 150 K------SIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDF 198
Query: 117 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLL 167
G+A + V + G + Y+ PE I + +S KSDV+ G +L
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 168 EMTGGR--------RNSNLKATRSSKAY--FPSWVSDQLNKGGNLELRNVTEIESMIARK 217
MT G+ + S L A FP L + ++
Sbjct: 259 YMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL--------------QDVLKC- 303
Query: 218 LCVIGLWCIQVKPADRPSM 236
C++ P R S+
Sbjct: 304 -------CLKRDPKQRISI 315
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 41/158 (25%), Positives = 64/158 (40%), Gaps = 20/158 (12%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPK 59
+ S E+ E S + H ++V+LL S +V+EFM L I +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE-IVKR 120
Query: 60 ESRGQSCSWEKLHEVASGTAH----GIEYLH-NGCDVCILHLDIKPHNILL---DHNFVP 111
G S E VAS + Y H N I+H D+KPH +LL +++
Sbjct: 121 ADAGFVYS-EA---VASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPV 172
Query: 112 NVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 149
+ FG+A + GT ++APE++ R
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV--GTPHFMAPEVVKRE 208
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRG 63
K E + EV + ++ H N+++L F + LV E G L D I ++
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-IISRKRFS 124
Query: 64 QSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLA 119
+ + + +V S GI Y+H N I+H D+KP N+LL + + DFGL+
Sbjct: 125 EVDAARIIRQVLS----GITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
GT YIAPE++ + K DV+ G++L
Sbjct: 177 THFEASKKMKDKI---GTAYYIAPEVLHGTYDE---KCDVWSTGVIL 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 23/157 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
EE NE+S + ++ H N++QL + LV E++ G L DR I + +
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII----DESYNLT- 185
Query: 69 EKLHEVASGT---AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNV--SDFGLAKFH 122
E + GI ++H ILHLD+KP NIL + + DFGLA+ +
Sbjct: 186 EL--DTILFMKQICEGIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
GT ++APE+++ +F VS +D+
Sbjct: 240 KPREKLKVNF---GTPEFLAPEVVNYDF--VSFPTDM 271
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKES 61
+N + EE NE+S + + H N+++L + LV EF G L ++ I +
Sbjct: 84 KNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ-IINRHK 142
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFG 117
+ + + ++ S GI YLH + I+H DIKP NILL + + DFG
Sbjct: 143 FDECDAANIMKQILS----GICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
L+ F K+ GT YIAPE++ + + K DV+ G+++
Sbjct: 195 LSSFFSKDYKLRDRL---GTAYYIAPEVLKKKYNE---KCDVWSCGVIM 237
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-16
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 18/164 (10%)
Query: 13 INEVSTIGRIHHVNVVQLLG-FCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL 71
I E+ + + +V G F S+G + ++ E M GSLD+ + + + L
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL----KKAGRIPEQIL 133
Query: 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK--FHPKENDFV 129
+V+ G+ YL I+H D+KP NIL++ + DFG++ N FV
Sbjct: 134 GKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
GT Y++PE + S +SD++ G+ L+EM GR
Sbjct: 192 ------GTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-16
Identities = 31/181 (17%), Positives = 63/181 (34%), Gaps = 34/181 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+ +H N+V ++ +V FM GS + + + +
Sbjct: 71 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLI------CTHFMD 123
Query: 70 KLHE-----VASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA---- 119
++E + G ++Y+H G +H +K +IL+ + +S
Sbjct: 124 GMNELAIAYILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 120 -------KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
H V + +++PE++ +N KSD+Y G+ E+ G
Sbjct: 180 SHGQRQRVVHDFPKYSV------KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
Query: 173 R 173
Sbjct: 234 H 234
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-16
Identities = 31/240 (12%), Positives = 69/240 (28%), Gaps = 45/240 (18%)
Query: 12 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFM----PNGSLDRHIFPKESRGQSCS 67
FI + ++++ + + + + + + S +S
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 68 WEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN 126
++ + LH G ++H ++P +I+LD ++ F ++
Sbjct: 205 HHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDG 257
Query: 127 DFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLLEM-TGGRRNS 176
V + + G+ PEL +R ++ D + G+V+ +
Sbjct: 258 ARVV---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA----- 309
Query: 177 NLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
P D G R+ I R L ++ DR
Sbjct: 310 ----------DLP-ITKDAALGGSEWIFRSCKNI-PQPVRALL---EGFLRYPKEDRLLP 354
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 4e-16
Identities = 47/207 (22%), Positives = 72/207 (34%), Gaps = 37/207 (17%)
Query: 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRA------LVYEFMPNGSLDRHIFPKESRGQSCS 67
E+ + +++H NVV K A L E+ G L +++ C
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCC- 116
Query: 68 WEKLHEVASGT-----AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN---VSDFGLA 119
L E T + + YLH + I+H D+KP NI+L + D G A
Sbjct: 117 --GLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 120 KFHPKENDFVSISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMTGGRR---- 174
K + GT+ Y+APEL+ + + D + FG + E G R
Sbjct: 172 KELDQGELCTEFV---GTLQYLAPELLEQKKYT---VTVDYWSFGTLAFECITGFRPFLP 225
Query: 175 ---NSNLKATRSSKAYFPSWVSDQLNK 198
K+ V D L
Sbjct: 226 NWQPVQWHGKVREKSNEHIVVYDDLTG 252
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
+ + EV+ + + H N+++L F + LV E G L D I + + +
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE-IIHRMKFNEVDAA 139
Query: 69 EKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPK 124
+ +V S G+ YLH + I+H D+KP N+LL + + + + DFGL+
Sbjct: 140 VIIKQVLS----GVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
+ GT YIAPE++ + + K DV+ G++L
Sbjct: 192 QKKMKERL---GTAYYIAPEVLRKKYDE---KCDVWSIGVIL 227
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-16
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 20/156 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
E+ EVS + I H NV+ L + L+ E + G L D + KES + +
Sbjct: 59 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEAT 117
Query: 69 EKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGLAKFHP 123
E L ++ + G+ YLH I H D+KP NI+L VP + DFGLA
Sbjct: 118 EFLKQILN----GVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
N+F +I GT ++APE+++ + ++D+
Sbjct: 170 FGNEFKNIF---GTPEFVAPEIVNYEP--LGLEADM 200
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-16
Identities = 39/207 (18%), Positives = 69/207 (33%), Gaps = 45/207 (21%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+ + + E EV + ++HH N+ +L + LV E G L +
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 61 SRGQSCSWEKLHEVASGTAH------------------------------------GIEY 84
+ + + Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 85 LH-NGCDVCILHLDIKPHNILL--DHNFVPNVSDFGLAKFHP--KENDFVSISATRGTIG 139
LH G I H DIKP N L + +F + DFGL+K ++ ++ GT
Sbjct: 184 LHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 140 YIAPELISRNFGTVSCKSDVYGFGMVL 166
++APE+++ + K D + G++L
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 7e-16
Identities = 15/134 (11%), Positives = 36/134 (26%), Gaps = 10/134 (7%)
Query: 42 LVYEFMP--NGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIK 99
L+ L + LH + + L ++H
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFT 221
Query: 100 PHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
P N+ + + + D K S+ + Y E ++ + T + +
Sbjct: 222 PDNLFIMPDGRLMLGDVSALW---KVGTRGPASS--VPVTYAPREFLNASTATFTHALNA 276
Query: 160 YGFGMVLLEMTGGR 173
+ G+ + +
Sbjct: 277 WQLGLSIYRVWCLF 290
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-16
Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 17/154 (11%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
NE+S + ++HH ++ L + + L+ EF+ G L DR + S
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSE 148
Query: 69 EKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNV--SDFGLAKFHPKE 125
++ G++++H + I+HLDIKP NI+ + +V DFGLA +
Sbjct: 149 AEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204
Query: 126 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
+ T + APE++ R V +D+
Sbjct: 205 EIVKVTT---ATAEFAAPEIVDREP--VGFYTDM 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 42/199 (21%), Positives = 72/199 (36%), Gaps = 31/199 (15%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
E+ + R+ H NV+QL+ K+ +V E+ G + + +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK------RFP 107
Query: 73 EVASGTAH--------GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
AH G+EYLH+ I+H DIKP N+LL +S G+A+
Sbjct: 108 V---CQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKAT 181
+ ++G+ + PE+ + K D++ G+ L +T G N+
Sbjct: 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL 221
Query: 182 R----SSKAYFPSWVSDQL 196
P L
Sbjct: 222 FENIGKGSYAIPGDCGPPL 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 24/161 (14%)
Query: 23 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82
V G + E M + SLD+ +GQ+ + L ++A +
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG--------LAKFHPKENDFVSISAT 134
E+LH+ + ++H D+KP N+L++ + DFG +AK +
Sbjct: 123 EHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-----DIDA----- 170
Query: 135 RGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
G Y+APE I N S KSD++ G+ ++E+ R
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 32/157 (20%), Positives = 61/157 (38%), Gaps = 23/157 (14%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
E+S + H N++ L + +++EF+ + +R + +
Sbjct: 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN----TSAFELN- 100
Query: 69 EKLHEVASGT---AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNV--SDFGLAKFH 122
E+ E+ S +++LH + I H DI+P NI+ + +FG A+
Sbjct: 101 ER--EIVSYVHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
K D + Y APE+ + VS +D+
Sbjct: 155 -KPGDNFRLLF--TAPEYYAPEVHQHDV--VSTATDM 186
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
+ EV + ++ H N+++L + S +V E G L D I R
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRK----- 116
Query: 69 EKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLA 119
+ E + GI Y+H + I+H D+KP NILL + + + DFGL+
Sbjct: 117 -RFSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
+ GT YIAPE++ + K DV+ G++L
Sbjct: 172 TCFQQNTKMKDRI---GTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-15
Identities = 54/185 (29%), Positives = 79/185 (42%), Gaps = 16/185 (8%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E+ ++H NVV+ G EG+ + L E+ G L I P + + H++
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
+G + YLH + I H DIKP N+LLD +SDFGLA N ++
Sbjct: 115 MAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR--------RNSNLKATRSSKA 186
GT+ Y+APEL+ R + DV+ G+VL M G + K
Sbjct: 168 CGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 187 YFPSW 191
Y W
Sbjct: 227 YLNPW 231
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 16/167 (9%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRG 63
S+ E+ E+ + + H N++++ + +V E G L +R I ++RG
Sbjct: 60 SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER-IVSAQARG 118
Query: 64 QSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLA 119
++ S + E+ + + Y H ++H D+KP NIL + + DFGLA
Sbjct: 119 KALSEGYVAELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
+ + + + GT Y+APE+ R+ K D++ G+V+
Sbjct: 175 ELFKSDEHSTNAA---GTALYMAPEVFKRDVTF---KCDIWSAGVVM 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-15
Identities = 41/164 (25%), Positives = 60/164 (36%), Gaps = 20/164 (12%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
LV M G + HI+ + + + G+E+LH I++ D+KP
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPE 318
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELISRNFGTVSCKSDVY 160
N+LLD + +SD GLA GT G++APEL+ S D +
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELLLGEEYDFSV--DYF 373
Query: 161 GFGMVLLEMTGGR---RNSNLKATR--------SSKAYFPSWVS 193
G+ L EM R R K +P S
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 28/167 (16%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
+ + M G L H+ S+ S + A+ G+E++HN +++ D+KP
Sbjct: 269 FILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPA 321
Query: 102 NILLDHNFVPNVSDFGLAKFHPKE--NDFVSISATRGTIGYIAPELISRNFG-TVSCKSD 158
NILLD + +SD GLA K+ + V GT GY+APE++ + S D
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGVAYDSSA--D 373
Query: 159 VYGFGMVLLEMTGGR----------RNSNLKATRSSKAYFPSWVSDQ 195
+ G +L ++ G ++ + T + P S +
Sbjct: 374 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 15/157 (9%)
Query: 23 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-FPKESRGQSCSWEKLHEVASGTAHG 81
+VQ G + E M + S D+ + E L ++ T
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIG-- 139
+ +L ++ I+H DIKP NILLD + + DFG++ V A G
Sbjct: 138 LNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG------QLVDSIAKTRDAGCR 189
Query: 140 -YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y+APE I S + +SDV+ G+ L E+ GR
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-15
Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 32/196 (16%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----FPKESRGQ--S 65
E + R+ H V+L + K + NG L ++I F E+ + +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYT 136
Query: 66 CSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124
E+ S +EYLH G I+H D+KP NILL+ + ++DFG AK
Sbjct: 137 A------EIVSA----LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKAT 181
E+ ++ GT Y++PEL++ S SD++ G ++ ++ G R N
Sbjct: 183 ESKQARANSFVGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLI 240
Query: 182 ----RSSKAYFPSWVS 193
+ FP
Sbjct: 241 FQKIIKLEYDFPEKFF 256
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 26/177 (14%)
Query: 10 EEFIN-EVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPKESR 62
+ F N E+ + ++ H N+V+L F S G K+ LV +++P ++ R
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 149
Query: 63 GQSCSWEKLHEVASGT---AHGIEYLHNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGL 118
Q+ + V + Y+H+ I H DIKP N+LLD + V + DFG
Sbjct: 150 KQTLP---VIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 203
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTV--SCKSDVYGFGMVLLEMTGGR 173
AK + VS +R Y APELI FG + DV+ G VL E+ G+
Sbjct: 204 AKQLVRGEPNVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 37/171 (21%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
+V + + G L H+ F E + C E+ ++YL I
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFK-EETVKLFIC------ELVMA----LDYLQNQR----I 136
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153
+H D+KP NILLD + +++DF +A P+E +++ GT Y+APE+ S G
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSRKGAG 193
Query: 154 SCKS-DVYGFGMVLLEMTGGRR----------NSNLKATRSSKAYFPSWVS 193
+ D + G+ E+ GRR + ++ +PS S
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 27/159 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
E E+ T+ + H +V L + ++ ++YEFM G L ++
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK------- 251
Query: 69 EKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNV--SDFGLAK 120
+ E + G+ ++H N +HLD+KP NI+ + DFGL
Sbjct: 252 --MSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
V ++ GT + APE+ V +D+
Sbjct: 306 HL-DPKQSVKVTT--GTAEFAAPEVA--EGKPVGYYTDM 339
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-15
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+E I E+S + + +VV+ G + + +V E+ GS+ I +
Sbjct: 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT------- 121
Query: 70 KLHE-----VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAK 120
L E + T G+EYLH +H DIK NILL+ ++DFG L
Sbjct: 122 -LTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
K N + GT ++APE+I +C +D++ G+ +EM
Sbjct: 178 TMAKRNTVI------GTPFWMAPEVIQE--IGYNCVADIWSLGITAIEM 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-15
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 26/170 (15%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLD---RHIFPKESRGQSC 66
E NEV + H NVV++ G + ++ EF+ G+L + E + +
Sbjct: 87 ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV 146
Query: 67 SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAKFH 122
L + YLH ++H DIK +ILL + +SDFG ++K
Sbjct: 147 CEAVLQ--------ALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
PK V GT ++APE+ISR+ + + D++ G++++EM G
Sbjct: 196 PKRKSLV------GTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDG 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 6e-15
Identities = 50/233 (21%), Positives = 89/233 (38%), Gaps = 49/233 (21%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGS-----LDRH--IFPKESRGQSCS 67
E++ + R+ H N++++L LV E +G +DRH + +
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS----- 133
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
++ S + YL I+H DIK NI++ +F + DFG A + +
Sbjct: 134 -YIFRQLVSA----VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGK 184
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRN--SNLKATRSSK 185
GTI Y APE++ N + +++ G+ L + N L+ T +
Sbjct: 185 LFYTFC--GTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFE-ENPFCELEETVEAA 240
Query: 186 AYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
+ P VS E+ S+++ L Q P R ++ K
Sbjct: 241 IHPPYLVSK--------------ELMSLVSGLL--------QPVPERRTTLEK 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-15
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 30/172 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E INE+ + + N+V L G + +V E++ GSL +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---------- 111
Query: 70 KLHE-----VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAK 120
+ E V +E+LH+ ++H DIK NILL + ++DFG +
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
K + V GT ++APE+++R K D++ G++ +EM G
Sbjct: 169 EQSKRSTMV------GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEG 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-15
Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 26/177 (14%)
Query: 10 EEFIN-EVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEFMPNGSLDRHIFPKESR 62
+ F N E+ + + H NVV L F S G K+ LV E++P ++ R
Sbjct: 76 KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL 134
Query: 63 GQSCSWEKLHEVASGT---AHGIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGL 118
Q+ + + + Y+H+ + I H DIKP N+LLD + V + DFG
Sbjct: 135 KQTMP---MLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGS 188
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTV--SCKSDVYGFGMVLLEMTGGR 173
AK VS +R Y APELI FG + D++ G V+ E+ G+
Sbjct: 189 AKILIAGEPNVSYICSR---YYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E++I E+ + H +V+LLG K ++ EF P G++D + +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-------- 112
Query: 70 KLHE-----VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----LAK 120
L E V + +LH+ I+H D+K N+L+ ++DFG K
Sbjct: 113 GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVS---CKSDVYGFGMVLLEM 169
K + F+ GT ++APE++ + K+D++ G+ L+EM
Sbjct: 170 TLQKRDSFI------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 54/191 (28%), Positives = 80/191 (41%), Gaps = 28/191 (14%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK------ESRGQSCSW 68
E+ ++H NVV+ G EG+ + L E+ G L I P +++
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ------ 108
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
H++ +G + YLH + I H DIKP N+LLD +SDFGLA N
Sbjct: 109 RFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR--------RNSNLKA 180
++ GT+ Y+APEL+ R + DV+ G+VL M G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220
Query: 181 TRSSKAYFPSW 191
+ K Y W
Sbjct: 221 WKEKKTYLNPW 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 34/164 (20%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCS 67
E ++E++ + V+ L S+ L+ E+ G + P+ +
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL-CLPELA------ 125
Query: 68 WEKLHEVASGTAH-------GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSD 115
E + E G+ YLH N I+HLD+KP NILL + P + D
Sbjct: 126 -EMVSEND--VIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIY-PLGDIKIVD 177
Query: 116 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159
FG+++ + GT Y+APE+++ + ++ +D+
Sbjct: 178 FGMSRKI-GHACELREIM--GTPEYLAPEILNYDP--ITTATDM 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 52/235 (22%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF------PKESRGQSCSW 68
EV + ++H N+V+L L+ E+ G + ++ KE+R
Sbjct: 64 EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR------ 117
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
K ++ S ++Y H I+H D+K N+LLD + ++DFG +
Sbjct: 118 SKFRQIVSA----VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGK 169
Query: 129 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKATR--- 182
+ G Y APEL + DV+ G++L + G NLK R
Sbjct: 170 LDAFC--GAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226
Query: 183 -SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
K P ++S T+ E+++ R L + P R ++
Sbjct: 227 LRGKYRIPFYMS--------------TDCENLLKRFL--------VLNPIKRGTL 259
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 30/180 (16%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE ++ E+ E++ + + V + G + +K ++ E++ GS + P
Sbjct: 57 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-- 114
Query: 62 RGQSCSWEKLHE-----VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDF 116
L E + G++YLH+ +H DIK N+LL + ++DF
Sbjct: 115 --------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF 163
Query: 117 G----LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
G L K N FV GT ++APE+I + K+D++ G+ +E+ G
Sbjct: 164 GVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARG 215
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 2e-14
Identities = 17/175 (9%), Positives = 51/175 (29%), Gaps = 14/175 (8%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEF--MP-----NGSLDRHIFPKES 61
A+ + + + +++ + ++ F P + + S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
+S ++ + LH ++H ++P +I+LD ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 122 HPKENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMTGGR 173
+ I A ++ + ++ D + G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-14
Identities = 46/173 (26%), Positives = 68/173 (39%), Gaps = 38/173 (21%)
Query: 21 RIHHVNVVQLL-GFCSEGSKR------ALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73
+HH N+VQL F + G + +V E++P+ +L R R +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI---- 129
Query: 74 VASGTAH----------GIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFH 122
I LH V + H DIKPHN+L++ + + DFG AK
Sbjct: 130 ------LIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTV--SCKSDVYGFGMVLLEMTGGR 173
V+ +R Y APELI FG + D++ G + EM G
Sbjct: 183 SPSEPNVAYICSR---YYRAPELI---FGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-14
Identities = 34/170 (20%), Positives = 63/170 (37%), Gaps = 17/170 (10%)
Query: 10 EEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
+ + ++ + + +VQ G + + E M + K+
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKL----KKRMQGPIPE 123
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF 128
L ++ + YL ++H D+KP NILLD + DFG++
Sbjct: 124 RILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISG-----RLV 176
Query: 129 VSISATR--GTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMTGGR 173
+ R G Y+APE I ++DV+ G+ L+E+ G+
Sbjct: 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-14
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 20/162 (12%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
+ F E+ + + H N+++L + + LV E G L +R + K +S +
Sbjct: 51 DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER-VVHKRVFRESDAA 109
Query: 69 EKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPK 124
+ +V S + Y H + H D+KP N L + + DFGLA
Sbjct: 110 RIMKDVLSA----VAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
+ GT Y++P+++ +G + D + G+++
Sbjct: 162 GKMMRTKV---GTPYYVSPQVLEGLYGP---ECDEWSAGVMM 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-14
Identities = 37/154 (24%), Positives = 63/154 (40%), Gaps = 24/154 (15%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRG 63
S ++ E + H N+V+L SE L+++ + G L + I +E
Sbjct: 50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED-IVAREYYS 108
Query: 64 QSCSWEKLHEVASGTAH----GIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSD 115
E AS + + H G ++H ++KP N+LL ++D
Sbjct: 109 -----EA---DASHCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLAD 156
Query: 116 FGLAKFHPKENDFVSISATRGTIGYIAPELISRN 149
FGLA E A GT GY++PE++ ++
Sbjct: 157 FGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKD 188
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-14
Identities = 36/146 (24%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
++ E ++ H N+V+L E S LV++ + G L + I +E ++ +
Sbjct: 50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED-IVAREFYSEADAS 108
Query: 69 EKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGLAKFHP 123
+ ++ I Y H NG I+H ++KP N+LL ++DFGLA
Sbjct: 109 HCIQQILE----SIAYCHSNG----IVHRNLKPENLLLASKA-KGAAVKLADFGLAIEVN 159
Query: 124 KENDFVSISATRGTIGYIAPELISRN 149
+ + GT GY++PE++ ++
Sbjct: 160 DSEAWHGFA---GTPGYLSPEVLKKD 182
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
+ EV + ++ H N+++L + S +V E G L D I R
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRK----- 116
Query: 69 EKLHEVASGT-----AHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLA 119
+ E + GI Y+H + I+H D+KP NILL + + + DFGL+
Sbjct: 117 -RFSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 120 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166
+ GT YIAPE++ + K DV+ G++L
Sbjct: 172 TCFQQNTKMKDRI---GTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 40/155 (25%), Positives = 65/155 (41%), Gaps = 27/155 (17%)
Query: 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRG 63
S ++ E ++ H N+V+L E S LV++ + G L + I +E
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED-IVAREFYS 126
Query: 64 QSCSWEKLHEVASGTAH----GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VS 114
E AS I Y H NG I+H ++KP N+LL ++
Sbjct: 127 -----EA---DASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKA-KGAAVKLA 173
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 149
DFGLA + + GT GY++PE++ ++
Sbjct: 174 DFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKD 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-13
Identities = 55/194 (28%), Positives = 85/194 (43%), Gaps = 37/194 (19%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+ E+ + + H N++ LL S +LV++FM L+ I + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLT---PS 112
Query: 73 EVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDF 128
+ + G+EYLH ILH D+KP+N+LLD N V ++DFGLAK F +
Sbjct: 113 HIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 129 VSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSK 185
TR Y APEL+ +R +G V D++ G +L E+ R
Sbjct: 170 THQVVTR---WYRAPELLFGARMYGVGV----DMWAVGCILAEL----------LLR--V 210
Query: 186 AYFP-SWVSDQLNK 198
+ P DQL +
Sbjct: 211 PFLPGDSDLDQLTR 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-13
Identities = 39/148 (26%), Positives = 59/148 (39%), Gaps = 25/148 (16%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCS 67
E + EV + ++ H N++QL + LV++ M G L D + K
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEK-------- 118
Query: 68 WEKLHEV-ASGTAH----GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
L E I LH I+H D+KP NILLD + ++DFG +
Sbjct: 119 -VTLSEKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 122 HPKENDFVSISATRGTIGYIAPELISRN 149
+ GT Y+APE+I +
Sbjct: 174 LDPGEKLREVC---GTPSYLAPEIIECS 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-13
Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 33/192 (17%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+ E+ + ++ H N+V LL + LV+E+ + ++ + + + +
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVK 105
Query: 73 EVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVS 130
+ T + + H + +H D+KP NIL+ + V + DFG A+ + +
Sbjct: 106 SITWQTLQAVNFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161
Query: 131 ISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAY 187
ATR Y +PEL+ +G V DV+ G V E+ G
Sbjct: 162 EVATR---WYRSPELLVGDTQYGPPV----DVWAIGCVFAELLSGV------------PL 202
Query: 188 FP-SWVSDQLNK 198
+P DQL
Sbjct: 203 WPGKSDVDQLYL 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 28/158 (17%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+E E E+ + H N+V+ + A++ E+ G L I
Sbjct: 52 YIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI---- 107
Query: 61 SRGQSCSWEKLHEVASGTAH--------GIEYLHNGCDVCILHLDIKPHNILLDHNFVPN 112
C+ + E A G+ Y H+ + I H D+K N LLD + P
Sbjct: 108 -----CNAGRFSE---DEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPR 156
Query: 113 --VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 148
+ DFG +K + + GT YIAPE++ R
Sbjct: 157 LKICDFGYSKS-SVLHSQPKSTV--GTPAYIAPEVLLR 191
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 46/201 (22%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN---GSLDRHIFPKESRGQSCSWE 69
I E+S + + H N+V+L +K LV+EFM N +D RG
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE---- 106
Query: 70 KLHEVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKE 125
L+ V G+ + H ILH D+KP N+L++ + DFGLA+ F
Sbjct: 107 -LNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162
Query: 126 NDF----VSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMTGGRRNSNL 178
N F V T+ Y AP+++ SR + T + D++ G +L EM
Sbjct: 163 NTFSSEVV-------TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEM--------- 202
Query: 179 KATRSSKAYFP-SWVSDQLNK 198
T K FP + +QL
Sbjct: 203 -ITG--KPLFPGTNDEEQLKL 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 34/151 (22%), Positives = 64/151 (42%), Gaps = 26/151 (17%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSC 66
A E+ + +++H ++++ F + +V E M G L D+ +
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK--- 234
Query: 67 SWEKLHEVASGT-----AHGIEYLHNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGL 118
+L E ++YLH + I+H D+KP N+LL + + + ++DFG
Sbjct: 235 ---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRN 149
+K E + GT Y+APE++
Sbjct: 289 SKIL-GETSLMRTLC--GTPTYLAPEVLVSV 316
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-13
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 29/150 (19%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
+ E+ + R+ H N+++L ++ +LV E + G L DR I K
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR-IVEK--------- 142
Query: 69 EKLHEV-ASGTAH----GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGL 118
E A+ + YLH NG I+H D+KP N+L P+ ++DFGL
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHENG----IVHRDLKPENLLYATPA-PDAPLKIADFGL 197
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISR 148
+K + ++ GT GY APE++
Sbjct: 198 SKIVEHQVLMKTVC---GTPGYCAPEILRG 224
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-13
Identities = 48/166 (28%), Positives = 68/166 (40%), Gaps = 27/166 (16%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLH--EVASGTAHGIEYLHNGCDVCILHLDIK 99
LV M G L HI+ G + + E+ G +E LH I++ D+K
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLH---RERIVYRDLK 313
Query: 100 PHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELISRNFGTVSCKSD 158
P NILLD + +SD GLA H E + R GT+GY+APE++ T S D
Sbjct: 314 PENILLDDHGHIRISDLGLAV-HVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSP--D 367
Query: 159 VYGFGMVLLEMTGGR---RNSNLKATR--------SSKAYFPSWVS 193
+ G +L EM G+ + K R + S
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-13
Identities = 44/229 (19%), Positives = 92/229 (40%), Gaps = 40/229 (17%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E+ + H ++++L S + +V E++ G L +I + + ++
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
S ++Y H ++H D+KP N+LLD + ++DFGL+ + +F+ S
Sbjct: 121 LSA----VDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC- 171
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKATR----SSKAY 187
G+ Y APE+IS + D++ G++L + G + ++ Y
Sbjct: 172 -GSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY 229
Query: 188 FPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
P +++ + +++ L QV P R ++
Sbjct: 230 IPEYLN--------------RSVATLLMHML--------QVDPLKRATI 256
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 47/173 (27%), Positives = 71/173 (41%), Gaps = 24/173 (13%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ S ++ I EV + ++ H N +Q G LV E+ + D K+
Sbjct: 92 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-- 149
Query: 63 GQSCSWEKLHE-----VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
L E V G G+ YLH+ ++H D+K NILL + + DFG
Sbjct: 150 -------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG 199
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEM 169
A N FV GT ++APE+I G K DV+ G+ +E+
Sbjct: 200 SASIMAPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 24/142 (16%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEK-----LHEVASGTAHGIEYLHNGCDVCILHL 96
LV ++ G L + S+ + E+ L E+ I+ +H + +H
Sbjct: 151 LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIA----IDSVHQ---LHYVHR 199
Query: 97 DIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG----- 151
DIKP NIL+D N ++DFG ++ S A GT YI+PE++ G
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRY 258
Query: 152 TVSCKSDVYGFGMVLLEMTGGR 173
C D + G+ + EM G
Sbjct: 259 GPEC--DWWSLGVCMYEMLYGE 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-13
Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 18/149 (12%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSW 68
EV + + H NV++L+ F E + LV+E M GS+ HI + + +
Sbjct: 55 SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS 114
Query: 69 EKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPK 124
+ +VAS +++LH G I H D+KP NIL + + DF L
Sbjct: 115 VVVQDVASA----LDFLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
Query: 125 ENDFVSISATR-----GTIGYIAPELISR 148
D IS G+ Y+APE++
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEA 195
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 35/193 (18%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
I EVS + + H N+V L LV+E++ L +++ + G + +H
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNIIN---MH 100
Query: 73 EVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDF 128
V G+ Y H +LH D+KP N+L++ ++DFGLA+ +
Sbjct: 101 NVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157
Query: 129 VSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
+ T Y P+++ S ++ T + D++G G + EM AT +
Sbjct: 158 DNEVVTL---WYRPPDILLGSTDYST---QIDMWGVGCIFYEM----------ATG--RP 199
Query: 187 YFP-SWVSDQLNK 198
FP S V +QL+
Sbjct: 200 LFPGSTVEEQLHF 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 30/151 (19%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSW 68
NE++ + +I H N+V L + LV + + G L DR I +
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR-ILER--------- 100
Query: 69 EKLHEV-ASGTAH----GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGL 118
E AS ++YLH NG I+H D+KP N+L N ++DFGL
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPE-ENSKIMITDFGL 155
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRN 149
+K + + GT GY+APE++++
Sbjct: 156 SKME-QNGIMSTAC---GTPGYVAPEVLAQK 182
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+ E+ + ++ H N+V LL C + + LV+EF+ + ++ + E ++ +
Sbjct: 72 MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQ 127
Query: 73 EVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVS 130
+ +GI + H + I+H DIKP NIL+ + V + DFG A+ +
Sbjct: 128 KYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 131 ISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMTGGR 173
ATR Y APEL+ +G V DV+ G ++ EM G
Sbjct: 184 EVATR---WYRAPELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-12
Identities = 45/202 (22%), Positives = 79/202 (39%), Gaps = 49/202 (24%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPN---GSLDRHIFPKESRGQSCSWE 69
I EVS + + H N+++L + L++E+ N +D++ +S ++
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN-----VSDFGLAK-FHP 123
++ G+ + H LH D+KP N+LL + + DFGLA+ F
Sbjct: 141 LIN--------GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
Query: 124 KENDF----VSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSN 177
F + T+ Y PE++ SR++ T D++ + EM
Sbjct: 190 PIRQFTHEII-------TLWYRPPEILLGSRHYST---SVDIWSIACIWAEM-------- 231
Query: 178 LKATRSSKAYFP-SWVSDQLNK 198
+ FP DQL K
Sbjct: 232 --LMK--TPLFPGDSEIDQLFK 249
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 38/148 (25%), Positives = 59/148 (39%), Gaps = 25/148 (16%)
Query: 10 EEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCS 67
E E + ++ H +++ L+ S LV++ M G L D +
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKV---- 195
Query: 68 WEKLHEV-ASGTAH----GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
L E + +LH N I+H D+KP NILLD N +SDFG +
Sbjct: 196 --ALSEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 122 HPKENDFVSISATRGTIGYIAPELISRN 149
+ GT GY+APE++ +
Sbjct: 250 LEPGEKLRELC---GTPGYLAPEILKCS 274
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 61/238 (25%)
Query: 15 EVSTIGRIHHV--NVVQLLGFCSEGSKRALVYEF-MPNGSLDRHIFPKESRGQSCSWEKL 71
EV + ++ V++LL + L+ E P L I RG L
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERG------AL 146
Query: 72 HEVASGT-----AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNV--SDFGLAKFHPK 124
E + + + + HN +LH DIK NIL+D N + DFG
Sbjct: 147 QEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKD 202
Query: 125 E--NDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMTGGRR--NSNL 178
DF GT Y PE I + G + V+ G++L +M G +
Sbjct: 203 TVYTDFD------GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDE 253
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ R + +F VS +E + +I WC+ ++P+DRP+
Sbjct: 254 EIIR-GQVFFRQRVS--------------SECQHLIR--------WCLALRPSDRPTF 288
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 5 SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
SK E++ + H N+V+L + LV E + G L I K+
Sbjct: 45 SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS 104
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAK 120
++ + + ++ S + ++H DV ++H D+KP N+L + N + DFG A+
Sbjct: 105 ETEASYIMRKLVSA----VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRN 149
P +N + T+ Y APEL+++N
Sbjct: 158 LKPPDNQPLKTPC--FTLHYAAPELLNQN 184
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 15 EVSTIGR-IHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCSWEKLH 72
E+ + R H N++ L +G +V E M G L D+ I ++ + + L
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK-ILRQKFFSEREASAVLF 123
Query: 73 EVASGTAHGIEYLH-NGCDVCILHLDIKPHNILL----DHNFVPNVSDFGLAKFHPKEND 127
+ +EYLH G ++H D+KP NIL + + DFG AK EN
Sbjct: 124 TITKT----VEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 128 FVSISATR-GTIGYIAPELISRN 149
+ T T ++APE++ R
Sbjct: 176 LLM---TPCYTANFVAPEVLERQ 195
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 3e-12
Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 5/135 (3%)
Query: 35 SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCIL 94
S+ S + E ++ P++ + E L + A G+E+L CI
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI- 215
Query: 95 HLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 154
H D+ NILL V + DFGLA+ K+ D+V R + ++APE I T+
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI- 274
Query: 155 CKSDVYGFGMVLLEM 169
+SDV+ FG++L E+
Sbjct: 275 -QSDVWSFGVLLWEI 288
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 54/228 (23%), Positives = 85/228 (37%), Gaps = 57/228 (25%)
Query: 24 HVNVVQLLGFCSEGSKRALVYEF-MPNGSLDRHIFPKESRGQSCSWEKLHEVASGT---- 78
H V++LL + LV E +P L +I +G L E S
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKG------PLGEGPSRCFFGQ 147
Query: 79 -AHGIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKEN--DFVSISAT 134
I++ H ++H DIK NIL+D + DFG E DF
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----- 199
Query: 135 RGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMTGGRR--NSNLKATRSSKAYFPS 190
GT Y PE ISR+ + V+ G++L +M G + + ++ +FP+
Sbjct: 200 -GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILE-AELHFPA 254
Query: 191 WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
VS + ++I C+ KP+ RPS+ +
Sbjct: 255 HVS--------------PDCCALIR--------RCLAPKPSSRPSLEE 280
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-12
Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 34/193 (17%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
+ E+ + + H N+V+L K LV+EF L ++ +S
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLD---PE 101
Query: 73 EVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDF 128
V S G+ + H +LH D+KP N+L++ N +++FGLA+ F +
Sbjct: 102 IVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158
Query: 129 VSISATRGTIGYIAPELISRNFGTV--SCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
+ T Y P+++ FG S D++ G + E+ +
Sbjct: 159 SAEVVTL---WYRPPDVL---FGAKLYSTSIDMWSAGCIFAELANAG-----------RP 201
Query: 187 YFP-SWVSDQLNK 198
FP + V DQL +
Sbjct: 202 LFPGNDVDDQLKR 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-12
Identities = 34/148 (22%), Positives = 61/148 (41%), Gaps = 26/148 (17%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL-DRHIFPKESRGQSCS 67
A E+ + +++H ++++ F + +V E M G L D+ +
Sbjct: 59 ALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK---- 109
Query: 68 WEKLHEVASGT-----AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN---VSDFGLA 119
+L E ++YLH + I+H D+KP N+LL ++DFG +
Sbjct: 110 --RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 120 KFHPKENDFVSISATRGTIGYIAPELIS 147
K E + GT Y+APE++
Sbjct: 165 KIL-GETSLMRTLC--GTPTYLAPEVLV 189
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-12
Identities = 24/171 (14%), Positives = 43/171 (25%), Gaps = 50/171 (29%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSL----DRHIFPKESRGQ 64
+E ++ + RI V ++L + +V E++ GSL D P +
Sbjct: 75 LQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAI-- 132
Query: 65 SCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
A + H G + P + VS G
Sbjct: 133 --------RAMQSLAAAADAAHRAG----VALSIDHPSRVR--------VSIDGDVVL-- 170
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
+ + + D+ G G L + R
Sbjct: 171 ------------AYPATMPD---------ANPQDDIRGIGASLYALLVNRW 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 37/194 (19%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
I E+S + +HH N+V L+ LV+EFM L + + +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQ---DS 119
Query: 73 EVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDF 128
++ G+ + H ILH D+KP N+L++ + ++DFGLA+ F +
Sbjct: 120 QIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176
Query: 129 VSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSK 185
T Y AP+++ S+ + T V D++ G + EM T K
Sbjct: 177 THEVVTL---WYRAPDVLMGSKKYSTSV----DIWSIGCIFAEM----------ITG--K 217
Query: 186 AYFP-SWVSDQLNK 198
FP DQL K
Sbjct: 218 PLFPGVTDDDQLPK 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-12
Identities = 36/150 (24%), Positives = 56/150 (37%), Gaps = 30/150 (20%)
Query: 14 NEVSTIGRI-HHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHIFPKESRGQSCSW 68
EV R ++V+++ +V E + G L I + RG
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFT 159
Query: 69 EK-----LHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGL 118
E+ + + I+YLH I H D+KP N+L PN ++DFG
Sbjct: 160 EREASEIMKSIGEA----IQYLHSIN----IAHRDVKPENLLYTSKR-PNAILKLTDFGF 210
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISR 148
AK N + T Y+APE++
Sbjct: 211 AKETTSHNSLTTPC---YTPYYVAPEVLGP 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 7e-12
Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 35/193 (18%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72
I E+S + + H N+V+L + LV+E + L + + +
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLE---SV 100
Query: 73 EVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDF 128
S +GI Y H D +LH D+KP N+L++ ++DFGLA+ F +
Sbjct: 101 TAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 129 VSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
T Y AP+++ S+ + T D++ G + EM
Sbjct: 158 THEIVTL---WYRAPDVLMGSKKYST---TIDIWSVGCIFAEM----------VNG--TP 199
Query: 187 YFP-SWVSDQLNK 198
FP +DQL +
Sbjct: 200 LFPGVSEADQLMR 212
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-12
Identities = 37/139 (26%), Positives = 56/139 (40%), Gaps = 16/139 (11%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEK--LHEVASGTAHGIEYLHNGCDVCILHLDIK 99
LV E+ G L + K + L E+ I+ +H + +H DIK
Sbjct: 138 LVMEYYVGGDLLTLL-SKFGERIPAEMARFYLAEIVMA----IDSVHR---LGYVHRDIK 189
Query: 100 PHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS-- 157
P NILLD ++DFG + S+ A GT Y++PE++ G S
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYG 248
Query: 158 ---DVYGFGMVLLEMTGGR 173
D + G+ EM G+
Sbjct: 249 PECDWWALGVFAYEMFYGQ 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 10/96 (10%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYI 141
++ +H+ + +H D+KP N+LLD + ++DFG KE +A GT YI
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 236
Query: 142 APELISRNFG----TVSCKSDVYGFGMVLLEMTGGR 173
+PE++ G C D + G+ L EM G
Sbjct: 237 SPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGD 270
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 34/148 (22%), Positives = 59/148 (39%), Gaps = 27/148 (18%)
Query: 14 NEVSTIGRI-HHVNVVQLLGFCSEGSKRA----LVYEFMPNGSLDRHIFPKESRGQSCSW 68
EV + ++V +L ++ E M G L I + RG
Sbjct: 70 QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI---QERGDQAFT 126
Query: 69 EK-----LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAK 120
E+ + ++ + I++LH I H D+KP N+L + + V ++DFG AK
Sbjct: 127 EREAAEIMRDIGTA----IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 121 FHPKENDFVSISATRGTIGYIAPELISR 148
+N + T Y+APE++
Sbjct: 180 E-TTQNALQTPC---YTPYYVAPEVLGP 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
V E+ G L H+ SR + S ++ + ++YLH+ + +++ D+K
Sbjct: 225 FVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLE 278
Query: 102 NILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSD 158
N++LD + ++DFGL K K+ + GT Y+APE++ N + D
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGA-----TMKTFCGTPEYLAPEVLEDNDYGRAV--D 331
Query: 159 VYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
+G G+V+ EM GR + + FP +
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 25/174 (14%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLG------FCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
EE E++ + + HH N+ G + LV EF GS+ I K ++
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTK 122
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG----L 118
G + E + + G+ +LH ++H DIK N+LL N + DFG L
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS---CKSDVYGFGMVLLEM 169
+ + N F+ GT ++APE+I+ + + KSD++ G+ +EM
Sbjct: 180 DRTVGRRNTFI------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-11
Identities = 48/229 (20%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E+ + H ++++L S S +V E++ G L +I + S ++
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
SG ++Y H ++H D+KP N+LLD + ++DFGL+ + +F+ S
Sbjct: 126 LSG----VDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC- 176
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKATR----SSKAY 187
G+ Y APE+IS + D++ G++L + G + ++ Y
Sbjct: 177 -GSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY 234
Query: 188 FPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
P +++ + S++ L QV P R ++
Sbjct: 235 TPQYLN--------------PSVISLLKHML--------QVDPMKRATI 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 42/170 (24%), Positives = 66/170 (38%), Gaps = 40/170 (23%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
V +++ G L H+ F E R + + E+AS + YLH I
Sbjct: 116 FVLDYINGGELFYHLQRERCFL-EPRARFYAA------EIASA----LGYLHSLN----I 160
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNF 150
++ D+KP NILLD ++DFGL K + + N T GT Y+APE++ +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-----TSTFCGTPEYLAPEVLHKQP 215
Query: 151 GTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
+ D + G VL EM G + ++
Sbjct: 216 YDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-11
Identities = 44/170 (25%), Positives = 72/170 (42%), Gaps = 40/170 (23%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
L+ +F+ G L + F E + E+A +++LH G I
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA------ELALA----LDHLHSLG----I 147
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNF 150
++ D+KP NILLD ++DFGL+K GT+ Y+APE+++R
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-----AYSFCGTVEYMAPEVVNRRG 202
Query: 151 GTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
T S D + FG+++ EM G R + +K P ++S
Sbjct: 203 HTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-11
Identities = 45/173 (26%), Positives = 73/173 (42%), Gaps = 42/173 (24%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
V E++ G L HI F SR + E+ G +++LH G I
Sbjct: 95 FVMEYLNGGDLMYHIQSCHKFD-LSRATFYAA------EIILG----LQFLHSKG----I 139
Query: 94 LHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRN 149
++ D+K NILLD + + ++DFG+ K + + T GT YIAPE++
Sbjct: 140 VYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK-----TNTFCGTPDYIAPEILLGQ 193
Query: 150 FGTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVSDQ 195
S D + FG++L EM G+ + R ++P W+ +
Sbjct: 194 KYNHSV--DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-11
Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 40/170 (23%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
L+ E++ G L + F E E++ + +LH G I
Sbjct: 98 LILEYLSGGELFMQLEREGIFM-EDTACFYLA------EISMA----LGHLHQKG----I 142
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNF 150
++ D+KP NI+L+H ++DFGL K + T GTI Y+APE++ R+
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-----VTHTFCGTIEYMAPEILMRSG 197
Query: 151 GTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
+ D + G ++ +M G R + K P +++
Sbjct: 198 HNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-11
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 40/172 (23%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
V EF+ G L HI F E+R + + E+ S + +LH G I
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFD-EARARFYAA------EIISA----LMFLHDKG----I 145
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNF 150
++ D+K N+LLDH ++DFG+ K T GT YIAPE++
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-----TATFCGTPDYIAPEILQEML 200
Query: 151 GTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVSDQ 195
+ D + G++L EM G + +A + + +P+W+ +
Sbjct: 201 YGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 51/229 (22%), Positives = 93/229 (40%), Gaps = 41/229 (17%)
Query: 15 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEV 74
E+S + + H ++++L + + +V E+ G L +I K+ + ++
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
IEY H I+H D+KP N+LLD N ++DFGL+ + +F+ S
Sbjct: 118 IC----AIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTSC- 168
Query: 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKATRS--SKAYF- 188
G+ Y APE+I+ + DV+ G+VL M GR + + + +
Sbjct: 169 -GSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV 226
Query: 189 -PSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
P ++S +S+I R + P R ++
Sbjct: 227 MPDFLS--------------PGAQSLIRRMI--------VADPMQRITI 253
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 42/171 (24%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
V E+ G L H+ F E R + E+ S +EYLH +
Sbjct: 82 FVMEYANGGELFFHLSRERVFT-EERARFYGA------EIVSA----LEYLHSRD----V 126
Query: 94 LHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRN 149
++ DIK N++LD + + ++DFGL K + + GT Y+APE++ N
Sbjct: 127 VYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGA-----TMKTFCGTPEYLAPEVLEDN 180
Query: 150 FGTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPSWVS 193
+ D +G G+V+ EM GR + + FP +S
Sbjct: 181 DYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-11
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRA--------LVYEFMPN---GSLDRHIFPKES 61
+ E+ + + H NVV L+ C + LV++F + G L +
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT- 122
Query: 62 RGQSCSWEKLHEVASGTA---HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGL 118
L E+ +G+ Y+H ILH D+K N+L+ + V ++DFGL
Sbjct: 123 ---------LSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
Query: 119 AKFHPKENDFVSISATRG--TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
A+ + T T+ Y PEL+ R++G D++G G ++ EM
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP---PIDLWGAGCIMAEMWTRS 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-11
Identities = 32/135 (23%), Positives = 60/135 (44%), Gaps = 13/135 (9%)
Query: 42 LVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPH 101
++ E++P+ +L + + G+S + + ++H+ + I H DIKP
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQ 170
Query: 102 NILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV--SCKSD 158
N+L++ + + DFG AK V+ +R Y APEL+ G + D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR---FYRAPELM---LGATEYTPSID 224
Query: 159 VYGFGMVLLEMTGGR 173
++ G V E+ G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 24/125 (19%)
Query: 81 GIEYLH-NGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATR--- 135
G+ +L G I++ D+K N++LD + ++DFG+ K + + T+
Sbjct: 133 GLFFLQSKG----IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGV-----TTKTFC 182
Query: 136 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYF 188
GT YIAPE+I+ S D + FG++L EM G+ + ++ +
Sbjct: 183 GTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240
Query: 189 PSWVS 193
P +S
Sbjct: 241 PKSMS 245
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 38/158 (24%), Positives = 73/158 (46%), Gaps = 23/158 (14%)
Query: 23 HHVNVVQLLG-FCSEGSKR-ALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80
N++ L S+ ALV+E + N + ++ + + ++E+
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFY--MYEILKA--- 142
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKF-HPKE--NDFVSISATRG 136
++Y H+ I+H D+KPHN+++DH + + D+GLA+F HP + N V A+R
Sbjct: 143 -LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASR- 194
Query: 137 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
+ PEL+ ++ D++ G +L M +
Sbjct: 195 --YFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 33/197 (16%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----FPKESRGQSCS 67
+NE + ++ +V+L + S +V E++ G + H+ F E + +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYA 147
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP-KEN 126
++ EYLH + +++ D+KP N+L+D V+DFG AK +
Sbjct: 148 ----AQIVLT----FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 127 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---RNSNLKAT-- 181
GT +APE+I + D + G+++ EM G
Sbjct: 197 TLC------GTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 182 --RSSKAYFPSWVSDQL 196
S K FPS S L
Sbjct: 249 KIVSGKVRFPSHFSSDL 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 31/123 (25%), Positives = 55/123 (44%), Gaps = 20/123 (16%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GT 137
G+ +L I++ D+K N++LD ++DFG+ K + + T+ GT
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-----TTKTFCGT 505
Query: 138 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR-------RNSNLKATRSSKAYFPS 190
YIAPE+I+ S D + FG++L EM G+ + ++ +P
Sbjct: 506 PDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 563
Query: 191 WVS 193
+S
Sbjct: 564 SMS 566
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 39/143 (27%), Positives = 61/143 (42%), Gaps = 33/143 (23%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
V E++ G L H+ P E + S E++ + YLH G I
Sbjct: 87 FVIEYVNGGDLMFHMQRQRKLP-EEHARFYSA------EISLA----LNYLHERG----I 131
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNF 150
++ D+K N+LLD ++D+G+ K + D T GT YIAPE++
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-----TSTFCGTPNYIAPEILRGED 186
Query: 151 GTVSCKSDVYGFGMVLLEMTGGR 173
S D + G+++ EM GR
Sbjct: 187 YGFSV--DWWALGVLMFEMMAGR 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 42/203 (20%), Positives = 76/203 (37%), Gaps = 29/203 (14%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEFMPN---GSLDRHIFPKESRGQSCS 67
E++ + + H NV+ L + R L++++ + + H K ++
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125
Query: 68 WEKLHEVASGTA---HGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----VSDFGLA 119
V S GI YLH N +LH D+KP NIL+ ++D G A
Sbjct: 126 --PRGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 120 -KFHPKENDFVSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMTGGRRN 175
F+ + T Y APEL+ +R++ + D++ G + E+
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE-- 233
Query: 176 SNLKATRSSKAYFPSWVSDQLNK 198
+ + DQL++
Sbjct: 234 PIFHCRQEDIKTSNPYHHDQLDR 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-10
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 45/200 (22%)
Query: 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----FPKESRGQ--S 65
+E + + H ++++ G + + ++ +++ G L + FP + +
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-NPVAKFYA 112
Query: 66 CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
EV +EYLH+ D I++ D+KP NILLD N ++DFG AK
Sbjct: 113 A------EVCLA----LEYLHS-KD--IIYRDLKPENILLDKNGHIKITDFGFAK---YV 156
Query: 126 NDFVSISATR---GTIGYIAPELISRN-FGTVSCKS-DVYGFGMVLLEMTGGR---RNSN 177
D T GT YIAPE++S + KS D + FG+++ EM G +SN
Sbjct: 157 PD-----VTYTLCGTPDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLAGYTPFYDSN 207
Query: 178 LKAT----RSSKAYFPSWVS 193
T +++ FP + +
Sbjct: 208 TMKTYEKILNAELRFPPFFN 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-10
Identities = 39/143 (27%), Positives = 61/143 (42%), Gaps = 33/143 (23%)
Query: 42 LVYEFMPNGSLDRHI-----FPKESRGQ--SCSWEKLHEVASGTAHGIEYLH-NGCDVCI 93
V E++ G L H+ P E + S E++ + YLH G I
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLP-EEHARFYSA------EISLA----LNYLHERG----I 174
Query: 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNF 150
++ D+K N+LLD ++D+G+ K + D T GT YIAPE++
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTSTFCGTPNYIAPEILRGED 229
Query: 151 GTVSCKSDVYGFGMVLLEMTGGR 173
S D + G+++ EM GR
Sbjct: 230 YGFSV--DWWALGVLMFEMMAGR 250
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 12/97 (12%)
Query: 81 GIEYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR---G 136
+E+LH G I++ DIK NILLD N ++DFGL+ KE G
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLS----KEFVADETERAYDFCG 222
Query: 137 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
TI Y+AP+++ D + G+++ E+ G
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 8e-10
Identities = 45/186 (24%), Positives = 74/186 (39%), Gaps = 37/186 (19%)
Query: 23 HHVNVVQLL-----GFCSEGSKRALVYEFMPN---GSLDRHIFPKESRGQSCSWEKLHEV 74
H NVV+L +K LV+E + LD+ P + ++
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM--MFQL 129
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
G +++LH ++H D+KP NIL+ + ++DFGLA+ + + S+ T
Sbjct: 130 LRG----LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 135 RGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFP-SWV 192
Y APE++ + + D++ G + EM R K F S
Sbjct: 183 L---WYRAPEVL---LQSSYATPVDLWSVGCIFAEM----------FRR--KPLFRGSSD 224
Query: 193 SDQLNK 198
DQL K
Sbjct: 225 VDQLGK 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 46/186 (24%), Positives = 74/186 (39%), Gaps = 37/186 (19%)
Query: 23 HHVNVVQLLGFCSEGSKRA-----LVYEFMPN---GSLDRHIFPKESRGQSCSWEKLHEV 74
H NVV+L+ C+ LV+E + LD+ P + +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL--MRQF 129
Query: 75 ASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISAT 134
G +++LH CI+H D+KP NIL+ ++DFGLA+ + + + T
Sbjct: 130 LRG----LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182
Query: 135 RGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFP-SWV 192
Y APE++ T + D++ G + EM R K F +
Sbjct: 183 L---WYRAPEVL---LQSTYATPVDMWSVGCIFAEM----------FRR--KPLFCGNSE 224
Query: 193 SDQLNK 198
+DQL K
Sbjct: 225 ADQLGK 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSISATRGTIG 139
G+ Y+H I+H D+KP N+ ++ + + DFGLA+ + +V TR
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV---VTR---W 190
Query: 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE+I N+ + D++ G ++ EM G+
Sbjct: 191 YRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK-FHPKENDFVSISATRGTIG 139
G++Y+H+ ++H D+KP N+ ++ + + DFGLA+ + +V TR
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV---VTR---W 188
Query: 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE+I ++ + D++ G ++ EM G+
Sbjct: 189 YRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 28/96 (29%), Positives = 42/96 (43%), Gaps = 13/96 (13%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN---DFVSISATRGT 137
G+ LH ++H D+ P NILL N + DF LA+ + +V R
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV---THR-- 197
Query: 138 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APEL+ F + D++ G V+ EM +
Sbjct: 198 -WYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 10/94 (10%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
GI++LH+ I+H D+KP NI++ + + DFGLA+ TR Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 192
Query: 141 IAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
APE+I + D++ G ++ EM G
Sbjct: 193 RAPEVILGMGYKE---NVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-08
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSIS----ATRG 136
G++Y+H+ +LH D+KP N+LL+ + DFGLA+ ++D ATR
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR- 195
Query: 137 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE++ N + D++ G +L EM R
Sbjct: 196 --WYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-08
Identities = 27/93 (29%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGY 140
G++Y+H+ I+H D+KP N+ ++ + + DFGLA+ ++ ATR Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATR---WY 195
Query: 141 IAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
APE++ N+ + D++ G ++ E+ GR
Sbjct: 196 RAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 16/97 (16%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEN---DFVSISATRGT 137
GI++LH+ I+H D+KP NI++ + + DFGLA+ +V TR
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTR-- 227
Query: 138 IGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE+I + D++ G ++ EM +
Sbjct: 228 -YYRAPEVILGMGYKE---NVDIWSVGCIMGEMVRHK 260
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-07
Identities = 35/175 (20%), Positives = 75/175 (42%), Gaps = 27/175 (15%)
Query: 11 EFINEVSTIGRIH--HVNVVQLLG-FCSEGSKRA---LVYEFMPNGSLDRHIFPKESRGQ 64
+ +N+ ++++LL F +G +V+E + + K+ +
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALIKKYEHR 126
Query: 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN------VSDFGL 118
+ +++ G++Y+H C I+H DIKP N+L++ P ++D G
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEM-TG 171
A + + + + TR Y +PE++ G C +D++ ++ E+ TG
Sbjct: 185 ACW--YDEHYTNSIQTR---EYRSPEVL---LGAPWGCGADIWSTACLIFELITG 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTI-- 138
++ LH ++H D+KP N+L++ N V DFGLA+ + S + +
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 139 GYI------APELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
++ APE++ S DV+ G +L E+ R
Sbjct: 181 EFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 24/98 (24%), Positives = 45/98 (45%), Gaps = 12/98 (12%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSIS----ATR 135
G++Y+H+ +LH D+KP N+ ++ + V + DFGLA+ T+
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 136 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y +P L+ + + D++ G + EM G+
Sbjct: 189 ---WYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 30/127 (23%), Positives = 46/127 (36%), Gaps = 29/127 (22%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA----LVYEFMPNGSL-DRHIFPKESRG 63
+ EV R ++V+++ +V E + G L R RG
Sbjct: 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRG 110
Query: 64 QSCSWEK-----LHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNFVPN----V 113
E+ + + I+YLH I H D+KP N+L PN +
Sbjct: 111 DQAFTEREASEIMKSIGEA----IQYLHSIN----IAHRDVKPENLLYTSKR-PNAILKL 161
Query: 114 SDFGLAK 120
+DFG AK
Sbjct: 162 TDFGFAK 168
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 30/129 (23%), Positives = 48/129 (37%), Gaps = 25/129 (19%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIG- 139
G ++H I+H D+KP N LL+ + V DFGLA+ E D ++
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 140 -------------------YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
Y APELI + D++ G + E+ + S++
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLNMLQ-SHIND 255
Query: 181 TRSSKAYFP 189
+ FP
Sbjct: 256 PTNRFPLFP 264
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-05
Identities = 10/42 (23%), Positives = 20/42 (47%), Gaps = 7/42 (16%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAK 120
+E+LH +H ++ NI + D + V ++ +G A
Sbjct: 172 LEFLHE---NEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 19/97 (19%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPN--VSDFGLAKFHPKENDFVS--ISATRG 136
++ LH I+H D+KP NILL V DFG + + E+ V I +R
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQ-SR- 263
Query: 137 TIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEM-TG 171
Y APE+I G D++ G +L E+ TG
Sbjct: 264 --FYRAPEVI---LGARYGMPIDMWSLGCILAELLTG 295
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 23/112 (20%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIG- 139
I+YLH+G +LH D+KP NILL+ V+DFGL++ +
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 140 ------------------YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
Y APE++ + D++ G +L E+ G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 14/42 (33%), Positives = 24/42 (57%), Gaps = 7/42 (16%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAK 120
+EY+H +H DIK N+LL + + V ++D+GL+
Sbjct: 164 LEYIHE---NEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 15/42 (35%), Positives = 23/42 (54%), Gaps = 7/42 (16%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAK 120
+EY+H +H DIK N+LL + + V + D+GLA
Sbjct: 165 LEYIHE---HEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 15/96 (15%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPN--VSDFGLAKFHPKENDFV-SISATRGT 137
+ +L ++ I+H D+KP NILL + + DFG + + +R
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQSR-- 222
Query: 138 IGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM-TG 171
Y +PE++ G D++ G +L+EM TG
Sbjct: 223 -FYRSPEVL---LGMPYDLAIDMWSLGCILVEMHTG 254
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 17/39 (43%), Positives = 25/39 (64%), Gaps = 3/39 (7%)
Query: 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLA 119
G++Y+H+ ILH D+KP N L++ + V DFGLA
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 13/45 (28%), Positives = 24/45 (53%), Gaps = 10/45 (22%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILL------DHNFVPNVSDFGLAK 120
+EY+H+ +++ D+KP N L+ + ++ DF LAK
Sbjct: 118 MEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 6e-04
Identities = 13/44 (29%), Positives = 21/44 (47%), Gaps = 8/44 (18%)
Query: 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPN-----VSDFGLAK 120
++ +H +++ DIKP N L+ N V DFG+ K
Sbjct: 119 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 8e-04
Identities = 31/184 (16%), Positives = 57/184 (30%), Gaps = 65/184 (35%)
Query: 42 LVYEFMPNG-SLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKP 100
+V+E + G L + + +S Q + ++ G++YLH C + H DIKP
Sbjct: 122 MVFEVL--GHHLLK--WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKP 175
Query: 101 HNILL-------------------------------------------------DHNFVP 111
NILL
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 112 NVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMT 170
++D G A ++ I T Y + E++ G+ + +D++ + E+
Sbjct: 236 KIADLGNA-CWVHKHFTEDIQ----TRQYRSLEVL---IGSGYNTPADIWSTACMAFELA 287
Query: 171 GGRR 174
G
Sbjct: 288 TGDY 291
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 238 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.68 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.41 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.02 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.21 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.67 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.91 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.36 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 91.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 84.72 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=339.19 Aligned_cols=209 Identities=20% Similarity=0.260 Sum_probs=174.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+++|++++|||||++++++++++.+|+||||+.||+|.+++ ...+.+++..+..++.||+.||+||
T Consensus 73 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i----~~~~~l~e~~~~~~~~qi~~al~yl 148 (311)
T 4aw0_A 73 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 148 (311)
T ss_dssp TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999998 3346899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||+
T Consensus 149 H~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvi 223 (311)
T 4aw0_A 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCI 223 (311)
T ss_dssp HHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHH
T ss_pred HHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHH
Confidence 999 9999999999999999999999999999866544333333445699999999999886 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||........ ....... ... .+..+++++.+|+.+||+.||++|||++|
T Consensus 224 lyeml~G~~PF~~~~~~~~-------~~~i~~~-~~~-------~p~~~s~~~~dli~~lL~~dp~~R~t~~e 281 (311)
T 4aw0_A 224 IYQLVAGLPPFRAGNEGLI-------FAKIIKL-EYD-------FPEKFFPKARDLVEKLLVLDATKRLGCEE 281 (311)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------HHHHHHT-CCC-------CCTTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred HHHHHhCCCCCCCCCHHHH-------HHHHHcC-CCC-------CCcccCHHHHHHHHHHccCCHhHCcChHH
Confidence 9999999999975432221 1111111 111 11235678999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=333.08 Aligned_cols=218 Identities=24% Similarity=0.436 Sum_probs=166.8
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....++|.+|+.++++++|||||++++++.+ +.+++|||||++|+|.+++.. ....+++..+..++.||+.||+|
T Consensus 72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~y 147 (307)
T 3omv_A 72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDY 147 (307)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHH
Confidence 44566889999999999999999999998865 568999999999999999842 33579999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG 163 (238)
||++ +|+||||||+|||+++++.+||+|||+++...............||+.|+|||++.+. ...++.++||||||
T Consensus 148 LH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~G 224 (307)
T 3omv_A 148 LHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYG 224 (307)
T ss_dssp HHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHH
T ss_pred HHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHH
Confidence 9999 9999999999999999999999999999765443332223345699999999998653 12478899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++|||+||+.||....... ............. ........+++.+.+|+.+||+.||++|||++|
T Consensus 225 vvl~Elltg~~Pf~~~~~~~-------~~~~~~~~~~~~p--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 290 (307)
T 3omv_A 225 IVLYELMTGELPYSHINNRD-------QIIFMVGRGYASP--DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQ 290 (307)
T ss_dssp HHHHHHHHSSCTTTTCCCHH-------HHHHHHHTTCCCC--CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred HHHHHHHHCCCCCCCCChHH-------HHHHHHhcCCCCC--CcccccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 99999999999996433211 1111111111111 111223446778999999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=330.86 Aligned_cols=215 Identities=22% Similarity=0.399 Sum_probs=174.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC---------CCCCCCCHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE---------SRGQSCSWEKLHEVA 75 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~~~~~~~~~ 75 (238)
+....++|.+|+++|++++|||||++++++.+++..++|||||++|+|.+++.... .....+++..+..++
T Consensus 55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 134 (299)
T 4asz_A 55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence 34556889999999999999999999999999999999999999999999984321 234579999999999
Q ss_pred HHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc
Q 037755 76 SGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 76 ~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...............||+.|+|||.+.+. .++.
T Consensus 135 ~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~ 209 (299)
T 4asz_A 135 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTT 209 (299)
T ss_dssp HHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCH
T ss_pred HHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC--CCCc
Confidence 9999999999999 9999999999999999999999999999755443332222334589999999999876 7889
Q ss_pred cCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
++|||||||++|||+| |+.||....... +...+..+.... .+..+++++.+|+.+||+.||++||
T Consensus 210 k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dP~~RP 275 (299)
T 4asz_A 210 ESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIECITQGRVLQ------RPRTCPQEVYELMLGCWQREPHMRK 275 (299)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCccchHHHHHHHHHHcCCChhHCc
Confidence 9999999999999998 899997543221 112222222111 1234677899999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|++|
T Consensus 276 s~~~ 279 (299)
T 4asz_A 276 NIKG 279 (299)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9854
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=336.97 Aligned_cols=209 Identities=24% Similarity=0.310 Sum_probs=171.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++. ...+++..+..++.||+.||+||
T Consensus 112 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~yl 186 (346)
T 4fih_A 112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVL 186 (346)
T ss_dssp CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456778999999999999999999999999999999999999999999882 35699999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.+|.+||+|||++........ ......||+.|+|||++.+. .++.++|||||||+
T Consensus 187 H~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvi 259 (346)
T 4fih_A 187 HAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIM 259 (346)
T ss_dssp HHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHH
T ss_pred HHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHH
Confidence 999 999999999999999999999999999976544322 12334599999999999876 77899999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||........ ...+......... ....+++++.+|+.+||+.||++|||++|
T Consensus 260 lyeml~G~~PF~~~~~~~~--------~~~i~~~~~~~~~----~~~~~s~~~~dli~~~L~~dP~~R~ta~e 320 (346)
T 4fih_A 260 VIEMVDGEPPYFNEPPLKA--------MKMIRDNLPPRLK----NLHKVSPSLKGFLDRLLVRDPAQRATAAE 320 (346)
T ss_dssp HHHHHHSSCTTTTSCHHHH--------HHHHHHSSCCCCS----CGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHCCCCCCCcCHHHH--------HHHHHcCCCCCCC----ccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999975432221 1111111111111 11346778999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=329.40 Aligned_cols=215 Identities=26% Similarity=0.417 Sum_probs=166.9
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-----------CCCCCCHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-----------RGQSCSWEKLHE 73 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~ 73 (238)
+....++|.+|+++|++++|||||++++++.++..+++|||||++|+|.+++..... ...++++..+..
T Consensus 83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 162 (329)
T 4aoj_A 83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162 (329)
T ss_dssp SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHH
Confidence 445578899999999999999999999999999999999999999999999854322 235799999999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...............||+.|+|||.+.+. .+
T Consensus 163 i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~ 237 (329)
T 4aoj_A 163 VASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KF 237 (329)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTC--CC
T ss_pred HHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC--CC
Confidence 999999999999999 9999999999999999999999999999765443333233344599999999999876 78
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++|||||||++|||+| |+.||....... +...+....... .+..+++++.+|+.+||+.||++
T Consensus 238 ~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--------~~~~i~~g~~~~------~p~~~~~~~~~li~~cl~~dP~~ 303 (329)
T 4aoj_A 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--------AIDCITQGRELE------RPRACPPEVYAIMRGCWQREPQQ 303 (329)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--------HHHHHHHTCCCC------CCTTCCHHHHHHHHHHCCSSTTT
T ss_pred CccccccchHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCCCC------CcccccHHHHHHHHHHcCcChhH
Confidence 899999999999999998 899997543222 112222222111 12346778999999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 304 RPs~~e 309 (329)
T 4aoj_A 304 RHSIKD 309 (329)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=333.62 Aligned_cols=210 Identities=23% Similarity=0.311 Sum_probs=171.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+++|++++|||||++++++.+++.+|+|||||.||+|.+++.. .++..+++..++.++.||+.||.||
T Consensus 64 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~yl 141 (350)
T 4b9d_A 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHV 141 (350)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 44578899999999999999999999999999999999999999999999832 2345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 142 H~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvi 214 (350)
T 4b9d_A 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENK--PYNNKSDIWALGCV 214 (350)
T ss_dssp HHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHH
T ss_pred HHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHH
Confidence 999 999999999999999999999999999975533211 11223599999999999886 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||........ ....... ... .....+++++.+||.+||+.||++|||++|
T Consensus 215 lyemltG~~PF~~~~~~~~-------~~~i~~~-~~~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 273 (350)
T 4b9d_A 215 LYELCTLKHAFEAGSMKNL-------VLKIISG-SFP------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNS 273 (350)
T ss_dssp HHHHHHSSCSCCCSSHHHH-------HHHHHHT-CCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCCcCHHHH-------HHHHHcC-CCC------CCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999975433221 1111111 111 112235778999999999999999999854
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=325.06 Aligned_cols=207 Identities=23% Similarity=0.335 Sum_probs=164.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....++|.+|+++|++++|||||++++++.+ +..+|+|||||.+|+|.+++. ....+++..+..++.||+.|
T Consensus 66 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~a 141 (290)
T 3fpq_A 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKG 141 (290)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHH
Confidence 4456889999999999999999999999865 346899999999999999983 35689999999999999999
Q ss_pred HHHhHcCCCCc--eeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 82 IEYLHNGCDVC--ILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 82 l~~Lh~~~~~~--i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|+|||++ + |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++.+ .++.++|
T Consensus 142 L~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~D 211 (290)
T 3fpq_A 142 LQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE---KYDESVD 211 (290)
T ss_dssp HHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHH
T ss_pred HHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC---CCCcHHH
Confidence 9999998 7 99999999999998 47899999999997543322 123459999999998864 5788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||||++|+|+||+.||....... .+...+...... ...+...++++.+|+.+||+.||++|||++|
T Consensus 212 iwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 279 (290)
T 3fpq_A 212 VYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP-----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC-----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHHcCCCC-----CCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999999999996432211 111111111111 1122334567899999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=325.51 Aligned_cols=214 Identities=21% Similarity=0.340 Sum_probs=173.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHE 73 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~ 73 (238)
....++|.+|+.++++++|||||+++|++.++..+++|||||++|+|.+++..... ....+++..+..
T Consensus 70 ~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (308)
T 4gt4_A 70 GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149 (308)
T ss_dssp C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHH
Confidence 44568999999999999999999999999999999999999999999999854321 124689999999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...............||+.|+|||.+.+. .+
T Consensus 150 i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~ 224 (308)
T 4gt4_A 150 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KF 224 (308)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CC
T ss_pred HHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CC
Confidence 999999999999999 9999999999999999999999999998755433322223344699999999999876 78
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++|||||||++|||+| |..||....... +...+....... .+..+++.+.+|+.+||+.||++
T Consensus 225 s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--------~~~~i~~~~~~~------~p~~~~~~~~~li~~C~~~dP~~ 290 (308)
T 4gt4_A 225 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--------VVEMIRNRQVLP------CPDDCPAWVYALMIECWNEFPSR 290 (308)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CccchhhhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CcccchHHHHHHHHHHcCCChhH
Confidence 999999999999999998 899996543321 112222222111 12346778999999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 291 RPs~~e 296 (308)
T 4gt4_A 291 RPRFKD 296 (308)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=322.63 Aligned_cols=206 Identities=21% Similarity=0.314 Sum_probs=160.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+++|++++||||+++++++.+++.+|+||||+ +|+|.+.+. +.+.+++..+..++.||+.||+||
T Consensus 54 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~yl 128 (275)
T 3hyh_A 54 SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYC 128 (275)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999 679999883 346799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||+++++.+||+|||+++....... .....||+.|+|||++.+. ..++.++||||+||+
T Consensus 129 H~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvi 201 (275)
T 3hyh_A 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVI 201 (275)
T ss_dssp HHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSS-SCCCTHHHHHHHHHH
T ss_pred HHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHH
Confidence 999 999999999999999999999999999975543322 2234599999999999875 234678999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||....... .... ....... .+..+++++.+|+.+||+.||++|||++|
T Consensus 202 ly~lltg~~PF~~~~~~~-------~~~~-i~~~~~~-------~p~~~s~~~~~li~~~L~~dP~~R~s~~e 259 (275)
T 3hyh_A 202 LYVMLCRRLPFDDESIPV-------LFKN-ISNGVYT-------LPKFLSPGAAGLIKRMLIVNPLNRISIHE 259 (275)
T ss_dssp HHHHHHSSCSSCCSSHHH-------HHHH-HHHTCCC-------CCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCCCCHHH-------HHHH-HHcCCCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999996543221 1111 1111111 11235778899999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=338.36 Aligned_cols=209 Identities=25% Similarity=0.320 Sum_probs=171.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.+|++++|||||++++++.+++.+|+|||||.||+|.+++. ...+++..+..++.||+.||+||
T Consensus 189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~yl 263 (423)
T 4fie_A 189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVL 263 (423)
T ss_dssp CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHH
Confidence 4456778999999999999999999999999999999999999999999882 35699999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.+|.+||+|||++........ ......||+.|+|||++.+. .++.++|||||||+
T Consensus 264 H~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvi 336 (423)
T 4fie_A 264 HAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIM 336 (423)
T ss_dssp HHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHH
T ss_pred HHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHH
Confidence 999 999999999999999999999999999976543321 12334599999999999876 78899999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||........ ...+.......... ...+++++.+||.+||+.||++|||++|
T Consensus 337 lyeml~G~~PF~~~~~~~~--------~~~i~~~~~~~~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~e 397 (423)
T 4fie_A 337 VIEMVDGEPPYFNEPPLKA--------MKMIRDNLPPRLKN----LHKVSPSLKGFLDRLLVRDPAQRATAAE 397 (423)
T ss_dssp HHHHHHSSCTTTTSCHHHH--------HHHHHHSCCCCCSC----TTSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHCCCCCCCcCHHHH--------HHHHHcCCCCCCcc----cccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999965433221 11111111111111 1235678999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=329.99 Aligned_cols=205 Identities=21% Similarity=0.238 Sum_probs=164.7
Q ss_pred HHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCc
Q 037755 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVC 92 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 92 (238)
.+|+.++++++|||||++++++.++..+|+|||||+||+|.+++. ..+.+++..+..++.||+.||+|||++ +
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~ 170 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---R 170 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 479999999999999999999999999999999999999999983 346799999999999999999999999 9
Q ss_pred eeeeccCCCcEEEccCC-ccccccccccccCCCCCcc---ccccccCCccccCCcceeecCCCcccccCceehHHHHHHH
Q 037755 93 ILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 168 (238)
Q Consensus 93 i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ 168 (238)
|+||||||+|||++.+| ++||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 171 IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilye 248 (336)
T 4g3f_A 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLH 248 (336)
T ss_dssp EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHH
T ss_pred ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHH
Confidence 99999999999999887 6999999999765443211 112234599999999999886 67889999999999999
Q ss_pred HhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 169 MTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 169 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++|+.||........ + ....... ......+..+++.+.+|+.+||+.||++|||+.|
T Consensus 249 mltG~~Pf~~~~~~~~---~----~~i~~~~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~e 306 (336)
T 4g3f_A 249 MLNGCHPWTQYFRGPL---C----LKIASEP-----PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAME 306 (336)
T ss_dssp HHHSSCSSTTTCCSCC---H----HHHHHSC-----CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHCcCCCCCCCHHHH---H----HHHHcCC-----CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999975433221 1 1111111 1111233456788999999999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=329.82 Aligned_cols=204 Identities=23% Similarity=0.288 Sum_probs=161.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...++.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++ .+.+.+++..+..++.||+.||+|||+
T Consensus 69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~ 144 (304)
T 3ubd_A 69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHS 144 (304)
T ss_dssp ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999999999999999999999999998 334679999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|
T Consensus 145 ~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvily 217 (304)
T 3ubd_A 145 L---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMF 217 (304)
T ss_dssp T---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHH
T ss_pred C---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHH
Confidence 9 999999999999999999999999999975433221 12234599999999999876 7788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+|++|+.||........ ....... ... .+..+++++.+|+.+||+.||++|||+.
T Consensus 218 emltG~~PF~~~~~~~~-------~~~i~~~-~~~-------~p~~~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 218 EMLTGTLPFQGKDRKET-------MTMILKA-KLG-------MPQFLSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp HHHHSSCSSCCSSHHHH-------HHHHHHC-CCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred HHHhCCCCCCCcCHHHH-------HHHHHcC-CCC-------CCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence 99999999975433221 1111111 111 1123677899999999999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=319.39 Aligned_cols=214 Identities=27% Similarity=0.414 Sum_probs=170.7
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHH
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLH 72 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~ 72 (238)
...++|.+|+++|+++. |||||++++++.+ +..+++|||||++|+|.+++..... ....+++..+.
T Consensus 109 ~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 188 (353)
T 4ase_A 109 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHH
Confidence 44678999999999996 5999999999865 4678999999999999999843221 23468999999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...............||+.|+|||++.+. .
T Consensus 189 ~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~ 263 (353)
T 4ase_A 189 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--V 263 (353)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--C
T ss_pred HHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--C
Confidence 9999999999999999 9999999999999999999999999999865444333333444589999999999886 7
Q ss_pred ccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
++.++|||||||++|||+| |+.||....... .+...+..+.... .+..+++++.+++.+||+.||+
T Consensus 264 y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-------~~~~~i~~g~~~~------~p~~~~~~~~~li~~c~~~dP~ 330 (353)
T 4ase_A 264 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMR------APDYTTPEMYQTMLDCWHGEPS 330 (353)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHHcCCCCC------CCccCCHHHHHHHHHHcCcChh
Confidence 8899999999999999998 899996543221 1222222222211 1233567899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 331 ~RPt~~e 337 (353)
T 4ase_A 331 QRPTFSE 337 (353)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=307.62 Aligned_cols=212 Identities=19% Similarity=0.291 Sum_probs=156.5
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC------------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ 72 (238)
.+...+++.+|+++|++++|||||++++++.+.+ .+|++||||.+|+|.+++.... .....+...++
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~ 121 (299)
T 4g31_A 43 RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCL 121 (299)
T ss_dssp SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHH
Confidence 3455688999999999999999999999986543 3799999999999999984322 22345567788
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc----------cccccCCccccCC
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV----------SISATRGTIGYIA 142 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~----------~~~~~~~~~~~~a 142 (238)
.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......... ......||+.|+|
T Consensus 122 ~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmA 198 (299)
T 4g31_A 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198 (299)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSC
T ss_pred HHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccC
Confidence 9999999999999999 99999999999999999999999999997654332111 1122359999999
Q ss_pred cceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHH
Q 037755 143 PELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 143 PE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 222 (238)
||++.+. .++.++|||||||++|+|++ ||...... . . ....... ...+......++.+.+|+
T Consensus 199 PE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~~-----~-~-~~~~~~~------~~~p~~~~~~~~~~~~li 260 (299)
T 4g31_A 199 PEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQMER-----V-R-TLTDVRN------LKFPPLFTQKYPCEYVMV 260 (299)
T ss_dssp HHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----H-H-HHHHHHT------TCCCHHHHHHCHHHHHHH
T ss_pred HHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccHH-----H-H-HHHHHhc------CCCCCCCcccCHHHHHHH
Confidence 9999886 78899999999999999996 66432111 0 0 0011111 111233445567788999
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||++|||+.|
T Consensus 261 ~~~L~~dP~~Rps~~e 276 (299)
T 4g31_A 261 QDMLSPSPMERPEAIN 276 (299)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHcCCChhHCcCHHH
Confidence 9999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=307.50 Aligned_cols=221 Identities=20% Similarity=0.220 Sum_probs=159.4
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
+..|+..+.+++|||||++++++.+++ .+++||||+++|+|.+++. ...+++..+..++.|++.||+|||+
T Consensus 44 ~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~ 118 (303)
T 3hmm_A 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 118 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345666667889999999999997643 5799999999999999993 3568999999999999999999997
Q ss_pred CC-----CCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCC----Cccccc
Q 037755 88 GC-----DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNF----GTVSCK 156 (238)
Q Consensus 88 ~~-----~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~~ 156 (238)
++ ..+|+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+.. ..++.+
T Consensus 119 ~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChh
Confidence 52 3489999999999999999999999999987554433221 112345999999999987531 136778
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCC--------cchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKA--------YFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
+|||||||++|||+||..||.......... ...............+... ........++.+.+|+.+||+.
T Consensus 199 ~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p-~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-GGGGSSHHHHHHHHHHHTTCCS
T ss_pred HhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCC-ccccchHHHHHHHHHHHHHccc
Confidence 999999999999999998875443322111 0111111111111111111 1111234567889999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||+.|
T Consensus 278 dP~~RPt~~e 287 (303)
T 3hmm_A 278 NGAARLTALR 287 (303)
T ss_dssp SGGGSCCHHH
T ss_pred CHhHCcCHHH
Confidence 9999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=310.88 Aligned_cols=223 Identities=18% Similarity=0.208 Sum_probs=166.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEe------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|+++|++++|||||++++++.. .+.+|+|||||. |+|.+++ ...+.+++..+..++.||+.
T Consensus 95 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~ 169 (398)
T 4b99_A 95 TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLR 169 (398)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHH
Confidence 445788899999999999999999998753 467899999995 6899988 34578999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc--cccccccCCccccCCcceeecCCCcccccCc
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
||.|||++ +|+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+. ..++.++|
T Consensus 170 al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~D 245 (398)
T 4b99_A 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAID 245 (398)
T ss_dssp HHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHH
T ss_pred HHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCC-CCCCChhh
Confidence 99999999 999999999999999999999999999975543221 1112334699999999998774 35688999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhh----------------hhhhhccCCCccccchhHHHHHHHHHHHHHH
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSW----------------VSDQLNKGGNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 222 (238)
|||+||++|+|++|+.||...........+... ......................+++++.+|+
T Consensus 246 iWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 325 (398)
T 4b99_A 246 LWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLL 325 (398)
T ss_dssp HHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHH
T ss_pred eehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHH
Confidence 999999999999999999765432211100000 0000000000111111122234567899999
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||++|||++|
T Consensus 326 ~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 326 GRMLRFEPSARISAAA 341 (398)
T ss_dssp HHHSCSSTTTSCCHHH
T ss_pred HHHCcCChhHCcCHHH
Confidence 9999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=302.04 Aligned_cols=163 Identities=19% Similarity=0.277 Sum_probs=139.2
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....++.+|+++|+++ +||||+++++++.+.+++|+||||+++|+|.+++ +.+++..+..++.||+.||+||
T Consensus 61 ~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~yl 133 (361)
T 4f9c_A 61 SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRI 133 (361)
T ss_dssp SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999 6999999999999999999999999999999988 3589999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccC-CccccccccccccCCCCCcc--------------------------ccccccCCcc
Q 037755 86 HNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDF--------------------------VSISATRGTI 138 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~--------------------------~~~~~~~~~~ 138 (238)
|++ ||+||||||+|||++.+ +.+||+|||+++........ .......||+
T Consensus 134 H~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 210 (361)
T 4f9c_A 134 HQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTP 210 (361)
T ss_dssp HHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCG
T ss_pred HHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCc
Confidence 999 99999999999999876 79999999999754432210 0112235999
Q ss_pred ccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCccc
Q 037755 139 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 139 ~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
.|+|||++.+. ..++.++||||+||++|+|++|+.||....
T Consensus 211 ~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 211 GFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 99999998774 357889999999999999999999996443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=318.65 Aligned_cols=212 Identities=19% Similarity=0.268 Sum_probs=171.7
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+.+.+|+.+|++++||||+++++++.+...+|+|||||.||+|.+++. .....+++..+..++.||+.||.|
T Consensus 194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~y 270 (573)
T 3uto_A 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCH 270 (573)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999999999999999999999999883 234679999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEcc--CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDH--NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
||++ +|+||||||+|||++. .+.+||+|||++......... ....||+.|+|||++.+. .++.++|||||
T Consensus 271 lH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~---~~~~GT~~y~APEv~~~~--~y~~~~DiWSl 342 (573)
T 3uto_A 271 MHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSV 342 (573)
T ss_dssp HHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHH
T ss_pred HHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce---eeeEECccccCHHHhCCC--CCCcHHHHHHH
Confidence 9999 9999999999999985 489999999999866544322 233599999999999886 77889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||++|+|++|..||........ ......... .........+++++.+||.+||+.||++|||++|
T Consensus 343 Gvilyeml~G~~Pf~~~~~~~~-------~~~i~~~~~----~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e 407 (573)
T 3uto_A 343 GVLSYILLSGLSPFGGENDDET-------LRNVKSCDW----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407 (573)
T ss_dssp HHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCC----CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHHHHCCCCCCCcCHHHH-------HHHHHhCCC----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999999975443221 111111100 1111222346778999999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=314.76 Aligned_cols=199 Identities=23% Similarity=0.270 Sum_probs=160.8
Q ss_pred HHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCce
Q 037755 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCI 93 (238)
Q Consensus 14 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i 93 (238)
.++.+++.++|||||++++++.+...+|+||||+.||+|.+++. ..+.+++..+..++.||+.||.|||++ ||
T Consensus 241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gI 313 (689)
T 3v5w_A 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FV 313 (689)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TE
T ss_pred HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 34666777899999999999999999999999999999999993 346799999999999999999999999 99
Q ss_pred eeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCC
Q 037755 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173 (238)
Q Consensus 94 ~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~ 173 (238)
+||||||+|||++.+|.+||+|||++........ ....||+.|+|||++.+. ..++.++|+|||||++|+|++|.
T Consensus 314 iHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~ 388 (689)
T 3v5w_A 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGH 388 (689)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCCchHHeEEeCCCCEEecccceeeecCCCCC----CCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999976544322 234599999999998642 26788999999999999999999
Q ss_pred CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 174 RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 174 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
.||......... ........... ..+..+++++.+||.+||+.||++|++.
T Consensus 389 ~PF~~~~~~~~~----~i~~~i~~~~~--------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 389 SPFRQHKTKDKH----EIDRMTLTMAV--------ELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp CTTCGGGCCCHH----HHHHHHHHCCC--------CCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred CCCCCCChHHHH----HHHHhhcCCCC--------CCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 999754432211 11111111110 1123467889999999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=280.55 Aligned_cols=227 Identities=35% Similarity=0.626 Sum_probs=177.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.+++..++|+||+.+|+|.+++.........+++..+..++.|++.||.||
T Consensus 76 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 155 (321)
T 2qkw_B 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155 (321)
T ss_dssp SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh
Confidence 44568899999999999999999999999999999999999999999999855444445799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||.+................|++.|+|||.+.+. .++.++||||||++
T Consensus 156 H~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~i 230 (321)
T 2qkw_B 156 HTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVV 230 (321)
T ss_dssp HHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHH
T ss_pred cCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC--CCCcccchHhHHHH
Confidence 999 9999999999999999999999999998754433322222333489999999998775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCC---ccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGN---LELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||.......... ...+.......... ............++..+.+++.+||+.||++|||++|
T Consensus 231 l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 305 (321)
T 2qkw_B 231 LFEVLCARSAIVQSLPREMVN-LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305 (321)
T ss_dssp HHHHHHCCTTCSCSSSSSCCC-HHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhCCCcccccCcHHHHH-HHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 999999999997654433221 11111111111110 1111122334567889999999999999999999854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=280.04 Aligned_cols=210 Identities=23% Similarity=0.335 Sum_probs=169.3
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+.+.+|+.++++++||||+++++++..++..++||||+.+|+|.+++. ...+++..+..++.|++.||.|
T Consensus 57 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~ 131 (297)
T 3fxz_A 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131 (297)
T ss_dssp GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHH
Confidence 34457889999999999999999999999999999999999999999999882 2468999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++||||||+||+++.++.++|+|||++........ ......||+.|+|||.+.+. .++.++||||||+
T Consensus 132 lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ 204 (297)
T 3fxz_A 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGI 204 (297)
T ss_dssp HHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHH
T ss_pred HHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCC--CCCcHHHHHHHHH
Confidence 9999 999999999999999999999999999875544322 12334599999999999876 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||........ ....... ....... +..+++.+.+++.+||+.||++|||++|
T Consensus 205 il~ell~g~~pf~~~~~~~~-------~~~~~~~-~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (297)
T 3fxz_A 205 MAIEMIEGEPPYLNENPLRA-------LYLIATN-GTPELQN----PEKLSAIFRDFLNRCLEMDVEKRGSAKE 266 (297)
T ss_dssp HHHHHHHSSCTTTTSCHHHH-------HHHHHHH-CSCCCSC----GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHhCCCCCCCCCHHHH-------HHHHHhC-CCCCCCC----ccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999999999965332211 0000000 1111111 1235677899999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=283.14 Aligned_cols=208 Identities=21% Similarity=0.290 Sum_probs=170.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.+....++||||+.+|+|.+++ .....+++..+..++.||+.||.|||+
T Consensus 58 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~ 133 (361)
T 2yab_A 58 CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHT 133 (361)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 5688999999999999999999999999999999999999999999998 345679999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCC----ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNF----VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
. +|+||||||+||+++.++ .++|+|||++........ .....||+.|+|||++.+. .++.++||||||
T Consensus 134 ~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG 205 (361)
T 2yab_A 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIG 205 (361)
T ss_dssp T---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHH
T ss_pred C---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHH
Confidence 9 999999999999998776 799999999976544322 1234599999999999775 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ . ..+.... ..........+++.+.+|+.+||+.||++|||++|
T Consensus 206 vil~~ll~g~~Pf~~~~~~~~-------~-~~i~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 269 (361)
T 2yab_A 206 VITYILLSGASPFLGDTKQET-------L-ANITAVS---YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269 (361)
T ss_dssp HHHHHHHHSCCSSCCSSHHHH-------H-HHHHTTC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHH-------H-HHHHhcC---CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 999999999999965432211 1 1111110 11112233456778999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=284.10 Aligned_cols=207 Identities=19% Similarity=0.296 Sum_probs=167.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|++++++++||||+++++++.+.+..++||||+.+++|.+++. ....+++..+..++.|++.||+||
T Consensus 55 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~l 130 (328)
T 3fe3_A 55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYC 130 (328)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999883 345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++||||||+||+++.++.++|+|||++........ .....||+.|+|||.+.+. ...+.++||||||++
T Consensus 131 H~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~i 203 (328)
T 3fe3_A 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVI 203 (328)
T ss_dssp HHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHH
T ss_pred HHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCC-CcCCchhhhhhhHHH
Confidence 999 999999999999999999999999999875544322 2334599999999999875 233578999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ . ......... .+..+++++.+|+.+||+.||++|||++|
T Consensus 204 l~ell~g~~pf~~~~~~~~-------~-~~i~~~~~~-------~p~~~s~~~~~li~~~L~~dP~~R~t~~e 261 (328)
T 3fe3_A 204 LYTLVSGSLPFDGQNLKEL-------R-ERVLRGKYR-------IPFYMSTDCENLLKRFLVLNPIKRGTLEQ 261 (328)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------H-HHHHHCCCC-------CCTTSCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred HHHHHhCCCCCCCCCHHHH-------H-HHHHhCCCC-------CCCCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9999999999965432211 1 111111111 11224677889999999999999999854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=280.99 Aligned_cols=211 Identities=16% Similarity=0.212 Sum_probs=170.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++. .....+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~l 118 (321)
T 1tki_A 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118 (321)
T ss_dssp THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456778999999999999999999999999999999999999999999982 2235799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEcc--CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDH--NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|+. +++||||||+||+++. ++.++|+|||.+........ .....+++.|+|||.+.+. .++.++||||||
T Consensus 119 H~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG 190 (321)
T 1tki_A 119 HSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLG 190 (321)
T ss_dssp HHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHH
T ss_pred HHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCC--CCCchhhHHHHH
Confidence 999 9999999999999986 78999999999976544332 1233489999999999775 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ........ ..........+++++.+|+.+||+.||++|||+.|
T Consensus 191 ~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 254 (321)
T 1tki_A 191 TLVYVLLSGINPFLAETNQQI-------IENIMNAE----YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp HHHHHHHHSSCTTCCSSHHHH-------HHHHHHTC----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCcCCCHHHH-------HHHHHcCC----CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999999999965432211 11111111 11112223456788999999999999999999854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=278.36 Aligned_cols=208 Identities=23% Similarity=0.306 Sum_probs=169.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++++.+....++||||+.+++|.+++ .....+++..+..++.|++.||.|||+
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~ 132 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHS 132 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999999999999999999999999999999999999998 335679999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCC----ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNF----VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
. +++||||||+||+++.++ .++|+|||++........ .....||+.|+|||.+.+. .++.++||||||
T Consensus 133 ~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG 204 (326)
T 2y0a_A 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIG 204 (326)
T ss_dssp T---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHH
T ss_pred C---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHH
Confidence 9 999999999999998877 799999999976543322 1234599999999998765 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ... .... ...........+++.+.+|+.+||+.||++|||++|
T Consensus 205 ~il~~ll~g~~pf~~~~~~~~-------~~~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 268 (326)
T 2y0a_A 205 VITYILLSGASPFLGDTKQET-------LAN-VSAV---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268 (326)
T ss_dssp HHHHHHHHSCCSSCCSSHHHH-------HHH-HHHT---CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHCcCCCCCCCHHHH-------HHH-HHhc---CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999999999999965432211 111 1110 011112233456778999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=281.66 Aligned_cols=212 Identities=23% Similarity=0.293 Sum_probs=169.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++++.++...++||||+.+++|.+.+......+..+++..+..++.||+.||+|||+
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999999999999999999999999999999988774433344568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCc---cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFV---PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+ +|+||||||+||+++.++. ++|+|||++........ ......||+.|+|||++.+. .++.++||||||+
T Consensus 149 ~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ 221 (351)
T 3c0i_A 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGV 221 (351)
T ss_dssp T---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHH
T ss_pred C---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHH
Confidence 9 9999999999999986554 99999999976544322 12234599999999999875 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||...... ........ . ..........+++++.+|+.+||+.||++|||+.|
T Consensus 222 il~~ll~g~~pf~~~~~~--------~~~~i~~~-~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 283 (351)
T 3c0i_A 222 ILFILLSGCLPFYGTKER--------LFEGIIKG-K---YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 283 (351)
T ss_dssp HHHHHHHSSCSSCSSHHH--------HHHHHHHT-C---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHCCCCCCCcHHH--------HHHHHHcC-C---CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 999999999999653211 11111111 0 01111222346788999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=276.44 Aligned_cols=214 Identities=26% Similarity=0.410 Sum_probs=169.2
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+.+.+|++++++++||||+++++++.++...++||||+.+++|.+++.. ....+++..+..++.|++.||+|
T Consensus 47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~ 123 (310)
T 3s95_A 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAY 123 (310)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999999999999999999999999999999832 24678999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc------------ccccCCccccCCcceeecCCCc
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS------------ISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
||+. +++||||||+||+++.++.++|+|||.+........... .....||+.|+|||.+.+. .
T Consensus 124 lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~ 198 (310)
T 3s95_A 124 LHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--S 198 (310)
T ss_dssp HHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTC--C
T ss_pred HHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCC--C
Confidence 9999 999999999999999999999999999876544322110 0133589999999999875 7
Q ss_pred ccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
++.++||||||+++|+|++|..|+.............. ..... ...+..+++.+.+++.+||+.||++
T Consensus 199 ~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 199 YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV--RGFLD----------RYCPPNCPPSFFPITVRCCDLDPEK 266 (310)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--HHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGG
T ss_pred CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--hcccc----------ccCCCCCCHHHHHHHHHHccCChhh
Confidence 78899999999999999999998865433322211110 00000 0011234567889999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 267 Rps~~~ 272 (310)
T 3s95_A 267 RPSFVK 272 (310)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=276.99 Aligned_cols=226 Identities=35% Similarity=0.608 Sum_probs=178.3
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.++.+|++++++++||||+++++++.+....++||||+.+|+|.+++.........+++..+..++.+++.||+|||+.+
T Consensus 72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 151 (326)
T 3uim_A 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151 (326)
T ss_dssp CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 47899999999999999999999999999999999999999999999665555667999999999999999999999976
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
..+++||||||+||+++.++.++|+|||.+......... ......||+.|+|||.+.+. .++.++||||||+++|+|
T Consensus 152 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l 228 (326)
T 3uim_A 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLEL 228 (326)
T ss_dssp SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHH
T ss_pred CCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHH
Confidence 668999999999999999999999999999765443322 22334489999999999775 678899999999999999
Q ss_pred hcCCCCCCcccccccC-CcchhhhhhhhccCCCcc---ccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSK-AYFPSWVSDQLNKGGNLE---LRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|..||......... .....+............ ...........++.+.+++.+||+.||++|||++|
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 301 (326)
T 3uim_A 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301 (326)
T ss_dssp HHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred HhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence 9999999644333222 122222222222111111 11112234567889999999999999999999854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=278.70 Aligned_cols=211 Identities=27% Similarity=0.351 Sum_probs=166.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.++...++||||+.+++|.+++ .....+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~ 123 (323)
T 3tki_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG 123 (323)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3577899999999999999999999999999999999999999999988 345679999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||++................||+.|+|||.+.+. ...+.++||||||+++|
T Consensus 124 ~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 199 (323)
T 3tki_A 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLT 199 (323)
T ss_dssp T---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHH
T ss_pred C---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHH
Confidence 9 9999999999999999999999999998755333322222344699999999998765 23477899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||........ .+..+ ...... .. ....+++.+.+|+.+||+.||++|||++|
T Consensus 200 ~ll~g~~pf~~~~~~~~--~~~~~----~~~~~~--~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e 258 (323)
T 3tki_A 200 AMLAGELPWDQPSDSCQ--EYSDW----KEKKTY--LN----PWKKIDSAPLALLHKILVENPSARITIPD 258 (323)
T ss_dssp HHHHSSCSCSSSCTTSH--HHHHH----HTTCTT--ST----TGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHhCCCCCCCCchHHH--HHHHH----hccccc--CC----ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999965432211 01010 000000 00 01235677889999999999999999753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=273.81 Aligned_cols=226 Identities=32% Similarity=0.513 Sum_probs=173.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++||||+++++++.++...++++||+.+++|.+++.... ....+++..++.++.+++.||.||
T Consensus 71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~l 149 (307)
T 2nru_A 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFL 149 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999999999999999999999999999999884322 235689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||.+................|++.|+|||.+.+ .++.++||||||++
T Consensus 150 H~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~i 223 (307)
T 2nru_A 150 HEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVV 223 (307)
T ss_dssp HHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHH
T ss_pred hcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHH
Confidence 999 999999999999999999999999999876554333322333458999999998865 46788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||...........+..........................+..+.+++.+||+.||++|||+.|
T Consensus 224 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 296 (307)
T 2nru_A 224 LLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296 (307)
T ss_dssp HHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 9999999999976544332221111111000000000000111223456788999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=273.47 Aligned_cols=217 Identities=20% Similarity=0.303 Sum_probs=153.8
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
.....+.+|+.+++++. ||||+++++++.++...++||||+.+|+|.+++. ....+++..+..++.|++.||+||
T Consensus 47 ~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~L 122 (325)
T 3kn6_A 47 RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHM 122 (325)
T ss_dssp GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 35678889999999997 9999999999999999999999999999999983 346799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCC---ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNF---VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|++ +|+||||||+||+++.++ .++|+|||.+........ ......+|+.|+|||.+.+. .++.++|||||
T Consensus 123 H~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~~Diwsl 195 (325)
T 3kn6_A 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQN--GYDESCDLWSL 195 (325)
T ss_dssp HHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------C--CCCHHHHHHHH
T ss_pred HHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCC--CCCCccchHHH
Confidence 999 999999999999998665 799999999975544322 12234589999999999876 67889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||................ ...... ...........+++++.+|+.+||+.||++|||++|
T Consensus 196 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 267 (325)
T 3kn6_A 196 GVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKG---DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267 (325)
T ss_dssp HHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTT---CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred HHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcC---CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHH
Confidence 999999999999997654332211111111 111111 111222334557888999999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=280.75 Aligned_cols=209 Identities=21% Similarity=0.277 Sum_probs=166.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.++...++||||+.+|+|.+.+ .....+++..+..++.||+.||.|||
T Consensus 70 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH 145 (362)
T 2bdw_A 70 RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCH 145 (362)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44578899999999999999999999999999999999999999999988 33467899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccC---CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHN---FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
+. +|+||||||+||+++.+ +.++|+|||++........ .....||+.|+|||++.+. .++.++||||||
T Consensus 146 ~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG 217 (362)
T 2bdw_A 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACG 217 (362)
T ss_dssp HT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHH
T ss_pred HC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHH
Confidence 99 99999999999999864 4599999999875543322 1234599999999999875 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||....... ....+........ ......+++++.+|+.+||+.||++|||++|
T Consensus 218 ~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 281 (362)
T 2bdw_A 218 VILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDYP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 281 (362)
T ss_dssp HHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCC---TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCC---cccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999999999996533211 1111111111000 1111335678899999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=287.41 Aligned_cols=210 Identities=19% Similarity=0.241 Sum_probs=167.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.+++..++||||+.+|+|.+.+. ....+++..+..++.||+.||.|||
T Consensus 52 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH 127 (444)
T 3soa_A 52 RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCH 127 (444)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999883 3467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEc---cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
+. +|+||||||+||+++ .++.++|+|||++........ ......||+.|+|||++.+. .++.++||||||
T Consensus 128 ~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlG 200 (444)
T 3soa_A 128 QM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACG 200 (444)
T ss_dssp HT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHH
T ss_pred HC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHH
Confidence 99 999999999999998 467899999999975544322 12234599999999999875 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ...+........ ......+++++.+|+.+||+.||++|||++|
T Consensus 201 vilyell~G~~Pf~~~~~~~~--------~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 264 (444)
T 3soa_A 201 VILYILLVGYPPFWDEDQHRL--------YQQIKAGAYDFP---SPEWDTVTPEAKDLINKMLTINPSKRITAAE 264 (444)
T ss_dssp HHHHHHHHSSCSCCCSSHHHH--------HHHHHHTCCCCC---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHhCCCCCCCccHHHH--------HHHHHhCCCCCC---ccccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 999999999999965432211 111111111100 0111235678899999999999999999854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=277.29 Aligned_cols=213 Identities=22% Similarity=0.406 Sum_probs=169.6
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLHE 73 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~ 73 (238)
...+++.+|+.+++++ +||||+++++++.+.+..++||||+.+|+|.+++..... ....+++..+..
T Consensus 128 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (370)
T 2psq_A 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207 (370)
T ss_dssp HHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHH
Confidence 4457899999999999 899999999999999999999999999999999854321 124588999999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++................+++.|+|||.+.+. .+
T Consensus 208 i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~ 282 (370)
T 2psq_A 208 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VY 282 (370)
T ss_dssp HHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CC
T ss_pred HHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CC
Confidence 999999999999999 9999999999999999999999999999755443322222333477899999999875 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++||||||+++|+|++ |..||....... ............ .+..++..+.+++.+||+.||++
T Consensus 283 ~~~~DvwslG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~ 348 (370)
T 2psq_A 283 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQ 348 (370)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhh
Confidence 889999999999999999 999986543221 111111111111 11235678999999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 349 Rpt~~e 354 (370)
T 2psq_A 349 RPTFKQ 354 (370)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=281.80 Aligned_cols=227 Identities=15% Similarity=0.139 Sum_probs=166.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.+++..++||||+.+|+|.+++... ....+++..+..++.||+.||+|||
T Consensus 68 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH 145 (389)
T 3gni_B 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIH 145 (389)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 44578889999999999999999999999999999999999999999988432 2356899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-----ccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
++ +|+||||||+|||++.++.++|+|||.+......... .......|+..|+|||.+.+....++.++||||
T Consensus 146 ~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 222 (389)
T 3gni_B 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222 (389)
T ss_dssp HT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHH
T ss_pred hC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHH
Confidence 99 9999999999999999999999999987543221110 111223588999999999874336788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCC-------------------------------CccccchhHH
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGG-------------------------------NLELRNVTEI 210 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 210 (238)
|||++|+|++|+.||........................ ..........
T Consensus 223 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (389)
T 3gni_B 223 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302 (389)
T ss_dssp HHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------------------------
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcc
Confidence 999999999999999654332211000000000000000 0000001123
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 211 ESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 211 ~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
...+++.+.+|+.+||+.||++|||++|
T Consensus 303 ~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 303 HRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp ---CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred ccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 3456778999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=278.03 Aligned_cols=204 Identities=22% Similarity=0.292 Sum_probs=165.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.+++.++||||+++++++.+....++||||+ +|+|.+++. ....+++..+..++.|++.||.|||+
T Consensus 52 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~ 126 (336)
T 3h4j_B 52 MHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHR 126 (336)
T ss_dssp CSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999999999999999 679988873 34579999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||++........ .....||+.|+|||.+.+. ...+.++||||||+++|
T Consensus 127 ~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 199 (336)
T 3h4j_B 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLY 199 (336)
T ss_dssp H---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHH
T ss_pred C---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHH
Confidence 9 999999999999999999999999999875544322 2334599999999999875 23367899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||...........+. ... ...+..+++.+.+|+.+||+.||++|||++|
T Consensus 200 ~ll~g~~Pf~~~~~~~~~~~i~--------~~~-------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~e 255 (336)
T 3h4j_B 200 VMLVGRLPFDDEFIPNLFKKVN--------SCV-------YVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255 (336)
T ss_dssp HHHHSSCSSBCSSSTTCBCCCC--------SSC-------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHhCCCCCCCccHHHHHHHHH--------cCC-------CCCcccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999996543332211110 000 0111235678899999999999999999854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=275.15 Aligned_cols=227 Identities=24% Similarity=0.314 Sum_probs=167.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
......+.+|+.++++++||||+++++++.... ..++||||+.+|+|.+++. ...+++..++.++.|++.|
T Consensus 59 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~a 133 (322)
T 3soc_A 59 DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARG 133 (322)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHH
Confidence 344566677999999999999999999997744 4799999999999999982 2458999999999999999
Q ss_pred HHHhHcCC-------CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC---C
Q 037755 82 IEYLHNGC-------DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF---G 151 (238)
Q Consensus 82 l~~Lh~~~-------~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~ 151 (238)
|+|||+.+ ..+++||||||+||+++.++.+||+|||++................||+.|+|||.+.+.. .
T Consensus 134 l~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 213 (322)
T 3soc_A 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213 (322)
T ss_dssp HHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCH
T ss_pred HHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCc
Confidence 99999741 2289999999999999999999999999997654443322233345899999999987631 1
Q ss_pred cccccCceehHHHHHHHHhcCCCCCCcccccccCCcc---------hhhhhhhhccCCCccccchhHHHHHHHHHHHHHH
Q 037755 152 TVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF---------PSWVSDQLNKGGNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 152 ~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 222 (238)
.++.++||||||+++|+|++|+.||............ ................. ........++.+.+|+
T Consensus 214 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 292 (322)
T 3soc_A 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETI 292 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC-GGGGSSHHHHHHHHHH
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCcc-ccccccchHHHHHHHH
Confidence 4567889999999999999999999765443322211 11111111111111111 1111224567799999
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||++|||++|
T Consensus 293 ~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 293 EECWDHDAEARLSAGC 308 (322)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHccCChhhCcCHHH
Confidence 9999999999999854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=278.95 Aligned_cols=208 Identities=24% Similarity=0.359 Sum_probs=167.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++ .....+++..+..++.+|+.||.|||
T Consensus 57 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH 132 (384)
T 4fr4_A 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQ 132 (384)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH----HTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999999999999998 33567999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~ 165 (238)
+. ||+||||||+||+++.++.++|+|||++........ .....||+.|+|||++.+. ...++.++|+||||++
T Consensus 133 ~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i 206 (384)
T 4fr4_A 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206 (384)
T ss_dssp HT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred HC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence 99 999999999999999999999999999976543322 2334599999999998753 1257889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|..||.......... .... ...... ..+..+++.+.+|+.+||+.||++||+.
T Consensus 207 l~elltG~~Pf~~~~~~~~~~----~~~~-~~~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~s~ 265 (384)
T 4fr4_A 207 AYELLRGRRPYHIRSSTSSKE----IVHT-FETTVV-------TYPSAWSQEMVSLLKKLLEPNPDQRFSQ 265 (384)
T ss_dssp HHHHHHSSCSSCCCTTSCHHH----HHHH-HHHCCC-------CCCTTSCHHHHHHHHHHSCSSGGGSCCS
T ss_pred HHHHHhCCCCCCCCCCccHHH----HHHH-Hhhccc-------CCCCcCCHHHHHHHHHHhcCCHhHhccc
Confidence 999999999996543322111 1111 111000 0112356789999999999999999983
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=277.72 Aligned_cols=203 Identities=22% Similarity=0.268 Sum_probs=165.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.+++.++||||+++++++.+...+++||||+.+|+|.+++. ....+++..+..++.||+.||.||
T Consensus 46 ~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L 121 (337)
T 1o6l_A 46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL 121 (337)
T ss_dssp TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999998882 345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+||+++.+|.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||++
T Consensus 122 H~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 194 (337)
T 1o6l_A 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVV 194 (337)
T ss_dssp HHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHH
T ss_pred HHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCC--CCCchhhcccchhH
Confidence 999 999999999999999999999999999875332221 12234589999999999875 67899999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
+|+|++|..||....... ........... .+..+++++.+++.+||+.||++||
T Consensus 195 l~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~--------~p~~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 195 MYEMMCGRLPFYNQDHER-------LFELILMEEIR--------FPRTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------CCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC--------CCCCCCHHHHHHHHHHhhcCHHHhc
Confidence 999999999996533221 11111111100 1123567889999999999999999
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=278.38 Aligned_cols=211 Identities=21% Similarity=0.289 Sum_probs=165.9
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|..+++++ +||||+++++++.++..+++||||+.+|+|.+++. ....+++..+..++.||+.||.|||
T Consensus 95 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH 170 (396)
T 4dc2_A 95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLH 170 (396)
T ss_dssp -CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999988 79999999999999999999999999999998883 3457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +|+||||||+|||++.++.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||+++
T Consensus 171 ~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvll 243 (396)
T 4dc2_A 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLM 243 (396)
T ss_dssp HT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHH
T ss_pred HC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHH
Confidence 99 999999999999999999999999999875322221 12334599999999999876 778999999999999
Q ss_pred HHHhcCCCCCCcccccccC-CcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSK-AYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+|++|+.||......... ................. .+..+++++.+|+.+||+.||++||++
T Consensus 244 yell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 244 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 9999999999654322211 11111111111111111 112356788999999999999999997
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=276.14 Aligned_cols=211 Identities=28% Similarity=0.435 Sum_probs=159.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++.+....++||||+.+|+|.+++.... ....+++..++.++.|++.||+|||
T Consensus 76 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH 154 (309)
T 3p86_A 76 ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH 154 (309)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999983211 1124899999999999999999999
Q ss_pred cCCCCc--eeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 87 NGCDVC--ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 87 ~~~~~~--i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+. + ++||||||+||+++.++.++|+|||++........ ......||+.|+|||.+.+. .++.++||||||+
T Consensus 155 ~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ 227 (309)
T 3p86_A 155 NR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGV 227 (309)
T ss_dssp TS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTC--CCCTTHHHHHHHH
T ss_pred cC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHH
Confidence 98 8 99999999999999999999999999874433221 12234589999999999876 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|+.||........ ........... ..+..+++.+.+++.+||+.||++|||++|
T Consensus 228 il~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 288 (309)
T 3p86_A 228 ILWELATLQQPWGNLNPAQV-------VAAVGFKCKRL------EIPRNLNPQVAAIIEGCWTNEPWKRPSFAT 288 (309)
T ss_dssp HHHHHHHCCCTTTTSCHHHH-------HHHHHHSCCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCCC------CCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999965432211 11110011111 111335678899999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=271.33 Aligned_cols=207 Identities=22% Similarity=0.285 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.+++.+|++++++++||||+++++++.+ +...++||||+.+++|.++. ....+++..+..++.|++.||.|||
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999976 56899999999999998865 3457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC-cccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-TVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~Di~slG~~ 165 (238)
+. +++||||||+||+++.++.++|+|||++........ ......||+.|+|||.+.+... ..+.++||||||++
T Consensus 155 ~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~ 229 (298)
T 2zv2_A 155 YQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229 (298)
T ss_dssp HT---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred HC---CeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence 99 999999999999999999999999999876544322 1233459999999999876421 24678999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||....... .. ........... . ...+++.+.+++.+||+.||++|||++|
T Consensus 230 l~~l~~g~~pf~~~~~~~-------~~-~~~~~~~~~~~-~----~~~~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 230 LYCFVFGQCPFMDERIMC-------LH-SKIKSQALEFP-D----QPDIAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp HHHHHHSSCSSCCSSHHH-------HH-HHHHHCCCCCC-S----SSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHHHCCCCCCCccHHH-------HH-HHHhcccCCCC-C----ccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence 999999999996432211 11 11111110000 0 1234677899999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=272.09 Aligned_cols=221 Identities=21% Similarity=0.241 Sum_probs=166.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++++.++...++||||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~ 137 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ 137 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999999999999999999999999975 88777732 34568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +|+||||||+||+++.++.++|+|||.+........ ......+|+.|+|||.+.+. ..++.++||||||+++|
T Consensus 138 ~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp T---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHH
T ss_pred C---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHH
Confidence 9 999999999999999999999999999976543221 12234589999999998763 35788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhh-------------hhhc--cCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVS-------------DQLN--KGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~-------------~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+|++|+.||...........+..... .... ................+++++.+|+.+||+.||++
T Consensus 212 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 212 EMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp HHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 99999999975443321111000000 0000 00001111112223345678899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 292 Rpt~~e 297 (311)
T 3niz_A 292 RISARD 297 (311)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=268.11 Aligned_cols=209 Identities=23% Similarity=0.342 Sum_probs=168.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++. ...+++..+..++.+++.||.||
T Consensus 83 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~L 157 (321)
T 2c30_A 83 QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYL 157 (321)
T ss_dssp CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHH
Confidence 4456889999999999999999999999999999999999999999999882 35689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||++........ ......||+.|+|||.+.+. .++.++||||||++
T Consensus 158 H~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~i 230 (321)
T 2c30_A 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIM 230 (321)
T ss_dssp HHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHH
T ss_pred HHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCC--CCCchhhHHHHHHH
Confidence 999 999999999999999999999999999875543321 12334599999999999775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||........ ...+.......... ...+++.+.+++.+||+.||++|||++|
T Consensus 231 l~el~~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 231 VIEMVDGEPPYFSDSPVQA--------MKRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp HHHHHHSSCTTTTSCHHHH--------HHHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhCCCCCCCCCHHHH--------HHHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999965432211 11111111111111 1235677899999999999999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=271.49 Aligned_cols=211 Identities=25% Similarity=0.326 Sum_probs=163.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.+++..++||||+.+++|.+++. ....+++..+..++.|++.||+||
T Consensus 52 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~l 127 (294)
T 4eqm_A 52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHA 127 (294)
T ss_dssp HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3445789999999999999999999999999999999999999999999982 345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||.+......... ......||+.|+|||.+.+. .++.++||||||++
T Consensus 128 H~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~ 201 (294)
T 4eqm_A 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIV 201 (294)
T ss_dssp HHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTC--CCCTTHHHHHHHHH
T ss_pred HHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHH
Confidence 999 9999999999999999999999999998755433211 12233589999999999876 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||........ ........ ...........+++.+.+++.+||+.||++||+.
T Consensus 202 l~~ll~g~~pf~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 202 LYEMLVGEPPFNGETAVSI-------AIKHIQDS---VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT 262 (294)
T ss_dssp HHHHHHSSCSSCSSCHHHH-------HHHHHSSC---CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred HHHHHhCCCCCCCCChHHH-------HHHHhhcc---CCCcchhcccCCCHHHHHHHHHHhcCCHhHcccc
Confidence 9999999999965432211 11111110 0111112223467789999999999999999953
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=270.55 Aligned_cols=214 Identities=23% Similarity=0.387 Sum_probs=170.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC--------------------CCCC
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES--------------------RGQS 65 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------------------~~~~ 65 (238)
....+++.+|++++++++||||+++++++.++...++||||+.+++|.+++..... ....
T Consensus 67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (314)
T 2ivs_A 67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146 (314)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence 34557889999999999999999999999999999999999999999999854332 1235
Q ss_pred CCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcce
Q 037755 66 CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 145 (238)
Q Consensus 66 ~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 145 (238)
+++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+|||.+................+++.|+|||.
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES 223 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence 89999999999999999999999 999999999999999999999999999876654433333333457888999999
Q ss_pred eecCCCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 146 ISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 146 ~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
+.+. .++.++||||||+++|+|++ |..||....... ............ .+..+++.+.+++.+
T Consensus 224 ~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~ 287 (314)
T 2ivs_A 224 LFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--------LFNLLKTGHRME------RPDNCSEEMYRLMLQ 287 (314)
T ss_dssp HHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCC------CCTTCCHHHHHHHHH
T ss_pred hcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHhhcCCcCC------CCccCCHHHHHHHHH
Confidence 9875 67889999999999999999 999986543221 111111111111 112356789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 288 ~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 288 CWKQEPDKRPVFAD 301 (314)
T ss_dssp HTCSSGGGSCCHHH
T ss_pred HccCChhhCcCHHH
Confidence 99999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=272.44 Aligned_cols=212 Identities=29% Similarity=0.468 Sum_probs=167.0
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+++.+|+.++++++||||+++++++.++...++||||+.+++|.+++.. ....++...+..++.+++.||.|
T Consensus 90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~ 166 (325)
T 3kul_A 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRY 166 (325)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999999999999999999832 33579999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||+. +|+||||||+||+++.++.++|+|||++.......... ......+|..|+|||.+.+. .++.++||||||
T Consensus 167 LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG 241 (325)
T 3kul_A 167 LSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFG 241 (325)
T ss_dssp HHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHH
T ss_pred HHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHH
Confidence 9999 99999999999999999999999999997654432211 12223367789999999875 778899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||+.|
T Consensus 242 ~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 303 (325)
T 3kul_A 242 VVMWEVLAYGERPYWNMTNRD--------VISSVEEGYRLP------APMGCPHALHQLMLDCWHKDRAQRPRFSQ 303 (325)
T ss_dssp HHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCCCC------CCCCcCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999998 999985433221 111111111111 11235678899999999999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=271.86 Aligned_cols=212 Identities=21% Similarity=0.282 Sum_probs=166.5
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|..+++++ +||||+++++++.+...+++||||+.+|+|.+++. ....+++..++.++.||+.||.||
T Consensus 51 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~L 126 (345)
T 3a8x_A 51 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYL 126 (345)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788999999998 89999999999999999999999999999999883 335799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +|+||||||+||+++.++.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||++
T Consensus 127 H~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 199 (345)
T 3a8x_A 127 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVL 199 (345)
T ss_dssp HHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHH
T ss_pred HHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHH
Confidence 999 999999999999999999999999999875332221 12334599999999999876 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccC-CcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSK-AYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|..||......... ................. .+..++..+.+++.+||+.||++|||+
T Consensus 200 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 200 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 99999999999643222111 01111111111111111 112356788999999999999999997
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=279.34 Aligned_cols=210 Identities=20% Similarity=0.304 Sum_probs=167.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.....+.+|+.++++++||||+++++++.++...++||||+.+|+|.+++. .....+++..+..++.||+.||.|||
T Consensus 90 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH 166 (387)
T 1kob_A 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH 166 (387)
T ss_dssp HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999883 23357999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEcc--CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDH--NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+. +|+||||||+||+++. ++.++|+|||++......... ....||+.|+|||++.+. .++.++||||||+
T Consensus 167 ~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~ 238 (387)
T 1kob_A 167 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGV 238 (387)
T ss_dssp HT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHH
T ss_pred hC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcce---eeeccCCCccCchhccCC--CCCCcccEeeHhH
Confidence 99 9999999999999974 567999999999765443221 223589999999999875 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||........ ............ ......+++++.+|+.+||+.||++|||++|
T Consensus 239 il~elltg~~Pf~~~~~~~~-------~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 301 (387)
T 1kob_A 239 LGYVLLSGLSPFAGEDDLET-------LQNVKRCDWEFD----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301 (387)
T ss_dssp HHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCCCC----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCCC----ccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999999975432211 111111100000 1111235678999999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=265.29 Aligned_cols=212 Identities=28% Similarity=0.509 Sum_probs=169.1
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+....+++.+|++++++++||||+++++++.++...++||||+.+++|.+++.. ....++...++.++.|++.|++
T Consensus 44 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ 120 (269)
T 4hcu_A 44 EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMA 120 (269)
T ss_dssp TTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHH
Confidence 3455678899999999999999999999999999999999999999999998832 3457899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. +++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++||||||
T Consensus 121 ~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 194 (269)
T 4hcu_A 121 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFG 194 (269)
T ss_dssp HHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHH
T ss_pred HHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCC--CCCchhhhHHHH
Confidence 99999 999999999999999999999999999875543221 112233467889999999875 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||....... ............. +..+++.+.+++.+||+.||++|||++|
T Consensus 195 ~~l~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (269)
T 4hcu_A 195 VLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYK------PRLASTHVYQIMNHCWRERPEDRPAFSR 256 (269)
T ss_dssp HHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhcCCCCCCCCCCHHH--------HHHHHhcCccCCC------CCcCCHHHHHHHHHHccCCcccCcCHHH
Confidence 99999999 899986533221 1111111111111 1224567899999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=264.62 Aligned_cols=212 Identities=25% Similarity=0.440 Sum_probs=169.3
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
......+++.+|++++++++||||+++++++.++...++||||+.+++|.+++.. .+..+++..++.++.|++.||+
T Consensus 42 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ 118 (268)
T 3sxs_A 42 EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMA 118 (268)
T ss_dssp BTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHH
Confidence 4455678899999999999999999999999999999999999999999998832 2356899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. +++||||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++||||||
T Consensus 119 ~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 192 (268)
T 3sxs_A 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFG 192 (268)
T ss_dssp HHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHH
T ss_pred HHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhcc--CCchhhhhHHHH
Confidence 99999 9999999999999999999999999998765443322 22233467789999999875 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||........ ............ +...++.+.+++.+||+.||++|||+.|
T Consensus 193 ~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ 254 (268)
T 3sxs_A 193 ILMWEVFSLGKMPYDLYTNSEV--------VLKVSQGHRLYR------PHLASDTIYQIMYSCWHELPEKRPTFQQ 254 (268)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCCCCC------CTTSCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHHcCCCCCccccChHHH--------HHHHHcCCCCCC------CCcChHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999998 9999864332211 111111111111 1123567889999999999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=285.69 Aligned_cols=213 Identities=21% Similarity=0.262 Sum_probs=171.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.+...+|+||||+.||+|.+++.........+++..+..++.||+.||.|||
T Consensus 227 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH 306 (543)
T 3c4z_A 227 KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306 (543)
T ss_dssp TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999999999999999999999999988554444567999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+||+++.+|.++|+|||++......... .....||+.|+|||++.+. .++.++|+|||||++
T Consensus 307 ~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvil 379 (543)
T 3c4z_A 307 QR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTL 379 (543)
T ss_dssp HT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHH
T ss_pred Hc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCC--CCChHHhcCcchHHH
Confidence 99 9999999999999999999999999999765433221 1233599999999999875 778999999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||......... ........... . ..+..+++.+.+|+.+||+.||++||++.
T Consensus 380 yelltG~~PF~~~~~~~~~---~~~~~~i~~~~-~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 380 YEMIAARGPFRARGEKVEN---KELKQRVLEQA-V-------TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp HHHHHSSCSSCCTTCCCCH---HHHHHHHHHCC-C-------CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred HHHHhCCCCCCCCccchhH---HHHHHHHhhcc-c-------CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 9999999999764322111 11111111111 0 01134577889999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=270.43 Aligned_cols=208 Identities=22% Similarity=0.288 Sum_probs=169.3
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.++...++|+||+.+++|.+++. ....+++..+..++.|++.||.|||+
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~ 133 (321)
T 2a2a_A 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT 133 (321)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 57889999999999999999999999999999999999999999999983 34678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCC----ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNF----VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
. +++||||||+||+++.++ .++|+|||.+........ .....|++.|+|||.+.+. .++.++||||||
T Consensus 134 ~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG 205 (321)
T 2a2a_A 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIG 205 (321)
T ss_dssp T---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHH
T ss_pred C---CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHH
Confidence 9 999999999999999887 799999999876544322 1233589999999998765 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ . ...... ...........+++.+.+++.+||+.||++|||++|
T Consensus 206 ~il~~l~~g~~pf~~~~~~~~-------~-~~i~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 269 (321)
T 2a2a_A 206 VITYILLSGASPFLGDTKQET-------L-ANITSV---SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269 (321)
T ss_dssp HHHHHHHHSCCSSCCSSHHHH-------H-HHHHTT---CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHH
T ss_pred HHHHHHHHCCCCCCCCCHHHH-------H-HHHHhc---ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999999965332211 1 111111 011112333456778999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=276.43 Aligned_cols=204 Identities=22% Similarity=0.249 Sum_probs=164.0
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|..+++.+ +||||+++++++.+...+++||||+.+|+|.+++. ....+++..++.++.||+.||.||
T Consensus 65 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L 140 (353)
T 3txo_A 65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFL 140 (353)
T ss_dssp TTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567788999999998 69999999999999999999999999999999882 346799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.++.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||++
T Consensus 141 H~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 213 (353)
T 3txo_A 141 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVL 213 (353)
T ss_dssp HHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHH
T ss_pred HHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHH
Confidence 999 999999999999999999999999999874332221 12334599999999999876 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|..||........ ....... ... .+..+++.+.+++.+||+.||++||++
T Consensus 214 l~ell~G~~Pf~~~~~~~~-------~~~i~~~-~~~-------~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 214 LYEMLCGHAPFEAENEDDL-------FEAILND-EVV-------YPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------HHHHHHC-CCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred HHHHHhCCCCCCCCCHHHH-------HHHHHcC-CCC-------CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 9999999999975433221 1111111 111 112256778999999999999999997
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=267.72 Aligned_cols=226 Identities=18% Similarity=0.242 Sum_probs=169.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC--eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+.+.+|++++++++||||+++++++.... ..++||||+.+++|.+++.... ....+++..++.++.|++.||+
T Consensus 48 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~ 126 (319)
T 4euu_A 48 LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMN 126 (319)
T ss_dssp GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHH
Confidence 345688899999999999999999999987655 7899999999999999984322 1234899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEE----ccCCccccccccccccCCCCCccccccccCCccccCCcceeecC------CCcc
Q 037755 84 YLHNGCDVCILHLDIKPHNILL----DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN------FGTV 153 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~ 153 (238)
|||+. +++||||||+||++ +.++.++|+|||.+......... ....|+..|+|||.+... ...+
T Consensus 127 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 200 (319)
T 4euu_A 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKY 200 (319)
T ss_dssp HHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCB
T ss_pred HHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCC
Confidence 99999 99999999999999 77788999999999765443322 233589999999987621 1367
Q ss_pred cccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhh--------ccCCC------ccccchhHHHHHHHHHHH
Q 037755 154 SCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQL--------NKGGN------LELRNVTEIESMIARKLC 219 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~------~~~~~~~~~~~~~~~~l~ 219 (238)
+.++||||||+++|+|++|..||...............+.... ..... ............++..+.
T Consensus 201 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 280 (319)
T 4euu_A 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT 280 (319)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhH
Confidence 8899999999999999999999964332221111100000000 00000 001111233467788899
Q ss_pred HHHhhhccCCCCCCCCCCC
Q 037755 220 VIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 220 ~li~~cl~~dp~~Rps~~e 238 (238)
+++.+||+.||++|||++|
T Consensus 281 ~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 281 PVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp HHHHHHSCCCTTTSCCHHH
T ss_pred HHHHHhccCChhhhccHHH
Confidence 9999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=273.43 Aligned_cols=205 Identities=20% Similarity=0.248 Sum_probs=167.0
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|..+++.+ +||||+++++++.+...+++||||+.+|+|.+++. ....+++..+..++.||+.||.||
T Consensus 59 ~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L 134 (345)
T 1xjd_A 59 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFL 134 (345)
T ss_dssp TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567788999999987 89999999999999999999999999999999883 335789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+||+++.+|.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||++
T Consensus 135 H~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 207 (345)
T 1xjd_A 135 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVL 207 (345)
T ss_dssp HHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHH
T ss_pred HHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHH
Confidence 999 999999999999999999999999999875432221 12334599999999999876 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+|+|++|..||........ ....... ... .+..+++++.+++.+||+.||++|||+.
T Consensus 208 l~ell~g~~Pf~~~~~~~~-------~~~i~~~-~~~-------~p~~~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 208 LYEMLIGQSPFHGQDEEEL-------FHSIRMD-NPF-------YPRWLEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------HHHHHHC-CCC-------CCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred HHHHhcCCCCCCCCCHHHH-------HHHHHhC-CCC-------CCcccCHHHHHHHHHHhcCCHhHcCCCh
Confidence 9999999999965432211 1111111 100 1123567889999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=274.65 Aligned_cols=214 Identities=23% Similarity=0.403 Sum_probs=170.7
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLH 72 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~ 72 (238)
....+++.+|+++++++ +||||+++++++.+++..++||||+.+|+|.+++..... ....+++..++
T Consensus 115 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 194 (382)
T 3tt0_A 115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence 34457889999999999 899999999999999999999999999999999854331 12469999999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++................++..|+|||.+.+. .
T Consensus 195 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~ 269 (382)
T 3tt0_A 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--I 269 (382)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--C
T ss_pred HHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--C
Confidence 9999999999999999 9999999999999999999999999999765443322223334578899999999875 6
Q ss_pred ccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
++.++||||||+++|+|++ |..||....... ....+........ +..+++++.+++.+||+.||+
T Consensus 270 ~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~ 335 (382)
T 3tt0_A 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPS 335 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCCCC------CSSCCHHHHHHHHHHTCSSGG
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC------CccCCHHHHHHHHHHcCCChh
Confidence 7889999999999999999 999986443221 1111211111111 123567889999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||+.|
T Consensus 336 ~Rps~~e 342 (382)
T 3tt0_A 336 QRPTFKQ 342 (382)
T ss_dssp GSCCHHH
T ss_pred hCcCHHH
Confidence 9999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=269.99 Aligned_cols=200 Identities=24% Similarity=0.310 Sum_probs=165.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+++.++||||+++++++.+...+++||||+.+|+|.+++. ....+++..+..++.+|+.||.|||
T Consensus 48 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH 123 (318)
T 1fot_A 48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLH 123 (318)
T ss_dssp TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788899999999999999999999999999999999999999999983 3467899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+||+++.+|.++|+|||++....... ....||+.|+|||.+.+. .++.++|+||||+++
T Consensus 124 ~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il 193 (318)
T 1fot_A 124 SK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILI 193 (318)
T ss_dssp TT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHH
T ss_pred HC---CccccCCChheEEEcCCCCEEEeecCcceecCCcc-----ccccCCccccCHhHhcCC--CCCcccchhhhHHHH
Confidence 99 99999999999999999999999999987543321 233589999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|+|++|..||....... ........... .+..+++++.+++.+||+.||++||+
T Consensus 194 ~ell~g~~pf~~~~~~~-------~~~~i~~~~~~--------~p~~~~~~~~~li~~lL~~dp~~R~~ 247 (318)
T 1fot_A 194 YEMLAGYTPFYDSNTMK-------TYEKILNAELR--------FPPFFNEDVKDLLSRLITRDLSQRLG 247 (318)
T ss_dssp HHHHHSSCTTCCSSHHH-------HHHHHHHCCCC--------CCTTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred HHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--------CCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 99999999996533221 11111111100 11235678899999999999999993
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=282.93 Aligned_cols=205 Identities=20% Similarity=0.341 Sum_probs=167.4
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++ .....+++..+..++.||+.||.|||+
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~ 134 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHR 134 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999999999999998 345679999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+ +|+||||||+||+++.++.++|+|||++........ .....||+.|+|||.+.+. ...+.++||||||+++|
T Consensus 135 ~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 135 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILY 207 (476)
T ss_dssp T---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHH
T ss_pred C---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHH
Confidence 9 999999999999999999999999999876544322 2234599999999999875 23467899999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||....... .... +...... .+..+++++.+|+.+||+.||++|||++|
T Consensus 208 elltG~~Pf~~~~~~~-------~~~~-i~~~~~~-------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~e 263 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPT-------LFKK-ICDGIFY-------TPQYLNPSVISLLKHMLQVDPMKRATIKD 263 (476)
T ss_dssp HHHHSSCSSCCSSSHH-------HHHH-HHTTCCC-------CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHhhCCCCCCCCCHHH-------HHHH-HhcCCcC-------CCccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9999999996543221 1111 1111111 01224567899999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=279.82 Aligned_cols=209 Identities=24% Similarity=0.426 Sum_probs=165.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|++++++++||||+++++++.++...++||||+.+|+|.+++.. .+..++...+..++.|++.||+|||+
T Consensus 155 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~ 231 (377)
T 3cbl_A 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES 231 (377)
T ss_dssp HHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 446788999999999999999999999999999999999999999998832 23468999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|
T Consensus 232 ~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~ 306 (377)
T 3cbl_A 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLW 306 (377)
T ss_dssp T---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHH
T ss_pred C---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHH
Confidence 9 9999999999999999999999999998754332211111222357789999998765 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||++|
T Consensus 307 el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 364 (377)
T 3cbl_A 307 ETFSLGASPYPNLSNQQ--------TREFVEKGGRLP------CPELCPDAVFRLMEQCWAYEPGQRPSFST 364 (377)
T ss_dssp HHHTTSCCSSTTSCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9998 999986543221 111122211111 11235677899999999999999999753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=272.51 Aligned_cols=213 Identities=26% Similarity=0.394 Sum_probs=167.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC--------------------CCCC
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR--------------------GQSC 66 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~--------------------~~~~ 66 (238)
...+++.+|+.++++++||||+++++++.++...++||||+.+++|.+++...... ...+
T Consensus 92 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (343)
T 1luf_A 92 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171 (343)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCC
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCC
Confidence 34678999999999999999999999999999999999999999999988543211 2678
Q ss_pred CHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCccee
Q 037755 67 SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 146 (238)
Q Consensus 67 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 146 (238)
++..++.++.||+.||.|||+. +++||||||+||+++.++.++|+|||.+................++..|+|||.+
T Consensus 172 ~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 9999999999999999999999 9999999999999999999999999998654333222222334578899999998
Q ss_pred ecCCCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhh
Q 037755 147 SRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 147 ~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 225 (238)
.+. .++.++||||||+++|+|++ |..||....... ............ .+..+++.+.+++.+|
T Consensus 249 ~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~ 312 (343)
T 1luf_A 249 FYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--------VIYYVRDGNILA------CPENCPLELYNLMRLC 312 (343)
T ss_dssp HHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHH
T ss_pred ccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCChHH--------HHHHHhCCCcCC------CCCCCCHHHHHHHHHH
Confidence 875 67889999999999999999 999986433221 111111111111 1123567889999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||++|||+.|
T Consensus 313 l~~~p~~Rps~~~ 325 (343)
T 1luf_A 313 WSKLPADRPSFCS 325 (343)
T ss_dssp TCSSGGGSCCHHH
T ss_pred cccCcccCCCHHH
Confidence 9999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=274.41 Aligned_cols=213 Identities=23% Similarity=0.266 Sum_probs=156.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++||||+++++++.+....++||||+.+|+|.+++. ..+.+++..+..++.|++.||+||
T Consensus 57 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~L 132 (361)
T 3uc3_A 57 AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYC 132 (361)
T ss_dssp TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3445778999999999999999999999999999999999999999999882 345799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCc--cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFV--PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|+. +|+||||||+||+++.++. ++|+|||++........ .....||+.|+|||.+.+. ...+.++||||||
T Consensus 133 H~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG 205 (361)
T 3uc3_A 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQ-EYDGKIADVWSCG 205 (361)
T ss_dssp HHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCS-SCCHHHHHHHHHH
T ss_pred HHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCC-CCCCCeeeeehhH
Confidence 999 9999999999999987665 99999999863322221 1233599999999998765 2334558999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|+.||........ +................ ...+++.+.+|+.+||+.||++|||++|
T Consensus 206 ~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~s~~~~~li~~~L~~dP~~Rps~~e 271 (361)
T 3uc3_A 206 VTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVKYSIPD------DIRISPECCHLISRIFVADPATRISIPE 271 (361)
T ss_dssp HHHHHHHHSSCSCC----CCC---HHHHHHHHHTTCCCCCT------TSCCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCCCCCCC------cCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999999975433221 11111111111111000 0124577889999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=263.92 Aligned_cols=209 Identities=16% Similarity=0.228 Sum_probs=168.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|++++++++||||+++++++.++...++||||+.+++|.+++. ....+++..+..++.+++.||.||
T Consensus 47 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~l 122 (277)
T 3f3z_A 47 VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYC 122 (277)
T ss_dssp CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999998883 345689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEE---ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|+. +++||||||+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+ .++.++|||||
T Consensus 123 H~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~sl 193 (277)
T 3f3z_A 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSA 193 (277)
T ss_dssp HHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHH
T ss_pred HHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhcc---cCCchhhehhH
Confidence 999 99999999999999 7888999999999875543322 233458999999999865 47889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||........ ........ ..........+++.+.+++.+||+.||++|||+.|
T Consensus 194 G~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~ 258 (277)
T 3f3z_A 194 GVMMYVLLCGYPPFSAPTDSEV--------MLKIREGT---FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQ 258 (277)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCC---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHCCCCCCCCCHHHH--------HHHHHhCC---CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999965332211 11111110 11111222346788999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=277.70 Aligned_cols=210 Identities=24% Similarity=0.285 Sum_probs=167.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++++.+....++||||+.+++|.+++.. ....+++..+..++.||+.||.|||
T Consensus 128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH 204 (373)
T 2x4f_A 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMH 204 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999888732 2356899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEE--ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 87 NGCDVCILHLDIKPHNILL--DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+. +|+||||||+|||+ +.++.++|+|||++......... ....||+.|+|||.+.+. .++.++||||||+
T Consensus 205 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ 276 (373)
T 2x4f_A 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGV 276 (373)
T ss_dssp HT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---CCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHH
T ss_pred HC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---ccccCCCcEeChhhccCC--CCCcHHhHHHHHH
Confidence 99 99999999999999 56778999999999765443321 233589999999998765 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||........ ............ ......+++++.+|+.+||+.||++|||++|
T Consensus 277 il~elltg~~pf~~~~~~~~-------~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e 339 (373)
T 2x4f_A 277 IAYMLLSGLSPFLGDNDAET-------LNNILACRWDLE----DEEFQDISEEAKEFISKLLIKEKSWRISASE 339 (373)
T ss_dssp HHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCCSC----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCCHHHH-------HHHHHhccCCCC----hhhhccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99999999999965432211 111111111100 1112335678999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=273.39 Aligned_cols=200 Identities=23% Similarity=0.235 Sum_probs=165.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.+++.++||||+++++++.++..+++||||+.+|+|.+++. ....+++..+..++.||+.||.|||
T Consensus 83 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH 158 (350)
T 1rdq_E 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLH 158 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999983 2356899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+||+++.++.++|+|||++....... ....||+.|+|||++.+. .++.++|+||||+++
T Consensus 159 ~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il 228 (350)
T 1rdq_E 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLI 228 (350)
T ss_dssp HT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHH
T ss_pred HC---CcccccCccceEEECCCCCEEEcccccceeccCCc-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhH
Confidence 99 99999999999999999999999999987553321 223489999999999876 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|+|++|..||........ . ..+...... .+..+++++.+++.+||+.||++||+
T Consensus 229 ~ell~g~~Pf~~~~~~~~-------~-~~i~~~~~~-------~p~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 229 YEMAAGYPPFFADQPIQI-------Y-EKIVSGKVR-------FPSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp HHHHHSSCSSCCSSHHHH-------H-HHHHHCCCC-------CCTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred hHHhhCCCCCCCCCHHHH-------H-HHHHcCCCC-------CCCCCCHHHHHHHHHHhhcCHHhccC
Confidence 999999999965432211 1 111111111 11235678899999999999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=270.42 Aligned_cols=210 Identities=22% Similarity=0.377 Sum_probs=164.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.++ ..+++++|+.+|+|.+++.. ....++...++.++.|++.||.||
T Consensus 58 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L 133 (327)
T 3poz_A 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL 133 (327)
T ss_dssp --CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35668899999999999999999999999875 47889999999999998843 245789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||++................+|..|+|||.+.+. .++.++||||||++
T Consensus 134 H~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~i 208 (327)
T 3poz_A 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVT 208 (327)
T ss_dssp HHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHH
T ss_pred hhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHH
Confidence 999 9999999999999999999999999998765444333323334478899999999876 77889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |..||....... ............. +..++..+.+++.+||+.||++|||+.|
T Consensus 209 l~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e 268 (327)
T 3poz_A 209 VWELMTFGSKPYDGIPASE--------ISSILEKGERLPQ------PPICTIDVYMIMVKCWMIDADSRPKFRE 268 (327)
T ss_dssp HHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCCCC------CTTBCHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred HHHHHhcCCCCccCCCHHH--------HHHHHHcCCCCCC------CccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 999999 999996543322 1111111111111 1224567889999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=260.28 Aligned_cols=212 Identities=26% Similarity=0.345 Sum_probs=167.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.+++..++|+||+.+++|.+++ .....++...+..++.|++.||.|||
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH 122 (276)
T 2yex_A 47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 122 (276)
T ss_dssp THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHH
Confidence 44688999999999999999999999999999999999999999999988 33467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++|+||+|+||+++.++.++|+|||.+................|+..|+|||.+.+. ...+.++||||||+++
T Consensus 123 ~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il 198 (276)
T 2yex_A 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVL 198 (276)
T ss_dssp HT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHH
T ss_pred hC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHH
Confidence 99 9999999999999999999999999998754332222222334589999999998764 2347789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ .+..+ ...... .. ....+++.+.+++.+||+.||++|||++|
T Consensus 199 ~~l~~g~~p~~~~~~~~~--~~~~~-----~~~~~~-~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2yex_A 199 TAMLAGELPWDQPSDSCQ--EYSDW-----KEKKTY-LN----PWKKIDSAPLALLHKILVENPSARITIPD 258 (276)
T ss_dssp HHHHHSSCCCSCSCTTSH--HHHHH-----HTTCTT-ST----TGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHhCCCCCCCCchHHH--HHHHh-----hhcccc-cC----chhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence 999999999965432211 01111 110000 00 11235677889999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=266.11 Aligned_cols=222 Identities=18% Similarity=0.212 Sum_probs=163.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++++.+++..++||||+.+ +|.+++.. ....++...+..++.|++.||+|||
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH 117 (288)
T 1ob3_A 42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH 117 (288)
T ss_dssp CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999999999999999999975 89888732 2357899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++||||||+||+++.++.++|+|||.+........ ......+|+.|+|||.+.+. ..++.++||||||+++
T Consensus 118 ~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 191 (288)
T 1ob3_A 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIF 191 (288)
T ss_dssp HT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHH
T ss_pred HC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCC-CCCCcHHHHHHHHHHH
Confidence 99 999999999999999999999999999875433211 11233589999999998753 3578899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhh-------hhhcc-------CCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVS-------DQLNK-------GGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
|+|++|..||...........+..... ..... ...............+++++.+|+.+||+.||++
T Consensus 192 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 271 (288)
T 1ob3_A 192 AEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271 (288)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCccc
Confidence 999999999965432211000000000 00000 0000001111122345678899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 272 Rpt~~e 277 (288)
T 1ob3_A 272 RITAKQ 277 (288)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 999854
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=271.46 Aligned_cols=215 Identities=24% Similarity=0.390 Sum_probs=167.2
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC-------------------CCC
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR-------------------GQS 65 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~-------------------~~~ 65 (238)
....+++.+|+.+++++ .||||+++++++...+..++||||+.+|+|.+++...... ...
T Consensus 89 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (344)
T 1rjb_A 89 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168 (344)
T ss_dssp ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccccccc
Confidence 34557899999999999 8999999999999999999999999999999998543211 134
Q ss_pred CCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcce
Q 037755 66 CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 145 (238)
Q Consensus 66 ~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 145 (238)
+++..++.++.||+.||.|||+. +++||||||+||+++.++.++|+|||.+................+++.|+|||.
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence 78999999999999999999999 999999999999999999999999999875543332222333447889999999
Q ss_pred eecCCCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 146 ISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 146 ~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
+.+. .++.++||||||+++|+|++ |..||....... .............. +..+++.+.+++.+
T Consensus 246 ~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~l~~li~~ 310 (344)
T 1rjb_A 246 LFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-------NFYKLIQNGFKMDQ------PFYATEEIYIIMQS 310 (344)
T ss_dssp HHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHTTCCCCC------CTTCCHHHHHHHHH
T ss_pred hccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH-------HHHHHHhcCCCCCC------CCCCCHHHHHHHHH
Confidence 8775 67889999999999999998 999986543221 11111111111111 12246788999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||+.|
T Consensus 311 ~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 311 CWAFDSRKRPSFPN 324 (344)
T ss_dssp HTCSSGGGSCCHHH
T ss_pred HcCCCchhCcCHHH
Confidence 99999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=272.92 Aligned_cols=214 Identities=27% Similarity=0.415 Sum_probs=166.7
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCC-eeeEEEEeCCCCChhhhccCCCCC----------------------
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS-KRALVYEFMPNGSLDRHIFPKESR---------------------- 62 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~---------------------- 62 (238)
...+++.+|+++++++ +||||+++++++.+.. ..++||||+.+|+|.+++......
T Consensus 67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (359)
T 3vhe_A 67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence 3456799999999999 7999999999987754 589999999999999998543321
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCc
Q 037755 63 ----------------------------------------GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHN 102 (238)
Q Consensus 63 ----------------------------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~n 102 (238)
...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~N 223 (359)
T 3vhe_A 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 223 (359)
T ss_dssp -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhh
Confidence 12289999999999999999999999 99999999999
Q ss_pred EEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhc-CCCCCCcccc
Q 037755 103 ILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKAT 181 (238)
Q Consensus 103 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~ 181 (238)
|+++.++.++|+|||++................+|..|+|||.+.+. .++.++||||||+++|+|++ |..||.....
T Consensus 224 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp EEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred EEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 99999999999999999765444333333344588899999999875 67889999999999999998 9999865432
Q ss_pred cccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.. .............. +..+++++.+++.+||+.||++|||++|
T Consensus 302 ~~-------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 302 DE-------EFCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp SH-------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hH-------HHHHHHHcCCCCCC------CCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 21 11111111111111 1224677899999999999999999854
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=263.84 Aligned_cols=222 Identities=18% Similarity=0.215 Sum_probs=163.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.++...++||||+.+ ++.+.+. .....+++..++.++.|++.||+|||
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH 118 (292)
T 3o0g_A 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCH 118 (292)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3457888999999999999999999999999999999999976 6655552 23467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +|+||||||+||+++.++.++|+|||.+........ ......+|+.|+|||.+.+. ..++.++||||||+++
T Consensus 119 ~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il 192 (292)
T 3o0g_A 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIF 192 (292)
T ss_dssp HT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHH
T ss_pred hC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHH
Confidence 99 999999999999999999999999999976543221 12334589999999998764 2478899999999999
Q ss_pred HHHhcCCCCCCccccccc-CCcchhhh-------hhhhcc---CCC----ccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 167 LEMTGGRRNSNLKATRSS-KAYFPSWV-------SDQLNK---GGN----LELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~-~~~~~~~~-------~~~~~~---~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
|+|++|..||........ ...+.... ...... ... ............+++.+.+|+.+||+.||+
T Consensus 193 ~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 272 (292)
T 3o0g_A 193 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272 (292)
T ss_dssp HHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChh
Confidence 999998888643221110 00000000 000000 000 000011112234567889999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 273 ~R~t~~e 279 (292)
T 3o0g_A 273 QRISAEE 279 (292)
T ss_dssp GSCCHHH
T ss_pred hCCCHHH
Confidence 9999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=268.52 Aligned_cols=225 Identities=22% Similarity=0.300 Sum_probs=166.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE--SRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|++++++++||||+++++++.+++..++||||+. ++|.+++.... .....++...+..++.||+.||.|
T Consensus 45 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~ 123 (317)
T 2pmi_A 45 GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123 (317)
T ss_dssp CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999999999999999999997 59988873321 223468999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +|+||||||+||+++.++.++|+|||.+........ ......+|+.|+|||.+.+. ..++.++||||||+
T Consensus 124 lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~ 197 (317)
T 2pmi_A 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGC 197 (317)
T ss_dssp HHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHH
T ss_pred HHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHH
Confidence 9999 999999999999999999999999999876543221 12234589999999998763 25688999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchh-----------hhhhhhccCCCcc---ccchh-----HHHHHHHHHHHHHHhhh
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPS-----------WVSDQLNKGGNLE---LRNVT-----EIESMIARKLCVIGLWC 225 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~l~~li~~c 225 (238)
++|+|++|+.||...........+.. ............. ..... .....++.++.+|+.+|
T Consensus 198 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 277 (317)
T 2pmi_A 198 ILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGL 277 (317)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHH
Confidence 99999999999975443211000000 0000000000000 00000 01113567899999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||++|||++|
T Consensus 278 L~~dP~~Rpt~~e 290 (317)
T 2pmi_A 278 LQLNPDMRLSAKQ 290 (317)
T ss_dssp SCSSGGGSCCHHH
T ss_pred CCCCcccCCCHHH
Confidence 9999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=274.21 Aligned_cols=213 Identities=20% Similarity=0.260 Sum_probs=158.4
Q ss_pred HHHHHHHHHHHhhc-CCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 9 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
...+.+|+.++.++ +||||+++++++.. +..+++||||+.+|+|.+++.. .....+++..+..++.||+.||.
T Consensus 98 ~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~ 175 (400)
T 1nxk_A 98 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQ 175 (400)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHH
Confidence 35678899998555 79999999999865 5678999999999999999843 22356999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEcc---CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|||+. +|+||||||+|||++. ++.+||+|||++........ .....||+.|+|||++.+. .++.++|||
T Consensus 176 ~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Diw 247 (400)
T 1nxk_A 176 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMW 247 (400)
T ss_dssp HHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCC--CSSSHHHHH
T ss_pred HHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCC--CCCCcccHH
Confidence 99999 9999999999999997 78899999999875543221 1234589999999999765 778899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++|+|++|..||...............+. ....... ......+++++.+|+.+||+.||++|||++|
T Consensus 248 slG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 318 (400)
T 1nxk_A 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 318 (400)
T ss_dssp HHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 999999999999999976543332211111111 1100000 0011235678999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=263.37 Aligned_cols=206 Identities=24% Similarity=0.360 Sum_probs=148.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++++.++...++++||+.+++|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~ 130 (278)
T 3cok_A 54 MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS 130 (278)
T ss_dssp CHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999999999999998832 23678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+. .++.++|+||||+++|
T Consensus 131 ~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ 203 (278)
T 3cok_A 131 H---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFY 203 (278)
T ss_dssp T---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--------------------------------CTHHHHHHHHHH
T ss_pred C---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHH
Confidence 9 9999999999999999999999999998755432211 1223489999999998875 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||............ ... .. ..+..++.++.+++.+||+.||++|||++|
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~~-------~~~----~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 259 (278)
T 3cok_A 204 TLLIGRPPFDTDTVKNTLNKV-------VLA----DY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSS 259 (278)
T ss_dssp HHHHSSCSSCCCSCC-----C-------CSS----CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHhCCCCCCChhHHHHHHHH-------hhc----cc----CCccccCHHHHHHHHHHcccCHhhCCCHHH
Confidence 999999999754432211110 000 00 011234667889999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=270.08 Aligned_cols=204 Identities=21% Similarity=0.227 Sum_probs=166.5
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|..+++.+ +||||+++++++.+...+|+||||+.+|+|.+++. ....+++..++.++.||+.||.||
T Consensus 62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L 137 (353)
T 2i0e_A 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFL 137 (353)
T ss_dssp TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567888999999998 79999999999999999999999999999999883 335789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+||+++.+|.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||++
T Consensus 138 H~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 210 (353)
T 2i0e_A 138 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVL 210 (353)
T ss_dssp HHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHH
T ss_pred HHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHH
Confidence 999 999999999999999999999999999875332221 12334599999999999875 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|..||....... ......... .. .+..+++++.+|+.+||+.||++||++
T Consensus 211 l~ell~G~~Pf~~~~~~~-------~~~~i~~~~-~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 211 LYEMLAGQAPFEGEDEDE-------LFQSIMEHN-VA-------YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HHHHHHSSCSSCCSSHHH-------HHHHHHHCC-CC-------CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred HHHHHcCCCCCCCCCHHH-------HHHHHHhCC-CC-------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 999999999996543221 111111111 10 112356789999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=268.68 Aligned_cols=221 Identities=19% Similarity=0.268 Sum_probs=164.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++++.++...++||||+.+++|.+++ .....++...+..++.+++.||+|||+
T Consensus 45 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH~ 120 (311)
T 4agu_A 45 IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCHK 120 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3577889999999999999999999999999999999999999998877 334678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+. ..++.++||||||+++|
T Consensus 121 ~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~ 194 (311)
T 4agu_A 121 H---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFA 194 (311)
T ss_dssp T---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHH
T ss_pred C---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHH
Confidence 9 9999999999999999999999999998765433221 1233589999999998763 35688999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhh-------hh-----h-hccCCCcc---ccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWV-------SD-----Q-LNKGGNLE---LRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~-------~~-----~-~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
+|++|..||...........+.... .. . ........ ..........+++.+.+|+.+||+.||+
T Consensus 195 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 274 (311)
T 4agu_A 195 ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT 274 (311)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChh
Confidence 9999999997554332111100000 00 0 00000000 0111111234677899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 275 ~Rpt~~e 281 (311)
T 4agu_A 275 ERLTCEQ 281 (311)
T ss_dssp TSCCHHH
T ss_pred hcCCHHH
Confidence 9999854
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=264.06 Aligned_cols=212 Identities=22% Similarity=0.338 Sum_probs=163.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|++++++++||||+++++++.+....++|+||+.+++|.+.+......+..+++..++.++.|++.||.||
T Consensus 61 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 140 (285)
T 3is5_A 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140 (285)
T ss_dssp CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999999999999999999999999988844333457899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEE---ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|+. +++||||||+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+ .++.++|||||
T Consensus 141 H~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~sl 211 (285)
T 3is5_A 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSA 211 (285)
T ss_dssp HHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT---CCCHHHHHHHH
T ss_pred HhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhcc---CCCcccCeehH
Confidence 999 99999999999999 4567899999999875443221 223458999999999864 56788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||........ ........... .. ....+++.+.+++.+||+.||++|||++|
T Consensus 212 G~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~-~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e 275 (285)
T 3is5_A 212 GVVMYFLLTGCLPFTGTSLEEV-------QQKATYKEPNY-AV----ECRPLTPQAVDLLKQMLTKDPERRPSAAQ 275 (285)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCC-CC------CCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHH-------HhhhccCCccc-cc----ccCcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999965432211 11111000000 00 00114567889999999999999999854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=270.40 Aligned_cols=214 Identities=24% Similarity=0.405 Sum_probs=169.5
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC--------------CCCCCCHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES--------------RGQSCSWEKL 71 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------------~~~~~~~~~~ 71 (238)
...+.+.+|+.+++++ +||||+++++++.+++..++||||+.+|+|.+++..... ....+++..+
T Consensus 68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 4568899999999999 899999999999999999999999999999998844321 1235899999
Q ss_pred HHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC
Q 037755 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 151 (238)
Q Consensus 72 ~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 151 (238)
+.++.|++.||.|||++ +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+.
T Consensus 148 ~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-- 222 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-- 222 (313)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--
T ss_pred HHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--
Confidence 99999999999999999 9999999999999999999999999998766554433223334477899999998775
Q ss_pred cccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCC
Q 037755 152 TVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 152 ~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
.++.++||||||+++|+|++ |..||........ ............. +..+++.+.+++.+||+.||
T Consensus 223 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp 289 (313)
T 1t46_A 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------FYKMIKEGFRMLS------PEHAPAEMYDIMKTCWDADP 289 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-------HHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSG
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-------HHHHhccCCCCCC------cccCCHHHHHHHHHHcCCCc
Confidence 67889999999999999998 9999865432211 1111111111110 12346788999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||++|
T Consensus 290 ~~Rps~~e 297 (313)
T 1t46_A 290 LKRPTFKQ 297 (313)
T ss_dssp GGSCCHHH
T ss_pred hhCcCHHH
Confidence 99999853
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=268.14 Aligned_cols=223 Identities=22% Similarity=0.267 Sum_probs=164.4
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....+++.+|+++++++ +||||+++++++.+++..++||||+.+++|.+++. ....+++..+..++.||+.||+|
T Consensus 51 ~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~ 126 (316)
T 2ac3_A 51 GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDF 126 (316)
T ss_dssp SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHH
Confidence 44578899999999995 79999999999999999999999999999999983 34578999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCc---cccccccccccCCCCCcc-----ccccccCCccccCCcceeecCC---Ccc
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFV---PNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNF---GTV 153 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~---~~~ 153 (238)
||++ +++||||||+||+++.++. ++|+|||++......... .......|++.|+|||.+.+.. ..+
T Consensus 127 lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 203 (316)
T 2ac3_A 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203 (316)
T ss_dssp HHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHH
T ss_pred HHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCC
Confidence 9999 9999999999999987765 899999998654322111 1112234899999999986520 146
Q ss_pred cccCceehHHHHHHHHhcCCCCCCcccccccCCcc----h---hhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhc
Q 037755 154 SCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF----P---SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 226 (238)
+.++||||||+++|+|++|..||............ + ............ .........+++.+.+|+.+||
T Consensus 204 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~li~~~L 280 (316)
T 2ac3_A 204 DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY---EFPDKDWAHISCAAKDLISKLL 280 (316)
T ss_dssp TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC---CCCHHHHTTSCHHHHHHHHHHS
T ss_pred CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc---ccCchhcccCCHHHHHHHHHHh
Confidence 78999999999999999999999765433211110 0 001111111110 1111122346778999999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||++|||++|
T Consensus 281 ~~dP~~Rps~~e 292 (316)
T 2ac3_A 281 VRDAKQRLSAAQ 292 (316)
T ss_dssp CSSTTTSCCHHH
T ss_pred hCChhhCCCHHH
Confidence 999999999854
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=273.36 Aligned_cols=219 Identities=22% Similarity=0.243 Sum_probs=164.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC-------------------------
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------------------------- 60 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------------------- 60 (238)
....+++.+|++++++++||||+++++++.++...++||||+.+|+|.+++....
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (345)
T 3hko_A 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148 (345)
T ss_dssp -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence 4556889999999999999999999999999999999999999999999883100
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCC--ccccccccccccCCCCCc
Q 037755 61 -----------SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF--VPNVSDFGLAKFHPKEND 127 (238)
Q Consensus 61 -----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~--~~~l~d~~~~~~~~~~~~ 127 (238)
.....+++..++.++.|++.||+|||+. +++||||||+||+++.++ .++|+|||.+........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~ 225 (345)
T 3hko_A 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225 (345)
T ss_dssp HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC
T ss_pred ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCc
Confidence 0022346778899999999999999999 999999999999998766 899999999875432211
Q ss_pred --cccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCcccc
Q 037755 128 --FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELR 205 (238)
Q Consensus 128 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (238)
........|++.|+|||.+.+....++.++||||||+++|+|++|+.||........ .............
T Consensus 226 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~- 297 (345)
T 3hko_A 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-------ISQVLNKKLCFEN- 297 (345)
T ss_dssp C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCTTS-
T ss_pred cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-------HHHHHhcccccCC-
Confidence 111233458999999999876434678899999999999999999999965432211 1111111111111
Q ss_pred chhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 206 NVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 206 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.....+++.+.+++.+||+.||++|||+.|
T Consensus 298 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 298 ---PNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp ---GGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 111235678899999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=275.91 Aligned_cols=214 Identities=24% Similarity=0.385 Sum_probs=166.4
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC---CCCCCCCHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE---SRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l 82 (238)
.....++.+|+.++++++||||+++++++.++...++||||+.+|+|.+++.... .....++...++.++.||+.||
T Consensus 115 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 194 (367)
T 3l9p_A 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHH
Confidence 4455678999999999999999999999999999999999999999999984432 2234689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCC---ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNF---VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
+|||+. +|+||||||+|||++.++ .++|+|||++................+|+.|+|||.+.+. .++.++||
T Consensus 195 ~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv 269 (367)
T 3l9p_A 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDT 269 (367)
T ss_dssp HHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHH
T ss_pred HHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHH
Confidence 999999 999999999999999554 5999999998643222211122233478899999998776 67889999
Q ss_pred ehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||+++|+|++ |..||....... ............. +..++..+.+|+.+||+.||++|||++|
T Consensus 270 wslG~il~ellt~g~~pf~~~~~~~--------~~~~i~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~e 335 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPSKSNQE--------VLEFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 335 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC------CccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 999999999998 999986543221 1111111111111 1234567889999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=274.50 Aligned_cols=209 Identities=19% Similarity=0.260 Sum_probs=153.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|++++++++||||+++++++.+....++||||+.+++|.+++ .....+++..+..++.|++.||.|||+
T Consensus 91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH~ 166 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLHE 166 (349)
T ss_dssp --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999988 334678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEcc---CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
. +++||||||+||+++. ++.++|+|||++........ .....||+.|+|||.+.+. .++.++||||||+
T Consensus 167 ~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ 238 (349)
T 2w4o_A 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGI 238 (349)
T ss_dssp T---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTC--CCCTHHHHHHHHH
T ss_pred C---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCC--CCCcccchHHHHH
Confidence 9 9999999999999975 88999999999875433221 1233589999999999875 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||........ ............ .......++.++.+|+.+||+.||++|||+.|
T Consensus 239 il~ell~g~~pf~~~~~~~~-------~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (349)
T 2w4o_A 239 ITYILLCGFEPFYDERGDQF-------MFRRILNCEYYF---ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302 (349)
T ss_dssp HHHHHHHSSCTTCCTTCHHH-------HHHHHHTTCCCC---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCcccHH-------HHHHHHhCCCcc---CCchhhhCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999964332210 111111111100 11112345678899999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=263.04 Aligned_cols=221 Identities=19% Similarity=0.251 Sum_probs=163.1
Q ss_pred ccHHHHHHHHHHHhh--cCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGR--IHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+.+|.+++.. ++||||+++++++.. ....++||||+.+|+|.+++ ....+++..+..++.|++.
T Consensus 42 ~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~ 116 (301)
T 3q4u_A 42 RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIAS 116 (301)
T ss_dssp GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHH
T ss_pred ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHH-----hhcccCHHHHHHHHHHHHH
Confidence 345666777777777 789999999998643 34689999999999999998 2357999999999999999
Q ss_pred HHHHhH--------cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCC
Q 037755 81 GIEYLH--------NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNF 150 (238)
Q Consensus 81 ~l~~Lh--------~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 150 (238)
||+||| +. +++||||||+||+++.++.++|+|||++.......... ......||+.|+|||.+.+..
T Consensus 117 ~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (301)
T 3q4u_A 117 GLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193 (301)
T ss_dssp HHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCC
T ss_pred HHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcC
Confidence 999999 87 99999999999999999999999999986544332221 112235999999999987642
Q ss_pred C----cccccCceehHHHHHHHHhcC----------CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHH
Q 037755 151 G----TVSCKSDVYGFGMVLLEMTGG----------RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIAR 216 (238)
Q Consensus 151 ~----~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (238)
. .++.++||||||+++|+|++| ..||......... ... ......................+++
T Consensus 194 ~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (301)
T 3q4u_A 194 QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS--FED-MRKVVCVDQQRPNIPNRWFSDPTLT 270 (301)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHH-HHHHHTTSCCCCCCCGGGGGSHHHH
T ss_pred CCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc--hhh-hhHHHhccCCCCCCChhhccCccHH
Confidence 2 345789999999999999999 6666433222111 111 1111111111111122223345778
Q ss_pred HHHHHHhhhccCCCCCCCCCCC
Q 037755 217 KLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 217 ~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+.+++.+||+.||++|||++|
T Consensus 271 ~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 271 SLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHH
Confidence 8999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=263.71 Aligned_cols=212 Identities=25% Similarity=0.433 Sum_probs=168.8
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
......+++.+|++++++++||||+++++++.++...++||||+.+++|.+++.. ....+++..+..++.|++.||.
T Consensus 58 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~ 134 (283)
T 3gen_A 58 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAME 134 (283)
T ss_dssp TTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999999999999999999999999832 2356999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. +++||||||+||+++.++.++|+|||.+........ .......+++.|+|||.+.+. .++.++||||||
T Consensus 135 ~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG 208 (283)
T 3gen_A 135 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFG 208 (283)
T ss_dssp HHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHH
T ss_pred HHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccC--CCCchhhHHHHH
Confidence 99999 999999999999999999999999999875543221 112233467889999999876 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||........ ............ +..+++.+.+++.+||+.||++|||++|
T Consensus 209 ~~l~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ 270 (283)
T 3gen_A 209 VLMWEIYSLGKMPYERFTNSET--------AEHIAQGLRLYR------PHLASEKVYTIMYSCWHEKADERPTFKI 270 (283)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCccccChhHH--------HHHHhcccCCCC------CCcCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999998 9999865332211 111111111111 1123567889999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=276.56 Aligned_cols=163 Identities=21% Similarity=0.332 Sum_probs=133.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
....+++.+|+++|++++||||+++++++... ...|+||||+. ++|.+++ .....+++..+..++.||+.
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qil~ 140 (432)
T 3n9x_A 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF----KTPIFLTEEHIKTILYNLLL 140 (432)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHH----HSSCCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHH----hccCCCCHHHHHHHHHHHHH
Confidence 34567899999999999999999999999765 57999999986 5999988 33467999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc--------------------ccccccCCcccc
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--------------------VSISATRGTIGY 140 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------------~~~~~~~~~~~~ 140 (238)
||+|||+. +|+||||||+|||++.++.++|+|||+++........ .......||+.|
T Consensus 141 aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 217 (432)
T 3n9x_A 141 GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217 (432)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTT
T ss_pred HHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccc
Confidence 99999999 9999999999999999999999999999765443211 011334589999
Q ss_pred CCcceeecCCCcccccCceehHHHHHHHHhcCCCCCC
Q 037755 141 IAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSN 177 (238)
Q Consensus 141 ~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 177 (238)
+|||++... ..++.++|||||||++|+|++|..||.
T Consensus 218 ~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 218 RAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence 999986443 367889999999999999998665554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=266.93 Aligned_cols=220 Identities=25% Similarity=0.393 Sum_probs=163.6
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
+....+++.+|++++++++||||+++++++.. ....++||||+.+++|.+++.. ....++...+..++.|++.||
T Consensus 51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l 127 (295)
T 3ugc_A 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 127 (295)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHH
Confidence 34455789999999999999999999999854 4568999999999999999832 234689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceeh
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+|||+. +++||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+. .++.++||||
T Consensus 128 ~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s 202 (295)
T 3ugc_A 128 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWS 202 (295)
T ss_dssp HHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC--CCCHHHHHHH
T ss_pred HHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHH
Confidence 999999 99999999999999999999999999997654433221 12223477789999999876 6788999999
Q ss_pred HHHHHHHHhcCCCCCCccccccc-----CCc---chhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSS-----KAY---FPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~-----~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
||+++|+|++|..|+........ ... ................ .+..+++++.+++.+||+.||++|
T Consensus 203 lG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~R 276 (295)
T 3ugc_A 203 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQR 276 (295)
T ss_dssp HHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC------CCcCcCHHHHHHHHHHcCCChhhC
Confidence 99999999999998865432210 000 0001111111111111 122456789999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||++|
T Consensus 277 ps~~e 281 (295)
T 3ugc_A 277 PSFRD 281 (295)
T ss_dssp CCHHH
T ss_pred CCHHH
Confidence 99854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=271.14 Aligned_cols=199 Identities=22% Similarity=0.278 Sum_probs=163.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNG-SLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+.++++++||||+++++++.+....++|+||+.+| +|.+++ .....+++..+..++.|++.||.|||
T Consensus 72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH 147 (335)
T 3dls_A 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLR 147 (335)
T ss_dssp TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHH----HTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999999999999998766 999888 34457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||.+......... ....||+.|+|||.+.+. ...+.++||||||+++
T Consensus 148 ~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il 220 (335)
T 3dls_A 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTL 220 (335)
T ss_dssp HT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHH
T ss_pred hC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCce---eccCCCccccChhhhcCC-CCCCCcccchhHHHHH
Confidence 99 9999999999999999999999999999765443322 223489999999998775 2337789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||.......... . .. +..+++++.+|+.+||+.||++|||++|
T Consensus 221 ~el~~g~~pf~~~~~~~~~~-------------~-~~-------~~~~~~~l~~li~~~L~~dP~~Rps~~e 271 (335)
T 3dls_A 221 YTLVFEENPFCELEETVEAA-------------I-HP-------PYLVSKELMSLVSGLLQPVPERRTTLEK 271 (335)
T ss_dssp HHHHHSSCSCSSGGGGTTTC-------------C-CC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhCCCchhhHHHHHhhc-------------c-CC-------CcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999996422111100 0 00 0114667899999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=270.08 Aligned_cols=205 Identities=20% Similarity=0.266 Sum_probs=156.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++. ....+++..+..++.||+.||.|||
T Consensus 63 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH 138 (327)
T 3a62_A 63 KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLH 138 (327)
T ss_dssp --------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999883 3457889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +|+||||||+||+++.++.++|+|||++........ ......||+.|+|||.+.+. .++.++||||||+++
T Consensus 139 ~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il 211 (327)
T 3a62_A 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALM 211 (327)
T ss_dssp HT---TCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHH
T ss_pred hC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHH
Confidence 99 999999999999999999999999999864332221 12234589999999999775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||........ .......... .+..+++.+.+++.+||+.||++||++.
T Consensus 212 ~el~~g~~pf~~~~~~~~-------~~~i~~~~~~--------~p~~~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 212 YDMLTGAPPFTGENRKKT-------IDKILKCKLN--------LPPYLTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp HHHHHSSCSCCCSSHHHH-------HHHHHHTCCC--------CCTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred HHHHHCCCCCCCCCHHHH-------HHHHHhCCCC--------CCCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence 999999999965432211 1111111100 1123567889999999999999999653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.21 Aligned_cols=214 Identities=29% Similarity=0.423 Sum_probs=171.0
Q ss_pred CcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
..+....++|.+|+.++++++||||+++++++.++...++||||+.+|+|.+++... ....++...+..++.||+.||
T Consensus 254 ~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L 331 (495)
T 1opk_A 254 KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAM 331 (495)
T ss_dssp CSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHH
T ss_pred cCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHH
Confidence 344556889999999999999999999999999999999999999999999998432 245689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+|||++ +|+||||||+|||++.++.+||+|||++........ .......++..|+|||.+... .++.++|||||
T Consensus 332 ~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSl 405 (495)
T 1opk_A 332 EYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAF 405 (495)
T ss_dssp HHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHH
T ss_pred HHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcC--CCCcHHhHHhH
Confidence 999999 999999999999999999999999999976543221 112233467889999998775 67889999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++ |..||....... +...+....... .+..+++.+.+|+.+||+.||++|||+.|
T Consensus 406 G~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~e 468 (495)
T 1opk_A 406 GVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRME------RPEGCPEKVYELMRACWQWNPSDRPSFAE 468 (495)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 999999999 888986543221 111111111111 11235678899999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=269.24 Aligned_cols=222 Identities=22% Similarity=0.312 Sum_probs=165.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.++...++||||+.+++|.++. .....+++..+..++.+++.||.|||
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH 141 (331)
T 4aaa_A 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCH 141 (331)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999998888876 23457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. ..++.++||||||+++
T Consensus 142 ~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il 215 (331)
T 4aaa_A 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLV 215 (331)
T ss_dssp HT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHH
T ss_pred HC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHH
Confidence 99 999999999999999999999999999875443221 12334589999999998764 3568889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcc--------hhhh----hh-hhcc---CCCccccchhHHHHHHHHHHHHHHhhhccCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYF--------PSWV----SD-QLNK---GGNLELRNVTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~--------~~~~----~~-~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
|+|++|+.||...........+ +... .. .... ...............+++.+.+|+.+||+.||
T Consensus 216 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 295 (331)
T 4aaa_A 216 TEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDP 295 (331)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCc
Confidence 9999999999765432211100 0000 00 0000 00011111122223467889999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||++|
T Consensus 296 ~~Rpt~~e 303 (331)
T 4aaa_A 296 DKRPFCAE 303 (331)
T ss_dssp GGSCCGGG
T ss_pred ccCCCHHH
Confidence 99999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=273.16 Aligned_cols=211 Identities=27% Similarity=0.443 Sum_probs=157.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.++...++||||+++|+|.+++. ..+..+++..+..++.+|+.||+||
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~L 163 (373)
T 2qol_A 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999999983 2345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +|+||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++||||||+
T Consensus 164 H~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~ 238 (373)
T 2qol_A 164 SDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGI 238 (373)
T ss_dssp HHT---TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHC--CCCHHHHHHHHHH
T ss_pred HHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHH
Confidence 999 9999999999999999999999999998755433211 111122356789999999875 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|++++ |+.||....... ............ ....++..+.+++.+||+.||++|||+.|
T Consensus 239 il~ellt~g~~P~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~~ 299 (373)
T 2qol_A 239 VLWEVMSYGERPYWEMSNQD--------VIKAVDEGYRLP------PPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299 (373)
T ss_dssp HHHHHHTTC-CTTTTCCHHH--------HHHHHHTTEECC------CCTTCBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCccccHHHHHHHHHHhCcChhhCcCHHH
Confidence 9999997 999986433221 111111111000 11235677899999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=264.52 Aligned_cols=209 Identities=21% Similarity=0.269 Sum_probs=165.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.++++++||||+++++++.++...++++||+.+++|.+.+. ....+++..+..++.+++.||.|||
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH 122 (284)
T 3kk8_A 47 RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCH 122 (284)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345778899999999999999999999999999999999999999988873 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCc---cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFV---PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
+. +++||||||+||+++.++. ++|+|||.+........ .....|++.|+|||.+.+. .++.++||||||
T Consensus 123 ~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 194 (284)
T 3kk8_A 123 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACG 194 (284)
T ss_dssp HT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHH
T ss_pred HC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHH
Confidence 99 9999999999999986655 99999999875544322 1234589999999999875 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ............ ......+++.+.+++.+||+.||++|||++|
T Consensus 195 ~~l~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (284)
T 3kk8_A 195 VILYILLVGYPPFWDEDQHRL--------YAQIKAGAYDYP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 258 (284)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH--------HHHHHHTCCCCC---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHCCCCCCCCchhHH--------HHHHHhccccCC---chhhcccCHHHHHHHHHHcccChhhCCCHHH
Confidence 999999999999965332211 111111100000 0111235677899999999999999999854
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=266.41 Aligned_cols=213 Identities=22% Similarity=0.372 Sum_probs=157.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCee------eEEEEeCCCCChhhhccCCC--CCCCCCCHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR------ALVYEFMPNGSLDRHIFPKE--SRGQSCSWEKLHEVASG 77 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~------~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~~ 77 (238)
....+++.+|++++++++||||+++++++...... ++++||+.+|+|.+++.... .....+++..++.++.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q 145 (323)
T 3qup_A 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145 (323)
T ss_dssp CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence 34568899999999999999999999999776654 99999999999999884322 22336899999999999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccC
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
++.||+|||+. +++||||||+||+++.++.++|+|||.+................+++.|+|||.+.+. .++.++
T Consensus 146 i~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~ 220 (323)
T 3qup_A 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHS 220 (323)
T ss_dssp HHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHC--CCCHHH
T ss_pred HHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCC--CCCCcc
Confidence 99999999999 9999999999999999999999999998765443332223334477899999999876 678899
Q ss_pred ceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 158 DVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 158 Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
||||||+++|+|++ |..||........ . .......... ....+++.+.+++.+||+.||++|||+
T Consensus 221 Di~slG~il~ell~~g~~p~~~~~~~~~-------~-~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~ 286 (323)
T 3qup_A 221 DVWAFGVTMWEIMTRGQTPYAGIENAEI-------Y-NYLIGGNRLK------QPPECMEEVYDLMYQCWSADPKQRPSF 286 (323)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCGGGH-------H-HHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred chhhHHHHHHHHHhCCCCCccccChHHH-------H-HHHhcCCCCC------CCCccCHHHHHHHHHHccCChhhCcCH
Confidence 99999999999999 8999865433211 1 1111111111 112345778999999999999999996
Q ss_pred C
Q 037755 237 T 237 (238)
Q Consensus 237 ~ 237 (238)
.
T Consensus 287 ~ 287 (323)
T 3qup_A 287 T 287 (323)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=272.87 Aligned_cols=211 Identities=20% Similarity=0.302 Sum_probs=159.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe----eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK----RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
...+++.+|+.++++++||||+++++++..... .++||||+.+++|.+++. ....+++..++.++.|++.||
T Consensus 54 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l 129 (311)
T 3ork_A 54 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQAL 129 (311)
T ss_dssp HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999866543 499999999999999983 345789999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+|||+. +++||||||+||+++.++.++|+|||.+......... .......|++.|+|||.+.+. .++.++||||
T Consensus 130 ~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s 204 (311)
T 3ork_A 130 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYS 204 (311)
T ss_dssp HHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTC--CCCHHHHHHH
T ss_pred HHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHH
Confidence 999999 9999999999999999999999999998755443221 112233489999999999876 6788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
||+++|+|++|+.||........ ........ ..........+++++.+++.+||+.||++||++.
T Consensus 205 lG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~ 269 (311)
T 3ork_A 205 LGCVLYEVLTGEPPFTGDSPVSV-------AYQHVRED----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269 (311)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCC----CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred HHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCC----CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhH
Confidence 99999999999999965432211 11111111 1111122234677899999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=265.49 Aligned_cols=212 Identities=19% Similarity=0.298 Sum_probs=163.0
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC----------------------------------------------
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS---------------------------------------------- 38 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---------------------------------------------- 38 (238)
.....+.+.+|++++++++||||+++++++.+..
T Consensus 44 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 123 (332)
T 3qd2_B 44 RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123 (332)
T ss_dssp TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------------------------
T ss_pred chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccc
Confidence 3446788999999999999999999999885543
Q ss_pred -----------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEcc
Q 037755 39 -----------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH 107 (238)
Q Consensus 39 -----------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~ 107 (238)
..+++|||+.+++|.+++.... .....+...++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 124 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 199 (332)
T 3qd2_B 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTM 199 (332)
T ss_dssp --------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred cccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeC
Confidence 3799999999999999984332 234556677899999999999999999 9999999999999999
Q ss_pred CCccccccccccccCCCCCcc----------ccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCC
Q 037755 108 NFVPNVSDFGLAKFHPKENDF----------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSN 177 (238)
Q Consensus 108 ~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~ 177 (238)
++.++|+|||++......... .......||+.|+|||.+.+. .++.++||||||+++|+|++|..|+.
T Consensus 200 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 200 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp TCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999998765543211 112234599999999999876 67889999999999999999876542
Q ss_pred cccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 178 LKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.... ....... ...+......++.+.+++.+||+.||++|||++|
T Consensus 278 ~~~~----------~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 278 ERVR----------IITDVRN------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp HHHH----------HHHHHHT------TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred HHHH----------HHHHhhc------cCCCcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 1100 0000111 1122334556778899999999999999999854
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=265.18 Aligned_cols=215 Identities=17% Similarity=0.191 Sum_probs=167.4
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|+.+++++ +|+|++++++++.++...++|+||+ +++|.+++.. .+..++...+..++.|++.||+|||
T Consensus 48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH 123 (298)
T 1csn_A 48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH 123 (298)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH
Confidence 445688999999999 7999999999999999999999999 8999999832 2356999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCc-----cccccccccccCCCCCcc-----ccccccCCccccCCcceeecCCCccccc
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFV-----PNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~-----~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
+. +++||||||+||+++.++. ++|+|||.+......... .......||+.|+|||.+.+. .++.+
T Consensus 124 ~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~ 198 (298)
T 1csn_A 124 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRR 198 (298)
T ss_dssp TT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHH
T ss_pred hC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC--CCChH
Confidence 99 9999999999999987765 999999998765443221 112334599999999998775 67889
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+||||||+++|+|++|+.||...........+........ ..........+++.+.+++.+||+.||++|||+
T Consensus 199 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~ 271 (298)
T 1csn_A 199 DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-------STPLRELCAGFPEEFYKYMHYARNLAFDATPDY 271 (298)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCH
Confidence 9999999999999999999976432221111111100000 011122223467889999999999999999997
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
+|
T Consensus 272 ~~ 273 (298)
T 1csn_A 272 DY 273 (298)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=262.31 Aligned_cols=208 Identities=21% Similarity=0.302 Sum_probs=166.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.++...++|+||+.+++|.+++. ....++...+..++.|++.||.|||+
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~ 126 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHS 126 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 57899999999999999999999999999999999999999999999883 34578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCC----ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNF----VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
. +++||||||+||+++.++ .++|+|||.+........ .....+++.|+|||.+.+. .++.++|+||||
T Consensus 127 ~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 198 (283)
T 3bhy_A 127 K---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIG 198 (283)
T ss_dssp T---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHH
T ss_pred C---CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHH
Confidence 9 999999999999998776 799999999875543322 1233489999999998765 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ....... ...........+++.+.+++.+||+.||++|||++|
T Consensus 199 ~il~~l~~g~~p~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 262 (283)
T 3bhy_A 199 VITYILLSGASPFLGETKQET--------LTNISAV---NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262 (283)
T ss_dssp HHHHHHHHSSCTTCCSSHHHH--------HHHHHTT---CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCCCCCcchHHH--------HHHhHhc---ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999999999965432211 1111110 011112333456778999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=265.90 Aligned_cols=218 Identities=27% Similarity=0.482 Sum_probs=156.2
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+.+.+|+.++++++||||++++++. .....++|+||+.+++|.+++. .....++...+..++.|++.||.|
T Consensus 60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~ 135 (289)
T 3og7_A 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDY 135 (289)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999965 4567899999999999999883 234678999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG 163 (238)
||+. +++||||||+||+++.++.++|+|||.+................|++.|+|||.+... ...++.++||||||
T Consensus 136 lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 212 (289)
T 3og7_A 136 LHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212 (289)
T ss_dssp HHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHH
T ss_pred HHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHH
Confidence 9999 9999999999999999999999999998755433222222334589999999998632 12567789999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ............ ........+++.+.+++.+||+.||++|||++|
T Consensus 213 ~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 278 (289)
T 3og7_A 213 IVLYELMTGQLPYSNINNRDQ-------IIEMVGRGSLSP--DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR 278 (289)
T ss_dssp HHHHHHHHSSCTTSSCCCHHH-------HHHHHHHTSCCC--CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCCccccchHHH-------HHHHhcccccCc--chhhccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999999999999965332211 111111111100 011112345678999999999999999999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=267.18 Aligned_cols=211 Identities=23% Similarity=0.367 Sum_probs=161.3
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+++.+|+.++++++||||+++++++..+. .+++++++.+|+|.+++.. ....++...++.++.|++.||.|
T Consensus 57 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~ 132 (327)
T 3lzb_A 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 132 (327)
T ss_dssp SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999998754 7889999999999998832 24578999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++||||||+||+++.++.++|+|||++................++..|+|||.+.+. .++.++||||||+
T Consensus 133 LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~ 207 (327)
T 3lzb_A 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGV 207 (327)
T ss_dssp HHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHH
T ss_pred HhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHH
Confidence 9999 9999999999999999999999999999765444333333334478899999999876 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |..||........ ............ +..++.++.+++.+||+.||++|||+.|
T Consensus 208 il~ell~~g~~p~~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~e 268 (327)
T 3lzb_A 208 TVWELMTFGSKPYDGIPASEI--------SSILEKGERLPQ------PPICTIDVYMIMRKCWMIDADSRPKFRE 268 (327)
T ss_dssp HHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHCCCCCCCCCCHHHH--------HHHHHcCCCCCC------CccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999 9999965433221 111111111111 1224567899999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=261.97 Aligned_cols=219 Identities=22% Similarity=0.329 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHhhcC---CCcceeeeeEEEeCC-----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIH---HVNVVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+|+.++++++ ||||+++++++.... ..++++||+. ++|.+++.. .....+++..++.++.|++.
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~ 131 (308)
T 3g33_A 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLR 131 (308)
T ss_dssp CHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHH
Confidence 456778888888775 999999999997755 5899999996 599998833 22345999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||+. +++||||||+||+++.++.++|+|||.+......... ....+|+.|+|||.+.+. .++.++|||
T Consensus 132 al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~Diw 203 (308)
T 3g33_A 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQS--TYATPVDMW 203 (308)
T ss_dssp HHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTS--CCCSTHHHH
T ss_pred HHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCC--CCCchHHHH
Confidence 99999999 9999999999999999999999999998755433221 233589999999999876 678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhh----hhhc--------cCCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVS----DQLN--------KGGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
|||+++|+|++|..||...........+..... ..+. ................+++.+.+|+.+||+.
T Consensus 204 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 283 (308)
T 3g33_A 204 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF 283 (308)
T ss_dssp HHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence 999999999999999965443321111000000 0000 0000011112223345678899999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||++|
T Consensus 284 dP~~R~t~~e 293 (308)
T 3g33_A 284 NPHKRISAFR 293 (308)
T ss_dssp STTTSCCHHH
T ss_pred CCccCCCHHH
Confidence 9999999854
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=272.48 Aligned_cols=206 Identities=24% Similarity=0.316 Sum_probs=163.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++.++...++||||+. |+|.+.+.. ....+++..+..++.+++.||.|||
T Consensus 96 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH 171 (348)
T 1u5q_A 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH 171 (348)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999997 588777632 2467899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~ 165 (238)
++ +++||||||+||+++.++.++|+|||++...... ....||+.|+|||.+.+. ...++.++||||||++
T Consensus 172 ~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 242 (348)
T 1u5q_A 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242 (348)
T ss_dssp HT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHH
T ss_pred hC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHH
Confidence 99 9999999999999999999999999998755332 223589999999998531 1357889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||........ ....... ...... ...+++.+.+|+.+||+.||++|||++|
T Consensus 243 l~ell~g~~p~~~~~~~~~-------~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ 302 (348)
T 1u5q_A 243 CIELAERKPPLFNMNAMSA-------LYHIAQN-ESPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEV 302 (348)
T ss_dssp HHHHHHSSCTTTTSCHHHH-------HHHHHHS-CCCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhCCCCCCCCChHHH-------HHHHHhc-CCCCCC-----CCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 9999999999865432211 1111111 111111 1234567889999999999999999753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=269.95 Aligned_cols=208 Identities=25% Similarity=0.414 Sum_probs=163.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++++.+ ...++|+||+.+|+|.+++.. ....+++..+..++.|++.||+|||+
T Consensus 58 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~ 133 (325)
T 3kex_A 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE 133 (325)
T ss_dssp CBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999864 578999999999999998832 23578899999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|
T Consensus 134 ~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ 208 (325)
T 3kex_A 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVW 208 (325)
T ss_dssp T---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHH
T ss_pred C---CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHH
Confidence 9 9999999999999999999999999999876554433333344578899999999876 6788999999999999
Q ss_pred HHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++ |..||....... ............. +..++..+.+++.+||+.||++|||+.|
T Consensus 209 el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (325)
T 3kex_A 209 ELMTFGAEPYAGLRLAE--------VPDLLEKGERLAQ------PQICTIDVYMVMVKCWMIDENIRPTFKE 266 (325)
T ss_dssp HHHTTSCCTTTTSCTTH--------HHHHHHTTCBCCC------CTTBCTTTTHHHHHHTCSCTTTSCCHHH
T ss_pred HHHhCCCCCccccCHHH--------HHHHHHcCCCCCC------CCcCcHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999 999996543221 1111111111111 1124556888999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=261.75 Aligned_cols=209 Identities=23% Similarity=0.362 Sum_probs=155.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++. ++..++||||+.+++|.+++.. ....+++..+..++.|++.||.||
T Consensus 57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l 132 (281)
T 1mp8_A 57 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYL 132 (281)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999985 4678999999999999999832 234789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||.+......... ......+++.|+|||.+.+. .++.++||||||++
T Consensus 133 H~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~ 206 (281)
T 1mp8_A 133 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVC 206 (281)
T ss_dssp HHT---TCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHH
T ss_pred HhC---CeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHH
Confidence 999 9999999999999999999999999998755433211 11223467889999999765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |..||........ ........... .+..+++.+.+++.+||+.||++|||+.|
T Consensus 207 l~ell~~g~~pf~~~~~~~~--------~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 266 (281)
T 1mp8_A 207 MWEILMHGVKPFQGVKNNDV--------IGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTE 266 (281)
T ss_dssp HHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhcCCCCCCcCCHHHH--------HHHHHcCCCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999996 8899865432211 11111111111 11235678899999999999999999753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=259.17 Aligned_cols=205 Identities=28% Similarity=0.420 Sum_probs=157.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|++++++++||||+++++++.++...++||||+.+++|.+++ ....+++..++.++.|++.|+.|||
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH 122 (271)
T 3dtc_A 48 QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLH 122 (271)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34578999999999999999999999999999999999999999999988 2457899999999999999999999
Q ss_pred cCCCCc---eeeeccCCCcEEEcc--------CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc
Q 037755 87 NGCDVC---ILHLDIKPHNILLDH--------NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 87 ~~~~~~---i~H~dl~p~nil~~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
+. + ++||||||+||+++. ++.++|+|||.+........ ....|++.|+|||.+.+. .++.
T Consensus 123 ~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~ 193 (271)
T 3dtc_A 123 DE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSK 193 (271)
T ss_dssp HS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHC--CCSH
T ss_pred hC---CCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccC--CCCc
Confidence 98 7 999999999999985 67899999999875443322 223489999999999875 6788
Q ss_pred cCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
++||||||+++|+|++|+.||........ ............ .+..+++.+.+++.+||+.||++|||
T Consensus 194 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps 260 (271)
T 3dtc_A 194 GSDVWSYGVLLWELLTGEVPFRGIDGLAV-------AYGVAMNKLALP------IPSTCPEPFAKLMEDCWNPDPHSRPS 260 (271)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHHTSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHhhhcCCCCCC------CCcccCHHHHHHHHHHhcCCcccCcC
Confidence 99999999999999999999965332211 011111111101 11234678899999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
+.|
T Consensus 261 ~~e 263 (271)
T 3dtc_A 261 FTN 263 (271)
T ss_dssp HHH
T ss_pred HHH
Confidence 854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=278.47 Aligned_cols=158 Identities=23% Similarity=0.342 Sum_probs=129.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe-----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
....+++.+|+++|++++||||+++++++.. ...+|+||||+ +++|.+++ .....+++..+..++.||+.
T Consensus 93 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~----~~~~~l~~~~~~~~~~qi~~ 167 (458)
T 3rp9_A 93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLF----RTPVYLTELHIKTLLYNLLV 167 (458)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHH----HSSCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhc----ccCCCCCHHHHHHHHHHHHH
Confidence 3456789999999999999999999999843 35789999998 56998888 33467999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-------------------------ccccccC
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-------------------------VSISATR 135 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------------------~~~~~~~ 135 (238)
||+|||+. +|+||||||+|||++.++.+||+|||+++........ .......
T Consensus 168 aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (458)
T 3rp9_A 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244 (458)
T ss_dssp HHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------
T ss_pred HHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCc
Confidence 99999999 9999999999999999999999999999765432110 0112234
Q ss_pred CccccCCcceeecCCCcccccCceehHHHHHHHHhcC
Q 037755 136 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172 (238)
Q Consensus 136 ~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g 172 (238)
||+.|+|||++... ..++.++|||||||++|+|++|
T Consensus 245 gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 245 VTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence 79999999986432 2678899999999999999993
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=262.54 Aligned_cols=206 Identities=23% Similarity=0.327 Sum_probs=167.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.++++++||||+++++++.+++..++++||+.+++|.+++. ....+++..+..++.|++.|+.|||
T Consensus 57 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH 132 (294)
T 2rku_A 57 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLH 132 (294)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999872 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++
T Consensus 133 ~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l 205 (294)
T 2rku_A 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIM 205 (294)
T ss_dssp HT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHH
T ss_pred HC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999999876543221 12234589999999998775 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ ... ....... .+..+++.+.+++.+||+.||++|||++|
T Consensus 206 ~~l~~g~~p~~~~~~~~~-------~~~-~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 262 (294)
T 2rku_A 206 YTLLVGKPPFETSCLKET-------YLR-IKKNEYS-------IPKHINPVAASLIQKMLQTDPTARPTINE 262 (294)
T ss_dssp HHHHHSSCTTCCSSHHHH-------HHH-HHTTCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred HHHHhCCCCCCCCCHHHH-------HHH-HhhccCC-------CccccCHHHHHHHHHHcccChhhCcCHHH
Confidence 999999999965432211 111 1111100 11234567889999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=263.58 Aligned_cols=203 Identities=20% Similarity=0.380 Sum_probs=162.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+.+. ....++...+..++.+++.||.|||+
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~ 127 (279)
T 3fdn_A 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS 127 (279)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45678999999999999999999999999999999999999999999882 33568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+. ..+.++||||||+++|
T Consensus 128 ~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ 198 (279)
T 3fdn_A 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCY 198 (279)
T ss_dssp T---TCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHH
T ss_pred C---CEecccCChHhEEEcCCCCEEEEeccccccCCcccc----cccCCCCCccCHhHhccC--CCCccchhHhHHHHHH
Confidence 8 999999999999999999999999998854433221 233589999999998775 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||........ .......... .+..+++.+.+|+.+||+.||++|||+.|
T Consensus 199 ~l~~g~~p~~~~~~~~~--------~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e 254 (279)
T 3fdn_A 199 EFLVGKPPFEANTYQET--------YKRISRVEFT-------FPDFVTEGARDLISRLLKHNPSQRPMLRE 254 (279)
T ss_dssp HHHHSSCTTCCSSHHHH--------HHHHHHTCCC-------CCTTSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHCCCCCCCCcHHHH--------HHHHHhCCCC-------CCCcCCHHHHHHHHHHhccChhhCCCHHH
Confidence 99999999964332211 1111111100 11224667889999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=262.09 Aligned_cols=213 Identities=29% Similarity=0.425 Sum_probs=170.3
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+....+++.+|++++++++||||+++++++.++...++|+||+.+++|.+++.. .....++...++.++.+++.||+
T Consensus 48 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~ 125 (288)
T 3kfa_A 48 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 125 (288)
T ss_dssp SCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHH
Confidence 3455678899999999999999999999999999999999999999999999843 23467899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. +++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++||||||
T Consensus 126 ~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 199 (288)
T 3kfa_A 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFG 199 (288)
T ss_dssp HHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHH
T ss_pred HHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccC--CCCchhhHHHHH
Confidence 99999 999999999999999999999999999876544332 122233467889999999876 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||........ ........... .+..+++.+.+++.+||+.||++|||++|
T Consensus 200 ~il~~ll~~g~~p~~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 261 (288)
T 3kfa_A 200 VLLWEIATYGMSPYPGIDLSQV--------YELLEKDYRME------RPEGCPEKVYELMRACWQWNPSDRPSFAE 261 (288)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGH--------HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHH--------HHHHhccCCCC------CCCCCCHHHHHHHHHHhCCChhhCcCHHH
Confidence 99999999 8888865432211 11111111111 11234678899999999999999999853
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=267.70 Aligned_cols=206 Identities=23% Similarity=0.315 Sum_probs=167.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++. ....+++..+..++.|++.||.|||
T Consensus 83 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH 158 (335)
T 2owb_A 83 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLH 158 (335)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456889999999999999999999999999999999999999999999872 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++||||||+||+++.++.++|+|||.+........ ......|+..|+|||.+.+. .++.++||||||+++
T Consensus 159 ~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il 231 (335)
T 2owb_A 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIM 231 (335)
T ss_dssp HT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHH
T ss_pred HC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccC--CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999999876543221 12334589999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||........ ..... ..... .+..+++.+.+++.+||+.||++|||++|
T Consensus 232 ~~l~~g~~pf~~~~~~~~-------~~~~~-~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e 288 (335)
T 2owb_A 232 YTLLVGKPPFETSCLKET-------YLRIK-KNEYS-------IPKHINPVAASLIQKMLQTDPTARPTINE 288 (335)
T ss_dssp HHHHHSSCTTCCSSHHHH-------HHHHH-HTCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred HHHHHCcCCCCCCCHHHH-------HHHHh-cCCCC-------CCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999965332211 11111 11000 11234567889999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=264.35 Aligned_cols=213 Identities=22% Similarity=0.406 Sum_probs=168.3
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCC------------CCCCCHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR------------GQSCSWEKLHE 73 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~------------~~~~~~~~~~~ 73 (238)
...+++.+|+++++++ +||||+++++++.+.+..++|+||+.+|+|.+++...... ...+++..++.
T Consensus 82 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (334)
T 2pvf_A 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161 (334)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence 4567889999999999 8999999999999999999999999999999998543321 23588999999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcc
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
++.||+.||.|||+. +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+. .+
T Consensus 162 i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~ 236 (334)
T 2pvf_A 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VY 236 (334)
T ss_dssp HHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EE
T ss_pred HHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--Cc
Confidence 999999999999999 9999999999999999999999999998765544322222333477889999998775 67
Q ss_pred cccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 154 SCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
+.++||||||+++|+|++ |..||....... ............ .+..++..+.+++.+||+.||++
T Consensus 237 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~ 302 (334)
T 2pvf_A 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQ 302 (334)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--------HHHHHhcCCCCC------CCccCCHHHHHHHHHHccCChhh
Confidence 889999999999999999 999986533221 111111111111 11235677899999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 303 Rps~~e 308 (334)
T 2pvf_A 303 RPTFKQ 308 (334)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.22 Aligned_cols=209 Identities=24% Similarity=0.320 Sum_probs=168.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.+|++++||||+++++++.++..+++||||+.||+|.+++... ....+++..+..++.||+.||.|||
T Consensus 226 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH 303 (576)
T 2acx_A 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLH 303 (576)
T ss_dssp TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34577889999999999999999999999999999999999999999988432 2345899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+|||++.+|.++|+|||++......... ....||+.|+|||++.+. .++.++|+||||+++
T Consensus 304 ~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvil 375 (576)
T 2acx_A 304 RE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLL 375 (576)
T ss_dssp HT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE---ECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHH
T ss_pred HC---CEeccCCchheEEEeCCCCeEEEecccceecccCccc---cccCCCccccCHHHHcCC--CCCccchHHHHHHHH
Confidence 99 9999999999999999999999999999765443221 233599999999999875 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|+|++|..||.......... .+......... ..+..+++++.+|+.+||+.||++||++
T Consensus 376 yeLltG~~PF~~~~~~~~~~----~i~~~i~~~~~-------~~p~~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 376 YEMIAGQSPFQQRKKKIKRE----EVERLVKEVPE-------EYSERFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp HHHHHSSCSSSCSSSCCCHH----HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHHHhCCCCCcccccchhHH----HHHHHhhcccc-------cCCccCCHHHHHHHHHhccCCHHHcCCC
Confidence 99999999997543321111 11111111100 0112356789999999999999999953
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=266.45 Aligned_cols=213 Identities=16% Similarity=0.165 Sum_probs=165.4
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+.+++++ +||||+++++++..+...++||||+ +++|.+++... ...+++..+..++.|++.||+|||
T Consensus 47 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH 122 (330)
T 2izr_A 47 RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVH 122 (330)
T ss_dssp SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999 8999999999999999999999999 89999998322 468999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCc-----cccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCccccc
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFV-----PNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~-----~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
+. +|+||||||+||+++.++. ++|+|||++.......... ......||+.|+|||.+.+. .++.+
T Consensus 123 ~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~ 197 (330)
T 2izr_A 123 SK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRR 197 (330)
T ss_dssp HT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHH
T ss_pred hC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC--CCCch
Confidence 99 9999999999999998877 9999999997553332211 11234599999999999876 67889
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+||||||+++|+|++|..||...........+........ ...........+ ++.+++.+||+.||.+|||+
T Consensus 198 ~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~ 269 (330)
T 2izr_A 198 DDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDY 269 (330)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCH
T ss_pred hHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCH
Confidence 9999999999999999999976432221111111100000 000011111234 89999999999999999997
Q ss_pred C
Q 037755 237 T 237 (238)
Q Consensus 237 ~ 237 (238)
+
T Consensus 270 ~ 270 (330)
T 2izr_A 270 D 270 (330)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=258.91 Aligned_cols=210 Identities=24% Similarity=0.416 Sum_probs=167.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|++++++++||||+++++++ .....++|+||+.+++|.+++. .....+++..+..++.|++.||.||
T Consensus 51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~l 126 (287)
T 1u59_A 51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL 126 (287)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHH
Confidence 44568899999999999999999999999 4567899999999999999883 2346799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. .++.++||||||+
T Consensus 127 H~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ 201 (287)
T 1u59_A 127 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGV 201 (287)
T ss_dssp HHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHH
T ss_pred HHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC--CCCchhhHHHHHH
Confidence 999 99999999999999999999999999987664433221 12223468899999999765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||+.|
T Consensus 202 il~ellt~g~~p~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 262 (287)
T 1u59_A 202 TMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRME------CPPECPPELYALMSDCWIYKWEDRPDFLT 262 (287)
T ss_dssp HHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHcCCCCCcccCCHHH--------HHHHHhcCCcCC------CCCCcCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999998 999986533221 111111111111 11245678999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=258.73 Aligned_cols=212 Identities=28% Similarity=0.498 Sum_probs=168.1
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
......+++.+|++++++++||||+++++++.++...++++||+.+++|.+++.. ....++...+..++.|++.||.
T Consensus 42 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~ 118 (267)
T 3t9t_A 42 EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMA 118 (267)
T ss_dssp TTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999999999999999999999998832 2356899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. +++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++|+||||
T Consensus 119 ~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 192 (267)
T 3t9t_A 119 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFG 192 (267)
T ss_dssp HHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHH
T ss_pred HHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccChhhhcCC--CccchhchhhhH
Confidence 99999 999999999999999999999999999875543211 112233477889999999875 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||....... ............. +..+++.+.+++.+||+.||++|||++|
T Consensus 193 ~il~~l~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ 254 (267)
T 3t9t_A 193 VLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYK------PRLASTHVYQIMNHCWRERPEDRPAFSR 254 (267)
T ss_dssp HHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhccCCCCCCCCCHHH--------HHHHHhcCCcCCC------CccCcHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999 898986533221 1111111111111 1124567889999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=280.41 Aligned_cols=208 Identities=25% Similarity=0.328 Sum_probs=168.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.++...++||||+.+|+|.+.+. ....+++..+..++.||+.||.|||
T Consensus 88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH 163 (504)
T 3q5i_A 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLH 163 (504)
T ss_dssp CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999998883 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCC---ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNF---VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
+. +|+||||||+||+++.++ .++|+|||++........ .....||+.|+|||.+.+ .++.++||||+|
T Consensus 164 ~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG 234 (504)
T 3q5i_A 164 KH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCG 234 (504)
T ss_dssp HT---TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHH
T ss_pred HC---CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHH
Confidence 99 999999999999998765 689999999976544322 233459999999999864 578899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ...+.... ..........+++++.+|+.+||+.||++|||++|
T Consensus 235 ~il~~ll~g~~pf~~~~~~~~--------~~~i~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 298 (504)
T 3q5i_A 235 VIMYILLCGYPPFGGQNDQDI--------IKKVEKGK---YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298 (504)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH--------HHHHHHCC---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHH--------HHHHHcCC---CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 999999999999975433211 11111111 01111222346788999999999999999999854
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=264.48 Aligned_cols=211 Identities=26% Similarity=0.430 Sum_probs=164.2
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC------------CCCCCCCHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------------SRGQSCSWEKLH 72 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~ 72 (238)
....+++.+|+.+++++ +||||+++++++.+++..++||||+.+++|.+++.... .....++...++
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (327)
T 1fvr_A 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145 (327)
T ss_dssp ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence 34567789999999999 89999999999999999999999999999999984332 223579999999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+. .
T Consensus 146 ~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~ 217 (327)
T 1fvr_A 146 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--V 217 (327)
T ss_dssp HHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--E
T ss_pred HHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccc--c
Confidence 9999999999999999 99999999999999999999999999986332211 11223367889999998775 6
Q ss_pred ccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
++.++||||||+++|+|++ |..||....... ............ .+..+++.+.+++.+||+.||+
T Consensus 218 ~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~ 283 (327)
T 1fvr_A 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPY 283 (327)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHGGGTCCCC------CCTTBCHHHHHHHHHHTCSSGG
T ss_pred CCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------HHHHhhcCCCCC------CCCCCCHHHHHHHHHHccCChh
Confidence 7889999999999999998 999996543221 111111111111 1123467789999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 284 ~Rps~~e 290 (327)
T 1fvr_A 284 ERPSFAQ 290 (327)
T ss_dssp GSCCHHH
T ss_pred hCcCHHH
Confidence 9999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=272.14 Aligned_cols=204 Identities=25% Similarity=0.281 Sum_probs=157.0
Q ss_pred cHHHHHHHHHH-HhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|..+ ++.++||||+++++++.+...+|+||||+.+|+|.+++. ....+++..++.++.+|+.||.|||
T Consensus 81 ~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH 156 (373)
T 2r5t_A 81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLH 156 (373)
T ss_dssp ----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34566777777 577899999999999999999999999999999999883 3457889999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+|||++.+|.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||+++
T Consensus 157 ~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il 229 (373)
T 2r5t_A 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVL 229 (373)
T ss_dssp HT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHH
T ss_pred HC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHH
Confidence 99 999999999999999999999999999875322211 12334599999999999876 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|+|++|..||........ .......... .+..++..+.+|+.+||+.||++||++.
T Consensus 230 ~ell~G~~Pf~~~~~~~~-------~~~i~~~~~~--------~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 230 YEMLYGLPPFYSRNTAEM-------YDNILNKPLQ--------LKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHSSCTTCCSBHHHH-------HHHHHHSCCC--------CCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHcCCCCCCCCCHHHH-------HHHHHhcccC--------CCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 999999999965432211 1111111111 1123567789999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.96 Aligned_cols=209 Identities=23% Similarity=0.318 Sum_probs=165.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|++++++++||||+++++++.+....++|+||+.+++|.+.+. ....+++..+..++.||+.||.||
T Consensus 62 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~l 137 (486)
T 3mwu_A 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYM 137 (486)
T ss_dssp CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999999999999999999999999988883 345789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEc---cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|+. +|+||||||+||+++ .++.++|+|||++........ .....||+.|+|||++.+ .++.++|||||
T Consensus 138 H~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~Diwsl 208 (486)
T 3mwu_A 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSA 208 (486)
T ss_dssp HHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHH
T ss_pred HHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHH
Confidence 999 999999999999995 456799999999875543322 233459999999999875 46788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||........ ............ ......+++++.+|+.+||+.||++|||+.|
T Consensus 209 G~il~~ll~g~~pf~~~~~~~~--------~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~ 273 (486)
T 3mwu_A 209 GVILYILLSGTPPFYGKNEYDI--------LKRVETGKYAFD---LPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273 (486)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH--------HHHHHHTCCCSC---SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCCCCC---CcccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999999965432211 111111111000 0111335678899999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=281.56 Aligned_cols=209 Identities=24% Similarity=0.304 Sum_probs=168.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.++++++||||+++++++.+....++|+||+.+|+|.+.+. ....+++..+..++.||+.||.||
T Consensus 67 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~l 142 (484)
T 3nyv_A 67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYM 142 (484)
T ss_dssp SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999999883 346789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEE---ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|++ +|+||||||+||++ +.++.++|+|||++......... ....||+.|+|||++.+ .++.++|||||
T Consensus 143 H~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~Diwsl 213 (484)
T 3nyv_A 143 HKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG---TYDEKCDVWST 213 (484)
T ss_dssp HHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT---CCCTHHHHHHH
T ss_pred HHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc---ccCCCCccccCceeecC---CCCCcceeHHH
Confidence 999 99999999999999 46789999999998765443321 23359999999999876 56789999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||........ ...+........ ......+++.+.+|+.+||+.||++|||+.|
T Consensus 214 G~il~~ll~g~~pf~~~~~~~~--------~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 278 (484)
T 3nyv_A 214 GVILYILLSGCPPFNGANEYDI--------LKKVEKGKYTFE---LPQWKKVSESAKDLIRKMLTYVPSMRISARD 278 (484)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCCCC---SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHCCCCCCCCCHHHH--------HHHHHcCCCCCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9999999999999975432211 111111111000 1111345778999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=268.80 Aligned_cols=214 Identities=23% Similarity=0.417 Sum_probs=166.5
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC----------CCCCCCHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES----------RGQSCSWEKLHEVA 75 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~----------~~~~~~~~~~~~~~ 75 (238)
...+.+.+|+.+++++ +||||+++++++.++...++||||+.+|+|.+++..... ....++...++.++
T Consensus 91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (333)
T 2i1m_A 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170 (333)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence 3567899999999999 899999999999999999999999999999998832110 13467999999999
Q ss_pred HHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc
Q 037755 76 SGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 76 ~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
.|++.||.|||+. +++||||||+||+++.++.++|+|||++................++..|+|||.+.+. .++.
T Consensus 171 ~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~ 245 (333)
T 2i1m_A 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTV 245 (333)
T ss_dssp HHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCH
T ss_pred HHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC--CCCh
Confidence 9999999999999 9999999999999999999999999998754333322222334477899999998875 6788
Q ss_pred cCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
++||||||+++|+|++ |..||....... .............. +..+++.+.+++.+||+.||++||
T Consensus 246 ~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rp 312 (333)
T 2i1m_A 246 QSDVWSYGILLWEIFSLGLNPYPGILVNS-------KFYKLVKDGYQMAQ------PAFAPKNIYSIMQACWALEPTHRP 312 (333)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSSTTCCSSH-------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcccchhH-------HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHhccChhhCc
Confidence 9999999999999998 888886433221 11111111111110 112356788999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|+.|
T Consensus 313 s~~~ 316 (333)
T 2i1m_A 313 TFQQ 316 (333)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9853
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=262.03 Aligned_cols=219 Identities=20% Similarity=0.352 Sum_probs=166.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+++.+|++++++++||||+++++++... ...++||||+.+++|.+++.. ....++...++.++.|++.||+
T Consensus 64 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~ 140 (302)
T 4e5w_A 64 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMD 140 (302)
T ss_dssp -CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999766 678999999999999998832 2356899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|||+. +++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. .++.++|||||
T Consensus 141 ~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~sl 215 (302)
T 4e5w_A 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSF 215 (302)
T ss_dssp HHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHH
T ss_pred HhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHH
Confidence 99999 99999999999999999999999999987665443221 22334588889999999876 67889999999
Q ss_pred HHHHHHHhcCCCCCCccccccc-------CCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSS-------KAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
|+++|+|++|..|+........ ................... .+..+++.+.+++.+||+.||++|||
T Consensus 216 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps 289 (302)
T 4e5w_A 216 GVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP------CPPNCPDEVYQLMRKCWEFQPSNRTS 289 (302)
T ss_dssp HHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC------CCCCCCHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999987643321100 0000001111111111111 11235678999999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
+.|
T Consensus 290 ~~~ 292 (302)
T 4e5w_A 290 FQN 292 (302)
T ss_dssp HHH
T ss_pred HHH
Confidence 853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=275.51 Aligned_cols=218 Identities=21% Similarity=0.233 Sum_probs=160.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....+++.+|+.+++.++||||+++++++... ...++||||+.+ +|.+.+ ...+++..+..++.||+
T Consensus 102 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~------~~~l~~~~~~~~~~qil 174 (464)
T 3ttj_A 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI------QMELDHERMSYLLYQML 174 (464)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHH------TSCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHH------hhcCCHHHHHHHHHHHH
Confidence 44567889999999999999999999999654 467999999976 566666 23588999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.||+|||+. +|+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+. .++.++||
T Consensus 175 ~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di 246 (464)
T 3ttj_A 175 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDI 246 (464)
T ss_dssp HHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTC--CCCTTHHH
T ss_pred HHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCC--CCCHHHHH
Confidence 999999999 999999999999999999999999999975543221 2234589999999999876 77889999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCc---------------chhhhhhhhccCCCc------------cccchhHHHH
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAY---------------FPSWVSDQLNKGGNL------------ELRNVTEIES 212 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~------------~~~~~~~~~~ 212 (238)
|||||++|+|++|+.||........... +.............. ..........
T Consensus 247 wSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (464)
T 3ttj_A 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 326 (464)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccccc
Confidence 9999999999999999976432211000 000000000000000 0001112334
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 213 MIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 213 ~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
..++++.+|+.+||+.||++|||++|
T Consensus 327 ~~s~~~~dLl~~mL~~dP~~R~ta~e 352 (464)
T 3ttj_A 327 LKASQARDLLSKMLVIDPAKRISVDD 352 (464)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 45788999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=278.63 Aligned_cols=211 Identities=25% Similarity=0.435 Sum_probs=166.8
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
......+++.+|+.++++++||||+++++++. ....++||||+.+|+|.+++... ....++...+..++.||+.||+
T Consensus 222 ~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~ 298 (454)
T 1qcf_A 222 PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMA 298 (454)
T ss_dssp TTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHH
T ss_pred CCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHH
Confidence 34557889999999999999999999999987 56789999999999999998321 1236888999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||++ +++||||||+|||++.++.+||+|||++........ .......++..|+|||.+... .++.++||||||
T Consensus 299 ~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG 372 (454)
T 1qcf_A 299 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFG 372 (454)
T ss_dssp HHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHH
T ss_pred HHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccC--CCCcHHHHHhHH
Confidence 99999 999999999999999999999999999976543211 111223467889999999765 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+++|+|++ |+.||....... +...+....... .+..+++.+.+++.+||+.||++|||++
T Consensus 373 ~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~ 433 (454)
T 1qcf_A 373 ILLMEIVTYGRIPYPGMSNPE--------VIRALERGYRMP------RPENCPEELYNIMMRCWKNRPEERPTFE 433 (454)
T ss_dssp HHHHHHHTTSCCSSTTCCHHH--------HHHHHHHTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999999 999996533221 111111111111 1123567899999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=269.26 Aligned_cols=216 Identities=23% Similarity=0.388 Sum_probs=166.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|++++++++||||+++++++.+ ....++||||+.+++|.+++. ...+++..++.++.+++.||+|
T Consensus 75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~ 149 (318)
T 3lxp_A 75 QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAY 149 (318)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999987 467899999999999999982 2358999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||+. +++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. .++.++||||||
T Consensus 150 LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 224 (318)
T 3lxp_A 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFG 224 (318)
T ss_dssp HHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHH
T ss_pred HHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHH
Confidence 9999 99999999999999999999999999998665543221 12233478889999999875 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccC---Cc---ch-hhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSK---AY---FP-SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~---~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+++|+|++|..||......... .. .. .............. .+..+++.+.+++.+||+.||++|||+
T Consensus 225 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~ 298 (318)
T 3lxp_A 225 VTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP------RPDKCPAEVYHLMKNCWETEASFRPTF 298 (318)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC------CCccccHHHHHHHHHHcCCCcccCcCH
Confidence 9999999999998654322100 00 00 00111111111111 112356789999999999999999997
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
+|
T Consensus 299 ~e 300 (318)
T 3lxp_A 299 EN 300 (318)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=273.77 Aligned_cols=208 Identities=21% Similarity=0.316 Sum_probs=157.0
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
..+.+|+.+|++++||||+++++++.. ...++||||+.+|+|.+++ .....+++..+..++.|++.||+|||+.
T Consensus 185 ~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~- 258 (419)
T 3i6u_A 185 LNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN- 258 (419)
T ss_dssp CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 358899999999999999999999865 5689999999999999988 3456799999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCC---ccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNF---VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMV 165 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~ 165 (238)
+|+||||||+|||++.++ .++|+|||++........ .....||+.|+|||.+.+. ...++.++||||||++
T Consensus 259 --~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 333 (419)
T 3i6u_A 259 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333 (419)
T ss_dssp --TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHH
T ss_pred --CccccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHH
Confidence 999999999999997544 599999999976543321 2234589999999998541 2356789999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ +. ....... ..........+++.+.+|+.+||+.||++|||++|
T Consensus 334 l~~lltg~~pf~~~~~~~~---~~----~~i~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 396 (419)
T 3i6u_A 334 LFICLSGYPPFSEHRTQVS---LK----DQITSGK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396 (419)
T ss_dssp HHHHHHSSCSSCCCSSSCC---HH----HHHHTTC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHCCCCCCCCcchHH---HH----HHHhcCC---CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999965332211 11 1111111 11122333456788999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=280.04 Aligned_cols=202 Identities=21% Similarity=0.267 Sum_probs=155.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....++.+|+.+++.++||||+++++++.+.+..++||||+.+|+|.+++ .....+++..+..++.||+.||+|||
T Consensus 190 ~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH 265 (446)
T 4ejn_A 190 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLH 265 (446)
T ss_dssp -----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34567789999999999999999999999999999999999999999888 23457899999999999999999999
Q ss_pred c-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 N-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+ . +|+||||||+|||++.++.++|+|||++........ ......||+.|+|||++.+. .++.++||||||++
T Consensus 266 ~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 338 (446)
T 4ejn_A 266 SEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVV 338 (446)
T ss_dssp HHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHH
T ss_pred hcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHH
Confidence 8 8 999999999999999999999999999875332221 12334599999999999775 77899999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
+|+|++|+.||........ .......... .+..+++++.+|+.+||+.||++||
T Consensus 339 l~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~--------~p~~~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 339 MYEMMCGRLPFYNQDHEKL-------FELILMEEIR--------FPRTLGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC--------CCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHhhCCCCCCCCCHHHH-------HHHHHhCCCC--------CCccCCHHHHHHHHHHcccCHHHhC
Confidence 9999999999965432211 1111111110 1123567889999999999999999
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=277.59 Aligned_cols=212 Identities=28% Similarity=0.436 Sum_probs=163.2
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
......++|.+|++++++++||||+++++++.+ ...++||||+.+|+|.+++.. ..+..++...+..++.|++.||+
T Consensus 218 ~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~ 294 (452)
T 1fmk_A 218 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMA 294 (452)
T ss_dssp TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999876 678999999999999999832 12346899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||++ +++||||||+|||++.++.++|+|||++........ .......++..|+|||.+... .++.++||||||
T Consensus 295 ~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG 368 (452)
T 1fmk_A 295 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFG 368 (452)
T ss_dssp HHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHC--CCCHHHHHHHHH
T ss_pred HHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcC--CCCccccHHhHH
Confidence 99999 999999999999999999999999999875543221 111223467889999998765 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||....... +...+....... .+..+++.+.+++.+||+.||++|||++|
T Consensus 369 ~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 430 (452)
T 1fmk_A 369 ILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEY 430 (452)
T ss_dssp HHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999 899986433221 111122211111 11245678899999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=264.11 Aligned_cols=207 Identities=22% Similarity=0.334 Sum_probs=163.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.++...++++||+.+++|.+++. ....+++..+..++.|++.||.|||+
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~ 124 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHE 124 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999883 24578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEE---ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
. +++||||||+||++ +.++.++|+|||.+....... .....|++.|+|||.+.+. .++.++||||||+
T Consensus 125 ~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ 195 (304)
T 2jam_A 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGV 195 (304)
T ss_dssp T---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHH
T ss_pred C---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccC--CCCchhhHHHHHH
Confidence 9 99999999999999 778899999999986543321 1223489999999999875 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||....... ....+....... .......+++.+.+++.+||+.||++|||++|
T Consensus 196 il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (304)
T 2jam_A 196 ITYILLCGYPPFYEETESK--------LFEKIKEGYYEF---ESPFWDDISESAKDFICHLLEKDPNERYTCEK 258 (304)
T ss_dssp HHHHHHHSSCTTTTSCHHH--------HHHHHHHCCCCC---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred HHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCC---CccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999996543221 111111111000 01112335678999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=266.71 Aligned_cols=209 Identities=22% Similarity=0.298 Sum_probs=161.9
Q ss_pred HHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 11 EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 11 ~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
...+|++++.++ +||||+++++++.++...++||||+.+|+|.+.+. ....+++..+..++.+|+.||.|||++
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~- 135 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ- 135 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 346799999988 79999999999999999999999999999999883 345799999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccC----CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 90 DVCILHLDIKPHNILLDHN----FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+|+||||||+||++... +.++|+|||++........ ......+|+.|+|||++.+. .++.++||||||++
T Consensus 136 --givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~i 209 (342)
T 2qr7_A 136 --GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVL 209 (342)
T ss_dssp --TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHH
T ss_pred --CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCC--CCCCccCeeeHhHH
Confidence 99999999999998533 3589999999875543322 12234589999999999875 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ ..+...+........ ......+++.+.+|+.+||+.||++|||++|
T Consensus 210 l~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 274 (342)
T 2qr7_A 210 LYTMLTGYTPFANGPDDTP-----EEILARIGSGKFSLS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL 274 (342)
T ss_dssp HHHHHHSSCSSCSSTTSCH-----HHHHHHHHHCCCCCC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhcCCCCCCCCCcCCH-----HHHHHHHccCCcccC---ccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9999999999964321111 111111111111111 1112345678899999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=266.01 Aligned_cols=206 Identities=23% Similarity=0.312 Sum_probs=160.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+++.+|+.++++++||||+++++++.+++..++||||+.+++|.+++.. ....++...+..++.|++.||.|
T Consensus 52 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~ 128 (289)
T 4fvq_A 52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHF 128 (289)
T ss_dssp GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999999832 23458999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCc--------cccccccccccCCCCCccccccccCCccccCCcceeecCCCccccc
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFV--------PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
||+. +++||||||+||+++.++. ++|+|||.+...... ....++..|+|||.+.+. ..++.+
T Consensus 129 LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~ 198 (289)
T 4fvq_A 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLA 198 (289)
T ss_dssp HHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHH
T ss_pred HhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCch
Confidence 9999 9999999999999998876 999999998644322 122378889999998762 267889
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+||||||+++|+|++|..|+....... ............. ...++++.+++.+||+.||++|||+
T Consensus 199 ~DiwslG~il~el~~g~~~~~~~~~~~-------~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~ 263 (289)
T 4fvq_A 199 TDKWSFGTTLWEICSGGDKPLSALDSQ-------RKLQFYEDRHQLP--------APKAAELANLINNCMDYEPDHRPSF 263 (289)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCCCC--------CCSSCTTHHHHHHHSCSSGGGSCCH
T ss_pred hHHHHHHHHHHHHHcCCCCCccccchH-------HHHHHhhccCCCC--------CCCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999999655443221111 0011111111111 1124568889999999999999997
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
+|
T Consensus 264 ~~ 265 (289)
T 4fvq_A 264 RA 265 (289)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=261.60 Aligned_cols=203 Identities=18% Similarity=0.308 Sum_probs=165.7
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|++++++++||||+++++++.++...++++||+.+++|.+++. ....++...+..++.|++.||.|||+
T Consensus 57 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~ 132 (284)
T 2vgo_A 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHE 132 (284)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45788999999999999999999999999999999999999999999883 23568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||.+....... .....|+..|+|||.+.+. .++.++|+||||+++|
T Consensus 133 ~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ 203 (284)
T 2vgo_A 133 R---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCY 203 (284)
T ss_dssp T---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHH
T ss_pred C---CceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHH
Confidence 9 99999999999999999999999999886543322 1234589999999999875 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||........ . ......... .+..++..+.+++.+||+.||++|||++|
T Consensus 204 ~l~~g~~pf~~~~~~~~-------~-~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 259 (284)
T 2vgo_A 204 EFLVGMPPFDSPSHTET-------H-RRIVNVDLK-------FPPFLSDGSKDLISKLLRYHPPQRLPLKG 259 (284)
T ss_dssp HHHHSSCTTCCSSHHHH-------H-HHHHTTCCC-------CCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHCCCCCCCCCHhHH-------H-HHHhccccC-------CCCcCCHHHHHHHHHHhhcCHhhCCCHHH
Confidence 99999999965332211 0 111111000 11234677899999999999999999753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=260.24 Aligned_cols=213 Identities=28% Similarity=0.409 Sum_probs=159.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC-----eeeEEEEeCCCCChhhhccCC--CCCCCCCCHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEFMPNGSLDRHIFPK--ESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 79 (238)
...+++.+|+.++++++||||+++++++.+.. ..++++||+.+++|.+++... ......+++..++.++.+++
T Consensus 78 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 157 (313)
T 3brb_A 78 REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157 (313)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHH
Confidence 44577899999999999999999999987654 459999999999999987322 23456799999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.||.|||+. +++||||||+||+++.++.++|+|||.+................+++.|+|||.+.+. .++.++||
T Consensus 158 ~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di 232 (313)
T 3brb_A 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDV 232 (313)
T ss_dssp HHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHH
T ss_pred HHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC--Cccchhhh
Confidence 999999999 9999999999999999999999999998755443322222333478899999999875 67889999
Q ss_pred ehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||+++|+|++ |..||........ ........... .+..+++.+.+++.+||+.||++|||++|
T Consensus 233 ~slG~il~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 298 (313)
T 3brb_A 233 WAFGVTMWEIATRGMTPYPGVQNHEM--------YDYLLHGHRLK------QPEDCLDELYEIMYSCWRTDPLDRPTFSV 298 (313)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGH--------HHHHHTTCCCC------CBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHhcCCCCCccCCHHHH--------HHHHHcCCCCC------CCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999999 8888865432211 11111111111 11235678899999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=257.57 Aligned_cols=207 Identities=23% Similarity=0.340 Sum_probs=163.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+.+.+|+.++++++||||+++++++.. +...++||||+.+++|.+++. ....++...++.++.+++.|
T Consensus 66 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~ 141 (290)
T 1t4h_A 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKG 141 (290)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHH
Confidence 4456789999999999999999999998865 456899999999999999982 33678999999999999999
Q ss_pred HHHhHcCCCCc--eeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 82 IEYLHNGCDVC--ILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 82 l~~Lh~~~~~~--i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|.|||+. + ++||||||+||+++ .++.++|+|||.+........ ....|++.|+|||.+.+ .++.++|
T Consensus 142 l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~D 211 (290)
T 1t4h_A 142 LQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE---KYDESVD 211 (290)
T ss_dssp HHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHH
T ss_pred HHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhc---cCCCcch
Confidence 9999998 8 99999999999997 789999999999865443321 22348999999998864 5678999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||||+++|+|++|..||........ ........... .......++.+.+++.+||+.||++|||++|
T Consensus 212 i~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 279 (290)
T 1t4h_A 212 VYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKP-----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCC-----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcCcHHH-------HHHHHhccCCc-----cccCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999999999999964322111 11111111110 1112223467899999999999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=259.20 Aligned_cols=207 Identities=23% Similarity=0.422 Sum_probs=164.6
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|++++++++||||+++++++ .....++|+||+.+++|.+++. ....++...+..++.|++.||.|||+
T Consensus 61 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~ 135 (291)
T 1xbb_A 61 LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 135 (291)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHH----hCcCCCHHHHHHHHHHHHHHHHHHHh
Confidence 367899999999999999999999999 5577899999999999999983 34568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
. +++||||||+||+++.++.++|+|||.+........... .....++..|+|||.+.+. .++.++||||||+++
T Consensus 136 ~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il 210 (291)
T 1xbb_A 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLM 210 (291)
T ss_dssp T---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHH
T ss_pred C---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHH
Confidence 9 999999999999999999999999999876544332211 1223367889999999775 678899999999999
Q ss_pred HHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||+.|
T Consensus 211 ~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 269 (291)
T 1xbb_A 211 WEAFSYGQKPYRGMKGSE--------VTAMLEKGERMG------CPAGCPREMYDLMNLCWTYDVENRPGFAA 269 (291)
T ss_dssp HHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999 999986533221 111111111111 11245678999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=280.04 Aligned_cols=208 Identities=23% Similarity=0.329 Sum_probs=165.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+.++++++||||+++++++.+....++||||+.+|+|.+.+. ....+++..+..++.||+.||.|||
T Consensus 78 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH 153 (494)
T 3lij_A 78 SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLH 153 (494)
T ss_dssp CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 446788999999999999999999999999999999999999999988873 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccC---CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHN---FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
+. +|+||||||+||+++.. +.++|+|||++........ .....||+.|+|||++.+ .++.++||||+|
T Consensus 154 ~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG 224 (494)
T 3lij_A 154 KH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIG 224 (494)
T ss_dssp HT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHH
T ss_pred HC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHH
Confidence 99 99999999999999754 4599999999875543322 223459999999999864 578899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ ............ ......+++.+.+|+.+||+.||++|||+.|
T Consensus 225 ~il~~ll~g~~pf~~~~~~~~--------~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 225 VILFILLAGYPPFGGQTDQEI--------LRKVEKGKYTFD---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH--------HHHHHHTCCCCC---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCCCCC---chhcccCCHHHHHHHHHHCCCChhhCccHHH
Confidence 999999999999975433211 111111111000 1111235678899999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=277.11 Aligned_cols=210 Identities=20% Similarity=0.215 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|+.+++.++||||+++++++.++..+++||||+.+|+|.+++. ...+++..+..++.||+.||.|||+.
T Consensus 113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~ 187 (410)
T 3v8s_A 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM 187 (410)
T ss_dssp CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3457899999999999999999999999999999999999999999882 24689999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC--cccccCceehHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG--TVSCKSDVYGFGMVL 166 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~~Di~slG~~l 166 (238)
+|+||||||+|||++.++.++|+|||++........ .......||+.|+|||++.+... .++.++|+||||+++
T Consensus 188 ---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvil 263 (410)
T 3v8s_A 188 ---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263 (410)
T ss_dssp ---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHH
T ss_pred ---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHH
Confidence 999999999999999999999999999976544322 11224459999999999876421 277899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC--CCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD--RPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~e 238 (238)
|+|++|..||.......... ....... ..... ....+++++.+|+.+||+.+|.+ ||+++|
T Consensus 264 yell~G~~Pf~~~~~~~~~~---~i~~~~~-~~~~p-------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~e 326 (410)
T 3v8s_A 264 YEMLVGDTPFYADSLVGTYS---KIMNHKN-SLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEE 326 (410)
T ss_dssp HHHHHSSCTTCCSSHHHHHH---HHHTHHH-HCCCC-------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred HHHHhCCCCCCCCChhhHHH---HHHhccc-cccCC-------CcccccHHHHHHHHHHccChhhhCCCCCHHH
Confidence 99999999997543322111 1100000 00000 00135678899999999999988 998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=255.77 Aligned_cols=208 Identities=18% Similarity=0.271 Sum_probs=162.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+++.+|+.++++++||||+++++++.+. ...++++||+.+|+|.+++.. .....+++..++.++.|++.||+
T Consensus 48 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~ 125 (271)
T 3kmu_A 48 TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMA 125 (271)
T ss_dssp HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999876 788999999999999999943 22346899999999999999999
Q ss_pred HhHcCCCCc--eeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC-CcccccCcee
Q 037755 84 YLHNGCDVC--ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF-GTVSCKSDVY 160 (238)
Q Consensus 84 ~Lh~~~~~~--i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~ 160 (238)
|||+. + ++||||||+||+++.++.+++.||+.+..... ....+|+.|+|||.+.+.. ...+.++|||
T Consensus 126 ~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~ 195 (271)
T 3kmu_A 126 FLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMW 195 (271)
T ss_dssp HHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHH
T ss_pred HHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHH
Confidence 99998 8 99999999999999999999988877643222 1234889999999987641 1233479999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++|+|++|..||........ ............ .+..+++.+.+++.+||+.||++|||++|
T Consensus 196 slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (271)
T 3kmu_A 196 SFAVLLWELVTREVPFADLSNMEI-------GMKVALEGLRPT------IPPGISPHVSKLMKICMNEDPAKRPKFDM 260 (271)
T ss_dssp HHHHHHHHHHHCSCTTTTSCHHHH-------HHHHHHSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHhCCCCccccChHHH-------HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999999999964332211 111111111111 11235678999999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=270.53 Aligned_cols=166 Identities=25% Similarity=0.333 Sum_probs=137.4
Q ss_pred ccccHHHHHHHHHHHhhcC-CCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
.....+++.+|+.+++++. ||||+++++++... ..+|+||||+. ++|.+.+. ...++...+..++.|++.|
T Consensus 48 ~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~ 121 (388)
T 3oz6_A 48 NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKV 121 (388)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHH
Confidence 3455678889999999997 99999999999754 37899999997 58988882 2578899999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc-------------------cccccccCCccccCC
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND-------------------FVSISATRGTIGYIA 142 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~a 142 (238)
|+|||+. +|+||||||+|||++.++.++|+|||+++....... ........||+.|+|
T Consensus 122 L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 198 (388)
T 3oz6_A 122 IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA 198 (388)
T ss_dssp HHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCC
T ss_pred HHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCC
Confidence 9999999 999999999999999999999999999875432110 011123359999999
Q ss_pred cceeecCCCcccccCceehHHHHHHHHhcCCCCCCccc
Q 037755 143 PELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 143 PE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
||++.+. ..++.++|||||||++|+|++|+.||....
T Consensus 199 PE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 199 PEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp HHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998763 367889999999999999999999997544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=263.65 Aligned_cols=211 Identities=28% Similarity=0.442 Sum_probs=161.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
.....++.+|+.++++++||||+++++++.+....++||||+.+++|.+++.. ....++...+..++.|++.||.||
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L 163 (333)
T 1mqb_A 87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYL 163 (333)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999832 245789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +++||||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++||||||+
T Consensus 164 H~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ 238 (333)
T 1mqb_A 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGI 238 (333)
T ss_dssp HHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHH
T ss_pred HhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC--CCCchhhhHHHHH
Confidence 999 9999999999999999999999999998755433211 111223367889999998765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |..||....... ............. +..+++.+.+++.+||+.||++|||++|
T Consensus 239 il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ 299 (333)
T 1mqb_A 239 VMWEVMTYGERPYWELSNHE--------VMKAINDGFRLPT------PMDCPSAIYQLMMQCWQQERARRPKFAD 299 (333)
T ss_dssp HHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCC------CTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHcCCCCCcccCCHHH--------HHHHHHCCCcCCC------cccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999998 999985433211 1111111111111 1235677899999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=266.22 Aligned_cols=163 Identities=26% Similarity=0.301 Sum_probs=140.7
Q ss_pred ccccHHHHHHHHHHHhhcC-----CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIH-----HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
.....+.+..|+.+++.+. ||||+++++++......++||||+ +++|.+++... ....++...+..++.||+
T Consensus 71 ~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~ 147 (360)
T 3llt_A 71 IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEIL 147 (360)
T ss_dssp CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHH
T ss_pred chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHH
Confidence 3445677888999999996 999999999999999999999999 88999988432 234689999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEcc-------------------------CCccccccccccccCCCCCcccccccc
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDH-------------------------NFVPNVSDFGLAKFHPKENDFVSISAT 134 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~-------------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~ 134 (238)
.||+|||+. +|+||||||+|||++. ++.++|+|||++....... ...
T Consensus 148 ~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~ 219 (360)
T 3llt_A 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSI 219 (360)
T ss_dssp HHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSC
T ss_pred HHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCc
Confidence 999999999 9999999999999975 7889999999997543322 233
Q ss_pred CCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCccc
Q 037755 135 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 135 ~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
.||+.|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 220 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 220 INTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 589999999999876 67899999999999999999999996543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=273.06 Aligned_cols=206 Identities=26% Similarity=0.412 Sum_probs=163.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC-eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...++|.+|+.++++++||||+++++++.+.. ..++||||+.+|+|.+++... ....++...+..++.||+.||+||
T Consensus 228 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~L 305 (450)
T 1k9a_A 228 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL 305 (450)
T ss_dssp TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999986654 799999999999999998432 233578999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +++||||||+|||++.++.+||+|||++....... ....++..|+|||.+.+. .++.++||||||++
T Consensus 306 H~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~ 375 (450)
T 1k9a_A 306 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK--KFSTKSDVWSFGIL 375 (450)
T ss_dssp HHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSS--CCCHHHHHHHHHHH
T ss_pred HhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHH
Confidence 999 99999999999999999999999999987443321 122477899999999875 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |..||........ ...+....... .+..+++.+.+++.+||+.||++|||+.|
T Consensus 376 l~el~t~g~~P~~~~~~~~~--------~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 376 LWEIYSFGRVPYPRIPLKDV--------VPRVEKGYKMD------APDGCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp HHHHHTTTCCSSTTSCTTTH--------HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCC------CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999998 9999865432211 11111211111 11345778999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=261.96 Aligned_cols=213 Identities=24% Similarity=0.368 Sum_probs=166.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC------CCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------SRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~~i~~ 80 (238)
....++.+|+.++++++||||+++++++.++...++||||+.+|+|.+++.... .....++...+..++.|++.
T Consensus 70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 149 (322)
T 1p4o_A 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149 (322)
T ss_dssp HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence 445678999999999999999999999999999999999999999999883211 11246789999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||.|||++ +++||||||+||+++.++.++|+|||.+................+++.|+|||.+.+. .++.++|||
T Consensus 150 ~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~ 224 (322)
T 1p4o_A 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVW 224 (322)
T ss_dssp HHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHH
T ss_pred HHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHH
Confidence 99999999 9999999999999999999999999998754333222222333468899999998875 678899999
Q ss_pred hHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++|+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||+.|
T Consensus 225 slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 289 (322)
T 1p4o_A 225 SFGVVLWEIATLAEQPYQGLSNEQ--------VLRFVMEGGLLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLE 289 (322)
T ss_dssp HHHHHHHHHHHTSCCTTTTSCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHhcCCCccccCCHHH--------HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999999999 888886433221 111111111111 11235677899999999999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=255.86 Aligned_cols=205 Identities=26% Similarity=0.427 Sum_probs=160.8
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+++.+|+.++++++||||+++++++.+.. ++||||+.+++|.+.+.. ....+++..+..++.|++.|++|||+.
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~- 141 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ- 141 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS-
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC-
Confidence 78899999999999999999999997654 699999999999888732 345799999999999999999999998
Q ss_pred CCc--eeeeccCCCcEEEccCCc-----cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 90 DVC--ILHLDIKPHNILLDHNFV-----PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 90 ~~~--i~H~dl~p~nil~~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+ ++||||||+||+++.++. ++|+|||.+...... .....+++.|+|||.+.+....++.++|||||
T Consensus 142 --~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~sl 214 (287)
T 4f0f_A 142 --NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214 (287)
T ss_dssp --SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHH
T ss_pred --CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHH
Confidence 8 999999999999987776 899999998743321 23345899999999985443467889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|+.||........ ............. ..+..+++.+.+++.+||+.||++|||++|
T Consensus 215 G~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 279 (287)
T 4f0f_A 215 AMILYTILTGEGPFDEYSYGKI-----KFINMIREEGLRP------TIPEDCPPRLRNVIELCWSGDPKKRPHFSY 279 (287)
T ss_dssp HHHHHHHHHSSCTTTTCCCCHH-----HHHHHHHHSCCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCccccccHH-----HHHHHHhccCCCC------CCCcccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 9999999999999964332211 0011111111111 111235678999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=267.45 Aligned_cols=218 Identities=20% Similarity=0.303 Sum_probs=159.7
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
.+.+|+.++++++||||+++++++.++...++||||+. ++|.+++.. .+..++...+..++.|++.||.|||+.
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~-- 119 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 44579999999999999999999999999999999997 588888732 345789999999999999999999999
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHh
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll 170 (238)
+|+||||||+||+++.++.++|+|||.+........ ......+|..|+|||.+.+. ..++.++||||||+++|+|+
T Consensus 120 -~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~ 195 (324)
T 3mtl_A 120 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMA 195 (324)
T ss_dssp -TEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHH
T ss_pred -CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999875433221 12233589999999998763 35788999999999999999
Q ss_pred cCCCCCCcccccccCCcc------------hhhhhhh-hcc--CCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 171 GGRRNSNLKATRSSKAYF------------PSWVSDQ-LNK--GGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 171 ~g~~p~~~~~~~~~~~~~------------~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+|+.||...........+ +...... ... ...............+++++.+|+.+||+.||++|||
T Consensus 196 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 275 (324)
T 3mtl_A 196 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275 (324)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC
Confidence 999999765432211000 0000000 000 0000001111222345678899999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
++|
T Consensus 276 ~~e 278 (324)
T 3mtl_A 276 AED 278 (324)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=263.99 Aligned_cols=212 Identities=19% Similarity=0.287 Sum_probs=165.1
Q ss_pred cccHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
......+.+|+.+++++. ||||+++++++.+....++||||+.+|+|.+++.. .....+++..++.++.|++.||+|
T Consensus 69 ~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~ 146 (327)
T 3lm5_A 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYY 146 (327)
T ss_dssp EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHH
Confidence 345788999999999995 79999999999999999999999999999998832 334679999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEcc---CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 85 LHNGCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
||+. +++||||||+||+++. ++.++|+|||.+........ .....|++.|+|||.+.+. .++.++||||
T Consensus 147 LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Diws 218 (327)
T 3lm5_A 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWN 218 (327)
T ss_dssp HHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHH
T ss_pred HHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHH
Confidence 9999 9999999999999987 78999999999976543322 1234589999999999765 6788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++|..||........ .......... ........+++.+.+++.+||+.||++|||++|
T Consensus 219 lG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 219 IGIIAYMLLTHTSPFVGEDNQET-------YLNISQVNVD----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCC----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhCCCCCCCCCchHH-------HHHHHhcccc----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999999999999965432211 0010100000 011111335677899999999999999999753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.29 Aligned_cols=211 Identities=24% Similarity=0.334 Sum_probs=163.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCee-eEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-ALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+++.+|+.++++++||||+++++++.+.... +++++|+.+++|.+++.. ....+++..+..++.|++.||+||
T Consensus 64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~L 140 (298)
T 3pls_A 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140 (298)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999766554 999999999999999832 346788999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc--ccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|+. +++||||||+||+++.++.++|+|||.+......... .......++..|.|||.+.+. .++.++||||||
T Consensus 141 H~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 215 (298)
T 3pls_A 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFG 215 (298)
T ss_dssp HHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHH
T ss_pred HhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC--CCChhhchhhHH
Confidence 999 9999999999999999999999999998755433211 112233478899999999875 678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..|+....... .............. +..+++.+.+++.+||+.||++|||+.|
T Consensus 216 ~il~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ 277 (298)
T 3pls_A 216 VLLWELLTRGAPPYRHIDPF-------DLTHFLAQGRRLPQ------PEYCPDSLYQVMQQCWEADPAVRPTFRV 277 (298)
T ss_dssp HHHHHHHHTSCCTTTTSCGG-------GHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhhCCCCCCccCCHH-------HHHHHhhcCCCCCC------CccchHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999665543222111 01111111111111 1224567899999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=256.27 Aligned_cols=207 Identities=20% Similarity=0.308 Sum_probs=167.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.+++++.||||+++++++.++...++||||+.+++|.+++ ....++...+..++.+++.||.||
T Consensus 61 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~l 135 (303)
T 3a7i_A 61 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYL 135 (303)
T ss_dssp STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 455788999999999999999999999999999999999999999999988 235789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++||||||++
T Consensus 136 H~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~i 208 (303)
T 3a7i_A 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGIT 208 (303)
T ss_dssp HHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHH
T ss_pred HHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHH
Confidence 999 999999999999999999999999999865543221 12334589999999999775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||....... ............ ....++..+.+++.+||+.||++|||++|
T Consensus 209 l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 267 (303)
T 3a7i_A 209 AIELARGEPPHSELHPMK--------VLFLIPKNNPPT------LEGNYSKPLKEFVEACLNKEPSFRPTAKE 267 (303)
T ss_dssp HHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCC------CCSSCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHccCCCCCCCcCHHH--------HHHHhhcCCCCC------CccccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999986432211 111111111111 11234567899999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=264.35 Aligned_cols=220 Identities=25% Similarity=0.373 Sum_probs=168.9
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEE--eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
.....+++.+|++++++++||||+++++++. ++...++||||+.+++|.+++.. ....+++..++.++.+++.||
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al 140 (327)
T 3lxl_A 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGM 140 (327)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHH
Confidence 3445677999999999999999999999885 55678999999999999998832 134689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceeh
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
+|||+. +++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. .++.++||||
T Consensus 141 ~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s 215 (327)
T 3lxl_A 141 EYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWS 215 (327)
T ss_dssp HHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHH
T ss_pred HHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC--CCChHHhHHH
Confidence 999999 99999999999999999999999999998665443222 12233478889999999875 6788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCc-------chhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAY-------FPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
||+++|+|++|..||........... ................ .+..+++.+.+++.+||+.||++||
T Consensus 216 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rp 289 (327)
T 3lxl_A 216 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP------APPACPAEVHELMKLCWAPSPQDRP 289 (327)
T ss_dssp HHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCC------CCCcccHHHHHHHHHHcCCChhhCc
Confidence 99999999999999865443211000 0001111111111111 1123567899999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|++|
T Consensus 290 s~~e 293 (327)
T 3lxl_A 290 SFSA 293 (327)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9853
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=267.57 Aligned_cols=209 Identities=21% Similarity=0.307 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
.+.+.+|+.+++++ .||||+++++++......++||||+.+++|.+++. ....+++..+..++.||+.||.|||+
T Consensus 143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~ 218 (365)
T 2y7j_A 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHA 218 (365)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 56788999999999 79999999999999999999999999999999883 34578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC----CCcccccCceehHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFG 163 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~slG 163 (238)
. |++|+||||+||+++.++.++|+|||++........ .....||+.|+|||.+.+. ...++.++||||||
T Consensus 219 ~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 292 (365)
T 2y7j_A 219 N---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292 (365)
T ss_dssp T---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHH
T ss_pred C---CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHH
Confidence 9 999999999999999999999999998875544322 2234589999999998642 12467899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||........ . ....... ..........++..+.+++.+||+.||++|||++|
T Consensus 293 ~il~ell~g~~pf~~~~~~~~-------~-~~i~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 293 VILFTLLAGSPPFWHRRQILM-------L-RMIMEGQ---YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH-------H-HHHHHTC---CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHCCCCCCCCCHHHH-------H-HHHHhCC---CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999999999964322110 0 1111100 00111112235677999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=261.62 Aligned_cols=214 Identities=27% Similarity=0.415 Sum_probs=166.5
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeC-CeeeEEEEeCCCCChhhhccCCCCC------------CCCCCHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG-SKRALVYEFMPNGSLDRHIFPKESR------------GQSCSWEKLH 72 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~------------~~~~~~~~~~ 72 (238)
...+++.+|+.+++++ +||||+++++++... ...++++||+.+++|.+++...... ...++...++
T Consensus 72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T 2xir_A 72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151 (316)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence 3456789999999999 699999999998765 4589999999999999998443321 2238899999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
.++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+. .
T Consensus 152 ~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~ 226 (316)
T 2xir_A 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--V 226 (316)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--C
T ss_pred HHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--c
Confidence 9999999999999999 9999999999999999999999999998765444333333344578899999999875 6
Q ss_pred ccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
++.++||||||+++|+|++ |..||....... .............. +..+++.+.+++.+||+.||+
T Consensus 227 ~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~ 293 (316)
T 2xir_A 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPS 293 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGG
T ss_pred ccchhHHHHHHHHHHHHHhCCCCCCcccchhH-------HHHHHhccCccCCC------CCCCCHHHHHHHHHHcCCChh
Confidence 7889999999999999998 999986533221 11111111111111 122466789999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 294 ~Rps~~e 300 (316)
T 2xir_A 294 QRPTFSE 300 (316)
T ss_dssp GSCCHHH
T ss_pred hCcCHHH
Confidence 9999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.50 Aligned_cols=210 Identities=23% Similarity=0.409 Sum_probs=164.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+++|++++||||+++++++.. ...++||||+.+|+|.+++. .....+++..+..++.||+.||+||
T Consensus 377 ~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~L 452 (613)
T 2ozo_A 377 KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL 452 (613)
T ss_dssp STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999976 56899999999999999983 2346799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +|+||||||+|||++.++.+||+|||++.......... ......++..|+|||.+.+. .++.++||||||+
T Consensus 453 H~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv 527 (613)
T 2ozo_A 453 EEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGV 527 (613)
T ss_dssp HHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC--CCCHHHHHHHHHH
T ss_pred HHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHH
Confidence 999 99999999999999999999999999997654332211 11222356889999999765 7788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |+.||....... +...+....... .+..+++++.+++.+||+.||++|||+.|
T Consensus 528 ~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 588 (613)
T 2ozo_A 528 TMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRME------CPPECPPELYALMSDCWIYKWEDRPDFLT 588 (613)
T ss_dssp HHHHHHTTSCCTTTTCCSHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred HHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999998 999996543221 112222221111 11246778999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=263.72 Aligned_cols=211 Identities=21% Similarity=0.313 Sum_probs=157.1
Q ss_pred ccHHHHHHHHHHHhhcCC--CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|+.++++++| |||+++++++.++...++|||+ .+++|.+++. ....+++..+..++.|++.||.|
T Consensus 49 ~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~ 123 (343)
T 3dbq_A 49 QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 123 (343)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Confidence 345788999999999976 9999999999999999999995 5789999983 34678999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---------CCcccc
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---------FGTVSC 155 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~~ 155 (238)
||+. +|+||||||+|||++ ++.++|+|||++................||+.|+|||.+.+. ...++.
T Consensus 124 lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~ 199 (343)
T 3dbq_A 124 IHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199 (343)
T ss_dssp HHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCH
T ss_pred HHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCc
Confidence 9999 999999999999997 678999999999765443322222344599999999998641 125678
Q ss_pred cCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
++||||||+++|+|++|+.||....... ................ ...+..+.+|+.+||+.||++|||
T Consensus 200 ~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~L~~dp~~Rpt 267 (343)
T 3dbq_A 200 KSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNHEIEFP------DIPEKDLQDVLKCCLKRDPKQRIS 267 (343)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHCTTSCCCCC------CCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred hhhHHHHHHHHHHHHhCCCcchhhhhHH------HHHHHHhcCCcccCCc------ccCCHHHHHHHHHHcCCChhHCCC
Confidence 8999999999999999999995421110 1111111111111111 112457889999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
+.|
T Consensus 268 ~~e 270 (343)
T 3dbq_A 268 IPE 270 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=259.00 Aligned_cols=202 Identities=23% Similarity=0.294 Sum_probs=158.5
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...++..|+..+.++ .||||+++++++.++...++||||+ +++|.+++.. .+..+++..++.++.|++.||.|||
T Consensus 99 ~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH 174 (311)
T 3p1a_A 99 DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLH 174 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345556666666666 8999999999999999999999999 6699888733 2457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +|+||||||+||+++.++.++|+|||++........ .....||+.|+|||++.+ .++.++||||||+++
T Consensus 175 ~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il 245 (311)
T 3p1a_A 175 SQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTI 245 (311)
T ss_dssp HT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHH
T ss_pred HC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHH
Confidence 99 999999999999999999999999999875544322 223348999999998875 567899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..|+...... ..+... .........+++.+.+++.+||+.||++|||++|
T Consensus 246 ~el~~g~~~~~~~~~~-----------~~~~~~-----~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 301 (311)
T 3p1a_A 246 LEVACNMELPHGGEGW-----------QQLRQG-----YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEA 301 (311)
T ss_dssp HHHHHTCCCCSSHHHH-----------HHHTTT-----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHhCCCCCCCccHH-----------HHHhcc-----CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999997666432211 111111 0112344556788999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=268.92 Aligned_cols=217 Identities=19% Similarity=0.243 Sum_probs=164.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|++++++++||||+++++++... ...++||||+ +++|.+++. ...++...+..++.||+.
T Consensus 66 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~qi~~ 139 (367)
T 1cm8_A 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139 (367)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHH
Confidence 4467889999999999999999999999765 3469999999 789999883 256899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||+. |++||||||+||+++.++.++|+|||++....... ....+|+.|+|||.+.+. ..++.++|||
T Consensus 140 ~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~Diw 210 (367)
T 1cm8_A 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIW 210 (367)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHH
T ss_pred HHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCC-CCCChhhhHH
Confidence 99999999 99999999999999999999999999997654321 223589999999998763 3678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcch-------hhhh---------hhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFP-------SWVS---------DQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|+||++|+|++|+.||...........+. .... .....................++.+.+|+.+
T Consensus 211 slG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 290 (367)
T 1cm8_A 211 SVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290 (367)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 99999999999999997544321100000 0000 0000000001111112223456789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 291 mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 291 MLVLDAEQRVTAGE 304 (367)
T ss_dssp HSCSSTTTSCCHHH
T ss_pred HccCChhHCCCHHH
Confidence 99999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=267.70 Aligned_cols=210 Identities=15% Similarity=0.159 Sum_probs=161.5
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+.+|+..++.++||||+++++++.. +...++||||+ +++|.+++. ....+++..++.++.||+.||+||
T Consensus 93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~L 167 (345)
T 2v62_A 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYI 167 (345)
T ss_dssp HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 456788899999999999999999977 77899999999 899999983 234899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCC--ccccccccccccCCCCCcc-----ccccccCCccccCCcceeecCCCcccccCc
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNF--VPNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~--~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|+. +|+||||||+||+++.++ .++|+|||++......... .......|+..|+|||.+.+. .++.++|
T Consensus 168 H~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~D 242 (345)
T 2v62_A 168 HEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSD 242 (345)
T ss_dssp HHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHH
T ss_pred HhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhh
Confidence 999 999999999999999777 9999999999755332211 111234589999999999875 6788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHH-----HHHHHHHHHHHhhhccCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIE-----SMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~R 233 (238)
|||||+++|+|++|+.||......... ... ....... ....... ..+++++.+++.+||+.||++|
T Consensus 243 i~slG~il~ell~g~~pf~~~~~~~~~--~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 313 (345)
T 2v62_A 243 VEILGYCMLRWLCGKLPWEQNLKDPVA--VQT-AKTNLLD------ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEK 313 (345)
T ss_dssp HHHHHHHHHHHHHSSCTTGGGTTCHHH--HHH-HHHHHHH------TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCC
T ss_pred HHHHHHHHHHHHhCCCCccccccccHH--HHH-HHHhhcc------cccHHHHhhccccccHHHHHHHHHHHhhcCcccC
Confidence 999999999999999999542211110 000 0000000 0000000 1456789999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||++|
T Consensus 314 ps~~~ 318 (345)
T 2v62_A 314 PNYQA 318 (345)
T ss_dssp CCHHH
T ss_pred CCHHH
Confidence 99753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=266.42 Aligned_cols=212 Identities=20% Similarity=0.307 Sum_probs=158.6
Q ss_pred cccHHHHHHHHHHHhhcC--CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+.+.+|+.+++++. ||||+++++++..+...++||| +.+++|.+++. ....+++..+..++.||+.||.
T Consensus 95 ~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~ 169 (390)
T 2zmd_A 95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVH 169 (390)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Confidence 345678999999999996 5999999999999999999999 56789999883 3457889999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---------CCccc
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---------FGTVS 154 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~ 154 (238)
|||+. +|+||||||+|||++ ++.++|+|||++................||+.|+|||++.+. ...++
T Consensus 170 ~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 245 (390)
T 2zmd_A 170 TIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245 (390)
T ss_dssp HHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CC
T ss_pred HHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCC
Confidence 99999 999999999999995 588999999999765443322222344599999999998642 12567
Q ss_pred ccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
.++||||||+++|+|++|..||....... ................ ...+..+.+|+.+||+.||++||
T Consensus 246 ~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rp 313 (390)
T 2zmd_A 246 PKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNHEIEFP------DIPEKDLQDVLKCCLKRDPKQRI 313 (390)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHCTTSCCCCC------CCSCHHHHHHHHHHTCSSTTTSC
T ss_pred ChhhHHHHHHHHHHHHHCCCcchhhhHHH------HHHHHHhCccccCCCC------ccchHHHHHHHHHHcccChhhCC
Confidence 88999999999999999999996422110 1111111111111111 11246788999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|+.|
T Consensus 314 s~~e 317 (390)
T 2zmd_A 314 SIPE 317 (390)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=263.67 Aligned_cols=219 Identities=25% Similarity=0.271 Sum_probs=164.9
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+.+.+|++++++++||||+++++++.+....++|+||+.+ +|.+.+. .....+++..+..++.+++.||+|||++
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 131 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 131 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4678999999999999999999999999999999999975 8888873 2345788999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+++||||||+||+++.++.++|+|||.+........ ......+|+.|+|||.+.+. ..++.++||||||+++|+|
T Consensus 132 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el 206 (346)
T 1ua2_A 132 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAEL 206 (346)
T ss_dssp --TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHH
T ss_pred --CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHH
Confidence 999999999999999999999999999875543321 12234589999999998653 2467889999999999999
Q ss_pred hcCCCCCCcccccccCCcchhhhh----hhhc------c---CCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYFPSWVS----DQLN------K---GGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~~~~~~----~~~~------~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
++|.+||...........+..... ..+. + ...............+++++.+|+.+||+.||++|||+
T Consensus 207 l~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 286 (346)
T 1ua2_A 207 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 286 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH
Confidence 999999865433211000000000 0000 0 00000011112224456789999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
+|
T Consensus 287 ~e 288 (346)
T 1ua2_A 287 TQ 288 (346)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=257.93 Aligned_cols=210 Identities=25% Similarity=0.365 Sum_probs=161.2
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEE-EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+++.+|+.++++++||||+++++++ ..+...+++|||+.+++|.+++.. ....++...+..++.|++.||+||
T Consensus 68 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~l 144 (298)
T 3f66_A 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYL 144 (298)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999985 556788999999999999999832 346788999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc--ccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|+. +++||||||+||+++.++.++|+|||.+......... .......+++.|+|||.+.+. .++.++||||||
T Consensus 145 H~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 219 (298)
T 3f66_A 145 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFG 219 (298)
T ss_dssp HHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHH
T ss_pred HhC---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHH
Confidence 999 9999999999999999999999999998755433211 112233477889999999876 678899999999
Q ss_pred HHHHHHhcC-CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGG-RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++| .+||....... .. ........... +..+++.+.+++.+||+.||++|||+.|
T Consensus 220 ~il~~l~~~~~~~~~~~~~~~----~~----~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~e 281 (298)
T 3f66_A 220 VLLWELMTRGAPPYPDVNTFD----IT----VYLLQGRRLLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSE 281 (298)
T ss_dssp HHHHHHHTTSCCSSTTSCTTT----HH----HHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCCccCCHHH----HH----HHHhcCCCCCC------CccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999995 45554322211 11 11111111110 1224567899999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=261.15 Aligned_cols=211 Identities=22% Similarity=0.278 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEE--EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
...+.+.+|++++++++||||+++++++ .++...++||||+.++ |.+.+... ....+++..+..++.|++.||.|
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~ 124 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEY 124 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999998 4556889999999875 66666322 24678999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +++||||||+||+++.++.++|+|||.+................++..|+|||.+.+.....+.++||||||+
T Consensus 125 LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 201 (305)
T 2wtk_C 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201 (305)
T ss_dssp HHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHH
T ss_pred HHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHH
Confidence 9999 9999999999999999999999999998765433322223344589999999998764334577899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||....... ....+...... .+..+++.+.+++.+||+.||++|||++|
T Consensus 202 il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 260 (305)
T 2wtk_C 202 TLYNITTGLYPFEGDNIYK--------LFENIGKGSYA-------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQ 260 (305)
T ss_dssp HHHHHHHSSCSCCCSSHHH--------HHHHHHHCCCC-------CCSSSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHhCCCCCCCchHHH--------HHHHHhcCCCC-------CCCccCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999999999996533211 11111111111 11234667889999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=256.70 Aligned_cols=206 Identities=19% Similarity=0.314 Sum_probs=162.6
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....++.+|+..+.++ +||||+++++++.+.+..++|+||+++++|.+++.........+++..++.++.||+.||.|
T Consensus 51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~ 130 (289)
T 1x8b_A 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130 (289)
T ss_dssp SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 34567888999999999 89999999999999999999999999999999984332223678999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccC-------------------CccccccccccccCCCCCccccccccCCccccCCcce
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHN-------------------FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 145 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~-------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 145 (238)
||++ +++||||||+||+++.+ ..++|+|||.+....... ...++..|+|||.
T Consensus 131 lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~ 201 (289)
T 1x8b_A 131 IHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEV 201 (289)
T ss_dssp HHHT---TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHH
T ss_pred HHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhH
Confidence 9999 99999999999999844 478999999987654432 2238999999999
Q ss_pred eecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhh
Q 037755 146 ISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWC 225 (238)
Q Consensus 146 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 225 (238)
+.+. ..++.++||||||+++|+|++|.+++...... .......... .+..+++.+.+++.+|
T Consensus 202 ~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----------~~~~~~~~~~------~~~~~~~~~~~li~~~ 263 (289)
T 1x8b_A 202 LQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW-----------HEIRQGRLPR------IPQVLSQEFTELLKVM 263 (289)
T ss_dssp HTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-----------HHHHTTCCCC------CSSCCCHHHHHHHHHH
T ss_pred hcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-----------HHHHcCCCCC------CCcccCHHHHHHHHHH
Confidence 8764 35567899999999999999998776432110 1111111111 1123567889999999
Q ss_pred ccCCCCCCCCCCC
Q 037755 226 IQVKPADRPSMTK 238 (238)
Q Consensus 226 l~~dp~~Rps~~e 238 (238)
|+.||++|||+.|
T Consensus 264 l~~dp~~Rps~~~ 276 (289)
T 1x8b_A 264 IHPDPERRPSAMA 276 (289)
T ss_dssp TCSSGGGSCCHHH
T ss_pred hCCCcccCCCHHH
Confidence 9999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=256.98 Aligned_cols=209 Identities=24% Similarity=0.371 Sum_probs=162.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.+ ...++|+||+.+++|.+++.. ....++...+..++.+++.||.||
T Consensus 54 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l 129 (281)
T 3cc6_A 54 LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYL 129 (281)
T ss_dssp HHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999999999875 457899999999999998832 235689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++||||||++
T Consensus 130 H~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~i 203 (281)
T 3cc6_A 130 ESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR--RFTTASDVWMFAVC 203 (281)
T ss_dssp HHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHH
T ss_pred HHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccC--CCCchhccHHHHHH
Confidence 999 999999999999999999999999999875543321 112233477899999999765 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |+.||........ ............ +..+++.+.+++.+||+.||++|||++|
T Consensus 204 l~~llt~g~~p~~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~e 263 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDV--------IGVLEKGDRLPK------PDLCPPVLYTLMTRCWDYDPSDRPRFTE 263 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGH--------HHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhCCCCCcccCChHHH--------HHHHhcCCCCCC------CCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 999998 9999964332211 111111111111 1224677899999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=267.06 Aligned_cols=208 Identities=15% Similarity=0.156 Sum_probs=158.1
Q ss_pred HHHHHHHHHhhcCCCcceeeeeEEEeC----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 11 EFINEVSTIGRIHHVNVVQLLGFCSEG----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 11 ~~~~e~~~l~~l~h~ni~~~~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.+.+|+..++.++||||+++++++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||
T Consensus 94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH 169 (364)
T 3op5_A 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIH 169 (364)
T ss_dssp HHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 344566677778899999999998654 4589999999 9999999832 3467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEc--cCCccccccccccccCCCCCcccc-----ccccCCccccCCcceeecCCCcccccCce
Q 037755 87 NGCDVCILHLDIKPHNILLD--HNFVPNVSDFGLAKFHPKENDFVS-----ISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
+. +|+||||||+|||++ .++.++|+|||++........... .....||+.|+|||.+.+. .++.++||
T Consensus 170 ~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di 244 (364)
T 3op5_A 170 EH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDL 244 (364)
T ss_dssp HT---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHH
T ss_pred HC---CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhH
Confidence 99 999999999999999 889999999999975543321111 1223499999999999876 67899999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHH------HHHHHHHHHHHhhhccCCCCCC
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIE------SMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dp~~R 233 (238)
||||+++|+|++|+.||........ .......... ....... ..+++++.+++.+||+.||++|
T Consensus 245 ~slG~~l~el~~g~~Pf~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 314 (364)
T 3op5_A 245 EILGYCMIQWLTGHLPWEDNLKDPK---YVRDSKIRYR-------ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEK 314 (364)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHH---HHHHHHHHHH-------HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCC
T ss_pred HHHHHHHHHHHhCCCCccccccCHH---HHHHHHHHhh-------hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999975322211 0000000000 0011111 2237789999999999999999
Q ss_pred CCCC
Q 037755 234 PSMT 237 (238)
Q Consensus 234 ps~~ 237 (238)
||++
T Consensus 315 P~~~ 318 (364)
T 3op5_A 315 PLYE 318 (364)
T ss_dssp CCHH
T ss_pred CCHH
Confidence 9975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=256.09 Aligned_cols=212 Identities=25% Similarity=0.438 Sum_probs=166.0
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
......+.+.+|++++++++||||+++++++.+ +..++|+||+.+++|.+++.. ..+..++...+..++.|++.||+
T Consensus 47 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~ 123 (279)
T 1qpc_A 47 QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMA 123 (279)
T ss_dssp TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHH
T ss_pred CCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999874 568999999999999999821 11236899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. +++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++||||||
T Consensus 124 ~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG 197 (279)
T 1qpc_A 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFG 197 (279)
T ss_dssp HHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHH
T ss_pred HHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccC--CCCchhhhHHHH
Confidence 99999 999999999999999999999999999876544321 112233467889999999765 678899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||++|
T Consensus 198 ~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 259 (279)
T 1qpc_A 198 ILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYRMV------RPDNCPEELYQLMRLCWKERPEDRPTFDY 259 (279)
T ss_dssp HHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCCcccCHHH--------HHHHHhcccCCC------CcccccHHHHHHHHHHhccChhhCCCHHH
Confidence 99999999 888886433221 111111111111 11235678899999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=264.76 Aligned_cols=220 Identities=18% Similarity=0.221 Sum_probs=157.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.++++++||||+++++++.++...++||||+. ++|.+++. ....+++..++.++.||+.||.|||+
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~ 150 (329)
T 3gbz_A 76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHS 150 (329)
T ss_dssp ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34677899999999999999999999999999999999997 49999883 34568999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEc-----cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 88 GCDVCILHLDIKPHNILLD-----HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
. +|+||||||+||+++ ..+.++|+|||.+........ ......+|..|+|||.+.+. ..++.++|||||
T Consensus 151 ~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diwsl 224 (329)
T 3gbz_A 151 R---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSI 224 (329)
T ss_dssp T---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHH
T ss_pred C---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHH
Confidence 9 999999999999994 445699999999875433221 12233479999999998764 247889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhh-----------hh--hhhccCCC--ccccchhHHHHHHHHHHHHHHhhhcc
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSW-----------VS--DQLNKGGN--LELRNVTEIESMIARKLCVIGLWCIQ 227 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~-----------~~--~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~ 227 (238)
|+++|+|++|..||...........+... .. ........ ............+++++.+|+.+||+
T Consensus 225 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 304 (329)
T 3gbz_A 225 ACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLE 304 (329)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHcc
Confidence 99999999999999654332110000000 00 00000000 00000111223356789999999999
Q ss_pred CCCCCCCCCCC
Q 037755 228 VKPADRPSMTK 238 (238)
Q Consensus 228 ~dp~~Rps~~e 238 (238)
.||++|||++|
T Consensus 305 ~dP~~R~t~~e 315 (329)
T 3gbz_A 305 MDPVKRISAKN 315 (329)
T ss_dssp SSGGGSCCHHH
T ss_pred CChhhCCCHHH
Confidence 99999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=263.61 Aligned_cols=208 Identities=20% Similarity=0.264 Sum_probs=158.1
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++++..++..++++||+.+++|.+++. ....+++..+..++.+++.||.|||+
T Consensus 77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~ 152 (309)
T 2h34_A 77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHA 152 (309)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35789999999999999999999999999999999999999999999883 23578999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++||||||+++|
T Consensus 153 ~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ 226 (309)
T 2h34_A 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLY 226 (309)
T ss_dssp T---TCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC------CCCHHHHHHHHHH
T ss_pred C---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHH
Confidence 9 999999999999999999999999999865543221 112234589999999998775 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC-CCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP-SMT 237 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ 237 (238)
+|++|..||....... .......... ........+++.+.+++.+||+.||++|| |++
T Consensus 227 ~l~~g~~pf~~~~~~~--------~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~ 285 (309)
T 2h34_A 227 ECLTGSPPYQGDQLSV--------MGAHINQAIP----RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCG 285 (309)
T ss_dssp HHHHSSCSSCSCHHHH--------HHHHHHSCCC----CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred HHHHCCCCCCCchHHH--------HHHHhccCCC----CccccCCCCCHHHHHHHHHhccCCHHHHHHhHH
Confidence 9999999996543221 1111111111 11122234567889999999999999999 553
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=269.12 Aligned_cols=212 Identities=17% Similarity=0.152 Sum_probs=165.8
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+.+.+|+.+++.++||||+++++++.++..+++||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+.
T Consensus 119 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~- 194 (437)
T 4aw2_A 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL- 194 (437)
T ss_dssp CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3488999999999999999999999999999999999999999999832 246799999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeec---CCCcccccCceehHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Di~slG~~l 166 (238)
+|+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.. ....++.++||||||+++
T Consensus 195 --giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil 271 (437)
T 4aw2_A 195 --HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271 (437)
T ss_dssp --TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHH
T ss_pred --CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHH
Confidence 9999999999999999999999999998755433221 1223459999999999862 113678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC--CCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD--RPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~e 238 (238)
|+|++|+.||.......... ....... .... + .....+++++.+||.+||+.+|++ ||+++|
T Consensus 272 ~elltG~~Pf~~~~~~~~~~---~i~~~~~-~~~~--p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e 335 (437)
T 4aw2_A 272 YEMLYGETPFYAESLVETYG---KIMNHKE-RFQF--P----TQVTDVSENAKDLIRRLICSREHRLGQNGIED 335 (437)
T ss_dssp HHHHHSSCTTCCSSHHHHHH---HHHTHHH-HCCC--C----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred HHHHhCCCCCCCCChhHHHH---hhhhccc-cccC--C----cccccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence 99999999997543322111 1110000 0000 0 001225678899999999998888 998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=271.91 Aligned_cols=210 Identities=20% Similarity=0.233 Sum_probs=163.7
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+.+|+++++++ +||||+++++++..+...++||||+.+++|.+++. ....+++..+..++.||+.||.||
T Consensus 100 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L 175 (355)
T 1vzo_A 100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHL 175 (355)
T ss_dssp SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456778899999999 69999999999999999999999999999999983 335789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +|+||||||+||+++.++.++|+|||++........ .......||+.|+|||.+.+....++.++||||||++
T Consensus 176 H~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~i 251 (355)
T 1vzo_A 176 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251 (355)
T ss_dssp HHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHH
T ss_pred HHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHH
Confidence 999 999999999999999999999999999875433221 1122335899999999998643357889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
+|+|++|..||.......... ......... .. ..+..++..+.+|+.+||+.||++||+
T Consensus 252 l~ell~g~~pf~~~~~~~~~~---~~~~~~~~~-~~-------~~~~~~~~~~~~li~~~L~~dP~~R~~ 310 (355)
T 1vzo_A 252 MYELLTGASPFTVDGEKNSQA---EISRRILKS-EP-------PYPQEMSALAKDLIQRLLMKDPKKRLG 310 (355)
T ss_dssp HHHHHHSSCTTSCTTSCCCHH---HHHHHHHHC-CC-------CCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred HHHHHHCCCCCccCCccchHH---HHHHHHhcc-CC-------CCCcccCHHHHHHHHHHhhhCHHHhcC
Confidence 999999999997543322211 111111111 00 111235667889999999999999993
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=259.83 Aligned_cols=223 Identities=20% Similarity=0.247 Sum_probs=162.5
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEe--------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSE--------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....+.+|+.++++++||||+++++++.. ++..++||||+.+ +|.+.+. .....+++..+..++.|++
T Consensus 59 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~ 134 (351)
T 3mi9_A 59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLL 134 (351)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHH
Confidence 34678899999999999999999999876 4568999999975 7777663 2335699999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc--ccccccCCccccCCcceeecCCCcccccC
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
.||+|||+. +|+||||||+||+++.++.++|+|||.+......... .......||+.|+|||.+.+. ..++.++
T Consensus 135 ~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~ 210 (351)
T 3mi9_A 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPI 210 (351)
T ss_dssp HHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHH
T ss_pred HHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHh
Confidence 999999999 9999999999999999999999999998765432211 112334589999999998763 3568899
Q ss_pred ceehHHHHHHHHhcCCCCCCcccccccCCcc------------hhhhhhhhccCCCccccchhHH-----HHHHHHHHHH
Q 037755 158 DVYGFGMVLLEMTGGRRNSNLKATRSSKAYF------------PSWVSDQLNKGGNLELRNVTEI-----ESMIARKLCV 220 (238)
Q Consensus 158 Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~ 220 (238)
||||||+++|+|++|..||...........+ +..................... ....++.+.+
T Consensus 211 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (351)
T 3mi9_A 211 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 290 (351)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHH
Confidence 9999999999999999999764332111000 0000000000000000000011 1123567899
Q ss_pred HHhhhccCCCCCCCCCCC
Q 037755 221 IGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 221 li~~cl~~dp~~Rps~~e 238 (238)
|+.+||+.||++|||++|
T Consensus 291 li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 291 LIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp HHHHHSCSSGGGSCCHHH
T ss_pred HHHHHhcCChhhCCCHHH
Confidence 999999999999999854
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=260.93 Aligned_cols=212 Identities=22% Similarity=0.312 Sum_probs=165.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEE--eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+.+.+|+.++++++||||+++++++. .+...++||||+.+++|.+++.........+++..++.++.|++.||.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 125 (279)
T 2w5a_A 46 EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125 (279)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999874 467899999999999999998543333456999999999999999999
Q ss_pred HhHcCCCCc-----eeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 84 YLHNGCDVC-----ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 84 ~Lh~~~~~~-----i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|||+. + ++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|
T Consensus 126 ~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~D 198 (279)
T 2w5a_A 126 ECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRM--SYNEKSD 198 (279)
T ss_dssp HHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC---CCHHHH
T ss_pred HHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccC--CCCchhh
Confidence 99998 8 99999999999999999999999999875543221 11223488999999999875 6788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||||+++|+|++|..||....... ....+....... .+..++.++.+++.+||+.||++|||++|
T Consensus 199 i~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 264 (279)
T 2w5a_A 199 IWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRR------IPYRYSDELNEIITRMLNLKDYHRPSVEE 264 (279)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHHHCCCCCcccCHHH--------HHHHHhhccccc------CCcccCHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999999999999999986543211 111111111111 11235678999999999999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=270.68 Aligned_cols=211 Identities=25% Similarity=0.354 Sum_probs=155.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEE-eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....+++.+|+.++++++||||+++++++. .++..++||||+.+|+|.+++. .....++...+..++.||+.||.|
T Consensus 131 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~ 207 (373)
T 3c1x_A 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKF 207 (373)
T ss_dssp SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999864 4568899999999999999983 234568889999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCCCcccccCceehH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
||+. +++||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+. .++.++|||||
T Consensus 208 LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSl 282 (373)
T 3c1x_A 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSF 282 (373)
T ss_dssp HHHT---TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHC--CCCHHHHHHHH
T ss_pred HHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHH
Confidence 9999 99999999999999999999999999987543322111 11223477889999999875 67889999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++ |.+||....... ... .......... +..++..+.+++.+||+.||++|||++|
T Consensus 283 G~il~ellt~~~~p~~~~~~~~----~~~----~~~~~~~~~~------p~~~~~~l~~li~~cl~~dp~~RPs~~e 345 (373)
T 3c1x_A 283 GVLLWELMTRGAPPYPDVNTFD----ITV----YLLQGRRLLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSE 345 (373)
T ss_dssp HHHHHHHHTTSCCSCTTSCSSC----HHH----HHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCcCCCCCCCCHHH----HHH----HHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999999 566775433221 111 1111111111 1234667899999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=262.51 Aligned_cols=214 Identities=21% Similarity=0.315 Sum_probs=165.0
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhcc----CCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF----PKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~----~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
+.+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++. -.......+++..++.++.|++.||.||
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 889999999999999999999999999999999999999999999821 0222257899999999999999999999
Q ss_pred Hc-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc-cCceehHH
Q 037755 86 HN-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC-KSDVYGFG 163 (238)
Q Consensus 86 h~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~-~~Di~slG 163 (238)
|+ . +++||||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. ..++. ++||||||
T Consensus 168 H~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG 239 (348)
T 2pml_X 168 HNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLG 239 (348)
T ss_dssp HHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHH
T ss_pred hccC---CEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHH
Confidence 98 8 9999999999999999999999999998754332 12334589999999998764 23344 89999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCcc------------ccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLE------------LRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
+++|+|++|..||....... . ............ ..........+++.+.+|+.+||+.||+
T Consensus 240 ~il~~l~~g~~pf~~~~~~~------~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 312 (348)
T 2pml_X 240 ICLYVMFYNVVPFSLKISLV------E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312 (348)
T ss_dssp HHHHHHHHSSCSSCCSSCSH------H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhCCCCCCCCCcHH------H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChh
Confidence 99999999999997543310 0 000000000000 0001112245677899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 313 ~Rps~~e 319 (348)
T 2pml_X 313 ERITSED 319 (348)
T ss_dssp GSCCHHH
T ss_pred hCCCHHH
Confidence 9999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=258.23 Aligned_cols=206 Identities=20% Similarity=0.350 Sum_probs=158.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.++++++||||+++++++.+....++|+||+.+++|.+++. ....++...+..++.|++.||.|||
T Consensus 53 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH 128 (276)
T 2h6d_A 53 DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCH 128 (276)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 446789999999999999999999999999999999999999999999883 2356899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +++|+||+|+||+++.++.++|+|||.+........ .....+++.|+|||.+.+. ...+.++|+||||+++
T Consensus 129 ~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l 201 (276)
T 2h6d_A 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVIL 201 (276)
T ss_dssp HH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTS-CCCHHHHHHHHHHHHH
T ss_pred HC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHH
Confidence 99 999999999999999999999999999875543221 1233488999999998764 2346789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||....... ........... .+..++..+.+++.+||+.||++|||++|
T Consensus 202 ~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2h6d_A 202 YALLCGTLPFDDEHVPT--------LFKKIRGGVFY-------IPEYLNRSVATLLMHMLQVDPLKRATIKD 258 (276)
T ss_dssp HHHHHSSCSSCCSSHHH--------HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhCCCCCCCCcHHH--------HHHHhhcCccc-------CchhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999996432211 11111111110 11224567889999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=268.60 Aligned_cols=223 Identities=17% Similarity=0.246 Sum_probs=167.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC--eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+.+.+|++++++++||||+++++++.+.. ..++||||+.+|+|.+++.... ....+++..++.++.|++.||+
T Consensus 48 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~ 126 (396)
T 4eut_A 48 LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMN 126 (396)
T ss_dssp GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHH
Confidence 345688899999999999999999999997655 7899999999999999983322 1234899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEE----ccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC------Ccc
Q 037755 84 YLHNGCDVCILHLDIKPHNILL----DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF------GTV 153 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~ 153 (238)
|||+. +|+||||||+||++ +.++.++|+|||.+........ .....|+..|+|||.+.+.. ..+
T Consensus 127 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 200 (396)
T 4eut_A 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKY 200 (396)
T ss_dssp HHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHH
T ss_pred HHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCC
Confidence 99999 99999999999999 7777899999999976544322 12345899999999886410 156
Q ss_pred cccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCC-----------C------ccccchhHHHHHHHH
Q 037755 154 SCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGG-----------N------LELRNVTEIESMIAR 216 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~------~~~~~~~~~~~~~~~ 216 (238)
+.++||||||+++|+|++|+.||............ ......... . ............++.
T Consensus 201 ~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 277 (396)
T 4eut_A 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV---MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQV 277 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH---HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH---HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHh
Confidence 77899999999999999999999643322111110 000000000 0 001111223466788
Q ss_pred HHHHHHhhhccCCCCCCCCCCC
Q 037755 217 KLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 217 ~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+.+++.+||+.||++|||++|
T Consensus 278 ~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 278 LLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp HHHHHHHHHSCCCTTTSCCHHH
T ss_pred hchHHHHHhhccChhhhccHHH
Confidence 8999999999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=272.79 Aligned_cols=208 Identities=20% Similarity=0.179 Sum_probs=162.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.+|..+++.++||||+++++++.+...+|+||||+.+|+|.+++.. .+..+++..++.++.+|+.||.|||+.
T Consensus 105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~ 181 (412)
T 2vd5_A 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL 181 (412)
T ss_dssp GCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34578999999999999999999999999999999999999999999832 234789999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-----CCcccccCceehHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFG 163 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Di~slG 163 (238)
+|+||||||+|||++.++.+||+|||++......... ......||+.|+|||++... ...++.++|+||||
T Consensus 182 ---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlG 257 (412)
T 2vd5_A 182 ---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257 (412)
T ss_dssp ---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHH
T ss_pred ---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHh
Confidence 9999999999999999999999999999765443221 11234599999999998731 12578899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
+++|+|++|+.||......... ........ . ...+.....+++++.+||.+||+ +|++|+
T Consensus 258 vilyelltG~~Pf~~~~~~~~~---~~i~~~~~-~------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 258 VFAYEMFYGQTPFYADSTAETY---GKIVHYKE-H------LSLPLVDEGVPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHH---HHHHTHHH-H------CCCC----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred HHHHHHHhCCCCCCCCCHHHHH---HHHHhccc-C------cCCCccccCCCHHHHHHHHHHcC-ChhhcC
Confidence 9999999999999654332211 11110000 0 00111224467889999999999 999995
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=270.72 Aligned_cols=162 Identities=25% Similarity=0.375 Sum_probs=140.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.++...++||||+.+++|.+++. ....++...+..++.+++.||.||
T Consensus 72 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~l 147 (360)
T 3eqc_A 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYL 147 (360)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999999983 335789999999999999999999
Q ss_pred Hc-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HN-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+ + +++||||||+||+++.++.++|+|||.+....... .....|++.|+|||.+.+. .++.++||||||+
T Consensus 148 h~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~ 218 (360)
T 3eqc_A 148 REKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGL 218 (360)
T ss_dssp HHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTC--CCSHHHHHHHHHH
T ss_pred HHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccccc----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHH
Confidence 97 5 89999999999999999999999999885332211 1223589999999999875 6788999999999
Q ss_pred HHHHHhcCCCCCCccc
Q 037755 165 VLLEMTGGRRNSNLKA 180 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~ 180 (238)
++|+|++|+.||....
T Consensus 219 il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 219 SLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HHHHHHHTSCCSSCCC
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999996543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=259.65 Aligned_cols=215 Identities=22% Similarity=0.338 Sum_probs=159.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.++...++|+||+.+++|.+++.........++...++.++.+++.||.||
T Consensus 73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (310)
T 2wqm_A 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152 (310)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999998843333456789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++||||||++
T Consensus 153 H~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i 225 (310)
T 2wqm_A 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCL 225 (310)
T ss_dssp HHT---TCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTC--CCCHHHHHHHHHHH
T ss_pred hhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCC--CCCchhhHHHHHHH
Confidence 999 999999999999999999999999999875443221 11233588999999998775 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||....... .. .............. ...+++.+.+++.+||+.||++|||+.|
T Consensus 226 l~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ 287 (310)
T 2wqm_A 226 LYEMAALQSPFYGDKMNL-----YS-LCKKIEQCDYPPLP-----SDHYSEELRQLVNMCINPDPEKRPDVTY 287 (310)
T ss_dssp HHHHHHSSCTTC---CCH-----HH-HHHHHHTTCSCCCC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHhCCCCCcccchhH-----HH-HHHHhhcccCCCCc-----ccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 999999999986432211 01 11111111111110 1235678899999999999999999753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=257.58 Aligned_cols=215 Identities=18% Similarity=0.240 Sum_probs=165.0
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEE-EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+.++++++|++++..+..+ .++...+++|||+ +++|.+++.. ....+++..+..++.|++.||+|||
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH 122 (296)
T 4hgt_A 47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH 122 (296)
T ss_dssp -CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 335688999999999988877666654 7778899999999 8899998832 2457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEE---ccCCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCcccccCc
Q 037755 87 NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+. +++||||||+||++ +.++.++|+|||.+.......... ......|+..|+|||.+.+. .++.++|
T Consensus 123 ~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~D 197 (296)
T 4hgt_A 123 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDD 197 (296)
T ss_dssp HT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHH
T ss_pred HC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC--CCCchhH
Confidence 99 99999999999999 788999999999987654432211 12234589999999999876 6788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||||+++|+|++|+.||...........+......... .........+++.+.+++.+||+.||++|||++|
T Consensus 198 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 270 (296)
T 4hgt_A 198 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY 270 (296)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred HHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHH
Confidence 999999999999999999765443332222221111110 0111122335778999999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=261.78 Aligned_cols=209 Identities=21% Similarity=0.311 Sum_probs=162.1
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|++++++++||||+++++++..+. .++|+||+.+++|.+++ .....+++..+..++.||+.||.|||++
T Consensus 59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (322)
T 2ycf_A 59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN 133 (322)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456889999999999999999999997754 89999999999999988 3456799999999999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCc---cccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFV---PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGM 164 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~ 164 (238)
+++||||||+||+++.++. ++|+|||.+........ .....|++.|+|||.+.+. ...++.++||||||+
T Consensus 134 ---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 207 (322)
T 2ycf_A 134 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207 (322)
T ss_dssp ---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHH
T ss_pred ---CeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHH
Confidence 9999999999999987654 99999999876543221 1223489999999997531 135678999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||........ +. ....... ..........+++.+.+++.+||+.||++|||++|
T Consensus 208 il~~l~~g~~pf~~~~~~~~---~~----~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~ 271 (322)
T 2ycf_A 208 ILFICLSGYPPFSEHRTQVS---LK----DQITSGK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271 (322)
T ss_dssp HHHHHHHSSCSSCSTTCSSC---HH----HHHHHTC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHhCCCCCcccchHHH---HH----HHHHhCc---cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHH
Confidence 99999999999965432211 11 1111111 01112333456788999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=280.93 Aligned_cols=208 Identities=22% Similarity=0.412 Sum_probs=163.4
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++.. ...++||||+.+|+|.+++. ....+++..+..++.||+.||+|||
T Consensus 412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH 486 (635)
T 4fl3_A 412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE 486 (635)
T ss_dssp GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 446889999999999999999999999975 46889999999999999982 3467899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
++ +|+||||||+|||++.++.+||+|||++.......... ......++..|+|||.+.+. .++.++||||||++
T Consensus 487 ~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~ 561 (635)
T 4fl3_A 487 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVL 561 (635)
T ss_dssp HT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC--CCCHHHHHHHHHHH
T ss_pred HC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHH
Confidence 99 99999999999999999999999999987654433211 11223367889999999775 77889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |+.||....... +...+....... .+..+++++.+++.+||+.||++|||++|
T Consensus 562 l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~~ 621 (635)
T 4fl3_A 562 MWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMG------CPAGCPREMYDLMNLCWTYDVENRPGFAA 621 (635)
T ss_dssp HHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 999998 999996543321 112222221111 11235678999999999999999999753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=256.14 Aligned_cols=215 Identities=18% Similarity=0.240 Sum_probs=165.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEE-EeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+.++++++|++++..+..+ .++...++++||+ +++|.+++.. ....+++..+..++.|++.||+|||
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH 122 (296)
T 3uzp_A 47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH 122 (296)
T ss_dssp SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH
Confidence 345789999999999988876655554 6778889999999 8899998832 2357999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEE---ccCCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCcccccCc
Q 037755 87 NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
++ +++||||||+||++ +.++.++|+|||.+.......... ......|+..|+|||.+.+. .++.++|
T Consensus 123 ~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~D 197 (296)
T 3uzp_A 123 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDD 197 (296)
T ss_dssp HT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHH
T ss_pred hC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCC--CCCcchh
Confidence 99 99999999999999 488899999999987654432211 11234589999999999876 6788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||||+++|+|++|+.||...........+......... .........+++.+.+++.+||+.||++|||++|
T Consensus 198 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 270 (296)
T 3uzp_A 198 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY 270 (296)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred hHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHH
Confidence 999999999999999999765433322222221111111 0111222345788999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=266.45 Aligned_cols=217 Identities=18% Similarity=0.237 Sum_probs=153.1
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|+++++.++||||+++++++... ...+++++++ +++|.+++. ...++...+..++.||+.
T Consensus 70 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~ 143 (367)
T 2fst_X 70 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILR 143 (367)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHH
Confidence 4567888999999999999999999998654 5689999999 679988872 357999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||+. |++||||||+||+++.++.++|+|||++...... .....+|+.|+|||.+.+. ..++.++|||
T Consensus 144 aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Diw 214 (367)
T 2fst_X 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIW 214 (367)
T ss_dssp HHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTC-CSCCTTHHHH
T ss_pred HHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHH
Confidence 99999999 9999999999999999999999999998754332 1223589999999998763 3678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchh----------------hhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPS----------------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
||||++|+|++|+.||...........+.. ........................++.+.+|+.+
T Consensus 215 slG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~ 294 (367)
T 2fst_X 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 294 (367)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 999999999999999975443211000000 0000000000111111122223456789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 295 mL~~dP~~R~t~~e 308 (367)
T 2fst_X 295 MLVLDSDKRITAAQ 308 (367)
T ss_dssp HSCSSGGGSCCHHH
T ss_pred hCCCCcccCcCHHH
Confidence 99999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=258.86 Aligned_cols=215 Identities=24% Similarity=0.335 Sum_probs=164.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+.+++.++||||+++++++.+.+..++|+||+.+++|.+++.... ....+++..+..++.+++.||.||
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~l 138 (295)
T 2clq_A 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYL 138 (295)
T ss_dssp C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999999999999999999999999999999884322 234567889999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +++|+||||+||+++. ++.++|+|||.+........ ......|+..|+|||.+.+....++.++||||||+
T Consensus 139 H~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 213 (295)
T 2clq_A 139 HDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213 (295)
T ss_dssp HHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHH
T ss_pred HhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHH
Confidence 999 9999999999999987 89999999999875543221 12234589999999998764224678899999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|+.||........ ......... .. ...+..+++.+.+++.+||+.||++|||++|
T Consensus 214 il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 275 (295)
T 2clq_A 214 TIIEMATGKPPFYELGEPQA-----AMFKVGMFK-VH------PEIPESMSAEAKAFILKCFEPDPDKRACAND 275 (295)
T ss_dssp HHHHHHHTSCTTGGGSSHHH-----HHHHHHHHC-CC------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred HHHHHHHCCCCccCCCchhH-----HHHhhcccc-cc------ccccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999999854321110 000000000 00 0112235678899999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=255.14 Aligned_cols=209 Identities=23% Similarity=0.345 Sum_probs=166.9
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+++.+|+.++++++||||+++++++.+....++|+||+.+++|.+++.. ....++...+..++.+++.||.|||+
T Consensus 67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~ 143 (314)
T 3com_A 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF 143 (314)
T ss_dssp CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457889999999999999999999999999999999999999999998831 24678999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
. +++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++||||||+++|
T Consensus 144 ~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ 216 (314)
T 3com_A 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAI 216 (314)
T ss_dssp T---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHH
T ss_pred C---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHH
Confidence 9 999999999999999999999999999865433221 12234589999999998875 6788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||........ . ............. +..++..+.+++.+||+.||++|||+.|
T Consensus 217 ~l~~g~~p~~~~~~~~~-------~-~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ 275 (314)
T 3com_A 217 EMAEGKPPYADIHPMRA-------I-FMIPTNPPPTFRK----PELWSDNFTDFVKQCLVKSPEQRATATQ 275 (314)
T ss_dssp HHHHSSCTTTTSCHHHH-------H-HHHHHSCCCCCSS----GGGSCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHhCCCCCCCCChHHH-------H-HHHhcCCCcccCC----cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999964332110 0 0011111111111 1224677899999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=260.81 Aligned_cols=220 Identities=24% Similarity=0.398 Sum_probs=166.3
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeC--CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
+....+++.+|++++++++||||+++++++... ...++|+||+.+++|.+++.. ....++...++.++.+++.||
T Consensus 82 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL 158 (326)
T 2w1i_A 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGM 158 (326)
T ss_dssp CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999988654 478999999999999999832 235689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceeh
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
.|||+. +++||||||+||+++.++.++|+|||.+........... .....++..|+|||.+.+. .++.++||||
T Consensus 159 ~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s 233 (326)
T 2w1i_A 159 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWS 233 (326)
T ss_dssp HHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHH
T ss_pred HHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC--CCCchhhHHH
Confidence 999999 999999999999999999999999999876654432211 1223477789999998875 6788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccc-----cCC---cchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRS-----SKA---YFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADR 233 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~-----~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 233 (238)
||+++|+|++|..|+....... ... ................. .+..+++.+.+++.+||+.||++|
T Consensus 234 lG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~R 307 (326)
T 2w1i_A 234 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQR 307 (326)
T ss_dssp HHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC------CCCcccHHHHHHHHHHcCCChhhC
Confidence 9999999999998876432110 000 00001111111111111 112356789999999999999999
Q ss_pred CCCCC
Q 037755 234 PSMTK 238 (238)
Q Consensus 234 ps~~e 238 (238)
||+.|
T Consensus 308 ps~~e 312 (326)
T 2w1i_A 308 PSFRD 312 (326)
T ss_dssp CCHHH
T ss_pred cCHHH
Confidence 99753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=258.37 Aligned_cols=218 Identities=17% Similarity=0.240 Sum_probs=164.4
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
...+++.+|+.+++++. ||||+++++++.+ ....+++|||+.+++|.+++ ..++...+..++.|++.||+
T Consensus 72 ~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~ 144 (330)
T 3nsz_A 72 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALD 144 (330)
T ss_dssp CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHH
Confidence 45688999999999997 9999999999987 67889999999999999988 45889999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCC-ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|||+. +++||||||+||+++.++ .++|+|||++........ .....++..|+|||.+.+. ..++.++|||||
T Consensus 145 ~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Diwsl 217 (330)
T 3nsz_A 145 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSL 217 (330)
T ss_dssp HHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHH
T ss_pred HHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCC-CcCCchhhHHHH
Confidence 99999 999999999999999766 899999999975544332 2233588999999998763 357889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCc---------------------chhhhhhhhccCCCcc--ccchhHHHHHHHHHHH
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAY---------------------FPSWVSDQLNKGGNLE--LRNVTEIESMIARKLC 219 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~ 219 (238)
|+++|+|++|..||........... ................ ..........+++++.
T Consensus 218 G~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (330)
T 3nsz_A 218 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 297 (330)
T ss_dssp HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHH
T ss_pred HHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHH
Confidence 9999999999999954322110000 0000000000000000 0001111223578899
Q ss_pred HHHhhhccCCCCCCCCCCC
Q 037755 220 VIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 220 ~li~~cl~~dp~~Rps~~e 238 (238)
+|+.+||+.||++|||++|
T Consensus 298 ~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 298 DFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp HHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHhcCCcccCCCHHH
Confidence 9999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=264.65 Aligned_cols=223 Identities=19% Similarity=0.229 Sum_probs=165.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
....+++.+|++++++++||||+++++++... ...++++||+. ++|.+++. ...++...+..++.|++.
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~ 139 (364)
T 3qyz_A 66 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILR 139 (364)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHH
Confidence 34457889999999999999999999998654 46899999996 59988882 346899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCce
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
||+|||+. +|+||||||+||+++.++.++|+|||.+........... .....||+.|+|||.+.+. ..++.++||
T Consensus 140 aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di 215 (364)
T 3qyz_A 140 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDI 215 (364)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHH
T ss_pred HHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCC-CCCCcchhH
Confidence 99999999 999999999999999999999999999976544322111 2234589999999987653 257889999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCcchhh----------------hhhhhccCCCccccchhHHHHHHHHHHHHHHh
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAYFPSW----------------VSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 223 (238)
||||+++|+|++|+.||...........+... ......................+++++.+|+.
T Consensus 216 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 295 (364)
T 3qyz_A 216 WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD 295 (364)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHH
Confidence 99999999999999999755433221111000 00000000000111112222345678999999
Q ss_pred hhccCCCCCCCCCCC
Q 037755 224 WCIQVKPADRPSMTK 238 (238)
Q Consensus 224 ~cl~~dp~~Rps~~e 238 (238)
+||+.||++|||++|
T Consensus 296 ~~L~~dP~~R~t~~e 310 (364)
T 3qyz_A 296 KMLTFNPHKRIEVEQ 310 (364)
T ss_dssp HHTCSSTTTSCCHHH
T ss_pred HHcCCChhhCCCHHH
Confidence 999999999999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=261.07 Aligned_cols=214 Identities=24% Similarity=0.388 Sum_probs=164.6
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES---RGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l 82 (238)
.....++.+|+.++++++||||+++++++.+....++||||+.+++|.+++..... ....++...++.++.+++.||
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al 153 (327)
T 2yfx_A 74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153 (327)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999999999999999999999999999854332 124688999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEcc---CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.|||+. +++||||||+||+++. +..++|+|||.+................++..|+|||.+.+. .++.++||
T Consensus 154 ~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di 228 (327)
T 2yfx_A 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDT 228 (327)
T ss_dssp HHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHH
T ss_pred HHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhH
Confidence 999999 9999999999999984 446999999988643322222222233478899999998775 67889999
Q ss_pred ehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||+++|+|++ |..||....... ............. ...+++.+.+++.+||+.||++|||++|
T Consensus 229 ~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ 294 (327)
T 2yfx_A 229 WSFGVLLWEIFSLGYMPYPSKSNQE--------VLEFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 294 (327)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCcCHHH--------HHHHHhcCCCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 999999999998 888886533221 1111111111111 1235667899999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=264.71 Aligned_cols=218 Identities=20% Similarity=0.221 Sum_probs=157.4
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....+++.+|+.+++.++||||+++++++.... ..++||||+.+ +|.+.+. ..++...+..++.||+
T Consensus 65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~ 137 (371)
T 2xrw_A 65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQML 137 (371)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHH
Confidence 345578889999999999999999999997654 78999999965 7888772 4588999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.||.|||++ +++||||||+||+++.++.++|+|||.+....... ......||+.|+|||.+.+. .++.++||
T Consensus 138 ~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~Di 209 (371)
T 2xrw_A 138 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDI 209 (371)
T ss_dssp HHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTC--CCCTTHHH
T ss_pred HHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCC--CCCchHhH
Confidence 999999999 99999999999999999999999999987543322 11234589999999999875 67889999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCc---------------chhhhhhhhccCCC------------ccccchhHHHH
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAY---------------FPSWVSDQLNKGGN------------LELRNVTEIES 212 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~---------------~~~~~~~~~~~~~~------------~~~~~~~~~~~ 212 (238)
||||+++|+|++|+.||........... +............. ...........
T Consensus 210 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (371)
T 2xrw_A 210 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289 (371)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccc
Confidence 9999999999999999975433211000 00000000000000 00011122334
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 213 MIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 213 ~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
..+..+.+|+.+||+.||++|||++|
T Consensus 290 ~~~~~~~~li~~mL~~dP~~R~t~~e 315 (371)
T 2xrw_A 290 LKASQARDLLSKMLVIDASKRISVDE 315 (371)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccHHHHHHHHHHCcCChhhCCCHHH
Confidence 56788999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=279.23 Aligned_cols=211 Identities=28% Similarity=0.452 Sum_probs=166.6
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....++|.+|+++|++++||||+++++++.+ ...++||||+.+|+|.+++.. ..+..++...+..++.||+.||+|
T Consensus 302 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~ 378 (535)
T 2h8h_A 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAY 378 (535)
T ss_dssp TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999876 678999999999999999832 123468999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +|+||||||+|||++.++.+||+|||++....... ........++..|+|||.+... .++.++||||||+
T Consensus 379 LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv 452 (535)
T 2h8h_A 379 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGI 452 (535)
T ss_dssp HHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHH
T ss_pred HHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccC--CCCchhhHHHHHH
Confidence 9999 99999999999999999999999999997554321 1111223467889999998765 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |+.||....... +...+....... .+..++..+.+||.+||+.||++|||++|
T Consensus 453 ~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 513 (535)
T 2h8h_A 453 LLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEY 513 (535)
T ss_dssp HHHHHTTTTCCSSTTCCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999 899986433221 112222211111 11235678899999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=257.87 Aligned_cols=221 Identities=20% Similarity=0.248 Sum_probs=164.0
Q ss_pred ccHHHHHHHHHHHhh--cCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGR--IHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+.+|+++++. ++||||+++++++.... ..++|+||+.+|+|.+++. ...+++..++.++.+++.
T Consensus 76 ~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~ 150 (342)
T 1b6c_B 76 REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTAS 150 (342)
T ss_dssp GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHH
Confidence 345778899999988 68999999999998765 7899999999999999983 246899999999999999
Q ss_pred HHHHhH--------cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCC
Q 037755 81 GIEYLH--------NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNF 150 (238)
Q Consensus 81 ~l~~Lh--------~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 150 (238)
||.||| +. +++||||||+||+++.++.++|+|||++.......... ......|++.|+|||.+.+..
T Consensus 151 ~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (342)
T 1b6c_B 151 GLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227 (342)
T ss_dssp HHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCC
T ss_pred HHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccc
Confidence 999999 77 99999999999999999999999999986554433211 123345899999999987641
Q ss_pred C----cccccCceehHHHHHHHHhcC----------CCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHH
Q 037755 151 G----TVSCKSDVYGFGMVLLEMTGG----------RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIAR 216 (238)
Q Consensus 151 ~----~~~~~~Di~slG~~l~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (238)
. .++.++||||||+++|+|++| ..||........ ................... .......+++
T Consensus 228 ~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 304 (342)
T 1b6c_B 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQKLRPNIP-NRWQSCEALR 304 (342)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCC-GGGGTSHHHH
T ss_pred cccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc--cHHHHHHHHHHHHhCCCCc-ccccchhHHH
Confidence 1 234679999999999999999 556643322111 1111111111111111111 1112235677
Q ss_pred HHHHHHhhhccCCCCCCCCCCC
Q 037755 217 KLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 217 ~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+.+++.+||+.||++|||+.|
T Consensus 305 ~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 305 VMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHHhccChhhCCCHHH
Confidence 8999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=260.54 Aligned_cols=222 Identities=22% Similarity=0.334 Sum_probs=155.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccC----CCCCCCCCCHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFP----KESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+++.+|+.++++++||||+++++++..++..++|+||+.+++|.+++.. .......++...+..++.|++.|
T Consensus 54 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 133 (303)
T 2vwi_A 54 QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133 (303)
T ss_dssp ------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHH
Confidence 34567888999999999999999999999999999999999999999988732 11234578999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc---ccccccCCccccCCcceeecCCCcccccCc
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|.|||+. +++||||||+||+++.++.++|+|||.+......... .......|++.|+|||.+.+. ..++.++|
T Consensus 134 l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 209 (303)
T 2vwi_A 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKAD 209 (303)
T ss_dssp HHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHH
T ss_pred HHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhh
Confidence 9999999 9999999999999999999999999988655433211 111233589999999998652 24678899
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCcccc--chhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELR--NVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
|||||+++|+|++|..||........ .............. ........+++.+.+++.+||+.||++|||+
T Consensus 210 i~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 282 (303)
T 2vwi_A 210 IWSFGITAIELATGAAPYHKYPPMKV-------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA 282 (303)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHHHHHHHhCCCCCccCchhhH-------HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH
Confidence 99999999999999999965432211 00011100000000 0001112345678999999999999999997
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
+|
T Consensus 283 ~~ 284 (303)
T 2vwi_A 283 AE 284 (303)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=257.01 Aligned_cols=210 Identities=20% Similarity=0.262 Sum_probs=165.8
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.++.+.+|+++++++. ||||+++++++..+...++|+||+.+++|.+++. ....++...+..++.+++.||.|||
T Consensus 66 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH 141 (298)
T 1phk_A 66 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALH 141 (298)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3577889999999996 9999999999999999999999999999999983 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC----CCcccccCceehH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGF 162 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~sl 162 (238)
+. +++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+. ...++.++|||||
T Consensus 142 ~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 215 (298)
T 1phk_A 142 KL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215 (298)
T ss_dssp HT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred HC---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhH
Confidence 99 999999999999999999999999999875543322 2234589999999988531 2356788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||........ ............ ......++..+.+++.+||+.||++|||++|
T Consensus 216 G~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (298)
T 1phk_A 216 GVIMYTLLAGSPPFWHRKQMLM-------LRMIMSGNYQFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280 (298)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCCC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHHCCCCCcCccHHHH-------HHHHhcCCcccC----cccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 9999999999999964332111 111111110000 0111235678999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=261.72 Aligned_cols=222 Identities=20% Similarity=0.235 Sum_probs=163.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....++.+|+.++++++||||+++++++... ...++++||+. ++|.+.+. ...++...+..++.|++.|
T Consensus 51 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~ 124 (353)
T 2b9h_A 51 LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRA 124 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHH
Confidence 4457788999999999999999999988654 67899999996 58988872 2568999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--------cccccCCccccCCcceeecCCCcc
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--------SISATRGTIGYIAPELISRNFGTV 153 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~ 153 (238)
|+|||+. +++||||||+||+++.++.++|+|||.+.......... ......||+.|+|||.+.+. ..+
T Consensus 125 L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 200 (353)
T 2b9h_A 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKY 200 (353)
T ss_dssp HHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSC-CCC
T ss_pred HHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccC-CCc
Confidence 9999999 99999999999999999999999999987654322111 11123589999999987652 367
Q ss_pred cccCceehHHHHHHHHhcCCCCCCcccccccCCcc-----------------hhhhhhhhccCCCccccchhHHHHHHHH
Q 037755 154 SCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF-----------------PSWVSDQLNKGGNLELRNVTEIESMIAR 216 (238)
Q Consensus 154 ~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (238)
+.++||||||+++|+|++|..||...........+ .........................+++
T Consensus 201 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
T 2b9h_A 201 SRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNP 280 (353)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCH
Confidence 88999999999999999999999754422110000 0000000001011111112222335678
Q ss_pred HHHHHHhhhccCCCCCCCCCCC
Q 037755 217 KLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 217 ~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+.+|+.+||+.||++|||++|
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 281 KGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHhcCcCcccCCCHHH
Confidence 8999999999999999999854
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=281.86 Aligned_cols=204 Identities=21% Similarity=0.225 Sum_probs=167.3
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+.+..|..+++.+ +||||+++++++.+...+|+||||+.+|+|.+++. ....+++..+..++.||+.||.||
T Consensus 383 ~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~L 458 (674)
T 3pfq_A 383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFL 458 (674)
T ss_dssp TTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4557788999999998 69999999999999999999999999999999983 335799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +|+||||||+|||++.++.++|+|||++........ ......||+.|+|||++.+. .++.++|+||||++
T Consensus 459 H~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvi 531 (674)
T 3pfq_A 459 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVL 531 (674)
T ss_dssp HHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHH
T ss_pred HhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHH
Confidence 999 999999999999999999999999999875332221 12334599999999999776 77899999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|..||........ ....... ... .+..+++++.+|+.+||+.||++||++
T Consensus 532 lyelltG~~Pf~~~~~~~~-------~~~i~~~-~~~-------~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 532 LYEMLAGQAPFEGEDEDEL-------FQSIMEH-NVA-------YPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------HHHHHSS-CCC-------CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred HHHHHcCCCCCCCCCHHHH-------HHHHHhC-CCC-------CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 9999999999975433211 1111111 111 112457789999999999999999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=255.74 Aligned_cols=211 Identities=24% Similarity=0.385 Sum_probs=156.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|++++++++||||+++++++.+ ..++||||+.+++|.+++.... ....++...++.++.|++.||.||
T Consensus 42 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~L 118 (307)
T 2eva_A 42 ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYL 118 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999999998874 4889999999999999984322 123578899999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCc-cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFV-PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+.+..+++||||||+||+++.++. ++|+|||.+....... ....|+..|+|||.+.+. .++.++||||||+
T Consensus 119 H~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~ 191 (307)
T 2eva_A 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGI 191 (307)
T ss_dssp HTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCC--CCCTHHHHHHHHH
T ss_pred HhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceEChhhhCCC--CCCcHHHHHHHHH
Confidence 9921129999999999999998886 7999999986443221 223489999999999875 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|+.||........ . ............ ....+++.+.+++.+||+.||++|||++|
T Consensus 192 il~el~~g~~p~~~~~~~~~-----~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 253 (307)
T 2eva_A 192 ILWEVITRRKPFDEIGGPAF-----R-IMWAVHNGTRPP------LIKNLPKPIESLMTRCWSKDPSQRPSMEE 253 (307)
T ss_dssp HHHHHHHTCCTTTTTCSSHH-----H-HHHHHHTTCCCC------CBTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHCCCCchhhCccHH-----H-HHHHHhcCCCCC------cccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 99999999999964322110 0 001111111111 11234667899999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=259.65 Aligned_cols=211 Identities=25% Similarity=0.365 Sum_probs=164.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|++++++++||||+++++++.++. .++++||+.+++|.+++.. ....+++..+..++.+++.||.||
T Consensus 62 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l 137 (291)
T 1u46_A 62 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 137 (291)
T ss_dssp CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999998754 8899999999999998832 235689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|++ +++|+||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+. .++.++||||||+
T Consensus 138 H~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ 212 (291)
T 1u46_A 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGV 212 (291)
T ss_dssp HHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHH
T ss_pred HhC---CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHH
Confidence 999 99999999999999999999999999987665443221 11223477889999999775 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |..||....... ............. ....+++.+.+++.+||+.||++|||++|
T Consensus 213 il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 274 (291)
T 1u46_A 213 TLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGERLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVA 274 (291)
T ss_dssp HHHHHHTTSCCTTTTCCHHH-------HHHHHHTSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCcccCCHHH-------HHHHHHccCCCCC------CCcCcCHHHHHHHHHHccCCcccCcCHHH
Confidence 9999999 999986543221 1111111111111 11235678999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=261.97 Aligned_cols=216 Identities=21% Similarity=0.265 Sum_probs=161.3
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCee------eEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR------ALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~------~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|+.+++.++||||+++++++...... ++|+||+. ++|.+.+ ...+++..+..++.|++.
T Consensus 83 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~ 155 (371)
T 4exu_A 83 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLK 155 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHH
Confidence 3467889999999999999999999999876654 99999996 5888877 345999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||+. +|+||||||+||+++.++.++|+|||.+....... ....+|+.|+|||.+.+. ..++.++|||
T Consensus 156 aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~Diw 226 (371)
T 4exu_A 156 GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSW-MHYNQTVDIW 226 (371)
T ss_dssp HHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCC-SCCCTTHHHH
T ss_pred HHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccCc-----CCcccCccccCHHHhcCC-CCCCcHHhHH
Confidence 99999999 99999999999999999999999999987543321 233589999999998763 3678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchh----------------hhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPS----------------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|||+++|+|++|+.||...........+.. .......................+++.+.+|+.+
T Consensus 227 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 306 (371)
T 4exu_A 227 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 306 (371)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHH
Confidence 999999999999999975432211000000 0000000001111111122223457889999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 307 ~L~~dP~~Rpt~~e 320 (371)
T 4exu_A 307 MLELDVDKRLTAAQ 320 (371)
T ss_dssp HSCSCTTTSCCHHH
T ss_pred HCCCChhhcCCHHH
Confidence 99999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=264.46 Aligned_cols=219 Identities=21% Similarity=0.223 Sum_probs=158.0
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEe-----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+++.+|+.++++++||||+++++++.. ....++||||+. |+|.+.+. .....++...+..++.||+.||.
T Consensus 73 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~ 148 (362)
T 3pg1_A 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLH 148 (362)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHH
Confidence 4889999999999999999999999843 346899999997 58888773 23457999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|||+. +++||||||+||+++.++.++|+|||.+........ .....+++.|+|||.+.+. ..++.++||||||
T Consensus 149 ~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG 221 (362)
T 3pg1_A 149 VLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAG 221 (362)
T ss_dssp HHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHH
T ss_pred HHHHC---cCEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHH
Confidence 99999 999999999999999999999999999864333221 2233588999999998763 3678899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchh----------------hhhhhh-ccCCCccccchhHHHHHHHHHHHHHHhhhc
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPS----------------WVSDQL-NKGGNLELRNVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 226 (238)
+++|+|++|+.||...........+.. ...... ..................++.+.+|+.+||
T Consensus 222 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 301 (362)
T 3pg1_A 222 CVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKML 301 (362)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHh
Confidence 999999999999975432221100000 000000 000111111222233445778999999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||++|||++|
T Consensus 302 ~~dP~~Rpt~~e 313 (362)
T 3pg1_A 302 EFNPQRRISTEQ 313 (362)
T ss_dssp CSSGGGSCCHHH
T ss_pred cCChhhCCCHHH
Confidence 999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=253.68 Aligned_cols=221 Identities=19% Similarity=0.256 Sum_probs=157.6
Q ss_pred cHHHHHHHHHHHhhc--CCCcceeeeeEEEeC----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI--HHVNVVQLLGFCSEG----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+.+|.+++..+ +||||+++++++... ...++||||+.+|+|.+++. ...+++..++.++.+++.|
T Consensus 72 ~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~ 146 (337)
T 3mdy_A 72 EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSG 146 (337)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHH
Confidence 345556677776665 899999999999877 78999999999999999982 3468999999999999999
Q ss_pred HHHhHcCC-----CCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc--ccccCCccccCCcceeecCCCccc
Q 037755 82 IEYLHNGC-----DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTVS 154 (238)
Q Consensus 82 l~~Lh~~~-----~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~ 154 (238)
|.|||+.+ ..+++||||||+||+++.++.++|+|||++........... .....||+.|+|||.+.+. ...
T Consensus 147 l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~ 224 (337)
T 3mdy_A 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNR 224 (337)
T ss_dssp HHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCT
T ss_pred HHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCC
Confidence 99999741 23899999999999999999999999999865544322211 1233599999999998764 223
Q ss_pred c------cCceehHHHHHHHHhcCCC----------CCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHH
Q 037755 155 C------KSDVYGFGMVLLEMTGGRR----------NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKL 218 (238)
Q Consensus 155 ~------~~Di~slG~~l~~ll~g~~----------p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 218 (238)
. ++||||||+++|+|++|.. ||........ .... ......................+++.+
T Consensus 225 ~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (337)
T 3mdy_A 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP--SYED-MREIVCIKKLRPSFPNRWSSDECLRQM 301 (337)
T ss_dssp TCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHH-HHHHHTTSCCCCCCCGGGGGSHHHHHH
T ss_pred ccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC--chhh-hHHHHhhhccCccccccchhhHHHHHH
Confidence 3 4899999999999999944 4432211111 1111 111111111111111112234678889
Q ss_pred HHHHhhhccCCCCCCCCCCC
Q 037755 219 CVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 219 ~~li~~cl~~dp~~Rps~~e 238 (238)
.+++.+||+.||++|||+.|
T Consensus 302 ~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 302 GKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp HHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHhhhhChhhCCCHHH
Confidence 99999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=262.55 Aligned_cols=213 Identities=23% Similarity=0.312 Sum_probs=159.1
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEe------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
....+.+.+|+.+++++ +||||+++++++.. ....++||||+.+++|.+++... ....++...+..++.||
T Consensus 61 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi 138 (326)
T 2x7f_A 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREI 138 (326)
T ss_dssp SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHH
Confidence 44567899999999999 79999999999976 46889999999999999998432 24578999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSC 155 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~ 155 (238)
+.||.|||+. +++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+... ...++.
T Consensus 139 ~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 213 (326)
T 2x7f_A 139 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDF 213 (326)
T ss_dssp HHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCT
T ss_pred HHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCc
Confidence 9999999999 999999999999999999999999999865433211 11233589999999998631 125678
Q ss_pred cCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 156 KSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
++||||||+++|+|++|..||........ ... .......... ...+++.+.+++.+||+.||++|||
T Consensus 214 ~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~-~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps 280 (326)
T 2x7f_A 214 KSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFL-IPRNPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPA 280 (326)
T ss_dssp THHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHH-HHHSCCCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCC
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHH-hhcCccccCC-----ccccCHHHHHHHHHHhccChhhCCC
Confidence 89999999999999999999864332111 000 1010000000 1224567899999999999999999
Q ss_pred CCC
Q 037755 236 MTK 238 (238)
Q Consensus 236 ~~e 238 (238)
++|
T Consensus 281 ~~~ 283 (326)
T 2x7f_A 281 TEQ 283 (326)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=260.66 Aligned_cols=219 Identities=23% Similarity=0.294 Sum_probs=165.9
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEE----eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
+....+.+.+|+.++++++||||+++++++. .....++|+||+.+++|.+++......+..+++..++.++.|++.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 145 (317)
T 2buj_A 66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145 (317)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 3456788999999999999999999999986 234789999999999999988544344678999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-------cccccCCccccCCcceeecCC-Cc
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-------SISATRGTIGYIAPELISRNF-GT 152 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~-~~ 152 (238)
||.|||+. +++||||||+||+++.++.++|+|||.+.......... ......|++.|+|||.+.+.. ..
T Consensus 146 ~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 146 GLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred HHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence 99999999 99999999999999999999999999876443221110 011223789999999987541 13
Q ss_pred ccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
++.++||||||+++|+|++|..||........ ..... ......... ...+++.+.+++.+||+.||++
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALA----VQNQLSIPQ------SPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHH----HHCC--CCC------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHH----hhccCCCCc------cccCCHHHHHHHHHHhhcChhh
Confidence 57899999999999999999999854322111 01111 111000000 1234668999999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 291 Rps~~~ 296 (317)
T 2buj_A 291 RPHIPL 296 (317)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=257.30 Aligned_cols=206 Identities=17% Similarity=0.079 Sum_probs=163.7
Q ss_pred ccHHHHHHHHHHHhhcC---CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC-CCCCCCCHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE-SRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 82 (238)
....++.+|++++++++ |+||+++++++..++..++||||+.+|+|.+++.... .....+++..++.++.||+.||
T Consensus 106 ~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L 185 (365)
T 3e7e_A 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185 (365)
T ss_dssp CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHH
T ss_pred CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence 45677889999999886 9999999999999999999999999999999984321 1356799999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEcc-----------CCccccccccccccCCCCCccccccccCCccccCCcceeecCCC
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDH-----------NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 151 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~-----------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 151 (238)
+|||+. +|+||||||+|||++. ++.++|+|||++................||..|+|||.+.+.
T Consensus 186 ~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 260 (365)
T 3e7e_A 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-- 260 (365)
T ss_dssp HHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--
T ss_pred HHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--
Confidence 999998 9999999999999998 899999999999644322222223445699999999999876
Q ss_pred cccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 152 TVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 152 ~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
.++.++||||||+++|+|++|+.||......... .. . ..... ...+.+.+++..||+.+|.
T Consensus 261 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~----~-------~~~~~------~~~~~~~~~~~~~l~~~p~ 321 (365)
T 3e7e_A 261 PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--PE----G-------LFRRL------PHLDMWNEFFHVMLNIPDC 321 (365)
T ss_dssp CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--EC----S-------CCTTC------SSHHHHHHHHHHHHCCCCT
T ss_pred CCCccccHHHHHHHHHHHHhCCCccccCCCCcee--ec----h-------hcccc------CcHHHHHHHHHHHcCCCCC
Confidence 6889999999999999999999998543321110 00 0 00000 1245677899999999999
Q ss_pred CCCCC
Q 037755 232 DRPSM 236 (238)
Q Consensus 232 ~Rps~ 236 (238)
+|++.
T Consensus 322 ~r~~~ 326 (365)
T 3e7e_A 322 HHLPS 326 (365)
T ss_dssp TCCCC
T ss_pred CcchH
Confidence 99764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=259.71 Aligned_cols=221 Identities=22% Similarity=0.293 Sum_probs=165.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCc------ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVN------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
.....+.+.+|+++++.++|++ ++++++++...+..++||||+ +++|.+++.. .....++...+..++.|+
T Consensus 51 ~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi 127 (339)
T 1z57_A 51 VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQI 127 (339)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHH
Confidence 3445678899999999997654 999999999999999999999 7899998833 223468899999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEcc-------------------CCccccccccccccCCCCCccccccccCCccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDH-------------------NFVPNVSDFGLAKFHPKENDFVSISATRGTIG 139 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~-------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 139 (238)
+.||+|||++ +++||||||+||+++. ++.++|+|||.+....... ....||+.
T Consensus 128 ~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~ 199 (339)
T 1z57_A 128 CKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRH 199 (339)
T ss_dssp HHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGG
T ss_pred HHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCcc
Confidence 9999999999 9999999999999987 6689999999987543322 23358999
Q ss_pred cCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcc-------hhhhhhhhccC-----CCc-----
Q 037755 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF-------PSWVSDQLNKG-----GNL----- 202 (238)
Q Consensus 140 ~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~-----~~~----- 202 (238)
|+|||.+.+. .++.++||||||+++|+|++|..||...........+ +.......... ...
T Consensus 200 y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
T 1z57_A 200 YRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277 (339)
T ss_dssp GCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTT
T ss_pred ccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccccc
Confidence 9999999875 6788999999999999999999999754432211100 00000000000 000
Q ss_pred ------------cccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 203 ------------ELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 203 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
............++.+.+|+.+||+.||++|||++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 000000112345788999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=261.04 Aligned_cols=226 Identities=21% Similarity=0.282 Sum_probs=156.2
Q ss_pred cHHHHHHHHHHH--hhcCCCcceeeeeEEEe-----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTI--GRIHHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 8 ~~~~~~~e~~~l--~~l~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
..+.+..|.+++ +.++||||+++++.+.. ....++||||+.+|+|.+++. ....++..+..++.||+.
T Consensus 48 ~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~ 122 (336)
T 3g2f_A 48 NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTR 122 (336)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHH
Confidence 345555555554 45899999999986532 336789999999999999982 234588899999999999
Q ss_pred HHHHhHcCC------CCceeeeccCCCcEEEccCCccccccccccccCCCCCcc------ccccccCCccccCCcceeec
Q 037755 81 GIEYLHNGC------DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF------VSISATRGTIGYIAPELISR 148 (238)
Q Consensus 81 ~l~~Lh~~~------~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~ 148 (238)
||.|||+.+ ..+|+||||||+|||++.++.++|+|||++......... .......||+.|+|||.+.+
T Consensus 123 ~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp HHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred HHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 999999752 228999999999999999999999999999765432211 11123359999999999876
Q ss_pred CC-----CcccccCceehHHHHHHHHhcCCCCCCccccccc-CCcchh---------hhhh-hhccCCCccccchhHHHH
Q 037755 149 NF-----GTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSS-KAYFPS---------WVSD-QLNKGGNLELRNVTEIES 212 (238)
Q Consensus 149 ~~-----~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~---------~~~~-~~~~~~~~~~~~~~~~~~ 212 (238)
.. ..++.++||||||+++|+|++|..||........ ...+.. .... ..................
T Consensus 203 ~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
T 3g2f_A 203 AVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282 (336)
T ss_dssp CCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCS
T ss_pred CcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccccc
Confidence 21 1456789999999999999999776643322221 111100 0000 001111111111111123
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 213 MIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 213 ~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.+++.+.+|+.+||+.||++|||++|
T Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 283 LAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred chHHHHHHHHHHHhcCChhhCcchHH
Confidence 46778999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=255.66 Aligned_cols=214 Identities=21% Similarity=0.296 Sum_probs=161.9
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+++.+|++++++++||||+++++++..+...++|+||+.+++|.+++.. ....++...+..++.+++.||.|
T Consensus 56 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~ 132 (302)
T 2j7t_A 56 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNF 132 (302)
T ss_dssp --CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999988732 23568999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeec---CCCcccccCceeh
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYG 161 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Di~s 161 (238)
||+. +++||||||+||+++.++.++|+|||.+....... .......|+..|+|||.+.. ....++.++||||
T Consensus 133 lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 207 (302)
T 2j7t_A 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 207 (302)
T ss_dssp HHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHH
T ss_pred HhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHH
Confidence 9999 99999999999999999999999999864221110 11122348999999999842 1125678899999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++|..||........ ..... ........ .+..++..+.+++.+||+.||++|||++|
T Consensus 208 lG~il~~l~~g~~p~~~~~~~~~-------~~~~~-~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 272 (302)
T 2j7t_A 208 LGITLIEMAQIEPPHHELNPMRV-------LLKIA-KSDPPTLL----TPSKWSVEFRDFLKIALDKNPETRPSAAQ 272 (302)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHH-------HHHHH-HSCCCCCS----SGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHhcCCCCCccCCHHHH-------HHHHh-ccCCcccC----CccccCHHHHHHHHHHcccChhhCCCHHH
Confidence 99999999999999865332211 11111 11111111 11234667899999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=254.39 Aligned_cols=201 Identities=25% Similarity=0.409 Sum_probs=160.4
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEe----------------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSE----------------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ 72 (238)
.+.+.+|++++++++||||+++++++.. ....+++|||+.+++|.+++... ....+++..++
T Consensus 48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~ 125 (284)
T 2a19_B 48 NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLAL 125 (284)
T ss_dssp SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHH
T ss_pred cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHH
Confidence 3567899999999999999999998854 44589999999999999998432 23578999999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........ .....+++.|+|||.+.+. .
T Consensus 126 ~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~ 197 (284)
T 2a19_B 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--D 197 (284)
T ss_dssp HHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--C
T ss_pred HHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccC--C
Confidence 9999999999999999 999999999999999999999999999876544322 1233489999999999875 6
Q ss_pred ccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
++.++||||||+++|+|++|..|+..... ......... ....++..+.+++.+||+.||++
T Consensus 198 ~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~ 258 (284)
T 2a19_B 198 YGKEVDLYALGLILAELLHVCDTAFETSK----------FFTDLRDGI---------ISDIFDKKEKTLLQKLLSKKPED 258 (284)
T ss_dssp CCTHHHHHHHHHHHHHHHSCCSSHHHHHH----------HHHHHHTTC---------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CcchhhhHHHHHHHHHHHhcCCcchhHHH----------HHHHhhccc---------ccccCCHHHHHHHHHHccCChhh
Confidence 78899999999999999999887642110 001111110 01224567889999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||+.|
T Consensus 259 Rps~~e 264 (284)
T 2a19_B 259 RPNTSE 264 (284)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=268.71 Aligned_cols=204 Identities=14% Similarity=0.131 Sum_probs=152.0
Q ss_pred cccHHHHHHHH---HHHhhcCCCcceeee-------eEEEeCC-----------------eeeEEEEeCCCCChhhhccC
Q 037755 6 KFSAEEFINEV---STIGRIHHVNVVQLL-------GFCSEGS-----------------KRALVYEFMPNGSLDRHIFP 58 (238)
Q Consensus 6 ~~~~~~~~~e~---~~l~~l~h~ni~~~~-------~~~~~~~-----------------~~~lv~e~~~~~sL~~~~~~ 58 (238)
....+.+.+|+ +++++++||||++++ +++.+.+ ..+++|||+ +|+|.+++..
T Consensus 114 ~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~ 192 (377)
T 3byv_A 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEV 192 (377)
T ss_dssp TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHh
Confidence 34568899999 455555899999998 7666553 288999999 6799998842
Q ss_pred CC---CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccC
Q 037755 59 KE---SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATR 135 (238)
Q Consensus 59 ~~---~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 135 (238)
.. .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...... .....
T Consensus 193 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~ 264 (377)
T 3byv_A 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSV 264 (377)
T ss_dssp HHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCC
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCC
Confidence 11 1122344588889999999999999999 9999999999999999999999999998753331 12334
Q ss_pred CccccCCcceeecC---------CCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccc
Q 037755 136 GTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRN 206 (238)
Q Consensus 136 ~~~~~~aPE~~~~~---------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (238)
| +.|+|||.+.+. ...++.++||||||+++|+|++|+.||...........+. . .
T Consensus 265 g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~---~-------- 328 (377)
T 3byv_A 265 S-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF----R---S-------- 328 (377)
T ss_dssp C-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG----S---S--------
T ss_pred C-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh----h---h--------
Confidence 6 999999998753 0146789999999999999999999996544332211110 0 0
Q ss_pred hhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 207 VTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 207 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
...+++++.+|+.+||+.||++|||+.|
T Consensus 329 ----~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 329 ----CKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp ----CCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred ----ccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 0234678899999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=266.45 Aligned_cols=218 Identities=21% Similarity=0.200 Sum_probs=157.2
Q ss_pred HHHHHHHhhcCCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 13 INEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.+|++++++++||||+++++++.... ..++||||+.+ ++.+.+.........+++..++.++.||+.||+|||
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH 158 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999985433 37899999976 443333211223568999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+. +|+||||||+||+++ .++.++|+|||++......... ....+|+.|+|||.+.+. ..++.++|||||||+
T Consensus 159 ~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~i 231 (394)
T 4e7w_A 159 SI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCV 231 (394)
T ss_dssp HT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHH
T ss_pred HC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHH
Confidence 99 999999999999999 7999999999999765333221 223489999999998764 357889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhh-----------hhhhhccCCCccccc---hhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSW-----------VSDQLNKGGNLELRN---VTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
+|+|++|+.||...........+... ............... .......+++++.+|+.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (394)
T 4e7w_A 232 MAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311 (394)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChh
Confidence 99999999999765432211100000 000000000000000 0111223567899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||+.|
T Consensus 312 ~R~t~~e 318 (394)
T 4e7w_A 312 ARLTAIE 318 (394)
T ss_dssp GSCCHHH
T ss_pred hCCCHHH
Confidence 9999753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=253.49 Aligned_cols=207 Identities=27% Similarity=0.408 Sum_probs=156.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....+++.+|++++++++||||+++++++.+ +...++|+||+.+++|.+++... ....++...+..++.+++.||.|
T Consensus 55 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~ 132 (278)
T 1byg_A 55 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEY 132 (278)
T ss_dssp CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHH
Confidence 3466889999999999999999999998744 45789999999999999988321 11237889999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++||||||+||+++.++.++|+|||.+....... ....++..|+|||.+.+. .++.++||||||+
T Consensus 133 lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ 202 (278)
T 1byg_A 133 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK--KFSTKSDVWSFGI 202 (278)
T ss_dssp HHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHC--CCCHHHHHHHHHH
T ss_pred HHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCC--CCCchhcHHHHHH
Confidence 9999 99999999999999999999999999986443322 122478899999998775 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++ |..||........ ........... .+..+++.+.+++.+||+.||++|||+.|
T Consensus 203 il~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 263 (278)
T 1byg_A 203 LLWEIYSFGRVPYPRIPLKDV--------VPRVEKGYKMD------APDGCPPAVYEVMKNCWHLDAAMRPSFLQ 263 (278)
T ss_dssp HHHHHHTTSCCSCTTSCGGGH--------HHHHTTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHH--------HHHHhcCCCCC------CcccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 9999998 9999865432211 11111111111 11235678899999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=265.69 Aligned_cols=219 Identities=17% Similarity=0.161 Sum_probs=160.0
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEe--------------------------------------CCeeeEEEEeCCCCChh
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSE--------------------------------------GSKRALVYEFMPNGSLD 53 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~sL~ 53 (238)
..+|+++++.++||||+++++++.. +...++||||+. ++|.
T Consensus 47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 125 (383)
T 3eb0_A 47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH 125 (383)
T ss_dssp CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHH
T ss_pred HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHH
Confidence 3579999999999999999999843 334889999997 4877
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCcccccc
Q 037755 54 RHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSIS 132 (238)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~ 132 (238)
+.+......+..+++..++.++.||+.||+|||+. +|+||||||+||+++ .++.++|+|||.+......... .
T Consensus 126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~ 199 (383)
T 3eb0_A 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---V 199 (383)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---C
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---c
Confidence 76643223457899999999999999999999999 999999999999998 6889999999999755443321 2
Q ss_pred ccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchh--------hhhh---hhccCCC
Q 037755 133 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPS--------WVSD---QLNKGGN 201 (238)
Q Consensus 133 ~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~---~~~~~~~ 201 (238)
...+++.|+|||.+.+. ..++.++||||+|+++|+|++|+.||...........+.. .... .......
T Consensus 200 ~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 278 (383)
T 3eb0_A 200 AYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF 278 (383)
T ss_dssp CCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCC
T ss_pred CcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccC
Confidence 33488999999998764 3578899999999999999999999976443221110000 0000 0000000
Q ss_pred cc---ccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 202 LE---LRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 202 ~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
.. .......+..+++.+.+|+.+||+.||++|||+.|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 00 00011122335678999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=257.06 Aligned_cols=223 Identities=20% Similarity=0.264 Sum_probs=162.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEE--------------eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCS--------------EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL 71 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~ 71 (238)
....+++.+|++++++++||||+++++++. +....++|+||+. |+|.+++ ....++...+
T Consensus 49 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~-----~~~~~~~~~~ 122 (320)
T 2i6l_A 49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL-----EQGPLLEEHA 122 (320)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHH-----TTCCCCHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHh-----hcCCccHHHH
Confidence 345678899999999999999999999873 4467899999997 5999988 2357899999
Q ss_pred HHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecC
Q 037755 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRN 149 (238)
Q Consensus 72 ~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~ 149 (238)
+.++.|++.||+|||+. +++||||||+||+++ .++.++|+|||.+......... .......++..|+|||.+.+.
T Consensus 123 ~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (320)
T 2i6l_A 123 RLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP 199 (320)
T ss_dssp HHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT
T ss_pred HHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCc
Confidence 99999999999999999 999999999999997 5679999999998755432111 111223478899999988653
Q ss_pred CCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchh-------hhhhhhc--------cCCCccccchhHHHHHH
Q 037755 150 FGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPS-------WVSDQLN--------KGGNLELRNVTEIESMI 214 (238)
Q Consensus 150 ~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------~~~~~~~--------~~~~~~~~~~~~~~~~~ 214 (238)
..++.++||||||+++|+|++|+.||...........+.. ....... ................+
T Consensus 200 -~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (320)
T 2i6l_A 200 -NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI 278 (320)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTC
T ss_pred -ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchh
Confidence 2678899999999999999999999975443211000000 0000000 00000111112222346
Q ss_pred HHHHHHHHhhhccCCCCCCCCCCC
Q 037755 215 ARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 215 ~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++.+.+|+.+||+.||++|||++|
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 279 SREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hHHHHHHHHHHcCCCccccCCHHH
Confidence 788999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.17 Aligned_cols=168 Identities=20% Similarity=0.284 Sum_probs=129.7
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEE--eCCeeeEEEEeCCCCChhhhccC-----CCCCCCCCCHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEFMPNGSLDRHIFP-----KESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
.+.+.+|+.+|++++||||+++++++. .+...++||||+. ++|.+.+.. .......+++..++.++.||+.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 457889999999999999999999994 4678999999996 488776621 11223358999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEE----ccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCccccc
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILL----DHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
|+|||+. +|+||||||+|||+ +.++.++|+|||++......... .......||+.|+|||++.+. ..++.+
T Consensus 141 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 216 (405)
T 3rgf_A 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKA 216 (405)
T ss_dssp HHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHH
T ss_pred HHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-Ccccch
Confidence 9999999 99999999999999 67789999999999765432211 112234589999999998764 257889
Q ss_pred CceehHHHHHHHHhcCCCCCCcccc
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKAT 181 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~ 181 (238)
+|||||||++|+|++|..||.....
T Consensus 217 ~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 217 IDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred hhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999965443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=265.00 Aligned_cols=215 Identities=8% Similarity=0.004 Sum_probs=146.4
Q ss_pred cccHHHHHHHHHHHhhc--CCCcceeee-------eEEEeC-----------------CeeeEEEEeCCCCChhhhccCC
Q 037755 6 KFSAEEFINEVSTIGRI--HHVNVVQLL-------GFCSEG-----------------SKRALVYEFMPNGSLDRHIFPK 59 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l--~h~ni~~~~-------~~~~~~-----------------~~~~lv~e~~~~~sL~~~~~~~ 59 (238)
....+.+.+|+.+++.+ +||||++++ +++... ...++||||+. |+|.+++...
T Consensus 103 ~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 181 (371)
T 3q60_A 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH
T ss_pred ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh
Confidence 34567788886655555 599987755 555433 33799999998 7999998432
Q ss_pred CCCCCCCCHHHH------HHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccc
Q 037755 60 ESRGQSCSWEKL------HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISA 133 (238)
Q Consensus 60 ~~~~~~~~~~~~------~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 133 (238)
+..++...+ ..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 182 ---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~ 250 (371)
T 3q60_A 182 ---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PA 250 (371)
T ss_dssp ---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EG
T ss_pred ---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cC
Confidence 223444455 67789999999999999 99999999999999999999999999997554322 12
Q ss_pred cCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHH
Q 037755 134 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESM 213 (238)
Q Consensus 134 ~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (238)
..+++.|+|||.+.+....++.++||||||+++|+|++|+.||.............. ...... ....... ....
T Consensus 251 ~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~-~~~~~~~----~~~~ 324 (371)
T 3q60_A 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP-SLRVPG-TDSLAFG----SCTP 324 (371)
T ss_dssp GGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBC-CTTSCC-CCSCCCT----TSSC
T ss_pred ccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhh-hhhhcc-ccccchh----hccC
Confidence 347799999999976222678899999999999999999999976543322111100 000000 0000000 1123
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 214 IARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 214 ~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++.+.+|+.+||+.||++|||++|
T Consensus 325 ~~~~~~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 325 LPDFVKTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp CCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHH
Confidence 5678999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=257.65 Aligned_cols=216 Identities=21% Similarity=0.280 Sum_probs=160.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe------eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+++.+|+.++++++||||+++++++..... .+++|||+. ++|.+.+ ...+++..+..++.||+.
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~ 137 (353)
T 3coi_A 65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLK 137 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHH
Confidence 345788999999999999999999999977654 499999996 5888877 245899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||++ +++||||||+||+++.++.++|+|||.+...... .....+++.|+|||.+.+. ..++.++|||
T Consensus 138 al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~ 208 (353)
T 3coi_A 138 GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIW 208 (353)
T ss_dssp HHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCC-SCCCTTHHHH
T ss_pred HHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHH
Confidence 99999999 9999999999999999999999999998754322 1223589999999998763 3678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchh--------h--------hhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPS--------W--------VSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~--------~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|||+++|+|++|..||...........+.. + ......................+++.+.+|+.+
T Consensus 209 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 3coi_A 209 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288 (353)
T ss_dssp HHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH
Confidence 999999999999999975442211000000 0 000000000000111111223457789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 289 ~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 289 MLELDVDKRLTAAQ 302 (353)
T ss_dssp HSCSCTTTSCCHHH
T ss_pred HcCCCcccCCCHHH
Confidence 99999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=264.04 Aligned_cols=163 Identities=22% Similarity=0.280 Sum_probs=139.0
Q ss_pred ccccHHHHHHHHHHHhhc------CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRI------HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
.....+.+.+|+.+++.+ .|+||+++++++......+++|||+. ++|.+++... ....+++..+..++.||
T Consensus 133 ~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi 209 (429)
T 3kvw_A 133 EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSI 209 (429)
T ss_dssp CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHH
Confidence 344457788899999988 57799999999999999999999995 5998888432 23468999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCc--cccccccccccCCCCCccccccccCCccccCCcceeecCCCccccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFV--PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
+.||+|||+. +|+||||||+|||++.++. ++|+|||++....... ....+|+.|+|||++.+. .++.+
T Consensus 210 ~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~ 279 (429)
T 3kvw_A 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGA--RYGMP 279 (429)
T ss_dssp HHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTB--CCCTH
T ss_pred HHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCC--CCCch
Confidence 9999999999 9999999999999998887 9999999986543322 223589999999999876 67899
Q ss_pred CceehHHHHHHHHhcCCCCCCccc
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
+|||||||++|+|++|..||....
T Consensus 280 ~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 280 IDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=254.05 Aligned_cols=209 Identities=23% Similarity=0.321 Sum_probs=164.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|++++++++||||+++++++.+....++++||+.+++|.+.+. ....++...++.++.+++.||.||
T Consensus 62 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~L 137 (287)
T 2wei_A 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYM 137 (287)
T ss_dssp SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999988873 235789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccC---CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHN---FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|+. +++||||||+||+++.+ +.++|+|||.+......... ....++..|+|||.+.+ .++.++|||||
T Consensus 138 H~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~Di~sl 208 (287)
T 2wei_A 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSA 208 (287)
T ss_dssp HHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT---CCCTHHHHHHH
T ss_pred HHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc---ccccCcccccChHHhcC---CCCCchhhHhH
Confidence 999 99999999999999754 46999999998755433221 22237889999999865 46788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|..||....... ............. ......+++.+.+++.+||+.||++|||++|
T Consensus 209 G~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 273 (287)
T 2wei_A 209 GVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAFD---LPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273 (287)
T ss_dssp HHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCC---SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCC---chhhhhcCHHHHHHHHHHcccChhhCcCHHH
Confidence 999999999999996543221 1111111111000 0111235678899999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=262.51 Aligned_cols=222 Identities=22% Similarity=0.280 Sum_probs=163.6
Q ss_pred ccccHHHHHHHHHHHhhcC--------CCcceeeeeEEE----eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIH--------HVNVVQLLGFCS----EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLH 72 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~--------h~ni~~~~~~~~----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ 72 (238)
.....+.+.+|+.++++++ |+||+++++++. ++...++||||+ ++++.+.+.. .....+++..++
T Consensus 73 ~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~ 149 (397)
T 1wak_A 73 AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVK 149 (397)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHH
T ss_pred CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHH
Confidence 3445678899999999995 788999999987 556899999999 5577666632 223579999999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCC-------------------------------------------
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF------------------------------------------- 109 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~------------------------------------------- 109 (238)
.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 150 ~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (397)
T 1wak_A 150 KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEP 227 (397)
T ss_dssp HHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSG
T ss_pred HHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccc
Confidence 99999999999999852 899999999999998765
Q ss_pred ------ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccc
Q 037755 110 ------VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183 (238)
Q Consensus 110 ------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~ 183 (238)
.++|+|||.+....... ....||..|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 228 ~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 228 KNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp GGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred ccccccceEeccccccccccccC-----ccCCCCCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 79999999987554321 233589999999999876 67889999999999999999999997544332
Q ss_pred cCCcchh--hhhhhhc------------------cC------CCccccc-------hhHHHHHHHHHHHHHHhhhccCCC
Q 037755 184 SKAYFPS--WVSDQLN------------------KG------GNLELRN-------VTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 184 ~~~~~~~--~~~~~~~------------------~~------~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
....... ....... .. ....... ........++.+.+|+.+||+.||
T Consensus 301 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 380 (397)
T 1wak_A 301 YTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP 380 (397)
T ss_dssp SCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSG
T ss_pred cCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccCh
Confidence 1110000 0000000 00 0000000 001235567889999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||++|
T Consensus 381 ~~Rpt~~e 388 (397)
T 1wak_A 381 EKRATAAE 388 (397)
T ss_dssp GGSCCHHH
T ss_pred hhcCCHHH
Confidence 99999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=254.41 Aligned_cols=214 Identities=22% Similarity=0.307 Sum_probs=156.0
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEe-------------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-------------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL 71 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~ 71 (238)
+....+.+.+|+.++++++||||+++++++.+ ....++|+||+.+++|.+++.. ....++...+
T Consensus 42 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~ 118 (303)
T 1zy4_A 42 TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEY 118 (303)
T ss_dssp EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHH
T ss_pred cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHH
Confidence 34456788999999999999999999998754 3568999999999999999832 3457788999
Q ss_pred HHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc------------cccccccCCccc
Q 037755 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND------------FVSISATRGTIG 139 (238)
Q Consensus 72 ~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~ 139 (238)
+.++.|++.||.|||++ +++||||||+||+++.++.++|+|||.+........ ........|+..
T Consensus 119 ~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (303)
T 1zy4_A 119 WRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM 195 (303)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CT
T ss_pred HHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCccc
Confidence 99999999999999999 999999999999999999999999999875543211 011123348899
Q ss_pred cCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHH
Q 037755 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLC 219 (238)
Q Consensus 140 ~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 219 (238)
|+|||.+.+. ..++.++||||||+++|+|++ ||....... ............ .........++.+.
T Consensus 196 y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~~~~~ 261 (303)
T 1zy4_A 196 YVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-------NILKKLRSVSIE---FPPDFDDNKMKVEK 261 (303)
T ss_dssp TSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-------HHHHHHHSTTCC---CCTTCCTTTSHHHH
T ss_pred ccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHH-------HHHHhccccccc---cCccccccchHHHH
Confidence 9999998753 357889999999999999998 443211100 011111111110 11112233456788
Q ss_pred HHHhhhccCCCCCCCCCCC
Q 037755 220 VIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 220 ~li~~cl~~dp~~Rps~~e 238 (238)
+++.+||+.||++|||+.|
T Consensus 262 ~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 262 KIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp HHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhcCcccCcCHHH
Confidence 9999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=263.93 Aligned_cols=217 Identities=20% Similarity=0.259 Sum_probs=153.6
Q ss_pred cHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCC---CCHHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQS---CSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~ 83 (238)
..+.+.+|+.+++++ +||||+++++++.++...++||||+. |+|.+++......... .++..++.++.||+.||+
T Consensus 51 ~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 129 (434)
T 2rio_A 51 FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129 (434)
T ss_dssp GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHH
Confidence 346788999999987 89999999999999999999999995 5999998433221111 123345789999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccC-------------CccccccccccccCCCCCccc--cccccCCccccCCcceeec
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHN-------------FVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISR 148 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~-------------~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~ 148 (238)
|||+. +|+||||||+||+++.+ +.++|+|||++.......... ......||+.|+|||++.+
T Consensus 130 ~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp HHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred HHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 99999 99999999999999754 379999999997665432211 1123459999999999865
Q ss_pred C-----CCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHH
Q 037755 149 N-----FGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 149 ~-----~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 222 (238)
. ...++.++|||||||++|+|++ |..||....... ........ ... .........+++++.+++
T Consensus 207 ~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~i~~~~~----~~~-~~~~~~~~~~~~~~~~li 276 (434)
T 2rio_A 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----SNIIRGIF----SLD-EMKCLHDRSLIAEATDLI 276 (434)
T ss_dssp CCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-----HHHHHTCC----CCC-CCTTCCCHHHHHHHHHHH
T ss_pred ccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-----HHHhcCCC----Ccc-cccccccccchHHHHHHH
Confidence 2 1357889999999999999998 899986432211 01111100 000 001111245678899999
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||++|||+.|
T Consensus 277 ~~~L~~dP~~Rps~~e 292 (434)
T 2rio_A 277 SQMIDHDPLKRPTAMK 292 (434)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHhhCChhhCCCHHH
Confidence 9999999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=261.06 Aligned_cols=225 Identities=22% Similarity=0.206 Sum_probs=161.0
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe-------eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-------RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
....++..++++.++.++||||+++++++..... .++||||+.+ +|.+.+.........++...+..++.++
T Consensus 60 ~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi 138 (360)
T 3e3p_A 60 PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138 (360)
T ss_dssp TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHH
Confidence 3445567888999999999999999999865332 7899999976 5554442222345688999999999999
Q ss_pred HHHHHHhH--cCCCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc
Q 037755 79 AHGIEYLH--NGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 79 ~~~l~~Lh--~~~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
+.|+.||| +. +|+||||||+||+++. ++.++|+|||++......... ....||+.|+|||.+.+. ..++.
T Consensus 139 ~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~ 211 (360)
T 3e3p_A 139 IRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGN-QHYTT 211 (360)
T ss_dssp HHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTC-SSCCT
T ss_pred HHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCC-CCCCc
Confidence 99999999 87 9999999999999996 899999999999765443322 233489999999998664 24788
Q ss_pred cCceehHHHHHHHHhcCCCCCCcccccccCCcchhh-------hhhhhcc-CCCcccc--ch-------hHHHHHHHHHH
Q 037755 156 KSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSW-------VSDQLNK-GGNLELR--NV-------TEIESMIARKL 218 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~~--~~-------~~~~~~~~~~l 218 (238)
++||||||+++|+|++|..||...........+... ....... ....... .. .......++.+
T Consensus 212 ~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (360)
T 3e3p_A 212 AVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEA 291 (360)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHH
Confidence 999999999999999999999764432211110000 0000000 0000000 00 00011246789
Q ss_pred HHHHhhhccCCCCCCCCCCC
Q 037755 219 CVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 219 ~~li~~cl~~dp~~Rps~~e 238 (238)
.+|+.+||+.||++|||+.|
T Consensus 292 ~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 292 YDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp HHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhccCccccCCHHH
Confidence 99999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=261.86 Aligned_cols=212 Identities=24% Similarity=0.326 Sum_probs=160.0
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.++++++||||+++++++.+....++++||+.+++|.+++.. ....+++..++.++.|++.||+|||
T Consensus 71 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH 147 (319)
T 2y4i_B 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH 147 (319)
T ss_dssp CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456778999999999999999999999999999999999999999999832 2357899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCc---cccccccCCccccCCcceeecCC-------Cccccc
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND---FVSISATRGTIGYIAPELISRNF-------GTVSCK 156 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~~ 156 (238)
+. +++||||||+||+++ ++.++|+|||++........ ........|+..|+|||.+.+.. ..++.+
T Consensus 148 ~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~ 223 (319)
T 2y4i_B 148 AK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223 (319)
T ss_dssp HT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHH
T ss_pred hC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCch
Confidence 99 999999999999998 67999999998764432211 11122334889999999986521 246788
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+||||||+++|+|++|..||........ .............. ..++..+.+++.+||+.||++|||+
T Consensus 224 ~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~ 290 (319)
T 2y4i_B 224 SDVFALGTIWYELHAREWPFKTQPAEAI--------IWQMGTGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTF 290 (319)
T ss_dssp HHHHHHHHHHHHHHHSSCSSSSCCHHHH--------HHHHHTTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHhccCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999999999999999999965332211 11111111111111 1245678899999999999999997
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
.|
T Consensus 291 ~~ 292 (319)
T 2y4i_B 291 TK 292 (319)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=262.03 Aligned_cols=217 Identities=18% Similarity=0.147 Sum_probs=162.4
Q ss_pred HHHHHHHHHHhhcCCCccee---------------eeeEEEe-CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHH
Q 037755 10 EEFINEVSTIGRIHHVNVVQ---------------LLGFCSE-GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHE 73 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~ 73 (238)
+.+.+|++++++++||||++ +++++.. +...++||||+ +++|.+++... ....+++..++.
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~ 163 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQ 163 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHH
Confidence 46889999999999999987 6777765 67899999999 89999998422 136799999999
Q ss_pred HHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCC--ccccccccccccCCCCCccc-----cccccCCccccCCccee
Q 037755 74 VASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF--VPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELI 146 (238)
Q Consensus 74 ~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~--~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~ 146 (238)
++.||+.||.|||+. +++||||||+||+++.++ .++|+|||++.......... ......|++.|+|||.+
T Consensus 164 i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 240 (352)
T 2jii_A 164 VACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH 240 (352)
T ss_dssp HHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence 999999999999999 999999999999999988 89999999997554332111 11223589999999999
Q ss_pred ecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhc
Q 037755 147 SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 147 ~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 226 (238)
.+. .++.++||||||+++|+|++|+.||........ .+........... . ...........+++.+.+++.+||
T Consensus 241 ~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~l~~li~~~l 314 (352)
T 2jii_A 241 KGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE--DIMKQKQKFVDKP-G-PFVGPCGHWIRPSETLQKYLKVVM 314 (352)
T ss_dssp TTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHHHHHHHSC-C-CEECTTSCEECCCHHHHHHHHHHH
T ss_pred ccC--CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH--HHHHHHHhccCCh-h-hhhhhccccCCCcHHHHHHHHHHH
Confidence 875 678899999999999999999999975432111 0101000000000 0 000000000124678999999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||++|||++|
T Consensus 315 ~~dp~~Rps~~~ 326 (352)
T 2jii_A 315 ALTYEEKPPYAM 326 (352)
T ss_dssp TCCTTCCCCHHH
T ss_pred hCChhhCCCHHH
Confidence 999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=253.12 Aligned_cols=218 Identities=21% Similarity=0.310 Sum_probs=161.6
Q ss_pred HHHHHHHHHHhhc---CCCcceeeeeEEE-----eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 10 EEFINEVSTIGRI---HHVNVVQLLGFCS-----EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 10 ~~~~~e~~~l~~l---~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
..+.+|+.+++.+ .||||+++++++. .....++|+||+. |+|.+++... ....+++..+..++.|++.|
T Consensus 56 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~ 132 (326)
T 1blx_A 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRG 132 (326)
T ss_dssp CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHH
Confidence 4567888888777 8999999999986 5567899999997 5999988432 23458999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|.|||+. |++||||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++||||
T Consensus 133 l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s 204 (326)
T 1blx_A 133 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWS 204 (326)
T ss_dssp HHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHH
T ss_pred HHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcC--CCCcchhHHH
Confidence 9999999 99999999999999999999999999987543322 12334589999999999775 6788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhh----hhhc--------cCCCccccchhHHHHHHHHHHHHHHhhhccCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVS----DQLN--------KGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 229 (238)
||+++|+|++|..||...........+..... ..+. ................++..+.+|+.+||+.|
T Consensus 205 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 284 (326)
T 1blx_A 205 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284 (326)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCC
Confidence 99999999999999975433211000000000 0000 00000011112222346778899999999999
Q ss_pred CCCCCCCCC
Q 037755 230 PADRPSMTK 238 (238)
Q Consensus 230 p~~Rps~~e 238 (238)
|++|||+.|
T Consensus 285 P~~Rpt~~e 293 (326)
T 1blx_A 285 PAKRISAYS 293 (326)
T ss_dssp TTTSCCHHH
T ss_pred cccCCCHHH
Confidence 999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=274.13 Aligned_cols=209 Identities=24% Similarity=0.375 Sum_probs=162.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.+ +..++||||+.+|+|.+++.. ....+++..+..++.|++.||.||
T Consensus 432 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L 507 (656)
T 2j0j_A 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYL 507 (656)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3445889999999999999999999999854 578999999999999999832 234689999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.++.++|+|||++......... ......+++.|+|||.+.+. .++.++||||||++
T Consensus 508 H~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~i 581 (656)
T 2j0j_A 508 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVC 581 (656)
T ss_dssp HHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHH
T ss_pred HhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHH
Confidence 999 9999999999999999999999999999765433221 12223467899999999775 67889999999999
Q ss_pred HHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++ |..||....... ............ .+..+++.+.+++.+||+.||++|||+.|
T Consensus 582 l~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~RPs~~e 641 (656)
T 2j0j_A 582 MWEILMHGVKPFQGVKNND--------VIGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTE 641 (656)
T ss_dssp HHHHHTTSCCTTTTCCHHH--------HHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHcCCCCCCCCCHHH--------HHHHHHcCCCCC------CCccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 999997 888986533221 111111111111 11235678899999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.77 Aligned_cols=225 Identities=22% Similarity=0.259 Sum_probs=165.2
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEe------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
+....+++.+|++++++++||||+++++++.. +...++||||+.+|+|.+++.... ....+++..++.++.++
T Consensus 52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QL 130 (676)
T 3qa8_A 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDI 130 (676)
T ss_dssp CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHH
Confidence 34456789999999999999999999998755 678899999999999999984422 23468899999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCc---cccccccccccCCCCCccccccccCCccccCCcceeecCCCcccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFV---PNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
+.||+|||+. +++||||||+||+++.++. ++|+|||.+........ .....|+..|+|||.+.+. .++.
T Consensus 131 l~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ 202 (676)
T 3qa8_A 131 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTV 202 (676)
T ss_dssp HHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCST
T ss_pred HHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccC--CCCc
Confidence 9999999999 9999999999999997664 89999999976544322 1234589999999999875 7788
Q ss_pred cCceehHHHHHHHHhcCCCCCCccccccc-CCcchhh------hhhhhccC--CCccccchhHHHHHHHHHHHHHHhhhc
Q 037755 156 KSDVYGFGMVLLEMTGGRRNSNLKATRSS-KAYFPSW------VSDQLNKG--GNLELRNVTEIESMIARKLCVIGLWCI 226 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~------~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl 226 (238)
++||||||+++|+|++|..||........ ...+... ........ ..............+++.+.+++.+||
T Consensus 203 ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL 282 (676)
T 3qa8_A 203 TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML 282 (676)
T ss_dssp THHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHS
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHc
Confidence 99999999999999999999964321110 0000000 00000000 000011112233446788999999999
Q ss_pred cCCCCCCCCCCC
Q 037755 227 QVKPADRPSMTK 238 (238)
Q Consensus 227 ~~dp~~Rps~~e 238 (238)
+.||++|||++|
T Consensus 283 ~~DP~kRPTa~e 294 (676)
T 3qa8_A 283 MWHQRQRGTDPQ 294 (676)
T ss_dssp CSSCC---CCTT
T ss_pred cCCHhhCcCHHH
Confidence 999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=254.11 Aligned_cols=206 Identities=18% Similarity=0.224 Sum_probs=135.7
Q ss_pred HHHHHhhcCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 037755 15 EVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCD 90 (238)
Q Consensus 15 e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~ 90 (238)
....++.+.||||+++++++.. +...++||||+.+|+|.+++.. .....+++..++.++.|++.||.|||+.
T Consensus 72 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~-- 147 (336)
T 3fhr_A 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH-- 147 (336)
T ss_dssp HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3344566789999999999876 4568999999999999999843 2235799999999999999999999999
Q ss_pred CceeeeccCCCcEEEcc---CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHH
Q 037755 91 VCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~ 167 (238)
+++||||||+||+++. ++.++|+|||.+....... .....+++.|+|||.+.+. .++.++||||||+++|
T Consensus 148 -~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ 220 (336)
T 3fhr_A 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMY 220 (336)
T ss_dssp -TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------C--HHHHHHHHHHHHHHHH
T ss_pred -CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHH
Confidence 9999999999999976 4559999999987554322 1233489999999998765 7788999999999999
Q ss_pred HHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 168 EMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 168 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|++|..||.................... ..........+++.+.+|+.+||+.||++|||++|
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 284 (336)
T 3fhr_A 221 ILLCGFPPFYSNTGQAISPGMKRRIRLGQ-------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQ 284 (336)
T ss_dssp HHHHSSCCC----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHCCCCCCCccchhhhhhHHHhhhccc-------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 99999999965443322111111000000 00000111235678899999999999999999854
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=256.42 Aligned_cols=221 Identities=20% Similarity=0.284 Sum_probs=163.4
Q ss_pred ccccHHHHHHHHHHHhhcCCCc------ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVN------VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
.....+.+.+|+.+++++.|++ ++.+.+++......++||||+ ++++.+.+.. .....+++..+..++.||
T Consensus 56 ~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi 132 (355)
T 2eu9_A 56 VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQL 132 (355)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHH
T ss_pred cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHH
Confidence 3455678899999999997766 899999999999999999999 5677776632 223578999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEE-------------------ccCCccccccccccccCCCCCccccccccCCccc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILL-------------------DHNFVPNVSDFGLAKFHPKENDFVSISATRGTIG 139 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~-------------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 139 (238)
+.||+|||+. +|+||||||+||++ +.++.++|+|||.+....... ....||+.
T Consensus 133 ~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~ 204 (355)
T 2eu9_A 133 CHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRH 204 (355)
T ss_dssp HHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGG
T ss_pred HHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCc
Confidence 9999999999 99999999999999 567899999999987543322 23358999
Q ss_pred cCCcceeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcc-------hhhhhhhhccCC-----C-c----
Q 037755 140 YIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF-------PSWVSDQLNKGG-----N-L---- 202 (238)
Q Consensus 140 ~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~-----~-~---- 202 (238)
|+|||.+.+. .++.++||||||+++|+|++|..||...........+ +........... . .
T Consensus 205 y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 2eu9_A 205 YRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDEN 282 (355)
T ss_dssp GCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTT
T ss_pred ccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccc
Confidence 9999999875 6788999999999999999999999754432211000 000000000000 0 0
Q ss_pred ------------cccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 203 ------------ELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 203 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
............+..+.+|+.+||+.||++|||++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 283 SSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 000000011234668999999999999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=249.48 Aligned_cols=212 Identities=19% Similarity=0.274 Sum_probs=151.5
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+.+.++...++.++||||+++++++.+++..++||||+. |+|.+++......+..+++..++.++.|++.||+|||++
T Consensus 50 ~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (290)
T 3fme_A 50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128 (290)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 3444556666888899999999999999999999999997 488777643333457899999999999999999999983
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC--CCcccccCceehHHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Di~slG~~l 166 (238)
+ +++||||||+||+++.++.++|+|||.+........ .....|++.|+|||.+... ...++.++||||||+++
T Consensus 129 ~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 203 (290)
T 3fme_A 129 L--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203 (290)
T ss_dssp S--CCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHH
T ss_pred C--CeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHH
Confidence 1 899999999999999999999999999875543322 1223589999999997321 12567889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|..||....... ............... ...+++++.+++.+||+.||++|||++|
T Consensus 204 ~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~e 263 (290)
T 3fme_A 204 IELAILRFPYDSWGTPF------QQLKQVVEEPSPQLP------ADKFSAEFVDFTSQCLKKNSKERPTYPE 263 (290)
T ss_dssp HHHHHTSCSSCCCSCHH------HHHHHHHHSCCCCCC------TTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHCCCCccccCchH------HHHHHHhccCCCCcc------cccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence 99999999996422111 111111111111111 1234677899999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=264.83 Aligned_cols=219 Identities=20% Similarity=0.201 Sum_probs=155.8
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeC------CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+|++++++++||||+++++++... ..+++|+||+.+ ++.+.+.........+++..++.++.||+.||+||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45799999999999999999988431 236789999975 66655532223356899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccC-CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|+. +|+||||||+|||++.+ +.+||+|||+++........ ....+|+.|+|||++.+. ..++.++|||||||
T Consensus 173 H~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~ 245 (420)
T 1j1b_A 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGC 245 (420)
T ss_dssp HTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHH
T ss_pred HHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHH
Confidence 999 99999999999999955 56899999999755433221 223589999999998753 35788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchh--------hhhhh---hccCCCccccc---hhHHHHHHHHHHHHHHhhhccCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPS--------WVSDQ---LNKGGNLELRN---VTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
++|+|++|+.||...........+.. .+... ........... .......+++++.+|+.+||+.||
T Consensus 246 il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP 325 (420)
T 1j1b_A 246 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325 (420)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCCh
Confidence 99999999999976443211100000 00000 00000000000 000112346789999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||+.|
T Consensus 326 ~~R~t~~e 333 (420)
T 1j1b_A 326 TARLTPLE 333 (420)
T ss_dssp GGSCCHHH
T ss_pred hHCCCHHH
Confidence 99999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=249.44 Aligned_cols=212 Identities=21% Similarity=0.308 Sum_probs=156.9
Q ss_pred cccHHHHHHHHHHHhhcC--CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
....+++.+|+.+++++. ||||+++++++.++...+++|| +.+++|.+++. ....++...+..++.|++.||.
T Consensus 67 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~ 141 (313)
T 3cek_A 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVH 141 (313)
T ss_dssp HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Confidence 345688999999999996 5999999999999999999999 55789999983 3457899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---------CCccc
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---------FGTVS 154 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---------~~~~~ 154 (238)
|||+. +++||||||+||++++ +.++|+|||.+................|++.|+|||.+.+. ...++
T Consensus 142 ~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 217 (313)
T 3cek_A 142 TIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 217 (313)
T ss_dssp HHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCC
T ss_pred HHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCC
Confidence 99999 9999999999999964 89999999998755443322222334589999999998651 12567
Q ss_pred ccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 155 CKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 155 ~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
.++||||||+++|+|++|..||....... ................ ...++.+.+++.+||+.||++||
T Consensus 218 ~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rp 285 (313)
T 3cek_A 218 PKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDPNHEIEFP------DIPEKDLQDVLKCCLKRDPKQRI 285 (313)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHCTTSCCCCC------CCSCHHHHHHHHHHTCSSTTTSC
T ss_pred chHHHHHHHHHHHHHHhCCCchhhHHHHH------HHHHHHHhcccccCCc------ccchHHHHHHHHHHccCCcccCc
Confidence 78999999999999999999996432111 0111111111111111 11256788999999999999999
Q ss_pred CCCC
Q 037755 235 SMTK 238 (238)
Q Consensus 235 s~~e 238 (238)
|++|
T Consensus 286 s~~e 289 (313)
T 3cek_A 286 SIPE 289 (313)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.42 Aligned_cols=214 Identities=18% Similarity=0.240 Sum_probs=165.0
Q ss_pred cHHHHHHHHHHHhhcCC-CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+++++.+.| +++..+..+..++...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||
T Consensus 45 ~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH 120 (483)
T 3sv0_A 45 KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH 120 (483)
T ss_dssp SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34568899999999986 55666666778888999999999 8899999832 2457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEE---ccCCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCcccccCc
Q 037755 87 NGCDVCILHLDIKPHNILL---DHNFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+. +|+||||||+|||+ +.++.++|+|||++.......... ......||..|+|||.+.+. .++.++|
T Consensus 121 ~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sD 195 (483)
T 3sv0_A 121 SK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDD 195 (483)
T ss_dssp HT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHH
T ss_pred HC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC--CCChHHH
Confidence 99 99999999999999 588999999999997654433211 11234599999999999876 6788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||||+++|+|++|+.||...........+........ ..........+++++.+++.+||+.||++||+++
T Consensus 196 vwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~ 267 (483)
T 3sv0_A 196 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYS 267 (483)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHH
Confidence 99999999999999999976443222111111111111 1111233345678899999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=255.10 Aligned_cols=212 Identities=20% Similarity=0.232 Sum_probs=144.1
Q ss_pred ccccHHHHHHHHHHHhhcC-CCcceeeeeEEE--------eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIH-HVNVVQLLGFCS--------EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVA 75 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~ 75 (238)
.....+.+.+|+.+++++. ||||+++++++. .....++++||+. |+|.+++.... ....+++..++.++
T Consensus 65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~ 142 (337)
T 3ll6_A 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIF 142 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHH
Confidence 3445678899999999996 999999999984 3445899999995 68988773321 23569999999999
Q ss_pred HHHHHHHHHhHcCCCCc--eeeeccCCCcEEEccCCccccccccccccCCCCCccc----------cccccCCccccCCc
Q 037755 76 SGTAHGIEYLHNGCDVC--ILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV----------SISATRGTIGYIAP 143 (238)
Q Consensus 76 ~~i~~~l~~Lh~~~~~~--i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~----------~~~~~~~~~~~~aP 143 (238)
.||+.||.|||+. + ++||||||+||+++.++.++|+|||.+.......... ......+++.|+||
T Consensus 143 ~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (337)
T 3ll6_A 143 YQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219 (337)
T ss_dssp HHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---------------------------
T ss_pred HHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence 9999999999998 8 9999999999999999999999999987654432211 01123488999999
Q ss_pred ceeec-CCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHH
Q 037755 144 ELISR-NFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 144 E~~~~-~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 222 (238)
|.+.. ....++.++||||||+++|+|++|..||......... ... ..... ....+..+.+|+
T Consensus 220 E~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------~~~----~~~~~------~~~~~~~~~~li 282 (337)
T 3ll6_A 220 EIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV-------NGK----YSIPP------HDTQYTVFHSLI 282 (337)
T ss_dssp ----CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCCT------TCCSSGGGHHHH
T ss_pred hhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-------cCc----ccCCc------ccccchHHHHHH
Confidence 99842 1125688999999999999999999999643322110 000 00000 011234578899
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||++|||++|
T Consensus 283 ~~~l~~~p~~Rps~~e 298 (337)
T 3ll6_A 283 RAMLQVNPEERLSIAE 298 (337)
T ss_dssp HHHSCSSGGGSCCHHH
T ss_pred HHHccCChhhCcCHHH
Confidence 9999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=256.05 Aligned_cols=221 Identities=18% Similarity=0.283 Sum_probs=159.9
Q ss_pred cccHHHHHHHHHHHhhcC-----------CCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHH
Q 037755 6 KFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEK 70 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~ 70 (238)
....+.+.+|+++++++. ||||+++++++.... ..++++|++ +++|.+++... ....++...
T Consensus 56 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~ 132 (373)
T 1q8y_A 56 KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIY 132 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHH
T ss_pred ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHH
Confidence 345678899999999986 899999999987543 789999999 88999988432 245689999
Q ss_pred HHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEcc------CCccccccccccccCCCCCccccccccCCccccCCcc
Q 037755 71 LHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH------NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 144 (238)
Q Consensus 71 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 144 (238)
+..++.||+.||+|||+++ +|+||||||+||+++. .+.++|+|||.+....... ....+|+.|+|||
T Consensus 133 ~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE 205 (373)
T 1q8y_A 133 VKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPE 205 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcH
Confidence 9999999999999999842 8999999999999953 3479999999987554321 2235899999999
Q ss_pred eeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhh--hhhhh------------------------cc
Q 037755 145 LISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSW--VSDQL------------------------NK 198 (238)
Q Consensus 145 ~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~------------------------~~ 198 (238)
.+.+. .++.++||||||+++|+|++|..||............... +.... ..
T Consensus 206 ~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 283 (373)
T 1q8y_A 206 VLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283 (373)
T ss_dssp HHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSS
T ss_pred HHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcc
Confidence 99876 6788999999999999999999999754422111100000 00000 00
Q ss_pred CCCccccch-------hHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 199 GGNLELRNV-------TEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 199 ~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
......... ......+++.+.+|+.+||+.||++|||++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp CCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred cccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 000000000 1123567889999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=255.39 Aligned_cols=209 Identities=23% Similarity=0.254 Sum_probs=150.2
Q ss_pred HHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 11 EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 11 ~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
.+.+|+++|+++ +||||+++++++.++...++||||+. |+|.+++.... ...+...+..++.||+.||.|||+.
T Consensus 63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~- 137 (432)
T 3p23_A 63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL- 137 (432)
T ss_dssp ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC-
Confidence 457899999999 79999999999999999999999996 59999884322 3344445678999999999999999
Q ss_pred CCceeeeccCCCcEEEcc---CC--ccccccccccccCCCCCcc-ccccccCCccccCCcceeecC-CCcccccCceehH
Q 037755 90 DVCILHLDIKPHNILLDH---NF--VPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGF 162 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~---~~--~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~sl 162 (238)
+|+||||||+||+++. ++ .++|+|||++......... .......||+.|+|||++.+. ...++.++|||||
T Consensus 138 --~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSl 215 (432)
T 3p23_A 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215 (432)
T ss_dssp --TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHH
T ss_pred --cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHH
Confidence 9999999999999953 33 4679999998765433211 112334599999999998742 1256778999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||++|+|++ |..||....... ........ ...... .....+..+.+|+.+||+.||++|||++|
T Consensus 216 G~il~ellt~g~~pf~~~~~~~--------~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~e 280 (432)
T 3p23_A 216 GCVFYYVISEGSHPFGKSLQRQ--------ANILLGAC-SLDCLH---PEKHEDVIARELIEKMIAMDPQKRPSAKH 280 (432)
T ss_dssp HHHHHHHHTTSCBTTBSTTTHH--------HHHHTTCC-CCTTSC---TTCHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCcchhhHHH--------HHHHhccC-CccccC---ccccccHHHHHHHHHHHhCCHhhCCCHHH
Confidence 999999999 888884322111 01111110 111111 11234566889999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=250.37 Aligned_cols=196 Identities=21% Similarity=0.281 Sum_probs=159.6
Q ss_pred HHHHHHHHHHhhcC--CCcceeeeeEEEeCCeeeEEEEeCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 10 EEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEFMPN-GSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 10 ~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
+++.+|+.+++++. ||||+++++++.+....++++|++.+ ++|.+++. ....+++..++.++.|++.||+|||
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH 166 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCH 166 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 56778999999996 59999999999999999999999975 89999883 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
+. +++||||||+||+++ .++.++|+|||.+........ ....|+..|+|||.+.+. ...+.++||||||++
T Consensus 167 ~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~i 238 (320)
T 3a99_A 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGIL 238 (320)
T ss_dssp HT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHH
T ss_pred HC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccC-CCCCccchHHhHHHH
Confidence 99 999999999999999 788999999999876543321 233489999999998764 234678999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ . ... ....+++.+.+++.+||+.||++|||++|
T Consensus 239 l~el~~g~~pf~~~~~~~~---------~-----~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 290 (320)
T 3a99_A 239 LYDMVCGDIPFEHDEEIIR---------G-----QVF-------FRQRVSSECQHLIRWCLALRPSDRPTFEE 290 (320)
T ss_dssp HHHHHHSSCSCCSHHHHHH---------C-----CCC-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCChhhhhc---------c-----ccc-------ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999964321110 0 000 01124567889999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=249.25 Aligned_cols=164 Identities=21% Similarity=0.224 Sum_probs=136.1
Q ss_pred cccHHHHHHHHHHHhhcC-CC-----cceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIH-HV-----NVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~-h~-----ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....+.+.+|+.+++.+. |+ +|+++++++..+...++||||+. ++|.+++... ....+++..+..++.|++
T Consensus 91 ~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~ 167 (382)
T 2vx3_A 91 KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMC 167 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHH
Confidence 344577888999999885 55 49999999999999999999996 5999988432 235689999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEc--cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccC
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLD--HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 157 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 157 (238)
.||.|||++ ..+|+||||||+|||++ .++.++|+|||++....... ....+|+.|+|||.+.+. .++.++
T Consensus 168 ~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~ 239 (382)
T 2vx3_A 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGM--PYDLAI 239 (382)
T ss_dssp HHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTC--CCCTHH
T ss_pred HHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCC--CCCcHH
Confidence 999999942 12899999999999995 47789999999997654321 233589999999999876 678899
Q ss_pred ceehHHHHHHHHhcCCCCCCccc
Q 037755 158 DVYGFGMVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 158 Di~slG~~l~~ll~g~~p~~~~~ 180 (238)
|||||||++|+|++|+.||....
T Consensus 240 DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 240 DMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=266.74 Aligned_cols=192 Identities=20% Similarity=0.239 Sum_probs=155.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCe-----eeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-----RALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
....+.+.+|++++++++||||+++++++..... .|+||||+.+++|.+++ ...+++..++.++.||+.
T Consensus 120 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~------~~~l~~~~~~~~~~qi~~ 193 (681)
T 2pzi_A 120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILP 193 (681)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHH------hCCCCHHHHHHHHHHHHH
Confidence 3455788999999999999999999999977655 79999999999998876 237899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||.|||++ +|+||||||+||+++.+ .++|+|||++...... ....||+.|+|||.+.+. .+.++|||
T Consensus 194 aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~ 260 (681)
T 2pzi_A 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG---PTVATDIY 260 (681)
T ss_dssp HHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHH
T ss_pred HHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC---CCCceehh
Confidence 99999999 99999999999999975 8999999998765443 233499999999998764 37889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||+++|+|++|..||......... ........++.+.+++.+||+.||++||+..
T Consensus 261 slG~~l~~l~~g~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~ 316 (681)
T 2pzi_A 261 TVGRTLAALTLDLPTRNGRYVDGLP---------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTA 316 (681)
T ss_dssp HHHHHHHHHHSCCCEETTEECSSCC---------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred hhHHHHHHHHhCCCCCccccccccc---------------------ccccccccCHHHHHHHhhhccCChhhCCCHH
Confidence 9999999999998887542211110 0011223467889999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=252.11 Aligned_cols=197 Identities=23% Similarity=0.310 Sum_probs=155.0
Q ss_pred HHHHHHHHHHHhhc----CCCcceeeeeEEEeCCeeeEEEEe-CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRI----HHVNVVQLLGFCSEGSKRALVYEF-MPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 9 ~~~~~~e~~~l~~l----~h~ni~~~~~~~~~~~~~~lv~e~-~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
...+.+|+.+++++ +||||+++++++...+..++++|+ +.+++|.+++. ....+++..++.++.|++.||.
T Consensus 78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~ 153 (312)
T 2iwi_A 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQ 153 (312)
T ss_dssp -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Confidence 34566799999999 899999999999999999999999 78899999983 2456899999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|||++ +++||||||+||+++ .++.++|+|||.+....... .....++..|+|||.+.+. ...+.++|||||
T Consensus 154 ~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~sl 225 (312)
T 2iwi_A 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSL 225 (312)
T ss_dssp HHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHH
T ss_pred HHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHH
Confidence 99999 999999999999999 88999999999987654432 1233489999999998764 233558999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|+|++|+.||...... ... .. .....++..+.+++.+||+.||++|||++|
T Consensus 226 G~il~~l~~g~~pf~~~~~~---------~~~----~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 280 (312)
T 2iwi_A 226 GILLYDMVCGDIPFERDQEI---------LEA----EL--------HFPAHVSPDCCALIRRCLAPKPSSRPSLEE 280 (312)
T ss_dssp HHHHHHHHHSSCSCCSHHHH---------HHT----CC--------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHCCCCCCChHHH---------hhh----cc--------CCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999998643211 000 00 011234667889999999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=246.94 Aligned_cols=216 Identities=21% Similarity=0.292 Sum_probs=141.7
Q ss_pred cHHHHHHHHH-HHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 8 SAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK-ESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 8 ~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...++.+|+. +++.++||||+++++++.+.+..++||||+.+ +|.+++... ......++...+..++.+++.||.||
T Consensus 63 ~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 141 (327)
T 3aln_A 63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141 (327)
T ss_dssp HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH
Confidence 3445566666 77778999999999999999999999999975 777766211 11246789999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC--CCcccccCceehHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFG 163 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Di~slG 163 (238)
|+. .+++||||||+||+++.++.++|+|||.+........ .....|+..|+|||.+... ...++.++||||||
T Consensus 142 H~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG 216 (327)
T 3aln_A 142 KEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216 (327)
T ss_dssp HHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHH
T ss_pred hcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHH
Confidence 984 2899999999999999999999999999875533221 1223589999999998421 12577899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|+|++|..||......... + .. .......... ......+++.+.+|+.+||+.||++|||+.|
T Consensus 217 ~il~~l~~g~~pf~~~~~~~~~--~----~~-~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 282 (327)
T 3aln_A 217 ITLYELATGRFPYPKWNSVFDQ--L----TQ-VVKGDPPQLS--NSEEREFSPSFINFVNLCLTKDESKRPKYKE 282 (327)
T ss_dssp HHHHHHHHSCCCSSCC-------------CC-CCCSCCCCCC--CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCCCCCcchHHHH--H----HH-HhcCCCCCCC--CcccccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 9999999999999653321110 0 00 0000000000 0011234678899999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=241.41 Aligned_cols=208 Identities=19% Similarity=0.243 Sum_probs=147.7
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-C
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN-G 88 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~ 88 (238)
+.+.++..+++.++||||+++++++.++...++||||+ ++.+..... .....+++..+..++.+++.||.|||+ +
T Consensus 69 ~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (318)
T 2dyl_A 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH 144 (318)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 34445556788889999999999999999999999999 445554441 124578999999999999999999998 6
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceehHHHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMV 165 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~slG~~ 165 (238)
+++|+||||+||+++.++.++|+|||.+........ .....+++.|+|||.+... ...++.++||||||++
T Consensus 145 ---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 145 ---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp ---CCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred ---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 899999999999999999999999999865433221 1233489999999998531 1256788999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||....... ......... ....... ...+++.+.+++.+||+.||.+|||++|
T Consensus 219 l~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDF------EVLTKVLQE-EPPLLPG----HMGFSGDFQSFVKDCLTKDHRKRPKYNK 280 (318)
T ss_dssp HHHHHHSSCTTTTCCSHH------HHHHHHHHS-CCCCCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred HHHHHhCCCCCCCCCccH------HHHHHHhcc-CCCCCCc----cCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999996422111 111111111 1111110 0124667889999999999999999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=237.37 Aligned_cols=192 Identities=18% Similarity=0.216 Sum_probs=146.6
Q ss_pred HHHHHHHHHHH-hhcCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTI-GRIHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 9 ~~~~~~e~~~l-~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
...+.+|+.++ +.++||||+++++++.. +...++||||+.+++|.+++.. .....+++..++.++.|++.||+
T Consensus 54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~ 131 (299)
T 3m2w_A 54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQ 131 (299)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHH
Confidence 35678899998 55589999999999876 6789999999999999999843 22357999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEcc---CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|||+. +++||||||+||+++. ++.++|+|||++..... ..++.++|||
T Consensus 132 ~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--------------------------~~~~~~~Diw 182 (299)
T 3m2w_A 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--------------------------EKYDKSCDMW 182 (299)
T ss_dssp HHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--------------------------CGGGGHHHHH
T ss_pred HHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccc--------------------------ccCCchhhHH
Confidence 99999 9999999999999997 78899999998753211 1567789999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++|+|++|..||.............. ................+++++.+++.+||+.||++|||++|
T Consensus 183 slG~il~el~tg~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 253 (299)
T 3m2w_A 183 SLGVIMYILLCGYPPFYSNHGLAISPGMKT-------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 253 (299)
T ss_dssp HHHHHHHHHHHSSCSCCC-------CCSCC-------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHH
Confidence 999999999999999965443321111100 00011111112223456788999999999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=233.31 Aligned_cols=183 Identities=15% Similarity=0.093 Sum_probs=143.9
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+.++++++||||+++++++.+++..|+||||+.+++|.+++. . ......+..++.|++.||+|||
T Consensus 73 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~--~~~~~~~~~i~~ql~~aL~~lH 146 (286)
T 3uqc_A 73 DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----T--SPSPVGAIRAMQSLAAAADAAH 146 (286)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT----T--CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh----c--CCChHHHHHHHHHHHHHHHHHH
Confidence 345889999999999999999999999999999999999999999999982 1 2355678889999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. ||+||||||+||+++.++.++|++++. ++ .++.++||||||+++
T Consensus 147 ~~---givH~Dikp~NIll~~~g~~kl~~~~~----------------------~~---------~~~~~~Di~slG~il 192 (286)
T 3uqc_A 147 RA---GVALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP---------DANPQDDIRGIGASL 192 (286)
T ss_dssp HT---TCCCCCCSGGGEEEETTSCEEECSCCC----------------------CT---------TCCHHHHHHHHHHHH
T ss_pred HC---CCccCCCCcccEEEcCCCCEEEEeccc----------------------cC---------CCCchhHHHHHHHHH
Confidence 99 999999999999999999999884432 11 356789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|+.||............. ................+++.+.+++.+||+.||++| |++|
T Consensus 193 ~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~e 255 (286)
T 3uqc_A 193 YALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SAST 255 (286)
T ss_dssp HHHHHSEECSCCCSBCCCSEECC--------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHH
T ss_pred HHHHHCCCCCCcCCcchhhHHHH--------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHH
Confidence 99999999997654432110000 000111112223334567889999999999999999 8753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=236.19 Aligned_cols=199 Identities=13% Similarity=0.085 Sum_probs=149.5
Q ss_pred cccHHHHHHHHHHHhhcC---------CCcceeeeeEE-----------------Ee-------------CCeeeEEEEe
Q 037755 6 KFSAEEFINEVSTIGRIH---------HVNVVQLLGFC-----------------SE-------------GSKRALVYEF 46 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~---------h~ni~~~~~~~-----------------~~-------------~~~~~lv~e~ 46 (238)
....+.+.+|+.+++.++ ||||+++.+++ .+ +...++||||
T Consensus 64 ~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~ 143 (336)
T 2vuw_A 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143 (336)
T ss_dssp CBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEE
T ss_pred chhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEe
Confidence 445588999999999986 66666665543 32 6789999999
Q ss_pred CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH-cCCCCceeeeccCCCcEEEccCC----------------
Q 037755 47 MPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH-NGCDVCILHLDIKPHNILLDHNF---------------- 109 (238)
Q Consensus 47 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~dl~p~nil~~~~~---------------- 109 (238)
+.+|++.+.+. ...+++..++.++.||+.||+||| +. +|+||||||+|||++.++
T Consensus 144 ~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~ 215 (336)
T 2vuw_A 144 EFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215 (336)
T ss_dssp ECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEE
T ss_pred cCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCcccccc
Confidence 99997766662 256899999999999999999999 88 999999999999999887
Q ss_pred ----ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH-HHHHhcCCCCCCccccccc
Q 037755 110 ----VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV-LLEMTGGRRNSNLKATRSS 184 (238)
Q Consensus 110 ----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~-l~~ll~g~~p~~~~~~~~~ 184 (238)
.+||+|||+++..... ...||+.|+|||++.+. . +.++||||+|++ .++++.|..||.....
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~--~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--- 282 (336)
T 2vuw_A 216 SCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGD--G-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--- 282 (336)
T ss_dssp CTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCC--S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---
T ss_pred CCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCC--C-ccceehhhhhCCCCcccccccCCCcchhh---
Confidence 8999999999755332 22489999999999875 3 778999998777 7778889888742110
Q ss_pred CCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCC
Q 037755 185 KAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229 (238)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 229 (238)
.........................+++++.+|+.+||+.|
T Consensus 283 ----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 283 ----LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp ----HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred ----hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 00011111111112222233456778999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=240.12 Aligned_cols=202 Identities=13% Similarity=0.105 Sum_probs=145.4
Q ss_pred ccHHHHHHHHHHHhhcCC-Ccce---------e------------eeeEEEe-----CCeeeEEEEeCCCCChhhhccCC
Q 037755 7 FSAEEFINEVSTIGRIHH-VNVV---------Q------------LLGFCSE-----GSKRALVYEFMPNGSLDRHIFPK 59 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h-~ni~---------~------------~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~ 59 (238)
...+.+.+|+.+++.+.| +|.. . +..++.. ....+++++.+ +++|.+++...
T Consensus 120 ~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l 198 (413)
T 3dzo_A 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 198 (413)
T ss_dssp -CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHh
Confidence 346789999999999977 3211 1 1111111 22456777765 67998887211
Q ss_pred ---CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCC
Q 037755 60 ---ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRG 136 (238)
Q Consensus 60 ---~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 136 (238)
......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... .....|
T Consensus 199 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g 270 (413)
T 3dzo_A 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG 270 (413)
T ss_dssp HHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC
T ss_pred hcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC
Confidence 22345788889999999999999999999 9999999999999999999999999998754332 223347
Q ss_pred ccccCCcceeecC--------CCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchh
Q 037755 137 TIGYIAPELISRN--------FGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVT 208 (238)
Q Consensus 137 ~~~~~aPE~~~~~--------~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (238)
+.|+|||.+.+. ...++.++||||||+++|+|++|+.||............ ....
T Consensus 271 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~-------~~~~--------- 333 (413)
T 3dzo_A 271 -RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI-------FRSC--------- 333 (413)
T ss_dssp -TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG-------GSSC---------
T ss_pred -CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH-------Hhhc---------
Confidence 999999998321 125678999999999999999999999755433221110 1000
Q ss_pred HHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 209 EIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 209 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
..+++.+.+|+.+||+.||++|||+.
T Consensus 334 ---~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 334 ---KNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp ---CCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ---ccCCHHHHHHHHHHccCChhhCcCHH
Confidence 02357799999999999999999964
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-33 Score=239.61 Aligned_cols=153 Identities=16% Similarity=0.175 Sum_probs=114.6
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+.+.++|.+|+++|+++ +|+||+++++++++++..|+||||++|++|.+.+. .+++++.. .++.||+.||+|
T Consensus 282 ~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~y 354 (569)
T 4azs_A 282 QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAA 354 (569)
T ss_dssp HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHH
Confidence 45567899999999999 69999999999999999999999999999999993 34566654 478999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+|++ ||+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+ .....+|+||+|+
T Consensus 355 lH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~ 426 (569)
T 4azs_A 355 LEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPV 426 (569)
T ss_dssp HHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------
T ss_pred HHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC---CCCCccccccccc
Confidence 9999 999999999999999999999999999875543321 1123359999999999986 3456789999999
Q ss_pred HHHHHhcCC
Q 037755 165 VLLEMTGGR 173 (238)
Q Consensus 165 ~l~~ll~g~ 173 (238)
+++.+.++.
T Consensus 427 ~~~~l~~~~ 435 (569)
T 4azs_A 427 HPFNLPQPW 435 (569)
T ss_dssp --CCCCTTH
T ss_pred chhhhcccc
Confidence 887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.1e-26 Score=192.09 Aligned_cols=151 Identities=15% Similarity=0.147 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
.+++.+|++++++++||||+++..+.......++||||+++++|.+++.. +..++.|++.+|.|||++
T Consensus 383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~ 450 (540)
T 3en9_A 383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN 450 (540)
T ss_dssp HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC
Confidence 56789999999999999999666666677788999999999999999822 568999999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-----cccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
+|+||||||+|||++. .++|+|||+++......... ......||+.|+|||++......++...|+||..
T Consensus 451 ---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v 525 (540)
T 3en9_A 451 ---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII 525 (540)
T ss_dssp ---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred ---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence 9999999999999998 99999999998665432111 0123348999999999987323677788999999
Q ss_pred HHHHHHhcCCCCC
Q 037755 164 MVLLEMTGGRRNS 176 (238)
Q Consensus 164 ~~l~~ll~g~~p~ 176 (238)
+-..+-+.++.++
T Consensus 526 l~~l~~v~~r~rY 538 (540)
T 3en9_A 526 LELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHTCSCC
T ss_pred HHHHHHHHhcccc
Confidence 9888877666543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=8.7e-20 Score=143.26 Aligned_cols=94 Identities=17% Similarity=0.176 Sum_probs=79.8
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
.+.++.+|+.++++++ | +++.+++.. +..++||||++|++|.+ +. . .....++.|++.|+.|||+
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~ 211 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYH 211 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHH
Confidence 4678999999999999 4 666665544 56799999999999988 41 1 1234699999999999999
Q ss_pred CCCCceeeeccCCCcEEEccCCccccccccccc
Q 037755 88 GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
. |++||||||+||+++ ++.++|+|||.+.
T Consensus 212 ~---giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 212 R---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp T---TEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred C---CCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 9 999999999999999 9999999999986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=118.24 Aligned_cols=97 Identities=18% Similarity=0.143 Sum_probs=76.4
Q ss_pred HHHHHHHHHHhhcCCCcc--eeeeeEEEeCCeeeEEEEeCCC-C----ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 10 EEFINEVSTIGRIHHVNV--VQLLGFCSEGSKRALVYEFMPN-G----SLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
..+.+|+..|+++.|+++ +.+++. ...++||||+.+ | +|.+... ..+...+..++.|++.++
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l 183 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENV 183 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHH
Confidence 478899999999988764 334432 357899999942 3 5665541 123456778999999999
Q ss_pred HHhH-cCCCCceeeeccCCCcEEEccCCccccccccccccC
Q 037755 83 EYLH-NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 83 ~~Lh-~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
.+|| +. +|+||||||+|||++. .++|+|||++...
T Consensus 184 ~~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 184 KRLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999 88 9999999999999998 8999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.26 E-value=5.7e-12 Score=102.08 Aligned_cols=94 Identities=13% Similarity=0.098 Sum_probs=68.4
Q ss_pred HHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCc
Q 037755 13 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVC 92 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~ 92 (238)
.+|...|.++.++++....-+... ..++||||+.|++|..... . .....++.|++.++.+||+. |
T Consensus 161 ~kE~~nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---g 225 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---G 225 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---C
Confidence 457777777755544322222222 3479999999988866541 1 12356789999999999998 9
Q ss_pred eeeeccCCCcEEEccCC----------cccccccccccc
Q 037755 93 ILHLDIKPHNILLDHNF----------VPNVSDFGLAKF 121 (238)
Q Consensus 93 i~H~dl~p~nil~~~~~----------~~~l~d~~~~~~ 121 (238)
||||||||.|||+++++ .+.|+||+-+..
T Consensus 226 IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 226 LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999999998776 378999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=2.5e-10 Score=88.21 Aligned_cols=104 Identities=14% Similarity=0.117 Sum_probs=82.1
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...++.+|+.+++.+. +..+.+++++..+.+..++|||+++|.+|.+.+. . ......++.+++.+++.||
T Consensus 52 ~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~---~~~~~~~~~~l~~~l~~LH 122 (263)
T 3tm0_A 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------D---EQSPEKIIELYAECIRLFH 122 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------T---TTCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC------C---cccHHHHHHHHHHHHHHHh
Confidence 3456899999999995 6778899999999899999999999999977641 1 1122467788999999999
Q ss_pred cCC--------------------------------------------------------CCceeeeccCCCcEEEccCCc
Q 037755 87 NGC--------------------------------------------------------DVCILHLDIKPHNILLDHNFV 110 (238)
Q Consensus 87 ~~~--------------------------------------------------------~~~i~H~dl~p~nil~~~~~~ 110 (238)
+.. ...++|||++|.||++++++.
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~ 202 (263)
T 3tm0_A 123 SIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV 202 (263)
T ss_dssp HSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE
T ss_pred CCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE
Confidence 810 035999999999999987656
Q ss_pred cccccccccc
Q 037755 111 PNVSDFGLAK 120 (238)
Q Consensus 111 ~~l~d~~~~~ 120 (238)
+.|+||+.+.
T Consensus 203 ~~lIDwe~a~ 212 (263)
T 3tm0_A 203 SGFIDLGRSG 212 (263)
T ss_dssp EEECCCTTCE
T ss_pred EEEEEchhcc
Confidence 6799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-09 Score=87.65 Aligned_cols=107 Identities=17% Similarity=0.208 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHhhcC--CCcceeeeeEEEeC---CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRIH--HVNVVQLLGFCSEG---SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
..++.+|+.+++.+. +..+.+++.++.+. +..++|||+++|..+.+.. ...++......++.+++.+|+
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La 153 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIA 153 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHH
Confidence 467889999999997 45678888888776 4589999999988775432 234678888889999999999
Q ss_pred HhHcCC-------------------------------------------------------CCceeeeccCCCcEEEccC
Q 037755 84 YLHNGC-------------------------------------------------------DVCILHLDIKPHNILLDHN 108 (238)
Q Consensus 84 ~Lh~~~-------------------------------------------------------~~~i~H~dl~p~nil~~~~ 108 (238)
.||+.. ...++|||+++.||+++.+
T Consensus 154 ~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~ 233 (359)
T 3dxp_A 154 AMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT 233 (359)
T ss_dssp HHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS
T ss_pred HHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC
Confidence 999720 1479999999999999976
Q ss_pred Cc--ccccccccccc
Q 037755 109 FV--PNVSDFGLAKF 121 (238)
Q Consensus 109 ~~--~~l~d~~~~~~ 121 (238)
+. +.|+||+.+..
T Consensus 234 ~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 234 EPRVLAVLDWELSTL 248 (359)
T ss_dssp SSCEEEECCCTTCEE
T ss_pred CCcEEEEECcccccc
Confidence 53 58999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=2e-09 Score=82.77 Aligned_cols=99 Identities=19% Similarity=0.205 Sum_probs=74.2
Q ss_pred HHHHHHHHHHhhcCCCc--ceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 10 EEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+|+.+++.+.+.+ +.+++++...++..++||||++|.++. .. ... ...++.+++..++.||+
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~ 125 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS-------HLA---PAEKVSIMADAMRRLHT 125 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS-------CCC---HHHHHHHHHHHHHHHTT
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC-------cCC---HhHHHHHHHHHHHHHhC
Confidence 56789999999996444 456888888878899999999998884 31 111 12456777777777776
Q ss_pred CC-------------------------------------------------------CCceeeeccCCCcEEEccCCccc
Q 037755 88 GC-------------------------------------------------------DVCILHLDIKPHNILLDHNFVPN 112 (238)
Q Consensus 88 ~~-------------------------------------------------------~~~i~H~dl~p~nil~~~~~~~~ 112 (238)
.. ...++|+|++|.||++++++.+.
T Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~ 205 (264)
T 1nd4_A 126 LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSG 205 (264)
T ss_dssp SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEE
T ss_pred CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEE
Confidence 41 11299999999999998776667
Q ss_pred cccccccc
Q 037755 113 VSDFGLAK 120 (238)
Q Consensus 113 l~d~~~~~ 120 (238)
|+||+.+.
T Consensus 206 liD~~~a~ 213 (264)
T 1nd4_A 206 FIDCGRLG 213 (264)
T ss_dssp ECCCTTCE
T ss_pred EEcchhcc
Confidence 99999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=7e-10 Score=87.69 Aligned_cols=160 Identities=19% Similarity=0.265 Sum_probs=99.4
Q ss_pred cHHHHHHHHHHHhhcC-CCc--ceeeeeEEEeCC---eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIH-HVN--VVQLLGFCSEGS---KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~n--i~~~~~~~~~~~---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
...++.+|+.+|+.+. +.. +.+++.....+. ..|+||++++|.++.+.. ...++......++.+++..
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~------~~~l~~~~~~~~~~~l~~~ 126 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLL------LNNLPKQSQNQAAKDLARF 126 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHH------HHTSCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccc------cccCCHHHHHHHHHHHHHH
Confidence 4578899999999984 433 344544443333 458899999998886533 1345666677777788887
Q ss_pred HHHhHcC-------------------------------------------------------CCCceeeeccCCCcEEEc
Q 037755 82 IEYLHNG-------------------------------------------------------CDVCILHLDIKPHNILLD 106 (238)
Q Consensus 82 l~~Lh~~-------------------------------------------------------~~~~i~H~dl~p~nil~~ 106 (238)
++.||+. ....++|+|++|.||+++
T Consensus 127 la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~ 206 (304)
T 3sg8_A 127 LSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFD 206 (304)
T ss_dssp HHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEE
T ss_pred HHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEe
Confidence 7777751 012589999999999999
Q ss_pred c--CCccccccccccccCCCCCccccccccCCccccCCcceee---cCCCc---------ccccCceehHHHHHHHHhcC
Q 037755 107 H--NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS---RNFGT---------VSCKSDVYGFGMVLLEMTGG 172 (238)
Q Consensus 107 ~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~---------~~~~~Di~slG~~l~~ll~g 172 (238)
. ++.+.++||+.+............. ....-..|+... ..++. .....+.|++|.++|.+.+|
T Consensus 207 ~~~~~~~~~iD~~~~~~~~~~~Dl~~~~---~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g 283 (304)
T 3sg8_A 207 TEKNTICGIIDFGDAAISDPDNDFISLM---EDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYG 283 (304)
T ss_dssp TTTTEEEEECCCTTCEEECTTHHHHTTC---CTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCEEEEEeCCCCccCChHHHHHHHH---hhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 7 5567899999876443221111000 000001222111 00000 11125789999999999999
Q ss_pred CCCC
Q 037755 173 RRNS 176 (238)
Q Consensus 173 ~~p~ 176 (238)
..+|
T Consensus 284 ~~~~ 287 (304)
T 3sg8_A 284 YMDW 287 (304)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 8655
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.5e-06 Score=67.14 Aligned_cols=105 Identities=14% Similarity=0.149 Sum_probs=75.0
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
....+.+|...|+.+. +--+.+++++..+.+..++||++++|.++.+.... .......+..++...++.||
T Consensus 62 ~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh 133 (272)
T 4gkh_A 62 VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLH 133 (272)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHH
T ss_pred CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhc
Confidence 3467889999999985 43467888999988999999999998777654410 11122334555555555555
Q ss_pred cCC-------------------------------------------------------CCceeeeccCCCcEEEccCCcc
Q 037755 87 NGC-------------------------------------------------------DVCILHLDIKPHNILLDHNFVP 111 (238)
Q Consensus 87 ~~~-------------------------------------------------------~~~i~H~dl~p~nil~~~~~~~ 111 (238)
+.. ...++|+|+.+.||+++.++.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~ 213 (272)
T 4gkh_A 134 SIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLI 213 (272)
T ss_dssp TSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEE
T ss_pred CCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEE
Confidence 421 0238999999999999987777
Q ss_pred ccccccccc
Q 037755 112 NVSDFGLAK 120 (238)
Q Consensus 112 ~l~d~~~~~ 120 (238)
-|+||+.+.
T Consensus 214 ~viDwe~a~ 222 (272)
T 4gkh_A 214 GCIDVGRVG 222 (272)
T ss_dssp EECCCTTCE
T ss_pred EEEECcccc
Confidence 799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.7e-06 Score=67.10 Aligned_cols=109 Identities=17% Similarity=0.153 Sum_probs=73.0
Q ss_pred cHHHHHHHHHHHhhcCCC---cceeeeeEEE-eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 8 SAEEFINEVSTIGRIHHV---NVVQLLGFCS-EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~---ni~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
...++.+|+.+|+.+.+. .+.+++.+.. ..+..+++|++++|.++.+... ..++......++.++...++
T Consensus 52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La 125 (306)
T 3tdw_A 52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMN 125 (306)
T ss_dssp HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHH
Confidence 457889999999999642 3556666664 4456789999999988765321 12334444444555555555
Q ss_pred HhHcC---------------------------------------------------------CCCceeeeccCCCcEEEc
Q 037755 84 YLHNG---------------------------------------------------------CDVCILHLDIKPHNILLD 106 (238)
Q Consensus 84 ~Lh~~---------------------------------------------------------~~~~i~H~dl~p~nil~~ 106 (238)
.||+. ....++|+|++|.||+++
T Consensus 126 ~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~ 205 (306)
T 3tdw_A 126 ELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTN 205 (306)
T ss_dssp HHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEEC
T ss_pred HHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEe
Confidence 54432 112579999999999998
Q ss_pred c---CCc-cccccccccccC
Q 037755 107 H---NFV-PNVSDFGLAKFH 122 (238)
Q Consensus 107 ~---~~~-~~l~d~~~~~~~ 122 (238)
. ++. +.|+||+.+...
T Consensus 206 ~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 206 LNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp TTCSSCCEEEECCCTTCEEE
T ss_pred cCCCCCceEEEEehhhcCCC
Confidence 7 455 479999977643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=4.3e-05 Score=61.36 Aligned_cols=45 Identities=9% Similarity=0.073 Sum_probs=33.9
Q ss_pred HHHHHHHHHHhhcC-C--CcceeeeeEEEeC---CeeeEEEEeCCCCChhh
Q 037755 10 EEFINEVSTIGRIH-H--VNVVQLLGFCSEG---SKRALVYEFMPNGSLDR 54 (238)
Q Consensus 10 ~~~~~e~~~l~~l~-h--~ni~~~~~~~~~~---~~~~lv~e~~~~~sL~~ 54 (238)
..+.+|+.+++.+. + -.+.+++.+..++ ...++|||+++|..+.+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 56788999999984 3 3567788877655 35789999998877654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.68 E-value=2.7e-05 Score=57.56 Aligned_cols=96 Identities=11% Similarity=0.025 Sum_probs=62.1
Q ss_pred ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc
Q 037755 51 SLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129 (238)
Q Consensus 51 sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 129 (238)
||.+.+ ...+.++++.++|.++.|.+.+|.-+-. . .-..+=+.|..|++..+|.|-+.+ ..+.
T Consensus 34 SL~eIL---~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEIL---RLYNQPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHH---HHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHH---HHcCCCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 677777 3457899999999999999999887621 1 111233457889999999887764 1110
Q ss_pred cccccCCccccCCcceeecCCCcccccCceehHHHHHHHHh
Q 037755 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170 (238)
Q Consensus 130 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll 170 (238)
.....+.+||... ...+.+.=|||||+++|..+
T Consensus 98 -----~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp --------------CCSS---SSSCHHHHHHHHHHHHHHHH
T ss_pred -----ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHh
Confidence 0223456888763 14456677999999999988
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.001 Score=52.74 Aligned_cols=30 Identities=27% Similarity=0.168 Sum_probs=27.0
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
..++|||+.+.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 379999999999999878889999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0045 Score=48.77 Aligned_cols=45 Identities=16% Similarity=0.204 Sum_probs=37.3
Q ss_pred cHHHHHHHHHHHhhcC---CCcceeeeeEEEeCCeeeEEEEeCCCCCh
Q 037755 8 SAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEFMPNGSL 52 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~~sL 52 (238)
....+..|+..|+.|. ...+++++.+.......++|||++++..+
T Consensus 71 ~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 71 YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4677899999999984 35678898888877889999999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0007 Score=53.73 Aligned_cols=34 Identities=26% Similarity=0.316 Sum_probs=28.0
Q ss_pred CceeeeccCCCcEEEccC----CccccccccccccCCC
Q 037755 91 VCILHLDIKPHNILLDHN----FVPNVSDFGLAKFHPK 124 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~----~~~~l~d~~~~~~~~~ 124 (238)
..++|||+.+.||+++.+ +.+.|+||+.+.....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 379999999999999864 6789999998764443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0046 Score=48.28 Aligned_cols=30 Identities=20% Similarity=0.159 Sum_probs=25.0
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccC
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
.++|+|+.+.||+ ..++.+.++||..+...
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 5899999999999 55667899999877533
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0039 Score=50.70 Aligned_cols=30 Identities=20% Similarity=0.299 Sum_probs=25.4
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccC
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
.++|||+.+.||+++.+ .+.++||..+...
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 79999999999999865 4889999877544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0092 Score=48.31 Aligned_cols=109 Identities=18% Similarity=0.219 Sum_probs=65.3
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhc-----------------cCCC-CCCCCCC-
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI-----------------FPKE-SRGQSCS- 67 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~-----------------~~~~-~~~~~~~- 67 (238)
......+|..+++.+. +.-..++++.+.++ +|++|++|..|...- .... ..++...
T Consensus 96 ~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~ 171 (379)
T 3feg_A 96 GVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHW 171 (379)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 4567779999999985 33335677666542 899999875543110 1100 1112222
Q ss_pred -HHHHHHHHHHHHH-------------------HHH----HhHcC-CCCceeeeccCCCcEEEccC----Cccccccccc
Q 037755 68 -WEKLHEVASGTAH-------------------GIE----YLHNG-CDVCILHLDIKPHNILLDHN----FVPNVSDFGL 118 (238)
Q Consensus 68 -~~~~~~~~~~i~~-------------------~l~----~Lh~~-~~~~i~H~dl~p~nil~~~~----~~~~l~d~~~ 118 (238)
+.++..+..++-. .+. .|.+. ....++|+|+.+.||+++.+ +.+.++||..
T Consensus 172 l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~ 251 (379)
T 3feg_A 172 LFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEY 251 (379)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTT
T ss_pred HHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEeccc
Confidence 3445555544322 122 23221 12369999999999999876 6889999987
Q ss_pred cc
Q 037755 119 AK 120 (238)
Q Consensus 119 ~~ 120 (238)
+.
T Consensus 252 a~ 253 (379)
T 3feg_A 252 SS 253 (379)
T ss_dssp CE
T ss_pred CC
Confidence 74
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.35 E-value=0.013 Score=47.96 Aligned_cols=30 Identities=13% Similarity=0.331 Sum_probs=26.6
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccC
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
.++|||+.|.||+++.++ +.++||+.+...
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 899999999999998776 899999987644
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.29 E-value=0.12 Score=39.76 Aligned_cols=24 Identities=25% Similarity=0.212 Sum_probs=20.0
Q ss_pred CceeeeccCCCcEEEccCCcccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSD 115 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d 115 (238)
+.++|+|+.+.|++++.++. .+.|
T Consensus 188 p~LvHGDlw~gNvl~~~~g~-~~iD 211 (288)
T 3f7w_A 188 PARIHGDLWNGNVLWQDDGA-VVID 211 (288)
T ss_dssp CEEECSCCSGGGEEEETTEE-EECS
T ss_pred CeeeecCCCCCcEEEcCCCe-EEEe
Confidence 46999999999999998875 3555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.67 E-value=0.019 Score=45.09 Aligned_cols=30 Identities=20% Similarity=0.323 Sum_probs=25.6
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+++|+|+.+.||++++++.+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 379999999999999987666899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.02 E-value=0.087 Score=41.32 Aligned_cols=30 Identities=33% Similarity=0.288 Sum_probs=25.1
Q ss_pred CceeeeccCCCcEEEccCCccccccccccccC
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
..++|||+++.||+++ + .+.++||+.+...
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 3689999999999999 4 7899999877533
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.91 E-value=0.078 Score=42.07 Aligned_cols=31 Identities=19% Similarity=0.285 Sum_probs=27.2
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccC
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~ 122 (238)
.++|+|+.+.||+++.++.+.++||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 6999999999999998888999999876543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.36 E-value=0.35 Score=35.58 Aligned_cols=84 Identities=10% Similarity=0.063 Sum_probs=60.2
Q ss_pred CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCc
Q 037755 23 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHN 102 (238)
Q Consensus 23 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~n 102 (238)
.||+.+.. .+-.+++.+.+.++.- .+...+- .-+.++....+.++.+|+....+++. =+|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57877766 5666666655555433 3333332 23677888999999999998866653 4577899999
Q ss_pred EEEccCCcccccccccc
Q 037755 103 ILLDHNFVPNVSDFGLA 119 (238)
Q Consensus 103 il~~~~~~~~l~d~~~~ 119 (238)
++++.++.+++...|+-
T Consensus 110 L~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp EEECTTSCEEESCCEET
T ss_pred EEEcCCCCEEEEEccCc
Confidence 99999999999987763
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.20 E-value=0.42 Score=35.32 Aligned_cols=83 Identities=10% Similarity=0.016 Sum_probs=59.3
Q ss_pred CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HhHcCCCCceeeeccCCC
Q 037755 23 HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE-YLHNGCDVCILHLDIKPH 101 (238)
Q Consensus 23 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~Lh~~~~~~i~H~dl~p~ 101 (238)
.||+. -..+-.+++.+.+.++.-.++.=...+ ..++....+..+.+|+.... +++ .-+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 57777 445556667777766654332212223 56778888999999888776 554 4567789999
Q ss_pred cEEEccCCcccccccccc
Q 037755 102 NILLDHNFVPNVSDFGLA 119 (238)
Q Consensus 102 nil~~~~~~~~l~d~~~~ 119 (238)
|++++.++.+++...|+-
T Consensus 114 NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GEEECTTCCEEESCCEET
T ss_pred eEEEeCCCcEEEEEcCCc
Confidence 999999999999988864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.17 E-value=0.14 Score=42.52 Aligned_cols=36 Identities=19% Similarity=0.206 Sum_probs=25.4
Q ss_pred HHHHHHHhhcCCCcc-eeeeeEEEeCCeeeEEEEeCCCCCh
Q 037755 13 INEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSL 52 (238)
Q Consensus 13 ~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~sL 52 (238)
.+|..+++.|...++ .++++.+.+ ..|++|++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 589999999975555 467776632 259999987444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.71 E-value=0.059 Score=43.21 Aligned_cols=28 Identities=21% Similarity=0.357 Sum_probs=23.6
Q ss_pred ceeeeccCCCcEEEccCCccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.++|+|+.+.||+++.++ +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 699999999999998654 7999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=91.20 E-value=0.075 Score=43.72 Aligned_cols=39 Identities=18% Similarity=0.347 Sum_probs=27.1
Q ss_pred HHHHHHHHHHhhcCCCcc-eeeeeEEEeCCeeeEEEEeCCCCCh
Q 037755 10 EEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSL 52 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~sL 52 (238)
+.+.+|..+++.+...++ .++++.+.+ .+|++|++|.++
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 667789999999853334 567766543 289999976444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.55 E-value=0.18 Score=41.06 Aligned_cols=28 Identities=29% Similarity=0.264 Sum_probs=23.7
Q ss_pred eeeeccCCCcEEEc------cCCccccccccccc
Q 037755 93 ILHLDIKPHNILLD------HNFVPNVSDFGLAK 120 (238)
Q Consensus 93 i~H~dl~p~nil~~------~~~~~~l~d~~~~~ 120 (238)
++|+|+.+.||++. +++.+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 68999999999993 45678999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=84.72 E-value=0.34 Score=39.73 Aligned_cols=28 Identities=18% Similarity=0.315 Sum_probs=25.2
Q ss_pred ceeeeccCCCcEEEccCCccccccccccc
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.++|+|+.+.||+ +.++.+.++||..+.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 5999999999999 778889999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 238 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-54
Identities = 61/238 (25%), Positives = 110/238 (46%), Gaps = 21/238 (8%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ + F NEV + + HVN++ +G+ + + A+V ++ SL H+ E++
Sbjct: 42 APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK 100
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
KL ++A TA G++YLH I+H D+K +NI L + + DFGLA
Sbjct: 101 F---EMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
Query: 123 PKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKAT 181
+ + G+I ++APE+I ++ S +SDVY FG+VL E+ G+
Sbjct: 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL------- 207
Query: 182 RSSKAYFPSWVSDQLNK--GGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
Y DQ+ G +++++ S + + + C++ K +RP
Sbjct: 208 ----PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-45
Identities = 55/238 (23%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
M++ S +EFI E + + H +VQL G C++ ++ E+M NG L ++
Sbjct: 35 MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 94
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
R ++L E+ +EYL + LH D+ N L++ V VSDFGL++
Sbjct: 95 HR---FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLK 179
+ ++++ S ++ + + PE++ S KSD++ FG+++ E+ + G+
Sbjct: 149 YVL-DDEYTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGK------ 199
Query: 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + S ++ + +G L + + K+ I C K +RP+
Sbjct: 200 --MPYERFTNSETAEHIAQGLRL------YRPHLASEKVYTIMYSCWHEKADERPTFK 249
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-45
Identities = 60/239 (25%), Positives = 111/239 (46%), Gaps = 24/239 (10%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ S + F+ E + + ++ H +V+L ++ ++ E+M NGSL + K
Sbjct: 44 SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFL--KT 100
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
G + KL ++A+ A G+ ++ +H D++ NIL+ ++DFGLA+
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLK 179
+N++ + + I + APE I N+GT + KSDV+ FG++L E+ T GR
Sbjct: 158 LIE-DNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRI----- 209
Query: 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
+P + ++ + NLE +L + C + +P DRP+
Sbjct: 210 -------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDY 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-44
Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 22/236 (9%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ S E F+ E + ++ H +VQL SE +V E+M GSL + +
Sbjct: 48 TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGE- 105
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
G+ +L ++A+ A G+ Y+ + +H D++ NIL+ N V V+DFGLA+
Sbjct: 106 -TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR 161
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+N++ + + I + APE G + KSDV+ FG++L E+T R
Sbjct: 162 LIE-DNEYTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGR------ 212
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+P V+ ++ +E L + C + +P +RP+
Sbjct: 213 -----VPYPGMVNREVLD--QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 4e-44
Identities = 53/236 (22%), Positives = 85/236 (36%), Gaps = 27/236 (11%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ S ++ I EV + ++ H N +Q G LV E+ + D
Sbjct: 53 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----H 108
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ ++ V G G+ YLH ++H D+K NILL + + DFG A
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 123 PKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKAT 181
N FV GT ++APE+I + + G K DV+ G+ +E+ +
Sbjct: 166 APANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP------- 212
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
F L E + + C+Q P DRP+
Sbjct: 213 ----PLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-44
Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 22/238 (9%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+ S E+FI E + ++ H +VQL G C E + LV+EFM +G L ++
Sbjct: 36 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--- 92
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
++ + E L + G + + C++H D+ N L+ N V VSDFG+ +
Sbjct: 93 TQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 149
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
F + S T+ + + +PE+ +F S KSDV+ FG+++ E+ +
Sbjct: 150 FVLDDQYTSSTG-TKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGK------ 200
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
+ S V + ++ G L + + + I C + +P DRP+ ++
Sbjct: 201 -IPYENRSNSEVVEDISTGFRL------YKPRLASTHVYQIMNHCWKERPEDRPAFSR 251
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-43
Identities = 47/258 (18%), Positives = 93/258 (36%), Gaps = 27/258 (10%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG----SKRALVYEFMPNGSLDRHI 56
+ + + + E+ + H N++ + ++ ++ LV ++ +GSL ++
Sbjct: 33 IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92
Query: 57 FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVC-----ILHLDIKPHNILLDHNFVP 111
+ + E + ++A TA G+ +LH I H D+K NIL+ N
Sbjct: 93 -----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147
Query: 112 NVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISRNF----GTVSCKSDVYGFGMV 165
++D GLA H D + I+ GT Y+APE++ + ++D+Y G+V
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207
Query: 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNV-------TEIESMIARKL 218
E+ + Y + + + R +
Sbjct: 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 267
Query: 219 CVIGLWCIQVKPADRPSM 236
I C A R +
Sbjct: 268 AKIMRECWYANGAARLTA 285
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-43
Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 22/231 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEFMPNGSLDRHIFPKESRGQSCS 67
+ ++EV+ + + H N+V+ + + L V E+ G L I Q
Sbjct: 48 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD 107
Query: 68 WEKLHEVASGTAHGIEYLH--NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKE 125
E + V + ++ H + +LH D+KP N+ LD + DFGLA+ +
Sbjct: 108 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167
Query: 126 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSK 185
F A GT Y++PE ++R + + KSD++ G +L E+
Sbjct: 168 TSFA--KAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMP----------- 212
Query: 186 AYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
P Q G + I + +L I + +K RPS+
Sbjct: 213 ---PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSV 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 2e-42
Identities = 57/239 (23%), Positives = 105/239 (43%), Gaps = 26/239 (10%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
++ +F++E S +G+ H NV+ L G ++ + ++ EFM NGSLD + + +
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ +L + G A G++YL + + +H D+ NIL++ N V VSDFGL++F
Sbjct: 125 ---FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 123 PKENDFVSISAT---RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNL 178
+ + ++ + I + APE I + + SDV+ +G+V+ E+ + G R
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGER---- 232
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + + +E L + L C Q RP
Sbjct: 233 --------PYWDMTNQDVIN--AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-42
Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 12/173 (6%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
LE + I E+ + + +V G + ++ E M GSLD+ +
Sbjct: 41 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---- 96
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
+ + L +V+ G+ YL I+H D+KP NIL++ + DFG++
Sbjct: 97 KAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
++ GT Y++PE + S +SD++ G+ L+EM GR
Sbjct: 155 LIDSMA----NSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-42
Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 25/237 (10%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
K EE + E + ++ + +V+L+G C + LV E G L + + +
Sbjct: 47 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GK 102
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ + E+ + G++YL +H D+ N+LL + +SDFGL+K
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159
Query: 123 PKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKA 180
++ + + SA + + + APE I NF S +SDV+ +G+ + E + G++
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKP----- 212
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
K V + +G + E +L + C K DRP
Sbjct: 213 ---YKKMKGPEVMAFIEQGKRM------ECPPECPPELYALMSDCWIYKWEDRPDFL 260
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-41
Identities = 54/249 (21%), Positives = 97/249 (38%), Gaps = 37/249 (14%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK--------- 59
E ++E+ + ++ H N+V LLG C+ L++E+ G L ++ K
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 60 ----------ESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF 109
E ++E L A A G+E+L +H D+ N+L+ H
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGK 201
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
V + DFGLA+ ++++V R + ++APE + G + KSDV+ +G++L E+
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI 259
Query: 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229
+ Y V K + + ++ +I C
Sbjct: 260 ----------FSLGVNPYPGIPVDANFYKLIQNGFK--MDQPFYATEEIYIIMQSCWAFD 307
Query: 230 PADRPSMTK 238
RPS
Sbjct: 308 SRKRPSFPN 316
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 5e-41
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 21/237 (8%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
L+ EEF+ E + + I H N+VQLLG C+ ++ EFM G+L ++ E
Sbjct: 49 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--E 106
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
Q S L +A+ + +EYL +H D+ N L+ N + V+DFGL++
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 163
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+ + + I + APE ++ S KSDV+ FG++L E+
Sbjct: 164 LMTGDTYTAH-AGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYG------- 213
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ +P Q+ + LE E K+ + C Q P+DRPS
Sbjct: 214 ----MSPYPGIDLSQVYE--LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFA 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 6e-41
Identities = 46/235 (19%), Positives = 91/235 (38%), Gaps = 42/235 (17%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+ EV + H N+++L G+ + ++ L+ E+ P G++ R + + +
Sbjct: 51 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQ 106
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
+ + A+ + Y H+ ++H DIKP N+LL ++DFG + P
Sbjct: 107 RTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------NSNLKATR 182
GT+ Y+ PE+I K D++ G++ E G+ K
Sbjct: 164 LC----GTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 217
Query: 183 SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ FP +V++ +I+R ++ P+ RP +
Sbjct: 218 RVEFTFPDFVTE--------------GARDLISR--------LLKHNPSQRPMLR 250
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 7e-41
Identities = 55/255 (21%), Positives = 92/255 (36%), Gaps = 38/255 (14%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
E S +F E + + + N+V+LLG C+ G L++E+M G L+ +
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113
Query: 63 GQSC--------------------SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHN 102
S + +A A G+ YL +H D+ N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170
Query: 103 ILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162
L+ N V ++DFGL++ + + + I ++ PE I N + +SDV+ +
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAY 228
Query: 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIG 222
G+VL E+ V + G N+ +L +
Sbjct: 229 GVVLWEIFSYGLQPYYGMA-------HEEVIYYVRDG------NILACPENCPLELYNLM 275
Query: 223 LWCIQVKPADRPSMT 237
C PADRPS
Sbjct: 276 RLCWSKLPADRPSFC 290
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-40
Identities = 50/239 (20%), Positives = 87/239 (36%), Gaps = 29/239 (12%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR----ALVYEFMPNGSLDRHIFP 58
+ +K + F E + + H N+V+ K LV E M +G+L ++
Sbjct: 46 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK- 104
Query: 59 KESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL-DHNFVPNVSDFG 117
R + + L G+++LH I+H D+K NI + + D G
Sbjct: 105 ---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG 160
Query: 118 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSN 177
LA A GT ++APE+ + DVY FGM +LEM
Sbjct: 161 LATLKRASFA----KAVIGTPEFMAPEMYEEKYDE---SVDVYAFGMCMLEMATSEY--- 210
Query: 178 LKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
Y + Q+ + ++ + + ++ I CI+ +R S+
Sbjct: 211 --------PYSECQNAAQIYRRVTSGVKPA-SFDKVAIPEVKEIIEGCIRQNKDERYSI 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-40
Identities = 49/236 (20%), Positives = 99/236 (41%), Gaps = 26/236 (11%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
N +E + E + + ++ + +V+++G C E LV E G L++++ +
Sbjct: 47 NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QN 101
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
+ + + E+ + G++YL +H D+ N+LL +SDFGL+K
Sbjct: 102 RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 124 KENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKAT 181
+ ++ + + + APE I+ S KSDV+ FG+++ E + G+
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQ-------- 208
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + S V+ L KG + + R++ + C +RP
Sbjct: 209 KPYRGMKGSEVTAMLEKGERM------GCPAGCPREMYDLMNLCWTYDVENRPGFA 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-40
Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 28/236 (11%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-ALVYEFMPNGSLDRHIFPKESR 62
+ +A+ F+ E S + ++ H N+VQLLG E +V E+M GSL ++ +
Sbjct: 39 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRG 96
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ L + + +EYL +H D+ N+L+ + V VSDFGL K
Sbjct: 97 RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKAT 181
D + + + APE + S KSDV+ FG++L E+ + GR
Sbjct: 154 SSTQDTG-----KLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYP---- 202
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
V ++ KG + + + + C + A RPS
Sbjct: 203 ----RIPLKDVVPRVEKGYKM------DAPDGCPPAVYEVMKNCWHLDAAMRPSFL 248
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-40
Identities = 47/239 (19%), Positives = 93/239 (38%), Gaps = 23/239 (9%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+ S+ E+++ E+ + H N+V+LL + ++ EF G++D +
Sbjct: 45 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--- 101
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ + ++ V T + YLH D I+H D+K NIL + ++DFG++
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158
Query: 121 FHPKENDFVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLLEMTGGRRNSN 177
+ + + GT ++APE++ + K+DV+ G+ L+EM
Sbjct: 159 KNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE---- 212
Query: 178 LKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
P V ++ K L + S + C++ R +
Sbjct: 213 ----PPHHELNPMRVLLKIAKSEPPTLAQPSRW-SSNFKDFL---KKCLEKNVDARWTT 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-39
Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 22/238 (9%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
+ + + ++FI EV+ + + H N+++L G + +V E P GSL + +
Sbjct: 48 VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG 106
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
L A A G+ YL + +H D+ N+LL + + DFGL +
Sbjct: 107 H---FLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160
Query: 122 HPKENDFVSISATR-GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
P+ +D + R + APE + T S SD + FG+ L EM
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEM----------F 208
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
T + + S L+K R + + + + C KP DRP+
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEGER--LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-39
Identities = 55/235 (23%), Positives = 84/235 (35%), Gaps = 20/235 (8%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
++ + E E+ ++H NVV+ G EG+ + L E+ G L I P
Sbjct: 40 MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-- 97
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
G+ YLH + I H DIKP N+LLD +SDFGLA
Sbjct: 98 --IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 152
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKAT 181
N ++ GT+ Y+APEL+ R + DV+ G+VL M G
Sbjct: 153 FRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGEL------- 204
Query: 182 RSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ E + I + + P+ R ++
Sbjct: 205 -----PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-39
Identities = 52/244 (21%), Positives = 95/244 (38%), Gaps = 32/244 (13%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSC-- 66
E ++E+ + + +H+N+V LLG C+ G ++ E+ G L + K
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 67 ------------SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVS 114
E L + A G+ +L + +H D+ NILL H + +
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKIC 187
Query: 115 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
DFGLA+ ++++V R + ++APE I + +SDV+ +G+ L E+
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGS 245
Query: 175 NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234
+ SK Y + +G + ++ I C P RP
Sbjct: 246 SPYPGMPVDSKFY------KMIKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 235 SMTK 238
+ +
Sbjct: 294 TFKQ 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-38
Identities = 48/236 (20%), Positives = 92/236 (38%), Gaps = 22/236 (9%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
S + +E ++E + + + +V +LLG C + + L+ + MP G L ++
Sbjct: 49 ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EH 104
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
+ + L A G+ YL + ++H D+ N+L+ ++DFGLAK
Sbjct: 105 KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATR 182
E + I ++A E I + +SDV+ +G+ + E+ +
Sbjct: 162 GAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGS-------K 212
Query: 183 SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
S +S L KG L + + +I + C + RP +
Sbjct: 213 PYDGIPASEISSILEKGERL------PQPPICTIDVYMIMVKCWMIDADSRPKFRE 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-37
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 22/229 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
+F+ E +G+ H N+++L G S+ ++ E+M NG+LD+ + + S
Sbjct: 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVL 110
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
+L + G A G++YL N + +H D+ NIL++ N V VSDFGL++ + +
Sbjct: 111 QLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167
Query: 130 -SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF 188
+ S + I + APE IS + SDV+ FG+V+ E+ R
Sbjct: 168 YTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGE-------RPYWELS 218
Query: 189 PSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
V +N G L + + + C Q + A RP
Sbjct: 219 NHEVMKAINDGFRL------PTPMDCPSAIYQLMMQCWQQERARRPKFA 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-37
Identities = 53/233 (22%), Positives = 88/233 (37%), Gaps = 24/233 (10%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+ E INE+ + + N+V L G + +V E++ GSL +
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---- 111
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
++ V +E+LH ++H DIK NILL + ++DFG
Sbjct: 112 -CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183
E S GT ++APE+++R K D++ G++ +EM G
Sbjct: 168 PEQSKR--STMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPP-------- 215
Query: 184 SKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
P + G EL+N ++ S I R C+ + R S
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKL-SAIFRDFL---NRCLDMDVEKRGSA 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-36
Identities = 56/249 (22%), Positives = 105/249 (42%), Gaps = 34/249 (13%)
Query: 3 ENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIF---- 57
SK +F E+ + ++ HH N++ LLG C L E+ P+G+L +
Sbjct: 48 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 107
Query: 58 --------PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF 109
S + S ++L A+ A G++YL +H D+ NIL+ N+
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENY 164
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
V ++DFGL++ +V + R + ++A E + N+ + SDV+ +G++L E+
Sbjct: 165 VAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEI 219
Query: 170 TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229
+ + ++L +G L E ++ + C + K
Sbjct: 220 VSLGG-------TPYCGMTCAELYEKLPQGYRL------EKPLNCDDEVYDLMRQCWREK 266
Query: 230 PADRPSMTK 238
P +RPS +
Sbjct: 267 PYERPSFAQ 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-36
Identities = 42/234 (17%), Positives = 79/234 (33%), Gaps = 38/234 (16%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E + R+ H V+L + K + NG L ++I + S
Sbjct: 53 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDET 108
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
TA + L I+H D+KP NILL+ + ++DFG AK E+
Sbjct: 109 ---CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------NSNLKATR 182
++ GT Y++PEL++ + SD++ G ++ ++ G +
Sbjct: 166 RANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223
Query: 183 SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ FP + ++ + + + R
Sbjct: 224 KLEYDFPEKFFP--------------KARDLVEK--------LLVLDATKRLGC 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-36
Identities = 49/231 (21%), Positives = 84/231 (36%), Gaps = 24/231 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-LVYEFMPNGSLDRHIFPKESRGQSCSW 68
+F+ E + H NV+ LLG C +V +M +G L I + +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTV 129
Query: 69 EKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF--HPKEN 126
+ L A G + +H D+ N +LD F V+DFGLA+ + +
Sbjct: 130 KDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 127 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKA 186
+ + + + ++A E + + KSDV+ FG++L E+
Sbjct: 187 SVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----- 239
Query: 187 YFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
++ L +G L L + L C K RPS +
Sbjct: 240 --TFDITVYLLQGRRL------LQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 126 bits (317), Expect = 3e-35
Identities = 42/238 (17%), Positives = 83/238 (34%), Gaps = 24/238 (10%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
++ + E E+ T+ + H +V L + ++ ++YEFM G L +
Sbjct: 59 VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--- 115
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILL--DHNFVPNVSDFGL 118
S ++ E G+ ++H + +HLD+KP NI+ + + DFGL
Sbjct: 116 DEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL 178
+ T GT + APE+ V +D++ G++ + G
Sbjct: 173 TAHLDPKQSVKV---TTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLS---- 223
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ + L + + S I+ + P R ++
Sbjct: 224 -------PFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-35
Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 25/229 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E+F+ E T+ + H ++V+L+G +E ++ E G L + R S
Sbjct: 53 EKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLA 108
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
L A + + YL +H DI N+L+ N + DFGL+++ +
Sbjct: 109 SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 165
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-TGGRRNSNLKATRSSKAYF 188
+ S + I ++APE I NF + SDV+ FG+ + E+ G +
Sbjct: 166 A-SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVK-------------- 208
Query: 189 PSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
P + G +E + L + C P+ RP T
Sbjct: 209 PFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-35
Identities = 50/235 (21%), Positives = 93/235 (39%), Gaps = 24/235 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK------ESRG 63
EF+NE S + + +VV+LLG S+G ++ E M G L ++
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
S K+ ++A A G+ YL+ +H D+ N ++ +F + DFG+ +
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRS 183
+ + + + +++PE + G + SDV+ FG+VL E+ +
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE-------QP 235
Query: 184 SKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
+ V + +G + + L + C Q P RPS +
Sbjct: 236 YQGLSNEQVLRFVMEG------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE 284
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-34
Identities = 54/250 (21%), Positives = 107/250 (42%), Gaps = 33/250 (13%)
Query: 3 ENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
+ ++ + I+E+ + I H N++ LLG C++ ++ E+ G+L ++ +
Sbjct: 56 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 115
Query: 62 RGQSC------------SWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNF 109
G S + L A A G+EYL +H D+ N+L+ +
Sbjct: 116 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 172
Query: 110 VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169
V ++DFGLA+ + + + R + ++APE + + +SDV+ FG++L E+
Sbjct: 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEI 230
Query: 170 -TGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228
T G +P ++L K L+ + + S +L ++ C
Sbjct: 231 FTLGGS------------PYPGVPVEELFK--LLKEGHRMDKPSNCTNELYMMMRDCWHA 276
Query: 229 KPADRPSMTK 238
P+ RP+ +
Sbjct: 277 VPSQRPTFKQ 286
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-33
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 31/243 (12%)
Query: 10 EEFINEVSTIGRI-HHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIF---------- 57
++E+ + I HH+NVV LLG C++ G ++ EF G+L ++
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 58 --PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSD 115
P++ + E L + A G+E+L + +H D+ NILL V + D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICD 177
Query: 116 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRN 175
FGLA+ K+ D+V R + ++APE I + +SDV+ FG++L E+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGA- 234
Query: 176 SNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
+ +L +G + ++ L C +P+ RP+
Sbjct: 235 -----SPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 236 MTK 238
++
Sbjct: 284 FSE 286
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 119 bits (299), Expect = 1e-32
Identities = 45/238 (18%), Positives = 89/238 (37%), Gaps = 24/238 (10%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+ NE+S + ++HH ++ L + + L+ EF+ G L I
Sbjct: 62 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---A 118
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNV--SDFGL 118
+ S ++ G++++H + I+HLDIKP NI+ + +V DFGL
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGL 175
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL 178
A + T T + APE++ R V +D++ G++ + G
Sbjct: 176 ATKLNPDEIVKV---TTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLS---- 226
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ + L + + S ++ + +Q +P R ++
Sbjct: 227 -------PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 2e-31
Identities = 35/239 (14%), Positives = 76/239 (31%), Gaps = 24/239 (10%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
++ E+S + H N++ L + +++EF+ + I
Sbjct: 37 FVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---N 93
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNV--SDFGL 118
+ + ++ +++LH I H DI+P NI+ + +FG
Sbjct: 94 TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL 178
A+ ++F Y APE+ VS +D++ G ++ + G
Sbjct: 151 ARQLKPGDNFRL---LFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGIN---- 201
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + N E E I+ + + + R + +
Sbjct: 202 -------PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTAS 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (287), Expect = 2e-31
Identities = 45/239 (18%), Positives = 91/239 (38%), Gaps = 26/239 (10%)
Query: 3 ENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES 61
E + E + EV + ++ H N++QL + LV++ M G L ++ +
Sbjct: 47 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----T 102
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
+ S ++ ++ I LH + I+H D+KP NILLD + ++DFG +
Sbjct: 103 EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159
Query: 122 HPKENDFVSISATRGTIGYIAPELIS----RNFGTVSCKSDVYGFGMVLLEMTGGRRNSN 177
+ GT Y+APE+I N + D++ G+++ + G
Sbjct: 160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP--- 213
Query: 178 LKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
++ L + + + + + + + V+P R +
Sbjct: 214 --------PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (288), Expect = 5e-31
Identities = 45/236 (19%), Positives = 88/236 (37%), Gaps = 24/236 (10%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ + A +S + +V + K + + + M G L H+ S+
Sbjct: 45 KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQ 100
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
S + A+ G+E++H + +++ D+KP NILLD + +SD GLA
Sbjct: 101 HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATR 182
K+ + GT GY+APE++ + +D + G +L ++ G
Sbjct: 158 SKKKPHA----SVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHS-------- 204
Query: 183 SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238
F + ++ + L E+ + +L + +Q R
Sbjct: 205 ----PFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (282), Expect = 9e-31
Identities = 44/239 (18%), Positives = 82/239 (34%), Gaps = 25/239 (10%)
Query: 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC----SEGSKRALVYEFMPNGSLDRHIF 57
L F E ++H +V + G +V E++ +L +
Sbjct: 44 LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH 103
Query: 58 PKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFG 117
+ ++ EV + + + I+H D+KP NI++ V DFG
Sbjct: 104 ----TEGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFG 156
Query: 118 LAKFHPKENDFVSISATR-GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNS 176
+A+ + V+ +A GT Y++PE +V +SDVY G VL E+ G
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEP-- 212
Query: 177 NLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
+ + + + ++ L + L + P +R
Sbjct: 213 ---------PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (282), Expect = 1e-30
Identities = 39/228 (17%), Positives = 75/228 (32%), Gaps = 20/228 (8%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
NE++ + +I H N+V L G L+ + + G L I +
Sbjct: 52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTER 107
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
+ ++YLH+ V LD + +SDFGL+K +
Sbjct: 108 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFP 189
+ GT GY+APE++++ S D + G++ + G ++
Sbjct: 168 TA---CGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYP-----------PFYD 211
Query: 190 SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ + E + I+ ++ P R +
Sbjct: 212 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 5e-29
Identities = 44/236 (18%), Positives = 82/236 (34%), Gaps = 41/236 (17%)
Query: 9 AEEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCS 67
E + E + H + + V E++ G L HI
Sbjct: 46 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD 101
Query: 68 WEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
+ A+ G+++L I++ D+K NILLD + ++DFG+ K + +
Sbjct: 102 LSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158
Query: 128 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------NSNLKA 180
+ GT YIAPE++ + D + FG++L EM G+ +
Sbjct: 159 --KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
R ++P W+ E + ++ + +P R +
Sbjct: 215 IRMDNPFYPRWLEK--------------EAKDLLVK--------LFVREPEKRLGV 248
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-28
Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 27/238 (11%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
S E+ EVS + I H NV+ L + L+ E + G L + KES
Sbjct: 51 SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL 110
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN----VSDFGL 118
+ + E L ++ +G ++ + I H D+KP NI+L VP + DFGL
Sbjct: 111 TEEEATEFLKQILNG-------VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 119 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNL 178
A N+F GT ++APE++ N+ + ++D++ G++ + G
Sbjct: 164 AHKIDFGNEF---KNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASP--- 215
Query: 179 KATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ + L + E S + + P R ++
Sbjct: 216 --------FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 2e-28
Identities = 44/233 (18%), Positives = 88/233 (37%), Gaps = 43/233 (18%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E +E + + H ++++ G + + ++ +++ G L + + +
Sbjct: 49 EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF 108
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
EV L I++ D+KP NILLD N ++DFG AK+ P
Sbjct: 109 YAAEVC-------LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--- 158
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------NSNLKATR 182
GT YIAPE++S + D + FG+++ EM G +
Sbjct: 159 --YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 214
Query: 183 SSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235
+++ FP + ++ +++ +++R I + R
Sbjct: 215 NAELRFPPFFNE--------------DVKDLLSR--------LITRDLSQRLG 245
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-28
Identities = 47/251 (18%), Positives = 90/251 (35%), Gaps = 22/251 (8%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
+ + + E+ + R H N++ + + + ++ + ++ K +
Sbjct: 44 FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLK 102
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF- 121
Q S + + G++Y+H +LH D+KP N+LL+ + DFGLA+
Sbjct: 103 TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159
Query: 122 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR----NSN 177
P + ++ T Y APE++ + G + D++ G +L EM R
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHY 218
Query: 178 LKATRSSKAYFPSWVSDQLNKGGNLELRNV------------TEIESMIARKLCVIGLWC 225
L S + LN NL+ RN + K +
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278
Query: 226 IQVKPADRPSM 236
+ P R +
Sbjct: 279 LTFNPHKRIEV 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 5e-28
Identities = 54/250 (21%), Positives = 85/250 (34%), Gaps = 23/250 (9%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
E + E+ + + H N++ LL S +LV++FM
Sbjct: 36 RSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---- 91
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ + T G+EYLH ILH D+KP+N+LLD N V ++DFGLAK
Sbjct: 92 DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR------- 173
N + + T Y APEL+ D++ G +L E+
Sbjct: 149 SFGSPNR--AYTHQVVTRWYRAPELL-FGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205
Query: 174 ------RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQ 227
R T + + + + + I S L +
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265
Query: 228 VKPADRPSMT 237
P R + T
Sbjct: 266 FNPCARITAT 275
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (260), Expect = 2e-27
Identities = 43/247 (17%), Positives = 78/247 (31%), Gaps = 27/247 (10%)
Query: 2 LENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
LE K + E + V + + +EG +V E + D F
Sbjct: 39 LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--- 95
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNIL---LDHNFVPNVSDFG 117
+ S + + +A IEY+H +H D+KP N L + + DFG
Sbjct: 96 -CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151
Query: 118 LAKFHPKENDFVSI-----SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGG 172
LAK + I GT Y + S + D+ G VL+ G
Sbjct: 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLG 209
Query: 173 RRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVT-EIESMIARKLCVIGLWCIQVKPA 231
+ + + +++ + + E + + C ++
Sbjct: 210 SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF--------CRSLRFD 261
Query: 232 DRPSMTK 238
D+P +
Sbjct: 262 DKPDYSY 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 5e-27
Identities = 45/249 (18%), Positives = 96/249 (38%), Gaps = 22/249 (8%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHI--FPKE 60
E S + + + H NVV+L C+ + +D+ + + +
Sbjct: 48 EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 107
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
E + ++ G+++LH ++H D+KP NIL+ + ++DFGLA+
Sbjct: 108 VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR----NS 176
+ + S+ T+ Y APE++ + + + D++ G + EM + +S
Sbjct: 165 IYSFQMALTSV---VVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219
Query: 177 NLK--------ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228
++ + +P V+ + + + + + I + L C+
Sbjct: 220 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 279
Query: 229 KPADRPSMT 237
PA R S
Sbjct: 280 NPAKRISAY 288
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-26
Identities = 45/237 (18%), Positives = 87/237 (36%), Gaps = 25/237 (10%)
Query: 9 AEEFINEVSTIGRI-HHVNVVQLLGFC----SEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+ EV R ++V+++ + +V E + G L I ++
Sbjct: 48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGD 105
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAK 120
Q+ + + E+ I+YLH + I H D+KP N+L N + ++DFG AK
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
N + T Y+APE++ D++ G+++ + G
Sbjct: 163 ETTSHNSLTTPCYTP---YYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYP---PFY 214
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237
+ A P + +E+ S + L ++ +P R ++T
Sbjct: 215 SNHGLAISPGMKTRIRMGQYEFPNPEWSEV-SEEVKMLI---RNLLKTEPTQRMTIT 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-26
Identities = 49/251 (19%), Positives = 84/251 (33%), Gaps = 29/251 (11%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
++ I E+S + ++H N+V+LL +K LV+EF+ F S
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASAL 96
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
+ G+ + +LH D+KP N+L++ ++DFGLA+
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR----NSNLK 179
+ T+ Y APE++ S D++ G + EM R +S +
Sbjct: 154 VPVRTYTHEV--VTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210
Query: 180 A--------TRSSKAYFPSWVSD-----QLNKGGNLELRNVTEIESMIARKLCVIGLWCI 226
+ +P S K + V R L +
Sbjct: 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLL---SQML 267
Query: 227 QVKPADRPSMT 237
P R S
Sbjct: 268 HYDPNKRISAK 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 1e-25
Identities = 42/233 (18%), Positives = 75/233 (32%), Gaps = 37/233 (15%)
Query: 8 SAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQS 65
+ EV + ++ V++LL + L+ E + +
Sbjct: 50 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGA 106
Query: 66 CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAKFHPK 124
E + + + +LH DIK NIL+D N + DFG
Sbjct: 107 LQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163
Query: 125 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-NSNLKATRS 183
+ GT Y PE I R + V+ G++L +M G + +
Sbjct: 164 TV----YTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218
Query: 184 SKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ +F VS + + WC+ ++P+DRP+
Sbjct: 219 GQVFFRQRVSSECQH----------------------LIRWCLALRPSDRPTF 249
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 99.5 bits (247), Expect = 1e-25
Identities = 38/249 (15%), Positives = 76/249 (30%), Gaps = 29/249 (11%)
Query: 2 LENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
E + A + +E T + + + F EG LV + + D +
Sbjct: 37 FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL----D 92
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPN-----VSD 115
G+ S + + A ++ +H + +++ DIKP N L+ N V D
Sbjct: 93 LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149
Query: 116 FGLAKFHPKEND-----FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMT 170
FG+ KF+ + GT Y++ S + D+ G V +
Sbjct: 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFL 207
Query: 171 GGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRN-VTEIESMIARKLCVIGLWCIQVK 229
G + + + G + + E+ + + + +
Sbjct: 208 RGSLPWQ--------GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLA 259
Query: 230 PADRPSMTK 238
P
Sbjct: 260 FDATPDYDY 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 6e-25
Identities = 47/240 (19%), Positives = 82/240 (34%), Gaps = 40/240 (16%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+K + E + H + L + V E+ G L H+ SR
Sbjct: 44 IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRE 99
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
+ + E+ A + L +++ DIK N++LD + ++DFGL K
Sbjct: 100 RVFTEERARFYG---AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------NS 176
+ + GT Y+APE++ D +G G+V+ EM GR
Sbjct: 157 SDGATMKTFC--GTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 177 NLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ + FP +S E +S++A ++ P R
Sbjct: 213 LFELILMEEIRFPRTLSP--------------EAKSLLAG--------LLKKDPKQRLGG 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 7e-24
Identities = 48/254 (18%), Positives = 81/254 (31%), Gaps = 35/254 (13%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--------LVYEFMPNGSLDRHIFPKES 61
+ E+ + + H NVV L+ C + LV++F +
Sbjct: 54 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK 113
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKF 121
S E+ + L+ ILH D+K N+L+ + V ++DFGLA+
Sbjct: 114 FTLS-------EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166
Query: 122 H--PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR----N 175
K + + T+ Y PEL+ D++G G ++ EM N
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225
Query: 176 SNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL------------ 223
+ S + N EL E+ RK+
Sbjct: 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 285
Query: 224 -WCIQVKPADRPSM 236
+ + PA R
Sbjct: 286 DKLLVLDPAQRIDS 299
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 1e-23
Identities = 45/174 (25%), Positives = 69/174 (39%), Gaps = 15/174 (8%)
Query: 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR------ALVYEFMPNGSLDRHIFPKES 61
E+ + ++ H N+V+L F ++ LV +++P R
Sbjct: 56 DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSR 114
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN-FVPNVSDFGLAK 120
Q+ + + Y+H I H DIKP N+LLD + V + DFG AK
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR 174
+ VS +R Y APELI + DV+ G VL E+ G+
Sbjct: 172 QLVRGEPNVSYICSR---YYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQP 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 2e-23
Identities = 40/249 (16%), Positives = 80/249 (32%), Gaps = 25/249 (10%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
++ + + E+ + + H N+V+L K LV+EF
Sbjct: 39 DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--- 95
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
V S ++ L +LH D+KP N+L++ N +++FGLA+
Sbjct: 96 ----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------- 174
S T+ Y P+++ S D++ G + E+ R
Sbjct: 152 GIPVRCYSAEVV--TLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208
Query: 175 NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIG-------LWCIQ 227
+ LK + K + + + + + + + ++
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268
Query: 228 VKPADRPSM 236
P R S
Sbjct: 269 CNPVQRISA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 93.0 bits (230), Expect = 3e-23
Identities = 42/247 (17%), Positives = 84/247 (34%), Gaps = 24/247 (9%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
+ I E+S + + H N+V+L + LV+E + +
Sbjct: 39 EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE 98
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
+ L ++ +G + D +LH D+KP N+L++ ++DFGLA+
Sbjct: 99 SVTAKSFLLQLLNG-------IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR---------- 173
+ T+ Y AP+++ S D++ G + EM G
Sbjct: 152 IPVR--KYTHEIVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 174 ---RNSNLKATRSSKAYFP-SWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVK 229
R + T +SK + + + E + + +++
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 230 PADRPSM 236
P R +
Sbjct: 269 PNQRITA 275
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 8e-23
Identities = 41/236 (17%), Positives = 82/236 (34%), Gaps = 20/236 (8%)
Query: 2 LENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE 60
+ + E E + I +V L +K L+ +++ G L H+ +E
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 124
Query: 61 SRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAK 120
+ + E+ L + + I++ DIK NILLD N ++DFGL+K
Sbjct: 125 RFTEHEVQIYVGEIVLA-------LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKA 180
+ + GTI Y+AP+++ D + G+++ E+ G
Sbjct: 178 EFVADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS------ 230
Query: 181 TRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236
+ + + L++ ++ + + P R
Sbjct: 231 -----PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.6 bits (229), Expect = 1e-22
Identities = 47/194 (24%), Positives = 77/194 (39%), Gaps = 21/194 (10%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
E +NE + ++ +V+L + S +V E++ G + H+ R S
Sbjct: 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEP 141
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV 129
A+ EYLH + +++ D+KP N+L+D V+DFG AK +
Sbjct: 142 HARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198
Query: 130 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------NSNLKATR 182
GT +APE+I + D + G+++ EM G +
Sbjct: 199 -----CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
Query: 183 SSKAYFPSWVSDQL 196
S K FPS S L
Sbjct: 252 SGKVRFPSHFSSDL 265
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 86.4 bits (213), Expect = 1e-20
Identities = 41/259 (15%), Positives = 93/259 (35%), Gaps = 41/259 (15%)
Query: 5 SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR--ALVYEFMPNGSLDRHIFPKES 61
++ E+ + + N++ L + R ALV+E + N +
Sbjct: 69 KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----- 123
Query: 62 RGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAK 120
Q+ + + ++Y H + I+H D+KPHN+++DH + + D+GLA+
Sbjct: 124 --QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 121 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR------R 174
F+ ++ + + + PEL+ ++ D++ G +L M +
Sbjct: 179 FYHPGQEY---NVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 175 NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL----------- 223
++ + R +K + D ++K +I +RK +
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294
Query: 224 ------WCIQVKPADRPSM 236
++ R +
Sbjct: 295 ALDFLDKLLRYDHQSRLTA 313
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 2e-20
Identities = 43/249 (17%), Positives = 93/249 (37%), Gaps = 25/249 (10%)
Query: 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRG 63
S+ A+ E+ + + H NV+ LL + +F K +
Sbjct: 56 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 115
Query: 64 QSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123
+ +++ + G+ Y+H I+H D+KP N+ ++ + + DFGLA+
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172
Query: 124 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR----NSNLK 179
E ++ T Y APE+I N+ + D++ G ++ EM G+ + +L
Sbjct: 173 SE-----MTGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 180 ATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL------------WCIQ 227
+ + ++ + + + E +N + + +K L +
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286
Query: 228 VKPADRPSM 236
+ R +
Sbjct: 287 LDAEQRVTA 295
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (183), Expect = 2e-16
Identities = 38/171 (22%), Positives = 66/171 (38%), Gaps = 21/171 (12%)
Query: 9 AEEFINEVSTIGRIHHVNVVQLLGFCS------EGSKRALVYEFMPNGSLDRHIFPKESR 62
A+ E+ + ++H N++ LL + E LV E M
Sbjct: 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---- 115
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
E++ + GI++LH+ I+H D+KP NI++ + + DFGLA+
Sbjct: 116 ---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173
+ T Y APE+I D++ G ++ EM +
Sbjct: 170 GTSFMM---TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.1 bits (183), Expect = 2e-16
Identities = 31/186 (16%), Positives = 70/186 (37%), Gaps = 17/186 (9%)
Query: 1 MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY--EFMPNGSLDRHI-- 56
++ K E +E+ + R++ + + + + L + PNG +
Sbjct: 45 IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104
Query: 57 --------FPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHN 108
K+ + + +++ G++Y+H C I+H DIKP N+L++
Sbjct: 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 162
Query: 109 -FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 167
N+ +A + + T Y +PE++ C +D++ ++
Sbjct: 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIF 220
Query: 168 EMTGGR 173
E+ G
Sbjct: 221 ELITGD 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 2e-15
Identities = 42/253 (16%), Positives = 85/253 (33%), Gaps = 31/253 (12%)
Query: 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESR 62
S A+ E+ + + H NV+ LL + + L +
Sbjct: 55 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 63 GQSCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFH 122
Q + + + + G++Y+H I+H D+KP N+ ++ + + DFGLA+
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 123 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGRR-------- 174
E + T Y APE++ N+ + D++ G ++ E+ GR
Sbjct: 172 DDEM-----TGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 175 -----------NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223
+ + + L + + NV + +A L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL---E 282
Query: 224 WCIQVKPADRPSM 236
+ + R +
Sbjct: 283 KMLVLDSDKRITA 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 49.0 bits (116), Expect = 6e-08
Identities = 21/118 (17%), Positives = 35/118 (29%), Gaps = 11/118 (9%)
Query: 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWE 69
F R + +L G VY + N L I KE
Sbjct: 51 LHFSVLAIRSARNEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENP 105
Query: 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKEND 127
EV + ++ I+H D+ +N+L+ + DF + +E
Sbjct: 106 D--EVLDMILEEVAKFYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 238 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.06 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=322.03 Aligned_cols=212 Identities=27% Similarity=0.318 Sum_probs=167.7
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|++++++++||||+++++++.+++..|+||||+++|+|.+++ .....+++..++.++.||+.||+|||
T Consensus 45 ~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH 120 (271)
T d1nvra_ 45 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120 (271)
T ss_dssp ----CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998 34568999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+|||+++++.+||+|||++................||+.|+|||++.+. ..++.++|||||||++
T Consensus 121 ~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvil 196 (271)
T d1nvra_ 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVL 196 (271)
T ss_dssp HT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHH
T ss_pred Hc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHH
Confidence 99 9999999999999999999999999999765443322223344699999999998775 2346789999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+|++|+.||........ ......... .. . .....+++++.+|+.+||+.||++|||++|
T Consensus 197 yeml~G~~pf~~~~~~~~------~~~~~~~~~-~~-~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 197 TAMLAGELPWDQPSDSCQ------EYSDWKEKK-TY-L----NPWKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp HHHHHSSCSCSSSSTTSH------HHHHHHTTC-TT-S----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHhCCCCCCCCChHHH------HHHHHhcCC-CC-C----CccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999999965432211 000111110 00 0 111235678889999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=319.11 Aligned_cols=205 Identities=20% Similarity=0.373 Sum_probs=170.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|++++++++||||+++++++.+++..++||||+.+|+|.+++ .....+++..+..++.||+.||+||
T Consensus 47 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l----~~~~~l~e~~~~~i~~qi~~al~~l 122 (263)
T d2j4za1 47 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYC 122 (263)
T ss_dssp TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999988 2346799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.++.+||+|||++........ ....||+.|+|||++.+. .++.++|||||||+
T Consensus 123 H~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvi 193 (263)
T d2j4za1 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVL 193 (263)
T ss_dssp HHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHH
T ss_pred HHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc----cccCCCCcccCHHHHcCC--CCCchhhhhhHhHH
Confidence 999 999999999999999999999999999975544322 234599999999999886 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||........ .......... .+..+++++.+|+.+||+.||++|||++|
T Consensus 194 lyell~G~~Pf~~~~~~~~--------~~~i~~~~~~-------~p~~~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 194 CYEFLVGKPPFEANTYQET--------YKRISRVEFT-------FPDFVTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp HHHHHHSSCTTCCSSHHHH--------HHHHHTTCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhcCCCCCCCCCHHHH--------HHHHHcCCCC-------CCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999999965432211 1111111111 11235678999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=318.57 Aligned_cols=210 Identities=23% Similarity=0.323 Sum_probs=171.1
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+.+.+|+.++++++||||+++++++.+++.+|+||||+.+|+|.+++. ...+++..+..++.||+.||+|
T Consensus 57 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~y 131 (293)
T d1yhwa1 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131 (293)
T ss_dssp GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999998772 3469999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ ||+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+. .++.++|||||||
T Consensus 132 LH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGv 204 (293)
T d1yhwa1 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGI 204 (293)
T ss_dssp HHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHH
T ss_pred HHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCC--CCCchhceehHhH
Confidence 9999 999999999999999999999999999976543322 12334599999999999876 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||........ ....... ...... .+..+++.+.+|+.+||+.||++|||++|
T Consensus 205 ilyemltG~~Pf~~~~~~~~-------~~~~~~~-~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 205 MAIEMIEGEPPYLNENPLRA-------LYLIATN-GTPELQ----NPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp HHHHHHHSSCTTTTSCHHHH-------HHHHHHH-CSCCCS----SGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHhhCCCCCCCCCHHHH-------HHHHHhC-CCCCCC----CcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999999999965332211 1111111 111111 12345778999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=318.62 Aligned_cols=209 Identities=21% Similarity=0.259 Sum_probs=168.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|++++++++||||+++++++.+++.+|+||||+++|+|.+++ ...+.+++..++.++.|++.||+||
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~----~~~~~l~e~~~~~~~~qi~~al~yl 124 (288)
T d1uu3a_ 49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 124 (288)
T ss_dssp TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhh----hccCCCCHHHHHHHHHHHHHHHHhh
Confidence 345678999999999999999999999999999999999999999999987 3456899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+||++++++.++|+|||+++...............||+.|+|||++.+. .++.++|||||||+
T Consensus 125 H~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvi 199 (288)
T d1uu3a_ 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCI 199 (288)
T ss_dssp HHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHH
T ss_pred ccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccC--CCCcccceehhhHH
Confidence 999 9999999999999999999999999999866544333223344599999999999876 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ . ......... .+..+++++.+||.+||+.||++|||++|
T Consensus 200 lyell~g~~Pf~~~~~~~~-------~-~~i~~~~~~-------~p~~~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 200 IYQLVAGLPPFRAGNEYLI-------F-QKIIKLEYD-------FPEKFFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------H-HHHHTTCCC-------CCTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred HHHHhhCCCCCCCcCHHHH-------H-HHHHcCCCC-------CCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999999975432211 1 111111111 11235678999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=315.22 Aligned_cols=218 Identities=27% Similarity=0.450 Sum_probs=166.1
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....++|.+|++++++++||||+++++++.+ ..+++||||+++|+|.+++.. ....+++..+..++.||+.||+|
T Consensus 44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~y 119 (276)
T d1uwha_ 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDY 119 (276)
T ss_dssp CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999998754 578999999999999998832 33579999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCC-CcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~~Di~slG 163 (238)
||++ +|+||||||+|||++.++.+||+|||++................||+.|+|||.+.+.. ..++.++||||||
T Consensus 120 LH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~G 196 (276)
T d1uwha_ 120 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196 (276)
T ss_dssp HHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHH
T ss_pred HhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhH
Confidence 9999 99999999999999999999999999997654433333333446999999999986531 2468899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|||+||+.||........ ........... .........+++++.+|+.+||+.||++|||++|
T Consensus 197 v~l~el~tg~~Pf~~~~~~~~-------~~~~~~~~~~~--p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~ 262 (276)
T d1uwha_ 197 IVLYELMTGQLPYSNINNRDQ-------IIFMVGRGYLS--PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ 262 (276)
T ss_dssp HHHHHHHHSSCTTTTCCCHHH-------HHHHHHHTSCC--CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCCCCCCChHHH-------HHHHHhcCCCC--CcchhccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 999999999999965332211 11111111111 1112233456788999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=309.46 Aligned_cols=207 Identities=23% Similarity=0.346 Sum_probs=164.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+++.+|+++|++++||||+++++++.+ +..+++||||+++|+|.+++ .....+++..+..++.||+.|
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~g 124 (270)
T d1t4ha_ 49 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKG 124 (270)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHH----hccccccHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999864 35689999999999999998 334679999999999999999
Q ss_pred HHHhHcCCCCc--eeeeccCCCcEEEc-cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 82 IEYLHNGCDVC--ILHLDIKPHNILLD-HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 82 l~~Lh~~~~~~--i~H~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
|+|||++ + |+||||||+|||++ .++.+||+|||+++....... ....||+.|+|||++.+ .++.++|
T Consensus 125 l~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~----~~~~GT~~Y~aPE~~~~---~~~~~~D 194 (270)
T d1t4ha_ 125 LQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE---KYDESVD 194 (270)
T ss_dssp HHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHH
T ss_pred HHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc----CCcccCccccCHHHhCC---CCCCcCc
Confidence 9999998 7 99999999999996 578999999999975443321 23459999999999865 5788999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||||++|+|++|+.||....... . ....+..... ........++++.+|+.+||+.||++|||++|
T Consensus 195 IwSlGvilyel~~g~~Pf~~~~~~~------~-~~~~i~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~e 262 (270)
T d1t4ha_ 195 VYAFGMCMLEMATSEYPYSECQNAA------Q-IYRRVTSGVK-----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 262 (270)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCSSHH------H-HHHHHTTTCC-----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhHHHHHHHHHHCCCCCCCcccHH------H-HHHHHHcCCC-----CcccCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999999999999996432111 0 1111111111 11122334667899999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=317.38 Aligned_cols=215 Identities=22% Similarity=0.311 Sum_probs=159.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
+...+.+.+|++++++++||||+++++++.+ .+.+|+||||+++|+|.+++......+..+++..++.++.||+.||+
T Consensus 44 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ 123 (269)
T d2java1 44 EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123 (269)
T ss_dssp HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999998854 45789999999999999988443334568999999999999999999
Q ss_pred HhHcCC--CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 84 YLHNGC--DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 84 ~Lh~~~--~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|||+.. ..+|+||||||+|||++.++.+||+|||++........ ......||+.|+|||.+.+. .++.++||||
T Consensus 124 ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwS 199 (269)
T d2java1 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRM--SYNEKSDIWS 199 (269)
T ss_dssp HHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTC--CCCHHHHHHH
T ss_pred HHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCC--CCChHHHHHh
Confidence 999861 01399999999999999999999999999976543321 12234589999999999875 6788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||++|+|++|+.||....... ....+....... .+..+++++.+|+.+||+.||++|||++|
T Consensus 200 lGvilyel~tg~~Pf~~~~~~~--------~~~~i~~~~~~~------~~~~~s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 200 LGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRR------IPYRYSDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hCHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCC------CCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999999996533221 111111111111 11235678999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=316.62 Aligned_cols=214 Identities=21% Similarity=0.272 Sum_probs=169.6
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+++.+|+++|++++||||+++++++.+++..++||||+.+|+|.+++.. ....+++..+..++.||+.||.|
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~y 125 (288)
T d2jfla1 49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNY 125 (288)
T ss_dssp SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHH
Confidence 445667899999999999999999999999999999999999999999988732 24579999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC---CCcccccCceeh
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYG 161 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~~Di~s 161 (238)
||++ +|+||||||+|||++.++.+||+|||++....... .......||+.|+|||++... ...++.++||||
T Consensus 126 lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwS 200 (288)
T d2jfla1 126 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200 (288)
T ss_dssp HHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHH
T ss_pred HHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHH
Confidence 9999 99999999999999999999999999986432211 112334599999999998532 124678999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||++|+|++|+.||........ ..... ........ .+..+++++.+|+.+||+.||++|||++|
T Consensus 201 lGvilyemltg~~Pf~~~~~~~~-------~~~i~-~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 201 LGITLIEMAEIEPPHHELNPMRV-------LLKIA-KSEPPTLA----QPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp HHHHHHHHHHSSCTTTTSCGGGH-------HHHHH-HSCCCCCS----SGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHhhCCCCCCCCCHHHH-------HHHHH-cCCCCCCC----ccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99999999999999965433221 11111 11111111 12345778999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-50 Score=316.09 Aligned_cols=206 Identities=24% Similarity=0.310 Sum_probs=166.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+++|++++||||+++++++.+++..|+|||||.+|+|..++ ...+.+++..++.++.||+.||.|||
T Consensus 57 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH 132 (309)
T d1u5ra_ 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLH 132 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44577899999999999999999999999999999999999999887665 23467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC-CCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Di~slG~~ 165 (238)
++ ||+||||||+|||++.++.+||+|||++....... ...||+.|+|||++.+. ...++.++|||||||+
T Consensus 133 ~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvi 203 (309)
T d1u5ra_ 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203 (309)
T ss_dssp HT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHH
T ss_pred hC---CEeccCCCcceEEECCCCCEEEeecccccccCCCC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHH
Confidence 99 99999999999999999999999999997554322 23599999999998653 2357889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|..||........ ...... ....... ...+++.+.+|+.+||+.||++|||++|
T Consensus 204 lyel~~g~~Pf~~~~~~~~-------~~~i~~-~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 204 CIELAERKPPLFNMNAMSA-------LYHIAQ-NESPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp HHHHHHSSCTTTTSCHHHH-------HHHHHH-SCCCCCS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCCCCHHHH-------HHHHHh-CCCCCCC-----CCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 9999999999965332211 111111 1111111 1235678999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-49 Score=310.37 Aligned_cols=212 Identities=27% Similarity=0.431 Sum_probs=161.1
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....++|.+|+++|++++|||||++++++.++...++||||+.+|+|.+++. .....+++..+..++.||+.||+|
T Consensus 67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~y 143 (299)
T d1jpaa_ 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKY 143 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHH
Confidence 34556789999999999999999999999999999999999999999999873 234578999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc---ccccCCccccCCcceeecCCCcccccCceeh
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS---ISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
||++ +++||||||+|||++.++.+||+|||+++.......... .....+|+.|+|||.+.+. .++.++||||
T Consensus 144 LH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS 218 (299)
T d1jpaa_ 144 LADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWS 218 (299)
T ss_dssp HHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSC--CCCHHHHHHH
T ss_pred HhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC--CCCccccccc
Confidence 9999 999999999999999999999999999976544322111 1123478999999998875 7788999999
Q ss_pred HHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||++|||+| |+.||....... +...+........ +..+++.+.+|+.+||+.||++|||++|
T Consensus 219 ~Gvvl~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~RPs~~e 282 (299)
T d1jpaa_ 219 YGIVMWEVMSYGERPYWDMTNQD--------VINAIEQDYRLPP------PMDCPSALHQLMLDCWQKDRNHRPKFGQ 282 (299)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred chHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC------CccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 9999999998 899986543221 1112222211111 1235678899999999999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=318.95 Aligned_cols=163 Identities=25% Similarity=0.373 Sum_probs=143.0
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....+++.+|+.+|++++||||+++++++.+....++||||+.+|+|.+++. +.+.+++..+..++.|++.||.|
T Consensus 44 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~y 119 (322)
T d1s9ja_ 44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTY 119 (322)
T ss_dssp CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHH
Confidence 34556889999999999999999999999999999999999999999999983 34579999999999999999999
Q ss_pred hHc-CCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHN-GCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~-~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||+ + +|+||||||+|||++.++.+||+|||++....... .....||+.|+|||++.+. .++.++||||+|
T Consensus 120 LH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlG 190 (322)
T d1s9ja_ 120 LREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMG 190 (322)
T ss_dssp HHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHH
T ss_pred HHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcCC--CCCcHHHHHHHH
Confidence 996 6 89999999999999999999999999987443221 1233599999999999886 788999999999
Q ss_pred HHHHHHhcCCCCCCccc
Q 037755 164 MVLLEMTGGRRNSNLKA 180 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~ 180 (238)
|++|+|++|+.||....
T Consensus 191 vil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 191 LSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHHHHHHHSSCCSSCCC
T ss_pred HHHHHHHHCCCCCCCCC
Confidence 99999999999997543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-49 Score=308.81 Aligned_cols=216 Identities=29% Similarity=0.420 Sum_probs=172.8
Q ss_pred CCcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
+..+..+.++|.+|+++|++++||||+++++++.++...+++|||+++|+|.+++.. .....+++..+..++.||+.|
T Consensus 50 i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~g 127 (287)
T d1opja_ 50 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127 (287)
T ss_dssp CCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHH
T ss_pred ECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHH
Confidence 345566788999999999999999999999999999999999999999999998843 234688999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|+|||++ +|+||||||+|||+++++.+||+|||+++........ ......|+..|+|||.+.+. .++.++||||
T Consensus 128 L~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS 201 (287)
T d1opja_ 128 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWA 201 (287)
T ss_dssp HHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHC--CCSHHHHHHH
T ss_pred HHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCC--CCCchhhhhh
Confidence 9999999 9999999999999999999999999999865443322 22333488899999998876 6789999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|+|++|..|+....... ............. .+..+++++.+|+.+||+.||++|||++|
T Consensus 202 ~Gv~l~ell~~~~p~~~~~~~~-------~~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~e 265 (287)
T d1opja_ 202 FGVLLWEIATYGMSPYPGIDLS-------QVYELLEKDYRME------RPEGCPEKVYELMRACWQWNPSDRPSFAE 265 (287)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhCCCCCCCcchHH-------HHHHHHhcCCCCC------CCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 9999999999877664322111 1111122211111 12235678999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-49 Score=314.49 Aligned_cols=208 Identities=21% Similarity=0.289 Sum_probs=155.2
Q ss_pred cHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 8 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
..+.+.+|+.+|++++||||+++++++.+++.+|+||||++||+|.+++ .....+++..+..++.||+.||+|||+
T Consensus 50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~ 125 (307)
T d1a06a_ 50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHD 125 (307)
T ss_dssp -----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH----HTCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhh----hcccCCCHHHHHHHHHHHHHHHHhhhh
Confidence 3467889999999999999999999999999999999999999999998 335689999999999999999999999
Q ss_pred CCCCceeeeccCCCcEEEc---cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 88 GCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 88 ~~~~~i~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
+ +|+||||||+||++. +++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||
T Consensus 126 ~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGv 197 (307)
T d1a06a_ 126 L---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGV 197 (307)
T ss_dssp T---TCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTC--CCCTHHHHHHHHH
T ss_pred c---eeeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhH
Confidence 9 999999999999995 578999999999975543322 2234599999999999876 6788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|+|++|..||........ ........... .......+++++.+|+.+||+.||++|||++|
T Consensus 198 ilyell~g~~Pf~~~~~~~~-------~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 198 IAYILLCGYPPFYDENDAKL-------FEQILKAEYEF----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp HHHHHHHSSCSCCCSSHHHH-------HHHHHTTCCCC----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCCHHHH-------HHHHhccCCCC----CCccccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 99999999999965332211 11111111111 11122346778999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=304.99 Aligned_cols=210 Identities=24% Similarity=0.413 Sum_probs=169.8
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
++...++|.+|+++|++++|||||++++++.+ +.+++||||+++|+|.+++. .....+++..+..++.||+.||+|
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~y 124 (285)
T d1u59a_ 49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKY 124 (285)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999999875 46899999999999999872 234679999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||++ +|+||||||+||+++.++.+||+|||+++.......... .....||+.|+|||.+.+. .++.++||||||
T Consensus 125 lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~G 199 (285)
T d1u59a_ 125 LEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYG 199 (285)
T ss_dssp HHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHH
T ss_pred HHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC--CCCccchhhcch
Confidence 9999 999999999999999999999999999986655433221 2233488999999999875 788899999999
Q ss_pred HHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 164 MVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 164 ~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
+++|||+| |+.||....... +...+..+.... .+..+++++.+|+.+||+.||++|||+.
T Consensus 200 v~l~E~lt~G~~Pf~~~~~~~--------~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~~p~~RPs~~ 260 (285)
T d1u59a_ 200 VTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRME------CPPECPPELYALMSDCWIYKWEDRPDFL 260 (285)
T ss_dssp HHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred HHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCCcCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 99999998 899996543221 112222222221 1234677899999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=305.18 Aligned_cols=209 Identities=22% Similarity=0.413 Sum_probs=167.4
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....++|.+|+++|++++||||+++++++.+ ...++||||+++|+|.+++ .....+++..+..++.||+.||+||
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~gl~yl 123 (277)
T d1xbba_ 49 PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 123 (277)
T ss_dssp CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHhhH
Confidence 3446789999999999999999999999865 4678999999999999988 3356799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|++ +|+||||||+|||++.++.++++|||+++......... ......||+.|+|||.+.+. .++.++||||||+
T Consensus 124 H~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv 198 (277)
T d1xbba_ 124 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGV 198 (277)
T ss_dssp HHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHH
T ss_pred HhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC--CCCchhhhccchh
Confidence 999 99999999999999999999999999997654443222 12234589999999999876 7888999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|||++ |+.||....... +...+..+.... .+..+++++.+|+.+||+.||++|||++|
T Consensus 199 ~l~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dp~~RPs~~~ 259 (277)
T d1xbba_ 199 LMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMG------CPAGCPREMYDLMNLCWTYDVENRPGFAA 259 (277)
T ss_dssp HHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhHHhhCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 9999997 899997543221 112222222111 12345678999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.4e-49 Score=315.29 Aligned_cols=212 Identities=20% Similarity=0.282 Sum_probs=170.9
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
.....+.+.+|+.+|++++||||+++++++.+++.+|+||||+.+|+|.+++. .....+++..+..++.||+.||.|
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~y 139 (350)
T d1koaa2 63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCH 139 (350)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHH
Confidence 34556889999999999999999999999999999999999999999999883 234579999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEc--cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 85 LHNGCDVCILHLDIKPHNILLD--HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
||++ +|+||||||+|||++ .++.+||+|||++......... ....||+.|+|||++.+. .++.++|||||
T Consensus 140 lH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSl 211 (350)
T d1koaa2 140 MHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSV 211 (350)
T ss_dssp HHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTC--CBCHHHHHHHH
T ss_pred HHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc---ceecCcccccCHHHHcCC--CCChhHhhhhh
Confidence 9999 999999999999996 4678999999999765544322 234589999999999876 67889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||++|+|++|..||........ ........... .......+++++.+|+.+||+.||++|||++|
T Consensus 212 Gvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 212 GVLSYILLSGLSPFGGENDDET-------LRNVKSCDWNM----DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCS----CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCC----CcccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999999965432211 11111111111 11222345778999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=313.02 Aligned_cols=216 Identities=24% Similarity=0.391 Sum_probs=169.5
Q ss_pred ccccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC-------------------CCC
Q 037755 5 SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES-------------------RGQ 64 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------------------~~~ 64 (238)
.....+.+.+|+.+++++ +|||||++++++.+.+..++||||+++|+|.+++..... ...
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (325)
T d1rjba_ 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159 (325)
T ss_dssp ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence 344557889999999998 899999999999999999999999999999999854321 124
Q ss_pred CCCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcc
Q 037755 65 SCSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 144 (238)
Q Consensus 65 ~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 144 (238)
.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...............||+.|+|||
T Consensus 160 ~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 236 (325)
T d1rjba_ 160 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236 (325)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence 688999999999999999999999 99999999999999999999999999997654444333333445899999999
Q ss_pred eeecCCCcccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHh
Q 037755 145 LISRNFGTVSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGL 223 (238)
Q Consensus 145 ~~~~~~~~~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 223 (238)
.+.+. .++.++|||||||++|||++ |..||........ ............ .+..+++++.+|+.
T Consensus 237 ~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~-------~~~~~~~~~~~~------~p~~~~~~l~~li~ 301 (325)
T d1rjba_ 237 SLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-------FYKLIQNGFKMD------QPFYATEEIYIIMQ 301 (325)
T ss_dssp HHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-------HHHHHHTTCCCC------CCTTCCHHHHHHHH
T ss_pred HHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH-------HHHHHhcCCCCC------CCCcCCHHHHHHHH
Confidence 98876 77889999999999999997 8999865432211 112222221111 11235678999999
Q ss_pred hhccCCCCCCCCCCC
Q 037755 224 WCIQVKPADRPSMTK 238 (238)
Q Consensus 224 ~cl~~dp~~Rps~~e 238 (238)
+||+.||++|||++|
T Consensus 302 ~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 302 SCWAFDSRKRPSFPN 316 (325)
T ss_dssp HHTCSSGGGSCCHHH
T ss_pred HHcCCChhHCcCHHH
Confidence 999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=302.72 Aligned_cols=214 Identities=27% Similarity=0.486 Sum_probs=161.3
Q ss_pred CCcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
+..+....++|.+|++++++++||||+++++++.+++..++||||+.+|+|.+++. .....+++..+..++.||+.|
T Consensus 37 i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~g 113 (263)
T d1sm2a_ 37 IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEG 113 (263)
T ss_dssp CCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHH
T ss_pred ECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHH
Confidence 34456677899999999999999999999999999999999999999999999873 234678899999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|+|||++ +|+||||||+|||+++++.+||+|||+++......... .....||..|+|||.+.+. .++.++||||
T Consensus 114 l~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS 187 (263)
T d1sm2a_ 114 MAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFS--RYSSKSDVWS 187 (263)
T ss_dssp HHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTC--CCCHHHHHHH
T ss_pred HHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee-ecceecCcccCChHHhcCC--CCCchhhhcc
Confidence 9999999 99999999999999999999999999987654433221 2234589999999999876 6788999999
Q ss_pred HHHHHHHHhcCC-CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGR-RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|||+|+. +|+....... +............ +..+++++.+|+.+||+.||++|||++|
T Consensus 188 ~Gvil~el~t~~~~~~~~~~~~~--------~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~p~~Rps~~~ 251 (263)
T d1sm2a_ 188 FGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYK------PRLASTHVYQIMNHCWKERPEDRPAFSR 251 (263)
T ss_dssp HHHHHHHHHTTSCCTTCSCCHHH--------HHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHhcCCCCC------ccccCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999999964 4443322111 1111111111111 1234678899999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=307.53 Aligned_cols=209 Identities=23% Similarity=0.305 Sum_probs=171.5
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+.+.+|+++|++++||||+++++++.+....|+||||+++|+|.+++. ..+.+++..++.++.|++.||+|||
T Consensus 55 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH 130 (293)
T d1jksa_ 55 VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH 130 (293)
T ss_dssp BCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhh
Confidence 457899999999999999999999999999999999999999999999982 3457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCC----ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNF----VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+. +|+||||||+||+++.++ .+|++|||++......... ....||+.|+|||++.+. .++.++||||+
T Consensus 131 ~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~--~~~~~~DiwSl 202 (293)
T d1jksa_ 131 SL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYE--PLGLEADMWSI 202 (293)
T ss_dssp HT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTC--CBCTHHHHHHH
T ss_pred hc---ceeecccccceEEEecCCCcccceEecchhhhhhcCCCccc---cccCCCCcccCHHHHcCC--CCCCcccchhh
Confidence 99 999999999999998766 4899999999766443322 233589999999999875 67899999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||++|+|++|..||........ . ...... ...........+++.+.+|+.+||+.||++|||++|
T Consensus 203 Gvilyell~g~~Pf~~~~~~~~-------~-~~i~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 203 GVITYILLSGASPFLGDTKQET-------L-ANVSAV---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH-------H-HHHHTT---CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hHHHHHHHcCCCCCCCCCHHHH-------H-HHHHhc---CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999999975433221 1 111111 111223344556788999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-48 Score=314.04 Aligned_cols=211 Identities=20% Similarity=0.286 Sum_probs=170.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+.+.+|+++|++++||||+++++++.++..+|+||||+.||+|.+.+. ..+..+++..++.++.||+.||+||
T Consensus 67 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~yl 143 (352)
T d1koba_ 67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHM 143 (352)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456788899999999999999999999999999999999999999988772 3345799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEc--cCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 86 HNGCDVCILHLDIKPHNILLD--HNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|++ ||+||||||+|||++ .++.+||+|||++......... ....||+.|+|||++.+. .++.++||||||
T Consensus 144 H~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG 215 (352)
T d1koba_ 144 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIG 215 (352)
T ss_dssp HHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHH
T ss_pred HHC---CeeecccccccccccccCCCeEEEeecccceecCCCCce---eeccCcccccCHHHHcCC--CCCCccchHHHH
Confidence 999 999999999999998 6789999999999866544322 233489999999999876 788999999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++|+|++|..||........ .......... ........+++++.+|+.+||+.||++|||++|
T Consensus 216 vilyelltG~~Pf~~~~~~~~-------~~~i~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 216 VLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWE----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp HHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCC----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC----CCcccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999999965432221 1111111111 111122346778999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=300.86 Aligned_cols=214 Identities=25% Similarity=0.426 Sum_probs=167.4
Q ss_pred CcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
..+....+.|.+|++++++++|||||++++++.+ +..++||||+.+|+|.+++.. ..+..+++..+..++.||+.||
T Consensus 46 ~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl 122 (272)
T d1qpca_ 46 KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 122 (272)
T ss_dssp CTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHH
Confidence 4455677899999999999999999999998765 567999999999999987722 2234689999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
+|||++ +|+||||||+|||+++++.+||+|||+++....... .......|++.|+|||.+.+. .++.++|||||
T Consensus 123 ~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~ 196 (272)
T d1qpca_ 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSF 196 (272)
T ss_dssp HHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHH
T ss_pred HHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccChHHHhCC--CCCchhhhhhh
Confidence 999999 999999999999999999999999999986654332 222334588999999999875 67889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|||+||..|+...... ......+....... .+..+++++.+|+.+||+.||++|||++|
T Consensus 197 Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~Rpt~~e 259 (272)
T d1qpca_ 197 GILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRMV------RPDNCPEELYQLMRLCWKERPEDRPTFDY 259 (272)
T ss_dssp HHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCC------CcccChHHHHHHHHHHcCCCHhHCcCHHH
Confidence 99999999976554322111 11112222221111 11245678999999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=305.14 Aligned_cols=205 Identities=21% Similarity=0.260 Sum_probs=169.9
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.+|++++||||+++++++.++..+|+||||+++|+|.+++ .....+++..++.++.||+.||.||
T Consensus 46 ~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~----~~~~~~~e~~~~~~~~qil~al~yl 121 (337)
T d1o6la_ 46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYL 121 (337)
T ss_dssp TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhh----hcccCCcHHHHHHHHHHHhhhhhhh
Confidence 345688999999999999999999999999999999999999999999988 3456889999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+. .++.++|+|||||+
T Consensus 122 H~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvi 194 (337)
T d1o6la_ 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVV 194 (337)
T ss_dssp HHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHH
T ss_pred hhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCC--CCChhhcccchhhH
Confidence 999 999999999999999999999999999975543322 12234599999999999886 77899999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|+.||........ ... ....... .+..+++++.+||.+||+.||++||+.
T Consensus 195 lyeml~G~~pf~~~~~~~~-------~~~-i~~~~~~-------~p~~~s~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 195 MYEMMCGRLPFYNQDHERL-------FEL-ILMEEIR-------FPRTLSPEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------HHH-HHHCCCC-------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHCCCCCCCcCHHHH-------HHH-HhcCCCC-------CCccCCHHHHHHHHhhccCCchhhccc
Confidence 9999999999976543221 111 1111111 112357788999999999999999973
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=295.45 Aligned_cols=213 Identities=24% Similarity=0.431 Sum_probs=172.6
Q ss_pred CcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 3 ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 3 ~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
..+..+.++|.+|+.++++++||||+++++++.+++.+++||||+.+|+|.+++. .....+++..++.++.|++.||
T Consensus 37 ~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl 113 (258)
T d1k2pa_ 37 KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAM 113 (258)
T ss_dssp ESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHH
T ss_pred CcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHH
Confidence 3455678899999999999999999999999999999999999999999998863 2345788999999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
.|||++ +|+||||||+||++++++.+||+|||++......... ......+|..|+|||.+... .++.++|||||
T Consensus 114 ~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~ 187 (258)
T d1k2pa_ 114 EYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAF 187 (258)
T ss_dssp HHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHC--CCCHHHHHHHH
T ss_pred HHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCC--CCCcceeeccc
Confidence 999999 9999999999999999999999999999755443222 22234589999999999876 67889999999
Q ss_pred HHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|+++|||+| |+.||........ ...+........ +..+++.+.+|+.+||+.||++|||++|
T Consensus 188 G~~l~el~t~g~~Pf~~~~~~~~--------~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPt~~e 250 (258)
T d1k2pa_ 188 GVLMWEIYSLGKMPYERFTNSET--------AEHIAQGLRLYR------PHLASEKVYTIMYSCWHEKADERPTFKI 250 (258)
T ss_dssp HHHHHHHHTTSCCTTTTSCHHHH--------HHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred chhhHhHHhcCCCCCCCCCHHHH--------HHHHHhCCCCCC------cccccHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999998 7889865443321 122222221111 1234578999999999999999999854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=302.48 Aligned_cols=213 Identities=19% Similarity=0.249 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHhhc-CCCcceeeeeEEEe----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 9 ~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
.+.+.+|+.++.++ +||||+++++++.+ +..+|+|||||+||+|.+++.. .....+++..++.++.||+.||+
T Consensus 48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ 125 (335)
T d2ozaa1 48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQ 125 (335)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHH
Confidence 35678999997665 79999999999865 4678999999999999999843 23457999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEcc---CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDH---NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|||+. +|+||||||+|||++. .+.+||+|||++........ .....||+.|+|||++.+. .++.++|||
T Consensus 126 ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~Diw 197 (335)
T d2ozaa1 126 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMW 197 (335)
T ss_dssp HHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHH
T ss_pred HHHHc---CCccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCC--CCCHHHHHH
Confidence 99999 9999999999999985 55799999999976544332 2334599999999999876 788999999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||++|+|++|+.||...........+.. ................+++++.+|+.+||+.||++|||+.|
T Consensus 198 SlGvily~lltg~~Pf~~~~~~~~~~~~~~-------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 268 (335)
T d2ozaa1 198 SLGVIMYILLCGYPPFYSNHGLAISPGMKT-------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268 (335)
T ss_dssp HHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhchhHHHHhhCCCCCCCCCHHHHHHHHHH-------HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999999999976543332111110 11111111222344567889999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=301.36 Aligned_cols=219 Identities=24% Similarity=0.245 Sum_probs=167.4
Q ss_pred HHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 037755 10 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGC 89 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~ 89 (238)
+++.+|+.++++++||||+++++++.+++..++||||+.++++.... .....+++..+..++.||+.||+|||++
T Consensus 45 ~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~- 119 (299)
T d1ua2a_ 45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119 (299)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc-
Confidence 56889999999999999999999999999999999999887776655 4457899999999999999999999999
Q ss_pred CCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHH
Q 037755 90 DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 169 (238)
Q Consensus 90 ~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~l 169 (238)
+|+||||||+|||++.++.+||+|||.+......... .....||+.|+|||++... ..++.++|||||||++|+|
T Consensus 120 --~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el 194 (299)
T d1ua2a_ 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAEL 194 (299)
T ss_dssp --TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHH
T ss_pred --ceecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHH
Confidence 9999999999999999999999999999755443221 2234589999999998653 3568899999999999999
Q ss_pred hcCCCCCCcccccccCCcc------------hhhhhh-hhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 170 TGGRRNSNLKATRSSKAYF------------PSWVSD-QLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 170 l~g~~p~~~~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
++|..||...........+ +..... ...................+++++.+|+.+||+.||++|||+
T Consensus 195 ~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa 274 (299)
T d1ua2a_ 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274 (299)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred HhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH
Confidence 9999999755432211000 000000 000000001111122223457789999999999999999998
Q ss_pred CC
Q 037755 237 TK 238 (238)
Q Consensus 237 ~e 238 (238)
+|
T Consensus 275 ~e 276 (299)
T d1ua2a_ 275 TQ 276 (299)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=297.51 Aligned_cols=213 Identities=27% Similarity=0.424 Sum_probs=162.1
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
++...++|.+|++++++++|||||++++++.+....++++||+.++++.+.+. .....+++..+..++.||+.|++|
T Consensus 49 ~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~ 125 (283)
T d1mqba_ 49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKY 125 (283)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhh
Confidence 34456789999999999999999999999999999999999999999988773 234679999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
||++ +|+||||||+|||++.++.+||+|||+++........ .......||..|+|||.+.+. .++.++||||||
T Consensus 126 lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~G 200 (283)
T d1mqba_ 126 LANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFG 200 (283)
T ss_dssp HHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC--CCCHHHHHHHHH
T ss_pred cccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC--CCCCcccccccH
Confidence 9999 9999999999999999999999999999765433221 122233589999999999876 778899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+++|||++|..|+....... .+...+..+..... +..++..+.+|+.+||+.||++|||++|
T Consensus 201 vil~el~t~~~~~~~~~~~~-------~~~~~i~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~e 262 (283)
T d1mqba_ 201 IVMWEVMTYGERPYWELSNH-------EVMKAINDGFRLPT------PMDCPSAIYQLMMQCWQQERARRPKFAD 262 (283)
T ss_dssp HHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCCCC------CTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHhCCCCccccCCHH-------HHHHHHhccCCCCC------chhhHHHHHHHHHHHCcCCHhHCcCHHH
Confidence 99999999766654322111 11122222221111 1235677899999999999999999854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-47 Score=297.74 Aligned_cols=210 Identities=20% Similarity=0.257 Sum_probs=169.2
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|+.++++++ ||||+++++++.+++..|+||||+++|+|.+++. ....+++..++.++.||+.||+|||
T Consensus 52 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH 127 (277)
T d1phka_ 52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALH 127 (277)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999997 9999999999999999999999999999999983 3467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC----CCcccccCceehH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGF 162 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Di~sl 162 (238)
++ +|+||||||+||+++.++.+||+|||.+......... ....||..|.|||.+.+. ...++.++||||+
T Consensus 128 ~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diwsl 201 (277)
T d1phka_ 128 KL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 201 (277)
T ss_dssp HT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred Hc---CCcccccccceEEEcCCCCeEEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEccc
Confidence 99 9999999999999999999999999999866543322 234599999999998642 2246788999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||++|+|++|+.||........ ........... .......+++++.+|+.+||+.||++|||++|
T Consensus 202 Gvilyeml~g~~Pf~~~~~~~~-------~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 202 GVIMYTLLAGSPPFWHRKQMLM-------LRMIMSGNYQF----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCC----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred chhhhhhccCCCCCCCCCHHHH-------HHHHHhCCCCC----CCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999999975432211 11111111111 11122346788999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=302.55 Aligned_cols=211 Identities=17% Similarity=0.227 Sum_probs=169.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
..+.+.+.+|+++|++++||||+++++++.+++.+|+|||||.||+|.+++. ..+..+++..++.++.||+.||+||
T Consensus 42 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yL 118 (321)
T d1tkia_ 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118 (321)
T ss_dssp THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999999999999999999999982 2335799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccC--CccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHN--FVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 163 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG 163 (238)
|++ +|+||||||+|||++.+ +.++|+|||.+......... ....+++.|+|||...+. .++.++||||||
T Consensus 119 H~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ape~~~~~--~~~~~~DiWSlG 190 (321)
T d1tkia_ 119 HSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHD--VVSTATDMWSLG 190 (321)
T ss_dssp HHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTC--EECHHHHHHHHH
T ss_pred HHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCcc---cccccccccccchhccCC--CCCchhhcccHH
Confidence 999 99999999999999854 47899999998765443322 233489999999998876 778899999999
Q ss_pred HHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 164 MVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 164 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|++|+|++|..||........ ....... ...........+++++.+|+.+||+.||++|||++|
T Consensus 191 vily~ll~G~~Pf~~~~~~~~-------~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 254 (321)
T d1tkia_ 191 TLVYVLLSGINPFLAETNQQI-------IENIMNA----EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp HHHHHHHHSSCTTCCSSHHHH-------HHHHHHT----CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHH-------HHHHHhC----CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999999976443221 1111111 111122333456788999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-47 Score=302.18 Aligned_cols=200 Identities=24% Similarity=0.317 Sum_probs=166.4
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.++++++||||+++++++.+++.+|+||||+.||+|...+ .....++...+..++.||+.||+||
T Consensus 45 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~l 120 (316)
T d1fota_ 45 LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYL 120 (316)
T ss_dssp TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccc----cccccccccHHHHHHHHHHHhhhhh
Confidence 345688999999999999999999999999999999999999999998888 3456788999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.+|.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||+
T Consensus 121 H~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvi 190 (316)
T d1fota_ 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGIL 190 (316)
T ss_dssp HTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHH
T ss_pred ccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccccCHHHHcCC--CCCchhhccccchh
Confidence 999 99999999999999999999999999998654432 224599999999999876 67889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
+|+|++|+.||........ ....... ... .+..+++++.+++.+||+.||++|+
T Consensus 191 lyemltG~~Pf~~~~~~~~-------~~~i~~~-~~~-------~p~~~s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 191 IYEMLAGYTPFYDSNTMKT-------YEKILNA-ELR-------FPPFFNEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp HHHHHHSSCTTCCSSHHHH-------HHHHHHC-CCC-------CCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred HHHHHhCCCCCCCcCHHHH-------HHHHHcC-CCC-------CCCCCCHHHHHHHHHHhhhCHHhcc
Confidence 9999999999975432211 1111111 111 1123567889999999999999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=293.58 Aligned_cols=215 Identities=27% Similarity=0.418 Sum_probs=163.5
Q ss_pred CCcccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 2 LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 2 l~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
+..+....+.|.+|+.++++++|||||++++++.+ +..++||||+.+|+|..++... ....+++..+..++.+|+.|
T Consensus 49 l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~g 125 (285)
T d1fmka3 49 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASG 125 (285)
T ss_dssp CCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHH
T ss_pred ECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHH
Confidence 34556677899999999999999999999999855 5689999999999998887322 23468999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceeh
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 161 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~s 161 (238)
|+|||++ +++||||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+... .++.++||||
T Consensus 126 l~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S 199 (285)
T d1fmka3 126 MAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG--RFTIKSDVWS 199 (285)
T ss_dssp HHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHC--CCCHHHHHHH
T ss_pred HHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCC--CCCcHHhhhc
Confidence 9999999 999999999999999999999999999975543322 222334589999999999876 7788999999
Q ss_pred HHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 162 FGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 162 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||+++|||++|..|+....... .....+....... .+..+++++.+++.+||+.||++|||++|
T Consensus 200 ~Giil~el~t~~~p~~~~~~~~-------~~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 263 (285)
T d1fmka3 200 FGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEY 263 (285)
T ss_dssp HHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred chHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCCC------CCcccCHHHHHHHHHHcccCHhHCcCHHH
Confidence 9999999999766654322211 1112122211111 12345678999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=292.25 Aligned_cols=210 Identities=24% Similarity=0.372 Sum_probs=158.8
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....++.+.+|++++++++||||+++++++.+ +..++||||+.+|+|.+++. .....+++..+..++.||+.||.|
T Consensus 48 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~y 123 (273)
T d1mp8a_ 48 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAY 123 (273)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhh
Confidence 34556889999999999999999999999964 67899999999999988763 234578999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +++||||||+||++++++.+||+|||++......... ......||+.|+|||.+.+. .++.++||||||+
T Consensus 124 lH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGv 197 (273)
T d1mp8a_ 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGV 197 (273)
T ss_dssp HHHT---TCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHC--CCSHHHHHHHHHH
T ss_pred hccc---CeeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccC--CCCCccccccchH
Confidence 9999 9999999999999999999999999998755433221 12233488999999999876 6788999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|||++ |.+||........ ...+....... .+..+++++.+|+.+||+.||++|||++|
T Consensus 198 il~e~lt~g~~P~~~~~~~~~--------~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rps~~e 258 (273)
T d1mp8a_ 198 CMWEILMHGVKPFQGVKNNDV--------IGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTE 258 (273)
T ss_dssp HHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 9999997 8888865443321 11112221111 12345778999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=298.41 Aligned_cols=206 Identities=20% Similarity=0.261 Sum_probs=168.5
Q ss_pred cccHHHHHHHHHHHh-hcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIG-RIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
....+.+.+|..++. .++||||+++++++.++...|+||||+++|+|.+++ .....+++..+..++.||+.||+|
T Consensus 43 ~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i----~~~~~~~e~~~~~~~~qi~~al~y 118 (320)
T d1xjda_ 43 DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQF 118 (320)
T ss_dssp TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHh----hccCCCCHHHHHHHHHHHHHHHHH
Confidence 345677888888776 579999999999999999999999999999999998 345678999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +++||||||+|||+++++.++|+|||.+........ ......||+.|+|||++.+. .++.++|||||||
T Consensus 119 lH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv 191 (320)
T d1xjda_ 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGV 191 (320)
T ss_dssp HHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHH
T ss_pred HHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhH
Confidence 9999 999999999999999999999999999975543322 22334599999999999876 7788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
++|+|++|+.||........ .......... .+..+++++.+|+.+||+.||++|||+.
T Consensus 192 ilyemltG~~PF~~~~~~~~--------~~~i~~~~~~-------~p~~~s~~~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 192 LLYEMLIGQSPFHGQDEEEL--------FHSIRMDNPF-------YPRWLEKEAKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp HHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCC-------CCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred HHHHHHhCCCCCCCCCHHHH--------HHHHHcCCCC-------CCccCCHHHHHHHHHhcccCCCCCcCHH
Confidence 99999999999975443321 1111111111 1123577899999999999999999984
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-46 Score=300.74 Aligned_cols=199 Identities=23% Similarity=0.234 Sum_probs=165.6
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+++|++++||||+++++++.+....++|+||+.+|+|.+.+ ...+.+++..++.++.||+.||.|||
T Consensus 83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l----~~~~~l~e~~~~~i~~qi~~aL~yLH 158 (350)
T d1rdqe_ 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhH----hhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999999999999999999999999988 23457999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
++ +|+||||||+|||++.+|.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvil 228 (350)
T d1rdqe_ 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLI 228 (350)
T ss_dssp HT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHH
T ss_pred hC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----ccccCccccCCHHHHcCC--CCCccccccchhHHH
Confidence 99 99999999999999999999999999998654322 223599999999999876 678899999999999
Q ss_pred HHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRP 234 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 234 (238)
|+|++|..||....... ...... ..... .+..+++++.+|+.+||+.||++|+
T Consensus 229 yemltG~~Pf~~~~~~~-------~~~~i~-~~~~~-------~p~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 229 YEMAAGYPPFFADQPIQ-------IYEKIV-SGKVR-------FPSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHHSSCSSCCSSHHH-------HHHHHH-HCCCC-------CCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHHHhCCCCCCCcCHHH-------HHHHHh-cCCCC-------CCccCCHHHHHHHHHHhhhCHHhcc
Confidence 99999999996543221 111111 11111 1123577899999999999999995
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=296.42 Aligned_cols=211 Identities=23% Similarity=0.380 Sum_probs=165.3
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+....++|.+|++++++++||||+++++++.++ ..+++++++.+|+|.+.+. .....+++..+..++.||+.||+|
T Consensus 51 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~y 126 (317)
T d1xkka_ 51 SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNY 126 (317)
T ss_dssp --CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999875 5678889999999988773 235689999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||++ +|+||||||+||+++.++.+||+|||++................||+.|+|||.+.+. .++.++||||||+
T Consensus 127 LH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gv 201 (317)
T d1xkka_ 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGV 201 (317)
T ss_dssp HHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHH
T ss_pred HHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcC--CCChhhhhhhHHH
Confidence 9999 9999999999999999999999999999866554433333334589999999999876 6789999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|||+| |..||....... +...+..+.... .+..+++++.+|+.+||+.||++|||+.|
T Consensus 202 il~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dP~~RPs~~e 262 (317)
T d1xkka_ 202 TVWELMTFGSKPYDGIPASE--------ISSILEKGERLP------QPPICTIDVYMIMVKCWMIDADSRPKFRE 262 (317)
T ss_dssp HHHHHHTTSCCTTTTSCGGG--------HHHHHHHTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCcccCHHHHHHHHHhCCCChhhCcCHHH
Confidence 9999998 788886543222 111222222111 11335678899999999999999999853
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-46 Score=302.06 Aligned_cols=199 Identities=23% Similarity=0.282 Sum_probs=159.6
Q ss_pred HHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCce
Q 037755 14 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNGCDVCI 93 (238)
Q Consensus 14 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i 93 (238)
+|+.+++.++||||+++++++.+.+.+|+||||+.+|+|.+++ .....+++..++.++.||+.||+|||++ +|
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~i 128 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FV 128 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHH----HhcccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 3467777778999999999999999999999999999999998 3346788999999999999999999999 99
Q ss_pred eeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHHHHHhcCC
Q 037755 94 LHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMTGGR 173 (238)
Q Consensus 94 ~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l~~ll~g~ 173 (238)
+||||||+|||++.+|.+||+|||++........ ....||+.|+|||++... ..++.++|||||||++|+|++|+
T Consensus 129 iHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~ 203 (364)
T d1omwa3 129 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGH 203 (364)
T ss_dssp ECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cceeeccceeEEcCCCcEEEeeeceeeecCCCcc----cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCC
Confidence 9999999999999999999999999976544322 233599999999998653 25788999999999999999999
Q ss_pred CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 174 RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 174 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
.||........ .. +....... .. ..+..+++++.+||.+||+.||++|||.
T Consensus 204 ~Pf~~~~~~~~----~~-~~~~~~~~---~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 204 SPFRQHKTKDK----HE-IDRMTLTM---AV----ELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp CSSCSSCSSCH----HH-HHHHSSSC---CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred CCCCCCCHHHH----HH-HHHhcccC---CC----CCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 99975432211 00 11111000 00 1112356789999999999999999995
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-47 Score=295.32 Aligned_cols=210 Identities=20% Similarity=0.295 Sum_probs=159.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+++.+|++++++++||||+++++++.... .+|+||||+.|++|.+.+ ...+.+++..+..++.||+.|
T Consensus 48 ~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~----~~~~~l~~~~~~~i~~qi~~a 123 (277)
T d1o6ya_ 48 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQA 123 (277)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhh----cccCCCCHHHHHHHHHHHHHH
Confidence 344678999999999999999999999986543 488999999999999887 334679999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcc-ccccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|+|||++ +|+||||||+||+++.++..+++|||.+......... .......||+.|+|||++.+. .++.++|||
T Consensus 124 l~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~Diw 198 (277)
T d1o6ya_ 124 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVY 198 (277)
T ss_dssp HHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTC--CCCHHHHHH
T ss_pred HHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCC--CCCcceecc
Confidence 9999999 9999999999999999999999999987644333221 122334599999999999875 678899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPS 235 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 235 (238)
||||++|+|++|..||....... ............ .......+++++.+++.+||+.||++||+
T Consensus 199 SlGvilyelltG~~Pf~~~~~~~-------~~~~~~~~~~~~----~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 199 SLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIP----PSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCC----GGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred cchHHHHHHHhCCCCCCCcCHHH-------HHHHHHhcCCCC----CchhccCCCHHHHHHHHHHccCCHhHCHh
Confidence 99999999999999996543221 111112111111 11122346778999999999999999994
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=292.33 Aligned_cols=223 Identities=20% Similarity=0.230 Sum_probs=166.8
Q ss_pred ccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 7 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
...+++.+|+++|++++||||+++++++.++..+|+||||+.+ ++.+.+. ......+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~--~~~~~~l~e~~~~~~~~qil~~L~yLH 119 (298)
T d1gz8a_ 43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCH 119 (298)
T ss_dssp -CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH--HTTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhh--hhcccCCCHHHHHHHHHHHHHHHHHhh
Confidence 3467899999999999999999999999999999999999976 4444432 233567999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 166 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~l 166 (238)
+. +|+||||||+|||++.++.+||+|||.+........ ......||+.|+|||.+... ...+.++||||+|+++
T Consensus 120 ~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvil 193 (298)
T d1gz8a_ 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIF 193 (298)
T ss_dssp HT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHH
T ss_pred cC---CEEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccc-cCCCccccccccchhh
Confidence 99 999999999999999999999999999875544322 22334599999999987764 3467889999999999
Q ss_pred HHHhcCCCCCCcccccccCCcc-----------hhhhhh---hhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCC
Q 037755 167 LEMTGGRRNSNLKATRSSKAYF-----------PSWVSD---QLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPAD 232 (238)
Q Consensus 167 ~~ll~g~~p~~~~~~~~~~~~~-----------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 232 (238)
|+|++|+.||............ ...... ...................+++++.+|+.+||+.||++
T Consensus 194 y~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 273 (298)
T d1gz8a_ 194 AEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273 (298)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTT
T ss_pred hHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhH
Confidence 9999999999754322110000 000000 00000011111112222345678999999999999999
Q ss_pred CCCCCC
Q 037755 233 RPSMTK 238 (238)
Q Consensus 233 Rps~~e 238 (238)
|||++|
T Consensus 274 R~t~~e 279 (298)
T d1gz8a_ 274 RISAKA 279 (298)
T ss_dssp SCCHHH
T ss_pred CcCHHH
Confidence 999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=289.78 Aligned_cols=211 Identities=25% Similarity=0.368 Sum_probs=166.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....++|.+|+.+|++++||||+++++++.+ ...++|+||+.+|++.+.+.. ....+++..+..++.||+.||.||
T Consensus 52 ~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 52 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHh
Confidence 3445789999999999999999999999976 467899999999999887732 345799999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCcccc-ccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|++ +|+||||||+||+++.++.+||+|||++........... .....++..|+|||.+.+. .++.++||||||+
T Consensus 128 H~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gv 202 (273)
T d1u46a_ 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGV 202 (273)
T ss_dssp HHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHH
T ss_pred hhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHH
Confidence 999 999999999999999999999999999986655433222 2233478899999999876 7888999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|||++ |..||........ ...........+ .+..+++.+.+|+.+||+.||++|||++|
T Consensus 203 il~emlt~G~~Pf~~~~~~~~-------~~~i~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~e 264 (273)
T d1u46a_ 203 TLWEMFTYGQEPWIGLNGSQI-------LHKIDKEGERLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264 (273)
T ss_dssp HHHHHHTTSCCTTTTCCHHHH-------HHHHHTSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCCCCCcCHHHH-------HHHHHhCCCCCC------CcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999998 8999864433221 112222221111 11235677899999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=290.99 Aligned_cols=214 Identities=25% Similarity=0.374 Sum_probs=168.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC--------------------CCCCC
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE--------------------SRGQS 65 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~--------------------~~~~~ 65 (238)
....++|.+|+++|++++||||+++++++.++...++++||+.+|+|.+++.... .....
T Consensus 57 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (301)
T d1lufa_ 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136 (301)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCC
Confidence 3456789999999999999999999999999999999999999999999884322 11335
Q ss_pred CCHHHHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcce
Q 037755 66 CSWEKLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 145 (238)
Q Consensus 66 ~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 145 (238)
+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...............+++.|+|||.
T Consensus 137 l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~ 213 (301)
T d1lufa_ 137 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence 88999999999999999999999 999999999999999999999999999875544433333334558899999999
Q ss_pred eecCCCcccccCceehHHHHHHHHhcCC-CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 146 ISRNFGTVSCKSDVYGFGMVLLEMTGGR-RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 146 ~~~~~~~~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
+.+. .++.++||||||+++|||++|. +||....... +...+.+..... .+..+++++.+|+.+
T Consensus 214 ~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e--------~~~~v~~~~~~~------~p~~~~~~~~~li~~ 277 (301)
T d1lufa_ 214 IFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--------VIYYVRDGNILA------CPENCPLELYNLMRL 277 (301)
T ss_dssp HHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCC------CCTTCCHHHHHHHHH
T ss_pred HccC--CCChhhhhccchhhHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCC------CCccchHHHHHHHHH
Confidence 9876 7889999999999999999996 5665433222 111222222111 123456789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||+.|
T Consensus 278 cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 278 CWSKLPADRPSFCS 291 (301)
T ss_dssp HTCSSGGGSCCHHH
T ss_pred HcCCChhHCcCHHH
Confidence 99999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=289.84 Aligned_cols=212 Identities=25% Similarity=0.412 Sum_probs=165.8
Q ss_pred ccccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCC------------CCCCCCCCHHHH
Q 037755 5 SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPK------------ESRGQSCSWEKL 71 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~------------~~~~~~~~~~~~ 71 (238)
+....++|.+|+++|+++ +||||+++++++.+++.+++||||+++|+|.+++... ......+++..+
T Consensus 50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (309)
T d1fvra_ 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129 (309)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence 344667899999999999 6999999999999999999999999999999998433 123568999999
Q ss_pred HHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCC
Q 037755 72 HEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 151 (238)
Q Consensus 72 ~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 151 (238)
..++.||+.|+.|||+. +++||||||+|||++.++.+||+|||+++........ ....||..|+|||.+.+.
T Consensus 130 ~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~-- 201 (309)
T d1fvra_ 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYS-- 201 (309)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHC--
T ss_pred HHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccC--
Confidence 99999999999999999 9999999999999999999999999998754433221 233489999999999876
Q ss_pred cccccCceehHHHHHHHHhcCCC-CCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCC
Q 037755 152 TVSCKSDVYGFGMVLLEMTGGRR-NSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 152 ~~~~~~Di~slG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
.++.++||||||+++|||++|.. ||....... +...+..+.... .+..+++++.+||.+||+.||
T Consensus 202 ~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dP 267 (309)
T d1fvra_ 202 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKP 267 (309)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHGGGTCCCC------CCTTBCHHHHHHHHHHTCSSG
T ss_pred CCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHhcCCCC------CCccCCHHHHHHHHHHcCCCh
Confidence 78889999999999999999765 564432221 111122211111 112356789999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||++|
T Consensus 268 ~~RPs~~e 275 (309)
T d1fvra_ 268 YERPSFAQ 275 (309)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=287.27 Aligned_cols=214 Identities=23% Similarity=0.403 Sum_probs=171.9
Q ss_pred cccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHH
Q 037755 6 KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLH 72 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~ 72 (238)
.....++.+|+..+.++ +||||+++++++.++...++||||+.+|+|.+++..... ....+++..++
T Consensus 59 ~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 138 (299)
T d1fgka_ 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHH
Confidence 34567888999999999 799999999999999999999999999999999854332 23568999999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+................+++.|+|||.+.+. .
T Consensus 139 ~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~ 213 (299)
T d1fgka_ 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--I 213 (299)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--C
T ss_pred HHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--C
Confidence 9999999999999999 9999999999999999999999999998765444433333445589999999999876 7
Q ss_pred ccccCceehHHHHHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
++.++||||||+++|+|++ |..||....... +...+........ +..+++++.+|+.+||+.||+
T Consensus 214 y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--------~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1fgka_ 214 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPS 279 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCCCC------CSSCCHHHHHHHHHHTCSSGG
T ss_pred CCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--------HHHHHHcCCCCCC------CccchHHHHHHHHHHccCCHh
Confidence 8899999999999999998 677775433221 1122222222221 123567899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||+.|
T Consensus 280 ~Rps~~e 286 (299)
T d1fgka_ 280 QRPTFKQ 286 (299)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=286.27 Aligned_cols=207 Identities=27% Similarity=0.408 Sum_probs=157.5
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEY 84 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 84 (238)
+...+.|.+|++++++++||||+++++++.+ ....++||||+++|+|.+++... ....+++..++.++.||+.|+.|
T Consensus 41 ~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~y 118 (262)
T d1byga_ 41 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEY 118 (262)
T ss_dssp CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccc
Confidence 4456889999999999999999999998854 46789999999999999998321 12358999999999999999999
Q ss_pred hHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 85 LHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 85 Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
||+. +++||||||+||+++.++.++++|||.++...... ....++..|+|||.+.+. .++.++||||||+
T Consensus 119 lH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~ 188 (262)
T d1byga_ 119 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK--KFSTKSDVWSFGI 188 (262)
T ss_dssp HHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHC--CCCHHHHHHHHHH
T ss_pred cccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCC--CCChHHHHHhHHH
Confidence 9999 99999999999999999999999999987543322 223478899999999875 7789999999999
Q ss_pred HHHHHhc-CCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 165 VLLEMTG-GRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 165 ~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
++|||++ |+.||......+. ...+......+ .+..+++++.+|+.+||+.||++|||+.|
T Consensus 189 il~el~t~~~~p~~~~~~~~~--------~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 249 (262)
T d1byga_ 189 LLWEIYSFGRVPYPRIPLKDV--------VPRVEKGYKMD------APDGCPPAVYEVMKNCWHLDAAMRPSFLQ 249 (262)
T ss_dssp HHHHHHTTSCCSCTTSCGGGH--------HHHHTTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHCCCCCCCCCCHHHH--------HHHHHcCCCCC------CCccCCHHHHHHHHHHcccCHhHCcCHHH
Confidence 9999998 6777754332221 11122221111 12235678899999999999999999853
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=287.03 Aligned_cols=214 Identities=23% Similarity=0.351 Sum_probs=167.1
Q ss_pred cccccHHHHHHHHHHHhhcCCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 037755 4 NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGI 82 (238)
Q Consensus 4 ~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 82 (238)
.+....++|.+|+++|++++||||+++++++.+ +...++||||+++|+|.+++. .....++...+..++.|++.||
T Consensus 67 ~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL 143 (311)
T d1r0pa_ 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM 143 (311)
T ss_dssp CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhh
Confidence 345566889999999999999999999999765 568999999999999999873 2345677888999999999999
Q ss_pred HHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCCCcccccCcee
Q 037755 83 EYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 83 ~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
.|||+. +|+||||||+|||+++++.+||+|||+++......... ......||..|+|||.+... .++.++|||
T Consensus 144 ~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~ 218 (311)
T d1r0pa_ 144 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVW 218 (311)
T ss_dssp HHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHH
T ss_pred hhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcC--CCCChhHhh
Confidence 999999 99999999999999999999999999997654433221 22234589999999998876 778999999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
|||+++|||++|+.||........ +...+ ..+.... .+..+++++.+|+.+||+.||++|||+.|
T Consensus 219 SfGivl~El~t~~~p~~~~~~~~~---~~~~i----~~g~~~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 219 SFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRRLL------QPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp HHHHHHHHHHTTSCCSCC---------CHHHH----HTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCCC------CcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 999999999998887754332211 11111 1111111 11235678899999999999999999854
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=286.45 Aligned_cols=214 Identities=27% Similarity=0.408 Sum_probs=159.9
Q ss_pred ccHHHHHHHHHHHhhc-CCCcceeeeeEEEe-CCeeeEEEEeCCCCChhhhccCCCC------------CCCCCCHHHHH
Q 037755 7 FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE-GSKRALVYEFMPNGSLDRHIFPKES------------RGQSCSWEKLH 72 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~ 72 (238)
...+.+.+|...+.++ +|+||+.+++++.+ +..+++||||+++|+|.+++..... ....+++..+.
T Consensus 58 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 137 (299)
T d1ywna1 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137 (299)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHH
Confidence 4456788888888887 68999999998755 4578999999999999999843221 23468999999
Q ss_pred HHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCc
Q 037755 73 EVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 152 (238)
Q Consensus 73 ~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 152 (238)
.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...............||+.|+|||.+.+. .
T Consensus 138 ~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~ 212 (299)
T d1ywna1 138 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--V 212 (299)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--C
T ss_pred HHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--C
Confidence 9999999999999999 9999999999999999999999999999765444433333445699999999999876 7
Q ss_pred ccccCceehHHHHHHHHhcCC-CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 153 VSCKSDVYGFGMVLLEMTGGR-RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 153 ~~~~~Di~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
++.++|||||||++|||++|. .||....... .+...+..+.... .+..+++++.+++.+||+.||+
T Consensus 213 ~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1ywna1 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMR------APDYTTPEMYQTMLDCWHGEPS 279 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-------HHHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCcccceeehHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcCCCCC------CCccCCHHHHHHHHHHcCCChh
Confidence 789999999999999999875 5664332211 1122222222111 1123567899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 280 ~Rpt~~e 286 (299)
T d1ywna1 280 QRPTFSE 286 (299)
T ss_dssp GSCCHHH
T ss_pred HCcCHHH
Confidence 9999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=284.85 Aligned_cols=221 Identities=21% Similarity=0.240 Sum_probs=158.9
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...|+..+++++||||+++++++.+.+ ..++||||+.+|+|.+++. ...+++..+..++.+++.|++|||+
T Consensus 44 ~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~ 118 (303)
T d1vjya_ 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 118 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 334555556789999999999986543 5899999999999999993 2468999999999999999999996
Q ss_pred CC-----CCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCCC----ccccc
Q 037755 88 GC-----DVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFG----TVSCK 156 (238)
Q Consensus 88 ~~-----~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~----~~~~~ 156 (238)
.+ ..+|+||||||+|||++.++.+||+|||++.......... ......||+.|+|||.+.+... .++.+
T Consensus 119 ~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k 198 (303)
T d1vjya_ 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp CBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred hhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcc
Confidence 20 1389999999999999999999999999987665443322 1233459999999999875311 25778
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcc-------hhhhhhhhcc-CCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYF-------PSWVSDQLNK-GGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
+|||||||++|||+||..||............ .......... ...+... ...........+.+++.+||+.
T Consensus 199 ~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T d1vjya_ 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-GGGGGCHHHHHHHHHHHTTCCS
T ss_pred hhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCC-cccCChHHHHHHHHHHHHHccc
Confidence 99999999999999999887544333221110 0111111111 1111111 1112234567799999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||+.|
T Consensus 278 dp~~Rps~~e 287 (303)
T d1vjya_ 278 NGAARLTALR 287 (303)
T ss_dssp SGGGSCCHHH
T ss_pred CHhHCcCHHH
Confidence 9999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-44 Score=284.22 Aligned_cols=223 Identities=18% Similarity=0.215 Sum_probs=166.8
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
+...+++.+|+.+|++++||||+++++++..++..+++++++.++.+.... ...+.+++..+..++.||+.||+||
T Consensus 41 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~L 116 (286)
T d1ob3a_ 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYC 116 (286)
T ss_dssp GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHh
Confidence 445688999999999999999999999999999999999999876666655 3457899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|+. +|+||||||+|||++.++.+|++|||.+........ ......+++.|.|||.+.+. ..++.++||||||++
T Consensus 117 H~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~ 190 (286)
T d1ob3a_ 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCI 190 (286)
T ss_dssp HHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHH
T ss_pred ccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCC-CCCCcceeehhcCcH
Confidence 999 999999999999999999999999999876543321 12233488999999998764 356889999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcc---------hhh--hhhh---hccCCCccccchhHHHHHHHHHHHHHHhhhccCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYF---------PSW--VSDQ---LNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPA 231 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~---------~~~--~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 231 (238)
+|+|++|+.||...........+ ..+ .... ..................+++++.+|+.+||+.||+
T Consensus 191 l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~ 270 (286)
T d1ob3a_ 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN 270 (286)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChh
Confidence 99999999999654322110000 000 0000 000000111111222334567899999999999999
Q ss_pred CCCCCCC
Q 037755 232 DRPSMTK 238 (238)
Q Consensus 232 ~Rps~~e 238 (238)
+|||++|
T Consensus 271 ~R~s~~e 277 (286)
T d1ob3a_ 271 QRITAKQ 277 (286)
T ss_dssp TSCCHHH
T ss_pred HCcCHHH
Confidence 9999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=285.29 Aligned_cols=216 Identities=23% Similarity=0.377 Sum_probs=170.5
Q ss_pred ccccHHHHHHHHHHHhhc-CCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC--------------CCCCCCCHH
Q 037755 5 SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE--------------SRGQSCSWE 69 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~--------------~~~~~~~~~ 69 (238)
......++.+|+.+++.+ +||||+++++++.++...+++|||+.+|+|.+++.... .....+++.
T Consensus 66 ~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~ 145 (311)
T d1t46a_ 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHH
Confidence 345667899999999999 69999999999999999999999999999999884332 123468899
Q ss_pred HHHHHHHHHHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecC
Q 037755 70 KLHEVASGTAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 149 (238)
Q Consensus 70 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 149 (238)
.+..++.||+.|++|||++ +++||||||+||+++.++.++++|||.++...............||+.|+|||.+...
T Consensus 146 ~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 222 (311)
T d1t46a_ 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC
Confidence 9999999999999999999 9999999999999999999999999999876655444444455689999999999875
Q ss_pred CCcccccCceehHHHHHHHHhcCCCC-CCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 150 FGTVSCKSDVYGFGMVLLEMTGGRRN-SNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 150 ~~~~~~~~Di~slG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
.++.++||||||+++|+|+|++.| |....... .+...+........ +...++++.+||.+||+.
T Consensus 223 --~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-------~~~~~i~~~~~~~~------~~~~~~~l~~Li~~cl~~ 287 (311)
T d1t46a_ 223 --VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-------KFYKMIKEGFRMLS------PEHAPAEMYDIMKTCWDA 287 (311)
T ss_dssp --CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-------HHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCS
T ss_pred --CCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcCCCCCC------cccccHHHHHHHHHHcCC
Confidence 778899999999999999995544 43322211 11112222211111 123567899999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||++|
T Consensus 288 dP~~RPs~~~ 297 (311)
T d1t46a_ 288 DPLKRPTFKQ 297 (311)
T ss_dssp SGGGSCCHHH
T ss_pred ChhHCcCHHH
Confidence 9999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=285.74 Aligned_cols=196 Identities=21% Similarity=0.281 Sum_probs=159.0
Q ss_pred HHHHHHHHHHhhcC--CCcceeeeeEEEeCCeeeEEEEeCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 10 EEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEFMPN-GSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 10 ~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
.++.+|+.++++++ ||||+++++++.+.+..++||||+.+ +++.+++ .....+++..++.++.||+.||+|||
T Consensus 52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~----~~~~~l~e~~~~~~~~qi~~al~~lH 127 (273)
T d1xwsa_ 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCH 127 (273)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44678999999996 89999999999999999999999975 5677776 23467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEcc-CCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 87 NGCDVCILHLDIKPHNILLDH-NFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
++ +|+||||||+|||++. ++.++|+|||++........ ....||+.|+|||++.+. ..++.++|||||||+
T Consensus 128 ~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvi 199 (273)
T d1xwsa_ 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGIL 199 (273)
T ss_dssp HT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHH
T ss_pred HC---CCccccCcccceEEecCCCeEEECccccceecccccc----cccccCCCcCCHHHHcCC-CCCCcccccccceee
Confidence 99 9999999999999985 57899999999976544322 234599999999998765 244677999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
+|+|++|+.||....... .. ... .+..+++++.+|+.+||+.||++|||++|
T Consensus 200 lyell~g~~Pf~~~~~i~-------------~~-~~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 200 LYDMVCGDIPFEHDEEII-------------RG-QVF-------FRQRVSSECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp HHHHHHSSCSCCSHHHHH-------------HC-CCC-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ehhHhhCCCCCCCchHHh-------------hc-ccC-------CCCCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999999996532110 00 000 01124678899999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=286.28 Aligned_cols=219 Identities=21% Similarity=0.281 Sum_probs=161.5
Q ss_pred HHHHHHHHHHHhhc---CCCcceeeeeEEEe-----CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 9 AEEFINEVSTIGRI---HHVNVVQLLGFCSE-----GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 9 ~~~~~~e~~~l~~l---~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
...+.+|+.+++.+ +||||+++++++.. ....++++||+.++++.... ......+++..++.++.|++.
T Consensus 51 ~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~ 127 (305)
T d1blxa_ 51 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLR 127 (305)
T ss_dssp BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHH---HSCTTCSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhh---hccCCCCCHHHHHHHHHHHHH
Confidence 34567888888776 79999999998843 34689999999887664433 234567899999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||++ +|+||||||+|||++.++.++|+|||.+....... ......||+.|+|||++.+. .++.++|||
T Consensus 128 aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~--~y~~~~Diw 199 (305)
T d1blxa_ 128 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLW 199 (305)
T ss_dssp HHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHH
T ss_pred HHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCC--CCChhehhh
Confidence 99999999 99999999999999999999999999987443322 22345699999999999876 778999999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchh------------hhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccC
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPS------------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQV 228 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 228 (238)
|+||++|+|++|..||...........+.. .......................+++.+.+|+.+||+.
T Consensus 200 SlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 279 (305)
T d1blxa_ 200 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 279 (305)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS
T ss_pred chHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcC
Confidence 999999999999999975543221100000 00000000000111112223344567889999999999
Q ss_pred CCCCCCCCCC
Q 037755 229 KPADRPSMTK 238 (238)
Q Consensus 229 dp~~Rps~~e 238 (238)
||++|||++|
T Consensus 280 dP~~R~sa~e 289 (305)
T d1blxa_ 280 NPAKRISAYS 289 (305)
T ss_dssp STTTSCCHHH
T ss_pred ChhHCcCHHH
Confidence 9999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=278.47 Aligned_cols=214 Identities=23% Similarity=0.352 Sum_probs=168.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCC------CCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKE------SRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~~i~ 79 (238)
..+...|.+|++++++++||||+++++++..+...++||||+.+|+|.+++.... .....++...+..++.+++
T Consensus 64 ~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia 143 (308)
T d1p4oa_ 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143 (308)
T ss_dssp HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHH
Confidence 3445678999999999999999999999999999999999999999998873211 1224578899999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.||.|||++ +|+||||||+|||+++++.+||+|||+++...............+++.|+|||.+.+. .++.++||
T Consensus 144 ~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv 218 (308)
T d1p4oa_ 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDV 218 (308)
T ss_dssp HHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHH
T ss_pred HHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC--CCCccccc
Confidence 999999999 9999999999999999999999999998755444333333444589999999999876 67889999
Q ss_pred ehHHHHHHHHhcCC-CCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 160 YGFGMVLLEMTGGR-RNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 160 ~slG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
||||+++|||+||. .||....... .. ..+.+..... .+..+++.+.+++.+||+.||++|||++|
T Consensus 219 ~S~G~il~El~t~~~~p~~~~~~~~-------~~-~~i~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~~ 284 (308)
T d1p4oa_ 219 WSFGVVLWEIATLAEQPYQGLSNEQ-------VL-RFVMEGGLLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLE 284 (308)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSCHHH-------HH-HHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ccHHHHHHHHHhCCCCCCCCCCHHH-------HH-HHHHhCCCCC------CcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999999985 6664432221 11 1122221111 11235678999999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=282.80 Aligned_cols=219 Identities=20% Similarity=0.255 Sum_probs=165.2
Q ss_pred ccccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC------eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGT 78 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i 78 (238)
+....+++.+|+++|++++||||+++++++...+ .+|+||||+ +.+|.... +...+++..++.++.||
T Consensus 57 ~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi 130 (346)
T d1cm8a_ 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQM 130 (346)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHH
Confidence 3345678899999999999999999999997654 579999999 56777766 24579999999999999
Q ss_pred HHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCc
Q 037755 79 AHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 79 ~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
+.||.|||++ ||+||||||+|||++.++.++++|||.+....... ....||+.|+|||.+.+. ..++.++|
T Consensus 131 ~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~D 201 (346)
T d1cm8a_ 131 LKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVD 201 (346)
T ss_dssp HHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHH
T ss_pred HHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCcc-----ccccccccccCHHHHcCC-CCCCccch
Confidence 9999999999 99999999999999999999999999997654432 234599999999998764 35688999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcch-------hh---------hhhhhccCCCccccchhHHHHHHHHHHHHHH
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFP-------SW---------VSDQLNKGGNLELRNVTEIESMIARKLCVIG 222 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 222 (238)
|||+||++|+|++|+.||............. .. ......................+++.+.+|+
T Consensus 202 iwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 281 (346)
T d1cm8a_ 202 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281 (346)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred hhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHH
Confidence 9999999999999999996543221100000 00 0000000001111111222234567889999
Q ss_pred hhhccCCCCCCCCCCC
Q 037755 223 LWCIQVKPADRPSMTK 238 (238)
Q Consensus 223 ~~cl~~dp~~Rps~~e 238 (238)
.+||+.||++|||++|
T Consensus 282 ~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 282 EKMLVLDAEQRVTAGE 297 (346)
T ss_dssp HHHSCSSTTTSCCHHH
T ss_pred HHHCcCChhHCcCHHH
Confidence 9999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=280.89 Aligned_cols=224 Identities=18% Similarity=0.218 Sum_probs=163.7
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCC----eeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHG 81 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 81 (238)
....+++.+|+.+|++++||||+++++++.... ..+++++++.+|+|.+++. ...+++..++.++.|++.|
T Consensus 47 ~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~a 121 (345)
T d1pmea_ 47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRG 121 (345)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHH
Confidence 345678899999999999999999999986543 2345556677899999983 3479999999999999999
Q ss_pred HHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc-cccccCCccccCCcceeecCCCcccccCcee
Q 037755 82 IEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 82 l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
|+|||++ +|+||||||+|||++.++.+||+|||++.......... ......|++.|+|||++... ..++.++|||
T Consensus 122 l~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~Diw 197 (345)
T d1pmea_ 122 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIW 197 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHH
T ss_pred HHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcC-CCCCchhhhh
Confidence 9999999 99999999999999999999999999987554432221 12334589999999998553 3567889999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchh----------------hhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPS----------------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
|+||++|+|++|..||.............. .......................+++++.+|+.+
T Consensus 198 SlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 277 (345)
T d1pmea_ 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277 (345)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred ccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHH
Confidence 999999999999999965443211100000 0000000000001111112223456789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 278 ~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 278 MLTFNPHKRIEVEQ 291 (345)
T ss_dssp HSCSSTTTSCCHHH
T ss_pred HccCChhHCcCHHH
Confidence 99999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-44 Score=283.64 Aligned_cols=211 Identities=21% Similarity=0.237 Sum_probs=167.3
Q ss_pred ccHHHHHHHHHHHhhcCC-CcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 7 FSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
...+++.+|++++++++| |||+++++++.+....++++||+.+|+|.+++ ...+.+++..+..++.||+.|+.||
T Consensus 70 ~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i----~~~~~~~e~~~~~~~~Qi~~al~~l 145 (322)
T d1vzoa_ 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHL 145 (322)
T ss_dssp SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHH----HhcccccHHHHHHHHHHHHHHHHHh
Confidence 345678899999999965 89999999999999999999999999999988 3445778899999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+||+++.++.++|+|||++......... ......|++.|+|||.+.+....++.++|||||||+
T Consensus 146 H~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~i 221 (322)
T d1vzoa_ 146 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221 (322)
T ss_dssp HHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHH
T ss_pred hcC---CEEeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHH
Confidence 999 9999999999999999999999999998765443322 223345899999999997654467888999999999
Q ss_pred HHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+|+|++|..||...........+ ....... . ...+..+++++.+|+.+||+.||++|||+
T Consensus 222 LyelltG~~PF~~~~~~~~~~~i---~~~~~~~-~-------~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 222 MYELLTGASPFTVDGEKNSQAEI---SRRILKS-E-------PPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp HHHHHHSSCTTSCTTSCCCHHHH---HHHHHHC-C-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred HHHHHhCCCCCCCCCHHHHHHHH---HHhcccC-C-------CCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 99999999999765443321111 1111111 0 01123467889999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=272.94 Aligned_cols=225 Identities=19% Similarity=0.216 Sum_probs=162.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEe--------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASG 77 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (238)
+...+++.+|+++|++++||||+++++++.. +...+++|||+.++.+.... .....+++..++.++.|
T Consensus 50 ~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~q 125 (318)
T d3blha1 50 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125 (318)
T ss_dssp TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHH
Confidence 4456788999999999999999999998844 34689999999876665544 34568899999999999
Q ss_pred HHHHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccc--cccccCCccccCCcceeecCCCcccc
Q 037755 78 TAHGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSC 155 (238)
Q Consensus 78 i~~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~ 155 (238)
|+.||.|||++ +|+||||||+|||++.++.++++|||++.......... ......||+.|+|||.+.+. ..++.
T Consensus 126 il~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~ 201 (318)
T d3blha1 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGP 201 (318)
T ss_dssp HHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCT
T ss_pred HHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCC-CCCCc
Confidence 99999999999 99999999999999999999999999997554432211 11223589999999998764 35788
Q ss_pred cCceehHHHHHHHHhcCCCCCCcccccccCCcchhhhh----------------hhhccCCCccccchhH-HHHHHHHHH
Q 037755 156 KSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVS----------------DQLNKGGNLELRNVTE-IESMIARKL 218 (238)
Q Consensus 156 ~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~-~~~~~~~~l 218 (238)
++||||+||++|+|++|+.||...........+..... ................ .....++.+
T Consensus 202 k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (318)
T d3blha1 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281 (318)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHH
T ss_pred HHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHH
Confidence 99999999999999999999965432221111000000 0000000000001111 112335678
Q ss_pred HHHHhhhccCCCCCCCCCCC
Q 037755 219 CVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 219 ~~li~~cl~~dp~~Rps~~e 238 (238)
.+|+.+||+.||++|||++|
T Consensus 282 ~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 282 LDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp HHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHCcCChhHCcCHHH
Confidence 89999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-42 Score=274.67 Aligned_cols=218 Identities=17% Similarity=0.247 Sum_probs=163.4
Q ss_pred ccHHHHHHHHHHHhhcC-CCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 037755 7 FSAEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIE 83 (238)
Q Consensus 7 ~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 83 (238)
...+++.+|+++|++++ ||||+++++++.. ....++||||+.+++|.... +.+++..++.++.||+.||.
T Consensus 71 ~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~ 143 (328)
T d3bqca1 71 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALD 143 (328)
T ss_dssp SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHH
Confidence 45678999999999995 9999999999974 45689999999999997754 57999999999999999999
Q ss_pred HhHcCCCCceeeeccCCCcEEEccCC-ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehH
Q 037755 84 YLHNGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 162 (238)
Q Consensus 84 ~Lh~~~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~sl 162 (238)
|||++ ||+||||||+|||++.++ .++|+|||++........ .....+|+.|+|||.+.+. ..++.++||||+
T Consensus 144 ~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~Diwsl 216 (328)
T d3bqca1 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSL 216 (328)
T ss_dssp HHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHH
T ss_pred HHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCC-CCCCcccchhhh
Confidence 99999 999999999999998655 689999999976544332 2334589999999998764 356889999999
Q ss_pred HHHHHHHhcCCCCCCcccccccCCc-ch--------------------hhhhhhhccCCC--ccccchhHHHHHHHHHHH
Q 037755 163 GMVLLEMTGGRRNSNLKATRSSKAY-FP--------------------SWVSDQLNKGGN--LELRNVTEIESMIARKLC 219 (238)
Q Consensus 163 G~~l~~ll~g~~p~~~~~~~~~~~~-~~--------------------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~ 219 (238)
||++|+|++|..||........... +. ............ ............+++++.
T Consensus 217 G~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 296 (328)
T d3bqca1 217 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296 (328)
T ss_dssp HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHH
T ss_pred hhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHH
Confidence 9999999999999965433211000 00 000000000000 000011112234577899
Q ss_pred HHHhhhccCCCCCCCCCCC
Q 037755 220 VIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 220 ~li~~cl~~dp~~Rps~~e 238 (238)
+||.+||+.||++|||++|
T Consensus 297 dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 297 DFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHccCChhHCcCHHH
Confidence 9999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=268.93 Aligned_cols=223 Identities=18% Similarity=0.203 Sum_probs=168.2
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
....+++.+|+.+|+.++||||+++++++.+....+++++++.++++..++ ...+.+++..+..++.|++.||+||
T Consensus 42 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~l 117 (292)
T d1unla_ 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFC 117 (292)
T ss_dssp TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccc----ccccccchhHHHHHHHHHHHHHHHh
Confidence 345688999999999999999999999999999999999999998887776 3457889999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 165 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~~ 165 (238)
|++ +|+||||||+|||++.++.++++|||.+......... .....++..|.|||.+.+. ..++.++||||+||+
T Consensus 118 H~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~i 191 (292)
T d1unla_ 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCI 191 (292)
T ss_dssp HHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHH
T ss_pred hcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccC-CCCCchhhccccchH
Confidence 999 9999999999999999999999999999766443322 1223477889999988764 346889999999999
Q ss_pred HHHHhcCCCCCCcccccccC-Ccchhhhh----------hhhccC----CCccccchhHHHHHHHHHHHHHHhhhccCCC
Q 037755 166 LLEMTGGRRNSNLKATRSSK-AYFPSWVS----------DQLNKG----GNLELRNVTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 166 l~~ll~g~~p~~~~~~~~~~-~~~~~~~~----------~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
+|+|++|+.||......... ..+..... ...... ..............+++.+.+|+.+||+.||
T Consensus 192 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 271 (292)
T d1unla_ 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271 (292)
T ss_dssp HHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCCh
Confidence 99999999987432221110 00000000 000000 0000111122233456788999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
.+||||+|
T Consensus 272 ~~R~sa~e 279 (292)
T d1unla_ 272 VQRISAEE 279 (292)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=279.37 Aligned_cols=219 Identities=20% Similarity=0.184 Sum_probs=157.0
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEEe------CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 037755 12 FINEVSTIGRIHHVNVVQLLGFCSE------GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYL 85 (238)
Q Consensus 12 ~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 85 (238)
+.+|+++|++++||||+++++++.. ..++++||||+.++. .+.+.........+++..++.++.||+.||+||
T Consensus 60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL 138 (350)
T d1q5ka_ 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138 (350)
T ss_dssp CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3579999999999999999999843 335789999997653 333322123456899999999999999999999
Q ss_pred HcCCCCceeeeccCCCcEEEccCC-ccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCceehHHH
Q 037755 86 HNGCDVCILHLDIKPHNILLDHNF-VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 164 (238)
Q Consensus 86 h~~~~~~i~H~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~slG~ 164 (238)
|++ ||+||||||+|||++.++ .+||+|||++......... ....|+..|+|||.+.+. ..++.++||||+||
T Consensus 139 H~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~ 211 (350)
T d1q5ka_ 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGC 211 (350)
T ss_dssp HTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHH
T ss_pred Hhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCccc---ccccccccccChHHhhcc-cCCCcceeecccce
Confidence 999 999999999999999765 8899999998755443221 234589999999988764 36788999999999
Q ss_pred HHHHHhcCCCCCCcccccccCCcc--------hhhhhhhh---ccCCCcccc---chhHHHHHHHHHHHHHHhhhccCCC
Q 037755 165 VLLEMTGGRRNSNLKATRSSKAYF--------PSWVSDQL---NKGGNLELR---NVTEIESMIARKLCVIGLWCIQVKP 230 (238)
Q Consensus 165 ~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp 230 (238)
++|+|++|..||...........+ ........ ......... .........++++.+|+.+||+.||
T Consensus 212 il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 291 (350)
T d1q5ka_ 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291 (350)
T ss_dssp HHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSG
T ss_pred EEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCCh
Confidence 999999999999654432211000 00000000 000000000 0011122356789999999999999
Q ss_pred CCCCCCCC
Q 037755 231 ADRPSMTK 238 (238)
Q Consensus 231 ~~Rps~~e 238 (238)
++|||+.|
T Consensus 292 ~~R~ta~e 299 (350)
T d1q5ka_ 292 TARLTPLE 299 (350)
T ss_dssp GGSCCHHH
T ss_pred hHCcCHHH
Confidence 99999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=273.51 Aligned_cols=218 Identities=22% Similarity=0.231 Sum_probs=158.3
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEE------eCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCS------EGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTA 79 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~ 79 (238)
....+++.+|+.++++++||||+++++++. +...+|+||||+.++ +.+.+ ...+++..++.++.||+
T Consensus 57 ~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~------~~~~~~~~i~~~~~qil 129 (355)
T d2b1pa1 57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQML 129 (355)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHH------TSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhh------hcCCCHHHHHHHHHHHH
Confidence 445678899999999999999999999985 346889999999765 44444 25689999999999999
Q ss_pred HHHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCce
Q 037755 80 HGIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDV 159 (238)
Q Consensus 80 ~~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di 159 (238)
.||.|||++ ||+||||||+|||++.++.++++|||.+........ .....+|+.|+|||.+.+. .+++++||
T Consensus 130 ~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~Di 201 (355)
T d2b1pa1 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDI 201 (355)
T ss_dssp HHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTC--CCCTTHHH
T ss_pred HHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccccc---cccccccccccChhhhcCC--CCCCCccc
Confidence 999999999 999999999999999999999999998775544322 2333589999999999876 77889999
Q ss_pred ehHHHHHHHHhcCCCCCCcccccccCCc---------------chhhhhhhhccCC------------CccccchhHHHH
Q 037755 160 YGFGMVLLEMTGGRRNSNLKATRSSKAY---------------FPSWVSDQLNKGG------------NLELRNVTEIES 212 (238)
Q Consensus 160 ~slG~~l~~ll~g~~p~~~~~~~~~~~~---------------~~~~~~~~~~~~~------------~~~~~~~~~~~~ 212 (238)
||+||++|+|++|+.||........... ............. ............
T Consensus 202 wSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (355)
T d2b1pa1 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281 (355)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred ccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccc
Confidence 9999999999999999965432211000 0000000000000 000111223445
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 213 MIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 213 ~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
..++++.+|+.+||+.||++||||+|
T Consensus 282 ~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 282 LKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 67889999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=273.32 Aligned_cols=219 Identities=16% Similarity=0.223 Sum_probs=160.1
Q ss_pred cccHHHHHHHHHHHhhcCCCcceeeeeEEEeC-----CeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 037755 6 KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAH 80 (238)
Q Consensus 6 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 80 (238)
....+++.+|+++|++++||||+++++++... ...+++++++.+|+|.+++ ..+.+++..++.++.||+.
T Consensus 58 ~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~-----~~~~l~e~~~~~i~~qil~ 132 (348)
T d2gfsa1 58 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILR 132 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHH-----TTCCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhc-----ccccccHHHHHHHHHHHHH
Confidence 34557889999999999999999999998532 3446677788899999988 2357999999999999999
Q ss_pred HHHHhHcCCCCceeeeccCCCcEEEccCCccccccccccccCCCCCccccccccCCccccCCcceeecCCCcccccCcee
Q 037755 81 GIEYLHNGCDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 160 (238)
Q Consensus 81 ~l~~Lh~~~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Di~ 160 (238)
||+|||++ ||+||||||+|||++.++.++++|||.+...... .....|++.|+|||...+. ..++.++|||
T Consensus 133 aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~Diw 203 (348)
T d2gfsa1 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIW 203 (348)
T ss_dssp HHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHH
T ss_pred HHHHHHhC---CCcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCC-ccCCcccchh
Confidence 99999999 9999999999999999999999999998644322 2334589999999987764 3567899999
Q ss_pred hHHHHHHHHhcCCCCCCcccccccCCcchh----------------hhhhhhccCCCccccchhHHHHHHHHHHHHHHhh
Q 037755 161 GFGMVLLEMTGGRRNSNLKATRSSKAYFPS----------------WVSDQLNKGGNLELRNVTEIESMIARKLCVIGLW 224 (238)
Q Consensus 161 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 224 (238)
||||++|+|++|..||...........+.. .......................+++++.+||.+
T Consensus 204 SlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 283 (348)
T d2gfsa1 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283 (348)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred hhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHH
Confidence 999999999999999965432211100000 0000000000111111112223457789999999
Q ss_pred hccCCCCCCCCCCC
Q 037755 225 CIQVKPADRPSMTK 238 (238)
Q Consensus 225 cl~~dp~~Rps~~e 238 (238)
||+.||++|||++|
T Consensus 284 mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 284 MLVLDSDKRITAAQ 297 (348)
T ss_dssp HSCSSGGGSCCHHH
T ss_pred HCcCChhhCcCHHH
Confidence 99999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-40 Score=261.63 Aligned_cols=214 Identities=17% Similarity=0.203 Sum_probs=159.5
Q ss_pred cHHHHHHHHHHHhhcCCCcc-eeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+++.+|++++++++|+|+ +.+.++..++...++||||+ ++++.+.+. .....+++..+..++.|++.||+|||
T Consensus 45 ~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH 120 (299)
T d1ckia_ 45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 120 (299)
T ss_dssp TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHH
Confidence 33568899999999986665 55566678888999999999 457766552 23467999999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEc---cCCccccccccccccCCCCCcc-----ccccccCCccccCCcceeecCCCcccccCc
Q 037755 87 NGCDVCILHLDIKPHNILLD---HNFVPNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSD 158 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 158 (238)
++ +|+||||||+||+++ .+..++++|||+++........ .......||+.|+|||.+.+. .++.++|
T Consensus 121 ~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~D 195 (299)
T d1ckia_ 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDD 195 (299)
T ss_dssp HT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHH
T ss_pred HC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC--CCCChhh
Confidence 99 999999999999986 3457999999999865443321 112334599999999999876 6789999
Q ss_pred eehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCCC
Q 037755 159 VYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSMT 237 (238)
Q Consensus 159 i~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 237 (238)
|||||+++|+|++|+.||...........+......... .........+++++.+++.+||+.||++||+++
T Consensus 196 iwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~ 267 (299)
T d1ckia_ 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267 (299)
T ss_dssp HHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred EEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-------CChhHhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999999999999999765444332222221111110 112223345678899999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-40 Score=258.02 Aligned_cols=213 Identities=17% Similarity=0.207 Sum_probs=164.9
Q ss_pred cHHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 037755 8 SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLH 86 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 86 (238)
..+.+.+|+++++.+. |+|++.+++++.++...++||||+ +++|.+.+.. .+..++...+..++.|++.||+|||
T Consensus 43 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH 118 (293)
T d1csna_ 43 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH 118 (293)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHH
Confidence 3456788999999996 489999999999999999999999 6799888732 3457899999999999999999999
Q ss_pred cCCCCceeeeccCCCcEEEcc-----CCccccccccccccCCCCCcc-----ccccccCCccccCCcceeecCCCccccc
Q 037755 87 NGCDVCILHLDIKPHNILLDH-----NFVPNVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCK 156 (238)
Q Consensus 87 ~~~~~~i~H~dl~p~nil~~~-----~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 156 (238)
+. ||+||||||+||+++. ++.++|+|||+++........ .......||+.|+|||.+.+. .++.+
T Consensus 119 ~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~ 193 (293)
T d1csna_ 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRR 193 (293)
T ss_dssp TT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHH
T ss_pred HC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC--CCChH
Confidence 99 9999999999999974 578999999999765433211 112234599999999999876 68899
Q ss_pred CceehHHHHHHHHhcCCCCCCcccccccCCcchhhhhhhhccCCCccccchhHHHHHHHHHHHHHHhhhccCCCCCCCCC
Q 037755 157 SDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSWVSDQLNKGGNLELRNVTEIESMIARKLCVIGLWCIQVKPADRPSM 236 (238)
Q Consensus 157 ~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 236 (238)
+||||||+++|+|++|..||...........+....... ......+....+++++.+++..|++.+|++||+.
T Consensus 194 ~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 194 DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence 999999999999999999997544332211111110000 0111223334467889999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-35 Score=235.33 Aligned_cols=223 Identities=17% Similarity=0.229 Sum_probs=152.5
Q ss_pred ccccHHHHHHHHHHHhhcC-----------CCcceeeeeEEEe--CCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHH
Q 037755 5 SKFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCSE--GSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKL 71 (238)
Q Consensus 5 ~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~ 71 (238)
.....+.+.+|+++++.+. |+||+++++++.. ....++++.++..+...... ........+++..+
T Consensus 49 ~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i 127 (362)
T d1q8ya_ 49 DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL-IKKYEHRGIPLIYV 127 (362)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHH-HHHTTTSCCCHHHH
T ss_pred cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccc-cccccccCCcHHHH
Confidence 3445678889999999885 4789999998754 35566677766444322221 12234578899999
Q ss_pred HHHHHHHHHHHHHhHc-CCCCceeeeccCCCcEEEccCC------ccccccccccccCCCCCccccccccCCccccCCcc
Q 037755 72 HEVASGTAHGIEYLHN-GCDVCILHLDIKPHNILLDHNF------VPNVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 144 (238)
Q Consensus 72 ~~~~~~i~~~l~~Lh~-~~~~~i~H~dl~p~nil~~~~~------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 144 (238)
+.++.||+.|++|||+ . ||+||||||+|||++.++ .++++|||.+....... ....||+.|+|||
T Consensus 128 ~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE 199 (362)
T d1q8ya_ 128 KQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPE 199 (362)
T ss_dssp HHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChh
Confidence 9999999999999997 6 999999999999998654 38999999987543322 2345999999999
Q ss_pred eeecCCCcccccCceehHHHHHHHHhcCCCCCCcccccccCCcchhh-------------hhh-------------hhcc
Q 037755 145 LISRNFGTVSCKSDVYGFGMVLLEMTGGRRNSNLKATRSSKAYFPSW-------------VSD-------------QLNK 198 (238)
Q Consensus 145 ~~~~~~~~~~~~~Di~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------------~~~-------------~~~~ 198 (238)
.+... .++.++|+||+|+++++|++|+.||............... ... ....
T Consensus 200 ~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (362)
T d1q8ya_ 200 VLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 277 (362)
T ss_dssp HHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSS
T ss_pred hcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhc
Confidence 98875 6788999999999999999999999654332211110000 000 0000
Q ss_pred CCCccccch-------hHHHHHHHHHHHHHHhhhccCCCCCCCCCCC
Q 037755 199 GGNLELRNV-------TEIESMIARKLCVIGLWCIQVKPADRPSMTK 238 (238)
Q Consensus 199 ~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 238 (238)
......... .......++++.+|+.+||+.||.+|||++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 278 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp CCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred cccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000000011 1112457789999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.70 E-value=2.7e-18 Score=125.46 Aligned_cols=96 Identities=18% Similarity=0.179 Sum_probs=76.8
Q ss_pred HHHHHHHHHHHhhcCCCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 037755 9 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHNG 88 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 88 (238)
...+.+|...+.++.|++++..+++.. .+++||++.+..+.+. +...+..++.|++.+++|||++
T Consensus 58 ~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~ 122 (191)
T d1zara2 58 IRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR 122 (191)
T ss_dssp HHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC
Confidence 345567899999999999998876532 3799999987655332 2333467899999999999999
Q ss_pred CCCceeeeccCCCcEEEccCCccccccccccccCC
Q 037755 89 CDVCILHLDIKPHNILLDHNFVPNVSDFGLAKFHP 123 (238)
Q Consensus 89 ~~~~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~ 123 (238)
||+||||||+|||+++++ ++|+|||.+....
T Consensus 123 ---giiHrDiKP~NILv~~~~-~~liDFG~a~~~~ 153 (191)
T d1zara2 123 ---GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153 (191)
T ss_dssp ---TEECSCCSTTSEEEETTE-EEECCCTTCEETT
T ss_pred ---CEEEccCChhheeeeCCC-EEEEECCCcccCC
Confidence 999999999999999654 7899999886543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.08 E-value=5.7e-06 Score=61.64 Aligned_cols=103 Identities=16% Similarity=0.100 Sum_probs=70.4
Q ss_pred HHHHHHHHHHHhhcC-CCcceeeeeEEEeCCeeeEEEEeCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 037755 9 AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEFMPNGSLDRHIFPKESRGQSCSWEKLHEVASGTAHGIEYLHN 87 (238)
Q Consensus 9 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~ 87 (238)
...+.+|...++.++ +--+.+++.+..+++..++||++++|.++.+... .... ...++.++...++.||+
T Consensus 53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~------~~~~---~~~~~~~l~~~l~~lH~ 123 (263)
T d1j7la_ 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQS---PEKIIELYAECIRLFHS 123 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT------TCSC---HHHHHHHHHHHHHHHHT
T ss_pred hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc------cccc---HHHHHHHHHHHHHHHhc
Confidence 445778999988885 4346678888888899999999999877755441 0111 12233444444445553
Q ss_pred CCC--------------------------------------------------------CceeeeccCCCcEEEccCCcc
Q 037755 88 GCD--------------------------------------------------------VCILHLDIKPHNILLDHNFVP 111 (238)
Q Consensus 88 ~~~--------------------------------------------------------~~i~H~dl~p~nil~~~~~~~ 111 (238)
... ..++|+|+.|.||++++++.+
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~ 203 (263)
T d1j7la_ 124 IDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVS 203 (263)
T ss_dssp SCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEE
T ss_pred cCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceE
Confidence 210 238999999999999987766
Q ss_pred ccccccccc
Q 037755 112 NVSDFGLAK 120 (238)
Q Consensus 112 ~l~d~~~~~ 120 (238)
.|+||+.+.
T Consensus 204 ~lIDwe~a~ 212 (263)
T d1j7la_ 204 GFIDLGRSG 212 (263)
T ss_dssp EECCCTTCE
T ss_pred EEeechhcc
Confidence 799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=2.1e-05 Score=58.12 Aligned_cols=45 Identities=18% Similarity=0.282 Sum_probs=34.3
Q ss_pred HHHHHHHHHHhhcCC--CcceeeeeEEEeCCeeeEEEEeCCCCChhh
Q 037755 10 EEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEFMPNGSLDR 54 (238)
Q Consensus 10 ~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~sL~~ 54 (238)
..+..|+..++.+.. -.+.+++.+..+++..++||++++|.++.+
T Consensus 49 ~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 49 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 457889999988843 235677888888888999999998866533
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.90 E-value=0.00061 Score=53.59 Aligned_cols=32 Identities=22% Similarity=0.317 Sum_probs=26.3
Q ss_pred ceeeeccCCCcEEEccCCccccccccccccCCC
Q 037755 92 CILHLDIKPHNILLDHNFVPNVSDFGLAKFHPK 124 (238)
Q Consensus 92 ~i~H~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 124 (238)
.++|||+.|.|||+++++ ++|+||..+...+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~~ 255 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYGPI 255 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEECT
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccCCH
Confidence 599999999999998764 79999988764433
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.79 E-value=0.006 Score=47.70 Aligned_cols=41 Identities=17% Similarity=0.343 Sum_probs=28.5
Q ss_pred cHHHHHHHHHHHhhcCCCcc-eeeeeEEEeCCeeeEEEEeCCCCCh
Q 037755 8 SAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEFMPNGSL 52 (238)
Q Consensus 8 ~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~sL 52 (238)
..-...+|..+++.+.-.++ .++++++.+ .+|++|++|.++
T Consensus 87 ~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 87 TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 34456789999999953344 577777754 478999877544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.28 E-value=0.016 Score=43.81 Aligned_cols=28 Identities=36% Similarity=0.385 Sum_probs=23.0
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.+++|+|+.+.|||++++ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 479999999999999743 3478998775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.06 E-value=0.0028 Score=47.89 Aligned_cols=30 Identities=20% Similarity=0.323 Sum_probs=26.6
Q ss_pred CceeeeccCCCcEEEccCCccccccccccc
Q 037755 91 VCILHLDIKPHNILLDHNFVPNVSDFGLAK 120 (238)
Q Consensus 91 ~~i~H~dl~p~nil~~~~~~~~l~d~~~~~ 120 (238)
.|++|+|+.++|++++++...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999764
|